<SEC-DOCUMENT>0000950170-25-068198.txt : 20250509
<SEC-HEADER>0000950170-25-068198.hdr.sgml : 20250509
<ACCEPTANCE-DATETIME>20250509170217
ACCESSION NUMBER:		0000950170-25-068198
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		96
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250509
DATE AS OF CHANGE:		20250509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Astrana Health, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		25931464

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Apollo Medical Holdings, Inc.
		DATE OF NAME CHANGE:	20080715

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>asth-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-09T16:55:38.5250+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:asth="http://www.astranahealth.com/20250331" xmlns:srt="http://fasb.org/srt/2024" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-Q</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_b1fc9651-f5ca-44a4-8059-556f18fc56fe" name="dei:CurrentFiscalYearEndDate" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">--12-31</ix:nonNumeric><ix:nonNumeric id="F_5cecff7a-c2bd-4114-aba6-4e1323305fcd" name="dei:DocumentFiscalPeriodFocus" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">Q1</ix:nonNumeric><ix:nonNumeric id="F_dcdc880e-faf8-4a27-b899-3843ae3b99cd" name="dei:DocumentFiscalYearFocus" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">2025</ix:nonNumeric><ix:nonNumeric id="F_161eb69e-b5ec-47ae-8742-313e4ab92d94" name="dei:AmendmentFlag" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" format="ixt:fixed-false">False</ix:nonNumeric><ix:nonNumeric id="F_e704d9e9-2112-42cb-afad-0db5ccf1a00b" name="dei:EntityCentralIndexKey" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">0001083446</ix:nonNumeric><ix:nonFraction id="F_6c1492df-fbc9-403e-b36b-cbe2a6c35037" name="us-gaap:CommitmentsAndContingencies" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_942d33bd-6fea-48e0-9338-60f3d993553a" name="us-gaap:CommitmentsAndContingencies" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_85a7fb24-2a46-4162-beeb-ab37e6433db9" name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember http://fasb.org/srt/2024#ChiefFinancialOfficerMember</ix:nonNumeric><ix:nonNumeric id="F_a6133d98-7b94-492e-8834-b1b4530ae2ee" name="us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742">http://fasb.org/us-gaap/2024#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#UnrealizedGainLossOnInvestments</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="asth-20250331.xsd"/></ix:references><ix:resources><xbrli:context id="C_80446148-a401-4cce-89ac-14f1418b9966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_80e76537-df9f-428c-93ad-7da9d13bb50d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockOptionAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_820936f1-0951-4659-b917-23fcb1da4cbf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8243a6ab-ccef-4b27-a5e5-fc7c8cc5d6bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8297f21e-2dac-46a3-bf2e-4b0c2ff5c175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_83766bc6-44a6-4789-9671-394dba982518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_84a45b5b-15c0-41fe-adf1-ca456ce3cf0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_84fa31dd-5a86-4282-8662-e45fc242151e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_86a4c592-7bab-4c59-bf8a-cfdcf0ecc6d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88dd1103-5401-475c-b0d3-88c0af26a48e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8ada5766-cd70-45e8-a299-c4904c89c0e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8b0919d3-15a4-433c-a537-c7cf98fef70b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8b9280f1-8e3e-4e01-b2b8-0697e6c860d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8c0c24cf-629d-468f-990d-739224e84719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8d32a733-9808-4cd7-b7c0-f21ceeb7f902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e1fbaba-ca27-4783-9682-64643b46acf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e22a9c3-e9e2-4f67-87cc-739826df0ebc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e631b93-40e7-40d3-8326-b5618bb62eed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8ef40c99-631c-434b-8193-71f59194c695"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f134208-f6d5-4c50-a680-3e055aa91882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f301b9f-cd6b-4eac-bd0f-1c2f7c9543f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f4dfe63-7e3c-4550-a1aa-0d1885663f72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_90d6d0bb-c95e-4885-bab2-bba445ae396a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_91422e50-b35a-4ab8-a125-5f4472712612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_92e5a4d9-669c-445f-ae84-87c0d970533d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_93eb1e59-ba73-4807-8847-1e31de1feffc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_952ec1b4-0412-4990-a574-cf7524a67b4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95410889-f77a-49be-96bd-dcaa6e56cd80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_95571c44-ac25-407c-a11f-70a6547c78ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_973e57e5-b73d-4cc7-94b0-6463141b31dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_98479280-cc4c-40f7-b636-b708537e9e1c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_985081e2-9a89-4282-bea5-465c5a88d3d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_99d1dd55-3e68-4959-ba9e-eff028c809f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_99ea2791-355d-432f-b116-de8fe51581b6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9a8924e1-57f9-410e-b002-cadf956446e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ac0c6d0-4628-4820-9917-37da7e90084b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9adc0920-b8bd-47d0-97bd-354c3679c0f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9af99720-afab-41bf-8f18-b88302257d99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9bb5d082-e558-46fe-93e8-c3308bb50e45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c3af7b7-7fc8-4c10-9520-574b3555c4e0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d156022-37ae-4ca3-ad28-343a96df50ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9d87bcf2-94d1-468d-bf39-ab8853daaa29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9da713da-4bde-499d-850b-07a0b56f32e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e031983-8e48-4e18-a080-9ef7b798c5c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e346eab-38d7-402b-bf8f-0d60cb0107a1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9e7792f7-702f-4f53-bc31-698f8ce0df84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9e921ba2-6ad9-43f7-bb6e-25d335ac8af4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_9f0059b7-fc7c-4e0a-9e5b-a7e9d0745aaa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9fa5f4aa-a01c-4fb8-b531-d0b936d239ba"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9feee836-d0ff-463c-b3e6-a83e692c0715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0af827e-2073-40a4-9366-c1c611fcf2e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0be7500-06cf-4f7d-a434-0f961d061842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0db209d-d0ac-4fda-b0be-cbfb62c51851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a103be58-2da8-49dd-aac7-8114b8e1d475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a1674af8-635b-46ac-b060-061caa2787f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a2bea5f5-db89-471f-9592-a236454f04a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a319aa70-1ce6-4734-8031-6b09d4cddad6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-24</xbrli:startDate><xbrli:endDate>2025-04-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a38c3842-fb3a-4695-9d09-f0d2fbf7975a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a5fa8d3f-8630-436e-bb55-37a26df286f9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a7e4265c-f495-4ea8-9abe-63aa02dd47c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ab1680b4-76ea-4b15-86a6-421050cb834d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_abd1bb36-649a-4b3f-b313-b8879975169d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_acc8f0ee-cf35-491f-b1bc-f32657bd0a84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ae5e6aed-1503-498b-a58c-7a51d4fe9172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:PreferredBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af039a31-ee84-42a7-82dd-8c7deb252ff1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af055ce3-c87f-4637-a806-c95905a23203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_afa4f934-11e5-4c39-b49b-0cb4a0e75483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b046e187-8392-4a7d-a3ab-f5065c36bf0b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b0e202af-bc90-4be3-a147-eec79b8a2bef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1bd11cd-8dd6-4de9-a5ed-b6ef0413b392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b1c3604a-49e6-44ea-82e9-36f2015f5d4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b3af013b-f74c-4b68-9ba2-7e9a3065d0ca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b3b64b0e-4eb5-45d0-b5f9-2d703131e99a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b427f9b8-5e88-4171-8639-300cf97af194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:DelayedDrawTermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b4ca8ae3-3bfd-4c53-99ad-240c6fa58860"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b57351e9-49af-4f6a-a532-91fd8bca805e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b6707bb2-894d-4ef5-b67b-4a9d78165cd2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b672f703-aedd-4bf1-94c4-160d381f1498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b6dd06dd-3e1a-4e3d-bd37-70d3a5857d75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b75ed518-5871-4767-8792-56c29fff2189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7aa5384-1c58-4d97-a748-b46442622060"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7f07760-d62f-4512-a664-d49bed1a90cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b83becec-a8a7-4250-98f0-8f5ba29d2848"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b899ab26-e619-4d58-a07b-38bf2016ab41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSMemberEnrollmentMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b8b87b9c-e6a0-406d-818f-112b6825b4cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b929ea35-4d57-4309-9729-8e223f59f4b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b959fdf1-fcd8-4458-9fe1-8862724296dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_baa505f3-0b22-4c7d-97da-d429c4957dac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedHealthManagementSystemsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bbf6403d-9162-483c-8776-b0ea02605c69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bca3f795-036a-486d-b7b3-5bde30763876"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bce624dd-14dc-4bb3-b213-4088492584ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_beaa67cb-6b14-49ee-84da-6671434aed28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_beafc79c-c290-4d5a-b082-1dafd30fba26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_beef7b88-15ad-4fab-977d-5bf2e6bb0e4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_bf6be12f-f3ab-4aa9-a56c-870966b9a04a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c0084b72-06a0-4ae0-91de-1a477153763a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c16d7a21-9458-4b38-a8c0-cfb657c898ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c1a29941-265e-47ee-bfab-5f1290b6297b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayEachFiscalQuarterThereafterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c24d9fbe-5f15-4c99-b3b6-14bc8e5f8a34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2e67330-5049-40a7-b292-d46f9324eb05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3a02d13-ffcb-4213-bda6-e5bb59c91eeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c3a3893e-219e-41f0-a38f-79683aa82945"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3a4e452-1161-4a5d-850f-16c304a662ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c3edf28a-a238-40d2-bd32-23ef178885d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4024cc1-119f-4d5f-ae31-02955c23c53f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c41d3eed-30db-4a53-8251-e8161f2a5685"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c4e85806-bf8b-4a55-ac88-31f987995966"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c627daaf-b808-4e00-85a0-596f504d8472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c63056ce-4e34-415d-bc81-ec89ac8aef55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-04</xbrli:startDate><xbrli:endDate>2024-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c7b860f3-00e7-4af6-b919-b03da362adc5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c8ddf934-6d23-4f44-9b9a-94254e17fd2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c98c4392-4a16-456e-9225-81de0aeddc35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca2b1674-f053-4711-99b6-46e02ae62634"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca44cbaa-887f-4bf8-b193-1e7fba9ea4ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ca4dfd0b-8bd6-4fbd-a03c-0d86bc0e20dd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ca845960-39f0-4a22-b0a8-870c481d2a9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_caa6bff7-c546-4734-8b91-b9cc35d645f7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondThirdFourthAndFifthMeasurementPeriodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cae1d15e-081f-4e25-9666-48ba5588bb71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cb205433-1776-4986-8156-9590d16dcda6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cd8693a7-bcaa-4246-bc4f-8864b40faac7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ceaebce1-eadc-44b5-9828-3ae63b4a713d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf778192-a620-4a66-876e-1b3bee77789f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cf787623-6175-4af2-9a0a-baa08dd1743a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d03830d6-ceb5-4d30-91b3-d682fd7848fb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d15c567f-3397-4492-8383-e863d7384893"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d16bace1-c79d-4e87-85bb-17ae493b3326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d3593fce-7c42-4759-889f-3843431c0c72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d44cee9d-e397-4f66-8ab9-60be5a5fe296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d455b109-46c4-4ef7-9caf-6da6c644c797"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d5454de7-c7d8-4458-b50e-0ea3109e6ecd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d58319c2-1e7d-404d-9de6-2c8ff0ce99e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d68d3e73-1a37-4898-87db-e2b73a6e4347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d73d22c6-9b06-42af-885b-ab1ea9552178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d7ac3eef-52f1-4e2c-8d64-851c37c3ee9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8fdeda6-ba99-41b0-8f1a-47bb18ab9f50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_da904c7b-408c-409f-b2c0-a578207cb75a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_daa1fc75-315e-4a15-918b-4217def968f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_db55fdec-4a85-4b80-a8d7-2659a2923a15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db6068f0-807f-4b86-b6ef-af05a0370ebd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_db9d68bb-77fd-49e6-9bc0-d0eaff33c66d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dbba92a9-68bd-4064-8de3-f595e744099a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc7280cd-a579-4b3e-92cd-3b6923b763e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dc8d6e4a-2466-4667-9a1b-22764f551de8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dcf3f17e-da41-43d4-8765-fa98896d0781"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_de80ca92-733d-4d31-8fc9-bb3a6ff69c9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df2728ff-ed37-42eb-8135-6412bf60637f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df83f06c-1bd7-4a08-a59a-dbb0d00b045d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_df93c67e-ab97-4281-ba2a-b871cd8e57a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dfa9936b-5186-4152-84d7-699c1a534b33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DMGAndSunLabsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e1740a99-900b-4902-9d5e-4d630ead0b03"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e21928d0-d834-46c0-97ad-f882fc6f862c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3605bfd-de05-44e6-96ef-5e21824f3ddf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e495f793-75dc-4d1d-8b73-1382c3cdff82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e5cdd2bb-60a6-4ebb-b03f-2092771d6a9f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e6d48615-5367-4a0f-ad3d-86dd6a0bbd6c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e76a7617-4b56-4fc3-99bd-e245633154cb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e7d1b03b-c982-4a71-9cb6-b34b0f7c2e9b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ea90d243-5c67-40e3-a543-1955b487feeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_eaf785cb-d155-4317-8f80-24864238f6c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eafa35a4-99f0-44d4-a6eb-107f2d35d4d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_eb098f65-c543-4b24-ae54-daae9a749c25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ec8f7056-c0e7-4865-bfc9-cc405c953592"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ed9a6b0a-2f21-4044-9c6e-5d6fe11bd1cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee076df7-779d-41be-82fa-78965cf2bb7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ee84bd0d-3633-4ffa-b982-879767a7cdad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ee86e486-beed-4909-b2c8-b2cf6dae3f11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f0efa117-c0df-40e9-9b6c-2738c0931341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f121a13f-7f62-4911-af4c-cdc74d7b71a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f29b54ab-fc06-4669-ae02-d8718105c456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f30cbeac-b9ab-48fd-96ce-75af5d6e0bfa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f497f166-f60f-4783-b578-7fc1e03156d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f58ff657-ab10-466b-ac21-a56b042b8f8e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f645eb5f-2f94-46c5-98c1-1dabebffc600"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f87a47bf-3205-4aee-8f68-e2bd18751281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f9e21867-5350-4ee9-bd3d-e27eaf98771f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb36bf2b-c780-4ab2-b3b8-d365c11db5d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb49430e-f221-42fd-ab2d-21a25ad7d7bc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbb3c763-fbfe-4d2d-bb20-60c7ade4a0d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbc31d75-110d-425d-9f53-3d8451a0d495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fbca9ee8-8163-4436-a2e2-bce055cb706c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcb6fb64-b6ca-4164-afb7-90087668e19b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd421a2b-dd0d-4238-b483-99535258a1cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd640251-91ea-4cc7-9495-ffa5d748fb28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_015f1704-89e6-4c03-afae-18a5d32c8336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_017c6b7e-32c1-4fc0-bb28-bb5b23e4d7dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02359f56-b244-409f-85a6-c9122ce3d2a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02cfd407-332a-4baf-987c-e88967c9572f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_03eaf310-f4d6-4b4c-9ee7-e536dd3096e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_049fe2ce-623c-47b8-956b-acb5e9467f17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05ea43c3-e314-4603-8d8f-a60b429d8f85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_080805e0-71f9-466e-995d-e3d7a0793b53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_087d9c30-c670-47d7-b3cc-1831b12e4e0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08a19b8a-9cd6-4016-9557-28e48707eeb4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_08b0fafe-b67b-4bd9-9a48-7f4c5f138bed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0aa38d95-e047-40ed-aae1-7c7af01d8b45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0ac128eb-5a33-4975-905f-b556a96e2c4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b125a20-c6ed-4951-af84-bbf48d18d034"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0b13f834-ee62-4361-8e5b-68ea07a37e23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0bcf495d-f6c9-4ab7-acd8-a670125428f4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0bde49a3-f8b1-43f5-93b8-2a4f2689faf3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c97d0ad-d27f-4202-b033-a921a4fd1636"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0cff01c6-12c7-4f38-864b-0bbcdc7a9295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0d98b790-089f-4f95-8f77-b2f98cd851c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0db515af-2807-4207-b8a5-46485e97024c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e18f7d0-badd-4b78-96bc-454449d1877e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e5954be-95e4-4557-b760-60d9a28d9308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0e90a0d4-f745-48d9-a24b-c58b53cc0548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0f2b4746-765e-4a23-95d4-385fe1476cce"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f6589d9-060b-4baf-90fe-b02db5eb589f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0f9cd5b5-b704-426f-9132-13af5d422b00"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-29</xbrli:startDate><xbrli:endDate>2024-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0fb6e99b-fca4-44d8-ad37-70ea90786ce7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1083cf69-b827-454e-8369-6d3fc314dfc0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_11101c20-415e-4281-8227-fa000c36a1ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1288fe82-ac30-4a05-9186-9dd06073739b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1365a955-4128-4b28-a0bb-c35ac458d684"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_16aa46eb-3f05-457c-861c-643f3c663612"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_17704f66-45bd-4b7c-af28-dd048a5f2457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1989d044-2b9d-4d1d-adb5-89940dd1bf1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1a4f7a0c-078b-46b3-a572-4429ae7dc5bf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1b553b00-2fc0-4ac1-92a8-7cfe88881549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1bff3c75-ef8c-43c8-8cd4-ddb311389b41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1c3552b0-b03a-4553-a29c-97b040f5699e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1dbcd7f4-15f4-485f-84c9-42d3bbcb06e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1dd1d251-19bf-4cd5-8a5d-6055b3033882"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023TargetAndGrowthMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1e5aa272-935d-4f32-9bfb-416c2178e6aa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondAndThirdMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e918ac4-70a3-44fc-b478-645d223adbf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1ea642ae-a35a-4119-b34f-c0c2715563a7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f767e2b-b61b-4ca0-98c7-e3058a5e5df3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2147af01-593e-4d79-ae19-38f7ac603a3e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21d8b068-a324-48d5-986a-6a1d66c692e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21dd06cf-9d3c-43d2-9980-e998c5f6f0c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_222bd65b-18c2-4e1e-ae1b-cbccc1f49d96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_226ae331-0b66-42c0-b281-4563dffea1fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_22d1feea-c756-468e-ac13-0faa2e9eac74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_22f45f1e-8c8c-4614-b22e-19a67b75190b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_236ccab9-0279-431e-981f-890a827b1ca0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23a6def1-fe99-4994-80d1-971c2b32a7da"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_23f8c634-36f7-44cf-9399-7b2106a9fe93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023MetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_242c5ffa-94be-4093-910a-0097e423df05"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_267bebe9-df3a-4348-8901-8b3074ee8ba5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2756304c-de02-4a8c-b11b-0af4c1d0f72b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2814e1a2-ab63-418d-b63e-dbd2d3f1801d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2a1a51c2-b17e-483d-80bc-bbee2ba2992a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2a253766-549b-48d9-804a-32af249a20f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2cbf692b-71ea-45e0-a47a-62ac40f45969"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2e55ed2c-9a1c-471f-b86f-f1b220d4588d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2f80e474-09c5-4498-a350-2d08cecdfc30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31f2c291-fe47-4c84-bb34-57cb71b36101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3201267a-d634-4169-826d-98d5f707cdfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3219815c-b8e4-4aee-977c-644ac98f25fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3551b884-1dd8-4237-84f2-7b976f23e2cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_35ed1a55-e356-4546-bdd7-e13888799768"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_367c7a54-311a-4f48-828c-ff0ef9db9d95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_369173ba-bef4-4c54-9896-61bf4704f842"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3696b868-57c7-4c52-8b1e-a7409de802a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36e16046-d6d5-4ac8-87fa-8e331f7c735a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3757db2b-c29b-442c-90e8-b518b6fde2b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_379e6a73-d6bc-454e-977a-efe6b3426bf8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_384def41-401d-433b-a083-2f0ed1630ae6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_38586056-d9a0-4723-b06e-423ac77877ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_388ec8dd-e407-47aa-b88b-930866d15cfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondAndThirdMetricMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_38996325-e035-49ee-a6cb-7fcc69167cfe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3952c0ce-7c90-43a0-8800-607b699b17a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39d701e3-06a4-4df9-b822-c0fcffba122c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a2ebc98-8101-4cf2-9108-4f593c2d8847"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a367d74-7d53-44d3-bbea-33e94ba22408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3acc1c89-3076-4ee5-a26e-94c06be58c7e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b445780-6235-4a8f-ba3b-abd685c6ec2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b49047f-ac09-4d40-b78d-73c4e56f102a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3b9afbd5-4210-4cba-a0f1-a98c07823a3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3bad1aa8-8683-4fde-8415-afca6a2c5cdb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3bc8f5ef-23a9-4f96-bc10-a52d7a540f3d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3bd97afb-8c37-43d8-b09f-783073d2929a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d384b8a-36f4-49d6-9e03-2c663c6f6dae"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3d79f704-e8f9-4c16-8574-e530d4eb0e3c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e76e350-ea44-40df-b69e-b28234065741"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3f74b900-fc5b-4144-b943-471127db7623"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3ff71d2b-ebbc-4683-8c33-29859e53eefe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40132981-89ba-4e41-815e-8b46af618908"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_40324dab-ee91-438e-8fee-dd30b551fea0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4103c318-abec-4453-8eb0-b888e91d21a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4119ea9a-9b96-42d3-bd3c-d9d8cc88b66c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_423ede0d-20f9-4418-b336-259b500c9fd8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_42bb4ed7-33be-47af-988b-992e494c103d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_43074c34-b768-45ea-9ed8-9013bbb22b45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_439f009f-2b98-4cfc-ba9d-62cbb1adf7e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_43ba0bc5-d5da-4f73-96ca-7e4df5bc7e92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_44dfee64-65b5-496e-98a1-6b501aa3532a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_455ccf48-8afa-43f7-9084-96bed70ceb5b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4620cbd3-1893-4a0c-9d80-94c7c2d51650"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47d471b9-bc25-4bfd-ba7e-f4308580c360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_47dc46dc-5dad-4a5f-967c-32e72a07d19c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48d15767-6248-4bb8-9a0c-0543b84f6436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48e4959b-0f1f-4be5-ab14-031e03179f1a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedHealthManagementSystemsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-31</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_495d4051-3ab2-4ec4-aac2-eb89210fcf3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4a4c4fe5-1018-477c-a9b5-a907e028c99f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a4ecf0b-afe3-484c-ad85-f7a6579c67a9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4a8637ec-690d-4853-a3e3-abf4a49d231a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4aad3ec6-80fd-4602-9c7b-59c3596c2d22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4b85094b-d44b-4343-9073-a47a57dcafe2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4c0af0d9-a715-49c1-818f-7bd0aa182dbe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4fbc38e4-4839-4ebf-a373-b96ad86a302b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51568cb6-3f1a-4554-92a1-e0a87a63611a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51d37c62-bd92-4b36-bda5-66bf4ab5d0f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5632426d-baaa-4109-8b29-9f7796b165df"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56bfe089-97e1-4466-af03-ff2f279f2e29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-01-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_577be10c-71a6-4648-8164-b2570291e50e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_57ab083d-904e-4e53-978c-f5c3da6822ed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_57c79a78-9732-4080-9239-22b71e33c266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5866792a-f02f-4281-bb96-b527c6b93742"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_58fba134-3b96-4623-9e04-19f42b73f4cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_598d420b-fa2c-4abf-b7c7-2b099761021d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_59d235ce-9711-4ef0-bfda-f40da6b2866b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5ab8feca-ce17-4204-bc5e-2c50a0f3326e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b31a718-c1c9-490e-911d-86d1062a0eeb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockOptionAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b43a6c1-a998-439d-ba82-792676c6568d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5edf9e77-4494-4d12-9667-31e210c6227e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f9b3463-0249-4f81-a7e3-f5f9afa4f5c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fb914a7-0520-41f4-83cf-9c07f5e46feb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_608c6900-ee56-4405-ae5d-6fc0640fc6b5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60a42d76-6c9a-4f99-93d9-4550f317d0fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60dd78d1-64db-4a8b-924c-509710d8f2d8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_60fac651-18d8-44ed-9d9c-07d7f1f63e2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6177be07-fab5-40c9-821f-deabcadf9b27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_61b01747-808d-4a48-a5cf-a6bdc4b2b455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_625b04f5-8205-44a5-ae85-4037620ce1b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6399433e-def4-4d84-b6b6-f762bf6ee833"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63adb938-c888-47f6-afd0-8fa1a58390b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6400c1e2-a6bb-49bc-af77-e72305173422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_651b11d9-1f6c-4cc8-af5e-b6decb5bd381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6576bf12-444e-4d4e-b361-dc0763d5edca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_65d1d249-71f7-46a2-a28a-9474d27d86f3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_65e86fd8-187a-4fa5-8ef5-554371a711f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_660533f2-bb98-4221-8734-e0be6ba384e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_66914d11-6398-4518-9398-8ccb5e2da66d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6876888c-242a-4666-a5ca-046144b65e95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69535d23-6b5a-4866-b0c2-b2062e9d8bed"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_697ba52d-2244-440b-9f20-87f75a1b40f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_69d8a835-e946-435c-8b6b-b394071da012"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6a8368f0-8774-4b22-a45d-899d1800a379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6aa69ca0-0134-44c6-9a4c-dfef95103988"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6afa4315-6042-4fb4-bfdb-562cff61568e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-02-26</xbrli:startDate><xbrli:endDate>2025-02-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6c8bf174-59c7-4577-a615-168c7e390b79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ce72f59-77e8-4dbe-aae6-f5d7f9f30d70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6d80e85a-168e-4e9b-80f3-ccebe319846c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6ecdd9eb-4e61-4714-82a4-da270a6dfb36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_70877b65-4861-4b51-a656-f2212a0647a5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7111af93-0249-4601-b68b-7488d9494f44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023TargetAndGrowthMetricsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_71250632-5809-4877-9e5a-4ea18f63b9b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_713fe850-c7c0-4c74-bb89-374b329bb348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71a445c4-c7ab-4d90-a288-fe1fead886c3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024MetricMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_71fe0c76-45fe-453d-84d9-fa9e245de91b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7207eb90-6e38-4c0b-adf2-11627269267f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_72cdfcac-2740-4878-88ae-2ceba95c47c8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_74ff5438-7469-415e-827f-4df6603c37f5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_766601e2-a6b4-4052-99ed-c5eca3f68c15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_77dce955-a90f-4883-84a3-2ecf12cbb7b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_782cba76-0dc6-4355-999d-51fc02a33e23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_787cb7d7-ebc8-4665-80e3-627cd2d9a92c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayEachFiscalQuarterThereafterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-30</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a198c7b-7dd4-4175-ba0f-59cc0ec75af0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7acb6b6e-5f3d-4e08-a797-82f25588ef01"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7d30ac99-4e7f-46aa-b268-23abada1cedd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7d764929-a2f0-4c7b-b54b-eba37cf55e23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DelayedDrawTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-04</xbrli:startDate><xbrli:endDate>2024-10-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>asth:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_State"><xbrli:measure>asth:State</xbrli:measure></xbrli:unit><xbrli:unit id="U_Member"><xbrli:measure>asth:Member</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Securities"><xbrli:measure>asth:Securities</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><ix:relationship linkRole="http://www.xbrl.org/2003/role/link" arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="FNT_99e48291-d907-4bff-bdda-34e68217cbf2" fromRefs="F_c7e2d019-0bd5-48b6-9f3d-aa213600f006 F_eeaffbef-52aa-44cf-b09d-2ce37173ba27 F_b5a02926-a7d8-4244-8588-e131eb0d1fca F_3caa0f8b-7e96-491f-8b69-dc963eefb25d"/></ix:resources></ix:header></div>
  <div style="padding-top:0.5in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="margin-left:0.84%;font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;margin-right:0.833%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double;padding-top:1pt;font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:3pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Washington, D.C. 20549</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e66ec606-a86b-4e11-9e9e-e7c96f45fe18" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10-Q</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.88%;box-sizing:content-box;"/>
     <td style="width:96.12%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_59a1c554-db7b-4d2d-9b09-554078bcfa5c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:1pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the quarterly period ended </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09016c9f-34a4-4b15-a0b3-fada2b98d568" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:1pt;line-height:1.38;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OR</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.88%;box-sizing:content-box;"/>
     <td style="width:96.12%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_6f521797-31ef-458e-ba85-ddf0981447fa" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:1pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the transition period from  ___ to ___.</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission File No. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6de5a79c-ace9-4c68-ada3-f4763991bf32" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">001-37392</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:4pt;line-height:1.6579166666666665;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img124443625_0.jpg" alt="img124443625_0.jpg" style="width:470px;height:83px;"/></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:14pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a51ec7c0-e62f-40f3-a901-c7ae7ba73246" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Health, Inc.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:3pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of registrant as specified in its charter)</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"/>
     <td style="width:50%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_a4390608-ef56-4b87-9f0a-974eb59ab183" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_e74fe11c-8b14-4ce3-9ea4-01b0a080d839" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95-4472349</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(I.R.S. Employer</span></p></td>
    </tr>
    <tr style="height:9pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">of Incorporation or Organization)</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Identification Number)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_41dfa5d0-c8fc-43e9-90fa-4f055e364ae3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1668 S. Garfield Avenue</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_97894742-5671-4b77-ab46-71264e6eef1f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;vertical-align:super;font-size:6.03pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">nd</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Floor</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_538afcd9-3a05-4d74-a982-c623cd1349f3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alhambra</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_26b60af4-5390-4a95-8301-e3842f23cf22" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">California</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cc37e990-8de1-41b3-8c0a-013b7b76ade0" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">91801</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Address of principal executive offices and zip code)</span></p><p style="font-size:10pt;margin-top:8pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6a9c0483-93a1-49ae-b3be-b682da72524b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">626</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe7ec2d4-1423-4004-bc41-61d8dfa8eb30" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">282-0288</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Registrant&#8217;s telephone number, including area code)</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:4pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:34.813%;box-sizing:content-box;"/>
     <td style="width:1.04%;box-sizing:content-box;"/>
     <td style="width:17.836%;box-sizing:content-box;"/>
     <td style="width:1.04%;box-sizing:content-box;"/>
     <td style="width:45.271%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Title of Each Class</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading Symbol</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Name of Each Exchange on Which Registered</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_c4a01ad9-7107-4b41-bdae-128081af1b2f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_058e906d-44b1-4188-ad8f-cb7cd142beef" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ASTH</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:9pt;"><ix:nonNumeric id="F_572b76ad-96c6-45d0-91a4-a524af1b0f72" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8bb1f784-64b8-446b-85af-80b6a7252f8b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityCurrentReportingStatus"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;  </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span><span style="font-size:9pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d99915b-bb19-43d9-bcd2-45f34462d109" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityInteractiveDataCurrent"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">     </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;  </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:3pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:47.12%;box-sizing:content-box;"/>
     <td style="width:2.88%;box-sizing:content-box;"/>
     <td style="width:47.12%;box-sizing:content-box;"/>
     <td style="width:2.88%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;"><ix:nonNumeric id="F_8096676f-5ab0-4b60-9a27-eb700d3dc3d9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Large accelerated filer</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-accelerated filer</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Smaller reporting company</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_69197fae-4e11-44a5-88c9-9cd1f7f55c6f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:9pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Emerging growth company</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_75dc0749-63fd-4365-ac00-bceb3a180974" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9744;  </span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Yes   </span><span style="font-size:9pt;font-family:Arial;"><ix:nonNumeric id="F_554d3289-b4b7-4225-8f75-36151f2ab91b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="dei:EntityShellCompany" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  No</span></p><p style="font-size:10pt;margin-top:3pt;line-height:1.38;font-family:Times New Roman;margin-bottom:3pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of May 5, 2025, there were </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e01a8480-12bb-4470-ab29-48597d335861" contextRef="C_21d8b068-a324-48d5-986a-6a1d66c692e9" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">56,061,712</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock of the registrant, $0.001 par value per share, issued and outstanding, which includes </span><span style="font-size:9pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3885bf4-48e6-4ebd-a475-db286490724a" contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,132,802</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> treasury shares that are owned by Allied Physicians of California, a Professional Medical Corporation d.b.a. Allied Pacific of California IPA (&#8220;APC&#8221;), a consolidated affiliate of Astrana Health, Inc. These shares are legally issued and outstanding but treated as treasury shares for accounting purposes.</span><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="padding-bottom:1pt;font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.5in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="margin-left:0.84%;font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;margin-right:0.833%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Health, Inc.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INDEX TO FORM 10-Q FILING</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">TABLE OF CONTENTS</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:11.738%;box-sizing:content-box;"/>
     <td style="width:79.904%;box-sizing:content-box;"/>
     <td style="width:8.358%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PAGE</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#glossary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Glossary</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#glossary"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">3</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Introductory Note</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#forward_looking_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Note About Forward-Looking Statements</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#forward_looking_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">4</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_i"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART I</span></a></p><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_i"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">FINANCIAL INFORMATION</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_financial_stmt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#condensed_consolidated_financial_stmt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Condensed Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#condensed_consolidated_financial_stmt"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">6</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#balance_sheets"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">6</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_income"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Income for the three months ended March 31, 2025 and 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#statements_of_income"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">9</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#stockholders_equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Mezzanine Deficit and Stockholders&#8217; Equity for the three months ended March 31, 2025 and 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#stockholders_equity"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">11</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#statements_of_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#statements_of_cash_flows"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">13</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#notes_to_condensed_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Notes to Condensed Consolidated Financial Statements</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#notes_to_condensed_financial_statements"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">16</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#managements_discussion_and_analysis"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 2.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#managements_discussion_and_analysis"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#managements_discussion_and_analysis"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">50</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#disclosures_about_market_risk"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 3.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#disclosures_about_market_risk"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Quantitative and Qualitative Disclosures about Market Risk</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#disclosures_about_market_risk"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">61</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 4.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Controls and Procedures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#controls_and_procedures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">61</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:left;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_ii"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">PART II</span></a></p><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><a href="#part_ii"><span style="color:#0000ff;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">OTHER INFORMATION</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Legal Proceedings</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#legal_proceedings"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">62</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 1A.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Risk Factors</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#risk_factors"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">62</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#securities_and_use_of_proceeds"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 2.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#securities_and_use_of_proceeds"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Unregistered Sales of Equity Securities</span></a><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;"> </span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">and</span><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">&#160;Use of Proceeds</span></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#securities_and_use_of_proceeds"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">63</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#defaults_upon_senior_securities"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 3.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#defaults_upon_senior_securities"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Defaults Upon Senior Securities</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#defaults_upon_senior_securities"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">63</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 4.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Mine Safety Disclosures</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#mine_safety_disclosures"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">63</span></a></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 5.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Other Information</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#other_information"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">64</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#exhibits"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Item 6.</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;"><p style="font-size:10pt;margin-top:3pt;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#exhibits"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Exhibits</span></a></p></td>
     <td style="padding-top:0in;padding-left:0.08in;vertical-align:middle;padding-bottom:0in;padding-right:0.08in;text-align:center;"><p style="font-size:10pt;margin-top:3pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><a href="#exhibits"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">65</span></a></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="glossary"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Glossary</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following abbreviations or acronyms that may be used in this document shall have the adjacent meanings set forth below:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:94.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:26.38%;box-sizing:content-box;"/>
     <td style="width:2.22%;box-sizing:content-box;"/>
     <td style="width:71.4%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">All-American Medical Group</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ACO REACH</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ACO Realizing Equity, Access, and Community Health</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Advanced Diagnostic and Surgical Center, Inc.</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AHMC Healthcare Inc.</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AHMS</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Advanced Health Management Systems, L.P.</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AHM</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Health Management, Inc. (f/k/a Network Medical Management Inc.)</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">APAACO</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">APA ACO, Inc.</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">APC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Allied Physicians of California, a Professional Medical Corporation</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">APC-LSMA</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">APC-LSMA Designated Shareholder Medical Corporation</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Health Inc. (f/k/a Apollo Medical Holdings, Inc.)</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Medical</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Health Medical Corporation (f/k/a AP-AMH Medical Corporation)</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Care Partners Medical</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Astrana Care Partners Medical Corporation (f/k/a AP-AMH 2 Medical Corporation)</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Community Family Care Medical Group IPA, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CMS</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Centers for Medicare &amp; Medicaid Services</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DMHC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">California Department of Managed Health Care</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">DMG</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Diagnostic Medical Group of Southern California</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Health Source MSO Inc., a California corporation</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">IPA</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Independent Practice Association</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LMA</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;text-indent:18pt;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="text-indent:-3.448%;padding-left:3.333%;font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Primary Community Care of Central Valley, Inc.</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PMIOC</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging and Oncology Center, Inc.</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Clinical Labs</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#cceeff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VIE</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Variable Interest Entity</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Valley Oaks Medical Group</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">INTRODUCTORY NOTE</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context dictates otherwise, references in this Quarterly Report on Form 10-Q to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana Health, Inc., a Delaware corporation (&#8220;Astrana&#8221;), and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Quarterly Report on Form 10-Q includes the financial statements for the quarter ended March 31, 2025, and provides management&#8217;s discussion and analysis of the Company&#8217;s financial condition, results of operations, and other required disclosures, as mandated by the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Centers for Medicare &amp; Medicaid Services (&#8220;CMS&#8221;) have not reviewed any statements contained in this Report, including statements describing the Company&#8217;s participation in the ACO Realizing Equity, Access, and Community Health Model (&#8220;ACO REACH Model&#8221;) and in the Medicare Shared Savings Program (&#8220;MSSP&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trade names and trademarks of Astrana and its subsidiaries referred to herein, and their respective logos, are our property. This Quarterly Report on Form 10-Q may contain additional trade names and/or trademarks of other companies, which are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names and/or trademarks, if any, to imply an endorsement or sponsorship of us by such companies, or any relationship with any of these companies.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="forward_looking_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTE ABOUT FORWARD-L</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OOKING STATEMENTS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Quarterly Report on Form 10-Q contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements other than statements of historical fact are &#8220;forward-looking statements&#8221; for purposes of federal and state securities laws, including, but not limited to, any statements about our business, financial condition, operating results, plans, objectives, expectations, and intentions; any projections of earnings, revenue, earnings before interest, taxes, depreciation, and amortization (&#8220;EBITDA&#8221;), Adjusted EBITDA, or other financial items, such as our projected capitation from CMS, our forward-looking guidance, and our future liquidity; any statements of any plans, strategies, and objectives of management for future operations, such as the material opportunities that we believe exist for our Company; any statements concerning proposed services, developments, mergers, or acquisitions, including statements regarding our pending acquisition of certain businesses and assets of Prospect Medical Holdings, Inc. (&#8220;Prospect&#8221;), which may not be completed in a timely manner, or at all, and the debt financing for the acquisition, and our ability to achieve the expected benefits of such acquisition; any statements with respect to dividends or stock repurchases and timing, methods, and payment of same; any statements regarding the outlook of the ACO REACH Model, the MSSP, or strategic transactions; any statements relating to delayed payments under, or potential cuts to, Medicaid and/or Medicaid programs and/or changes in federal or state funding policies; any statements regarding management&#8217;s view of future expectations and prospects for us; any statements about prospective adoption of new accounting standards or effects of changes in accounting standards; any statements regarding our ability to maintain effective internal control over financial reporting and disclosure controls and procedures; any statements regarding potential changes to our tax structure; any statements regarding future economic conditions or performance; any statements relating to the potential impact of cybersecurity breaches or disruptions to our management information systems or widespread outages, interruptions, or other failures of operational, communication, and other systems; any statements of belief; any statements of assumptions underlying any of the foregoing; and other statements that are not historical facts. Forward-looking statements may be identified by the use of forward-looking terms, such as &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;should,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;believe,&#8221; &#8220;think,&#8221; &#8220;plan,&#8221; &#8220;envision,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221; &#8220;target,&#8221; &#8220;seek,&#8221; &#8220;contemplate,&#8221; &#8220;budgeted,&#8221; &#8220;will,&#8221; or &#8220;would,&#8221; and the negative of such terms, other variations on such terms or other similar or comparable words, phrases, or terminology. These forward-looking statements present our estimates and assumptions only as of the date of this Quarterly Report on Form 10-Q and are subject to change.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Forward-looking statements involve risks and uncertainties, many of which are difficult to predict, are outside of our control, and are based on the current beliefs, expectations, and certain assumptions of management. Some or all of such beliefs, expectations, and assumptions may not materialize or may vary significantly from actual results. Such statements are qualified by important economic, competitive, governmental, and technological factors that could cause our business, strategy, or actual results or events to differ materially from those in our forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those discussed in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on March 14, 2025, including the risk factors discussed under the heading &#8220;Risk Factors&#8221; in Part I, Item 1A thereof. Although we believe the expectations reflected in our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change. Significant risks and uncertainties could cause actual conditions, outcomes, and results to differ materially from those indicated by such statements. Any forward-looking statement made by the Company in this Form 10-Q speaks only as of the date it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="part_i"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART I &#8211; FINA</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NCIAL INFORMATION</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="condensed_consolidated_financial_stmt"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1. CONDENSED </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONSOLIDATED FINANCIAL STATEMENTS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="balance_sheets"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDENSED CONSOLIDATE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">D BALANCE SHEETS</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Unaudited)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e518f6eb-82b8-44ae-9bcb-3bc6da604ac6" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258,517</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07dbebfd-87a3-4fcf-92a7-182bd3a64a08" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">288,455</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in marketable securities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcbf9fc5-2fec-41f6-a8a4-eba063fac7b3" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,397</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25af7667-d63e-4b72-b057-ad382405a1e6" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,378</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bc2ec2d-7ecf-49fb-8c34-05a54c330a92" contextRef="C_e3605bfd-de05-44e6-96ef-5e21824f3ddf" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241,078</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bef5b65-486a-45f0-9002-0573c668d4a4" contextRef="C_d8fdeda6-ba99-41b0-8f1a-47bb18ab9f50" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">225,733</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net &#8211; related parties</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cbccbe8-1618-4e99-9e72-5d2161484799" contextRef="C_df2728ff-ed37-42eb-8135-6412bf60637f" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56,846</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_653daef8-45b0-49c3-aa64-ae00c41bd875" contextRef="C_577be10c-71a6-4648-8164-b2570291e50e" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,257</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8084a98-cb79-4591-8fa0-aaa79dbb6afd" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:IncomeTaxesReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,802</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_27a9102f-859d-4fc8-bc4b-795ed17ba55e" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:IncomeTaxesReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,316</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20aa0a3d-eb0f-4d1c-93c3-f46e4f614e50" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,919</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6232204b-1747-4491-a831-c00593315356" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,496</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ac8c1ed-f8dc-43b0-83de-3db962d2d788" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,711</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdbc39ea-e322-4489-b9aa-0f846b870478" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,861</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be842bf5-efc3-4142-9de0-b175ed6cc2e8" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">613,270</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0df681b0-16f1-4647-be1f-e3c8fb0eea13" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">638,496</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current assets</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f66ac01-fa77-48e6-88be-3b6c929d72f5" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,849</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a4a3ab5-c7d3-4e1a-b7dc-c3f25b1f97e5" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,274</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d12fafbc-0811-4ce1-8168-e95e160bd7ba" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,916</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_539be4ca-5787-4d76-9ade-2323becec9d2" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,179</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dd2ddfa-9d05-41ff-b339-c54c31cd39fb" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">416,386</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87c69b49-dfb8-47e5-a04b-d008e69a9d9f" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">419,253</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_350d1403-6ae7-4b31-8c63-b19e94e7ac90" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:IncomeTaxesReceivableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,943</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea8bbdf3-43b8-4c2f-b5f6-44b735268d07" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:IncomeTaxesReceivableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,943</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loans receivable, non-current</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c29ef843-b966-4a00-bc35-af8a46f7d592" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,134</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fbf38fda-30dd-4adc-b735-b3977cc98bc3" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51,266</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc3607b7-7862-4457-826e-2d1e9b6e50f8" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,005</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35814182-735f-4384-9e0a-f3c0a8d753d1" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,319</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in privately held entities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_456e1764-a239-4b5e-8949-6feef8ec401b" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,896</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20d4f7f4-686d-4d18-88df-57105af1bc3b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,896</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80227941-7fa2-4522-9c2a-e48046f126c0" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f701c9fe-8ee0-478b-a2cb-c32a7af3f191" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">646</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ae89b6c-c27c-47b0-abf3-730293b13367" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,698</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc4e1d05-044d-4323-84ff-a7979287ae6c" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,601</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_64b5aaf6-9415-4732-b8cb-106c292ceb63" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,512</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc62453c-6a5e-4cd9-b467-90e44b1a8abb" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,021</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e338430c-bfbb-4609-a2da-2590063aa7f5" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">717,986</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88d661d9-4542-4160-b004-ad4da3b6e1c8" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">716,398</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5a02926-a7d8-4244-8588-e131eb0d1fca" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,331,256</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eeaffbef-52aa-44cf-b09d-2ce37173ba27" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,354,894</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Unaudited)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities, Mezzanine Deficit, and Stockholders&#8217; Equity</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2c43a0e-813b-4304-ad88-31ca23dfdf79" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105,559</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa03b55f-18d1-4a1f-873e-4bfceafaf2cf" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,142</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiduciary accounts payable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d01f442-f697-403d-b7b4-41746ba434a2" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:FiduciaryAccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,840</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0223541e-1455-4546-9121-3297b4271ec9" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:FiduciaryAccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,223</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb7cbc9c-812f-4a5f-b4d0-a2283e80494d" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">204,101</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceaa528e-934d-40f5-92bf-870150bcd8cf" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209,039</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend payable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8df352fe-7499-40e0-91ce-bb02e57e654f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:DividendsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0977e7c9-6bcf-4db8-b19a-c921922a4d29" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:DividendsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1de03bc3-456a-40c9-ae1d-aa97044175e5" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">471</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_45e91e13-a7b0-4761-bae3-bdea3fa9ba51" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">554</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_584581ed-fbe8-46b7-a24b-c1a2bb5eeea2" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,979</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b48de3e-5c7e-42b3-9b05-2306c2577969" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,350</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current portion of long-term debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5972006b-64dd-415e-9f0e-ac9cb033e567" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41f1c66e-05b4-4e53-9161-549417a2e96b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,375</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10945a85-6dd5-48bc-9bdd-3229bd8502a0" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,180</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee9095a4-f2e8-4a5b-9713-7386941cc0be" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,287</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_19521661-654b-4495-b5a7-a9e01740d299" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">361,268</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a761e03-8176-4289-912c-1f33ee052d15" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365,608</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current liabilities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_251a7457-81c9-44a8-baf2-3acb4003995d" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,197</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f26aa95d-e7fe-44d5-bae8-07813936aec6" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,555</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities, net of current portion</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1320d07a-d7bb-4bee-b88a-27dd7b2c458f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">543</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3828661-9b32-40a8-8a7c-2cd4197999b2" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">607</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5724fe8-d628-49a0-a77b-ed0f48e233bc" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,963</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e902c8d6-6417-4bd2-8436-fe1db07d3a6b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,654</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt, net of current portion and deferred financing costs</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_513ad74e-a03b-4708-ae6d-138b154b9d77" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">403,894</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecc3d465-2b52-4767-8d13-bc81b823b03a" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425,299</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51d8d986-9a95-404b-8363-563618c7da00" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,685</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f073789-2e40-4cc5-bf07-54df584e1249" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,003</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7775fd5-8f7b-4490-aa68-63209620eb90" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">452,282</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_070ad8a6-6584-4c80-bda3-b628154e9467" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">475,118</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3caa0f8b-7e96-491f-8b69-dc963eefb25d" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">813,550</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c7e2d019-0bd5-48b6-9f3d-aa213600f006" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">840,726</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Unaudited)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span><span style="-sec-ix-hidden:F_6c1492df-fbc9-403e-b36b-cbe2a6c35037;"><span style="-sec-ix-hidden:F_942d33bd-6fea-48e0-9338-60f3d993553a;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Commitments and contingencies</span></span></span></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">&#160;(Note 12)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Mezzanine deficit</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (&#8220;APC&#8221;)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9705f259-420b-4f56-b5c8-a9dc4f0019f7" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">232,733</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e60c789-7d97-4e76-84d7-40064315af0a" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">202,558</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;text-indent:10pt;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Preferred stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b90614e5-eb39-4456-88f6-6ec371a61e85" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_c6da3999-b94a-4a67-8476-19607c1eb099" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value per share; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b162b64-8153-4c05-b2e7-de57737ae44f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_4954dd91-b0b0-47fc-b17a-0e7c559bb4ae" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized as of March 31, 2025 and December 31, 2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series A Preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4236a83b-7259-4faa-90dd-36229bbc6724" contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_af074ac7-570f-4bb2-ae44-4e37285caa3f" contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;authorized and issued and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cd03142-78f6-4c81-9a97-2b0c9b4e116a" contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;outstanding as of March 31, 2025 and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d3ad465-05a1-4090-aae0-8c6b603b45ac" contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_420ab9cd-ea24-4ea1-862b-4f4f4ae09ebd" contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;authorized and issued and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_966e7f8f-aa46-4267-a880-24e93b3b37db" contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;outstanding as of December 31, 2024</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_569ff054-86d6-4c31-a192-cab952160733" contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0465b7b-92b6-44f4-8209-c304bb6695b3" contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Series B Preferred stock, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2eb9ce43-5b94-4749-88ad-5bf5015db94e" contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_8f80f3a8-1a07-4a65-aa2d-f0175b0f9a69" contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;authorized and issued and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b968a1f-d3d0-463e-b187-b6071f37d87a" contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;outstanding as of March 31, 2025 and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_133e7aa6-ff66-43d9-991e-d32ba04117ab" contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_470d6220-06a8-4c41-95d1-5c3e333219c8" contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;authorized and issued and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9bf2076-9560-4a30-930e-5a5fee7b5b19" contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;outstanding as of December 31, 2024</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_021eb613-8cb4-46bd-8da6-1449cd0e1703" contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_addea7bb-81ab-4716-ab54-c40060356418" contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock, $</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8687e98d-c4f0-424a-a772-0be17b80353d" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_b456d799-7f89-4b78-a566-069bda6a9edd" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF" format="ixt:num-dot-decimal">0.001</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;par value per share; </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3a5d2d1-c2a9-4b36-9645-f1088c30ce5c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_a4deac46-b7a1-4388-8748-5c2eab97010e" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">100,000,000</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares authorized, </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6bb010a6-9fe8-4c51-bc66-f4689ad1bc86" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_6bf01c18-cd25-4485-9bc6-71a8321dc4c1" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">49,028,624</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5da71b9c-4490-4e87-9ccb-dd8c6140ef0a" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal"><ix:nonFraction id="F_52815004-8bbb-46b6-b3a5-6195b088e9ba" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">47,929,872</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;shares issued and outstanding, excluding </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f95ecb98-58b1-40be-8e34-f2da72054f0a" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,903,953</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;and </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94981375-3481-47e5-a974-c3575fc768ce" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,603,849</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;treasury shares, as of March 31, 2025 and December 31, 2024, respectively</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98ad39fe-8c14-4a37-8b15-6d9012ad8aa3" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_95e74ecb-e31b-487a-bcf5-e02d078af154" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Additional paid-in capital</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89071e54-7460-4cf3-92f8-2211f2cc04e9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">452,439</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b36cb54-8c22-4ea9-ade6-047ee62aed3e" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">426,389</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Retained earnings</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d91f967a-8214-4270-83da-f62d97f8b55c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292,880</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9d24088-f2cf-4e37-96c6-e2df73a56eac" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286,283</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_249aa5ab-d480-4480-8dfc-09aad8ca9ee9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">745,368</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9bf5180-9f15-4086-9782-7603d5aadce4" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">712,720</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa0de7f6-ae67-424f-a511-aeb904d8d40f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,071</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2f938eb-f4a0-411c-9822-a0dc57af9dd7" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:MinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,006</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total equity</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fb4b890-c859-4730-9834-20f099b39bb3" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">750,439</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4262560f-8e13-4ab9-87b8-dfb5cb84cf3b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">716,726</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities, mezzanine deficit, and stockholders&#8217; equity</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7b520a0-adc7-4eb2-8cac-da9c4ce0c114" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,331,256</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31ddb3db-10a7-4967-9c40-dc57ddfd4b0f" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,354,894</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="margin-left:1.333%;font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:6.7pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(1)</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><ix:footnote id="FNT_99e48291-d907-4bff-bdda-34e68217cbf2" xml:lang="en-US" continuedAt="F_99e48291-d907-4bff-bdda-34e68217cbf2_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e774d8a6-1ca0-454d-8a66-2f6b6094debf" contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">678.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d919e4d3-907a-42df-ae53-171315784140" contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8" name="us-gaap:Assets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">712.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e82bc556-6036-4ed3-8f2f-80e0d59fdf99" contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">212.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6f34696-9301-4469-bcf7-1257e936f6f6" contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8" name="us-gaap:Liabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">207.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively. These VIE balances do not include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc209b8d-0e7f-41ff-b3e5-b4a6e4cd4d37" contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">190.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e3ce3138-139a-4408-89c3-29049931c274" contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of March 31, 2025, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a846b54e-7d99-4da5-876e-cb5325d45219" contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">224.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_931f02f0-4b30-448d-b9ca-605b2b0001a0" contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">48.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of December 31, 2024, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further details.</span></ix:footnote></p><ix:continuation id="F_99e48291-d907-4bff-bdda-34e68217cbf2_1"><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></ix:continuation><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_income"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDENSED CONSOLID</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ATED STATEMENTS OF INCOME</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(UNAUDITED)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:50.32%;box-sizing:content-box;"/>
     <td style="width:2.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitation, net</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab539edf-c6d6-4f3b-bcd6-e2053e45809f" contextRef="C_b57351e9-49af-4f6a-a532-91fd8bca805e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">583,963</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0d2c6ba-4f37-467b-83ca-d665125c5f9e" contextRef="C_17704f66-45bd-4b7c-af28-dd048a5f2457" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">365,910</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk pool settlements and incentives</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c00c6cb2-e2a9-455e-b002-a08e7c184137" contextRef="C_8c0c24cf-629d-468f-990d-739224e84719" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,491</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26514644-2f83-463e-9c8d-e9a613295e99" contextRef="C_a7e4265c-f495-4ea8-9abe-63aa02dd47c3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,377</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management fee income</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3c8c4132-cf70-438f-913b-0ceb6dd95625" contextRef="C_abd1bb36-649a-4b3f-b313-b8879975169d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,310</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f03f5d97-7123-47fc-aaa5-f4ed77484d47" contextRef="C_625b04f5-8205-44a5-ae85-4037620ce1b3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,078</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fee-for-service, net</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_390ba0c2-9526-44af-8da8-13eb42b24a22" contextRef="C_70877b65-4861-4b51-a656-f2212a0647a5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,890</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ab29764b-9e1f-4c95-b565-d4f0aeafa91b" contextRef="C_43074c34-b768-45ea-9ed8-9013bbb22b45" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,937</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other revenue</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9621a4cc-9247-42c5-b9a6-c8ec73054593" contextRef="C_2814e1a2-ab63-418d-b63e-dbd2d3f1801d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,736</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99dadea4-7a00-4b2f-9b82-10ebea3794d0" contextRef="C_d03830d6-ceb5-4d30-91b3-d682fd7848fb" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,054</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d025724-1ad5-49d8-96d2-fb579a5ff686" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">620,390</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ec336ea-82a4-44b7-a392-d2c08303ce63" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404,356</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services, excluding depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7d4f16c-f517-4fd0-8642-6745c2d2bd13" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">549,061</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06c28cda-a894-4c5b-b2dd-77be42e3ee2b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">330,399</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expenses</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1f050e36-f5c9-4bf1-8757-5f382f49e0ef" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,897</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21f25613-2e1e-44b0-aa11-e3cd9adc20c4" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,722</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_001755b0-38ca-41d5-b6b8-cd608489c8c1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,849</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3220a1f0-b109-40c2-94a9-5f83e8f84647" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,096</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f5ca191-f4e5-49dd-b59f-8eaa5aed83ad" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">599,807</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fce7af5-db64-4776-b8a5-07e899ba50de" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,217</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income from operations</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_420d21e7-8dd6-4e50-89e8-816194fd9fda" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,583</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9167dee-b33f-4b2b-98fe-d87a78e0cba5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,139</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other expense</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from equity method investments</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf906f49-1cc2-4d59-b2ae-dde1e262e72e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">867</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_15c67ade-6adc-41f1-8034-42db7e4eb252" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">632</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31559849-f1ea-43db-891a-8d5168cc8725" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:InterestExpenseNonoperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,308</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69d0dd95-d404-46f2-a4ae-40d397b8e7c1" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:InterestExpenseNonoperating" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,585</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32766688-4969-45d5-917c-9c198e547639" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,312</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8867c887-bda0-4fc8-bbaf-ef9df6f6adbc" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,996</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized (loss) gain on investments</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fb11999-ba86-4c6a-9500-6b86f4e7c4b8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53f69cb7-0c68-4b74-9186-7fc1b9c6dad5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:UnrealizedGainLossOnInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,099</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other loss</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09623a5f-5906-4328-b09e-c0621c3c46c3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">5,072</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5551a82-7018-42bb-9731-d7c5deca0c67" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:OtherNonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,277</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5.05pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.933%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other expense, net</span></p></td>
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_25dac64d-9e40-4d83-9aff-81f313609df2" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">10,979</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1cfec470-9f03-47cf-9fd2-fd9abaec24dd" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">6,135</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:50.32%;box-sizing:content-box;"/>
     <td style="width:2.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:2.44%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20.4%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income before provision for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1450c56f-4c41-4ee2-b3de-0279eb4ceb6f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,604</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10c01e6e-81e5-43d8-9461-9922e1becee0" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,004</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58264a1b-aee5-4602-afd8-1efd612770de" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,383</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5de1b1b8-a430-4967-b397-210ab8bfd7a6" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,142</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_138d3184-c9a7-47e6-9d94-7795af279a53" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,221</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdae3e93-c549-487a-8101-7f2b77922537" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,862</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income attributable to non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49b9ef3c-1cdf-4c7e-ba7d-0ca8c6d5e068" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">471</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5963a77-7fa7-4b7d-a95c-dbff10b4e920" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,027</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net income attributable to Astrana Health, Inc.</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35c555c2-51f9-4068-a585-bfd0a602f1f4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,692</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_543d0035-8567-4e5f-a5a4-08aa0c2ee1af" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,835</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; basic</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1544e84c-5a9b-4ba1-9a8f-b9bd77192304" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a94f5a43-33ce-493f-a66c-9adb99d44390" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.31</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; diluted</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f52787d-9a4d-418d-95dd-848bb9557000" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5259718d-9a7a-4dee-a7ce-73fd3a54bd5e" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.31</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="stockholders_equity"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDENSED CONSOLIDATED STATEM</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS&#8217; EQUITY</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(IN THOUSANDS, EXCEPT SHARE DATA)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(UNAUDITED)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.694%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.818%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.999%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.278%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.599%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Mezzanine<br/>Deficit &#8211;<br/>Non-controlling</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Outstanding</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid-in</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Retained</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-controlling</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Interest in APC</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Earnings</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Interest</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_351abcc8-ca9e-4b74-b195-82ce5aab6aa0" contextRef="C_8243a6ab-ccef-4b27-a5e5-fc7c8cc5d6bf" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">202,558</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3bdb4bc-937d-4b52-b073-f72df8ebd940" contextRef="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">47,929,872</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3883d049-f7f7-4f3c-b20e-bcdeae0962ae" contextRef="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f17f710e-31d4-441b-93c9-9329f04af848" contextRef="C_61b01747-808d-4a48-a5cf-a6bdc4b2b455" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">426,389</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eae452ba-3691-47b8-8b57-481aea20ad58" contextRef="C_fd421a2b-dd0d-4238-b483-99535258a1cf" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">286,283</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0219b2d-16f4-4e32-92d7-9c386139dcc3" contextRef="C_c4024cc1-119f-4d5f-ae31-02955c23c53f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,006</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04f7c596-9d84-489f-9815-5f75469f918a" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">716,726</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a3be08a-9e24-493a-8992-ea84b635884f" contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7" name="us-gaap:TemporaryEquityNetIncome" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,564</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b0968b9-1a55-4763-8075-c779f18853a1" contextRef="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,692</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fff54f8-5c34-470f-8562-8d2e34712b66" contextRef="C_ea90d243-5c67-40e3-a543-1955b487feeb" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,093</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e2528d0-0c3f-4e22-9fbf-631cc28fbf2e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,785</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3bf0fde8-703d-42c7-8fcb-2009509fd14e" contextRef="C_ea90d243-5c67-40e3-a543-1955b487feeb" name="us-gaap:MinorityInterestDecreaseFromRedemptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3d85dcf1-cc72-4c3b-b62c-b1a8bcabf7c9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:MinorityInterestDecreaseFromRedemptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares issued for vesting of restricted stock awards</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ebeb762-cc96-441a-96be-17db233cdc1d" contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">388,173</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a692072d-30c3-476e-8f02-c61ee7d9671d" contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55" name="asth:SharesIssuedForVestingOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_487f3faa-b817-4ad3-aa6f-f390d287fb79" contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f" name="asth:SharesIssuedForVestingOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,053</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0adf4ec9-50a0-4379-9b6f-b7889285c3cc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:SharesIssuedForVestingOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">4,052</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of subsidiary's shares</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_019a2bd2-a217-499e-aa3f-0e9636ad3526" contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0cb56820-6891-4cdc-9706-635a429eec1d" contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,867</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26bec014-6ede-411f-a80e-4582cd50e1bc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,867</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of shares for Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41844e05-e020-4bfc-bafb-024a62a6efd6" contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,683</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ad7a852-1ba0-45b9-a112-1377b6b2dd24" contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_849370d3-3196-42e4-ac33-0ed07de33f59" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividends</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88e8823f-d43c-41a0-a6a2-347cbd9b22e9" contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7" name="us-gaap:TemporaryEquityAccretionOfDividends" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">27,295</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3d166fc-71e8-4b56-9740-19f5968eb9a0" contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">699,896</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_888cd53d-a87f-4a80-9b3d-52793fa06533" contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">21,935</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01efa4de-a956-4c15-8c3a-7a14044e763a" contextRef="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01592a62-ddf3-4276-932e-1234b6bf9965" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">21,840</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b87abc3-412d-41fc-89f7-8b4f11d93917" contextRef="C_56bfe089-97e1-4466-af03-ff2f279f2e29" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">232,733</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3cd50716-bc1c-453d-b239-63565757502a" contextRef="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">49,028,624</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e36b74de-a5de-4424-b4cf-dc42d54811d5" contextRef="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c078ef6-edd1-4dae-a651-4783682d46de" contextRef="C_af055ce3-c87f-4637-a806-c95905a23203" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">452,439</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c808bdc-b6af-4fa6-bd18-a22c1e3e623f" contextRef="C_2f80e474-09c5-4498-a350-2d08cecdfc30" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">292,880</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07f0594f-2c21-4ecf-9c23-9484afc7686d" contextRef="C_1a4f7a0c-078b-46b3-a572-4429ae7dc5bf" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,071</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b79ab2ea-9ef2-4121-ad0b-4ad7d2b81d33" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">750,439</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:27.694%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.818%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.999%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.539%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.278%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:6.599%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Mezzanine<br/>Deficit &#8211;<br/>Non-controlling</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Common Stock Outstanding</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Additional<br/>Paid-in</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Retained</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-controlling</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Stockholders&#8217;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Interest in APC</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Shares</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Capital</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Earnings</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Interest</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Equity</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2024</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_63f7abd1-116a-414f-b79e-c0345e851e5a" contextRef="C_8ada5766-cd70-45e8-a299-c4904c89c0e1" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">205,883</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6f641717-abd7-4809-a1f5-5fe1df85b1e3" contextRef="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">46,843,743</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41fb4278-975a-4ac3-b8de-e58ca25f9650" contextRef="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3530213b-6bce-4ea4-88e3-c60a07395330" contextRef="C_087d9c30-c670-47d7-b3cc-1831b12e4e0a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">371,037</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b29fb42b-c40d-4e9d-a84e-0b045f5ade2f" contextRef="C_6ecdd9eb-4e61-4714-82a4-da270a6dfb36" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243,134</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55b7f2b2-e835-41f1-afdd-42de9b39afe8" contextRef="C_3ff71d2b-ebbc-4683-8c33-29859e53eefe" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,433</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4987ebf6-1121-4184-9ac3-0b8f28f2bd01" contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">616,651</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_329ea8b8-d243-49a2-a6f0-db668ba440e4" contextRef="C_36e16046-d6d5-4ac8-87fa-8e331f7c735a" name="us-gaap:TemporaryEquityNetIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">326</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2bf617bc-1c9e-4d3e-99e6-71391666aca1" contextRef="C_86a4c592-7bab-4c59-bf8a-cfdcf0ecc6d0" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,835</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98e39c72-9a58-4458-83b5-0c2b1336bd49" contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,701</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_972ed63f-f913-4c21-aba8-c949038b5b3f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,536</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6595aab-897c-46e1-9d50-f54e9c076ea8" contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24" name="us-gaap:MinorityInterestDecreaseFromRedemptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6698b1d6-ec3c-414a-90c6-83043bfea434" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:MinorityInterestDecreaseFromRedemptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sale of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9aa24410-db75-4d44-b905-5eb406a007dc" contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9670550-35fd-4edc-9899-045ec75f2d8f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Shares issued for vesting of restricted stock awards</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4bc13b81-45cd-47d8-998d-da21aa4d710b" contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,149</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d29ec02-96df-45bb-a28f-4fcfc79e6de9" contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199" name="asth:SharesIssuedForVestingOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,407</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6c6696b-9d74-492a-8879-088ccd3db41b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:SharesIssuedForVestingOfRestrictedStockAwards" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,407</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5442c047-fc69-43c5-b941-9331e5a660d8" contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,748</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_991e0231-79ba-4913-8038-b22f4f0f5a60" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,748</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of shares for business acquisition</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_186bfa23-5655-4e8f-81c8-5e19ee56bbfa" contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">631,712</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_999d9f51-a2c6-4bd1-a2f8-e5a0e99a207e" contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5f21be7-8ce5-4eac-8302-bdd9d4e7453b" contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,951</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87099183-9824-4266-87ec-0d8908d252cd" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,952</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquisition of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99aec90f-a5b4-44a0-83a7-6eb79c26ed5b" contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c" name="asth:AcquisitionOfNonControllingInterestShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">22,340</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a40219e9-036d-48e5-a7b5-c3fe6661efca" contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199" name="asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">856</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20da1691-3363-494d-b90d-52e4d3141202" contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24" name="asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">321</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57629ecc-97fa-4598-8dd8-f0093b74d136" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">535</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividends</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a75b707-72b9-4da7-9d51-b9fb54d9051a" contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ed08265-51ef-4f32-b345-c0e834ac8f25" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Balance at March 31, 2024</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8163bbf0-7c3a-4db5-94ab-afa060ddf8a2" contextRef="C_3bad1aa8-8683-4fde-8415-afca6a2c5cdb" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">205,557</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc0d8638-ae0e-4019-b679-9019d167243b" contextRef="C_b0e202af-bc90-4be3-a147-eec79b8a2bef" name="us-gaap:SharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">47,458,264</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_438703b3-e967-406a-a61c-f695477b8ea4" contextRef="C_b0e202af-bc90-4be3-a147-eec79b8a2bef" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8cb139f3-6623-47a7-9b7a-6301a5d4faaf" contextRef="C_9bb5d082-e558-46fe-93e8-c3308bb50e45" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">395,473</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e90929a-b2e0-4211-a752-786dd67d2cfe" contextRef="C_4620cbd3-1893-4a0c-9d80-94c7c2d51650" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">257,969</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f4ce85a-cdee-4eab-9c66-dff6ccc76db0" contextRef="C_ed9a6b0a-2f21-4044-9c6e-5d6fe11bd1cf" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,485</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57a6ead4-feb0-45b4-9af1-cd3730f7a3cc" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">657,975</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="statements_of_cash_flows"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CONDENSED CONSOLIDATE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">D STATEMENTS OF CASH FLOWS</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(IN THOUSANDS)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(UNAUDITED)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from operating activities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3dd80437-6ca6-4655-a2b2-b9e1ccff94d4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,221</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_135286d0-7ebd-4636-8607-509c8c2518df" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,862</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;text-indent:5pt;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments to reconcile net income to net cash provided by operating activities:</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7d2a5c0-8ee3-4f3f-81ce-ecf41b7c7ccf" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,849</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc947375-f4db-4974-8d1d-bf9511e517d7" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:DepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,096</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of debt issuance cost</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b05e5666-0948-479c-bbcf-50bf52fa0ca8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">691</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d686d418-0394-486f-832b-cc0b1cdaf7df" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:AmortizationOfFinancingCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">458</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Share-based compensation</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8b4fe80-eb5e-42a5-9ced-31de73f694ef" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,811</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_32dff704-e81c-432e-9a34-15d54aa9e72a" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,748</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-cash lease expense</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ad83b54-1dbe-4554-b2c5-6b9fda3a129b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NoncashLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,287</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0800c566-6133-4976-8096-dd33e0a45b60" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:NoncashLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,155</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of contingent consideration liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_685e33e1-f1c4-43b5-a9cf-f89e6992be01" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:ChangeInFairValueOfContingentConsiderationLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,407</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c1893f7-4ca2-4906-b60d-940900a19983" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:ChangeInFairValueOfContingentConsiderationLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss on debt extinguishment</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59cf6c1f-ce5a-41bc-bdd4-436835654ee8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">375</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_228e181e-911a-4faa-83c3-d3e72b7e12c4" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized loss (gain) on investments</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5593dc2d-613e-48d2-8b90-290e312d673f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:UnrealizedGainLossFromInvestmentInEquitySecurities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4934c1f-ae3c-4d4d-bb9f-d6c42ca7347d" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:UnrealizedGainLossFromInvestmentInEquitySecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,099</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss (income) from equity method investments</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9835e312-80f3-447a-977f-f7f53802264f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">867</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_032a3426-59e2-4a6f-b872-3741965b9217" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">632</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5632009-5ed1-4cdd-ae0d-1226904d23b1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">358</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a46794e-042d-4250-9e0f-d444889a8853" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">7,248</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:15pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:2.773%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aed32e12-b45c-41ea-a2b7-2176ce73dbfe" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:ProceedsPaymentsFromOtherOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">557</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a5a5c52b-9c7f-4a0f-9b5d-3e4414d6aef5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:ProceedsPaymentsFromOtherOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,795</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;text-indent:5pt;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Changes in operating assets and liabilities, net of business combinations:</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36c341dd-c083-47aa-b131-70dfc4809012" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,368</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0b90830-26e3-41eb-8993-f78d14795e3c" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInAccountsReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,128</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net &#8211; related parties</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2fc1b011-30a6-40be-ad33-acf13b65f301" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,589</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29f4c2a5-1ce8-4cf4-ba99-1947bd6b142e" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInDueFromRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,374</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dc6aa8ea-4304-45ed-90e6-2c1760562608" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,688</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a98fb2cb-f034-47c8-bf33-971732fc1911" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInOtherReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,403</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_486d67a7-dd5c-48c5-9b1e-1cf15978a66f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,674</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b61d482-8233-4650-a346-8240c11f9526" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,255</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fff54b26-fea4-4573-a714-8d3ecee9c0f5" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">314</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ef1d8e34-6739-418c-afb2-c79e053027a9" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">92</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bea2f10a-0eb6-446e-8c52-cf2c45c7aeb0" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6758377e-b79e-44f3-b249-7e2dc33dd22f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">905</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiduciary accounts payable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2860cd1-4282-4459-b97d-f044eef029ea" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,383</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72fb776f-074d-4481-ae4b-20247aefb1a6" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInOtherAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7c8eb39-92d8-4656-98dc-943bc614e6d8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:IncreaseDecreaseInMedicalLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,319</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9268c9e-1c8f-4ece-b59f-d46d440b5c2d" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:IncreaseDecreaseInMedicalLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">808</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b2aac2f-662f-4031-b628-7489715727ad" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,514</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f84dc559-3387-4fd8-8560-6725672cdc4b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInIncomeTaxesReceivable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">14,542</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c6431c84-07c9-4be1-8dd0-57175a8113df" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,090</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_17496f33-f939-4fa9-b8ee-dc341ef622f1" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,083</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:25pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:4.627%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_887f37f5-105b-4a62-aeb6-f75a12b85860" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">531</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d08ea1a6-ec48-4c36-8857-e630165eac83" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">298</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by operating activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9c84a5b-8919-41d2-a76b-dfd34876f2f1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,627</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5f1b48b-31c9-4088-9122-43a1b9f940e8" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,977</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from investing activities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments for business acquisition, net of cash acquired</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fde0019-959a-48e9-b63f-8d64afbd2cd6" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36e1fe20-c793-44cf-bec0-3cf87c524be5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,649</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from repayment of promissory notes, including those with related parties</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9c5642a-0ed5-4b74-8f0a-705237a43792" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">600</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_065d5acf-c2f3-4787-ba52-848ea920a938" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of marketable securities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6359b168-2f1c-4f55-a47a-2624d6876def" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_efecc4fd-3eaa-42da-bec0-e7a506a704d8" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Issuance of loan receivable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9299c484-e3e1-4be0-8210-754ef95c3d7d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsForProceedsFromLoansReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8a96ff7-2388-43be-9b0b-2cee8267f1ba" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsForProceedsFromLoansReceivable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchases of property and equipment</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e077a8ae-010f-4859-87ab-88564fce28de" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,070</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6efa31e3-7ad8-4662-844d-9d3f9aa7b3fd" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">369</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Distribution from investment - equity method</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_259f69b4-f508-4458-8b57-456c29f8f603" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9fe1317b-39e9-463f-90ff-887b3ce1c601" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf6cdcf0-3a78-4cd1-80f3-2cee0ad199be" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,394</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99e01cda-dd29-4169-84fe-e6043e258ec5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">71,039</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash flows from financing activities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividends paid</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_155f2347-1c00-4b56-8585-99f07634bf5c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,455</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d371c1d6-e54f-4754-9e71-b9b46ac21e05" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">95</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Borrowings on long-term debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce3ce7cb-9ea9-4d68-8e6b-e20706a5896f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">412,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41ee47c6-37e3-401b-a473-4194a9421096" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">110,000</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repayment of long-term debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a965e19-c398-425d-a906-8a4d6fe82537" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RepaymentsOfOtherLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">428,232</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c625852a-635c-483c-aa02-bb1974fbcc9b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RepaymentsOfOtherLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,500</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payment of finance lease obligations</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62eafb1f-eaa7-48e4-af0d-bd314a908635" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6858e9aa-2e85-456a-9671-556a5a05ff15" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred financing cost</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd800177-3921-46c8-87ed-1ab456b2e18e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,241</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d81e7f0-63f7-491d-9aa1-65b3ba31762c" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsOfDebtIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from ESPP purchases</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_227b0ba0-c60a-4b20-9d5e-2bf0e14e05e2" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8987854-8dde-40e0-b447-bd9841de9b2e" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Taxes paid from net share settlement of restricted stock</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68fce2b4-eb02-41b5-9eef-888f846eecf4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,052</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b45ab5d-be3c-435e-8c68-02156a1d416b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Repurchase of subsidiary's shares</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33e49205-8035-4345-8068-bfdd7d32e181" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,316</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9adb03b8-82ca-49fb-9003-1ffd0fd23ba7" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Proceeds from sale of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a5cb29d-a621-4b47-ae55-284c97ebe12e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4e977f82-10cf-48c0-ab6f-08c2e578720d" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ProceedsFromPaymentsToMinorityShareholders" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0f628ca1-6148-4e9d-952c-a608d4347390" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsOfDividendsMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ef0a426-b212-46bc-9ba8-373e9704649f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsOfDividendsMinorityInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by financing activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd881de1-fbe5-4282-a6b5-7e5c0c1f0ee9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">44,170</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_273b3e13-50f1-4e68-a8e8-c54c440775bb" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,351</ix:nonFraction></span></p></td>
     <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b6a0b891-c064-4562-bced-1f8aca610c3c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">29,937</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b3e095b-6656-4ee7-8418-778b19bf873f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">41,289</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and restricted cash, beginning of period</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6739108b-4670-4490-9c06-129c86ef0a73" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">289,101</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e82728d-a2aa-43d0-94d5-7d95296aa7ee" contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">294,152</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and restricted cash, end of period</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4509f15e-c81d-43ad-b495-b55fc16f09c2" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">259,164</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4631b88-67e0-4517-94d3-3d613410344f" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">335,441</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosures of cash flow information</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8952804f-eeb2-4edf-8115-750a04dc9b4a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeTaxesPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,338</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2849a4d0-3ed6-49d8-af34-2469252a014e" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeTaxesPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">194</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5.05pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.933%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2d53ac4-f978-499f-ad13-5d0a6f67d559" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,360</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eaa1755f-1816-496f-872b-3a71140483fc" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,430</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental disclosures of non-cash investing and financing activities</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Business acquisition in accounts payable and accrued liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b78c700-6b2f-4bf9-b0ec-1ade89251f7f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e62aa25a-429a-4ff2-baf7-23f8ea103e5f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,935</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Right-of-use assets obtained in exchange for operating lease liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a7741e2-19ad-4537-b15d-854525b1a5a5" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,729</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceec2258-4db5-4736-8906-1bad3b1bac29" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,910</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issued in business combination</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22c16f3b-cfd6-436c-86c1-122ce74464ca" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f7518c5-73ac-4924-a221-8f3583a63f87" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:StockIssued1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,952</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase of investments - equity method in accounts payable and accrued liabilities and other liabilities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0861ee15-5152-450a-8ead-89bb4bd114c6" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_48485bdb-1b20-4364-ac0a-dd7c5ded8106" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,487</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Draw on letter of credit through Revolver Loan</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3314681d-9914-400a-8415-d2bf9d9f55a8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:DrawOnLetterOfCreditThroughRevolverLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2efda3d4-5fcb-4286-b46c-34b1d16de714" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:DrawOnLetterOfCreditThroughRevolverLoan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,759</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:5pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:0.92%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend paid in the form of common stock</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11a7279e-d921-48a3-b6cf-9fc314bcb2a4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NonCashDividendPaidInFormOfStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,935</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e505729-d69f-4b55-86a8-933b15972742" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:NonCashDividendPaidInFormOfStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total amounts of cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:66.993%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.62%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.883000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5a811968-73ea-4efe-bbac-152703f2960f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">258,517</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ca09f3d-f86f-489c-99fe-943c4a446d6c" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">334,796</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6ccfa33c-1742-4f30-ae3f-3d019ffa8016" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">647</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe30c004-5b98-4d7a-85a4-e2d3ca413ca9" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">645</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3b8a69b-4054-4085-8854-d576a0306346" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">259,164</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9a7c2b4-8209-43ca-aed3-18cd74cb290f" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">335,441</ix:nonFraction></span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="notes_to_condensed_financial_statements"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTES TO CONDENSED CONS</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">OLIDATED FINANCIAL STATEMENTS</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(UNAUDITED)</span></p><div><ix:nonNumeric id="F_ea7cf9fe-215c-42bc-af29-b4685c284920" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NatureOfOperations" escape="true" continuedAt="F_ea7cf9fe-215c-42bc-af29-b4685c284920_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Description of Business</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context dictates otherwise, references in these notes to the financial statements to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana Health, Inc. (&#8220;Astrana&#8221;) and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#8217;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based Care Enablement services and Care Delivery with its consolidated Care Partners to serve patients of whom the majority are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;), with a small portion of its revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dd0d7b15-14e8-4a6d-8d4a-bfa1164730da" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segments are Care Partners, Care Delivery, and Care Enablement, which are described as follows:</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Partners</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#8217;s unique Care Enablement platform and ability to recruit, empower, and incentivize physicians to manage total cost of care effectively, the Company is able to organize partnered providers into successful multi-payer, risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare Advantage, Medicaid, Commercial, Exchange, and Medicare fee for service (&#8220;FFS&#8221;). The Company&#8217;s healthcare delivery entities consist of a network of risk-bearing organizations (&#8220;RBOs&#8221;) that encompass independent practice associations (&#8220;IPAs&#8221;), accountable care organizations (&#8220;ACOs&#8221;), and state-specific entities such as Restricted Knox-Keene licensed health plans in California. These entities are tasked with coordinating and providing high-quality care to patients within Astrana&#8217;s ecosystem. This helps provide a seamless continuity of care among patients in different age groups, stages of life, and life circumstances. The Company participates in the Accountable Care Organization Realizing Equity, Access, and Community Health Model (&#8220;ACO REACH&#8221;), and in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve care coordination  for Medicare beneficiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_ea7cf9fe-215c-42bc-af29-b4685c284920_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Delivery</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#8217;s Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Primary care clinics, including post-acute care services;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specialty care clinics and inpatient services, including cardiac care, endocrinology, and ophthalmology, as well as hospitalist and intensivist services; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Enablement</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information, all powered by the Company&#8217;s proprietary technology suite.  This platform enhances the delivery of high-quality, value-based care to patients and helps lead to superior clinical and financial outcomes. The Company provides solutions to payers and providers, including independent physicians, provider and medical groups, and ACOs.  The Company&#8217;s platform meets providers and payers wherever they are on the spectrum of total cost of care, offering solutions for fee-for-service entities to providers open to taking upside and downside risks on professional and institutional spending, and across all patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#8217;s wholly owned subsidiaries that operate as management services organizations (&#8220;MSOs&#8221;), which enter into long-term management and/or administrative services agreements with RBOs and other providers. By leveraging the Company&#8217;s Care Enablement platform, providers and payers can improve their ability to deliver high-quality patient care and achieve better patient outcomes.</span></p></ix:continuation></div><div><ix:nonNumeric id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" escape="true" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85b98b65-6f9e-43ce-8578-aedd2d023d7e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying condensed consolidated balance sheet at December 31, 2024, has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited condensed consolidated financial statements as of March 31, 2025, and for the three months ended March 31, 2025 and 2024, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025. In the opinion of management, all material adjustments (consisting of normal recurring adjustments as well as intercompany accounts and transactions, which have been eliminated) considered necessary for a fair presentation have been made to make the condensed consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or any future periods.</span></p></ix:nonNumeric></div><div><ix:nonNumeric id="F_3402a905-6eb8-4a8f-a437-def8d21aa4af" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ConsolidationPolicyTextBlock" escape="true" continuedAt="F_3402a905-6eb8-4a8f-a437-def8d21aa4af_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, and the condensed consolidated statements of income for the three months ended March 31, 2025 and 2024, include Astrana&#8217;s wholly owned subsidiaries and consolidated VIEs. All intercompany transactions and balances have been eliminated in consolidation.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_1" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_3402a905-6eb8-4a8f-a437-def8d21aa4af_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The unaudited condensed consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read, or have access to, our audited consolidated financial statements for the fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_45a400fc-8904-46df-95ce-aaded9ba3da9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:UseOfEstimates" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment assessment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including estimations of affiliated hospitals&#8217; claims costs which involves assumptions for IBNR, such as utilization of healthcare services, historical payment patterns, cost trends, seasonality, changes in membership, and other factors), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3a81edac-6ce1-48bf-8324-8804a2add196" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:BusinessCombinationsPolicy" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combinations</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination which are expensed as incurred.</span></p></ix:nonNumeric></div></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_2" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_de13ce27-c4e9-43bb-a968-05bf6c06ced6" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true" continuedAt="F_de13ce27-c4e9-43bb-a968-05bf6c06ced6_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_de13ce27-c4e9-43bb-a968-05bf6c06ced6_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains its cash in deposit accounts with several banks, which at times may exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents and restricted cash. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1022cd4b-56e1-4f5d-8c90-1bc59bca9ec9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashUninsuredAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">266.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e33d6aa3-928d-40aa-8f18-3367e82decad" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CashUninsuredAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">332.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_3" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_4"><div><ix:nonNumeric id="F_5e39fa57-c443-455b-be60-1ee23154469a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" escape="true" continuedAt="F_5e39fa57-c443-455b-be60-1ee23154469a_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Receivables, Receivables &#8211; Related Parties, Other Receivables, and Loan Receivables</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables are comprised of accounts receivable, capitation and fee-for-service receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated in the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s loan receivables consist of promissory notes that accrue interest per annum and are recorded and stated at amortized cost plus accrued interest. Interest income is accrued based on the outstanding principal amounts. As of March 31, 2025, promissory notes are expected to be collected by their maturity dates.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_4" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_5e39fa57-c443-455b-be60-1ee23154469a_1" continuedAt="F_5e39fa57-c443-455b-be60-1ee23154469a_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation receivables relate to each health plan&#8217;s capitation revenue and are usually received by the Company in the month following the month of service. Capitation receivables also include receivables from the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) related to the Company&#8217;s participation in the ACO REACH model. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ecdbcf97-895f-4db8-9ea9-178b48aae1bf" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" format="ixt-sec:durmonth"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months after the risk pool performance year is completed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other receivables consist of amounts due from the seller associated with acquisitions, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains reserves for potential credit losses on the receivables. Management reviews the composition of the Company&#8217;s receivables and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected, and adjustments are recorded when necessary. Reserves are recorded based on historical trends. Any change in such an estimate of reserves is recorded in the period when such change is identified.</span></p></ix:continuation></div><div><ix:continuation id="F_5e39fa57-c443-455b-be60-1ee23154469a_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided, and collection is reasonably likely to occur. The Company continuously monitors its receivables collections, and it expects that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_5" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_6"><div><ix:nonNumeric id="F_f389b1ec-9fee-4268-9043-1439149cd12c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ConcentrationRiskCreditRisk" escape="true" continuedAt="F_f389b1ec-9fee-4268-9043-1439149cd12c_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risks</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts, as used by our chief operating decision makers (&#8220;CODMs&#8221;). The condensed consolidated statements of income present disaggregated revenue by service type. </span><span><ix:nonNumeric id="F_bc3d38a6-a9e0-44ab-a8b3-88cee3ea1cd3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DisaggregationOfRevenueTableTextBlock" escape="true" continuedAt="F_bc3d38a6-a9e0-44ab-a8b3-88cee3ea1cd3_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents disaggregated revenue generated by each payer type </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands): <br/></span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_bc3d38a6-a9e0-44ab-a8b3-88cee3ea1cd3_1">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"/>
           <td style="width:1.62%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:12.883000000000001%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1.62%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:12.883000000000001%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b7029f5-8635-430d-be7b-46aadc21e749" contextRef="C_1dbcd7f4-15f4-485f-84c9-42d3bbcb06e1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">46,081</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78bbd81b-dd08-4303-9748-878fbdbf1b5c" contextRef="C_db6068f0-807f-4b86-b6ef-af05a0370ebd" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">49,512</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicare</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ebdf9ef-b18a-486e-8d89-13209640d661" contextRef="C_9feee836-d0ff-463c-b3e6-a83e692c0715" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">389,352</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0003559-4ac2-42e9-b353-629066a5b762" contextRef="C_38996325-e035-49ee-a6cb-7fcc69167cfe" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">246,564</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicaid</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7390d03a-d8e4-42e1-9705-0bd57873f4cd" contextRef="C_3201267a-d634-4169-826d-98d5f707cdfe" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">173,158</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ab08718-dcec-4dea-9f5c-7cfa770093c0" contextRef="C_b672f703-aedd-4bf1-94c4-160d381f1498" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">81,263</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other third parties</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_723d30cb-59d5-4698-9f48-bee25395503b" contextRef="C_4a4c4fe5-1018-477c-a9b5-a907e028c99f" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,799</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e26ff5d0-ada6-4dfa-b629-a6412489411f" contextRef="C_4c0af0d9-a715-49c1-818f-7bd0aa182dbe" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,017</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2d6598b3-30f5-4bd6-8014-c2a1453b67ab" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">620,390</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c5f9fe47-934c-4445-bf0e-0dfa44ca4025" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404,356</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_6" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_7"><div><ix:continuation id="F_f389b1ec-9fee-4268-9043-1439149cd12c_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d63aa031-fd9c-46da-8454-0f707b5e218e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" escape="true" continuedAt="F_d63aa031-fd9c-46da-8454-0f707b5e218e_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"/>
           <td style="width:1.16%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:13.343%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1.16%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:13.343%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2022384a-224f-451f-8676-809b6847efc8" contextRef="C_5fb914a7-0520-41f4-83cf-9c07f5e46feb" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">33.1</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_647d974c-0189-4516-9286-ffd801c04799" contextRef="C_dcf3f17e-da41-43d4-8765-fa98896d0781" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">34.0</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer B</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03442894-e77f-40de-94a4-759ea4ffb4e1" contextRef="C_95571c44-ac25-407c-a11f-70a6547c78ed" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">15.3</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7527b08b-fdf8-4956-95e8-19272107893a" contextRef="C_c2e67330-5049-40a7-b292-d46f9324eb05" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">13.5</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer C</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0971660-79b0-44b9-80b1-ce99adb33610" contextRef="C_598d420b-fa2c-4abf-b7c7-2b099761021d" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.5</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer D</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c03b85f9-6a2e-4306-a0fe-a4efabcaeaa1" contextRef="C_9adc0920-b8bd-47d0-97bd-354c3679c0f5" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.3</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8321e09-9c66-40b3-94a6-79259dcb066b" contextRef="C_015f1704-89e6-4c03-afae-18a5d32c8336" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">10.1</ix:nonFraction></span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Less than 10% of total net revenues</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers that contributed to the following percentages of receivables, net, receivables &#8211; related parties, and other receivables:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:64.527%;box-sizing:content-box;"/>
           <td style="width:1.1%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:14.637%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:1.1%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
           <td style="width:14.637%;box-sizing:content-box;"/>
           <td style="width:1%;box-sizing:content-box;"/>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of March 31,<br/>2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,<br/>2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_23f1ae0f-0862-44a0-8b9a-a966304bfd16" contextRef="C_d5454de7-c7d8-4458-b50e-0ea3109e6ecd" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">44.3</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddb6972f-1632-4a43-9d8d-cf89519b375c" contextRef="C_d3593fce-7c42-4759-889f-3843431c0c72" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">38.9</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer F</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26ff32f9-a107-43e1-a3f1-36245b02e73d" contextRef="C_40324dab-ee91-438e-8fee-dd30b551fea0" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">17.6</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7718f0cf-eea8-4b54-96b1-25a71a4e7872" contextRef="C_6876888c-242a-4666-a5ca-046144b65e95" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">16.1</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f527da7-3c89-4c2d-aa73-c0e08236d150" contextRef="C_9d87bcf2-94d1-468d-bf39-ab8853daaa29" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">12.9</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2e4941a-62fa-4152-a4fb-3f4e2fa66c0a" contextRef="C_f121a13f-7f62-4911-af4c-cdc74d7b71a9" name="us-gaap:ConcentrationRiskPercentage1" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">18.3</ix:nonFraction></span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
         </table></ix:nonNumeric></div></ix:continuation></div><div><ix:continuation id="F_d63aa031-fd9c-46da-8454-0f707b5e218e_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_7" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_8"><div><ix:nonNumeric id="F_7531d51c-a766-47c8-ac94-557e03bb8e14" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" escape="true" continuedAt="F_7531d51c-a766-47c8-ac94-557e03bb8e14_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company receives payments from the following sources for services rendered:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial insurers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal government under the Medicare program administered by CMS;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State governments under Medicaid and other programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other third-party payers (e.g., hospitals and IPAs); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual patients and clients.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue primarily consists of the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation revenue;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk pool settlements and incentives;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management fee income; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FFS revenue.</span></div></div></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_8" continuedAt="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_9"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_7531d51c-a766-47c8-ac94-557e03bb8e14_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related collection risk for such services may vary by type of revenue and the customer.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d6f019d-6c7e-4daa-ae5e-31b848e9efe7" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses a recognition threshold of &#8220;more-likely-than-not&#8221; and a measurement attribute on all tax positions taken, or expected to be taken, in a tax return in order to be recognized in the condensed consolidated financial statements. Once the recognition threshold is met, the tax position is measured to determine the actual amount of benefit to recognize in the condensed consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></ix:nonNumeric></div></ix:continuation></div><div><ix:nonNumeric id="F_59597c4e-9c15-4b97-89b1-cf5c79ab79ed" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e_9"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Not Yet Adopted</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221; to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a significant impact on its consolidated financial statements and related disclosures.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03 &#8220;Income Statement &#8212; Reporting Comprehensive Income &#8212; Expense Disaggregation Disclosures (Subtopic 220-40)&#8221; to provide disaggregated information about certain income statement costs and expenses. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the new standards discussed above, there have been no other recent accounting pronouncements not yet adopted that are expected to have significance, or potential significance, to the Company&#8217;s financial position, results of operations, and cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></ix:continuation></div></ix:nonNumeric></div><div><ix:nonNumeric id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:BusinessCombinationDisclosureTextBlock" escape="true" continuedAt="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Combinat</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ions and Goodwill</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, the Company finalized the purchase price allocation for Advanced Health Management Systems, L.P. (&#8220;AHMS&#8221;) and is in the process of finalizing Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks (collectively, &#8220;CHS&#8221;). Therefore, the balances were subject to change as a result of any working capital adjustments, primarily for the finalization of medical liabilities and CHS&#8217; participation in government savings programs for the 2024 performance year. As of March 31, 2025, measurement period adjustments impacted receivables, net, other receivables, accounts payable and accrued expenses, and medical liabilities with a net decrease </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b179c983-bdb7-4bd5-b554-d1e5e7545a62" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GoodwillPeriodIncreaseDecrease" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">goodwill.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_1" continuedAt="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AHMS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 31, 2024, the Company, through its wholly owned subsidiary, purchased all of the outstanding general and limited partnership interests of AHMS. AHMS&#8217;s wholly owned subsidiary operates a Restricted Knox-Keene licensed health plan in Los Angeles, California. The total consideration for the acquisition was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e20d289-f488-4a43-9b1b-96fcdc06d1b2" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">60.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, consisting of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_308dc7b7-4a7a-42b5-9598-e032bd7457f5" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">63.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash funded upon the close date and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84f9e23c-4b44-4dee-a665-1d03184aea3f" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="asth:EstimatedWorkingCapitalAdjustments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due from the seller based on estimated working capital adjustments. The consideration is subject to changes based on working capital adjustments, which are settled within one year from the close date as per the purchase agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_504affeb-419c-49da-bdb9-2f46220b95ee" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" escape="true" continuedAt="F_504affeb-419c-49da-bdb9-2f46220b95ee_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"/>
         <td style="width:1.8%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.099999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_609ae028-5de7-4f59-a67e-1f95b13c2dc3" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">63,935</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due from seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ced17487-f340-4037-bd44-4825f73ad4e9" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,995</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1a6876c-0be0-48d2-97e8-b995d770b321" contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,940</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1071428c-366a-4731-b697-362430e3b204" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,950</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad5f0473-5c7e-42cd-a0ee-ae164cff2c2e" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,007</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38e87820-4dc9-415b-a6fc-d5dc910750ef" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be5715e0-1219-4a08-a94b-fb0cb2b85c40" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,600</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1253393b-dcd6-416b-b134-f8083805d4d0" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,571</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cabcef0c-d89c-4c26-b5a9-c66a77d62ca8" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c3502e0-4769-40f6-8447-0e9ebdaec58e" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94,464</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7baac5ff-2973-4fe7-bf4d-f8ce8c229f8b" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,001</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c305bc2-c924-4f92-8459-0361037f9030" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,093</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cbe6560-a7f4-4d39-a3ef-5b941c25426b" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,430</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d37ac325-4809-4d50-8991-c955dc5bb2fb" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,524</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5f2e955-db52-42c7-a416-6b0ec899f617" contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60,940</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">22</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_2" continuedAt="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CHS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 4, 2024, the Company and its affiliated professional entity acquired all of the outstanding membership interest relating to CHS. CHS partners with independent providers in caring for over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71b52db3-49d9-4605-ad7c-ae1a95518a05" contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b" name="asth:NumberOfMedicareMembers" unitRef="U_Member" decimals="INF" format="ixt:num-dot-decimal">129,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members across </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e47116e6-63f1-4fa4-bc35-000d7d7b0e77" contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b" name="us-gaap:NumberOfStatesInWhichEntityOperates" unitRef="U_State" decimals="INF" format="ixt:num-dot-decimal">17</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> states. CHS provides comprehensive support for its physician partners by providing management services, risk contracting, and population health capabilities, including actionable data and other tools, to deliver care coordination and closure of gaps in care. CHS provides additional services to secure and deliver favorable value-based contracts with commercial and other health plans. Total consideration for the acquisition was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2cbb6f08-e440-478f-9c03-3391415c4909" contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">47.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, consisting of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aac2c3da-e47c-431d-91fa-b506e8a2db32" contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">35.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash funded upon the close date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9a05571-e8e0-4df9-ae7d-fdacbaabc705" contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b" name="asth:EstimatedWorkingCapitalAdjustments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due to the seller based on estimated working capital adjustments, contingent consideration fair valued at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e41e7f11-875f-478e-9fb7-57ebccc05048" contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_44ec5872-1e0c-45b4-9117-864a912c20af" contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b" name="asth:ReplacementOfRestrictedStockAwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of replacement restricted stock awards. The consideration is subject to changes based on working capital adjustments, which are settled December 31 of the year following the year in which the closing occurs as per the purchase agreement. See Note 19 &#8212; &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent consideration.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_504affeb-419c-49da-bdb9-2f46220b95ee_1" continuedAt="F_504affeb-419c-49da-bdb9-2f46220b95ee_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"/>
         <td style="width:1.8%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.099999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CHS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a58def1-c26e-403b-91ae-514bf4fdbaf7" contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,322</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due to seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_780c163d-65db-44a9-b6b4-03c44b25ed95" contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e" name="asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,944</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent consideration</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_538a7b6f-f657-480b-81d9-39da32d3bc67" contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,154</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issued and replacement awards</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_061930a5-f911-4e74-9809-b1bc2935b0ee" contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9ff3f30-d4d7-48a9-8ffa-9f9904dfe51a" contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e" name="us-gaap:BusinessCombinationConsiderationTransferred1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,538</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21dfe2d8-9137-4e1b-bda6-bb8bbd1d7bdd" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,556</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82be8699-dd04-409e-bc28-010379de9f5c" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">92,393</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53c48cca-d272-4809-881b-dda178481b43" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,336</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12dea3c3-5302-4958-aa96-cdd5a7c928ca" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">357</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b008672f-5678-4cf1-a376-324875f7c67a" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,200</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc0ec777-10da-40c8-be21-28606415459f" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,444</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be9a279e-f099-41c5-82c0-c25e8727c863" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d0ed6be-3ca6-46b0-8824-37b93edacda6" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">168,064</ix:nonFraction></span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7547163b-2686-491b-b54a-eed65326f0e3" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">68,276</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_db07eece-9eda-45bc-b640-bca06e22417c" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52,328</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-controlling interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2be0bb95-51e4-44d1-9350-1b5ee9adb897" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">78</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_648920aa-62f4-4837-a4a5-e40ab323669e" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">120,526</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42257018-1de9-4ae9-88b7-28dd23e2f9a5" contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,538</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">23</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_3" continuedAt="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_4"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Factors leading to goodwill being recognized are the Company&#8217;s expectation of synergies from combining the operations of entities acquired and the Company, as well as the value of intangible assets that are not separately recognized, such as the assembled workforce. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75c8506b-dd13-4d9e-a35c-91764806afdb" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GoodwillImpairmentLoss" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9af223da-5360-41e6-9fe1-acc9b71045c5" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:GoodwillImpairmentLoss" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairment of its goodwill or indefinite-lived intangible assets during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2dccd72a-d6ce-46e7-854e-f206a7279890" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfGoodwillTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the carrying value of goodwill for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"/>
         <td style="width:1.94%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.82%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_333b8719-8ef5-410c-ac66-d7b1c1e6708f" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">419,253</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7812cae-c87c-4232-b812-c5049c55a954" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GoodwillPurchaseAccountingAdjustments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">2,867</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cac6f7fe-bca9-4871-9531-fae83c76a54c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">416,386</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:continuation id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86_4"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_504affeb-419c-49da-bdb9-2f46220b95ee_2" continuedAt="F_504affeb-419c-49da-bdb9-2f46220b95ee_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unaudited Pro Forma Financial Information</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.34%;box-sizing:content-box;"/>
         <td style="width:1.84%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:20.82%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3036d997-ef0d-4319-9c88-2470f10e3637" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:BusinessAcquisitionsProFormaRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">678,640</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Astrana Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2695732-9b2e-4ffe-8dc1-bbe5b36ac937" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19,171</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_274f183f-7f0b-4f63-85c7-ce77bff1fb0b" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.41</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35ffe610-b7a8-4cfb-9b90-678794a94677" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.40</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:continuation></div><div><ix:continuation id="F_504affeb-419c-49da-bdb9-2f46220b95ee_3"></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">24</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_64207ddc-c761-428b-96d6-c1ba75c0179b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IntangibleAssetsDisclosureTextBlock" escape="true" continuedAt="F_64207ddc-c761-428b-96d6-c1ba75c0179b_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_abfaeab9-80fd-48f0-9f0f-3131d173cfbc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:12.803%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.782%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.802000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.782%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a927dde2-4b00-4849-b479-376325fc4e63" contextRef="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,150</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a610ba96-a4b3-444f-a7e7-8411e7f8cc5f" contextRef="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,150</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_322f2540-6eeb-4116-9ead-f404b0835c9a" contextRef="C_92e5a4d9-669c-445f-ae84-87c0d970533d" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fa3de7d-88a2-436d-8734-65ed43f89175" contextRef="C_92e5a4d9-669c-445f-ae84-87c0d970533d" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_763dd215-6bd5-4c47-90d8-7ec4fecb0a9e" contextRef="C_3a2ebc98-8101-4cf2-9108-4f593c2d8847" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_8b0ce2b7-6d98-45aa-a79e-af95334cbf64" contextRef="C_3551b884-1dd8-4237-84f2-7b976f23e2cc" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e8c7121-b867-4327-b648-64f587eb77dc" contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171,917</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a11e9fa-2f94-46a6-82be-75e61e30510b" contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">116,499</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ecdfac41-1e97-4245-937a-179b985b82b1" contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55,418</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7fd7b083-04d8-4d07-b2d8-12ad5ba145d1" contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_018cfd56-744a-4b05-acd4-8b7a6f1f004d" contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,832</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6f2c47e-158a-4252-8b33-a08291917dbc" contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,259</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9d4f5af-3259-4296-9e8b-4a0fced21488" contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,573</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_25f4a7e6-66ae-41ae-80b8-913419d073b5" contextRef="C_43ba0bc5-d5da-4f73-96ca-7e4df5bc7e92" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_94b7b890-f6de-4311-a5cf-830903c03978" contextRef="C_1288fe82-ac30-4a05-9186-9dd06073739b" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88f674c6-06c8-4a3b-8672-381f336c2c4c" contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,077</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9bdb8f78-48da-437f-a4e4-0bff0df4bf63" contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,893</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_104f1c58-7fbb-4756-bdb4-b2cf8f94cd2f" contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">47,184</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_e0a217e8-e0c9-44e6-a3c4-da8b743487fe" contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57f04868-1ad2-4c33-b90c-d4c82d318747" contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f4977da-5196-4a8d-b598-cf2025f5bcf7" contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_afd4432a-c167-407e-a697-a3d7b9545e4c" contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0b2d3de-268f-4b51-b3d5-71a63d629491" contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,011</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f51b3301-e0b8-4735-b0f4-d498ead6a817" contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">371</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ff27e0e-76f4-4232-87d2-393f944d2e0f" contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">640</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c82f2e43-663a-4356-87a3-c0ae10ad3f04" contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc9c53c5-89ab-4a35-af4d-fa02f63530eb" contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce3170ed-61b9-4b02-9ac6-3bdb95356404" contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">56</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20c751b6-7be6-47c5-91b0-237da50cad24" contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ae69c67-0b25-4c98-a08a-8b9ade76ba20" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275,054</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b2aad18-ab82-4a80-85da-db7e95b1c00c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">163,138</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ed74e884-c045-46a3-a366-71e6a4cbaf2b" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">111,916</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:12.803%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.782%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.802000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.24%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.782%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa787aee-01c8-4462-ad23-c44d0bd83699" contextRef="C_4a8637ec-690d-4853-a3e3-abf4a49d231a" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,150</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8ceb046b-575b-4233-a1e6-310c89be6bd3" contextRef="C_4a8637ec-690d-4853-a3e3-abf4a49d231a" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,150</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce64accc-bfbd-49f7-8142-4b938ae7a660" contextRef="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b12fcb0e-847b-40bb-b29e-8d1093a36211" contextRef="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,900</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_bf64b945-a88a-4da8-9d5b-59188ea40a55" contextRef="C_eafa35a4-99f0-44d4-a6eb-107f2d35d4d3" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_9cea3c8e-cce5-48a3-9e4f-bbbe56ff5671" contextRef="C_ca4dfd0b-8bd6-4fbd-a03c-0d86bc0e20dd" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d3f8907-6905-42f7-bffd-0449724830b6" contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">171,917</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9abeda93-ee41-4bf1-8ee3-f0b9ff81a75d" contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">114,046</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0278720f-701e-489c-910b-e50288a67b09" contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">57,871</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_6f8da79d-1d1f-4bfc-a333-fe8df356e8fc" contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fad24c10-9272-42db-9d1d-a23bcf8377dd" contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,832</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80a81a7d-8044-4feb-94b4-d39e6f524365" contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,953</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37ef78eb-f329-46d2-bea0-cd986803465a" contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,879</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_12421ec0-f1d9-4dd1-9120-f64f2f1aa178" contextRef="C_42bb4ed7-33be-47af-988b-992e494c103d" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><ix:nonNumeric id="F_5786ffff-8214-4ebc-99b4-6527b12a3ffb" contextRef="C_c0084b72-06a0-4ae0-91de-1a477153763a" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be956af6-8186-4abb-a2f2-309eac25c727" contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">73,077</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8850ab0d-c40a-453a-981b-99739901ae7f" contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,406</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_844b66ee-a601-4bdb-aff3-acc8d91ae67c" contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,671</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9e02151a-7254-4798-b2b2-d7eb7afa0ba8" contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e678e9c7-d6da-4d5f-9e0a-3b4a8ecc5d19" contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7778a1a6-6aae-43f4-82e7-b8817b24a9c6" contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,060</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_a32ae3c5-99e5-4ae4-83de-160ee82196d1" contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f8163ad3-8981-41b7-841a-f6f0102bf78b" contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,011</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a6b9cad1-16ce-441a-90ae-74c461e4aff9" contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">358</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a00f7812-35c4-4691-b8c4-dc70283df9a5" contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">653</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d11aca15-9c64-48db-aff8-ad834f20af90" contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></ix:nonNumeric></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d614662c-5d90-4822-b4cf-27070ec077ae" contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25" name="us-gaap:FiniteLivedIntangibleAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c188572a-929e-40ba-8900-b88bee7e19bd" contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">52</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beef100d-b38f-4adc-a92e-8372f8b31691" contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">55</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec4286a7-ce2c-4086-9959-4f4073c38815" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">275,054</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7bdb68f-c827-4ad2-aa1a-eddb97ffb14d" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">156,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a1bb747-5ff4-42bc-ba1d-45b49ccb7d02" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">118,179</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, the Company recognized amortization expenses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_03076d9c-fe5f-41ea-bc8d-79d847bd9bda" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_734a7596-b75b-45b9-856a-8042f938424e" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:AmortizationOfIntangibleAssets" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in depreciation and amortization in the accompanying condensed consolidated statements of income. The Company determined that ther</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f1d16382-3b56-437c-a777-a4b81a41ef24" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_14ff1a44-79a8-46c6-ae85-39e43dfa82ae" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impai</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rment of its finite-lived intangible or long-lived assets during the three months ended March 31, 2025 and 2024.</span></p><div><ix:nonNumeric id="F_cb9fcfbd-8639-4b54-9cd5-a65f74b71f0b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" escape="true" continuedAt="F_cb9fcfbd-8639-4b54-9cd5-a65f74b71f0b_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">25</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_64207ddc-c761-428b-96d6-c1ba75c0179b_1"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_cb9fcfbd-8639-4b54-9cd5-a65f74b71f0b_1">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.76%;box-sizing:content-box;"/>
         <td style="width:2.14%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:20.099999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb2a5b7e-0b9a-498b-bd4e-75d4b041da65" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,395</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eed8792b-1281-4bf0-9f42-76292a9f153f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,295</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8f31cba3-fa32-4ce3-b8f5-8a923061bf15" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,808</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7fddfb89-047f-4e58-8ec7-55966d0bc251" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,077</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba4a0ac1-663a-453d-ba3d-e3344140ba63" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,397</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_014de97e-3e2f-4b8f-a4f5-9d5c84e7d3b9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,894</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1d9036ff-0938-4b2d-9268-0544dd27d273" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FiniteLivedIntangibleAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">107,866</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_f84cfc71-7ce0-48dd-aac0-d50c1ce9aa7d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:EquityMethodAndOtherEquityInvestmentsTextBlock" escape="true" continuedAt="F_f84cfc71-7ce0-48dd-aac0-d50c1ce9aa7d_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investments in Other Entities</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4502b70c-ec1e-4d78-936b-96d6c1a67df8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EquityMethodInvestmentsTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, the Company&#8217;s equity method investment activity and balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.11%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:11.044%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.044%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.044%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.464%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.044%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.2%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.044%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>(Loss) Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_724092fc-9a96-4a55-a8f7-79278f453bf5" contextRef="C_973e57e5-b73d-4cc7-94b0-6463141b31dd" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3990bb9-3f19-4397-82a6-8691dfbf76d3" contextRef="C_8e22a9c3-e9e2-4f67-87cc-739826df0ebc" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,128</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7397fc3-3cda-464e-a523-96e48e10d33f" contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66bb4d92-d875-4226-ab4e-091ebc80ae70" contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">343</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36e6f06d-8b86-4b8e-8738-380a311bc1a3" contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e48a38b2-e46d-47fa-ae0c-5598ba8e2020" contextRef="C_973e57e5-b73d-4cc7-94b0-6463141b31dd" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,785</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4502a0cb-e213-4343-979a-53e4c350b18f" contextRef="C_0db515af-2807-4207-b8a5-46485e97024c" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e88d8444-f207-460f-b8cb-1ae78da30c27" contextRef="C_3f74b900-fc5b-4144-b943-471127db7623" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,660</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9361e581-afc9-4855-9ea8-1f483c60a0c6" contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba7bf8d2-47d5-4ddb-b4e8-dc1616a92878" contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43e1f35f-ebde-42cd-8723-d406c69d24a5" contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbe6dcab-5c1e-4e9f-b3c5-df87c6c7cbe3" contextRef="C_0db515af-2807-4207-b8a5-46485e97024c" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,664</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b246b3b-08eb-4060-85ca-c44d8a23b3c9" contextRef="C_c627daaf-b808-4e00-85a0-596f504d8472" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e331c887-0334-4752-a247-b3fb19207365" contextRef="C_90d6d0bb-c95e-4885-bab2-bba445ae396a" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,612</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a11ba0fc-41a0-4549-903c-36aa907d83fc" contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1445c75f-91ff-4618-927e-f43e3bd52ac3" contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">264</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0b500ad-3d12-4651-bf98-6736d016b1fe" contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66ded356-aea3-4a6a-b3d8-f15f81992e37" contextRef="C_c627daaf-b808-4e00-85a0-596f504d8472" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,876</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d1f2161-fd70-47a6-aef2-a6a8620a49c5" contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_381e2888-b4f5-40f4-9882-710cd1e5968a" contextRef="C_fbca9ee8-8163-4436-a2e2-bce055cb706c" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,077</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_59f5a73e-4a30-493a-b64e-ee05498f940b" contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b553fb46-eac7-4404-bc2b-48275aecd40e" contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">51</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bca575ea-a829-4a95-95b3-2174cf43b558" contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a94d530-870c-4bfe-9601-dcc3523a6342" contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,128</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0e54e62-a2f1-4ad3-9a43-2ed048d935b0" contextRef="C_39d701e3-06a4-4df9-b822-c0fcffba122c" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c79f8e95-9df9-4b15-b533-b88cde738246" contextRef="C_fb49430e-f221-42fd-ab2d-21a25ad7d7bc" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">51</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8930ec71-85cb-406e-989e-38a7ed4bc152" contextRef="C_6aa69ca0-0134-44c6-9a4c-dfef95103988" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,842</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36970ca6-9fc7-4394-9e3b-c22959061187" contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">347</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d6e8862-d206-48f6-8c1b-c25a5dfbae73" contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">843</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8781e2a2-7ae1-43d7-aab4-c93412e7c0d8" contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fecbf5a-0a7e-4426-bdfb-e97ae6475619" contextRef="C_7d30ac99-4e7f-46aa-b268-23abada1cedd" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,552</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1469860a-bd27-4cf8-a793-19cfd44acd6d" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,319</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f96343f4-2a38-4383-b218-f068eb6676d7" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">347</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a5fec0c-9585-492a-9fdd-0269a885b41a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">867</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_93b50967-57a4-46e8-b912-63066064dd16" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c11bfb81-52f3-440f-af95-91d6e86c0ee8" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,005</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments including those from the CHS acquisition.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:0.575;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.115%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:11.047%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.046999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.046999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:10.447999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.046999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.201%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.046999999999999%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1ced9e8-ec09-4656-8210-15b0380da481" contextRef="C_1083cf69-b827-454e-8369-6d3fc314dfc0" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_18cacd6c-7525-4ca4-aec1-f3d4c8315627" contextRef="C_60dd78d1-64db-4a8b-924c-509710d8f2d8" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,866</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_756482a8-7086-4260-8724-618f62c57e6d" contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70a948ad-2459-4d66-bfc0-915c4f6a2c06" contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">359</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_046c8488-2926-4ffa-935a-c49bb84fe876" contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a25ad94-e3be-48d8-87c0-e0cbeedfc18c" contextRef="C_1083cf69-b827-454e-8369-6d3fc314dfc0" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,225</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e301cc56-8aa2-4721-9d3c-85a00d70c361" contextRef="C_51568cb6-3f1a-4554-92a1-e0a87a63611a" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_495eb24f-c082-430c-b6fe-4781b672d6bc" contextRef="C_71fe0c76-45fe-453d-84d9-fa9e245de91b" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,691</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d254111-cfee-41f2-ad54-d2bdb04aebbf" contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83045481-d256-42e1-9548-97c3bfb5901d" contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e6602d5a-ef9a-4f9b-b7f4-a3b4f05fd85a" contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54f7a978-4dd3-49c5-a23c-c48dc933513e" contextRef="C_51568cb6-3f1a-4554-92a1-e0a87a63611a" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,718</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a113aea8-3ffc-439b-bd64-896ff8d59389" contextRef="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_557e9efd-5806-443c-977f-778d97cdb545" contextRef="C_d44cee9d-e397-4f66-8ab9-60be5a5fe296" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,660</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf878567-c56a-470f-97b0-6bab23b24d57" contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9aa1d70e-131d-4fc1-9c2c-52e8f9048c72" contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">186</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd13bbdc-66ec-4c96-a54e-58a5be9ae717" contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_82fa5879-8d95-406f-a2e9-cb600aec9a9e" contextRef="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,846</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_615095ad-f908-4516-adbe-b9c2a759dbc6" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beb2a6b4-11a2-40ca-a144-0b2e1562d871" contextRef="C_51d37c62-bd92-4b36-bda5-66bf4ab5d0f1" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_608defcf-e836-49c4-810d-2a0dd78d5d19" contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,487</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca305592-5e1b-45c7-b81f-b2b4f02c75ed" contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c2bd9e9-5100-4cee-8ece-6cd90b7b4a0e" contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7b1ce679-51cd-4c2b-8b5f-16ec73120f39" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,487</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba447842-dd61-417b-8d27-890559ed7b64" contextRef="C_1e918ac4-70a3-44fc-b478-645d223adbf1" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_333a7609-7fa7-4f7d-a96d-93df9177fc8f" contextRef="C_4aad3ec6-80fd-4602-9c7b-59c3596c2d22" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">557</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dfec1adc-2072-455c-a57a-a5ae464086e5" contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_85f39b37-4f70-40fe-ad78-de8182a1369a" contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">60</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0954749-26ac-4edb-b3dd-66236b87769b" contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8db686a0-5ee7-4a42-9eef-de5b1309d95d" contextRef="C_1e918ac4-70a3-44fc-b478-645d223adbf1" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">617</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c870521-1103-44d9-8f79-504718a90eeb" contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,774</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e78af40-9aa7-481b-a22b-72a5641c05c8" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:EquityMethodInvestmentAdditionalInvestment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,487</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_303a28a5-7e96-48d6-aa12-48f9c2aa5693" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">632</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ead7220f-4656-4822-a9cd-bd27d97776c8" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EquityMethodInvestmentSoldCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69baebfb-197d-4544-99ce-0408bb504987" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">35,893</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments.</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">26</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_f84cfc71-7ce0-48dd-aac0-d50c1ce9aa7d_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records its investments in certain non-consolidated VIEs within investments in other entities &#8211; equity method in the accompanying condensed consolidated balance sheets. These entities were determined to be VIEs but are not consolidated because despite providing financial support to these entities, the Company lacks a controlling financial interest and is not the primary beneficiary. Thus, these VIEs are accounted for under the equity method of accounting. The Company recognizes its share of the investee&#8217;s earnings or losses under the &#8220;hypothetical-liquidation-at-book-value&#8221; method. As of  March 31, 2025, the Company&#8217;s maximum exposure to loss was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_727d16c7-8ab9-4bbf-b398-0afdb74f4532" contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which represents the carrying value of the Company&#8217;s investments in the non-consolidated VIEs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity method investments are subject to impairment evaluation. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_794de7e3-cb91-43ff-b5bc-6a64bf951820" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_a4733265-bebc-44e6-a3ea-6501b7ae6dde" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mpairment loss was recorded related to equity method investments for the three months ended March 31, 2025 and 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Privately Held Entities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for certain equity investments using the cost basis, adjusted for observable price changes and impairments, when there is no readily determinable fair value. Observable price changes and impairments are recognized in net income. As of both March 31, 2025, and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, our investments in privately held entities was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_317cd4d6-ba9a-437b-8fee-de3d2fdd4029" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_d9b02f73-b652-410e-b854-8bc755bf734e" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.9</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, for which a fair value is not readily determinable and we do not have significant influence. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were no observable price changes to these investments.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4a27edfc-7810-40db-920e-a8d65321ff98" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:LoanReceivableTextBlock" escape="true"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loans Receivable</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loans receivable</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IntraCare</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2023, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8b0eb24e-4446-4037-9e43-fc6c3828bb8c" contextRef="C_e76a7617-4b56-4fc3-99bd-e245633154cb" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible promissory note with IntraCare as the borrower. The principal on the note is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8cec016-9086-4b13-bc85-ac6e6aa1b1a2" contextRef="C_57ab083d-904e-4e53-978c-f5c3da6822ed" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3e4ea83-ad17-44e0-ac24-f89ca459a42b" contextRef="C_57ab083d-904e-4e53-978c-f5c3da6822ed" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">8.81</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_06a66919-1148-4c29-8ffb-abb9638fdab7" contextRef="C_e76a7617-4b56-4fc3-99bd-e245633154cb" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 27, 2028</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of both </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the related note balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_42368efd-ddef-439a-aa73-e338b4b3486f" contextRef="C_0e5954be-95e4-4557-b760-60d9a28d9308" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_e761f1fd-898b-43de-8f95-ab42a318b59f" contextRef="C_3bd97afb-8c37-43d8-b09f-783073d2929a" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">28.3</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, was included in loan receivable &#8211;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-current in the accompanying condensed consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BASS Medical Group</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 29, 2024, the Company provided BASS Medical Group (&#8220;BASS&#8221;) with a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2a4ad9ce-3296-4c29-a7a4-4030e3dc940c" contextRef="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">20.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million senior secured promissory note (&#8220;BASS secured promissory note&#8221;). The promissory note is secured by certain assets of BASS. The BASS secured promissory note matures on </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9aea9884-a4ff-4861-b730-1c01fefcc5a4" contextRef="C_0f9cd5b5-b704-426f-9132-13af5d422b00" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 11, 2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has an interest rate per annum equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea37a1a9-a946-4628-b540-b8a5696879de" contextRef="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">8.21</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, compounded annually. The principal on the note, including unpaid interest, is due and payable on the maturity date. On April 24, 2025, the BASS secured promissory note was amended and restated to update the terms of the note to include terms of repayment, whereby the principal balance shall be payable in monthly installments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dec8e319-20e4-4950-aef8-7d499042045f" contextRef="C_a319aa70-1ce6-4734-8031-6b09d4cddad6" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6aa99862-ea5e-415e-9590-85924a8bd71d" contextRef="C_a319aa70-1ce6-4734-8031-6b09d4cddad6" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 11, 2031</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the maturity date. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the related non-current portion of the note balance of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78c267e7-6172-444b-a8a0-efab522f94c6" contextRef="C_d16bace1-c79d-4e87-85bb-17ae493b3326" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">19.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_89742dad-c928-4909-b943-f351306ca4ed" contextRef="C_60a42d76-6c9a-4f99-93d9-4550f317d0fa" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, was included in loan receivable, non-current in the accompanying condensed consolidated balance sheets. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the related current portion of the note of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cd0d619f-6030-4cbb-bcc2-8aaa307c3eef" contextRef="C_d16bace1-c79d-4e87-85bb-17ae493b3326" name="us-gaap:NotesAndLoansReceivableNetCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was included in loan receivable in the accompanying condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company assessed the outstanding loans receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, the value of any collateral, and reassessing any identified insolvency risk.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">27</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0dabe370-4ff1-47bb-bb10-73314840e1c3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" escape="true"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounts Payable and Accrued Expenses</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_82c538f0-8dbf-400a-bb2b-02bf6fcbd1f2" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and other accruals</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6647b1f7-f12c-43df-b273-0f9da7f6d574" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,911</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1459c1cb-7428-40e6-a4cd-cde2910ca4ff" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,168</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitation payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00260d79-440e-4b64-acb0-01d3e0c86c50" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:SpecialtyCapitationPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,703</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47d30673-dade-4e8c-bada-b8389f7ee186" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:SpecialtyCapitationPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,639</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subcontractor IPA payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_342ce3be-558a-4704-b204-94829682d91a" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:SubcontractorIPAPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,845</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b52cff7b-8bba-4aab-82d5-cd4d8dca6afd" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="asth:SubcontractorIPAPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,486</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_949e7963-3c05-438a-9cc2-4aa24fdf0d0c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,512</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c2cc5e4e-c4ae-4778-ab95-f65741bc5811" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,809</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due to related parties</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a85d5611-1809-42d8-98e3-ec04c21253bd" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:RelatedPartyDepositLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,111</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04ca23f5-0748-4293-b7cb-60a269277d7c" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:RelatedPartyDepositLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,924</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contract liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_848a817f-b9cc-472d-9a54-5f77a885e74b" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">686</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b60adbf-0c4f-477a-bdd9-2911c357f050" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,606</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f97a3189-60f9-4d93-93e2-5a87418a2618" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">13,752</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_66c2c25b-2573-4d67-a549-28f1e2533424" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22,409</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other provider payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e4044c2-923c-40da-bba8-bf94a0f57f25" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,039</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26465ccc-d0fe-4d68-a6eb-00ea592e2564" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40,101</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c56b171-3267-45e3-bf0a-6f89c96740c1" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105,559</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de24f929-6fbf-4244-a55f-6c7478eb7493" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,142</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4adf916e-658b-4cc2-8c75-f3553273e206" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" escape="true"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medical Liabilities</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_26b422d3-759f-4cbb-85c6-e7fc8ac74ac4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, beginning of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6b852635-5695-431f-94ee-7377b75c2c0b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">209,039</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f2fbc662-8e02-467b-8f3b-158273879020" contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">106,657</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_37805971-03e3-4d2f-96d4-33287f9b7a56" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">8,256</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf2c5190-b31c-43dd-a7d4-eb9f9df13168" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,645</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Components of medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7c9fbd56-a1f1-48e0-be68-c26adb78019e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">384,479</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10f787b8-abc7-4e57-a887-e673b6bdcf68" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">234,735</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5062960b-9ea7-4ffe-b20d-f19da2454129" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">658</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b591459-f72a-4c21-9d81-87472a05f70a" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">1,419</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total medical care costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b51db38-fa5b-4d1a-92ab-d2d1eb6624ed" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">383,821</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_24bd6453-d19a-4b34-9c24-ebbee7e6ae9d" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">233,316</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments for medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e7e0003-7663-4c00-8e68-4f4bdd272771" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">229,701</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8707f9e-860f-4e2c-aed9-278f882d20d1" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">130,014</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fbcecd7-6921-49b6-a6e7-2609f2f69a99" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">145,938</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b07fb665-e5a6-4fb5-9a63-920263e74bc1" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">94,335</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims paid for acquired balance</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4e449cb-a366-4f23-85e9-579829a8a384" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,864</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94f72e41-a4de-4a15-9477-ad4459baf50c" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,775</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f24eb7f7-aada-429c-8a6d-f2c11e44a454" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">380,503</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc0f1e46-13d2-478f-9705-9ac3d378d6e4" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">234,124</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, end of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b493a640-09f5-42e5-a973-aa3d45031527" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">204,101</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c327fac0-675a-4474-bb3d-beb11b33b532" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">136,494</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">28</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33c0a833-e870-415f-8569-a9d7356a1720" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DebtDisclosureTextBlock" escape="true" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Credit Facility, Bank Loans, and Lines of Credit</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f9ae7a90-916a-47ef-9c29-0f4ee7cc2f0f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s debt balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1c4b2ef-0c93-41e9-950d-16a09ed5608b" contextRef="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">250,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_31f97cd3-ca31-4b26-bb66-50de95ff3e0b" contextRef="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">281,500</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revolver Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3ced6eb-e5aa-42e0-848f-eac40c714f14" contextRef="C_2a253766-549b-48d9-804a-32af249a20f3" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">162,000</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a70839c7-62fa-4fde-9ad2-5f6cdf57c822" contextRef="C_242c5ffa-94be-4093-910a-0097e423df05" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">146,732</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bf414df7-b82d-4c4e-aba4-6468387d77fe" contextRef="C_4b85094b-d44b-4343-9073-a47a57dcafe2" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc267d34-6d9a-4553-a832-a71e1cb72837" contextRef="C_0fb6e99b-fca4-44d8-ad37-70ea90786ce7" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_935481f8-3613-4960-b7a9-d27da3fd127f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_34aa8810-d8fd-47ef-871b-6150d8fb9416" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">438,107</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Current portion of debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ae4ac49-002b-4948-908e-99c6ff4d0e95" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6859543a-c65c-408a-9fc7-6276af1fd0a6" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,375</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Unamortized financing costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_088be745-5d6c-449b-91f2-a3dcd33be6be" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,481</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2460409f-634f-428a-9017-afbc4921abcf" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,433</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac8e650a-6fb2-4a5a-b9e7-aadf4c034c42" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">403,894</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_53d5527b-9dc1-493a-ab76-5f0842ed8c62" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:LongTermDebtNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">425,299</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of the Company's long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of March 31, 2025, and December 31, 2024, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_34aed7d4-f529-48f5-8c68-33387d55747d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are the future commitments, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"/>
         <td style="width:1.94%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.82%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac607544-8be5-4e06-bee1-bf56db669a93" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,375</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c44a48fe-6b20-4b50-a178-af87361b0839" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,500</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bf93a68-ed17-4899-8ae3-e282d1ce10c0" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,063</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_547c11b4-fdab-4630-8d02-674ce5a877e4" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">18,750</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f905df79-92c4-40ad-a5a2-7ed39b947017" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">23,437</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ecd4cb9-84a6-4eb5-8741-9ba29bc2bd97" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">330,750</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04e6d336-d876-4494-b684-705250c645e3" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LineOfCredit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">421,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">29</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_1" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_2"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Credit Facility</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Second Amended and Restated Credit Agreement</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 26, 2025, the Company entered into the Second Amended and Restated Credit Agreement (the &#8220;Second Amended and Restated Credit Agreement&#8221; and the credit facility thereunder, the &#8220;Second Amended and Restated Credit Facility&#8221;) with Truist Bank, in its capacities as administrative agent for the lenders, issuing bank, swingline lender and a lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain amended credit agreement, dated June 16, 2021, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Second Amended and Restated Credit Agreement provides for (a) a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_929f034d-a2e3-4705-88a1-ecbcf43cb9c8" contextRef="C_b959fdf1-fcd8-4458-9fe1-8862724296dc" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> revolving credit facility (&#8220;Revolver Loan&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e24d5ac1-857e-4348-8892-738417381762" contextRef="C_236ccab9-0279-431e-981f-890a827b1ca0" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">300.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which includes a letter of credit sub-facility of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5b977a9-f379-447b-bba2-4027944b738a" contextRef="C_f29b54ab-fc06-4669-ae02-d8718105c456" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">100.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a swingline loan sub-facility of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1495045d-7384-4c99-bca4-debf243f96f6" contextRef="C_daa1fc75-315e-4a15-918b-4217def968f5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, (b) a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_712b4b71-098d-417b-afd9-8f1d8bb650fd" contextRef="C_8297f21e-2dac-46a3-bf2e-4b0c2ff5c175" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> term loan A credit facility (&#8220;Term Loan&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3671b86-3c63-4060-affe-dad71f194fb9" contextRef="C_6afa4315-6042-4fb4-bfdb-562cff61568e" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">250.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and (c) a </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_78607df2-bb79-40ef-83f5-790d6922f339" contextRef="C_0e18f7d0-badd-4b78-96bc-454449d1877e" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> delayed draw term loan credit facility (&#8220;DDTL A&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_762da20d-fabc-43a8-8c66-2e44130bf7da" contextRef="C_7d764929-a2f0-4c7b-b54b-eba37cf55e23" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">745.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The term loan A and revolving credit facilities are intended to be used to, among other things, refinance certain existing indebtedness of the Company and certain subsidiaries, pay transactions costs and expenses arising in connection with the Second Amended and Restated Credit Agreement, and provide for working capital needs and other general corporate purposes, and, in addition to the foregoing, the revolving credit facility will also be used to finance certain future permitted acquisitions and permitted investments and capital expenditures. The delayed draw term loan facility will be used to finance the purchase of all of the outstanding equity interests of Prospect Health Services RI, Inc. (d/b/a Prospect ACO Rhode Island), Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical Center), and Prospect Health Plan, Inc., and substantially all the assets of certain direct and indirect subsidiaries of PHP Holdings, LLC (&#8220;PHPH&#8221;), subject to customary adjustments, plus the assumption of certain identified liabilities of the sellers party thereto, (the &#8220;Transaction&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed under the Second Amended and Restated Credit Agreement bear interest at an annual rate equal to either, at the Company&#8217;s option, (a) the rate for term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) published by the CME Group Benchmark Administration Limited two days prior to the first day of the applicable interest period, plus a spread of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d3841c53-41c9-4b8f-89ed-b012bda71959" contextRef="C_9da713da-4bde-499d-850b-07a0b56f32e7" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">1.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd6ed1bd-95ec-4f3f-955d-7fcc70fa16dc" contextRef="C_ec8f7056-c0e7-4865-bfc9-cc405c953592" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">2.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd1a6ef2-4e6e-4aee-9dd1-dc9e8ac3e240" contextRef="C_db9d68bb-77fd-49e6-9bc0-d0eaff33c66d" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">0.25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb67849d-74a7-4b4a-b55d-6c40287245d3" contextRef="C_afa4f934-11e5-4c39-b49b-0cb4a0e75483" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">1.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the Company had outstanding borrowings under the Revolver Loan and Term Loan of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_263b3804-04ab-4314-ba9e-05eb9a255158" contextRef="C_3b49047f-ac09-4d40-b78d-73c4e56f102a" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">162.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4796dbd6-739c-4fd9-8934-30484230f17a" contextRef="C_5f9b3463-0249-4f81-a7e3-f5f9afa4f5c1" name="us-gaap:DebtInstrumentCarryingAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">250.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the interest rate on both loans was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_07482c68-0806-4446-a19c-977312685d71" contextRef="C_dbba92a9-68bd-4064-8de3-f595e744099a" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal"><ix:nonFraction id="F_8a7f3dbe-8c78-4d6f-a8f6-1cf9c70a6344" contextRef="C_6177be07-fab5-40c9-821f-deabcadf9b27" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.82</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Second Amended and Restated Credit Agreement, requires the Company to pay a commitment fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87843aef-2f11-45c3-a4cf-840364fa1dc7" contextRef="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">0.175</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33b535a0-c83e-4175-a2c2-f8c0231a8628" contextRef="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">0.35</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% multiplied by the daily amount of the unused revolving commitments during the availability period, with such fee determined on a quarterly basis based on the Company&#8217;s leverage ratio, and a ticking fee on the delayed draw term loan facility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5f646cd2-5b8a-42f2-864e-7369ae2cd04b" contextRef="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">0.175</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b176b102-347a-44d5-b0f4-5e4de6a0b09f" contextRef="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:num-dot-decimal">0.35</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% multiplied by the average daily unused portion of delayed draw term loan commitments, with such fee determined on a quarterly basis based on the Company&#8217;s leverage ratio. The Company is also required to comply with two financial ratios, each calculated on a consolidated basis. The Company must maintain (commencing with the fiscal quarter ending June 30, 2025) (x) a maximum consolidated total net leverage ratio of not greater than (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4d4e9be8-75e2-4c6e-93ec-6475c6c18a16" contextRef="C_d68d3e73-1a37-4898-87db-e2b73a6e4347" name="asth:DebtInstrumentCovenantLeverageRatioMaximum" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">5.00</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day of each fiscal quarter ending prior to March 31, 2027, and (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16bd97e4-e1bf-4ff8-b397-a9bf99c963c0" contextRef="C_c1a29941-265e-47ee-bfab-5f1290b6297b" name="asth:DebtInstrumentCovenantLeverageRatioMaximum" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">4.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day each fiscal quarter thereafter and (y) a minimum consolidated interest coverage ratio of not less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdf9c76f-4eb7-4a05-8095-470029d70e50" contextRef="C_787cb7d7-ebc8-4665-80e3-627cd2d9a92c" name="asth:DebtInstrumentCovenantInterestCoverageRatioMinimum" unitRef="U_pure" scale="0" decimals="2" format="ixt:num-dot-decimal">2.50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day of each fiscal quarter. The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with various affirmative covenants, including, without limitation, furnishing updated financial and other information, preserving existence and entitlements, maintaining properties and insurance, complying with laws, maintaining books and records, requiring any new subsidiary meeting a materiality threshold specified in the Second Amended and Restated Credit Agreement to become a guarantor thereunder and paying obligations.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">30</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_2" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with, and to use commercially reasonable efforts to the extent permitted by law to cause certain material associated practices of the Company to comply with, restrictions on liens, indebtedness and investments (including restrictions on acquisitions by the Company), subject to specified exceptions. The Second Amended and Restated Credit Agreement also contains certain negative covenants binding the Company and its subsidiaries, including restrictions on fundamental changes, dividends and distributions, dispositions, sales and leasebacks, transactions with affiliates, restrictive agreements, use of proceeds, amendments of organizational documents, accounting changes and prepayments and modifications of subordinated debt.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiary, Astrana Health Management, Inc. (&#8220;AHM&#8221;), have granted the lenders a security interest in all of their assets, including stock and other equity issued by their subsidiaries, pursuant to the Amended and Restated Guaranty and Security Agreement, dated as of February 26, 2025, by and among the Company, as borrower, and AHM, as guarantor, in favor of Truist Bank, which amends and restates that certain guaranty and security agreement dated as of September 11, 2019, in its entirety. The Second Amended and Restated Credit Agreement contains certain customary events of default. If any event of default occurs and is continuing under the Second Amended and Restated Credit Agreement, the lenders may terminate their commitments, and may require the Company and its guarantors to repay outstanding debt and/or to provide a cash deposit as additional security for outstanding letters of credit. In addition, the agent, on behalf of the lenders, may pursue other remedies, including, without limitation, transferring pledged securities of the Company&#8217;s subsidiaries in the name of the agent and exercising all rights with respect thereto (including the right to vote and to receive dividends), collect on pledged accounts, instruments and other receivables, and other rights provided by law.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_3" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_4"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">I Health, Inc. Promissory Note Payable &#8211; Related Party</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 1, 2024, the Company issued a promissory note in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29d67da5-bfc5-4444-90ab-1b8a47fbd22d" contextRef="C_dc7280cd-a579-4b3e-92cd-3b6923b763e6" name="us-gaap:RepaymentsOfRelatedPartyDebt" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a promissory note (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;I Health Promissory Note&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) with a maturity date of March 31, 2027. On March 31, 2024, the Company entered into a purchase agreement for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2dedd3ce-9071-45d8-80fa-0a639ea0b997" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health, Inc. (&#8220;I Health&#8221;) that included a call option to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_77776a58-be3d-4af7-86b6-6c945c6fd03f" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest on each of the first, second, and third anniversaries from when certain triggering events occur (&#8220;I Health Call Option&#8221;). I Health may accelerate the maturity date if the Company does not exercise the I Health Call Option</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The promissory note has an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78337b2e-f480-4082-872b-0fe53028203c" contextRef="C_985081e2-9a89-4282-bea5-465c5a88d3d2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">4.30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per annum on the principal amount. Accrued interest is payable on each anniversary of the promissory note payable. I Health is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e85e4108-cc2e-4bbc-a803-698411897fc1" contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held by the Company (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Equity Method&#8221;). On July 1, 2024, an amendment was made to the I Health Promissory Note that, among other things, increased the original principal amount by an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_385c69c7-48a9-42b5-b9a7-6462d5d8a93c" contextRef="C_08b0fafe-b67b-4bd9-9a48-7f4c5f138bed" name="asth:DebtInstrumentIncreaseInOriginalPrincipalAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the total amount payable under the I Health Promissory Note is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f94bcad-b2c5-466c-b881-9f0a8bc23568" contextRef="C_b8b87b9c-e6a0-406d-818f-112b6825b4cc" name="us-gaap:NotesAndLoansPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">9.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_4" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_5"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Financing Costs</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company paid debt financing costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff9cecf1-dbbc-4bf8-baf0-7215ec6f4343" contextRef="C_6400c1e2-a6bb-49bc-af77-e72305173422" name="us-gaap:PaymentsOfFinancingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the issuance of the Second Amended and Restated Credit Agreement. Of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ac6556a-4a7b-4fcd-a557-f13951e80817" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:DeferredFinanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">22.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million debt financing, the Company expensed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_791598ff-37af-4c57-9dac-b0c7ecdd957c" contextRef="C_4a4ecf0b-afe3-484c-ad85-f7a6579c67a9" name="asth:DebtFinancingExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within other expense on the accompanying condensed consolidated statements of income, and the remaining $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9dbc0e6f-2fe2-4a3a-b335-f3746df24b0b" contextRef="C_9af99720-afab-41bf-8f18-b88302257d99" name="us-gaap:DeferredFinanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">17.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was deferred and amortized over the life of the amended credit facility. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, unamortized deferred financing costs for the Revolver Loan, DDTL A, and Term Loan, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_04d9f4ed-32ce-46c0-b140-f3bf1f76fcc3" contextRef="C_47d471b9-bc25-4bfd-ba7e-f4308580c360" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b86d8f2e-e910-4ea7-a7da-53d39810a906" contextRef="C_b427f9b8-5e88-4171-8639-300cf97af194" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bdd6c039-3af5-4701-88d7-98b949d8108b" contextRef="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. As of December 31, 2024, unamortized deferred financing costs for the Revolver Loan and Term Loan were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b80fd97f-50d4-4579-9484-ec211c32efd3" contextRef="C_fb36bf2b-c780-4ab2-b3b8-d365c11db5d8" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7073656c-ac10-444a-9fb1-df0f3ed20ce7" contextRef="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Deferred financing costs associated with the Term Loan are presented as a direct reduction against the amounts borrowed on the Term Loan and amortized over the life of the loan using the effective interest rate method. D</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eferred financing costs associated with the Revolver Loan and the DDTL A are recognized in other assets in the accompanying condensed consolidated balance sheets and amortized over the life of the loans using the straight-line method. The deferred financing costs associated with the DDTL A will be presented as a direct reduction against the amounts borrowed and amortized using the effective interest rate method when the draw is made. Interest expense in the condensed consolidated statements of income includes amortization of deferred debt issuance costs.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">31</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_5" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_6"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Effective Interest Rate</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s average effective interest rate on its total debt during the three months ended March 31, 2025 and 2024, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4957370b-ae0d-479a-a45d-97ba8aaefe49" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39d885eb-f545-4ce2-913a-c9d514e29313" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.51</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Interest expense in the condensed consolidated statements of income included amortization of deferred debt issuance costs for the three months ended March 31, 2025 and 2024 of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_52e08712-9ee8-4e63-8fb4-1da168402b22" contextRef="C_0bde49a3-f8b1-43f5-93b8-2a4f2689faf3" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e559feb-67e9-45d0-a79c-6f1d19a3d2a5" contextRef="C_0e90a0d4-f745-48d9-a24b-c58b53cc0548" name="us-gaap:InterestExpense" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_6" continuedAt="F_33c0a833-e870-415f-8569-a9d7356a1720_7"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lines of Credit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC Business Loan</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4fbd2575-ceca-4721-b5f7-a36394481142" contextRef="C_ae5e6aed-1503-498b-a58c-7a51d4fe9172" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_33c0a833-e870-415f-8569-a9d7356a1720_7"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Standby Letters of Credit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company established irrevocable standby letters of credit with Truist Bank under the Second Amended and Restated Credit Agreement for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4cfe9ae2-b157-4a40-9861-fd86366b79ed" contextRef="C_59d235ce-9711-4ef0-bfda-f40da6b2866b" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of CMS and certain health plans as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_848e761c-d5a4-41ac-a618-8f64c98c73ee" contextRef="C_8e631b93-40e7-40d3-8326-b5618bb62eed" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> periods from the present or any future expiration date.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4007f4d3-cafa-4652-b040-507e38d95de3" contextRef="C_c98c4392-4a16-456e-9225-81de0aeddc35" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of certain health plans as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The standby letters of credit are automatically extended without amendment for additional </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e588aae8-912d-484d-a654-5e2c93d4aafd" contextRef="C_de80ca92-733d-4d31-8fc9-bb3a6ff69c9c" name="us-gaap:LineOfCreditFacilityExpirationPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2e663bd3-ff8c-4454-a25c-647f645450ba" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true" continuedAt="F_2e663bd3-ff8c-4454-a25c-647f645450ba_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mezzanine Deficit and Stockholders&#8217; Equity</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Mezzanine Deficit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the redemption feature of APC&#8217;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of March 31, 2025 and December 31, 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, APC repurchased $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f01dd106-fb9d-48a8-8e74-9ada690c4d26" contextRef="C_3e76e350-ea44-40df-b69e-b28234065741" name="us-gaap:PaymentsForRepurchaseOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of its common stock from its shareholders. There was no similar type of repurchase during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2e663bd3-ff8c-4454-a25c-647f645450ba_1" continuedAt="F_2e663bd3-ff8c-4454-a25c-647f645450ba_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_428e9afc-b82f-492f-9093-84a20ab16761" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:StockIssuedDuringPeriodSharesMerger" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">41,048</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 merger of Astrana with AHM, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro rata </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">portion of Astrana common stock as contemplated under the 2017 merger agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 merger. The condensed consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory, and the Company is legally obligated to issue these shares in connection with the 2017 merger.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">32</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2e663bd3-ff8c-4454-a25c-647f645450ba_2" continuedAt="F_2e663bd3-ff8c-4454-a25c-647f645450ba_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Treasury Stock</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, APC owned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ee1d960-ebbb-4d23-8aa0-72b4f8d5f27a" contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">6,132,802</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3168f39c-c90b-47b0-acfd-46364f46883a" contextRef="C_99d1dd55-3e68-4959-ba9e-eff028c809f0" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">7,132,698</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Astrana&#8217;s common stock, respectively. While such shares of Astrana&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the condensed consolidated financial statements. APC&#8217;s ownership in Astrana was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8fdcfb04-8cc7-41b5-8f94-011fd59180b5" contextRef="C_1c3552b0-b03a-4553-a29c-97b040f5699e" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">11.13</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ce680b39-2477-4367-a9ad-ed02db7318cf" contextRef="C_da904c7b-408c-409f-b2c0-a578207cb75a" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">12.96</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7cbe100d-8f5d-4f13-be57-b34030a71745" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockRepurchasedDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">300,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock from APC, pursuant to a stock repurchase agreement dated </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e04baac-cf9e-424b-ba1f-76b2441055f2" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RepurchaseAgreementDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 17, 2025</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for an aggregate purchase price of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6957b90a-7a8f-4fca-acb4-d6ac0b361672" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:PaymentsForRepurchaseOfCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">10.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of March 31, 2025 and December 31, 2024, the Company had repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5e38c600-349e-40d5-8fce-b846b9f2596c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:TreasuryStockSharesAcquired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,771,151</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1e712da2-d025-48ac-9ab9-3d7dc7e4e636" contextRef="C_226ae331-0b66-42c0-b281-4563dffea1fe" name="us-gaap:TreasuryStockSharesAcquired" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">3,471,151</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, of its common stock. These are included as treasury stock.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#8217;s stock held by APC, was </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"><ix:nonFraction id="F_e2ea05c8-638f-4def-a45b-58d20639cdc2" contextRef="C_f30cbeac-b9ab-48fd-96ce-75af5d6e0bfa" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">9,903,953</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16653edc-388e-4e8e-8347-08bcd9b0a6fa" contextRef="C_8b0919d3-15a4-433c-a537-c7cf98fef70b" name="us-gaap:TreasuryStockCommonShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,603,849</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_2e663bd3-ff8c-4454-a25c-647f645450ba_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, certain consolidated subsidiaries of the Company paid distributions of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf316cb5-bc57-47a6-be1d-2024f1b80e07" contextRef="C_8d32a733-9808-4cd7-b7c0-f21ceeb7f902" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_ca7a982e-da3c-4ff5-ae91-625338c16d8b" contextRef="C_c3edf28a-a238-40d2-bd32-23ef178885d8" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to the shareholders who own the non-controlling interests in the entities.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the APC board approved the distribution of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a4dc84c-3cdc-43d3-a170-d14a42992b43" contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc" name="asth:DistributionOfShares" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">699,896</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Company&#8217;s shares and a cash distribution of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be45f182-a918-474d-a2be-066a070c5c06" contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc" name="us-gaap:DistributionPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to its shareholders. During the three months ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f92845f8-ef4d-4bab-9554-516be7727f9b" contextRef="C_6576bf12-444e-4d4e-b361-dc0763d5edca" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> dividends were declared to the APC shareholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true" continuedAt="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c90a0a13-eae3-4d99-bc16-52653d055ee2" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, and associated with the issuance of restricted shares of common stock and restricted stock units and vesting of stock options that are included in general and administrative expenses in the accompanying condensed consolidated statements of income (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.391%;box-sizing:content-box;"/>
         <td style="width:1.88%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:18.424%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.88%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:18.424%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options and ESPP</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc695b21-69e4-4db0-8f72-3660b2dad01a" contextRef="C_5b31a718-c1c9-490e-911d-86d1062a0eeb" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">70</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d955549a-6b9a-4007-b1af-d59c16b2bce3" contextRef="C_80e76537-df9f-428c-93ad-7da9d13bb50d" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">349</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16d3632e-efdf-4835-83cc-74094780981e" contextRef="C_697ba52d-2244-440b-9f20-87f75a1b40f6" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,741</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7d81105-2afb-48c2-8c64-c1ec073d478c" contextRef="C_1b553b00-2fc0-4ac1-92a8-7cfe88881549" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,399</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_735c788b-58a8-45d5-b78c-4864dd70430d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,811</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55a932fe-b530-4d12-8990-04c37c1dcefe" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,748</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unrecognized compensation expense related to total share-based payments outstanding as of March 31, 2025, was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_815a18b7-1463-4bcd-9316-30975c90595a" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">44.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">33</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64_1" continuedAt="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Awards and Units</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company grants restricted stock awards and units to officers and employees, which are earned based on service and/or performance conditions. The awards will vest over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5b693fad-f92e-44a0-a212-4f3dabb62cf7" contextRef="C_439f009f-2b98-4cfc-ba9d-62cbb1adf7e2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_588234a6-710a-474f-aecb-194820de1dce" contextRef="C_db55fdec-4a85-4b80-a8d7-2659a2923a15" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in accordance with the terms of those plans. The grant date fair value of the restricted stock awards and units are the grant date&#8217;s closing market price of the Company&#8217;s common stock. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025, the Company granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e8dd1e2f-28bc-4463-a4c9-589168b24c2a" contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">417,787</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of restricted stock awards and units with performance-based conditions and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6efeae88-1fb2-4fff-a768-75f1d19c2f15" contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a" name="asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">234,516</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of restricted stock awards and units without performance-based conditions. During the three months ended March 31, 2025, the weighted average grant date fair value of restricted stock awards and units with and without performance-based conditions was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b6c5bd7-baf6-45ce-bdc0-bdc66173472e" contextRef="C_b6707bb2-894d-4ef5-b67b-4a9d78165cd2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.30</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9af1ff7b-cd7a-4ae0-8585-11174ce89b4d" contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">27.61</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Shares of restricted stock awards and units with performance-based conditions are recognized to the extent that the performance conditions are probable of being achieved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ESPP is a shareholder-approved plan that allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#8217;s common stock at a discounted price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2048a980-ae27-4936-a1f2-3695d7ed69d6" contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178" name="asth:CommonStockDiscountedPricePercentage" unitRef="U_pure" decimals="INF" format="ixt:num-dot-decimal">85</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_38629d60-8ddd-4193-92bf-13a34e4d9d6d" contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178" name="asth:CommonStockDiscountedPricePercentageMaximum" unitRef="U_pure" decimals="INF" format="ixt:num-dot-decimal">90</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the fair market values of the stock on the exercise date, subject to a maximum number of shares that can be purchased during any single offering period as well as an annual maximum dollar amount of shares during any single calendar year. A maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57480b13-1cc9-410c-9289-f5943908e779" contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">5,000,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares were authorized for issuance at the time the ESPP was approved. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc706d77-b234-4219-a756-b209e89583d1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">10,683</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued for the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><div><ix:nonNumeric id="F_15bae1ca-88f7-4840-8d0e-d425fe077b8e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true" continuedAt="F_15bae1ca-88f7-4840-8d0e-d425fe077b8e_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commitments and Contingencies</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory Matters</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a risk-bearing organization, the Company is required to follow the regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, a tangible net equity (&#8220;TNE&#8221;) requirement, a cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the Company&#8217;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Standby Letters of Credit and Surety Bonds</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company established irrevocable standby letters of credit with Truist Bank for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_60099a85-28bb-436b-8c8c-4bac3abd7f47" contextRef="C_bca3f795-036a-486d-b7b3-5bde30763876" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">25.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of CMS and certain health plans as of March 31, 2025 (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f882104c-a9a3-47ab-a8cc-7d73386b6cb8" contextRef="C_6d80e85a-168e-4e9b-80f3-ccebe319846c" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of certain health plans as of March 31, 2025 (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">34</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_15bae1ca-88f7-4840-8d0e-d425fe077b8e_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently has several surety bonds as required by CMS. The bonds total approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c0fdce5-1ed7-4e24-ba69-53254485e6e2" contextRef="C_4fbc38e4-4839-4ebf-a373-b96ad86a302b" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">46.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the aggregate, as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The bonds expire on various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b33e11f9-1307-4aad-bc0d-c586ee18130d" contextRef="C_69d8a835-e946-435c-8b6b-b394071da012" name="us-gaap:LineOfCreditFacilityExpirationDate1" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2030</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. Currently, management does not believe the Company is a party to any legal proceedings that would have a material adverse effect on its operations. The Company continuously evaluates potential contingencies and will accrue liabilities as necessary. However, the resolution of any claim or litigation is inherently uncertain and could impact the Company&#8217;s financial condition, cash flows, or results of operations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liability Insurance</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims &#8212;  including liabilities in excess of the Company&#8217;s insurance coverage &#8212; will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the Company currently maintains liability insurance policies on a claims-made basis which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may not continue to be available to the Company in future years at acceptable costs and on favorable terms.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_95a52cd6-ba62-4404-bcae-910a523fb911" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true" continuedAt="F_95a52cd6-ba62-4404-bcae-910a523fb911_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Related-Party Transactions</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method Investments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_112d520c-9ca3-44e4-bc4d-524d5d4e98e8" contextRef="C_e7d1b03b-c982-4a71-9cb6-b34b0f7c2e9b" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5c13c87-d7cd-4fc7-aa09-5980afddf711" contextRef="C_e1740a99-900b-4902-9d5e-4d630ead0b03" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Pacific Medical Imaging &amp; Oncology Center, Inc. (&#8220;PMIOC&#8221;) for provider services. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PMIOC provides covered services on behalf of the Company&#8217;s RBOs to enrollees of the plans. PMIOC is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bd0793fe-635e-400e-ab14-ab836377ffe3" contextRef="C_57c79a78-9732-4080-9239-22b71e33c266" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">40</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During each of the three months ended March 31, 2025, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00d963bc-ff7a-448a-8ad1-9da709674d88" contextRef="C_9e346eab-38d7-402b-bf8f-0d60cb0107a1" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_098cda05-ff2f-471b-a75a-c03a1f1d7825" contextRef="C_c41d3eed-30db-4a53-8251-e8161f2a5685" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for provider services to an equity method investment in which the Company has a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_16a0deb4-cc11-4294-bf05-dd3072afa046" contextRef="C_7acb6b6e-5f3d-4e08-a797-82f25588ef01" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership. (see Note 5 &#8212; &#8220;Investments in Other Entities &#8211; Equity Method&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company incurred expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8081f128-f17c-4b2c-ab80-6fb6e8ff14db" contextRef="C_820936f1-0951-4659-b917-23fcb1da4cbf" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in management fees and interest expense to I Health. The Company has a management service agreement and promissory note payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with I Health. I Health is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_10e07e34-1dda-4c02-a737-7ed1b1d9657f" contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company recognized approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b30cd143-6ca9-4430-af04-54d07bc1c9c2" contextRef="C_a1674af8-635b-46ac-b060-061caa2787f0" name="us-gaap:OperatingCostsAndExpenses" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in management fee income from equity method investments acquired through the CHS acquisition. The Company owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a09fe12c-3a1f-494d-b84c-5e948a0a4918" contextRef="C_423ede0d-20f9-4418-b336-259b500c9fd8" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">50</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a8f6de44-14da-46c6-a54b-092fbe7fe9d8" contextRef="C_a103be58-2da8-49dd-aac7-8114b8e1d475" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">51</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in these investments. These investments are accounted for under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">equity method (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">35</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95a52cd6-ba62-4404-bcae-910a523fb911_1" continuedAt="F_95a52cd6-ba62-4404-bcae-910a523fb911_2"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Astrana Board Members and Officers</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company recognized approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9248870-2432-4991-a438-f117569cb817" contextRef="C_0bcf495d-f6c9-4ab7-acd8-a670125428f4" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in expenses and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_75adacc9-8e7b-4cf5-b63a-7fc7e4532cb6" contextRef="C_69535d23-6b5a-4866-b0c2-b2062e9d8bed" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in revenue, net of expenses, from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;), respectively. Revenue consisted of management fees and surplus from shared risk arrangements. Expenses consisted of fees for provider services. Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. Arroyo Vista is a non-profit network of community health centers serving Greater Northeast Los Angeles. Arroyo Vista provides certain primary care services to enrollees of certain healthcare service plans, the providers of which have contracted with our affiliates.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company incurred rent expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f10b6542-2d95-4114-a96a-bea63500d955" contextRef="C_d58319c2-1e7d-404d-9de6-2c8ff0ce99e9" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9f629b1-6431-4d7a-8879-e5e4efdd1501" contextRef="C_b3af013b-f74c-4b68-9ba2-7e9a3065d0ca" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, from certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. As of March 31, 2025, and December 31, 2024, the Company&#8217;s operating right-of-use asset balance included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33b0762f-4fc0-4c55-9f51-af667e6cb382" contextRef="C_3757db2b-c29b-442c-90e8-b518b6fde2b8" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bb452dd4-9b77-47a8-9ec1-932d814f9f21" contextRef="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the Company&#8217;s operating lease liabilities included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0a8d6d40-792b-4198-8497-e8d8d04eb277" contextRef="C_3757db2b-c29b-442c-90e8-b518b6fde2b8" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c1d52e18-c1fa-4ae5-acf7-259fa243a8d5" contextRef="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. The chief executive officer of Allied Pacific Holdings Investment Management, LLC is a member of the Company&#8217;s board of directors.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a Simple Agreement for Future Equity ("SAFE") with Third Way Health (see Note 5 &#8212; &#8220;Investments in Other Entities"). As of March 31, 2025 and December 31, 2024 the investment was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bc8d69f5-0b97-4aa6-8adc-8491956e8c00" contextRef="C_c16d7a21-9458-4b38-a8c0-cfb657c898ac" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_621a1c52-8fa1-411c-a0e6-353f1bebfb87" contextRef="C_1f767e2b-b61b-4ca0-98c7-e3058a5e5df3" name="asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.0</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, the Company incurred approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9c0b7dd-2033-43c1-aa57-c51159b519f7" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:RelatedPartyExpensesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_80ee7618-f3ac-4259-a2ca-bf767a535953" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:RelatedPartyExpensesPayable" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in expenses payable to Third Way Health for call center and credentialing services. One of Astrana&#8217;s officers is a board member of Third Way Health.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00ded2d9-31f3-4bbd-95c5-8460078759fa" contextRef="C_65e86fd8-187a-4fa5-8ef5-554371a711f6" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1a054e0-d6ea-46c8-9e32-12251d6f78ea" contextRef="C_b3b64b0e-4eb5-45d0-b5f9-2d703131e99a" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">45,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Sunny Village Care Center for services as a provider. The Company has provider contracts with Sunny Village Care Center. Sunny Village Care Center shares common ownership with certain Astrana board members.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company incurred rent expense of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e81c3b77-d4ac-45c5-8170-e8824b4fdce1" contextRef="C_5ab8feca-ce17-4204-bc5e-2c50a0f3326e" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">42,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e47eca2d-7f62-47e6-9a20-0e5b0b9d825b" contextRef="C_95410889-f77a-49be-96bd-dcaa6e56cd80" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">38,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to First Commonwealth Property, LLC for an office lease. First Commonwealth Property, LLC shares common ownership with certain board members of APC and AHM. As of March 31, 2025 and December 31, 2024, the Company&#8217;s operating right-of-use asset balance included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff37cff4-69ed-4175-bc04-b6e8270558a6" contextRef="C_cf787623-6175-4af2-9a0a-baa08dd1743a" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_43ac1d1a-1c24-45fa-8f21-4e962c19dbc0" contextRef="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the Company&#8217;s operating lease liabilities included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8ab5b0e-81c2-4a02-9874-1540a1c23844" contextRef="C_cf787623-6175-4af2-9a0a-baa08dd1743a" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2842121c-5e99-4426-9390-5590a17769e5" contextRef="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for certain properties owned by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Commonwealth Property, LLC.</span></p></ix:continuation></div><div><ix:continuation id="F_95a52cd6-ba62-4404-bcae-910a523fb911_2" continuedAt="F_95a52cd6-ba62-4404-bcae-910a523fb911_3"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC Healthcare Inc. (&#8220;AHMC&#8221;) for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO and Aurion and is the sole owner of Aurion. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees, and expenses consisting of claims expenses, management fees, and consulting fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_099a465c-4f6f-437d-a0f2-6b565bc21854" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth revenue recognized and fees incurred related to AHMC, HSMSO, and Aurion for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.667%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:8.122%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d2d3b8ae-fa32-4979-aa01-88d39ca7fb20" contextRef="C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,771</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4710c306-ad26-4bfb-bf5d-969ea83d2888" contextRef="C_72cdfcac-2740-4878-88ae-2ceba95c47c8" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1ece673d-f04c-4565-9ba5-4b91f6d7456b" contextRef="C_84fa31dd-5a86-4282-8662-e45fc242151e" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcbfec0a-8a33-49b7-aed4-1a6da3953c5c" contextRef="C_02cfd407-332a-4baf-987c-e88967c9572f" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,920</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a9c3bbb7-da15-4d2d-833b-81b9e006ce47" contextRef="C_2cbf692b-71ea-45e0-a47a-62ac40f45969" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a0cd2a22-e455-4bfe-b9b2-c0d8b6d51c5a" contextRef="C_049fe2ce-623c-47b8-956b-acb5e9467f17" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b52be53b-bccf-4850-995b-418a426fd3da" contextRef="C_7a198c7b-7dd4-4175-ba0f-59cc0ec75af0" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">31,680</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_68714bb7-c7df-4149-b86b-3fdb6acc49d2" contextRef="C_e21928d0-d834-46c0-97ad-f882fc6f862c" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1af263df-0434-495d-8000-3045e4f75f3a" contextRef="C_b83becec-a8a7-4250-98f0-8f5ba29d2848" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_affce970-c3f4-4d9a-9c00-4374ec80c026" contextRef="C_3219815c-b8e4-4aee-977c-644ac98f25fc" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,557</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30325793-c926-4921-a33e-b14f32398e68" contextRef="C_e495f793-75dc-4d1d-8b73-1382c3cdff82" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_737d9cac-e1f4-49ad-bdf1-4425f616558f" contextRef="C_3d79f704-e8f9-4c16-8574-e530d4eb0e3c" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_844301bc-723f-4903-a2a7-75f9f9e5caf3" contextRef="C_cae1d15e-081f-4e25-9666-48ba5588bb71" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,909</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b0bb609-f20c-413c-8a71-7ed117824a91" contextRef="C_9e921ba2-6ad9-43f7-bb6e-25d335ac8af4" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74b97c19-5e4f-4d40-9a71-4c98af7d31d3" contextRef="C_1ea642ae-a35a-4119-b34f-c0c2715563a7" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">100</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_408dad59-8e3e-4545-8f87-81d74b6824e6" contextRef="C_c3a02d13-ffcb-4213-bda6-e5bb59c91eeb" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,363</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b3cb2504-4b1d-4990-b2fe-d17ede4571c4" contextRef="C_267bebe9-df3a-4348-8901-8b3074ee8ba5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">301</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7b419d9-571c-4176-862a-7a0504913116" contextRef="C_b929ea35-4d57-4309-9729-8e223f59f4b8" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">50</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">36</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95a52cd6-ba62-4404-bcae-910a523fb911_3" continuedAt="F_95a52cd6-ba62-4404-bcae-910a523fb911_4"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended March 31, 2025 and 2024, the Company had recognized risk pool revenues of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ad57161-36c2-47a3-980e-5b86a1c5ad30" contextRef="C_2e55ed2c-9a1c-471f-b86f-f1b220d4588d" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f15f93d1-cdf7-4bbb-9625-481a186b6bb6" contextRef="C_8e1fbaba-ca27-4783-9682-64643b46acf8" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">8.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. As of March 31, 2025 and December 31, 2024,  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14ccc010-3f6d-40f5-b96e-7f750b53a5f7" contextRef="C_fcb6fb64-b6ca-4164-afb7-90087668e19b" name="us-gaap:DeferredCreditsAndOtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">53.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_257d1910-4b97-48f0-9678-946362818ad6" contextRef="C_608c6900-ee56-4405-ae5d-6fc0640fc6b5" name="us-gaap:DeferredCreditsAndOtherLiabilities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">47.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remained in outstanding risk pool receivables, respectively.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95a52cd6-ba62-4404-bcae-910a523fb911_4" continuedAt="F_95a52cd6-ba62-4404-bcae-910a523fb911_5"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC Board Members</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid an aggregate of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad3f244c-7a0f-41b0-8f8a-969737535e7f" contextRef="C_651b11d9-1f6c-4cc8-af5e-b6decb5bd381" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_39128955-4a9d-4579-8563-b2779a51db11" contextRef="C_35ed1a55-e356-4546-bdd7-e13888799768" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to board members for provider services and repurchase of APC shares of common stock, which included approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c101b162-53da-4643-9882-61e12ed07e42" contextRef="C_74ff5438-7469-415e-827f-4df6603c37f5" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0e6a4130-7b66-4917-8f95-89ed3cefd252" contextRef="C_df93c67e-ab97-4281-ba2a-b871cd8e57a0" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Astrana board members and officers who are also board members and officers of APC.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, affiliates wholly owned by the Company&#8217;s key personnel are reported in the accompanying condensed consolidated statements of income on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_95a52cd6-ba62-4404-bcae-910a523fb911_5"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intercompany Transactions</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#8217;s key personnel, to engage in certain transactions and make intercompany loans from time to time.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For equity method investments and promissory note payable with related parties, see Note 5 &#8212; &#8220;Investments in Other Entities  &#8212; Equity Method&#8221; and Note 9 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; respectively.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d799574-4cb4-4c73-a183-52b5a1ffada1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">14.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income Taxes</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the liability method of accounting for income taxes as set forth in ASC 740 Income Taxes. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#8217;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#8217;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s effective income tax rate for the three months ended March 31, 2025 and 2024, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_de2181fb-ddf4-48d8-a77b-56445ff4f8b9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">35.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a39acf4f-4863-4376-a506-068fd289042f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">29.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The tax rate for the three months ended March 31, 2025, differed from the U.S. federal statutory rate primarily due to non deductible expenses, state income taxes and income from flow-through entities.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If recognized, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c93bec00-b04b-42b2-b0c9-96eda39622eb" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" unitRef="U_USD" scale="6" decimals="-6" format="ixt:num-dot-decimal">1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the unrecognized tax benefits as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, would reduce the annual effective tax rate. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes in the Company&#8217;s consolidated financial statements. For the period ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. the Company had recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8bafe606-37eb-42e4-9e69-04b822b1beb8" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">40,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of interest and penalties related to unrecognized tax benefits on its consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to U.S. federal income tax as well as state income tax in certain U.S. states. The Company and its subsidiaries&#8217; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2020 through December 31, 2024, and for the years ended December 31, 2021 through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">37</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bea29491-0b40-4236-a9a1-1d4e7d307fa4" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EarningsPerShareTextBlock" escape="true"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">15.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Earnings Per Share</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic earnings per share are calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period and are calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share are calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes and preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana's income from APC&#8217;s ownership of Astrana common stock, and this is included in the net income (loss) attributable to non-controlling interest on the condensed consolidated statements of income, therefore, none of the shares of Astrana held by APC are considered outstanding for the purpose of basic or diluted earnings per share computation.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#8217;s stock held by APC was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_55d9c34b-1768-40d5-bcae-c8716e924aef" contextRef="C_3e76e350-ea44-40df-b69e-b28234065741" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">9,903,953</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_985e9c46-a1ca-4f48-9736-21478c3c424f" contextRef="C_0cff01c6-12c7-4f38-864b-0bbcdc7a9295" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">10,603,849</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. These are treated as treasury shares for accounting purposes, and not included in the number of shares of common stock outstanding used to calculate earnings per share.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2024, restricted stock of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec88d6f6-bc64-4f4f-94a6-83d88fbcc9c4" contextRef="C_0ac128eb-5a33-4975-905f-b556a96e2c4d" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">409,736</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9db4447-2bb3-430c-bc45-33adb6afae0d" contextRef="C_782cba76-0dc6-4355-999d-51fc02a33e23" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">118,142</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, stock options of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e470dedd-e58c-4e62-8d6b-5a57af96906b" contextRef="C_a0af827e-2073-40a4-9366-c1c611fcf2e7" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">125,707</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6ace12c-8e80-4258-bff7-22d40d287484" contextRef="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">168,207</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, contingently issuable shares of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1611e501-2853-4c48-b404-7d228c28d090" contextRef="C_1989d044-2b9d-4d1d-adb5-89940dd1bf1a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">1,120,899</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84c4aa94-70ea-43fd-b70b-dda49d32b156" contextRef="C_9a8924e1-57f9-410e-b002-cadf956446e6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">973,461</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of March 31, 2025 and 2024, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fc4f1e80-f948-45b7-b472-a123b02c15f9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.2%;box-sizing:content-box;"/>
         <td style="width:1.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.26%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.419999999999998%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11eee6d5-3d25-467b-991a-f892b6d01c77" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6908bc5d-c32b-477e-b2f5-ab8c42115814" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EarningsPerShareBasic" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.31</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b2fd700e-938a-4eb3-ad59-84c9039cadb9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.14</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_509e21c2-812e-4c52-b28c-1d519a868210" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EarningsPerShareDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" format="ixt:num-dot-decimal">0.31</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ba627a0-7d8f-4ea0-80c1-a90d0f5299ba" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,470,682</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c57b267-2e20-40d0-857d-1490b91a40a4" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">47,260,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22c93660-503f-4438-8411-2a38ebcb4147" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,850,666</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_76356ef1-b47d-4cfb-8f80-d0220e2f1995" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">47,699,537</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_311be12e-d493-46f9-8d48-59cdf299a147" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the shares included in the diluted earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.187%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.737%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:16.877%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3e8fa4e2-380e-47b3-a73b-40c76ff454d8" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,470,682</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f7234ee8-f3d3-4e5d-af7d-d39be0baff47" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">47,260,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7bc8d74e-cff2-4f7e-9304-55facca17b19" contextRef="C_a0af827e-2073-40a4-9366-c1c611fcf2e7" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">112,858</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7822b5dd-c892-48ce-9979-1c0cabd119bb" contextRef="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">188,083</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26c976b8-41a9-4d1f-bc61-9db4d6a97ce4" contextRef="C_0ac128eb-5a33-4975-905f-b556a96e2c4d" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">130,055</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_953f37df-d673-44c3-ad6d-44842f60fa72" contextRef="C_782cba76-0dc6-4355-999d-51fc02a33e23" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">225,128</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingently issuable shares</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70896dba-a346-4aa5-8191-4efc7486c0ff" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">137,071</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af83a037-7642-4ecb-972f-710e913ddb7d" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">25,975</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61e32883-4208-4beb-ba58-a9f0cef347da" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">48,850,666</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3de3f91e-af4d-4e9c-958b-ac85498a72fe" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:num-dot-decimal">47,699,537</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">38</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:VariableInterestEntityDisclosureTextBlock" escape="true" continuedAt="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">16.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Variable Interest Entities (VIEs)</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some states have laws that prohibit business entities with non-physician owners&#8212;such as Astrana and its subsidiaries&#8212;from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements&#8212;such as fee-splitting&#8212;with physicians.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#8217;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholders of professional corporations that hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder, the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition, these entities are managed by the Company&#8217;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations and their consolidated medical corporations are consolidated by the Company in the accompanying condensed financial statements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Medical and Astrana Care Partners Medical were formed as designated shareholder professional corporations in May 2019 and July 2021, respectively, as designated shareholder professional corporations. The Company&#8217;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Care Partners Medical. Via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and Astrana Care Partners Medical. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Care Partners Medical. Therefore, Astrana Medical and Astrana Care Partners Medical are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs.</span></p><div><ix:nonNumeric id="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" escape="true" continuedAt="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolida</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tion, are included in the accompanying condensed consolidated balance sheets (in thousands).</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">39</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c_1" continuedAt="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c_2"><div><ix:continuation id="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76_1" continuedAt="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76_2"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"/>
         <td style="width:2.36%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.416%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.36%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.416%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7c93819-c0d3-480a-bee5-2ca3c977e7b5" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">150,013</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1a159a5b-8602-483f-a15b-cc7164283226" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">158,922</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in marketable securities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e330875f-0c60-42ef-9ebd-99226b9782e8" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,283</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f40fdbb-fe3a-4c04-8fd3-2c9b3d7b1392" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:MarketableSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,259</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7c3aa76-d15a-48a4-8f21-bcbdc51ba401" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">71,820</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_40396c0b-4fc7-4407-8100-5cc17150714f" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,977</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net &#8211; related party</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4de946df-94c8-4f16-bbaf-b94c1e520773" contextRef="C_ab1680b4-76ea-4b15-86a6-421050cb834d" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">54,873</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ee3a1b01-b29c-47ea-8f03-410fd873340a" contextRef="C_f87a47bf-3205-4aee-8f68-e2bd18751281" name="us-gaap:AccountsReceivableNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,251</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78b1de1d-bde0-4342-ad13-446923e53059" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">22</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d10ce613-b587-494e-9cab-f449348112e5" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherReceivablesNetCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,303</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_346b3aa5-bb26-4995-93d2-356de7739bb7" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,917</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b50787e0-a070-4290-aa13-b83b1ae85377" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,161</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b046980b-905c-4054-b524-36419a25d6b6" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">285,928</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fb173afc-25a2-426b-a820-5704c37e9284" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">318,873</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9663d342-c06f-4108-b46e-13ec48ad89bf" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,528</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11907088-a39c-410f-b87c-775c07122a12" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,875</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_265f7135-340c-4ada-b627-a0284eb098cd" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">83,582</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be3d8676-ffbf-4b69-b0e7-dbb0eaae9c25" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">87,840</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8dc3f870-c74e-4652-aacf-5535304ab1d4" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">241,531</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4527d9b-60ac-4b9b-ab98-918c52866620" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:Goodwill" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">243,283</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable, non-current</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9c914a24-1f19-4420-ada8-bfe24ef9a318" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:IncomeTaxesReceivableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,943</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e7a28b07-bd0c-4442-8302-1273c40319d8" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:IncomeTaxesReceivableNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,943</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33f119ca-dc58-4740-8a4a-c7d4739e4298" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,063</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_840ea6c7-0fb8-4871-bd14-321ecae26d77" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:EquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15,442</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in a privately held entity</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0fae14f2-42a1-419e-be59-f1c1fad5e9eb" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4a8b4864-85be-40bb-a37a-3401c0cd8239" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">405</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c007ca24-ef72-426b-a491-9166747072c5" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherLongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">190,178</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0b5118e4-4bcd-4458-8758-8de1a93deb81" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherLongTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">224,894</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e1e40417-4687-4dd0-9a93-fd8bd727d63e" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_043e2139-7049-4d80-ab2d-e95f5869a394" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">40</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7d66579-cff8-473c-9e2b-06f12f9b2e24" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">26,033</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ebf13ef7-741b-4b8c-9740-8630d62cff32" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,585</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eeaa41cf-153f-4f9c-8650-11da53755b94" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,055</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fdc86ac7-3460-46b7-ae8a-cbee078c4d00" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,019</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a2828f7-cdd4-4c29-9cf4-c778e646f558" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">582,358</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_13ad72d8-a7f8-4e49-8d91-719750ca5672" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:AssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">618,326</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a80c2310-7a63-46d9-b7da-0346411a3a66" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">868,286</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_981330aa-c810-48fd-b6c4-a5be4c3755eb" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">937,199</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">40</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c_2"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76_2">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"/>
         <td style="width:2.36%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.416%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:2.36%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:22.416%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ead77e1a-349b-484a-8bb5-ffbec82f4cea" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">37,804</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_beed38ec-8701-443a-ac20-d4c312399e83" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,800</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiduciary accounts payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b0ac2d87-458a-440e-ab40-4f2b9d315079" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="asth:FiduciaryAccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,840</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_810a34de-50ea-46e9-98f4-9ef33cc14f14" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="asth:FiduciaryAccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">8,223</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c543b331-10e7-4bec-8aa3-4f34a5161cd4" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">100,547</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_381b4ff7-8e0c-4c10-967a-f99dca31c419" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">105,486</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8c4c0a75-0ce9-43f0-9389-b65afa149321" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:DividendsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1680d1e0-3813-4680-9c2c-47ff413e57ed" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:DividendsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">638</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ddea73ea-e20c-49d5-87da-5bf476ed692d" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,140</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b56b1b8a-10d3-4e82-a423-40f83fc13d76" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:TaxesPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,041</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a50ceac-eb5e-4067-9453-af2860554bfe" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20fdf0bb-8851-4d1e-a1bb-1bfe624c8302" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">520</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6a1cbce5-180a-418f-9cf0-99b017c95e28" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,076</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_81c967ac-fc21-4e3b-b4bf-a191c4d41a78" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,487</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aa054d76-bb24-48dd-801b-e3a6a2082a8e" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,348</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3eb2acbd-cb61-4143-b71a-8ec51885bf04" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amount due to affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_add9e499-7a9d-4f75-9902-9928dea7a7e3" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,548</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_884d4621-f5ef-4d67-9bb2-8eed00849949" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">48,142</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0c63d670-d137-4fc3-94fe-25abdf7fc372" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">173,392</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eba5d9e8-0890-494f-b330-1cefbdc54764" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">222,688</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87d394c7-3d6e-4151-b311-b73fa5e21693" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,905</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_bcbe4545-ed38-46d0-bc96-db3330c4316a" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,237</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f25f4479-1c74-49ed-8ad1-8a4e2edb1c30" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">451</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df678977-c277-4ff5-96df-7b48475d1e35" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">520</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7df6c0e-f0c0-4e9a-bb9c-01d482db866f" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,006</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f5c85e7-8369-49de-989f-46eaa367dde0" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21,012</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f61cfab8-365d-46cf-b711-a81ff6854bc7" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,890</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c867673f-6e3e-40fe-aa3a-9f7bb3487787" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">619</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a3339d6d-3d8a-490f-bf12-a458fcc3f631" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,252</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d215972a-21ce-4512-8692-96a6c7195f88" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:LiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,388</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_62c6106a-d2b6-4fba-9ba0-ca45351a7563" contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">216,644</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_01d0d94f-66ed-41ca-a71f-38879a095ce8" contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">256,076</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Investment in affiliates includes the Company&#8217;s VIEs&#8217; investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></ix:continuation></div></ix:continuation></div><div><ix:nonNumeric id="F_312c7e30-34e2-448e-a0e3-d825f0525f2e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:LesseeOperatingAndFinanceLeasesTextBlock" escape="true" continuedAt="F_312c7e30-34e2-448e-a0e3-d825f0525f2e_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">17.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leases</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. These leases have remaining lease terms ranging from </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f6ed1b16-3f9f-4124-b53b-b3c02236a4c5" contextRef="C_9e7792f7-702f-4f53-bc31-698f8ce0df84" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> month</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_561ca5a8-cf06-4f2c-875a-727d4c5f926c" contextRef="C_80446148-a401-4cce-89ac-14f1418b9966" name="us-gaap:LesseeFinanceLeaseRemainingLeaseTerm" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, some of which may include options to extend the leases for up to </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2eac3fb4-b3c1-42a1-85dd-1227392eb21b" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:LesseeOperatingAndFinanceLeaseRenewalTerm" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and some of which may include options to terminate the leases within </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c3297bc-8167-427c-af2f-32d831dc0c5d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one year</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as the Consumer Price Index. As of March 31, 2025 and December 31, 2024, finance lease assets, net of depreciation, were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_421e2b95-1e32-4542-9d24-af6e9e8cfc5a" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99270987-f52d-4eeb-baea-541b7f7e4d8a" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FinanceLeaseRightOfUseAsset" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and accumulated depreciation associated with finance leases was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7e7cf9b8-d783-4f20-b709-33e2a32e3015" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba59242d-ed11-44f4-b745-ab31ae6fb37b" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets.</span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">41</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_312c7e30-34e2-448e-a0e3-d825f0525f2e_1" continuedAt="F_312c7e30-34e2-448e-a0e3-d825f0525f2e_2"><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ff5ac3ff-6d3a-4a4c-84e3-2c0f91a2229e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5c345c80-167a-4067-961e-50d7040f76be" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,611</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3dd1b9f5-64cf-41fa-8cdd-1aba228033f4" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,159</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of lease expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7592f42f-a994-43d9-85b6-a8811440725f" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_053dd4ee-f0e5-409c-8fce-f52f80ba8224" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_684074c5-c4e2-4001-a91e-6f8af5b33cfb" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a2b05c52-27db-4e3b-9bb6-01ee78f56323" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:FinanceLeaseInterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sublease income</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ffb02a7-1fa1-4e1b-99cc-4376ac71032d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SubleaseIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc86c6cc-a13d-4abf-ac7c-08d19075e8cf" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:SubleaseIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">226</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6992f974-0b75-488e-ab8e-376ecb468b2c" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,730</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0726aaf3-db77-4fd0-8c0d-b51d19a9b140" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,136</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to leases was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental Cash Flow Information</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f56881b-d25e-4bac-95df-3e854f9ca326" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,017</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1dfafdd1-7b9b-48e8-9cb2-9774a9bd60e9" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,837</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7ad97928-b53a-40d4-95b7-12d6d4dce640" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_459743f2-271a-49f4-9867-8d491eeda93f" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_35df48be-1d0b-4f3a-930b-10fc03597c63" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">147</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3a5db5e6-5327-4d06-8550-0d778ed07e9a" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:FinanceLeasePrincipalPayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">179</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.343%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:13.343%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Lease Term</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_e386ce0b-3496-4723-ae99-4f555dd088f8" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.22</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_82ec6fca-2ce1-464f-bd12-f72e131b0f96" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.39</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_44767ff6-3faf-421b-ad4b-aa572abeda59" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><ix:nonNumeric id="F_4758ddca-087e-4f7c-883f-8c7bdbd258fb" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.96</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Discount Rate</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a54665ad-cfaf-44fa-9d6c-72e0a9e4af9e" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.75</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1b81f726-e1c9-440c-8ff0-f2a994629844" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">6.15</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3b41bf37-7ee5-4bc6-9c25-a3a1e3b8bf77" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.79</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b873e9a5-70c6-40ec-8369-6889e1fc917f" contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">5.53</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">42</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_312c7e30-34e2-448e-a0e3-d825f0525f2e_2"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_053beca7-23d1-4d28-b4eb-5d903c0d7f47" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" escape="true" continuedAt="F_053beca7-23d1-4d28-b4eb-5d903c0d7f47_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_08a4581b-e8cb-4407-a5b6-c4bd8c344e85" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,269</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4986c7a3-63ae-47f4-8bbe-b3f7fa930dc4" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">443</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a05ef301-ccbe-497b-9c08-53897b3b7d8c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,851</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be7f85f5-2f6d-47e9-86a2-0e1c939e05c9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">345</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ff905574-8cf6-4c88-ba0a-9f83818be948" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,246</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11396775-54d6-4602-9295-2473038b375e" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">267</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ded160b-7567-4985-bfa3-6c49b6d509a7" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,973</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2732d0f8-f481-429f-bcf6-29c3453b56c6" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dde6e7d8-4ff2-43f9-b500-e1267e17d7a1" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,882</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4f731153-1781-4478-8eb9-eabe7e02f5b5" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fc70a263-c21a-460d-9942-1f7bcd2cf806" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">14,876</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7290341d-1683-4fc4-9569-3678cbf38775" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="asth:FinanceLeaseLiabilityToBePaidAfterYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future minimum lease payments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1c65c418-e083-4a9d-bb4e-c04d9152b357" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,097</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_abba8679-816d-43bb-802f-04af4c96cf54" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,091</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5da13df7-f51a-4d32-a5c3-338ce672e799" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,155</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cebf15f-d9e7-4f43-8f36-d30adaaaa116" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5b071c86-1481-4816-a34e-77042ac93396" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,942</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a085f478-bb60-4288-aa54-b0b13d2aa470" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,014</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4ecef208-fc15-472d-9815-a6ae89f49d08" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,979</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fd5f0112-2850-46ce-a488-84c7f2287707" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">471</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98ab2829-e722-4a32-b13b-9ce4a460ae0d" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,963</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_faeba382-cdb9-43fb-b11e-99e613bcc11c" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinanceLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">543</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:continuation></div><div><ix:continuation id="F_053beca7-23d1-4d28-b4eb-5d903c0d7f47_1"></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:nonNumeric id="F_fbb0a7ea-a0e5-442a-970e-dde087f0ef00" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SegmentReportingDisclosureTextBlock" escape="true" continuedAt="F_fbb0a7ea-a0e5-442a-970e-dde087f0ef00_1"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">18.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segments</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). Factors used in determining the reportable business segments include the nature of operating activities and the type of information presented to the Company's CODMS to evaluate all results of operations. The Company currently has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9afeaaba-0a58-4f7c-8056-d326edc9144b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:NumberOfReportableSegments" unitRef="U_Segment" decimals="0" format="ixt-sec:numwordsen">three</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#8212;&#8220;Description of Business&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Partners segment, revenue is primarily comprised of capitation and risk pool settlements and incentives. Cost of service for this segment is primarily capitation and claims expenses.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Delivery segment, revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives. Cost of service for this segment is primarily medical supplies costs and salaries expense related to medical staff and clinic employees.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Enablement segment, revenue for is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis. Cost of service for this segment is primarily MSO salaries expense.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_43064779-aba2-4426-ac3f-35387bad1512" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's CODMs are its</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_85a7fb24-2a46-4162-beeb-ab37e6433db9;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Chief Executive Officer and Chief Financial Officer.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The CODMs evaluate the performance of the Company&#8217;s operating segments based on segment revenue growth and operating income. The CODMs use revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3adbc4db-8514-4f38-836a-a52389f5cf2d" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. The CODMs do not evaluate the Company&#8217;s segments using asset information. The significant segment expenses that comprise operating income as a measure used by the CODMs in evaluating operating segment performance do not differ from the operating expenses as presented on the consolidated statements of income.</span></ix:nonNumeric></span></p></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">43</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_fbb0a7ea-a0e5-442a-970e-dde087f0ef00_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company&#8217;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs, and corporate shared costs, such as finance, human resources, legal, and executives.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amounts disclosed in prior period have been recast to conform to the current period presentation. Specifically, segments are presented net of intrasegment eliminations for the three months ended March 31, 2024. The following table presents information about our segments (in thousands):</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5830cbee-0d7a-4269-83c2-96fcca832466" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" escape="true"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about the Company&#8217;s segments (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.7%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.7%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_af03fec4-ea44-4d66-af14-3cfc86f44b4c" contextRef="C_3a367d74-7d53-44d3-bbea-33e94ba22408" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">600,951</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f168ec89-8576-482f-bf06-2559203c134e" contextRef="C_ee86e486-beed-4909-b2c8-b2cf6dae3f11" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,690</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f3006af6-fbfc-4ca4-9e5b-87bed9c6bae7" contextRef="C_77dce955-a90f-4883-84a3-2ecf12cbb7b4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,749</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3786300f-eca2-4df9-aba9-5896fcec4fb3" contextRef="C_b4ca8ae3-3bfd-4c53-99ad-240c6fa58860" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">620,390</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae44f2a6-13c7-44ac-9be3-6fbc56c7384a" contextRef="C_60fac651-18d8-44ed-9d9c-07d7f1f63e2f" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,698</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9e5b0f1-3efa-4e37-a3ee-4e9832b0313c" contextRef="C_f497f166-f60f-4783-b578-7fc1e03156d6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,813</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6310cedd-2f3a-4607-af2f-0444e3c2e1e5" contextRef="C_b7f07760-d62f-4512-a664-d49bed1a90cf" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,511</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a7f32fe2-06b6-41a6-b1e7-4e479bf04a8c" contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">600,951</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90fd043d-c2ee-4a25-be79-d5bd0d10d75d" contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,388</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0d072588-f387-4c37-9e63-58df9c6a6ae1" contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">39,562</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d4027799-f0d3-412e-ba9f-ab2307a9b701" contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,511</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d248818-ac89-4a5e-81f0-03f537d5b5fc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">620,390</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c8bf46ef-52a8-45ce-96f5-26d998321d1d" contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">512,668</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_858dca01-7e01-49e5-9bd6-1b0034e5817f" contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">27,139</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e38c4457-936d-4b39-896a-65410fda1bf2" contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">25,818</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_900bb35d-8fbf-4659-9f77-c07ac3f683ad" contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,564</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d50e5da-1f36-4f98-9c02-ba4abef47b7e" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">549,061</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7658162f-48ac-4a82-893f-7747e7a5a030" contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,068</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf622bcd-29b6-43f8-b86a-a34415947afb" contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,357</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e861f943-a247-49b4-a348-fe71f93ada6f" contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">10,209</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_12ffd247-a7e6-4938-8563-f07682b0287a" contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">36,950</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_418f703a-ac26-454f-a54c-3473aa1b067d" contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,062</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_afd5dcb8-b20a-4c07-82fd-e938e613965a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">50,746</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_977f52cf-b645-445e-a666-dfcfcc9f915b" contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">556,736</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9a7c5a8c-c0b6-4f77-9f0c-20bff7d3b58c" contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,496</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5cee79f6-84ca-4536-8137-7c9f2d661c94" contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">36,027</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3d113c3-d03d-4872-b1f4-10f817d6d30b" contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">53,514</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_11c7ded6-c64f-45f2-b2d0-a1a3a3c9546b" contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,062</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d1eabf7e-bf20-4b90-8cde-b7de327b5174" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">599,807</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cf60b6d4-9930-4224-9a19-642309e77e19" contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">44,215</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_be708269-c538-4ffe-9e5c-5ef3a1aaf7f3" contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">3,108</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a14ec555-7390-4336-a686-6b6e290095fa" contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,535</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54d5a39c-323f-43ea-8bd9-1a5fa4aee59e" contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c35d7cb-99ac-4c0c-93af-d243eaceb0c7" contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">24,062</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51541cda-d223-4a41-83d9-3957c943c7dc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">20,583</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.7%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.7%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.44%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:7.72%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.56%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_87f3c5b4-998d-4f5c-8098-b657f2ebdfcb" contextRef="C_6399433e-def4-4d84-b6b6-f762bf6ee833" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">382,318</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_54957fde-6549-4d13-95f5-63881cde9217" contextRef="C_2756304c-de02-4a8c-b11b-0af4c1d0f72b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,878</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72fdb3af-fa7a-464b-bb7c-9e9517cd8676" contextRef="C_8f4dfe63-7e3c-4550-a1aa-0d1885663f72" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,160</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a709d0bf-d15f-4469-bee0-f5a6759942f8" contextRef="C_3d384b8a-36f4-49d6-9e03-2c663c6f6dae" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404,356</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b1ad028-d5af-42ed-b5d2-3ba7db1d96bf" contextRef="C_455ccf48-8afa-43f7-9084-96bed70ceb5b" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_65789043-6b1d-4e55-ba5c-83dddf0fa7ff" contextRef="C_83766bc6-44a6-4789-9671-394dba982518" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,841</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c1483ed-7afb-4068-9cde-94c5175bc37a" contextRef="C_e6d48615-5367-4a0f-ad3d-86dd6a0bbd6c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,114</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5da61e24-cde4-4bd9-b25b-401ac891f57c" contextRef="C_d455b109-46c4-4ef7-9caf-6da6c644c797" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">41,955</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8b38eacc-cafb-438a-ae0e-0b7ec3d0f99d" contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">382,318</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_108d48aa-6685-4a54-b4ae-6e3377fdf329" contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,719</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d8e3a55-8151-4c2c-bc61-2598a22dcee4" contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">33,274</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_200fca29-bb18-4289-a4fd-ec9fd402076b" contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">41,955</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2b10ab9f-de44-47a9-b5ff-d5371fcc2105" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">404,356</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ae03f78-ade3-4f12-9a34-109e90935781" contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">300,189</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8a26a82f-0480-474a-9ec9-ab539efab0e5" contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">24,794</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1717dbba-5ecc-4471-9a38-2f6924b342ee" contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">17,373</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22724ca4-6ab1-4273-9ffd-6a3b074d4eba" contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">11,957</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_83c047f7-8e8c-4e51-8e9d-041a8a4d4ead" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">330,399</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9ea5abeb-40b0-4ee2-a982-e69cea603983" contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">38,933</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_69bb3186-5695-4c45-98c6-a2d09d83933e" contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,163</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2de3e6fc-e07d-45ac-9e97-f1b2b56a06a1" contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">12,397</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbd38380-ccc4-416c-a10d-0df979639153" contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">30,075</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ae31d8e6-eecb-469b-8ea4-81972a78c94e" contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,400</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3fd67aee-2e19-4967-9041-802dd4dac5dc" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,818</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f4a2a8b8-2dd3-4e97-915a-e75fe5f77f4c" contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">339,122</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fe50fb62-8040-4c9d-9c56-e00796acbbf7" contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,957</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_90a61c0a-79a5-43e6-8578-42dea7751b14" contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">29,770</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d796c397-3743-40b9-a077-b41b79dcf2d0" contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">42,032</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_477d4bb2-ef8e-4a56-8f42-bb1a5e9d825f" contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">16,400</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e9abd8e6-38c2-4bd1-8997-d1332ec7b42a" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:CostsAndExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">374,217</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d8c878e8-bb6d-474b-9458-e47d3ce9522d" contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">43,196</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b351abe7-cc75-41ca-a3b4-94779c400384" contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">238</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_99d579e8-5c88-4e96-a57d-a8189529bae9" contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,504</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b8f9378f-eec4-4ad5-945c-10cd986afabf" contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">77</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ba67c5ec-912f-4f3b-8874-beb523d44f77" contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">16,400</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cfa3ebb0-6499-4f16-961e-4ba25f1c9012" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,139</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balance includes general and administrative expenses, and depreciation and amortization. </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income that is not presented in the table. </span></div></div></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">44</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:nonNumeric id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19. Fair Value Measurements of Financial Instruments</span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3cfc17aa-cb70-4055-aaa1-465344402da3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" escape="true" continuedAt="F_3cfc17aa-cb70-4055-aaa1-465344402da3_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_61d5dd12-b416-44f6-a07e-6fd49d327b17" contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,755</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d6e66681-5e32-4136-90a2-4473d1b3890b" contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2e73e434-2954-4a7e-8545-81f0ffc71b92" contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5074e64b-4b91-4b31-920f-f7bef8d4633f" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,755</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_21395125-d0c5-48f3-838d-27c836dd6100" contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_41645851-ab8a-44de-bd17-97c5364e30fd" contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_280868c3-378f-44f1-b937-ed9cddba43aa" contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0ef023b0-369a-4790-bfdf-a9af73c62184" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,313</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d44dc7bd-1e20-4dd7-b984-b751a7dbe3de" contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9b6afac-e903-4d4c-af56-6d16674c4c8c" contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5657e497-0266-409e-9dd1-565a1bafb0cc" contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d293f803-e403-4b37-8955-0f722d37f1fa" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">84</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call option</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e51bd416-d9e0-4004-b15c-3580df7469f6" contextRef="C_5edf9e77-4494-4d12-9667-31e210c6227e" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_88c46c28-d16e-4ccb-ba0d-871473f0dfae" contextRef="C_eaf785cb-d155-4317-8f80-24864238f6c1" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b7b7e235-f5ec-4381-b3d9-99e9efbb1c8b" contextRef="C_3b445780-6235-4a8f-ba3b-abd685c6ec2e" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,867</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f9547812-49ad-48f9-a76b-2b8a458ef9eb" contextRef="C_a2bea5f5-db89-471f-9592-a236454f04a8" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,867</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f39796ed-104e-419c-9a45-10095c55f075" contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,152</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_faa8dfc4-6673-44bc-a720-23c4eae0df4c" contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_30979f97-e62c-43a7-a326-f78f8fc0f9c6" contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,867</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ec64b9cf-0c02-45ae-b026-9fffad2c469a" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,019</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f66cd7d7-e9b9-4994-b2bf-ab562c539182" contextRef="C_9fa5f4aa-a01c-4fb8-b531-d0b936d239ba" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_84611a84-9f43-4a1e-b84b-6ec0addecac0" contextRef="C_d15c567f-3397-4492-8383-e863d7384893" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c9bbac46-0cb8-4a26-8a57-64e3f435844f" contextRef="C_84a45b5b-15c0-41fe-adf1-ca456ce3cf0b" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_764ede08-e906-4c03-b8e0-8d2cb15da22b" contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_20924cf5-3c11-4b73-bb04-efff09bfd52f" contextRef="C_b1c3604a-49e6-44ea-82e9-36f2015f5d4d" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,075</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b8524f2-4293-4133-a925-07ee527a4428" contextRef="C_0b125a20-c6ed-4951-af84-bbf48d18d034" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f5a705ce-c844-47d4-9ad0-bdecb806a604" contextRef="C_beef7b88-15ad-4fab-977d-5bf2e6bb0e4d" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_055235b9-620f-4924-92d2-31099850066b" contextRef="C_c3a3893e-219e-41f0-a38f-79683aa82945" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,075</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1942abaf-97fd-4d62-9112-15d59f8b1087" contextRef="C_ceaebce1-eadc-44b5-9828-3ae63b4a713d" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_445d0533-57a1-455a-9389-c2047173c194" contextRef="C_03eaf310-f4d6-4b4c-9ee7-e536dd3096e1" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09022ae0-9050-4588-b1a3-01234ea8d24d" contextRef="C_48e4959b-0f1f-4be5-ab14-031e03179f1a" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_550e012d-554e-4d24-af89-5a4ce3180b76" contextRef="C_3b9afbd5-4210-4cba-a0f1-a98c07823a3b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e304972a-7f17-4b72-9ff0-d987fb77e00d" contextRef="C_a38c3842-fb3a-4695-9d09-f0d2fbf7975a" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f782ac3e-16ec-48eb-85bc-e308c9b4cd0a" contextRef="C_3bc8f5ef-23a9-4f96-bc10-a52d7a540f3d" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7d402425-467f-4ab4-8dd7-4ffe9fa95da9" contextRef="C_02359f56-b244-409f-85a6-c9122ce3d2a6" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,352</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_fa79ee1f-1e3f-4c44-8b07-315bad4fc4ce" contextRef="C_58fba134-3b96-4623-9e04-19f42b73f4cd" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,352</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b754591b-14bf-4160-93aa-80563681460e" contextRef="C_b046e187-8392-4a7d-a3ab-f5065c36bf0b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e59a1e28-2c76-4aa3-afa5-6a708542b8bc" contextRef="C_beafc79c-c290-4d5a-b082-1dafd30fba26" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5449c40-a910-454e-8a8c-d89e9cba17ed" contextRef="C_0aa38d95-e047-40ed-aae1-7c7af01d8b45" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,309</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9ca9a9f-9d59-4e0c-b13c-8ebf97650105" contextRef="C_713fe850-c7c0-4c74-bb89-374b329bb348" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,309</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94e0a45f-ac74-4092-8918-2449897b4a0b" contextRef="C_65d1d249-71f7-46a2-a28a-9474d27d86f3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b97c9022-94a0-40ee-a1c4-ec4e5ae1b83c" contextRef="C_0c97d0ad-d27f-4202-b033-a921a4fd1636" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_74c579f6-3000-4c48-9dea-65767c7fc40d" contextRef="C_48d15767-6248-4bb8-9a0c-0543b84f6436" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,170</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_aee26e74-4bbe-45b0-bf49-ad4a9803691b" contextRef="C_3952c0ce-7c90-43a0-8800-607b699b17a9" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">11,170</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e4b9e166-a576-4e78-b809-58573dbbf8ee" contextRef="C_16aa46eb-3f05-457c-861c-643f3c663612" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_36ca12a4-e918-48ab-9ed4-8efefa2062a5" contextRef="C_766601e2-a6b4-4052-99ed-c5eca3f68c15" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9f2b5538-bb60-4fb1-ad19-9b824ea71a61" contextRef="C_e5cdd2bb-60a6-4ebb-b03f-2092771d6a9f" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,450</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_378cb768-f7ff-4d55-a1ee-4735a5852fac" contextRef="C_2a1a51c2-b17e-483d-80bc-bbee2ba2992a" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,450</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d9edaf4f-1a48-4b67-9b2c-dbdc252803b4" contextRef="C_c3a4e452-1161-4a5d-850f-16c304a662ee" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_675bc572-21bd-43be-b5b8-2c303cc3c153" contextRef="C_5632426d-baaa-4109-8b29-9f7796b165df" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_629b0d7b-392c-4511-9437-7f4f2b0002e8" contextRef="C_c8ddf934-6d23-4f44-9b9a-94254e17fd2e" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,741</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4608770-6763-4058-94ae-97fe3cae1eac" contextRef="C_71250632-5809-4877-9e5a-4ea18f63b9b1" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,741</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0477741-1207-48a4-b638-6e00fbd55836" contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,075</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ca672535-c71b-4a0d-9c38-7c4836570112" contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">21</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c3d449dd-201a-4ce0-a153-f01ad89e5cb3" contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,037</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1999093c-4b13-48ba-8e28-ca88db419a1e" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">32,133</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p></ix:nonNumeric></div></ix:nonNumeric></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">45</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_1" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_2"><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_3cfc17aa-cb70-4055-aaa1-465344402da3_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.22%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:9.184000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_474ac1c4-e15b-4dfc-ae41-d80d1879a45d" contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,673</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c23b09f7-c77d-49d7-b9e6-3f6e531b4d3a" contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a43b3f38-1c25-4017-9cbe-2e6aa55b4ea2" contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_26ffca1d-a179-4bd5-b14a-0676859eba89" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,673</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_0395d847-ebd1-4526-837b-ee4fa22e3319" contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,289</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_72668719-655a-44b3-9e33-e822fd6e6547" contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6078738e-c56f-484f-b25a-a2de34079a55" contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_def159c9-46f5-426a-91a6-22e37b25e151" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,289</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_09587f3f-c95d-4304-99c0-6c3fd1240e0a" contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d988699c-4114-4361-8151-974e1b22158b" contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_94bd6b5c-a465-468f-94b7-e82f664c97bb" contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_98df7779-e1fd-4de0-b36f-72448e409b5e" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">89</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call options</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df39b108-4e00-459a-96b6-babc0da49928" contextRef="C_f645eb5f-2f94-46c5-98c1-1dabebffc600" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0f28208-8995-40a9-b014-7094d69b955d" contextRef="C_f0efa117-c0df-40e9-9b6c-2738c0931341" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_22d6d93b-ab96-4f05-b3e0-6f314d963cd5" contextRef="C_b75ed518-5871-4767-8792-56c29fff2189" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f6a8fafc-c360-4678-9a50-5b971319d60a" contextRef="C_f58ff657-ab10-466b-ac21-a56b042b8f8e" name="us-gaap:DerivativeAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_51333c7f-415a-4cf4-b7dd-6935cc6f996a" contextRef="C_ca2b1674-f053-4711-99b6-46e02ae62634" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_f0c77fc2-88fb-47eb-a979-6b8370299cc6" contextRef="C_c4e85806-bf8b-4a55-ac88-31f987995966" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6fbe9197-4e79-450b-b657-e2d54b3b7690" contextRef="C_4119ea9a-9b96-42d3-bd3c-d9d8cc88b66c" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_229dbe50-06ff-40d5-bfa9-cc3b01d87afd" contextRef="C_c7b860f3-00e7-4af6-b919-b03da362adc5" name="us-gaap:DerivativeLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e506c6c2-1c53-4372-929d-ddbef64e775a" contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">6,051</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b163252a-00e4-43e1-8fed-4ccda61dcd84" contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">19</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_70a3738a-caa6-4dd2-a541-b41c1c82d1cf" contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">3,778</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a23d0fd0-223b-4a4a-be37-78f5711f711c" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,848</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_abe3ecba-897b-4973-9e7a-d000635859f3" contextRef="C_cb205433-1776-4986-8156-9590d16dcda6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,110</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_737bd98a-1e4a-46cd-8851-1a8b273ac1e1" contextRef="C_11101c20-415e-4281-8227-fa000c36a1ad" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_849e0441-19a9-4be6-926d-4c271b3327e2" contextRef="C_acc8f0ee-cf35-491f-b1bc-f32657bd0a84" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4c70876a-cc55-462c-95b8-37494a3ec264" contextRef="C_38586056-d9a0-4723-b06e-423ac77877ea" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,110</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_3f63681e-4b83-4b21-823d-b6389233effe" contextRef="C_0f2b4746-765e-4a23-95d4-385fe1476cce" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6c06efb7-e104-42d4-a716-64b14e002335" contextRef="C_8ef40c99-631c-434b-8193-71f59194c695" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_91c437dd-dd2b-4f1b-9c07-cf458d319c90" contextRef="C_88dd1103-5401-475c-b0d3-88c0af26a48e" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58c0c4e6-d57b-4b78-a09b-6258da5d3318" contextRef="C_d7ac3eef-52f1-4e2c-8d64-851c37c3ee9c" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">15</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d5228273-4001-4cfb-8c45-e039f8b6eb3e" contextRef="C_b6dd06dd-3e1a-4e3d-bd37-70d3a5857d75" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_830be410-fc7a-4d35-9350-59e63d878529" contextRef="C_6ce72f59-77e8-4dbe-aae6-f5d7f9f30d70" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86de7f94-ded2-4e75-94d1-9bc179804bcb" contextRef="C_40132981-89ba-4e41-815e-8b46af618908" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,352</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_49df278d-ddd9-46ca-9589-0b00df1f01fc" contextRef="C_fbb3c763-fbfe-4d2d-bb20-60c7ade4a0d2" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">7,352</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_abff10bc-610a-4750-aa3a-ce9ef88c84c5" contextRef="C_cf778192-a620-4a66-876e-1b3bee77789f" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_7f66784b-9c5f-45ce-a6ca-352d0f2581e4" contextRef="C_47dc46dc-5dad-4a5f-967c-32e72a07d19c" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df8ffa59-8b58-428e-bbeb-97fdccbb44da" contextRef="C_fd640251-91ea-4cc7-9495-ffa5d748fb28" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,285</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ceb77823-312a-45a7-8905-cc6bebe2464f" contextRef="C_cd8693a7-bcaa-4246-bc4f-8864b40faac7" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">4,285</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9d8b580a-3afe-4949-a2ae-60d36335c804" contextRef="C_3696b868-57c7-4c52-8b1e-a7409de802a3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6dd4cbe2-9a04-4493-a9d6-3c3e619a00f0" contextRef="C_bf6be12f-f3ab-4aa9-a56c-870966b9a04a" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ea43e9c2-2b1d-441b-95c1-dd27e31cb292" contextRef="C_222bd65b-18c2-4e1e-ae1b-cbccc1f49d96" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,949</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_893064cb-d667-4db1-a2c0-192908c08c6f" contextRef="C_0b13f834-ee62-4361-8e5b-68ea07a37e23" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">9,949</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b4742f6a-14d9-4231-a9a8-6783536a7f42" contextRef="C_3acc1c89-3076-4ee5-a26e-94c06be58c7e" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_00a1cead-642e-438b-af71-c90529898773" contextRef="C_08a19b8a-9cd6-4016-9557-28e48707eeb4" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_9590505b-4bb4-4cbf-8be4-e81a2947ded6" contextRef="C_dc8d6e4a-2466-4667-9a1b-22764f551de8" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b86e87b7-00aa-406f-91ac-da6247606df6" contextRef="C_beaa67cb-6b14-49ee-84da-6671434aed28" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,351</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dcb07dbf-fdf5-4417-84ee-ace580d33b50" contextRef="C_af039a31-ee84-42a7-82dd-8c7deb252ff1" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac2357f5-eed9-4a1f-b515-2fc5285e4a3b" contextRef="C_ee076df7-779d-41be-82fa-78965cf2bb7f" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6736093b-53c9-4e7a-87dd-2487de355152" contextRef="C_22f45f1e-8c8c-4614-b22e-19a67b75190b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,643</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cc686e30-6743-4ae6-a4fa-97272d39244c" contextRef="C_6a8368f0-8774-4b22-a45d-899d1800a379" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5,643</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5db75fd0-adbf-4246-b8b4-b24a194a2f5b" contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">2,110</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2ecc87b7-b24a-4430-a5c1-effe2caa80a7" contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:fixed-zero">&#8212;</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8942bcb0-773b-45e5-9410-120600e79f29" contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,595</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_71a6fba8-854d-44e5-9f3c-cd9c088a5cfd" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,705</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p></ix:continuation></div><div style="font-size:12pt;font-family:Times New Roman;"><ix:nonNumeric id="F_769d4af5-fbdd-4801-b337-679b6616e83b" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" escape="true" continuedAt="F_769d4af5-fbdd-4801-b337-679b6616e83b_1"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the fair value of Level 3 </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a6133d98-7b94-492e-8834-b1b4530ae2ee;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">liabilities is recognized in unrealized loss on investments, other income, or general and administrative expenses</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the accompanying condensed consolidated statements of income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"/>
         <td style="width:1.94%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:15.82%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a62da82d-9d69-4d23-990b-45d02477f6ac" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">28,595</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of existing Level 3 liabilities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2f7f6f8b-b4fa-439e-94f8-c0d1f22bf8ee" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">1,442</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a94bde21-ab06-453f-9044-96f98d06c9b9" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">30,037</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></ix:nonNumeric></div></ix:continuation></div><div><ix:continuation id="F_769d4af5-fbdd-4801-b337-679b6616e83b_1"></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_2" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_3"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a49a5b02-3ca2-49a1-b428-810f7349f118" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:MarketableSecuritiesPolicy" escape="true" continuedAt="F_a49a5b02-3ca2-49a1-b428-810f7349f118_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Marketable Securities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_90f2a6b3-4df9-4f54-ac25-0b2eb1e99dcc" contextRef="C_ca44cbaa-887f-4bf8-b193-1e7fba9ea4ab" name="asth:MarketableSecuritiesCurrentMaturityPeriod" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ninety days</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, certificates of deposit amounted to approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b85e9561-1d70-49e7-a906-e773e07786c4" contextRef="C_c24d9fbe-5f15-4c99-b3b6-14bc8e5f8a34" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b521569e-c8f8-4f6a-85ce-571387c240ac" contextRef="C_9c3af7b7-7fc8-4c10-9520-574b3555c4e0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></p></ix:nonNumeric></div></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">46</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_3" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_4"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><ix:continuation id="F_a49a5b02-3ca2-49a1-b428-810f7349f118_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the equity securities were approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_eda81d53-acd3-432f-ae6a-ee474faf8889" contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_a1095286-28d2-48fc-9b2b-647542b8d128" contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b" name="us-gaap:EquitySecuritiesFvNi" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">0.1</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in the accompanying condensed consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying condensed consolidated statements of income as other income. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9b591eaa-614f-450f-8920-b71a6cc6a961" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:GainLossOnInvestmentsTextBlock" escape="true" continuedAt="F_9b591eaa-614f-450f-8920-b71a6cc6a961_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value on equity securities held are as follows (in thousands) for the periods listed below and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_14c44236-8c67-4a3c-8a67-971a75ad66fc" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NumberOfEquitySecuritiesSold" unitRef="U_Securities" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> securities had been sold in the respective periods:</span></ix:nonNumeric></span></p><div style="font-size:12pt;font-family:Times New Roman;"><ix:continuation id="F_9b591eaa-614f-450f-8920-b71a6cc6a961_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:1.62%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
         <td style="width:12.883000000000001%;box-sizing:content-box;"/>
         <td style="width:1%;box-sizing:content-box;"/>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gains (losses) recognized on equity securities held at end of period</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b9bed2f8-17da-4998-a948-09cbc8074e70" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" unitRef="U_USD" scale="3" decimals="-3" format="ixt:num-dot-decimal">5</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5d1cef67-5f06-45d7-89f5-a3cf2e826aa2" contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:num-dot-decimal">116</ix:nonFraction></span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></ix:continuation></div></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_4" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_5"><div style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_175ce601-0760-442b-9abc-d2230c4835f1" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="us-gaap:DerivativesPolicyTextBlock" escape="true" continuedAt="F_175ce601-0760-442b-9abc-d2230c4835f1_1"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivative Financial Instruments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Rate Collar Agreements</span></p></ix:nonNumeric></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_175ce601-0760-442b-9abc-d2230c4835f1_1"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company enters into agreements designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan, including the collar agreement. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on the Company&#8217;s debt. Under the terms of the agreement, the ceiling is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_293ba942-759a-42c0-8d96-a1b2bad9e806" contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495" name="asth:DerivativeCeilingInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and the floor is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ad2a6db9-d163-4ee7-89d0-960ca837df13" contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495" name="us-gaap:DerivativeFloorInterestRate" unitRef="U_pure" scale="-2" decimals="4" format="ixt:num-dot-decimal">2.34</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.  The collar agreement is not designated as a hedging instrument. Changes in the fair value of this contract are recognized as unrealized gain or loss on investments in the accompanying condensed consolidated statements of income and reflected in the accompanying condensed consolidated statements of cash flows as unrealized (gain) loss on investments. The estimated fair value of the collar was determined using Level 2. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the fair value of the collar was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_33449e42-c929-47f1-ba84-042143fff51a" contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495" name="us-gaap:DerivativeFairValueOfDerivativeAsset" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">21,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and presented within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> other liabilities in the accompanying condensed consolidated balance sheets.</span></ix:continuation></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the fair value of the collar was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_df84df5b-ef79-4ed4-9977-8ba849c4d19b" contextRef="C_c7b860f3-00e7-4af6-b919-b03da362adc5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" unitRef="U_USD" decimals="0" format="ixt:num-dot-decimal">19,000</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and presented within prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">I Health Call Option</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company acquired a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5282557-b333-46ce-931f-e8e16eaaed5e" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health, which included a call option that allows the Company to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_5ee22fbe-5531-47cd-a787-82459b450dff" contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest on each of the first, second, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> third anniversaries from when certain triggering events occur. The Company determined the fair value of the call option using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of the purchase price based on EBITDA and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the value of the call option was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_4b243496-080b-4b20-806d-ec16b64016f2" contextRef="C_44dfee64-65b5-496e-98a1-6b501aa3532a" name="asth:ValueOfCallOption" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6d477c89-07bf-4fdb-a9b8-72bbeb50bab2" contextRef="C_66914d11-6398-4518-9398-8ccb5e2da66d" name="asth:ValueOfCallOption" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">3.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The I Health call option is presented within other assets in the accompanying condensed consolidated balance sheet. The </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_57c140a0-4dce-47d7-bef0-0fc4561ced78" contextRef="C_21dd06cf-9d3c-43d2-9980-e998c5f6f0c9" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">25</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is accounted for under the equity method (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Equity Method&#8221;).</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_5" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_6"><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Remaining equity interest purchase</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) within </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bb73b5bf-96fc-4dd2-ad43-b273eabca51f" contextRef="C_dfa9936b-5186-4152-84d7-699c1a534b33" name="asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" format="ixt-sec:durwordsen"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three years</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date the Company consolidated Sun Labs. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_1bcee59a-5f27-435b-a328-2a79060f1215" contextRef="C_8f301b9f-cd6b-4eac-bd0f-1c2f7c9543f6" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_60bf1bc3-1d8e-4823-8d95-ab07b350f959" contextRef="C_8b9280f1-8e3e-4e01-b2b8-0697e6c860d0" name="asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">7.4</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As the financing obligation is embedded in the non-controlling interest, the non-controlling interest is recognized in other liabilities in the accompanying condensed consolidated balance sheets.</span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">47</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_6" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_7"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingent consideration</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">All American Medical Group</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AAMG&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b5060a0e-9769-4a60-ac9a-6a8b3a0912e3" contextRef="C_1bff3c75-ef8c-43c8-8cd4-ddb311389b41" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG stock contingent consideration&#8221;) in the form of the Company&#8217;s common stock. The additional consideration is contingent on AAMG meeting certain revenue and capitated member targets in 2023 (&#8220;2023 target metric&#8221;) and in 2024 (&#8220;2024 target metric&#8221;). Additional shares would be further issued for exceeding the revenue targets in 2023 (&#8220;2023 growth metric&#8221;) and in 2024 (&#8220;2024 growth metric&#8221;). The total amount of stock that can be issued for the 2023 target and growth metrics and 2024 target and growth metrics is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_86e8e206-0c88-4464-9265-84fc2645704e" contextRef="C_7111af93-0249-4601-b68b-7488d9494f44" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">157,059</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_50285000-b0ca-4508-abda-b275deee80a6" contextRef="C_df83f06c-1bd7-4a08-a59a-dbb0d00b045d" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">184,357</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. At the end of the earnout periods, the Company concluded on the achievement of the 2023 target and growth metrics and the 2024 target and growth metrics based on actual revenue and the value of the Company stock (Level 1) to calculate payment, representing the fair value of the contingent consideration.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2023 and 2024 growth metrics were considered variable and were presented within other liabilities in the accompanying consolidated balance sheet. As of March 31, 2025 and December 31, 2024, the AAMG stock contingent consideration for the 2024 growth metric had a fair value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_030d3694-5168-4020-b419-408b7f8e8241" contextRef="C_9f0059b7-fc7c-4e0a-9e5b-a7e9d0745aaa" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_9b07ab2c-4dfd-4b1b-a8b3-75b3e741224f" contextRef="C_660533f2-bb98-4221-8734-e0be6ba384e1" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">2.1</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in the AAMG stock contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had concluded that both the 2023 target metric and the 2023 growth metric were met and issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_cbbb7ce9-af69-48f8-b601-5a29f246e140" contextRef="C_1dd1d251-19bf-4cd5-8a5d-6055b3033882" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:num-dot-decimal">157,059</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the sellers in 2024.</span></p></ix:continuation></div><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_7" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_8"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advanced Diagnostic and Surgical Center (&#8220;ADSC&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_d7f33da3-4bcb-4481-87a0-843bbde4763a" contextRef="C_1365a955-4128-4b28-a0bb-c35ac458d684" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">95</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest of ADSC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent on ADSC achieving revenue and EBITDA metrics for fiscal years 2023 (&#8220;ADSC 2023 Metric&#8221;) and 2024 (&#8220;ADSC 2024 Metric&#8221;) (collectively, &#8220;ADSC contingent consideration&#8221;). The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the ADSC 2023 Metric and the 2024 Metric were valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e0a84a42-4cae-447f-ad26-27283e50f7b3" contextRef="C_23f8c634-36f7-44cf-9399-7b2106a9fe93" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal"><ix:nonFraction id="F_cd06594e-3cd3-4509-915b-6bc7befb7ff1" contextRef="C_71a445c4-c7ab-4d90-a288-fe1fead886c3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and were included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the ADSC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2025, the Company paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6af95a4f-510e-4c71-9ee9-4762862b3cb6" contextRef="C_a0db209d-d0ac-4fda-b0be-cbfb62c51851" name="us-gaap:PaymentsToAcquireBusinessesGross" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash to the sellers of ADSC for the contingent consideration that was achieved. As a result, the contingent liabilities are no longer outstanding.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Community Family Care Medical Group IPA, Inc. (&#8220;CFC&#8221;)</span></p><div><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_8" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_9"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring certain assets of CFC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent upon CFC maintaining or exceeding the target member month amount for the first, second, and third measurement period (&#8220;CFC contingent consideration&#8221;). The first measurement period means the period commencing on the first day of the month immediately following the close of AHMS and ending on the one-year anniversary thereof. The second measurement period is for one year after the first measurement period, and the third measurement period is for one year after the second measurement period. The contingent liability will be paid after achieving the metric in each measurement period. The Company will pay $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_2db2016c-2230-4585-a4bf-efee9987e29a" contextRef="C_b7aa5384-1c58-4d97-a748-b46442622060" name="asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each metric achieved for each measurement period, or a total of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_ac7772dd-6f3b-40df-8589-c98dfdd7146f" contextRef="C_b7aa5384-1c58-4d97-a748-b46442622060" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">15.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the CFC first and/or second contingent consideration metrics are not achieved during the first and/or the second measurement period, if the metric is met within the second and/or third measurement period, there is a catch-up payment that shall be paid concurrently with the payments of the CFC second contingent consideration and/or CFC third contingent consideration. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></ix:continuation></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">48</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_9" continuedAt="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_10"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024, the first metric was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e5d252d9-336c-4497-bd53-f05ac55ada90" contextRef="C_080805e0-71f9-466e-995d-e3d7a0793b53" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.9</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_047b3fd4-87f0-4184-85d7-c8428787e010" contextRef="C_017c6b7e-32c1-4fc0-bb28-bb5b23e4d7dc" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.2</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and was included in other liabilities in the accompanying condensed consolidated balance sheets. As of March 31, 2025 and December 31, 2024, the second and third metrics were valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_e35dbfbc-6997-4ae1-b67e-bfb073077cd0" contextRef="C_388ec8dd-e407-47aa-b88b-930866d15cfe" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">6.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_8e98bb24-334a-48fc-b277-47e342204f1f" contextRef="C_1e5aa272-935d-4f32-9bfb-416c2178e6aa" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in aggregate, and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CFC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Prime Community Care of Central Valley, Inc. (&#8220;PCCCV&#8221;)</span></p><div style="font-size:10pt;font-family:Times New Roman;"><ix:continuation id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a_10"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring certain assets of PCCCV in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash, contingent upon PCCCV meeting certain metrics related to financial ratios and member months for the first and second measurement periods (&#8220;PCCCV contingent consideration&#8221;). The first measurement period is the first day of the month immediately following the close and ending on June 30, 2024. The second measurement period is for one year after the first measurement period. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the first metric had been met, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_6e680922-dddf-409e-90fa-d5cb1ddfb644" contextRef="C_b1bd11cd-8dd6-4de9-a5ed-b6ef0413b392" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.0</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid in the fourth quarter of 2024. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the second metric was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_58f7c07b-abb5-4734-aebe-13fcf6fd6969" contextRef="C_bbf6403d-9162-483c-8776-b0ea02605c69" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_29310a2f-51c4-472b-bcb0-c9ac9d3c95e9" contextRef="C_5b43a6c1-a998-439d-ba82-792676c6568d" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">1.4</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively and was included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the PCCCV contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CHS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_c329dd67-b134-4163-bb6d-ad71a6387f5d" contextRef="C_a5fa8d3f-8630-436e-bb55-37a26df286f9" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" unitRef="U_pure" scale="-2" decimals="2" format="ixt:num-dot-decimal">100</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest of CHS in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n cash, contingent upon CHS achieving a gross profit per total member months metric for fiscal year 2025 (&#8220;CHS 2025 Gross Profit PMPM Metric&#8221;) and member enrollment metrics (&#8220;CHS Member Enrollment Metrics&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured over four measurement periods and an additional fifth measurement period contingent upon acquisition of an entity (the &#8220;earnout period&#8221;) (collectively, &#8220;CHS contingent consideration&#8221;). For the CHS Member Enrollment Metrics, the first measurement period means the period commencing on the first day immediately following the closure of CHS and ending on the one-year anniversary thereof. The second, third, fourth, and fifth measurement periods are for one year after each of the previous respective measurement periods. If the metrics are achieved, the contingent liability will be paid after the end of the earnout period. The Company will pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_b745f278-3041-4957-8923-289155b6df22" contextRef="C_f9e21867-5350-4ee9-bd3d-e27eaf98771f" name="asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.8</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the CHS 2025 Gross Profit PMPM Metric, and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_78dc050f-dd6c-4f9a-8475-266c2e9ab4f9" contextRef="C_caa6bff7-c546-4734-8b91-b9cc35d645f7" name="asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">4.3</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each metric achieved for each measurement period, or up to a total of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_47faa085-a5d3-456f-a800-e0e3a6a23a32" contextRef="C_b899ab26-e619-4d58-a07b-38bf2016ab41" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">21.5</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for the CHS Member Enrollment Metrics. T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the CHS contingent consideration was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_dbe3866a-236b-4f34-bea2-ffd0bf345fc8" contextRef="C_4103c318-abec-4453-8eb0-b888e91d21a3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.7</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"><ix:nonFraction id="F_06215318-f47b-46d2-8ca8-1e83e3053853" contextRef="C_495d4051-3ab2-4ec4-aac2-eb89210fcf3b" name="us-gaap:BusinessCombinationContingentConsiderationLiability" unitRef="U_USD" scale="6" decimals="-5" format="ixt:num-dot-decimal">5.6</ix:nonFraction></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The CHS 2025 Gross Profit PMPM Metric was included in other liabilities and the CHS Member Enrollment Metrics were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CHS contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p></ix:continuation></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">49</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="managements_discussion_and_analysis"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 2.  MANAGEMENT&#8217;S DISCUSSIO</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">N AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item 1, &#8220;Condensed Consolidated Financial Statements&#8221; of this Quarterly Report on Form 10-Q. In addition, reference is made to our audited consolidated financial statements and notes thereto and related Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 14, 2025.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">In this section, &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; and &#8220;us&#8221; refer to Astrana Health, Inc. (&#8220;Astrana&#8221;) and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Health, Inc. (&#8220;Astrana&#8221;) is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, Astrana operates an integrated, value-based healthcare model. This model aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Together with our affiliated physician groups and consolidated entities, we cost-effectively provide coordinated outcomes-based medical care.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Through our risk-bearing organizations with more than 12,000 contracted physicians, we are responsible for coordinating care in value-based care arrangements for over 1.0 million patients as of March 31, 2025. These covered patients are comprised of managed care members whose health coverage is provided either through their employers, acquired directly from a health plan, or as a result of their eligibility for Medicaid or Medicare benefits. Our managed patients benefit from an integrated approach that places physicians at the center of patient care and utilizes sophisticated risk management techniques and clinical protocols to provide high-quality, cost-effective care.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Developments</span></p><p style="font-size:10pt;margin-top:5pt;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Leadership Updates</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana announced several additions to its leadership team to support continued growth and execution. The Company welcomes Georgie Sam, Chief Data &amp; Analytics Officer, who will oversee enterprise-wide data and analytics strategy to deliver even faster, more actionable insights to our stakeholders, and Glenn Sobotka, Chief Accounting Officer, who brings deep experience to support Astrana&#8217;s continued financial discipline and scalability. Rita Pew was promoted to the role of Chief People Officer, helping Astrana further invest in the talent and culture that drive Astrana forward.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Acquisition Updates</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana received Hart-Scott-Rodino (&#8220;HSR&#8221;) approval for its pending acquisition of Prospect Health, which remains on track to close this summer.</span></p><p style="font-size:10pt;margin-top:7pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Key Financial Measures and Indicators</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Revenues</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our revenue, which is recorded in the period in which services are rendered and earned, primarily consists of capitation revenue as well as risk pool settlements and incentives, management fee income, and fee-for-service (&#8220;FFS&#8221;) revenue. The form of billing and related risk of collection for such services may vary by type of revenue and the customer.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">50</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Expenses</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our largest expenses consist of the cost of (i) patient care paid to contracted providers; (ii) information technology equipment and software; and (iii) staff to provide management and administrative support services to our affiliated physician groups, as further described in the following sections. These services include claims processing, utilization management, contracting, accounting, credentialing, and administrative oversight.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adjusted EBITDA and Adjusted EBITDA Margin</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adjusted EBITDA and Adjusted EBITDA margin are supplemental performance measures of our operations for financial and operational decision-making, and are used as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest, taxes, depreciation, and amortization, excluding income or loss from equity method investments, non-recurring and non-cash transactions, and stock-based compensation. The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">51</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Results of Operations</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Health, Inc.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Condensed Consolidated Statements of Income</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(In thousands)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Unaudited)</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.37%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.942%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.662%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">PCT Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitation, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">583,963</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">365,910</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218,053</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Risk pool settlements and incentives</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,491</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,377</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,886</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(17</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management fee income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,310</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,078</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,768</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(43</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fee-for-services, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,890</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,937</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,047</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other revenue</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,736</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,054</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,682</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">216,034</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating expenses</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services, excluding depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">549,061</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,399</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218,662</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">66</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative expenses</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,897</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,722</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,175</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,849</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,096</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,753</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">599,807</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">374,217</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,590</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income from operations</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,583</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,139</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(9,556</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(32</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Other expense</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Loss) income from equity method investments</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(867</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">632</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,499</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(237</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7,308</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(7,585</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">277</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,312</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,996</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,684</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(42</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized (loss) gain on investments</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(44</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,099</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(1,143</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(104</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other loss</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,072</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,277</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(795</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total other expense, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(10,979</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(6,135</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(4,844</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">79</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Income before provision for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,604</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,004</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(14,400</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(60</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,383</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,142</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,759</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(53</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,221</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,862</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(10,641</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(63</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (loss) income attributable to non-controlling interest</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(471</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,027</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,498</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(123</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net income attributable to Astrana Health, Inc.</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,692</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,835</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(8,143</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(55</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">52</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Risk-Bearing Organizations and Patients</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and 2024, we managed a total of 20 and 18 independent risk-bearing organizations, including both affiliated and non-affiliated, respectively. The total number of patients for whom we managed the delivery of healthcare services was over 1.0 million as of March 31, 2025 and 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Total revenue for the three months ended March 31, 2025, was $620.4 million, as compared to $404.4 million for the three months ended March 31, 2024, an increase of $216.0 million, or 53%. The increase in revenue was primarily attributable to capitation revenue. Capitation revenue increased by $218.0 million primarily as a result of our recent acquisitions within our Care Partners segment, along with enrollees transitioning to full risk through the Company</span><span style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8217;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">s Restricted Knox-Keene plans.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cost of Services, Excluding Depreciation and Amortization</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expenses related to cost of services, excluding depreciation and amortization for the three months ended March 31, 2025 were $549.1 million as compared to $330.4 million for the same period in 2024, an increase of  $218.7 million or 66%. The overall increase was primarily due to increased participation in a value-based Medicare FFS model and medical costs associated with both professional and institutional risk of our Restricted Knox-Keene licensed health plan as a result of our recent acquisitions within our Care Partners segment which were commensurate to our increase in revenue.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">General and Administrative Expenses</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">General and administrative expenses for the three months ended March 31, 2025 were $43.9 million, as compared to $38.7 million for the same period in 2024, an increase of $5.2 million or 13%. The increase was primarily due to increased general and administrative expenses to support operational growth such as stock-based compensation.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Depreciation and Amortization</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Depreciation and amortization expenses for the three months ended March 31, 2025 were $6.8 million, as compared to $5.1 million for the same period in 2024, an increase of $1.8 million or 34%. This amount includes depreciation of property and equipment and the amortization of intangible assets. The increase in depreciation and amortization was primarily related to the amortization of our acquired intangibles as a result of our recent business combinations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(Loss) Income From Equity Method Investments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss from equity method investments for the three months ended March 31, 2025 was $0.9 million as compared to income of $0.6 million for the same period in 2024, a decrease of $1.5 million or 237%. The decrease was primarily due to APC&#8217;s equity method investment in LMA.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Expense</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest expense for the three months ended March 31, 2025 was $7.3 million as compared to $7.6 million for the same period in 2024, a decrease of $0.3 million 4%. The decrease in interest expense was primarily due to a decrease in interest rates on our floating-rate debt. The interest rate for the Revolver and Term Loan was 5.82% as of March 31, 2025 and 7.42% for the Revolver and 7.68% for the Term Loan, respectively, as of March 31, 2024. This was offset by an increase in borrowings under the Second Amended and Restated Credit Facility. As of March 31, 2025, the Company borrowed $412.0 million on the Second Amended and Restated Credit Facility compared to $391.3 million as of March 31, 2024.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">53</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Income</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest income for the three months ended March 31, 2025 was $2.3 million as compared to $4.0 million for the three months ended March 31, 2024, a decrease of $1.7 million or 42%. Interest income reflects interest earned on cash held in bank accounts, money market and certificate of deposit accounts, and the interest from our loan receivables. The decrease in interest income was primarily due to a decrease in our cash held in interest bearing bank accounts.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unrealized Loss (Gain) on Investments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unrealized loss for the three months ended March 31, 2025 was $44,000 as compared to a gain of $1.1 million for the same period in 2024, a decrease in unrealized gain of $1.1 million or 104%. The decrease in unrealized gain on investments was primarily driven by changes in the fair value of the interest rate collar.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Other Loss</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other loss for the three months ended March 31, 2025 was $5.1 million as compared to $4.3 million for the same period in 2024, a decrease of $0.8 million or 19%. The increase in other loss was primarily due to debt issuance costs that were expensed in connection with the Second Amended and Restated Credit Facility.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Provision for Income Taxes</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Provision for income taxes was $3.4 million for the three months ended March 31, 2025, as compared to $7.1 million for the same period in 2024, a decrease of $3.8 million. The decrease in provision for income taxes was primarily due to a decrease in pre-tax income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net (Loss) Attributable to Non-controlling Interests</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Net loss attributable to non-controlling interests for the three months ended March 31, 2025 was a loss of  0.5 million as compared to income of $2.0 million for the same period in 2024, a decrease of $2.5 million. The decrease was primarily driven by a decrease net income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Net Income Attributable to Astrana Health, Inc.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our net income attributable to Astrana Health, Inc., for the three months ended March 31, 2025 was $6.7 million as compared to $14.8 million for the same period in 2024, a decrease of $8.1 million.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Adjusted EBITDA</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adjusted EBITDA for the three months ended March 31, 2025 was $36.4 million, as compared to $42.2 million for the same period in 2024, a decrease of $5.8 million. The decrease was primarily due to a decrease in operating income as a result of higher utilization and increase in general and administrative expenses. See &#8220;Reconciliation of Net Income to EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin&#8221; below for additional information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segment Financial Performance</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently has three reportable segments consisting of Care Partners, Care Delivery, and Care Enablement. The Company evaluates the performance of its operating segments based on segment revenue growth as well as operating income.  Management uses revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors. For more information about our segments, see Note 18 &#8212; &#8220;Segments&#8221; to our condensed consolidated financial statements under Item 1 in this Quarterly Report on Form 10-Q for additional information.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">54</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table sets forth our revenue and operating income by segment for the three months ended March 31, 2025 and 2024 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.38%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.184000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.184000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.944%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.645%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Segment Revenue</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Partners</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,951</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,318</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">218,633</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Delivery</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,388</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,719</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,669</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Enablement</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,562</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,274</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,288</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.38%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.184000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.184000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.944%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.645%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Segment Operating Income (Loss)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Partners</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,215</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,196</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,019</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Delivery</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,108</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(238</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,870</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Care Enablement</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,535</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,504</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Percentage change of over 500%</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Partners Segment</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue for the three months ended March 31, 2025 was $601.0 million as compared to $382.3 million for the three months ended March 31, 2024, an increase of $218.6 million or 57%. Operating income for the three months ended March 31, 2025 was $44.2 million, as compared to $43.2 million for the three months ended March 31, 2024, an increase in operating income of $1.0 million or 2%. The increase in revenue and operating income was primarily due to recent acquisitions within our Care Partners segment.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Delivery Segment</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue for the three months ended March 31, 2025 was $33.4 million as compared to $30.7 million for the three months ended March 31, 2024, an increase of $2.7 million or 9%. Operating loss for the three months ended March 31, 2025 was $3.1 million, as compared to a loss of $0.2 million for the three months ended March 31, 2024, an increase in operating loss of $2.9 million. The increase in revenue was primarily driven by increased volume in patient visits at our primary, multi-specialty, and ancillary Care Delivery entities. The increase in operating loss was due to an increase in expenses incurred related to our newer clinic locations that opened.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Enablement Segment</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue for the three months ended March 31, 2025 was $39.6 million, as compared to $33.3 million for three months ended March 31, 2024, an increase of $6.3 million or 19%. Operating income for the three months ended March 31, 2025 was $3.5 million, as compared to operating income of $3.5 million for the three months ended March 31, 2024. The increase in revenue was primarily due to managing more IPAs in our Care Partners segment.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">55</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reconciliation of Net Income to EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Set forth below are reconciliations of Net Income to EBITDA and Adjusted EBITDA, as well as the reconciliation to Adjusted EBITDA margin for the three months ended March 31, 2025 and 2024. The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:64.906%;box-sizing:content-box;"/>
     <td style="width:1.561%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.426%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.561%;box-sizing:content-box;"/>
     <td style="width:1.561%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:12.426%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.561%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="7" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,221</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,862</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest expense</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,308</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,585</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest income</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,312</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(3,996</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Provision for income taxes</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,383</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,142</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Depreciation and amortization</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,849</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,096</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">EBITDA</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,449</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,689</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Loss (income) from equity method investments</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">867</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(632</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other, net</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,259</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,440</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock-based compensation</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,811</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,748</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Adjusted EBITDA</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,386</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,245</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Adjusted EBITDA margin</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other, net for the three months ended March 31, 2025 relates to debt issuance costs expensed in connection with our Second Amended and Restated Credit Facility, transaction costs for our acquisition of Prospect, data transition costs for our recent acquisitions, certain costs associated with the CHS transaction, non-cash changes related to change in the fair value of our call option and Collar Agreement, and severance fees incurred.</span></div></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other, net for the three months ended March 31, 2024 relates to financial guarantee via a letter of credit that we provided almost three years ago in support of two local provider-led ACOs, non-cash changes related to change in the fair value of our financing obligation to purchase the remaining equity interests in one of our investments, non-cash changes related to change in the fair value of the Company&#8217;s Collar Agreement, and transaction costs incurred for our investments and tax restructuring fees. </span></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">56</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Non-GAAP Financial Measures</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This Quarterly Report on Form 10-Q contains the non-GAAP financial measures EBITDA, Adjusted EBITDA, and Adjusted EBITDA margin, of which the most directly comparable financial measure presented in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) is net income. These measures are not in accordance with, or alternatives to, GAAP, and may be calculated differently from similar non-GAAP financial measures used by other companies. The Company uses Adjusted EBITDA as a supplemental performance measure of our operations, for financial and operational decision-making, and as a supplemental means of evaluating period-to-period comparisons on a consistent basis. Adjusted EBITDA is calculated as earnings before interest expense, interest income, income taxes, depreciation, and amortization, excluding income or loss from equity method investments, non-recurring and non-cash transactions, and stock-based compensation. The Company defines Adjusted EBITDA margin as Adjusted EBITDA over total revenue.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company believes the presentation of these non-GAAP financial measures provides investors with relevant and useful information, as it allows investors to evaluate the operating performance of the business activities without having to account for differences recognized because of non-core or non-recurring financial information. When GAAP financial measures are viewed in conjunction with non-GAAP financial measures, investors are provided with a more meaningful understanding of the Company&#8217;s ongoing operating performance. In addition, these non-GAAP financial measures are among those indicators the Company uses as a basis for evaluating operational performance, allocating resources, and planning and forecasting future periods. Non-GAAP financial measures are not intended to be considered in isolation, or as a substitute for, GAAP financial measures. Other companies may calculate both EBITDA and Adjusted EBITDA differently, limiting the usefulness of these measures for comparative purposes. To the extent this Form 10-Q contains historical or future non-GAAP financial measures, the Company has provided corresponding GAAP financial measures for comparative purposes. The reconciliation between certain GAAP and non-GAAP measures is provided above.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Liquidity and Capital Resources</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash, cash equivalents, and investment in marketable securities at March 31, 2025 totaled $260.9 million as compared to $290.8 million at December 31, 2024. Working capital totaled $252.0 million at March 31, 2025, as compared to $272.9 million at December 31, 2024, a decrease of $20.9 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We have historically financed our operations primarily through internally generated funds and borrowings on long-term debt. We generate cash primarily from capitation contracts, risk pool settlements and incentives, fees for medical management services provided to our affiliated physician groups, and FFS reimbursements. We generally invest cash in money market accounts and certificates of deposit, which are classified as cash and cash equivalents. In February 2025, the Company entered into the Second Amended and Restated Credit Agreement which amended and restated that certain amended credit agreement and provided for a five-year revolving credit facility of $300.0 million, a term loan of $250.0 million, and a delayed-draw term loan of $745.0 million, which were primarily used to refinance certain existing indebtedness and intended to be used primarily to fund the costs associated with closing the Transaction. In addition, we have a current shelf registration statement filed with the SEC under which we may issue common stock, preferred stock, debt securities, and other securities that may be offered in one or more offerings on terms to be determined at the time of the offering. We believe we have sufficient liquidity to fund our operations through at least the next 12 months and the foreseeable future.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">57</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash Flow Activities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our cash flows are summarized as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:50.37%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.182%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.22%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:8.942%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.662%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">$ Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% Change</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash provided by operating activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,627</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,977</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,650</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">178</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash used in investing activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(2,394</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(71,039</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,645</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(97</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net cash (used in) provided by financing activities</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(44,170</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,351</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(150,521</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(142</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net (decrease) increase in cash and cash equivalents and restricted cash</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(29,937</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,289</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(71,226</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(173</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)%</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Operating Activities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash provided by operating activities for the three months ended March 31, 2025 was $16.6 million, as compared to cash provided by operating activities of  $6.0 million for the three months ended March 31, 2024. The increase in cash provided by operating activities was primarily driven by adjusted net income and changes in working capital. For the three months ended March 31, 2025, net income, exclusive of depreciation and amortization, amortization of debt issuance cost, share-based compensation, non-cash lease expense, change in fair value of contingent consideration liabilities, loss on debt extinguishment, unrealized gains or losses on investments, loss from equity method investments, deferred tax, and other was $24.6 million compared to $29.1 million for the three months ended March 31, 2024. Working capital for the three months ended March 31, 2025, decreased operating cash flow by $8.0 million, compared to a $23.2 million decrease in operating cash flow for the three months ended March 31, 2024. The change in working capital for the three months ended March 31, 2025 was mainly driven by an increase in receivables, net, including amounts with related parties, primarily due to timing of our receivables, including risk pool settlements that occur approximately 18 months after the risk pool performance year is completed, and a decrease in fiduciary accounts payable as a result of paying our sub-IPAs and providers. The decrease to operating cash flow due to changes in working capital was partially offset by an increase in medical liabilities due to timing of payments and a decrease in other receivables attributable to collections on reimbursements.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investing Activities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash used in investing activities during the three months ended March 31, 2025, was $2.4 million, primarily due to purchases of property and equipment of $3.1 million. The cash used in investing activities was partially offset by proceeds from repayment of a loan receivable of $0.6 million and distribution received from an equity method investment of $0.1 million. Cash used in investing activities during the three months ended March 31, 2024, was $71.0 million primarily due to payments for business and asset acquisitions, net of cash acquired of $50.6 million, issuances of loans of $20.0 million, and purchases of property and equipment of $0.4 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Financing Activities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cash used in financing activities during the three months ended March 31, 2025, was $44.2 million, primarily due to repayments of debt of $428.2 million, payment of deferred financing costs of $17.2 million, tax payments from net share settlement of restricted stock awards and units of $4.1 million, dividend payments of $5.5 million, APC repurchase of their treasury shares of $1.3 million, and repayment of finance lease obligations of $0.1 million.</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">This was partially offset by borrowings of long-term debt of $412.0 million and proceeds from ESPP purchases of $0.3 million. Cash provided by financing activities during the three months ended March 31, 2024, was $106.4 million, primarily due to borrowings on long-term debt totaling $110.0 million, partially offset by repayment of long term-debt of $3.5 million.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">58</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Credit Facilities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s debt balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:80.24%;box-sizing:content-box;"/>
     <td style="width:1.94%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term Loan</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revolver Loan</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,000</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Current portion of debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(12,500</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Unamortized financing costs</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(5,481</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403,894</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are the future commitments of the Company&#8217;s debt for the years ending December 31 (in thousands) below:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:80.24%;box-sizing:content-box;"/>
     <td style="width:1.94%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,375</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,063</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,750</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,437</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,750</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Second Amended and Restated Credit Agreement</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Second Amended and Restated Credit Agreement provides for (a) a five-year revolving credit facility to the Company of $300.0 million, which includes a letter of credit sub-facility of up to $100.0 million and a swingline loan sub-facility of $25.0 million, (b) a five-year term loan A credit facility to the Company of $250.0 million and (c) a five-year delayed draw term loan credit facility to the Company of $745.0 million, maturing on February 26, 2030. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; to our condensed consolidated financial statements under Item 1 in this quarterly report on Form 10-Q for additional information.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Critical Accounting Policies and Estimates</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires our management to make judgments, assumptions, and estimates that affect the amounts of revenue, expenses, income, assets, and liabilities reported in our condensed consolidated financial statements and accompanying notes. Actual results and the timing of recognition of such amounts could differ from those judgments, assumptions, and estimates. In addition, judgments, assumptions, and estimates routinely require adjustment based on changing circumstances and the receipt of new or better information. Understanding our accounting policies and the extent to which our management uses judgment, assumptions, and estimates in applying these policies,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">59</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">therefore, is integral to understanding our financial statements. Critical accounting policies and estimates are defined as those that reflect significant judgments and uncertainties, potentially resulting in materially different results under different assumptions and conditions. We summarize our most significant accounting policies in relation to the accompanying condensed consolidated financial statements in Note 2 &#8212; &#8220;Basis of Presentation and Summary of Significant Accounting Policies&#8221; thereto. Please also refer to the Critical Accounting Policies section of Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Off-Balance Sheet Arrangements</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, we had no off-balance sheet arrangements that are, or have been, reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to investors.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">60</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="disclosures_about_market_risk"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 3.  QUANTITATIVE AND QUALITAT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IVE DISCLOSURES ABOUT MARKET RISK</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Interest Rate Risk</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Borrowings under the Term Loan and Revolver Loan provided for under our Second Amended and Restated Credit Agreement, as of March 31, 2025, were $250.0 million and $162.0 million, respectively. The Term Loan and Revolver Loan bear interest at an annual rate equal to either, at the Company&#8217;s option, (a) the rate for term SOFR published by the CME Group Benchmark Administration Limited two days prior to the first day of the applicable interest period, plus a spread of 1.25% to 2.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of 0.25% to 1.50%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio. Borrowings under the Promissory Note Payable with I Health, as of March 31, 2025, were $9.9 million. The promissory note has an interest rate of 4.30% per annum on the principal amount. The Company has entered into a collar agreement for its Revolver Loan to effectively convert its floating-rate debt to a fixed-rate basis. The interest rate collar sets a cap of 5.00% and a floor of 2.34% for the SOFR portion of the interest rate. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. A hypothetical 1% change in our interest rates for our outstanding borrowings would have increased our interest expense for the three months ended March 31, 2025, by $0.9 million or decreased our interest expense by $1.1 million.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="controls_and_procedures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 4.  CONTROLS A</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ND PROCEDURES</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluation of Disclosure Controls and Procedures</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains &#8220;disclosure controls and procedures,&#8221; as defined in Rule 13a-15(e) under the Exchange Act, designed to ensure that information required to be disclosed by a company in the reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial and Operating Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial and Operating Officer, concluded that our disclosure controls and procedures were effective as of March 31, 2025.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Changes in Internal Control Over Financial Reporting</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">There were no changes in our internal control over financial reporting during the quarter ended March 31, 2025, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">61</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="part_ii"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PART II &#8211; OTHER</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> INFORMATION</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="legal_proceedings"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1.  LEGAL </span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PROCEEDINGS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">We are, from time to time, party to lawsuits, threatened lawsuits, disputes, and other claims arising in the normal course of business. We assess our liabilities and contingencies in connection with outstanding legal proceedings utilizing the latest information available. Where it is probable that we will incur a loss and the amount of the loss can be reasonably estimated, we record a liability in our consolidated financial statements. These legal accruals may be increased or decreased to reflect any relevant developments on a quarterly basis. Where a loss is not probable, or the amount of the loss is not estimable, we do not record an accrual, consistent with applicable accounting guidance. In the opinion of management, while the outcome of such claims and disputes cannot be predicted with certainty, our ultimate liability in connection with these matters is not expected to have a material adverse effect on our results of operations, financial position, or cash flows, and the amounts accrued for any individual matter are not material. However, legal proceedings are inherently uncertain. As a result, the outcome of a particular matter or a combination of matters may be material to our results of operations for a particular period, depending upon the size of the loss or our income for that particular period.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain of the pending or threatened legal proceedings or claims in which we are involved are discussed under Note 12 &#8212; &#8220;Commitments and Contingencies,&#8221; to our unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q, which disclosure is incorporated by reference herein.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="risk_factors"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 1A. RISK F</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ACTORS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Our business, financial condition, and operating results are affected by a number of factors, whether currently known or unknown, including risks specific to us or the healthcare industry, as well as risks that affect businesses in general. In addition to the information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 14, 2025. The risks disclosed in such Annual Report could materially adversely affect our business, financial condition, cash flows, or results of operations, and thus our stock price. We believe there have been no material changes in our risk factors from those disclosed in the Annual Report. However, additional risks and uncertainties not currently known or which we currently deem to be immaterial may also materially adversely affect our business, financial condition, or results of operations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of such risk factors, as well as other factors affecting the Company&#8217;s financial condition and operating results, past financial performance should not be considered to be a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods. In addition, the disclosure of any risk factor should not be interpreted to imply that the risk has not already materialized.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">62</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="securities_and_use_of_proceeds"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 2.  UNREGISTERED SALE</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">S OF EQUITY SECURITIES AND USE OF PROCEEDS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2022, Astrana&#8217;s Board of Directors approved a share repurchase plan authorizing the Company to repurchase up to $50.0 million of its shares of common stock on the open market and through privately negotiated transactions. This share repurchase plan does not have an expiration date. The Board may suspend or discontinue the repurchase plan at any time. This repurchase plan does not obligate the Company to make additional repurchases at any specific time or in any specific situation. During the three months ended March 31, 2025, no shares were repurchased under the Company&#8217;s share repurchase plan. As of March 31, 2025, $40.5 million remained available for repurchase under the repurchase plan.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table provides information about purchases made by the Company of shares of the Company&#8217;s common stock during the three months ended March 31, 2025.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:47.24%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.24%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.120000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:9.82%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:1.24%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:11.520000000000001%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(in thousands)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Period</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Number<br/>of Shares<br/>Purchased</span><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Average Price<br/>Paid per<br/>Share</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total Number of<br/>Shares<br/>Purchased as<br/>Part of Publicly<br/>Announced Plans<br/>or Programs</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Approximate Dollar<br/>Value of Shares that<br/>May Yet Be<br/>Purchased Under the<br/>Plans or Programs</span></p></td>
     <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 1, 2025 to January 31, 2025</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">310,303</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;top:-4.6899999999999995pt;white-space:pre-wrap;font-size:6.7pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.20</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,461</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">February 1, 2025 to February 28, 2025</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">566</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37.18</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,461</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">March 1, 2025 to March 31, 2025</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">133,908</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.36</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,461</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">444,777</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32.84</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
     <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,461</span></p></td>
     <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Shares were repurchased to satisfy tax withholding obligations due upon the vesting of restricted stock awards and units held by certain employees, except as otherwise disclosed in these footnotes. We did not pay cash to repurchase these shares, nor were these repurchases part of a publicly announced plan or program. </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Includes 300,000 shares of common stock repurchased from APC for an aggregate purchase price of approximately $10.6 million, based on a purchase price per share of $35.17, pursuant to a stock repurchase agreement with APC entered into on January 17, 2025. The Company&#8217;s Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.</span></div></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="defaults_upon_senior_securities"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 3.  DEFAULT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">S UPON SENIOR SECURITIES</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">None.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="mine_safety_disclosures"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 4.  MINE S</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AFETY DISCLOSURES</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Not applicable.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">63</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="other_information"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 5.  OTHER INF</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ORMATION</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Rule 10b5-1 Trading Plans</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the quarter ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, none of the Company&#8217;s directors or executive officers </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_421321c1-4e61-465c-8746-f0e3f8a693f3" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_894d3541-4b0e-4817-88cb-4e81f8837d6a" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">adopted</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_98727147-92d7-4c4f-9ef7-39b7e338e405" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:Rule10B51ArrModifiedFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_1ea7016b-1f2f-483c-96c9-1eff59f66562" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="asth:NonRule10B51ArrModifiedFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">modified,</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> or </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6158cd1-03f1-4e0a-96e4-9e34dedbf8d9" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false"><ix:nonNumeric id="F_435bc974-1f25-4b7a-aa76-ca4a9f254ad7" contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">terminated</span></ix:nonNumeric></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> any contract, instruction, or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; (as defined in Item 408(c) of Regulation S-K).</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">64</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;" id="exhibits"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ITEM 6.  EX</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">HIBITS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following exhibits are either incorporated by reference into or filed or furnished with this Quarterly Report on Form 10-Q, as indicated below.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:9.78%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:89.22%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit</span></p><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">No.</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #ffffff03;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm#a_annexa"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Agreement and Plan of Merger, dated December 21, 2016, among Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Apollo Acquisition Corp., and Kenneth Sim, M.D. (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017, that is a part of a Registration Statement on Form S-4)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment to the Agreement and Plan of Merger, dated March 30, 2017, among Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Apollo Acquisition Corp., and Kenneth Sim, M.D. (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017 that is a part of a Registration Statement on Form S-4)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417059199/tv479301_424b3.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amendment No. 2 to the Agreement and Plan of Merger, dated October 17, 2017, among Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), Astrana Health Management, Inc. (f/k/a Network Medical Management, Inc.), Apollo Acquisition Corp. and Kenneth Sim, M.D. (incorporated herein by reference to Annex A to the joint proxy statement/prospectus filed pursuant to Rule 424(b)(3) on November 15, 2017 that is a part of a Registration Statement on Form S-4)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.4&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420419025049/tv520199_ex2-4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Stock Purchase Agreement, dated March 15, 2019, by and between Allied Physicians of California, APC-LSMA Designated Shareholder Medical Corporation, and Dr. Kevin Tyson (incorporated herein by reference to Exhibit 2.4 to the Company&#8217;s Quarterly Report on Form 10-Q filed on May 10, 2019)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.5&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465920057432/tm2018794d1_ex2-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Stock Purchase Agreement, dated as of December 31, 2019, among Bright Health Company of California, Inc., the sellers party thereto, Universal Care, Inc., the seller representatives set forth therein, and Bright Health, Inc. (solely for purposes of Section 13.22 thereto) (incorporated herein by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on May 6, 2020)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.6&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924115969/tm2427779d2_ex2-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Asset and Equity Purchase Agreement, dated November 8, 2024, by and among Astrana Health, Inc., PHP Holdings, LLC, PHS Holdings, LLC, Prospect Intermediate Holdings, LLC, each of the entities set forth on Schedule C of the agreement, and Prospect Medical Holdings, Inc. (incorporated herein by reference to Exhibit 2.1 to the Company&#8217;s Current Report on Form 8-K filed on November 8, 2024)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415002897/v398912_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 21, 2015)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.2</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420415025170/v408340_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on April 27, 2015)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.3</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420417063540/tv481301_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on December 13, 2017)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000114420418035195/tv496923_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Restated Certificate of Incorporation (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on June 21, 2018)</span></a></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">65</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:9.78%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:89.22%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.5</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.1243750000000001;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924006988/tm244161d1_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Restated Certificate of Incorporation (effective February 26, 2024) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on January 26, 2024)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.6</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924071275/tm2416686d1_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certificate of Amendment of Restated Certificate of Incorporation (effective June 13, 2024) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on June 13, 2024)</span><span style="color:#0000ff;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.7</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465924028972/tm247268d2_ex3-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated By-laws (effective February 28, 2024) (incorporated herein by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed on February 29, 2024)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465925004739/tm253666d1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Stock Repurchase Agreement, dated January 17, 2025, between Astrana Health, Inc. and Allied Physicians of California, a Professional Medical Corporation (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on January 21, 2025)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.2&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/tm257416d1_ex10-1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Second Amended and Restated Credit Agreement, dated as of February 26, 2025, by and among Astrana Health, Inc., as Borrower, the Lenders from time to time party thereto, and Truist Bank, as administrative agent for the Lenders, as issuing bank and as swingline lender (incorporated herein by reference to Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3&#134;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000110465925018221/tm257416d1_ex10-2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Amended and Restated Guaranty and Security Agreement, dated as of February 26, 2025, by and among Astrana Health, Inc., as Borrower, Astrana Health Management, Inc., as Guarantor, in favor of Truist Bank, as administrative agent for the Secured Parties (incorporated herein by reference to Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K filed on February 27, 2025)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.4&#134;+</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="https://www.sec.gov/Archives/edgar/data/1083446/000095017025039122/asth-ex10_48.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Employment Agreement between Astrana Health, Inc. and Dinesh Kumar, MD (Amended and Restated as of January 31, 2025) (incorporated herein by reference to Exhibit 10.48 to the Company&#8217;s Annual Report on Form 10-K filed on March 14, 2025)</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.1*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="asth-ex31_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31.2*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="asth-ex31_2.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32**</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><a href="asth-ex32.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.INS*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Instance Document</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">101.SCH*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.26;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104*</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Filed herewith.</span></p><p style="font-size:10pt;margin-top:6pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">** Furnished herewith.</span></p><p style="font-size:10pt;margin-top:6pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">+ Management contract or compensatory plan, contract or arrangement.</span></p><p style="font-size:10pt;margin-top:6pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#134; Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request.</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">66</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="padding-top:0.5in;z-index:2;min-height:0.59in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:45%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:51%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.26;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ASTRANA HEALTH, INC.</span></p></td>
    </tr>
    <tr style="height:14.4pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:15.1pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Brandon K. Sim</span></p></td>
    </tr>
    <tr style="height:33.85pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Brandon K. Sim, M.S.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and President</span></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</span></p></td>
    </tr>
    <tr style="height:14.4pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:15.1pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Chandan Basho</span></p></td>
    </tr>
    <tr style="height:35.3pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chandan Basho, M.B.A.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial and Operating Officer</span></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.19in;min-height:0.59in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">67</span></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>asth-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.59in;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="section1"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> EXHIBIT 31.1</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.7249999999999999;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Brandon K. Sim, M.S., certify that:</font></p><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this quarterly report on Form 10-Q of Astrana Health, Inc.;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.59in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.59in;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8.06%;box-sizing:content-box;"></td>
     <td style="width:38.8%;box-sizing:content-box;"></td>
     <td style="width:53.14%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Brandon K. Sim</font></p></td>
    </tr>
    <tr style="height:35.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Brandon K. Sim, M.S.</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer &amp; President</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.59in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>asth-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.59in;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="section1"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> EXHIBIT 31.2</font></p><p style="font-size:10pt;margin-top:0;line-height:2.0029166666666662;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></p><p style="font-size:10pt;margin-top:0;line-height:2.0029166666666662;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;line-height:2.0029166666666662;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Chandan Basho, M.B.A., certify that:</font></p><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I have reviewed this quarterly report on Form 10-Q of Astrana Health, Inc.;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(c)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Evaluated the effectiveness of the registrant&#x2019;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(d)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Disclosed in this report any change in the registrant&#x2019;s internal control over financial reporting that occurred during the registrant&#x2019;s most recent fiscal quarter (the registrant&#x2019;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#x2019;s internal control over financial reporting; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:1.731%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.021929601400237%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The registrant&#x2019;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#x2019;s auditors and the audit committee of the registrant&#x2019;s board of directors (or persons performing the equivalent functions):</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(a)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#x2019;s ability to record, process, summarize and report financial information; and</font></div></div><div class="item-list-element-wrapper" style="margin-left:3.463%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.935%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:5.112029584511638%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(b)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#x2019;s internal control over financial reporting.</font></div></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.59in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:0.59in;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:8.06%;box-sizing:content-box;"></td>
     <td style="width:38.8%;box-sizing:content-box;"></td>
     <td style="width:53.14%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Chandan Basho</font></p></td>
    </tr>
    <tr style="height:35.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chandan Basho, M.B.A.</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Chief Operating Officer</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.59in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>asth-ex32.htm
<DESCRIPTION>EX-32
<TEXT>
<html>
 <head>
  <title>EX-32</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;position:relative;">
  <div style="z-index:2;min-height:0.59in;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:right;" id="section1"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT 32</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18 U.S.C. SECTION 1350.</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">AS ADOPTED PURSUANT TO</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:7pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Brandon K. Sim, M.S., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Astrana Health, Inc. for the quarter ended March 31, 2025 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Astrana Health, Inc.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
    <tr style="visibility:collapse;">
     <td style="width:5.419%;box-sizing:content-box;"></td>
     <td style="width:39.092%;box-sizing:content-box;"></td>
     <td style="width:55.489%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Brandon K. Sim</font></p></td>
    </tr>
    <tr style="height:35.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Brandon K. Sim, M.S.</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Executive Officer and President</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    </tr>
   </table><p style="text-indent:6.667%;font-size:10pt;margin-top:7pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">I, Chandan Basho, M.B.A., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Astrana Health, Inc. for the quarter ended March 31, 2025 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Astrana Health, Inc.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:5.419%;box-sizing:content-box;"></td>
     <td style="width:39.092%;box-sizing:content-box;"></td>
     <td style="width:55.489%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:14.4pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;text-align:right;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">May 9, 2025</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;border-bottom:1pt solid #000000;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:2.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ Chandan Basho</font></p></td>
    </tr>
    <tr style="height:35.3pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:top;padding-bottom:0in;padding-right:0.037in;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.037in;vertical-align:bottom;padding-bottom:0in;padding-right:0.037in;text-align:left;"><p style="font-size:10pt;margin-top:1.65pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Chandan Basho, M.B.A.</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Chief Financial Officer and Chief Operating Officer</font></p><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:1.5pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Principal Financial Officer)</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.59in;justify-content:flex-end;position:relative;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img124443625_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img124443625_0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_X0".17AI9@  34T *@    @  @$2  ,
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H
M# ,!  (1 Q$ /P#ZIHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBL7QEXEL/"7AZZU?5'(@A'"+]Z1S]U%]R?\>@HW'&+D
M[+<VJ*^+_&'QC\6^(KR1H-1FTJSS^[M[%S&5'NXPS'\<>PK-T#XH>,=$NEFM
M]>O;A0<F*\E,Z,/3#$X_#!K;V+L>FLJJN-VU<^XJ*X?X3_$&T\?:&TZ1BVU*
MV(2ZMLYVD]&7U4X./3!'N>XK)IIV9YTX2IR<9+5!1112("BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BO#/VG?&=UHMCI>BZ1>SVE[<L;
MF:2WD,;K&N0HR#G#-G_OBOGK_A,O$_\ T,>M?^!TO_Q5:QI.2N>CA\NG6@IW
MM<^^**^!_P#A,O$__0QZU_X'2_\ Q5=S\%_B)JUA\0-/CUO5[^[T^]/V21;J
MY>14+XVL Q(&&V\^A--T6E<NIE<X1<E*]CZ_HHHK$\L**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %?.O[7%_,%\.:>I(MV,UPX[,PVJOY M_P!]5]%5
MY)^T?X-N?$_A*"^TR)IK_2F:01*,M)$P&\ =R-JG\#WJZ;2DKG7@9QA7BY'R
M)11178?4'JW[,]_-:?%*UMXB?*O+>:*4=B I<?J@_.OL"OF[]EOP9<B^N/%=
M]$T=LL;6]GN&/,8GYW'L -N>^3Z5](URU6G+0^<S*<95_=Z!11161YX4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "OSLF_US_P"\:_1.OSLF_P!<_P#O
M&MZ'4]G*/M_+]1E?5G[)_P#R3[4O^PH__HJ*OE.OJS]D_P#Y)]J7_84?_P!%
M15=7X3KS/^ _5'M5%%%<I\V%%%% !1110 5F>*/^19U?_KSF_P#0#6G69XH_
MY%G5_P#KSF_] --;E0^)'Y^4445W'V)]>?LP_P#)+T_Z_)O_ &6O6J\E_9A_
MY)>G_7Y-_P"RUZU7%/XF?*8O^//U"BBBI.<**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /._VA/\ DC_B#Z0?
M^CXZ^+:^TOVA/^2/^(/I!_Z/CKXMKIH_"?093_!?K^B"OT.T[_D'VO\ UR7^
M0K\\:_0[3O\ D'VO_7)?Y"E7Z&.;[0^?Z%BBBBN<\4***\/_ &CO'.O^$KS0
MH?#NH&S\^.9YL1(^[!0+]Y3C'S=/6JC%R=D:T:,JTU".[/<**^*_^%S>/O\
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M$NB!O3[?%G_T*G9E*$GLC?HJE8:OINH?\>&H6=U_UPF5_P"1J[2$TUN%%%%
M@HHHH **** /._VA/^2/^(/I!_Z/CKXMK[2_:$_Y(_X@^D'_ */CKXMKIH_"
M?093_!?K^B"OT.T[_D'VO_7)?Y"OSQK]#M._Y!]K_P!<E_D*5?H8YOM#Y_H6
M****YSQ0KY3_ &J]22Y\=V-E&P/V.R7?[,[$X_[YVG\:^E/%OB/3_"N@W.K:
MM*([>%>%S\TC=D4=R?\ /%?"WBK6[GQ)XBU#6+[_ %]Y*9" <A1T"CV   ^E
M;48ZW/5RNBW4=1[(RJ^MOV6O^2:2_P#80E_]!2ODFOK;]EK_ ))I+_V$)?\
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MJDZP6=LF^1V_D/4D\ =R:XSY9)MV18O[RVT^SEN[Z>*WMH5W22RL%51ZDFO
M_'O[0L,$DEIX,M%N"/E-]=*0GU1."?J<?0UY5\5?B5J7CO4F4L]MHT39M[,'
MC_??U;]!T'<G@:Z(4EO(]S"Y;&*YJVK['2^(O'7B?Q$['5]:O9D;K"LFR/\
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M^>::=F%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK1116)Y05B>-M:'AWPCJ^K\%K2V>1 >A?&%'XL0*VZ\Y_:&+#X0Z[LS_ ,L
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M_"OF_P#9(_Y#_B#_ *]8_P#T,U]-US5?B/"S%OZP_E^14_LRP_Y\;7_ORO\
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MEU:2F)P.AQT(]B,$>QK.KK/I$TU='3?##_DH_A?_ +"=O_Z,6OO"O@_X8?\
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M'\.Z"FA:9*4U/4D/F.IPT4'0GV+'('L&]J^3JZ7XC^))/%GC35-69B8I92L
M/\,2\(/R )]R:YJNR$>5'U.#H*A24>O4*]M^$/P3F\16\.L>*#+::4X#PVR_
M++<+V8G^%3^9[8X)Q_V?? :>+O$SWVIQ;](TTJ\B,.)I#]U/<<9/T [U]@@
M# & *BI4MHCDS#&NF_94]^IF>'_#^D^'K,6NB:?;64(&"(D +>['JQ]R36G1
M17,>$VY.["L/Q1X3T/Q3:F#7=-M[L8PLC+B1/]UQ\P_ UN447L$9.+O%GR'\
M7?@[>>#DDU31WDOM#S\Y89EMO]_'5?\ :'X@=_):_1.>*.>&2&=%DBD4HZ.,
MA@>"".XKXO\ C=X%_P"$(\6%+-6_LB]!FM">=G/S1Y_V21^!%=-.IS:,][ 8
MUU?W=3?\SSRBBBMCU#[P^&/_ "3CPO\ ]@RV_P#1:UTU<S\,?^2<>%_^P9;?
M^BUKIJX7N?'U?C?J>=_M"?\ )'_$'T@_]'QU\6U]I?M"?\D?\0?2#_T?'7Q;
M711^$]W*?X+]?T05^AVG?\@^U_ZY+_(5^>-?H=IW_(/M?^N2_P A2K]#'-]H
M?/\ 0G=%D1D=0R,,%2,@BJO]F6'_ #XVO_?E?\*MT5SGC7:*G]F6'_/C:_\
M?E?\*^!?$H"^(]5"@ "[E  [?.:_06OS[\3?\C)JW_7W+_Z&:WH[L]C*6W*7
MR,VOJ_\ 9ALK6X^&\KSVT$K_ &^4;GC#'&U/6OE"OK;]EK_DFDO_ &$)?_04
MJZWPG5F?\#YGJO\ 9EA_SXVO_?E?\*/[,L/^?&U_[\K_ (5;HKE/G>9C8HTA
MC"1(J(.BJ, ?A3J**!'QA^T/_P E@U[Z6_\ Z3QUYQ7H_P"T/_R6#7OI;_\
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M+7F->G?M(?\ )6M3_P"N4'_HI:\QKMA\*/K,+_!AZ(][_9(_Y#_B#_KUC_\
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M6MITF&/56!_I76]CZ::YHM'Z%T4RWFCN((YH6#Q2*'1AT((R#3ZX3XX****
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MG_LE>2UUP^%'TF%=Z,/1&CHNAZKKDDD>C:;>7[Q ,ZVT+2%0>YP.*UO^%?\
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M'&B^-]-:ZT6=B\>!-;RC;+"3TW#T]",BNGJ6K:,YY1E!\LE9A1112)"BBB@
MHHHH *^1OVF/$W]M>//[,@?=::3'Y/!X,K8+G\/E7_@)KZ@\9:[#X:\+ZGK%
MQ@I:0M(%/\;=%7\6('XU\$7MU->WD]U=.9+B>1I9'/5F8Y)_,UM1CK<];*J/
M-)U7T(:**UO"OA_4/%&N6VE:1#YMU.>_"HO=F/8#_/-=)[C:BKLJZ/I=]K.H
M0V.E6LMW=S'"11+DG_ >_05]"^ _V>84CCNO&=VTDAY^PVK85?9Y.I^BX^IK
MU3X:_#_2O FDB"Q037\BC[3>.OSRGT'HOHOYY/-=C7-.JWI$\+%9E*;Y:6B[
M]3$\/^%-!\/1JNBZ1969 QOCB&\_5S\Q_$UMT45C<\N4G)W;"JU_86FHP&#4
M+6WNH3UCGC#J?P(Q5FB@2=MCRCQA\"_"FN(\FF1/HUX>0]MS&3[QGC'^[MKY
MR^(7PYU[P/<?\3. 2V+MMBO8,M$WL>ZGV/X9K[DJOJ%E;:C936=_!'<6LRE)
M(I%W*P]"*TC5<=SOP^85:3M)W1^>-%>J_&WX6R^";W^T=*#S:!</A2>6MG/\
M#'N/0_@>>3Y574FI*Z/H:56-6*G#8DMYI+>>.:!VCEC8.CJ<%6!R"*^\_ /B
M&/Q5X/TO6(]NZYA!E4?PR#AQ^# U\$5]$?LH^)]LNI^&;E^''VRV!/<8611^
M&TX]FK.M&ZN<.9T>>ESK='T=117@G[1GC3Q=X8U"TL](N$LM*O(25N(8_P!Z
M7!PZECG&,J1C!YZUSQCS.R/#H476GR1/8?$WBK0_#%OYVO:G;6:D95';+O\
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M^SG_ ,E<T?\ W)__ $2]=,_A9[V*_@S]&?9=<7\9=$/B#X:ZY9Q+NG2'[1$
M.2T9#X'N0"/QKM*",C!Z5QIV=SY6$W"2DNA^=-%=K\8/"3^#_'-]8I&5L9F^
MT6AQP8F)P/\ @)ROX5Q5=J=U<^OA-3BI1V9]D_L]^*4\1?#VTMY) ;[2P+29
M2>=H'[MOH5P/JIKTVOAGX6^-KKP+XGBU"$-+9R#RKN '_61Y[?[0ZC\NA-?:
MWA_6K#Q!I-OJ6D7*7-G.NY'4]/4$=B.X/2N6I#E=SYW'X9T:CDMF:%%%%9G
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MU4445RGS84444 %%%% !69XH_P"19U?_ *\YO_0#6G69XH_Y%G5_^O.;_P!
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M="DU#5) 9""MO;*?GG?^Z/;U/:OB7Q7K]]XGU^\U?5'WW-R^X@?=1>@5?8#
M%:TH7=ST\MPSG/VLME^9DT445U'T!]X?#'_DG'A?_L&6W_HM:Z:N9^&/_)./
M"_\ V#+;_P!%K735PO<^/J_&_4\[_:$_Y(_X@^D'_H^.OBVOM/\ :"!;X0>(
M .>(#_Y'CKXLKHH_">[E/\%^OZ(*_0[3O^0?:_\ 7)?Y"OSQK]"=#GCNM%L+
MB%@T4MO'(C#N"H(-*OT,LWVA\_T+M%%%<YX@5^?GB<8\2ZL#_P _<W_H9K]
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M %W'_H"U]NU\1?'#_DJWB/\ Z[C_ - 6HH[G+E/\5^APU?17[(77Q7_VZ?\
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MV]!T'YDN4U'1&E?%0HM4X[NWR/D*BBBM#L/T+TG_ )!5E_UP3_T$5;JII/\
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M2?L]>#68E9M70>BW"8_5*]AHJE.2ZF\<36BK*3/'/^&>/!__ #\ZS_X$1_\
MQ%=O\/O >E>!+2[M]&DNY$NG61_M+JQ! P,845UE%#FWHV$\35J+EE*Z"O+?
M%7P1\-^)?$%[K%_>:O'<W;AW6&:,(#@#@&,GMZUZE123:V(IU9TG>#L>,?\
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M/P7E1^ KT>BFFUL:0JSI_ ['CI_9Y\'$\7.LCV%PG_Q%)_PSQX/_ .?G6?\
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E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>asth-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2025-05-09T16:55:39.0444+00:00 -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.astranahealth.com/20250331" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:asth="http://www.astranahealth.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" namespace="http://xbrl.sec.gov/ecd-sub/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" namespace="http://fasb.org/srt/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" namespace="http://xbrl.sec.gov/dei/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" namespace="http://www.xbrl.org/dtr/type/2024-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" namespace="http://fasb.org/us-gaap/2024"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" namespace="http://xbrl.sec.gov/ecd/2024"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2023/calculation-1.1.xsd" namespace="https://xbrl.org/2023/calculation-1.1"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Cover" id="Cover">
        <link:definition>100000 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" id="StatementCondensedConsolidatedBalanceSheets1">
        <link:definition>100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" id="DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2">
        <link:definition>100020 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited" id="StatementCondensedConsolidatedStatementsOfIncomeUnaudited">
        <link:definition>100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity" id="StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity">
        <link:definition>100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" id="StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
        <link:definition>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness" id="DescriptionofBusiness">
        <link:definition>995455 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" id="BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill" id="DisclosureBusinessCombinationsAndGoodwill">
        <link:definition>995475 - Disclosure - Business Combinations and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet" id="IntangibleAssetsNet">
        <link:definition>995485 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities" id="InvestmentsinOtherEntities">
        <link:definition>995495 - Disclosure - Investments in Other Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable" id="LoansReceivable">
        <link:definition>995505 - Disclosure - Loans Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses" id="AccountsPayableandAccruedExpenses">
        <link:definition>995515 - Disclosure - Accounts Payable and Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities" id="MedicalLiabilities">
        <link:definition>995525 - Disclosure - Medical Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1" id="DisclosureCreditFacilityBankLoansAndLinesOfCredit1">
        <link:definition>995535 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity" id="DisclosureMezzanineDeficitAndStockholdersEquity">
        <link:definition>995545 - Disclosure - Mezzanine Deficit and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation" id="StockBasedCompensation">
        <link:definition>995555 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies" id="CommitmentsandContingencies">
        <link:definition>995565 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>995575 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>995585 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>995595 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs" id="VariableInterestEntitiesVIEs">
        <link:definition>995605 - Disclosure - Variable Interest Entities (VIEs)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Leases" id="Leases">
        <link:definition>995615 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Segments" id="Segments">
        <link:definition>995625 - Disclosure - Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments" id="FairValueMeasurementsofFinancialInstruments">
        <link:definition>995635 - Disclosure - Fair Value Measurements of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995645 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables" id="DisclosureBusinessCombinationsAndGoodwillTables">
        <link:definition>995675 - Disclosure - Business Combinations and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables" id="IntangibleAssetsNetTables">
        <link:definition>995685 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables" id="InvestmentsinOtherEntitiesTables">
        <link:definition>995695 - Disclosure - Investments in Other Entities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables" id="AccountsPayableandAccruedExpensesTables">
        <link:definition>995705 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables" id="MedicalLiabilitiesTables">
        <link:definition>995715 - Disclosure - Medical Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables" id="DisclosureCreditFacilityBankLoansAndLinesOfCreditTables">
        <link:definition>995725 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables" id="StockBasedCompensationTables">
        <link:definition>995735 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables" id="RelatedPartyTransactionsTables">
        <link:definition>995745 - Disclosure - Related-Party Transactions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables" id="EarningsPerShareTables">
        <link:definition>995755 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables" id="VariableInterestEntitiesVIEsTables">
        <link:definition>995765 - Disclosure - Variable Interest Entities (VIEs) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables" id="LeasesTables">
        <link:definition>995775 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables" id="SegmentsTables">
        <link:definition>995785 - Disclosure - Segments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables" id="FairValueMeasurementsofFinancialInstrumentsTables">
        <link:definition>995795 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails" id="DescriptionofBusinessDetails">
        <link:definition>995805 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>995815 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails">
        <link:definition>995825 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails">
        <link:definition>995835 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails" id="DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails">
        <link:definition>995845 - Disclosure - Business Combinations and Goodwill - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails" id="DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails">
        <link:definition>995855 - Disclosure - Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails" id="DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails">
        <link:definition>995865 - Disclosure - Business Combinations and Goodwill - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails" id="DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails">
        <link:definition>995875 - Disclosure - Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" id="IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
        <link:definition>995885 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails" id="IntangibleAssetsNetAdditionalInformationDetails">
        <link:definition>995895 - Disclosure - Intangible Assets, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" id="IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails">
        <link:definition>995905 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails" id="DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails">
        <link:definition>995915 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" id="InvestmentsinOtherEntitiesAdditionalInformationDetails">
        <link:definition>995925 - Disclosure - Investments in Other Entities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails" id="LoansReceivableDetails">
        <link:definition>995935 - Disclosure - Loans Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails" id="AccountsPayableandAccruedExpensesDetails">
        <link:definition>995945 - Disclosure - Accounts Payable and Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails" id="MedicalLiabilitiesDetails">
        <link:definition>995955 - Disclosure - Medical Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails" id="DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails">
        <link:definition>995965 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails" id="DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails">
        <link:definition>995975 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" id="CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails">
        <link:definition>995985 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails" id="DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails">
        <link:definition>995995 - Disclosure - Mezzanine Deficit and Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" id="StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails">
        <link:definition>996005 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails" id="StockBasedCompensationAdditionalInformationDetails">
        <link:definition>996015 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" id="StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails">
        <link:definition>996025 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Transactions Under Stock Option Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>996035 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails" id="RelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>996045 - Disclosure - Related-Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" id="RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails">
        <link:definition>996055 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails" id="IncomeTaxesDetails">
        <link:definition>996065 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails" id="EarningsPerShareAdditionalInformationDetails">
        <link:definition>996075 - Disclosure - Earnings Per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails" id="EarningsPerShareScheduleofEarningsPerShareComputationsDetails">
        <link:definition>996085 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" id="EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails">
        <link:definition>996095 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails" id="VariableInterestEntitiesVIEsAdditionalInformationDetails">
        <link:definition>996105 - Disclosure - Variable Interest Entities (VIEs)- Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails" id="DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails">
        <link:definition>996115 - Disclosure - Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails" id="LeasesAdditionalinformationDetails">
        <link:definition>996125 - Disclosure - Leases - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails" id="LeasesScheduleofComponentsofLeaseExpenseDetails">
        <link:definition>996135 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails" id="LeasesScheduleofOtherInformationRelatedtoLeasesDetails">
        <link:definition>996145 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails" id="DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails">
        <link:definition>996155 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" id="LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1">
        <link:definition>996165 - Disclosure - Leases - Schedule of Future Minimum Payments Under Non-cancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails" id="DisclosureSegmentsAdditionalInformationDetails">
        <link:definition>996175 - Disclosure - Segments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails" id="DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails">
        <link:definition>996185 - Disclosure - Segments - Schedule of Information about our Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" id="FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails">
        <link:definition>996195 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails" id="FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails">
        <link:definition>996205 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" id="FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails">
        <link:definition>996215 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails" id="DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails">
        <link:definition>996225 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" id="DisclosureSubsequentEventsAdditionalInformationDetails">
        <link:definition>996235 - Disclosure - Subsequent Events (Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="http://www.esma.europa.eu/xbrl/esef/arcrole/wider-narrower" xlink:href="http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd#wider-narrower" xlink:type="simple"/>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" xlink:href="asth-20250331.xsd#StatementCondensedConsolidatedBalanceSheets1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:href="asth-20250331.xsd#StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited" xlink:href="asth-20250331.xsd#StatementCondensedConsolidatedStatementsOfIncomeUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity" xlink:href="asth-20250331.xsd#StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:href="asth-20250331.xsd#IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails" xlink:href="asth-20250331.xsd#DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:href="asth-20250331.xsd#InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails" xlink:href="asth-20250331.xsd#LoansReceivableDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails" xlink:href="asth-20250331.xsd#DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:href="asth-20250331.xsd#CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails" xlink:href="asth-20250331.xsd#DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:href="asth-20250331.xsd#StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails" xlink:href="asth-20250331.xsd#StockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="asth-20250331.xsd#DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:href="asth-20250331.xsd#RelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:href="asth-20250331.xsd#RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails" xlink:href="asth-20250331.xsd#EarningsPerShareAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:href="asth-20250331.xsd#EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails" xlink:href="asth-20250331.xsd#VariableInterestEntitiesVIEsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails" xlink:href="asth-20250331.xsd#DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails" xlink:href="asth-20250331.xsd#LeasesAdditionalinformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails" xlink:href="asth-20250331.xsd#DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:href="asth-20250331.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:href="asth-20250331.xsd#FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:href="asth-20250331.xsd#DisclosureSubsequentEventsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm" xlink:type="simple"/>
        <link:roleRef roleURI="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd#eedm1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Cover" xlink:href="asth-20250331.xsd#Cover" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="asth-20250331.xsd#StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
        <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness" xlink:href="asth-20250331.xsd#DescriptionofBusiness" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwill" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet" xlink:href="asth-20250331.xsd#IntangibleAssetsNet" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities" xlink:href="asth-20250331.xsd#InvestmentsinOtherEntities" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable" xlink:href="asth-20250331.xsd#LoansReceivable" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses" xlink:href="asth-20250331.xsd#AccountsPayableandAccruedExpenses" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities" xlink:href="asth-20250331.xsd#MedicalLiabilities" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1" xlink:href="asth-20250331.xsd#DisclosureCreditFacilityBankLoansAndLinesOfCredit1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity" xlink:href="asth-20250331.xsd#DisclosureMezzanineDeficitAndStockholdersEquity" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation" xlink:href="asth-20250331.xsd#StockBasedCompensation" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies" xlink:href="asth-20250331.xsd#CommitmentsandContingencies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions" xlink:href="asth-20250331.xsd#RelatedPartyTransactions" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes" xlink:href="asth-20250331.xsd#IncomeTaxes" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare" xlink:href="asth-20250331.xsd#EarningsPerShare" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs" xlink:href="asth-20250331.xsd#VariableInterestEntitiesVIEs" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Leases" xlink:href="asth-20250331.xsd#Leases" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/Segments" xlink:href="asth-20250331.xsd#Segments" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments" xlink:href="asth-20250331.xsd#FairValueMeasurementsofFinancialInstruments" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/SubsequentEvents" xlink:href="asth-20250331.xsd#SubsequentEvents" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:href="asth-20250331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwillTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables" xlink:href="asth-20250331.xsd#IntangibleAssetsNetTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables" xlink:href="asth-20250331.xsd#InvestmentsinOtherEntitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables" xlink:href="asth-20250331.xsd#AccountsPayableandAccruedExpensesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables" xlink:href="asth-20250331.xsd#MedicalLiabilitiesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables" xlink:href="asth-20250331.xsd#DisclosureCreditFacilityBankLoansAndLinesOfCreditTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables" xlink:href="asth-20250331.xsd#StockBasedCompensationTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables" xlink:href="asth-20250331.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables" xlink:href="asth-20250331.xsd#EarningsPerShareTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables" xlink:href="asth-20250331.xsd#VariableInterestEntitiesVIEsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables" xlink:href="asth-20250331.xsd#LeasesTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables" xlink:href="asth-20250331.xsd#SegmentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables" xlink:href="asth-20250331.xsd#FairValueMeasurementsofFinancialInstrumentsTables" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails" xlink:href="asth-20250331.xsd#DescriptionofBusinessDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails" xlink:href="asth-20250331.xsd#DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:href="asth-20250331.xsd#IntangibleAssetsNetAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:href="asth-20250331.xsd#IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails" xlink:href="asth-20250331.xsd#AccountsPayableandAccruedExpensesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails" xlink:href="asth-20250331.xsd#MedicalLiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails" xlink:href="asth-20250331.xsd#DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" xlink:href="asth-20250331.xsd#StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails" xlink:href="asth-20250331.xsd#IncomeTaxesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails" xlink:href="asth-20250331.xsd#EarningsPerShareScheduleofEarningsPerShareComputationsDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:href="asth-20250331.xsd#LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails" xlink:href="asth-20250331.xsd#LeasesScheduleofOtherInformationRelatedtoLeasesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails" xlink:href="asth-20250331.xsd#DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails" xlink:href="asth-20250331.xsd#DisclosureSegmentsAdditionalInformationDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails" xlink:href="asth-20250331.xsd#FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails" xlink:href="asth-20250331.xsd#DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" xlink:href="asth-20250331.xsd#DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:href="asth-20250331.xsd#LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
        <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockIssuedDuringPeriodSharesMerger" xlink:label="asth_StockIssuedDuringPeriodSharesMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023And2024MetricMember" xlink:label="asth_A2023And2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HSMSOMember" xlink:label="asth_HSMSOMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondAndThirdMetricMember" xlink:label="asth_SecondAndThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" xlink:label="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepurchaseAgreementDate" xlink:label="us-gaap_RepurchaseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DrawOnLetterOfCreditThroughRevolverLoan" xlink:label="asth_DrawOnLetterOfCreditThroughRevolverLoan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentage" xlink:label="asth_CommonStockDiscountedPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PatientManagementPlatformMember" xlink:label="asth_PatientManagementPlatformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SongPCMember" xlink:label="asth_SongPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DelayedDrawTermLoanMember" xlink:label="us-gaap_DelayedDrawTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember" xlink:label="us-gaap_BaseRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HealthCareCapitationRevenueMember" xlink:label="asth_HealthCareCapitationRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProfessionalMedicalCorporationMember" xlink:label="asth_ProfessionalMedicalCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="us-gaap_IntersegmentEliminationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="us-gaap_PrivateEquityFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ManagementContractsMember" xlink:label="asth_ManagementContractsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnamortizedDeferredFinancingCosts" xlink:label="asth_UnamortizedDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueTable" xlink:label="asth_AccountsReceivableAndNetRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:label="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicareMember" xlink:label="asth_MedicareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMember" xlink:label="asth_CHSMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AurionMember" xlink:label="asth_AurionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsContribution" xlink:label="asth_EquityMethodInvestmentsContribution"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsPayableAndAccruedExpensesMember" xlink:label="asth_AccountsPayableAndAccruedExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorEMember" xlink:label="asth_PayorEMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ADSCMember" xlink:label="asth_ADSCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CFCMember" xlink:label="asth_CFCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtFinancingExpense" xlink:label="asth_DebtFinancingExpense"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTaxImpactFromDividends" xlink:label="asth_TemporaryEquityTaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:label="asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CreditAgreementMember" xlink:label="asth_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanAMember" xlink:label="asth_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstCommonwealthPropertyLLCMember" xlink:label="asth_FirstCommonwealthPropertyLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PerformanceBasedRestrictedStockMember" xlink:label="asth_PerformanceBasedRestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DelayedDrawTermLoanAMember" xlink:label="asth_DelayedDrawTermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdMetricMember" xlink:label="asth_ThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:label="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LeaseWeightedAverageDiscountRateAbstract" xlink:label="asth_LeaseWeightedAverageDiscountRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:label="asth_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CDSCMember" xlink:label="asth_CDSCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InterestRateCollarMember" xlink:label="asth_InterestRateCollarMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:label="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AcquisitionOfNonControllingInterestShares" xlink:label="asth_AcquisitionOfNonControllingInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentAdditionalInvestment" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondThirdFourthAndFifthMeasurementPeriodMember" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorDMember" xlink:label="asth_PayorDMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProviderServicesMember" xlink:label="asth_ProviderServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:label="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ContingentConsideration" xlink:label="asth_ContingentConsideration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyExpensesPayable" xlink:label="asth_RelatedPartyExpensesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ValueOfCallOption" xlink:label="asth_ValueOfCallOption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SunnyVillageCareCenterMember" xlink:label="asth_SunnyVillageCareCenterMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloMedicalHoldingsIncMember" xlink:label="asth_ApolloMedicalHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" xlink:label="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesLineItems" xlink:label="asth_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueLineItems" xlink:label="asth_AccountsReceivableAndNetRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorFMember" xlink:label="asth_PayorFMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanMember" xlink:label="asth_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxImpactFromDividends" xlink:label="asth_TaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NewTermLoanMember" xlink:label="asth_NewTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcBusinessLoanAgreementMember" xlink:label="asth_ApcBusinessLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedHealthManagementSystemsLPMember" xlink:label="asth_AdvancedHealthManagementSystemsLPMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SharesIssuedForVestingOfRestrictedStockAwards" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubordinatedLoanAgreementMember" xlink:label="asth_SubordinatedLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherThirdPartiesMember" xlink:label="asth_OtherThirdPartiesMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareMember" xlink:label="asth_PrimeCommunityCareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AirlineCompleteHealthcareOfTexasLtdMember" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_Rule10B51ArrModifiedFlag" xlink:label="asth_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncashLeaseExpense" xlink:label="asth_NoncashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificHoldingsInvestmentManagementLLCMember" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023MetricMember" xlink:label="asth_A2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareEnablementMember" xlink:label="asth_CareEnablementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCreditsAndOtherLiabilities" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthCallOptionMember" xlink:label="asth_IHealthCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PmiocMember" xlink:label="asth_PmiocMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesTable" xlink:label="asth_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ConsiderationOfAcquisitionInCashFunded" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" xlink:label="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReplacementOfRestrictedStockAwards" xlink:label="asth_ReplacementOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="us-gaap_TrademarksAndTradeNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BassMedicalGroupMember" xlink:label="asth_BassMedicalGroupMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorBMember" xlink:label="asth_PayorBMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaMedicalMember" xlink:label="asth_AstranaMedicalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstMetricMember" xlink:label="asth_FirstMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AAMGMember" xlink:label="asth_AAMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CarePartnersMember" xlink:label="asth_CarePartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditFacilityMember" xlink:label="asth_AmendedCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CompanyAndAPCMember" xlink:label="asth_CompanyAndAPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfMedicareMembers" xlink:label="asth_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EsppMember" xlink:label="asth_EsppMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OneMSOLLCMember" xlink:label="asth_OneMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorCMember" xlink:label="asth_PayorCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareLineItems" xlink:label="asth_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdWayHealthIncMember" xlink:label="asth_ThirdWayHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecuredOvernightFinancingRateMember" xlink:label="asth_SecuredOvernightFinancingRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicaidMember" xlink:label="asth_MedicaidMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersWhoAreAlsoOfficersMember" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023TargetAndGrowthMetricsMember" xlink:label="asth_A2023TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionExpensesIncurredMember" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInMedicalLiabilities" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PreferredBankMember" xlink:label="asth_PreferredBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="us-gaap_SubsegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsPaymentsFromOtherOperatingActivities" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcStockOptionMember" xlink:label="asth_ApcStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PCCCVMember" xlink:label="asth_PCCCVMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentNumberOfKeyFinancialRatios" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FinanceLeaseCostsAbstract" xlink:label="asth_FinanceLeaseCostsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiveThreeOneW.CollegeLLCMember" xlink:label="asth_FiveThreeOneW.CollegeLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NonCashDividendPaidInFormOfStock" xlink:label="asth_NonCashDividendPaidInFormOfStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorAMember" xlink:label="asth_PayorAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherAcquisitionsMember" xlink:label="asth_OtherAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareDeliveryMember" xlink:label="asth_CareDeliveryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentsToAcquireBusinessCashPayable" xlink:label="asth_PaymentsToAcquireBusinessCashPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:label="us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NonRule10B51ArrModifiedFlag" xlink:label="asth_NonRule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaHealthManagementIncMember" xlink:label="asth_AstranaHealthManagementIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareOfCentralValleyIncMember" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OfficeLeaseMember" xlink:label="asth_OfficeLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DMGAndSunLabsMember" xlink:label="asth_DMGAndSunLabsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ForYourBenefitPromissoryNoteMember" xlink:label="asth_ForYourBenefitPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="us-gaap_SubsegmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AHMCMember" xlink:label="asth_AHMCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024TargetAndGrowthMetricsMember" xlink:label="asth_A2024TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkMedicalManagementMember" xlink:label="asth_NetworkMedicalManagementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:label="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthPromissioryNoteMember" xlink:label="asth_IHealthPromissioryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditAgreementMember" xlink:label="asth_AmendedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DistributionOfShares" xlink:label="asth_DistributionOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalPurchaseConsiderationAbstract" xlink:label="asth_TotalPurchaseConsiderationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeasesTextBlock" xlink:label="asth_LesseeOperatingAndFinanceLeasesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="us-gaap_NotesPayableToBanksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsRollForward" xlink:label="asth_EquityMethodInvestmentsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MemberRelationshipsMember" xlink:label="asth_MemberRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkRelationshipsMember" xlink:label="asth_NetworkRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayable" xlink:label="us-gaap_NotesAndLoansPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets" xlink:label="us-gaap_DerivativeAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:label="us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:label="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DerivativeCeilingInterestRate" xlink:label="asth_DerivativeCeilingInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommercialMember" xlink:label="asth_CommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ArroyoVistaMember" xlink:label="asth_ArroyoVistaMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SeniorSecuredPromissoryNoteMember" xlink:label="asth_SeniorSecuredPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseRenewalTerm" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:label="asth_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EstimatedWorkingCapitalAdjustments" xlink:label="asth_EstimatedWorkingCapitalAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayEachFiscalQuarterThereafterMember" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineEquityAbstract" xlink:label="asth_MezzanineEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="us-gaap_OtherExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceMember" xlink:label="us-gaap_ManagementServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondMetricMember" xlink:label="asth_SecondMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CAIPAMSOLLCMember" xlink:label="asth_CAIPAMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DmgMember" xlink:label="asth_DmgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityNetIncome" xlink:label="us-gaap_TemporaryEquityNetIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubcontractorIPAPayable" xlink:label="asth_SubcontractorIPAPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersMember" xlink:label="asth_BoardMembersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_VOMGMember" xlink:label="asth_VOMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCarePatientServiceMember" xlink:label="us-gaap_HealthCarePatientServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalAcquisitionsMember" xlink:label="asth_TotalAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareTable" xlink:label="asth_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionPayable" xlink:label="us-gaap_DistributionPayable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedAndRestatedCreditAgreementMember" xlink:label="asth_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:label="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloSunLabsManagementLLCMember" xlink:label="asth_ApolloSunLabsManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RestructuringSpinoffTransactionPercentage" xlink:label="asth_RestructuringSpinoffTransactionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTransferOfCommonControlEntities" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TruistBankMember" xlink:label="asth_TruistBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ChangeInFairValueOfContingentConsiderationLiabilities" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024MetricMember" xlink:label="asth_A2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorInterestRate" xlink:label="us-gaap_DerivativeFloorInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineMember" xlink:label="asth_MezzanineMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:label="asth_EquityMethodAndOtherEquityInvestmentsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" xlink:label="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfEquitySecuritiesSold" xlink:label="asth_NumberOfEquitySecuritiesSold"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_Met2023MetricMember" xlink:label="asth_Met2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" xlink:label="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentageMaximum" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LasalleMedicalAssociatesIpaMember" xlink:label="asth_LasalleMedicalAssociatesIpaMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockAwardsAndUnitsMember" xlink:label="asth_StockAwardsAndUnitsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LmaMember" xlink:label="asth_LmaMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DwgasConvertiblePromissoryNoteReceivableMember" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LoanReceivableTextBlock" xlink:label="asth_LoanReceivableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SuretyBondMember" xlink:label="us-gaap_SuretyBondMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SpecialtyCapitationPayableCurrent" xlink:label="asth_SpecialtyCapitationPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesTable" xlink:label="asth_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Average effective interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Receivables, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiduciaryAccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiduciaryAccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fiduciary Accounts Payable Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiduciaryAccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fiduciary accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiduciaryAccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fiduciary accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combinations Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combinations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Net of Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Net of Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted, Adjustment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to weighted average shares of common stock (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring and Nonrecurring [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockIssuedDuringPeriodSharesMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of shares of stock issued during the period pursuant to merger.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockIssuedDuringPeriodSharesMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockIssuedDuringPeriodSharesMerger_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Holdback shares not issued to former shareholders (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finance leases, Total future minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023And2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 and 2024 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023And2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A2023 and 2024 Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023And2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2023 and 2024 metric.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenues [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenuesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combinations and Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HSMSOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">xxx_HSMSO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HSMSOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">HSMSO [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HSMSOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">HSMSO</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondAndThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second and Third Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondAndThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second And Third Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondAndThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second and Third metric.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability, Additions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability, Additions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated depreciation associated with finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for vesting of restricted stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares issued for vesting of restricted stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Equity, ending balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Equity, beginning balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Taxes Associated with Excluded Assets Spin-off</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxes Associated With Excluded Assets Spin-off [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Taxes associated with excluded assets spin-off.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepurchaseAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repurchase Agreement, Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepurchaseAgreementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock repurchase agreement date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity, Not Primary Beneficiary</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Claims and Claims Adjustment Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Medical liabilities, end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Medical liabilities, beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medical liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Medical liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consideration transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Consideration transferred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DrawOnLetterOfCreditThroughRevolverLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Draw On Letter Of Credit Through Revolver Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DrawOnLetterOfCreditThroughRevolverLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Draw On Letter Of Credit Through Revolver Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DrawOnLetterOfCreditThroughRevolverLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Draw on letter of credit through Revolver Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current portion of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current portion of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: Current portion of debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, 2025 (excluding the three months ended March 31, 2025)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock, Discounted Price, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Discounted Price, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, discounted price, percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCareOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care, Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCareOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk pool settlements and incentives</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PatientManagementPlatformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patient Management Platform</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PatientManagementPlatformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patient Management Platform [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PatientManagementPlatformMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patient management platform</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock by Class [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Change in Fair Value of Level 3 Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SongPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Song PC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SongPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Song PC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SongPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Song PC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Equity Interest Purchase Obligation, Period to Purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination, equity interest purchase obligation, period to purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivatives, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Liabilities, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DelayedDrawTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Delayed Draw Term Loan (DDTL) [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DelayedDrawTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Delayed Draw Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indefinite lived assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lender Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lender Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EquityMethodInvesteeNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation, Depletion and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BaseRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Base Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BaseRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Base Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased During Period, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares repurchased</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Debt and Lease Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Payment of finance lease obligations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Nonoperating, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseNonoperating_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Nonoperating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mezzanine Deficit and Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HealthCareCapitationRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ameh_HealthCareCapitationRevenueMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HealthCareCapitationRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care Capitation Revenue [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_HealthCareCapitationRevenueMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Capitation, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProfessionalMedicalCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Professional Medical Corporation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProfessionalMedicalCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Professional Medical Corporation [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProfessionalMedicalCorporationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AMG</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Income Taxes Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income taxes receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amount outstsnding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit Facility, Outstanding borrowings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntersegmentEliminationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intersegment Eliminations [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntersegmentEliminationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intersegment Elimination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Useful Life</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivateEquityFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement for Future Equity Fund</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivateEquityFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Equity Funds [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Options forfeited (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities, net of business combinations:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Management Contracts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Management Contracts [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ManagementContractsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Management contracts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Drawdowns</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnamortizedDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unamortized Deferred Financing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnamortizedDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unamortized Deferred Financing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnamortizedDeferredFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating and finance lease, liability, maturity.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Minimum Lease Payments Under Non-cancelable Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining lease term, operating</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Description and Basis of Presentation [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Covenant, Leverage Ratio, Incremental Change</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated leverage ratio, annual decrease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares for Employee Stock Purchase Plan ("ESPP")</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsReceivableAndNetRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable And Net Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsReceivableAndNetRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable And Net Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income before provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Equity Interest Purchase Obligation, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Remaining equity interest purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining equity interest purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Other Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Repayment of long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restructuring, Spinoff Transaction, Number Of Membership Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring, Spinoff Transaction, Number Of Membership Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Spinoff transaction, number of membership units per common share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductAndServiceOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service, Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductAndServiceOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProductAndServiceOtherMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intersegment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ameh:MedicareMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Medicare [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medicare</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CHS [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CHS.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CHS contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MajorCustomersAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer Concentration Risk [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer Concentration Risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AurionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">xxx_Aurion [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AurionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aurion [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AurionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aurion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Bonds expiration period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prior Year Claims and Claims Adjustment Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prior periods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Deferred financing cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of states</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of States in which Entity Operates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Debt Issuance Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of debt issuance cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Common, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Treasury shares (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockCommonShares_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Treasury stock, common, shares (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Earnings per share &#8211; basic (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity method investments contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments Contribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsContribution_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsPayableAndAccruedExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Payable and Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsPayableAndAccruedExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable And Accrued Expenses [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsPayableAndAccruedExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accounts payable and accrued expenses.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor E [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payer E</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorEMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor E Member</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares for business acquisition (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ADSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ADSC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ADSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ADSC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ADSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ADSC contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Advanced Diagnostic and Surgical Center, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advanced Diagnostic and Surgical Center, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advanced Diagnostic and Surgical Center, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Principal Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeasePrincipalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Financing cash flows from finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CFCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CFC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CFCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CFC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CFCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CFC contingent considerations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Contract liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount due to affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI and without Readily Determinable Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Investment in a privately held entity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidation Items [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity, Primary Beneficiary</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Licenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtFinancingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Financing Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtFinancingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt financing expense.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtFinancingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt financing expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">C H S Member Enrollment Metrics [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CHS member enrollment metrics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CHS Member Enrollment Metrics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination, Contingent Consideration, Liability, Each Measurement Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Contingent Consideration, Liability, Each Measurement Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent consideration, liability, each measurement period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Medical Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Medical Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medical liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary equity, Tax impact from dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Temporary equity, Tax impact from dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Tax Impact From Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity tax impact from dividends.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Business Acquisitions, by Acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Retained earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Beginning balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PacificMedicalImagingAndOncologyCenterIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pacific Medical Imaging and Oncology Center, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PacificMedicalImagingAndOncologyCenterIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pacific Medical Imaging &amp; Oncology Center, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Ordinary Dividends, Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments of ordinary dividends common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Dividends paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Expiration Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term of facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Other Long-Term Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Borrowings on long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonrelated Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonrelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nonrelated Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued in business combination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost, Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Land, property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revolving credit facility term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, 2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan A</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term Loan A.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash flows from operating activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstCommonwealthPropertyLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First Commonwealth Property, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstCommonwealthPropertyLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Commonwealth Property, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstCommonwealthPropertyLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Commonwealth Property, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accounts payable and other accruals</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options and ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PerformanceBasedRestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Performance Based Restricted Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PerformanceBasedRestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Based Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PerformanceBasedRestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Based Restricted Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DelayedDrawTermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Delayed Draw Term Loan A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DelayedDrawTermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Delayed Draw Term Loan A.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DelayedDrawTermLoanAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DDTL A</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income per share - diluted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medical Liabilities [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Taxes Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Taxes Payable, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Cash Flows [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase price of equity investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in other entities &#8211; equity method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Third Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Third Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted Stock Awards and Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Earnings Per Share Computations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accrued compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other expense, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable interest entity, ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum loan availability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum exposure to loss amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LeaseWeightedAverageDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Weighted Average Discount Rate [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LeaseWeightedAverageDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Discount Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LeaseWeightedAverageRemainingLeaseTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Weighted Average Remaining Lease Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LeaseWeightedAverageRemainingLeaseTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchase of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CDSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CDSC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CDSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CDSC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CDSCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CDSC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net (loss) income attributable to non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Amounts Due To Affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Amounts Due To Affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amounts due to affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InterestRateCollarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest Rate Collar</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InterestRateCollarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Rate Collar [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InterestRateCollarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest Rate Collar</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, Long-term lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medical Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AcquisitionOfNonControllingInterestShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Acquisition of Non-Controlling Interest, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AcquisitionOfNonControllingInterestShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Acquisition of Non-Controlling Interest, Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AcquisitionOfNonControllingInterestShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Acquisition of non-controlling interest (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivables [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ReceivablesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivables [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Line Of Credit Facility, Amount Funded At Closing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line Of Credit Facility, Amount Funded At Closing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount funded at closing</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income attributable to Astrana Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, Lease, Description [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity Method Investment, Additional Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Additional Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Investment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Third Fourth and Fifth Measurement Period [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second third fourth and fifth measurement period.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Third Fourth and Fifth Measurement Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for exercise of options and warrants (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Options exercised (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued for cash and exercise of options (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incurred expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Costs and Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Costs and Expenses, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingCostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expenses recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Customer [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_NameOfMajorCustomerDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Customer [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">C H S Two Thousand Twenty Five Gross Profit P M P M Metric and C H S Member Enrollment Metrics [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">C H S Two Thousand Twenty Five Gross Profit P M P M Metric and C H S Member Enrollment Metrics.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CHS 2025 Gross Profit PMPM Metric and CHS Member Enrollment Metrics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Finance Lease, Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining lease term, finance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">General and administrative expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor D.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor D [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorDMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payer D</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Accounts Payable And Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Accounts Payable And Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trademarks</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TrademarksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trademarks [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation of Revenue [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares issued (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating cash flows from operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative asset, fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cost of services, excluding depreciation and amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cost of services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payables and Accruals [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProviderServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Provider Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProviderServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Provider Services [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProviderServicesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provider Services</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares issued under stock purchase plan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of shares for Employee Stock Purchase Plan ("ESPP") (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidationItemsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidation Items [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options forfeited (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Income Taxes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Income Taxes Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Operating Segments That Share Similar Characteristics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Operating Segments That Share Similar Characteristics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segments that share similar characteristics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Community Family Care Medical Group IPA, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Community Family Care Medical Group IPA, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Community Family Care Medical Group IPA, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">CFC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Support to Nonconsolidated Legal Entity [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Borrowings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Current Borrowing Capacity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration by Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration by Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">I Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">I Health, Inc. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">I Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, par value (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contingent Consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ContingentConsideration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Land, property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Property and equipment, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Benchmark [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">C H S Two Thousand Twenty Five Gross Profit P M P M Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CHS two thousand twenty five gross profit PMPM metric.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CHS 2025 Gross Profit PMPM Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Shares Included in the Diluted Earnings Per Share Computations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total medical care costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total non-current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CollaborativeHealthSystemsLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">CHS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CollaborativeHealthSystemsLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Health Systems, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CollaborativeHealthSystemsLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Collaborative Health Systems, LLC.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unrealized (Gain) Loss from Investment in Equity Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized (Gain) Loss from Investment in Equity Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized loss (gain) on investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyExpensesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyExpensesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party, Expenses Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyExpensesPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party, Expenses Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity interest issued, number of shares (shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Quarterly Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentQuarterlyReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Quarterly Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ValueOfCallOption_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Call option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ValueOfCallOption_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Value Of Call Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ValueOfCallOption_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Value of call option.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents, and restricted cash, end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Related-Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Medical Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Temporary equity, carrying amount, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Temporary equity, carrying amount, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Equity Method Investments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Equity Method Investments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment, Principal</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal balance payable in monthly installments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SunnyVillageCareCenterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sunny Village Care Center</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SunnyVillageCareCenterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sunny Village Care Center [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SunnyVillageCareCenterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sunny Village Care Center</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Consideration Purchase Price due to (from) Seller</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Consideration Purchase Price due to (from) Seller</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Purchase price due to (from) seller</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease cost, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloMedicalHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Apollo Medical Holdings, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloMedicalHoldingsIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Apollo Medical Holdings, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Disaggregated Revenue by Each Payor Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Purchase Of Investments Equity Method In Accounts Payable And Accrued Liabilities And Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Purchase of investments equity method in accounts payable and accrued liabilities and other liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of investments - equity method in accounts payable and accrued liabilities and other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Payment on Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows from finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Support to Nonconsolidated Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommitmentsAndContingenciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Board [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortized intangible assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payments for business acquisition, net of cash acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsReceivableAndNetRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable And Net Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AccountsReceivableAndNetRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Receivable And Net Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor F</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor F [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorFMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payor F</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average grant date fair value granted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyNatureDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Nature [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Settlements</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Tax impact from dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax impact from dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Impact From Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TaxImpactFromDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax impact from dividends.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-Term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Long-term Debt Instruments [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Receivables, net - related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Due from Related Parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, covenant, leverage ratio, adjusted maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements Not Yet Adopted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NewTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">New Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NewTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Term Loan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NewTermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">New Term Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApcBusinessLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APC Business Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApcBusinessLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">APC Business Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Allocation of Net Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Equity Method Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">(Loss) income from equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss (income) from equity method investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedHealthManagementSystemsLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Advanced Health Management Systems, L.P.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedHealthManagementSystemsLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advanced Health Management Systems, L.P. [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AdvancedHealthManagementSystemsLPMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AHMS</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued for Vesting of Restricted Stock Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Shares issued for vesting of restricted stock awards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for vesting of restricted stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubordinatedLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subordinated Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubordinatedLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subordinated Loan Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubordinatedLoanAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subordinated Loan Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherThirdPartiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ameh:OtherThirdPartiesMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherThirdPartiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Third Parties [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherThirdPartiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other third parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prime Community Care</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Community Care [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PCCCV contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Commitments of Credit Facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Components of medical care costs related to claims incurred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Airline Complete Healthcare of Texas, Ltd</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Airline Complete Healthcare of Texas, Ltd [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Airline</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Remaining Contractual Term (Years)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">secured convertible promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt, principal sum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Call Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Call Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercisable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Rule 10b5-1 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_Rule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rule 10b5-1 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum consolidated interest coverage ratio (not less than)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncash Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncash Lease Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncashLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-cash lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Allied Pacific Holdings Investment Management, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allied Pacific Holdings Investment Management, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allied Pacific Holdings Investment Management, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares authorized for issuance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesAPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2023 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">2023 Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and penalties related to unrecognized tax benefits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareEnablementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Care Enablement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareEnablementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Care Enablement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareEnablementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Care Enablement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Equivalents, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Unrealized losses recognized on equity securities held at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized gains (losses) recognized on equity securities held at end of period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Receivable, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income taxes receivable, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, To Be Paid, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Credits and Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount outstanding under agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options canceled, forfeited or expired (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">I Health call option.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">I Health Call Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthCallOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">I Health call option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PmiocMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">PMIOC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PmiocMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PMIOC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments And Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommitmentsAndContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments And Contingencies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Debt Maturities Repayments of Principal After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term debt maturities repayments of principal after year four.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Chief Executive Officer [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Chief Executive Officer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase price adjustment from merger</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares issued for cash and exercise of options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee, Lease, Description [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Consideration of Acquisition in Cash Funded</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consideration of Acquisition in Cash Funded</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consideration of acquisition in cash funded</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Receivables, Net and Receivables-Related Parties and Other Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Acquisition of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquisition of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Increase (Decrease) from Business Combination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncontrolling Interest, Increase (Decrease) from Business Combination</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Covenant, Aggregate Purchase Price, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt covenant, aggregate purchase price, maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Balance Sheet Location [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The Receivables and receivables from related parties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Receivables, Receivables &#8211; Related Parties, Other Receivables And Loan Receivables [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Receivables, Receivables &#8211; Related Parties, Other Receivables and Loan Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReplacementOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Replacement of Restricted Stock Awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReplacementOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Replacement of restricted stock awards.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReplacementOfRestrictedStockAwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Replacement of restricted stock awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Noncurrent Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Noncurrent Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TrademarksAndTradeNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trademarks and Trade Names [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TrademarksAndTradeNamesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tradename/trademarks</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Information Related to Lease Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Stockholders' Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance at January 1, 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balace at March 31, 2025</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options exercised</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Taxes paid from net share settlement of restricted stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Excluding Current Maturities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term debt, net of current portion and deferred financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Long-term debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Other than Temporary Impairment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BassMedicalGroupMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Bass Medical Group</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BassMedicalGroupMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Bass Medical Group [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BassMedicalGroupMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">BASS Medical Group</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Goodwill [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Change in Carrying Value of Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Indefinite-lived Intangible Assets [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Variable Interest Entities (VIEs)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets recorded under finance leases. net of depreciation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor B [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor B [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payer B</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaMedicalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astrana Medical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaMedicalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astrana Medical [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaMedicalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astrana Medical</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Related Party Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments on promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FirstMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value (in millions)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AAMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">AAMG</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AAMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AAMG [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AAMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AAMG contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AAMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">AAMG</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CarePartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Care Partners</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CarePartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Care Partners [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CarePartnersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Care Partners</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended Credit Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended credit facility.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended Credit Facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price per share (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock issued and replacement awards</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Noncurrent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Repurchase of Common Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments for repurchase of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CompanyAndAPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Company And APC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CompanyAndAPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Company And APC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CompanyAndAPCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Company And APC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Taxes and Tax Credits</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease in goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Goodwill, Period Increase (Decrease), Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Investment in marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of medicare members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Medicare Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfMedicareMembers_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of medicare members.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prior periods</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_OwnershipAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Ownership [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ESPP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EsppMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ESPP [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OneMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">One MSO, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OneMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">One MSO, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OneMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">One MSO, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor C [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor C [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payer C</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">[Line Items] for Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit Facility [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesBPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination and Asset Acquisition [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Repurchased During Period, Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock repurchased, value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdWayHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third Way Health</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdWayHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Third Way Health Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ThirdWayHealthIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Third way health inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other provider payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Year Claims and Claims Adjustment Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecuredOvernightFinancingRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Secured Overnight Financing Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecuredOvernightFinancingRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Secured Overnight Financing Rate [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecuredOvernightFinancingRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Secured Overnight Financing Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Liabilities, Mezzanine Deficit, and Stockholders' Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Contributions to Revenue and Receivables by Payor</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Securities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Change in Fair Value on Equity Securities Held</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Investments in Other Entities Equity Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination recognized identifiable assets acquired and liabilities assumed current assets investments in other entities equity method.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in other entities - equity method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock options and ESPP</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Option And Employee Stock Purchase Plan [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock option and employee stock purchase plan.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Effective income tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity Note [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued for vesting of restricted stock awards (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities not included in the calculation of earnings per share (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Income Tax Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business combination, recognized identifiable assets acquired and liabilities assumed, current assets, income tax receivable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Ownership Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity interest (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">% of Ownership</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Payments to) Noncontrolling Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicaidMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ameh:MedicaidMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicaidMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Medicaid [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MedicaidMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Medicaid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Provision for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Board Members Who Are Also Officers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Board Members Who Are Also Officers [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Board Members Who Are Also Officers</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Receivable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income taxes receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A 2023 Target and Growth Metrics [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">A 2023 target and growth metrics.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2023TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023 Target and Growth Metrics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party Transaction, Expenses Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Expenses Incurred [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment of Intangible Assets, Finite-Lived</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of finite-lived intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) In Prepaid Expenses And Other Current Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other long-term liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeInstrumentRiskAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash paid contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash paid contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) In Medical Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Medical liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Goodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share-Based Compensation Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of existing Level 3 liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Variable Interest Entities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Assets and Liabilities, Variable Interest Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PreferredBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PreferredBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Bank</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Use of Estimates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsegments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsegmentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsegments [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total non-current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration risk</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds (Payments) From Other Operating Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds (payments) from other operating activities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApcStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APC Stock Option [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApcStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">APC Stock Option</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments in Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PCCCVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">PCCCV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PCCCVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">PCCCV [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PCCCVMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PCCCV</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition, Acquiree [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Number Of Key Financial Ratios</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Number Of Key Financial Ratios</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of key financial ratios</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Nature [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, 2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Event</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, mezzanine deficit, and stockholders' equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Gross (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Intangible Assets, Gross</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseCostsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance Lease Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseCostsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease Costs [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseCostsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease cost</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Extinguishment of Debt, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Extinguishment of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on debt extinguishment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease right-of-use assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures of cash flow information</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Liabilities Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiveThreeOneW.CollegeLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Five Three One W. College LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiveThreeOneW.CollegeLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">531 W. College, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Earnings per share &#8211; diluted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NonCashDividendPaidInFormOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Dividend Paid In Form Of Stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NonCashDividendPaidInFormOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash dividend paid in form of stock.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NonCashDividendPaidInFormOfStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend paid in the form of common stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities assumed</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loans receivable, current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loan receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total of Investment in privately held entity that does not report net asset value per share .</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment In Privately Held Entity That Does Not Report Net Asset Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Investments in privately held entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Issuance of common stock in connection with the Company's equity award programs (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares purchased by related party (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Vesting period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for (Proceeds from) Loans Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments for (Proceeds from) Loans Receivable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Issuance of loan receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDepositLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Deposit Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDepositLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Due to related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of warrant, number of securities called by each warrant (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payor A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payor A [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PayorAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payer A</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Equity, ending balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Equity, beginning balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating and finance lease, termination period, if applicable.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating and Finance Lease, Termination Period, If Applicable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, termination period, if applicable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits that would reduce annual effective tax rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchase of marketable securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Other Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Acquisitions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OtherAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense) [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stockholders&#8217; equity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareDeliveryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Care Delivery</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareDeliveryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Care Delivery [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CareDeliveryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Care Delivery</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-controlling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, Less: imputed interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentsToAcquireBusinessCashPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payments to Acquire Business, Cash Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentsToAcquireBusinessCashPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Business, Cash Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentsToAcquireBusinessCashPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForLossesAndLossAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForLossesAndLossAdjustmentExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonconsolidated Investees, Other [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherInvesteesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from repayment of promissory notes, including those with related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Repayment of Promissory Notes Including Related Parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Proceeds from repayment of promissory notes including related parties.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent considerations fair value</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Value of the contingent consideration for 2023 and 2024 metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Contingent consideration cash paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Finance leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Earnings Per Share</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mature Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Interest Rate at Period End</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments and Joint Ventures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Method Investments and Joint Ventures [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Other liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares of common stock outstanding &#8211; basic (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StandbyLettersOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Standby Letters of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StandbyLettersOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Standby Letters of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, Long-term lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Finance lease liabilities, net of current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Payment For Repurchase Of Treasury Stock, Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment For Repurchase Of Treasury Stock, Financing Activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Repurchase of subsidiary's shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Equity Method Investments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Equity Method Investments [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Credit Facility</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Rule 10b5-1 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NonRule10B51ArrModifiedFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non Rule 10b5-1 Arr Modified Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllOtherSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Segments [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllOtherSegmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares withheld from issuance upon exercise of options</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sublease Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubleaseIncome_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Sublease income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest on lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaHealthManagementIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astrana Health Management, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaHealthManagementIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astrana Health Management, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AstranaHealthManagementIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Astrana Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum consolidated leverage ratio (not greater than)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prime Community Care of Central Valley, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Community Care of Central Valley, Inc [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Community Care of Central Valley, Inc</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options exercisable (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OfficeLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Office Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OfficeLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Office Lease [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_OfficeLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Office Lease</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options granted (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amortization of Intangible Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DMGAndSunLabsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">DMG And Sun Labs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DMGAndSunLabsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">DMG And Sun Labs [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DMGAndSunLabsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DMG And Sun Labs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ForYourBenefitPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">For Your Benefit Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ForYourBenefitPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">For Your Benefit Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ForYourBenefitPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">FYB Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party Transaction, Revenue Recognized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Revenue Recognized [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Share-based compensation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Receivables, Net, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivablesNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsegmentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsegments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsegmentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsegments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income attributable to Astrana Health, Inc.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Net Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Securities, FV-NI, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquitySecuritiesFvNi_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Marketable securities &#8211; equity securities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Purchase Accounting Adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill, Impairment Loss</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillImpairmentLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of goodwill</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of shares for business acquisition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AHMCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AHMC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AHMCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">AHMC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AHMCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">AHMC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments for medical care costs related to claims incurred:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-Sale</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable securities &#8211; certificates of deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Policies [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Stock Option Transactions Under Stock Option Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, 2025 (excluding the three months ended March 31, 2025)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Line of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Drew down on revolver loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amount outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCredit_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Loan from company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A 2024 Target and Growth Metrics [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">A 2024 target and growth metrics.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024TargetAndGrowthMetricsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Target ang Growth Metrics</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Supplemental disclosures of non-cash investing and financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetworkMedicalManagementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Network Medical Management [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetworkMedicalManagementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">NMM</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Repayments of) Bank Overdrafts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from (repayments of) bank overdrafts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Reportable Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthPromissioryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">I Health Promissiory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthPromissioryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">I Health Promissiory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IHealthPromissioryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">I Health Promissiory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amended Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DistributionOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Distribution Of Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DistributionOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Distribution of shares.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DistributionOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Distribution of shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Event [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalPurchaseConsiderationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total Purchase Consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalPurchaseConsiderationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Purchase Consideration [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalPurchaseConsiderationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total purchase consideration:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating and finance leases.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating and Finance Leases [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Interest Entity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableInterestEntityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Interest Entity [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayableToBanksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Payable to Banks [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesPayableToBanksMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Promissory Note Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity Method Investments [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodInvestmentsRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Method Investments [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, To Be Paid, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MemberRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Member Relationships</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MemberRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Member Relationships [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MemberRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Member relationships</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (decrease) increase in cash, cash equivalents, and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Long-Term Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLongTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment in affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetworkRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Network Relationships</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetworkRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Network Relationships [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NetworkRelationshipsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Network relationships</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 (excluding the nine months ended March 31, 2025)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Notes and Loans Payable, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes and Loans Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notes payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Due from affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement of Financial Position [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investments [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Equity Method Investments Activity</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument increase in original principal amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Increase in Original Principal Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Principal Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income (loss) from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Income from operations</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Claims paid for acquired balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense Claims Paid for Acquired Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Liability for unpaid claims and claims adjustment expense claims paid for acquired balance.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Claims paid for acquired balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Asset</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNonSegmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate, Non-Segment [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateNonSegmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Letter of Credit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LetterOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Letter of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit Facility [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Professional fees</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Current period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Amounts of Transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related party transaction, amount of transaction</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, to be Paid, Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance leases, 2029</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accounts Payable and Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit facility interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Interest Rate During Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsequent Events [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate purchase price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentSoldCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method Investment, Amount Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityMethodInvestmentSoldCarryingAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Distribution from investment - equity method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Certificates of Deposit [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CertificatesOfDepositMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Certificates of Deposit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options canceled, forfeited or expired (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Options canceled, forfeited or expired (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Acquisition [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends Payable, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Dividend payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Related Party Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from promissory note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Contract [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeContractTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative Contract [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DerivativeCeilingInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Derivative Ceiling Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DerivativeCeilingInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Ceiling Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DerivativeCeilingInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative, ceiling interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Lender [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of Credit Facility, Lender [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Line of credit facility, unused capacity commitment fee percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommercialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ameh:CommercialMember</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommercialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commercial [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommercialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commercial</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ArroyoVistaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Arroyo Vista</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ArroyoVistaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Arroyo Vista [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ArroyoVistaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Arroyo Vista</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">IntraCare Convertible Promissory Note Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IntraCare Convertible Promissory Note Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IntraCare Convertible Promissory Note Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SeniorSecuredPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Senior Secured Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SeniorSecuredPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Senior Secured Promissory Note [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SeniorSecuredPromissoryNoteMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Senior Secured Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lessee, operating and finance lease, renewal term.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating and Finance Lease, Renewal Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease option to extend (up to)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CashPaidForLeaseLiabilitiesAbstractAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid For Lease Liabilities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CashPaidForLeaseLiabilitiesAbstractAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EstimatedWorkingCapitalAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Estimated Working Capital Adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EstimatedWorkingCapitalAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Estimated working capital adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EstimatedWorkingCapitalAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated working capital adjustments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">As of last day each fiscal quarter thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">As of Last Day Each Fiscal Quarter Thereafter [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">As of Last Day Each Fiscal Quarter Thereafter.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Income Taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MezzanineEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MEZZANINE EQUITY [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MezzanineEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Mezzanine deficit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Issuance Costs, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Issuance Costs, Net, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashUninsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Uninsured Amount</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashUninsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount deposit accounts exceeded FDIC insured limit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Expense [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Developed Technology Rights [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DevelopedTechnologyRightsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Developed technology</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Stated Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate (as a percent)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Retained Earnings</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Management Service [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ManagementServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Management fee income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivables</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Carrying Amounts and Fair Values of Financial Instruments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Operating Assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Allied Pacific Of California IPA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Allied Pacific Of California IPA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Allied Pacific Of California IPA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">APC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, 2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SecondMetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CAIPAMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">CAIPA MSO, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CAIPAMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">CAIPA MSO, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CAIPAMSOLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CAIPA MSO, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DmgMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">DMG [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DmgMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DMG remaining equity interest purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityNetIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Net Income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityNetIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net (loss) income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from ESPP purchases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options exercised (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubcontractorIPAPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Subcontractor IPA Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubcontractorIPAPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subcontractor IPA Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SubcontractorIPAPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Subcontractor IPA payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risks</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unamortized deferred financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Less: Unamortized financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025 (excluding the three months ended March 31, 2025)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Board Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Board Members [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BoardMembersMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Board Members</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized (loss) gain on investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrealizedGainLossOnInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrealized Gain (Loss) on Investments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common&#160;Stock&#160;Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts Payable and Accrued Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment, Name [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_VOMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">VOMG</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_VOMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">VOMG [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_VOMGMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">VOMG contingent consideration</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Accretion of Dividends</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Additional Paid-in&#160; Capital</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCarePatientServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fee-for-service, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCarePatientServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Third-Party</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_HealthCarePatientServiceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Health Care, Patient Service [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition, Pro Forma Earnings Per Share, Basic</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net income per share - basic (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Total Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Total Acquisitions [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TotalAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total Acquisitions</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Earnings Per Share [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loans receivable, non-current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Financing Receivable, after Allowance for Credit Loss, Noncurrent, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Variable Interest Entities [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Variable Interest Entities [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Distribution Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amended and Restated Credit Agreement</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amended and Restated Credit Agreement [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_AmendedAndRestatedCreditAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Agreement Amendment</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Income Location, Balance [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Related Party Transaction, Revenue (Expense), Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction, Revenue (Expense), Net [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating leases, 2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Reconciliation Of Cash Cash Equivalents And Restricted Cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Reconciliation of cash, cash equivalents, and restricted cash</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Other assets</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloSunLabsManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Apollo-Sun Labs Management, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloSunLabsManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Apollo-Sun Labs Management, LLC [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloSunLabsManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Apollo-Sun Labs Management, LLC</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ApolloSunLabsManagementLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Sun Labs remaining equity interest purchase</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Performance Shares [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PerformanceSharesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Performance Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Financing Costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments of Financing Costs, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfFinancingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments of debt financing costs</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Disaggregation of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Disaggregation of Revenue [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Noncontrolling Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restructuring, Spinoff Transaction, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restructuring, Spinoff Transaction, Percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RestructuringSpinoffTransactionPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Spinoff transaction, ownership percentage</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity, Transfer Of Common Control Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Transfer Of Common Control Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity, Transfer Of Common Control Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TruistBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Truist Bank</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TruistBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Truist Bank [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_TruistBankMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Truist Bank</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Expense Information Used by CODM, Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">CODM Description</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change In Fair Value Of Contingent Consideration Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Change in fair value of contingent consideration liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in fair value of contingent consideration liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Finance leases, Less: current portion</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finance lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Finance lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockValueAcquiredParValueMethod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Value, Acquired, Par Value Method</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockValueAcquiredParValueMethod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Temporary Equity, Repurchase of subsidiary's shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">2024 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">2024 Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_A2024MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeFloorInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative, Floor Interest Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeFloorInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative, floor interest rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value per share; 100,000,000 shares authorized, 49,028,624 and 47,929,872 shares issued and outstanding, excluding 9,903,953 and 10,603,849 treasury shares, as of March 31,2025 and December 31, 2024, respectively</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MezzanineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Mezzanine</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MezzanineMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Mezzanine [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Right-of-Use Asset, Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization of lease expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Schedule of Future Amortization Expense</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money market accounts</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Accounts Payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Fiduciary accounts payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodAndOtherEquityInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Equity Method And Other Equity Investments [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodAndOtherEquityInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Method And Other Equity Investments [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_EquityMethodAndOtherEquityInvestmentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Investments in Other Entities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Term Debt, Maturity, Year Three</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2028</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contingent Consideration Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContingentConsiderationTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent Consideration Type [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating leases, Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Marketable Securities, Current, Maturity Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Current, Maturity Period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term marketable securities, maturity period</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Distribution Made to Limited Partner, Cash Distributions Declared</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash distribution</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Commitments and contingencies (Note 12)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Asset, Expected Amortization, After Year Four</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for income taxes</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Information about our Segments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Receivables, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Receivable, after Allowance for Credit Loss, Current, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Receivables, net - related parties</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notes Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NotesReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Secured Promissory Note</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchase of non-controlling interest</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating leases, Total future minimum lease payments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfEquitySecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of equity securities sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfEquitySecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Equity Securities Sold</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_NumberOfEquitySecuritiesSold_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of equity securities sold.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk Benchmark [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration Risk Benchmark [Domain]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Finance leases, Total lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finance Lease, Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting Information [Line Items]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis spread on variable rate</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility, Bank Loans, and Lines of Credit</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Debt</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayments</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_Met2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Met 2023 Metric.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_Met2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Met 2023 Metric [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_Met2023MetricMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Met 2023 Metric</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivative Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Derivative liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Derivative liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativeLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Derivative Liability, Total</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Treasury Stock, Shares, Acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Treasury stock repurchased (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TreasuryStockSharesAcquired_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Purchase of treasury shares (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business acquisition in accounts payable and accrued liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Acquisition In Accounts Payable And Accrued Liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business acquisition in accounts payable and accrued liabilities.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total net assets acquired</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Common Stock, Discounted Price, Percentage, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Discounted Price, Percentage, Maximum</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, discounted price, percentage (up to)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility [Axis]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revolving Credit Facility [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevolvingCreditFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revolver Loan</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">General and Administrative Expenses and Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expenses and Depreciation and Amortization</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingently issuable shares (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Goodwill [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GoodwillRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Goodwill [Roll Forward]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Options outstanding, ending balance (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Options outstanding, beginning balance (in dollars per share)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LasalleMedicalAssociatesIpaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">LaSalle Medical Associates IPA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LasalleMedicalAssociatesIpaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LaSalle Medical Associates - IPA Line of Business</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk pool surplus or deficits, settlement period after performance year</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contingent on performance (in shares)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Intangible Assets, Net (Excluding Goodwill)</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangible assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Intangible Assets, Net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Intangible assets, net</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockAwardsAndUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock Awards And Units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockAwardsAndUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Awards And Units [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_StockAwardsAndUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted stock awards and units</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LmaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">LMA [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LmaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LMA</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DWGAS Convertible Promissory Note Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">DWGAS Convertible Promissory Note Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">DWGAS Convertible Promissory Note Receivable [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating leases</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Subsequent Events</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LoanReceivableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LoanReceivableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan Receivable [Text Block]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_LoanReceivableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Loans Receivable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Amounts Due From Affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Amounts Due From Affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amounts due from affiliates</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Costs and Expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CostsAndExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SuretyBondMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Surety Bond [Member]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SuretyBondMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Surety Bonds</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Income Taxes, Noncurrent</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SpecialtyCapitationPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the amount of specialty capitation payable current.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SpecialtyCapitationPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Specialty Capitation Payable Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SpecialtyCapitationPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Capitation payable</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="asth_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of significant accounting policies.</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities, Current</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accounts payable and accrued expenses</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accounts payable and accrued expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FiduciaryAccountsPayableCurrent" xlink:to="asth_FiduciaryAccountsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" xlink:to="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_StockIssuedDuringPeriodSharesMerger" xlink:to="asth_StockIssuedDuringPeriodSharesMerger_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_A2023And2024MetricMember" xlink:to="asth_A2023And2024MetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_HSMSOMember" xlink:to="asth_HSMSOMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SecondAndThirdMetricMember" xlink:to="asth_SecondAndThirdMetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" xlink:to="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" xlink:to="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementDate" xlink:to="us-gaap_RepurchaseAgreementDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DrawOnLetterOfCreditThroughRevolverLoan" xlink:to="asth_DrawOnLetterOfCreditThroughRevolverLoan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommonStockDiscountedPricePercentage" xlink:to="asth_CommonStockDiscountedPricePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOtherMember" xlink:to="us-gaap_HealthCareOtherMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PatientManagementPlatformMember" xlink:to="asth_PatientManagementPlatformMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SongPCMember" xlink:to="asth_SongPCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DelayedDrawTermLoanMember" xlink:to="us-gaap_DelayedDrawTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="srt_EquityMethodInvesteeNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BaseRateMember" xlink:to="us-gaap_BaseRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseNonoperating" xlink:to="us-gaap_InterestExpenseNonoperating_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_HealthCareCapitationRevenueMember" xlink:to="asth_HealthCareCapitationRevenueMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ProfessionalMedicalCorporationMember" xlink:to="asth_ProfessionalMedicalCorporationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentCarryingAmount" xlink:to="us-gaap_DebtInstrumentCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntersegmentEliminationMember" xlink:to="us-gaap_IntersegmentEliminationMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivateEquityFundsMember" xlink:to="us-gaap_PrivateEquityFundsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ManagementContractsMember" xlink:to="asth_ManagementContractsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_UnamortizedDeferredFinancingCosts" xlink:to="asth_UnamortizedDeferredFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:to="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="asth_AccountsReceivableAndNetRevenueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfOtherLongTermDebt" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:to="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_ConcentrationRiskTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductAndServiceOtherMember" xlink:to="us-gaap_ProductAndServiceOtherMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MedicareMember" xlink:to="asth_MedicareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CHSMember" xlink:to="asth_CHSMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AurionMember" xlink:to="asth_AurionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationDate1" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockCommonShares" xlink:to="us-gaap_TreasuryStockCommonShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EquityMethodInvestmentsContribution" xlink:to="asth_EquityMethodInvestmentsContribution_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:to="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AccountsPayableAndAccruedExpensesMember" xlink:to="asth_AccountsPayableAndAccruedExpensesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorEMember" xlink:to="asth_PayorEMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ADSCMember" xlink:to="asth_ADSCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeasePrincipalPayments" xlink:to="us-gaap_FinanceLeasePrincipalPayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CFCMember" xlink:to="asth_CFCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:to="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsDomain" xlink:to="srt_ConsolidationItemsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseMember" xlink:to="us-gaap_LicenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtFinancingExpense" xlink:to="asth_DebtFinancingExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CHSMemberEnrollmentMetricsMember" xlink:to="asth_CHSMemberEnrollmentMetricsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" xlink:to="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TemporaryEquityTaxImpactFromDividends" xlink:to="asth_TemporaryEquityTaxImpactFromDividends_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:to="asth_PacificMedicalImagingAndOncologyCenterIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonrelatedPartyMember" xlink:to="us-gaap_NonrelatedPartyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssued1" xlink:to="us-gaap_StockIssued1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EmployeeStockPurchasePlanMember" xlink:to="asth_EmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CreditAgreementMember" xlink:to="asth_CreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TermLoanAMember" xlink:to="asth_TermLoanAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FirstCommonwealthPropertyLLCMember" xlink:to="asth_FirstCommonwealthPropertyLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PerformanceBasedRestrictedStockMember" xlink:to="asth_PerformanceBasedRestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DelayedDrawTermLoanAMember" xlink:to="asth_DelayedDrawTermLoanAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ThirdMetricMember" xlink:to="asth_ThirdMetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LeaseWeightedAverageDiscountRateAbstract" xlink:to="asth_LeaseWeightedAverageDiscountRateAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:to="asth_LeaseWeightedAverageRemainingLeaseTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CDSCMember" xlink:to="asth_CDSCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_InterestRateCollarMember" xlink:to="asth_InterestRateCollarMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AcquisitionOfNonControllingInterestShares" xlink:to="asth_AcquisitionOfNonControllingInterestShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:to="asth_LineOfCreditFacilityAmountFundedAtClosing_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EquityMethodInvestmentAdditionalInvestment" xlink:to="asth_EquityMethodInvestmentAdditionalInvestment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SecondThirdFourthAndFifthMeasurementPeriodMember" xlink:to="asth_SecondThirdFourthAndFifthMeasurementPeriodMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingCostsAndExpenses" xlink:to="us-gaap_OperatingCostsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="srt_NameOfMajorCustomerDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:to="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorDMember" xlink:to="asth_PayorDMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksMember" xlink:to="us-gaap_TrademarksMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ProviderServicesMember" xlink:to="asth_ProviderServicesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:to="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IHealthIncMember" xlink:to="asth_IHealthIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ContingentConsideration" xlink:to="asth_ContingentConsideration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CollaborativeHealthSystemsLLCMember" xlink:to="asth_CollaborativeHealthSystemsLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:to="asth_UnrealizedGainLossFromInvestmentInEquitySecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RelatedPartyExpensesPayable" xlink:to="asth_RelatedPartyExpensesPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ValueOfCallOption" xlink:to="asth_ValueOfCallOption_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SunnyVillageCareCenterMember" xlink:to="asth_SunnyVillageCareCenterMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" xlink:to="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ApolloMedicalHoldingsIncMember" xlink:to="asth_ApolloMedicalHoldingsIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" xlink:to="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="asth_CommitmentsAndContingenciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AccountsReceivableAndNetRevenueLineItems" xlink:to="asth_AccountsReceivableAndNetRevenueLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorFMember" xlink:to="asth_PayorFMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_LossContingencyNatureDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TermLoanMember" xlink:to="asth_TermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipDomain" xlink:to="srt_OwnershipDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TaxImpactFromDividends" xlink:to="asth_TaxImpactFromDividends_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:to="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NewTermLoanMember" xlink:to="asth_NewTermLoanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ApcBusinessLoanAgreementMember" xlink:to="asth_ApcBusinessLoanAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AdvancedHealthManagementSystemsLPMember" xlink:to="asth_AdvancedHealthManagementSystemsLPMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SharesIssuedForVestingOfRestrictedStockAwards" xlink:to="asth_SharesIssuedForVestingOfRestrictedStockAwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SubordinatedLoanAgreementMember" xlink:to="asth_SubordinatedLoanAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_OtherThirdPartiesMember" xlink:to="asth_OtherThirdPartiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PrimeCommunityCareMember" xlink:to="asth_PrimeCommunityCareMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="asth_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AirlineCompleteHealthcareOfTexasLtdMember" xlink:to="asth_AirlineCompleteHealthcareOfTexasLtdMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CallOptionMember" xlink:to="us-gaap_CallOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_Rule10B51ArrModifiedFlag" xlink:to="asth_Rule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:to="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NoncashLeaseExpense" xlink:to="asth_NoncashLeaseExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AlliedPacificHoldingsInvestmentManagementLLCMember" xlink:to="asth_AlliedPacificHoldingsInvestmentManagementLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesAPreferredStockMember" xlink:to="us-gaap_SeriesAPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_A2023MetricMember" xlink:to="asth_A2023MetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CareEnablementMember" xlink:to="asth_CareEnablementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivableNoncurrent" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredCreditsAndOtherLiabilities" xlink:to="us-gaap_DeferredCreditsAndOtherLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IHealthCallOptionMember" xlink:to="asth_IHealthCallOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PmiocMember" xlink:to="asth_PmiocMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="asth_CommitmentsAndContingenciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:to="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ConsiderationOfAcquisitionInCashFunded" xlink:to="asth_ConsiderationOfAcquisitionInCashFunded_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" xlink:to="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:to="asth_DebtCovenantAggregatePurchasePriceMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" xlink:to="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ReplacementOfRestrictedStockAwards" xlink:to="asth_ReplacementOfRestrictedStockAwards_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TrademarksAndTradeNamesMember" xlink:to="us-gaap_TrademarksAndTradeNamesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BassMedicalGroupMember" xlink:to="asth_BassMedicalGroupMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorBMember" xlink:to="asth_PayorBMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AstranaMedicalMember" xlink:to="asth_AstranaMedicalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FirstMetricMember" xlink:to="asth_FirstMetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingSegmentsMember" xlink:to="us-gaap_OperatingSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AAMGMember" xlink:to="asth_AAMGMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CarePartnersMember" xlink:to="asth_CarePartnersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AmendedCreditFacilityMember" xlink:to="asth_AmendedCreditFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CompanyAndAPCMember" xlink:to="asth_CompanyAndAPCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NumberOfMedicareMembers" xlink:to="asth_NumberOfMedicareMembers_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EsppMember" xlink:to="asth_EsppMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_OneMSOLLCMember" xlink:to="asth_OneMSOLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorCMember" xlink:to="asth_PayorCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EarningsPerShareLineItems" xlink:to="asth_EarningsPerShareLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesBPreferredStockMember" xlink:to="us-gaap_SeriesBPreferredStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ThirdWayHealthIncMember" xlink:to="asth_ThirdWayHealthIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SecuredOvernightFinancingRateMember" xlink:to="asth_SecuredOvernightFinancingRateMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="us-gaap_GainLossOnInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" xlink:to="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MedicaidMember" xlink:to="asth_MedicaidMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BoardMembersWhoAreAlsoOfficersMember" xlink:to="asth_BoardMembersWhoAreAlsoOfficersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesReceivable" xlink:to="us-gaap_IncomeTaxesReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_A2023TargetAndGrowthMetricsMember" xlink:to="asth_A2023TargetAndGrowthMetricsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RelatedPartyTransactionExpensesIncurredMember" xlink:to="asth_RelatedPartyTransactionExpensesIncurredMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:to="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeInstrumentRiskAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IncreaseDecreaseInMedicalLiabilities" xlink:to="asth_IncreaseDecreaseInMedicalLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PreferredBankMember" xlink:to="asth_PreferredBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_AssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ProceedsPaymentsFromOtherOperatingActivities" xlink:to="asth_ProceedsPaymentsFromOtherOperatingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ApcStockOptionMember" xlink:to="asth_ApcStockOptionMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PCCCVMember" xlink:to="asth_PCCCVMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentNumberOfKeyFinancialRatios" xlink:to="asth_DebtInstrumentNumberOfKeyFinancialRatios_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditMember" xlink:to="us-gaap_LineOfCreditMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FinanceLeaseCostsAbstract" xlink:to="asth_FinanceLeaseCostsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FiveThreeOneW.CollegeLLCMember" xlink:to="asth_FiveThreeOneW.CollegeLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NonCashDividendPaidInFormOfStock" xlink:to="asth_NonCashDividendPaidInFormOfStock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDepositLiabilities" xlink:to="us-gaap_RelatedPartyDepositLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PayorAMember" xlink:to="asth_PayorAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" xlink:to="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_OtherAcquisitionsMember" xlink:to="asth_OtherAcquisitionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CareDeliveryMember" xlink:to="asth_CareDeliveryMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PaymentsToAcquireBusinessCashPayable" xlink:to="asth_PaymentsToAcquireBusinessCashPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="us-gaap_PaymentsForLossesAndLossAdjustmentExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInvesteesMember" xlink:to="us-gaap_OtherInvesteesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" xlink:to="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandbyLettersOfCreditMember" xlink:to="us-gaap_StandbyLettersOfCreditMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" xlink:to="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NonRule10B51ArrModifiedFlag" xlink:to="asth_NonRule10B51ArrModifiedFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllOtherSegmentsMember" xlink:to="us-gaap_AllOtherSegmentsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubleaseIncome" xlink:to="us-gaap_SubleaseIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseInterestExpense" xlink:to="us-gaap_FinanceLeaseInterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AstranaHealthManagementIncMember" xlink:to="asth_AstranaHealthManagementIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="asth_DebtInstrumentCovenantLeverageRatioMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_PrimeCommunityCareOfCentralValleyIncMember" xlink:to="asth_PrimeCommunityCareOfCentralValleyIncMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_OfficeLeaseMember" xlink:to="asth_OfficeLeaseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DMGAndSunLabsMember" xlink:to="asth_DMGAndSunLabsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ForYourBenefitPromissoryNoteMember" xlink:to="asth_ForYourBenefitPromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:to="asth_RelatedPartyTransactionRevenueRecognizedMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivablesNetCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsegmentsDomain" xlink:to="us-gaap_SubsegmentsDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesMember" xlink:to="us-gaap_OtherLiabilitiesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquitySecuritiesFvNi" xlink:to="us-gaap_EquitySecuritiesFvNi_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillImpairmentLoss" xlink:to="us-gaap_GoodwillImpairmentLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AHMCMember" xlink:to="asth_AHMCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LineOfCredit_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_A2024TargetAndGrowthMetricsMember" xlink:to="asth_A2024TargetAndGrowthMetricsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NetworkMedicalManagementMember" xlink:to="asth_NetworkMedicalManagementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:to="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IHealthPromissioryNoteMember" xlink:to="asth_IHealthPromissioryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AmendedCreditAgreementMember" xlink:to="asth_AmendedCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DistributionOfShares" xlink:to="asth_DistributionOfShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="asth_TotalPurchaseConsiderationAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LesseeOperatingAndFinanceLeasesTextBlock" xlink:to="asth_LesseeOperatingAndFinanceLeasesTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableToBanksMember" xlink:to="us-gaap_NotesPayableToBanksMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="asth_EquityMethodInvestmentsRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="asth_FinanceLeaseLiabilityToBePaidAfterYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MemberRelationshipsMember" xlink:to="asth_MemberRelationshipsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLongTermInvestments" xlink:to="us-gaap_OtherLongTermInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NetworkRelationshipsMember" xlink:to="asth_NetworkRelationshipsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansPayable" xlink:to="us-gaap_NotesAndLoansPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherReceivables" xlink:to="us-gaap_OtherReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" xlink:to="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" xlink:to="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeAssets" xlink:to="us-gaap_DerivativeAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateNonSegmentMember" xlink:to="us-gaap_CorporateNonSegmentMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LetterOfCreditMember" xlink:to="us-gaap_LetterOfCreditMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:to="us-gaap_EquityMethodInvestmentSoldCarryingAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CertificatesOfDepositMember" xlink:to="us-gaap_CertificatesOfDepositMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsPayableCurrent" xlink:to="us-gaap_DividendsPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="us-gaap_DerivativeContractTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DerivativeCeilingInterestRate" xlink:to="asth_DerivativeCeilingInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommercialMember" xlink:to="asth_CommercialMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ArroyoVistaMember" xlink:to="asth_ArroyoVistaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:to="asth_IntraCareConvertiblePromissoryNoteReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SeniorSecuredPromissoryNoteMember" xlink:to="asth_SeniorSecuredPromissoryNoteMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LesseeOperatingAndFinanceLeaseRenewalTerm" xlink:to="asth_LesseeOperatingAndFinanceLeaseRenewalTerm_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="asth_CashPaidForLeaseLiabilitiesAbstractAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EstimatedWorkingCapitalAdjustments" xlink:to="asth_EstimatedWorkingCapitalAdjustments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AsOfLastDayEachFiscalQuarterThereafterMember" xlink:to="asth_AsOfLastDayEachFiscalQuarterThereafterMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MezzanineEquityAbstract" xlink:to="asth_MezzanineEquityAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" xlink:to="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherExpenseMember" xlink:to="us-gaap_OtherExpenseMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DevelopedTechnologyRightsMember" xlink:to="us-gaap_DevelopedTechnologyRightsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ManagementServiceMember" xlink:to="us-gaap_ManagementServiceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AlliedPacificOfCaliforniaIPAMember" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SecondMetricMember" xlink:to="asth_SecondMetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CAIPAMSOLLCMember" xlink:to="asth_CAIPAMSOLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DmgMember" xlink:to="asth_DmgMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNetIncome" xlink:to="us-gaap_TemporaryEquityNetIncome_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SubcontractorIPAPayable" xlink:to="asth_SubcontractorIPAPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BoardMembersMember" xlink:to="asth_BoardMembersMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrealizedGainLossOnInvestments" xlink:to="us-gaap_UnrealizedGainLossOnInvestments_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_VOMGMember" xlink:to="asth_VOMGMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionOfDividends" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCarePatientServiceMember" xlink:to="us-gaap_HealthCarePatientServiceMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TotalAcquisitionsMember" xlink:to="asth_TotalAcquisitionsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EarningsPerShareTable" xlink:to="asth_EarningsPerShareTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionPayable" xlink:to="us-gaap_DistributionPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_AmendedAndRestatedCreditAgreementMember" xlink:to="asth_AmendedAndRestatedCreditAgreementMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:to="asth_RelatedPartyTransactionRevenueExpenseNetMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ApolloSunLabsManagementLLCMember" xlink:to="asth_ApolloSunLabsManagementLLCMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_SegmentDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PerformanceSharesMember" xlink:to="us-gaap_PerformanceSharesMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfFinancingCosts" xlink:to="us-gaap_PaymentsOfFinancingCosts_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RestructuringSpinoffTransactionPercentage" xlink:to="asth_RestructuringSpinoffTransactionPercentage_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TemporaryEquityTransferOfCommonControlEntities" xlink:to="asth_TemporaryEquityTransferOfCommonControlEntities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_TruistBankMember" xlink:to="asth_TruistBankMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ChangeInFairValueOfContingentConsiderationLiabilities" xlink:to="asth_ChangeInFairValueOfContingentConsiderationLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="us-gaap_TreasuryStockValueAcquiredParValueMethod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_A2024MetricMember" xlink:to="asth_A2024MetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeFloorInterestRate" xlink:to="us-gaap_DerivativeFloorInterestRate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MezzanineMember" xlink:to="asth_MezzanineMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:to="asth_EquityMethodAndOtherEquityInvestmentsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="us-gaap_ContingentConsiderationTypeDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:to="asth_MarketableSecuritiesCurrentMaturityPeriod_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" xlink:to="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:to="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesReceivableMember" xlink:to="us-gaap_NotesReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_NumberOfEquitySecuritiesSold" xlink:to="asth_NumberOfEquitySecuritiesSold_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_SegmentReportingInformationLineItems_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_Met2023MetricMember" xlink:to="asth_Met2023MetricMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockSharesAcquired" xlink:to="us-gaap_TreasuryStockSharesAcquired_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" xlink:to="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_CommonStockDiscountedPricePercentageMaximum" xlink:to="asth_CommonStockDiscountedPricePercentageMaximum_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevolvingCreditFacilityMember" xlink:to="us-gaap_RevolvingCreditFacilityMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:to="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_GoodwillRollForward_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LasalleMedicalAssociatesIpaMember" xlink:to="asth_LasalleMedicalAssociatesIpaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:to="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_StockAwardsAndUnitsMember" xlink:to="asth_StockAwardsAndUnitsMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LmaMember" xlink:to="asth_LmaMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_DwgasConvertiblePromissoryNoteReceivableMember" xlink:to="asth_DwgasConvertiblePromissoryNoteReceivableMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_LoanReceivableTextBlock" xlink:to="asth_LoanReceivableTextBlock_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SuretyBondMember" xlink:to="us-gaap_SuretyBondMember_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SpecialtyCapitationPayableCurrent" xlink:to="asth_SpecialtyCapitationPayableCurrent_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="asth_SummaryOfSignificantAccountingPoliciesTable" xlink:to="asth_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/Cover" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentQuarterlyReport" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="73.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="74.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="75.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="76.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="77.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="78.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineEquityAbstract" xlink:label="asth_MezzanineEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_NonrelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_MezzanineEquityAbstract" xlink:to="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="asth_FiduciaryAccountsPayableCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="asth_MezzanineEquityAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquityMethodInvestments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilities" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherReceivables" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HealthCareCapitationRevenueMember" xlink:label="asth_HealthCareCapitationRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceMember" xlink:label="us-gaap_ManagementServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCarePatientServiceMember" xlink:label="us-gaap_HealthCarePatientServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="asth_HealthCareCapitationRevenueMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCareOtherMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseNonoperating" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ManagementServiceMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCarePatientServiceMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductAndServiceOtherMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineMember" xlink:label="asth_MezzanineMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityNetIncome" xlink:label="us-gaap_TemporaryEquityNetIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTransferOfCommonControlEntities" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTaxImpactFromDividends" xlink:label="asth_TemporaryEquityTaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxImpactFromDividends" xlink:label="asth_TaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SharesIssuedForVestingOfRestrictedStockAwards" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AcquisitionOfNonControllingInterestShares" xlink:label="asth_AcquisitionOfNonControllingInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_17"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_MezzanineMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesOutstanding" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityNetIncome" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TreasuryStockValueAcquiredParValueMethod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TemporaryEquityTransferOfCommonControlEntities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TemporaryEquityTaxImpactFromDividends" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TaxImpactFromDividends" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_SharesIssuedForVestingOfRestrictedStockAwards" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_7" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_AcquisitionOfNonControllingInterestShares" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesOutstanding_17" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_18" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" xlink:label="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:label="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1" xlink:label="us-gaap_StockIssued1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" xlink:label="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncashLeaseExpense" xlink:label="asth_NoncashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DrawOnLetterOfCreditThroughRevolverLoan" xlink:label="asth_DrawOnLetterOfCreditThroughRevolverLoan"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ChangeInFairValueOfContingentConsiderationLiabilities" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:label="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NonCashDividendPaidInFormOfStock" xlink:label="asth_NonCashDividendPaidInFormOfStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInMedicalLiabilities" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsPaymentsFromOtherOperatingActivities" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_IncomeTaxesPaid" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_StockIssued1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="asth_NoncashLeaseExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="asth_DrawOnLetterOfCreditThroughRevolverLoan" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="asth_ChangeInFairValueOfContingentConsiderationLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="asth_NonCashDividendPaidInFormOfStock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="asth_UnrealizedGainLossFromInvestmentInEquitySecurities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="asth_IncreaseDecreaseInMedicalLiabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="asth_ProceedsPaymentsFromOtherOperatingActivities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="ecd_InsiderTradingArrLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_Rule10B51ArrModifiedFlag" xlink:label="asth_Rule10B51ArrModifiedFlag"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NonRule10B51ArrModifiedFlag" xlink:label="asth_NonRule10B51ArrModifiedFlag"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="asth_Rule10B51ArrModifiedFlag" order="14.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_InsiderTradingArrLineItems" xlink:to="asth_NonRule10B51ArrModifiedFlag" order="15.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodAndOtherEquityInvestmentsTextBlock" xlink:label="asth_EquityMethodAndOtherEquityInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="asth_EquityMethodAndOtherEquityInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LoanReceivableTextBlock" xlink:label="asth_LoanReceivableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="asth_LoanReceivableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:label="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:label="us-gaap_VariableInterestEntityDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_VariableInterestEntityDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/Leases" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeasesTextBlock" xlink:label="asth_LesseeOperatingAndFinanceLeasesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_LesseeOperatingAndFinanceLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/Segments" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/SubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" xlink:label="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:label="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BusinessCombinationsPolicy" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DerivativesPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:label="us-gaap_DisaggregationOfRevenueTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:label="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock" xlink:label="us-gaap_ScheduleOfGoodwillTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfGoodwillTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:label="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:label="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:label="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" xlink:label="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestmentsTextBlock" xlink:label="us-gaap_GainLossOnInvestmentsTextBlock"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_GainLossOnInvestmentsTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsPayableAndAccruedExpensesMember" xlink:label="asth_AccountsPayableAndAccruedExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesTable" xlink:label="asth_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="asth_AccountsPayableAndAccruedExpensesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="asth_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashUninsuredAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesTable" xlink:to="asth_SummaryOfSignificantAccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommercialMember" xlink:label="asth_CommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicareMember" xlink:label="asth_MedicareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicaidMember" xlink:label="asth_MedicaidMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherThirdPartiesMember" xlink:label="asth_OtherThirdPartiesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_CommercialMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DisaggregationOfRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_MedicareMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_MedicaidMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_OtherThirdPartiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueTable" xlink:label="asth_AccountsReceivableAndNetRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorAMember" xlink:label="asth_PayorAMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueLineItems" xlink:label="asth_AccountsReceivableAndNetRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorBMember" xlink:label="asth_PayorBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorCMember" xlink:label="asth_PayorCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorDMember" xlink:label="asth_PayorDMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorFMember" xlink:label="asth_PayorFMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorEMember" xlink:label="asth_PayorEMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_AccountsReceivableAndNetRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="asth_AccountsReceivableAndNetRevenueTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="srt_MajorCustomersAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorBMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="asth_AccountsReceivableAndNetRevenueLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorDMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorFMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorEMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AirlineCompleteHealthcareOfTexasLtdMember" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedHealthManagementSystemsLPMember" xlink:label="asth_AdvancedHealthManagementSystemsLPMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfMedicareMembers" xlink:label="asth_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareOfCentralValleyIncMember" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EstimatedWorkingCapitalAdjustments" xlink:label="asth_EstimatedWorkingCapitalAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReplacementOfRestrictedStockAwards" xlink:label="asth_ReplacementOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ContingentConsideration" xlink:label="asth_ContingentConsideration"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ConsiderationOfAcquisitionInCashFunded" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AirlineCompleteHealthcareOfTexasLtdMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedHealthManagementSystemsLPMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_NumberOfMedicareMembers" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_PrimeCommunityCareOfCentralValleyIncMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_EstimatedWorkingCapitalAdjustments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ReplacementOfRestrictedStockAwards" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ContingentConsideration" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ConsiderationOfAcquisitionInCashFunded" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalPurchaseConsiderationAbstract" xlink:label="asth_TotalPurchaseConsiderationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedHealthManagementSystemsLPMember" xlink:label="asth_AdvancedHealthManagementSystemsLPMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherAcquisitionsMember" xlink:label="asth_OtherAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentsToAcquireBusinessCashPayable" xlink:label="asth_PaymentsToAcquireBusinessCashPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalAcquisitionsMember" xlink:label="asth_TotalAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_TotalPurchaseConsiderationAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedHealthManagementSystemsLPMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_OtherAcquisitionsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="asth_PaymentsToAcquireBusinessCashPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_TotalAcquisitionsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_Goodwill" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward" xlink:label="us-gaap_GoodwillRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPurchaseAccountingAdjustments" xlink:label="us-gaap_GoodwillPurchaseAccountingAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_2"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_GoodwillRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_Goodwill" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_GoodwillPurchaseAccountingAdjustments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillRollForward" xlink:to="us-gaap_Goodwill_2" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:label="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkRelationshipsMember" xlink:label="asth_NetworkRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ManagementContractsMember" xlink:label="asth_ManagementContractsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MemberRelationshipsMember" xlink:label="asth_MemberRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PatientManagementPlatformMember" xlink:label="asth_PatientManagementPlatformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="us-gaap_TrademarksAndTradeNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_NetworkRelationshipsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_ManagementContractsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LicenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_MemberRelationshipsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_PatientManagementPlatformMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksAndTradeNamesMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:label="us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ImpairmentOfIntangibleAssetsFinitelived" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LasalleMedicalAssociatesIpaMember" xlink:label="asth_LasalleMedicalAssociatesIpaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsRollForward" xlink:label="asth_EquityMethodInvestmentsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:label="asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentAdditionalInvestment" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiveThreeOneW.CollegeLLCMember" xlink:label="asth_FiveThreeOneW.CollegeLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OneMSOLLCMember" xlink:label="asth_OneMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:label="us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CAIPAMSOLLCMember" xlink:label="asth_CAIPAMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsContribution" xlink:label="asth_EquityMethodInvestmentsContribution"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_LasalleMedicalAssociatesIpaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_EquityMethodInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_PacificMedicalImagingAndOncologyCenterIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_EquityMethodInvestmentsRollForward" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="asth_EquityMethodInvestmentAdditionalInvestment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_FiveThreeOneW.CollegeLLCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_OneMSOLLCMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_EquityMethodInvestmentSoldCarryingAmount" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CAIPAMSOLLCMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="asth_EquityMethodInvestmentsContribution" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_EquityMethodInvestments_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="us-gaap_OtherInvesteesMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentAdditionalInvestment" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:label="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_CallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_EquityMethodInvestmentAdditionalInvestment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SeniorSecuredPromissoryNoteMember" xlink:label="asth_SeniorSecuredPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BassMedicalGroupMember" xlink:label="asth_BassMedicalGroupMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DwgasConvertiblePromissoryNoteReceivableMember" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_NotesReceivableMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_IntraCareConvertiblePromissoryNoteReceivableMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_DebtInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_SeniorSecuredPromissoryNoteMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_BassMedicalGroupMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_DwgasConvertiblePromissoryNoteReceivableMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SpecialtyCapitationPayableCurrent" xlink:label="asth_SpecialtyCapitationPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubcontractorIPAPayable" xlink:label="asth_SubcontractorIPAPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="asth_SpecialtyCapitationPayableCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="asth_SubcontractorIPAPayable" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_RelatedPartyDepositLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:label="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:label="us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="us-gaap_PaymentsForLossesAndLossAdjustmentExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanMember" xlink:label="asth_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="us-gaap_NotesPayableToBanksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCreditFacilityTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_NotesPayableToBanksMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LongTermDebtCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_CreditFacilityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LineOfCreditFacilityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_LineOfCredit" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditAgreementMember" xlink:label="asth_AmendedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecuredOvernightFinancingRateMember" xlink:label="asth_SecuredOvernightFinancingRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TruistBankMember" xlink:label="asth_TruistBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="us-gaap_OtherExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanAMember" xlink:label="asth_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedAndRestatedCreditAgreementMember" xlink:label="asth_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember" xlink:label="us-gaap_BaseRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NewTermLoanMember" xlink:label="asth_NewTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PreferredBankMember" xlink:label="asth_PreferredBankMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayEachFiscalQuarterThereafterMember" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DelayedDrawTermLoanMember" xlink:label="us-gaap_DelayedDrawTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CreditAgreementMember" xlink:label="asth_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DelayedDrawTermLoanAMember" xlink:label="asth_DelayedDrawTermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubordinatedLoanAgreementMember" xlink:label="asth_SubordinatedLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanMember" xlink:label="asth_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcBusinessLoanAgreementMember" xlink:label="asth_ApcBusinessLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthPromissioryNoteMember" xlink:label="asth_IHealthPromissioryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ForYourBenefitPromissoryNoteMember" xlink:label="asth_ForYourBenefitPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditFacilityMember" xlink:label="asth_AmendedCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:label="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentNumberOfKeyFinancialRatios" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnamortizedDeferredFinancingCosts" xlink:label="asth_UnamortizedDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtFinancingExpense" xlink:label="asth_DebtFinancingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayable" xlink:label="us-gaap_NotesAndLoansPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="asth_SecuredOvernightFinancingRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_TruistBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedAndRestatedCreditAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_BaseRateMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="asth_NewTermLoanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_PreferredBankMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="asth_AsOfLastDayEachFiscalQuarterThereafterMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_DelayedDrawTermLoanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_CreditAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LineOfCreditMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_DelayedDrawTermLoanAMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_SubordinatedLoanAgreementMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_ApcBusinessLoanAgreementMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_IHealthPromissioryNoteMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_ForYourBenefitPromissoryNoteMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_StatementScenarioAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditFacilityMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_LineOfCreditFacilityAmountFundedAtClosing" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentNumberOfKeyFinancialRatios" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioMaximum" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtCovenantAggregatePurchasePriceMaximum" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_UnamortizedDeferredFinancingCosts" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtFinancingExpense" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfFinancingCosts" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_NotesAndLoansPayable" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloMedicalHoldingsIncMember" xlink:label="asth_ApolloMedicalHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockIssuedDuringPeriodSharesMerger" xlink:label="asth_StockIssuedDuringPeriodSharesMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CDSCMember" xlink:label="asth_CDSCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CompanyAndAPCMember" xlink:label="asth_CompanyAndAPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepurchaseAgreementDate" xlink:label="us-gaap_RepurchaseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DistributionOfShares" xlink:label="asth_DistributionOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionPayable" xlink:label="us-gaap_DistributionPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" xlink:label="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_ApolloMedicalHoldingsIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="asth_StockIssuedDuringPeriodSharesMerger" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_CDSCMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_CompanyAndAPCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_RepurchaseAgreementDate" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="asth_DistributionOfShares" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DistributionPayable" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockAwardsAndUnitsMember" xlink:label="asth_StockAwardsAndUnitsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EsppMember" xlink:label="asth_EsppMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_StockAwardsAndUnitsMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EsppMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcStockOptionMember" xlink:label="asth_ApcStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PerformanceBasedRestrictedStockMember" xlink:label="asth_PerformanceBasedRestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentage" xlink:label="asth_CommonStockDiscountedPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentageMaximum" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="asth_ApcStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="3.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_PerformanceBasedRestrictedStockMember" order="4.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EmployeeStockPurchasePlanMember" order="5.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_CommonStockDiscountedPricePercentage" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_CommonStockDiscountedPricePercentageMaximum" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditAgreementMember" xlink:label="asth_AmendedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesLineItems" xlink:label="asth_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SuretyBondMember" xlink:label="us-gaap_SuretyBondMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesTable" xlink:label="asth_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TruistBankMember" xlink:label="asth_TruistBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaHealthManagementIncMember" xlink:label="asth_AstranaHealthManagementIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_SuretyBondMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_TruistBankMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="asth_CommitmentsAndContingenciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AstranaHealthManagementIncMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_DebtInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCredit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="asth_CommitmentsAndContingenciesLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AHMCMember" xlink:label="asth_AHMCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProviderServicesMember" xlink:label="asth_ProviderServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdWayHealthIncMember" xlink:label="asth_ThirdWayHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="us-gaap_PrivateEquityFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LmaMember" xlink:label="asth_LmaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PmiocMember" xlink:label="asth_PmiocMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OfficeLeaseMember" xlink:label="asth_OfficeLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ArroyoVistaMember" xlink:label="asth_ArroyoVistaMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SongPCMember" xlink:label="asth_SongPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkMedicalManagementMember" xlink:label="asth_NetworkMedicalManagementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SunnyVillageCareCenterMember" xlink:label="asth_SunnyVillageCareCenterMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProfessionalMedicalCorporationMember" xlink:label="asth_ProfessionalMedicalCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstCommonwealthPropertyLLCMember" xlink:label="asth_FirstCommonwealthPropertyLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyExpensesPayable" xlink:label="asth_RelatedPartyExpensesPayable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaMedicalMember" xlink:label="asth_AstranaMedicalMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersMember" xlink:label="asth_BoardMembersMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersWhoAreAlsoOfficersMember" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificHoldingsInvestmentManagementLLCMember" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCreditsAndOtherLiabilities" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCareOtherMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AHMCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_ProviderServicesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipDomain" xlink:to="asth_ThirdWayHealthIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_PrivateEquityFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_LmaMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_PmiocMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_OfficeLeaseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_DirectorMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_ArroyoVistaMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_SongPCMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_NetworkMedicalManagementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_SunnyVillageCareCenterMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_ProfessionalMedicalCorporationMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_FirstCommonwealthPropertyLLCMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="asth_RelatedPartyExpensesPayable" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AstranaMedicalMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_BoardMembersMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ProductOrServiceAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_BoardMembersWhoAreAlsoOfficersMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AlliedPacificHoldingsInvestmentManagementLLCMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_OwnershipAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DeferredCreditsAndOtherLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AHMCMember" xlink:label="asth_AHMCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionExpensesIncurredMember" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HSMSOMember" xlink:label="asth_HSMSOMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AurionMember" xlink:label="asth_AurionMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionRevenueRecognizedMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AHMCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionExpensesIncurredMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_HSMSOMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionRevenueExpenseNetMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AurionMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:label="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareLineItems" xlink:label="asth_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareTable" xlink:label="asth_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="asth_EarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_PerformanceSharesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareTable" xlink:to="asth_EarningsPerShareLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareLineItems" xlink:label="asth_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareTable" xlink:label="asth_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="asth_EarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareTable" xlink:to="asth_EarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_NonrelatedPartyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="asth_FiduciaryAccountsPayableCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_VariableInterestEntityLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquityMethodInvestments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_TaxesPayableCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherLongTermInvestments" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_RestrictedCash" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilities" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseRenewalTerm" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="asth_LesseeOperatingAndFinanceLeaseRenewalTerm" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FinanceLeaseCostsAbstract" xlink:label="asth_FinanceLeaseCostsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_FinanceLeaseCostsAbstract" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_FinanceLeaseCostsAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_FinanceLeaseCostsAbstract" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_SubleaseIncome" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LeaseWeightedAverageDiscountRateAbstract" xlink:label="asth_LeaseWeightedAverageDiscountRateAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:label="asth_LeaseWeightedAverageRemainingLeaseTermAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:label="asth_CashPaidForLeaseLiabilitiesAbstractAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:label="us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments" xlink:label="us-gaap_FinanceLeasePrincipalPayments"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_LeaseWeightedAverageDiscountRateAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_LeaseWeightedAverageDiscountRateAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" xlink:to="us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="us-gaap_FinanceLeaseInterestPaymentOnLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="asth_LeaseWeightedAverageDiscountRateAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" xlink:to="us-gaap_FinanceLeasePrincipalPayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="asth_FinanceLeaseLiabilityToBePaidAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" xlink:label="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" xlink:label="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RestructuringSpinoffTransactionPercentage" xlink:label="asth_RestructuringSpinoffTransactionPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" xlink:label="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_NumberOfReportableSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="asth_RestructuringSpinoffTransactionPercentage" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="us-gaap_SubsegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="us-gaap_SubsegmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCarePatientServiceMember" xlink:label="us-gaap_HealthCarePatientServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CarePartnersMember" xlink:label="asth_CarePartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="us-gaap_IntersegmentEliminationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareDeliveryMember" xlink:label="asth_CareDeliveryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareEnablementMember" xlink:label="asth_CareEnablementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsegmentsDomain" xlink:to="us-gaap_HealthCarePatientServiceMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CarePartnersMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_IntersegmentEliminationMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsegmentsDomain" xlink:to="us-gaap_ProductAndServiceOtherMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CareDeliveryMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_CorporateNonSegmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SubsegmentsAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CareEnablementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SegmentReportingInformationLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_AllOtherSegmentsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostsAndExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AAMGMember" xlink:label="asth_AAMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InterestRateCollarMember" xlink:label="asth_InterestRateCollarMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_VOMGMember" xlink:label="asth_VOMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthCallOptionMember" xlink:label="asth_IHealthCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DmgMember" xlink:label="asth_DmgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloSunLabsManagementLLCMember" xlink:label="asth_ApolloSunLabsManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets" xlink:label="us-gaap_DerivativeAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ADSCMember" xlink:label="asth_ADSCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CFCMember" xlink:label="asth_CFCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareMember" xlink:label="asth_PrimeCommunityCareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMember" xlink:label="asth_CHSMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_AAMGMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_InterestRateCollarMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_VOMGMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_IHealthCallOptionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_DmgMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_ApolloSunLabsManagementLLCMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_ADSCMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_CFCMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_PrimeCommunityCareMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="asth_CHSMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilities" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" xlink:label="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DMGAndSunLabsMember" xlink:label="asth_DMGAndSunLabsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloSunLabsManagementLLCMember" xlink:label="asth_ApolloSunLabsManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InterestRateCollarMember" xlink:label="asth_InterestRateCollarMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023MetricMember" xlink:label="asth_A2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DmgMember" xlink:label="asth_DmgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_VOMGMember" xlink:label="asth_VOMGMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024TargetAndGrowthMetricsMember" xlink:label="asth_A2024TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AAMGMember" xlink:label="asth_AAMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023TargetAndGrowthMetricsMember" xlink:label="asth_A2023TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_Met2023MetricMember" xlink:label="asth_Met2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfEquitySecuritiesSold" xlink:label="asth_NumberOfEquitySecuritiesSold"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024MetricMember" xlink:label="asth_A2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DerivativeCeilingInterestRate" xlink:label="asth_DerivativeCeilingInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023And2024MetricMember" xlink:label="asth_A2023And2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PCCCVMember" xlink:label="asth_PCCCVMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorInterestRate" xlink:label="us-gaap_DerivativeFloorInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstMetricMember" xlink:label="asth_FirstMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondMetricMember" xlink:label="asth_SecondMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdMetricMember" xlink:label="asth_ThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondThirdFourthAndFifthMeasurementPeriodMember" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondAndThirdMetricMember" xlink:label="asth_SecondAndThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ValueOfCallOption" xlink:label="asth_ValueOfCallOption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_DMGAndSunLabsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CertificatesOfDepositMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_CallOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_ApolloSunLabsManagementLLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_InterestRateCollarMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023MetricMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_DmgMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_VOMGMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_MarketableSecuritiesCurrentMaturityPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2024TargetAndGrowthMetricsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AAMGMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023TargetAndGrowthMetricsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_Met2023MetricMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_NumberOfEquitySecuritiesSold" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2024MetricMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_DerivativeCeilingInterestRate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023And2024MetricMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_PCCCVMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeFloorInterestRate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_FirstMetricMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondMetricMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_ThirdMetricMember" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondThirdFourthAndFifthMeasurementPeriodMember" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSMemberEnrollmentMetricsMember" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondAndThirdMetricMember" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_ValueOfCallOption" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:label="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
        </link:presentationLink>
        <link:presentationLink xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SeniorSecuredPromissoryNoteMember" xlink:label="asth_SeniorSecuredPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BassMedicalGroupMember" xlink:label="asth_BassMedicalGroupMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_SeniorSecuredPromissoryNoteMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_BassMedicalGroupMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="2.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
        </link:presentationLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineEquityAbstract" xlink:label="asth_MezzanineEquityAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_NonrelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_MezzanineEquityAbstract" xlink:to="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="asth_FiduciaryAccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_CommitmentsAndContingencies" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="asth_MezzanineEquityAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:label="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivables" xlink:label="us-gaap_OtherReceivables"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherReceivables" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HealthCareCapitationRevenueMember" xlink:label="asth_HealthCareCapitationRevenueMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_NonoperatingIncomeExpenseAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceMember" xlink:label="us-gaap_ManagementServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCarePatientServiceMember" xlink:label="us-gaap_HealthCarePatientServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RevenuesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="asth_HealthCareCapitationRevenueMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingExpensesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCareOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InterestExpenseNonoperating" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ManagementServiceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NonoperatingIncomeExpenseAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_CostsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCarePatientServiceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_ProductAndServiceOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_ProfitLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_EarningsPerShareDiluted" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MezzanineMember" xlink:label="asth_MezzanineMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:label="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:label="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityNetIncome" xlink:label="us-gaap_TemporaryEquityNetIncome"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" xlink:label="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:label="us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:label="us-gaap_MinorityInterestDecreaseFromRedemptions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTransferOfCommonControlEntities" xlink:label="asth_TemporaryEquityTransferOfCommonControlEntities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:label="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TemporaryEquityAccretionOfDividends" xlink:label="us-gaap_TemporaryEquityAccretionOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityTaxImpactFromDividends" xlink:label="asth_TemporaryEquityTaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxImpactFromDividends" xlink:label="asth_TaxImpactFromDividends"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SharesIssuedForVestingOfRestrictedStockAwards" xlink:label="asth_SharesIssuedForVestingOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AcquisitionOfNonControllingInterestShares" xlink:label="asth_AcquisitionOfNonControllingInterestShares"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" xlink:label="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" xlink:label="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_MezzanineMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_SharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityNetIncome" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TreasuryStockValueAcquiredParValueMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_MinorityInterestDecreaseFromRedemptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TemporaryEquityTransferOfCommonControlEntities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="us-gaap_TemporaryEquityAccretionOfDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TemporaryEquityTaxImpactFromDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="asth_TaxImpactFromDividends" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_SharesIssuedForVestingOfRestrictedStockAwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodSharesAcquisitions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_AcquisitionOfNonControllingInterestShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="asth_SummaryOfSignificantAccountingPoliciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SummaryOfSignificantAccountingPoliciesTable" xlink:label="asth_SummaryOfSignificantAccountingPoliciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsPayableAndAccruedExpensesMember" xlink:label="asth_AccountsPayableAndAccruedExpensesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" xlink:label="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="asth_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_NumberOfReportableSegments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="asth_AccountsPayableAndAccruedExpensesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_CashUninsuredAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommercialMember" xlink:label="asth_CommercialMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicareMember" xlink:label="asth_MedicareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MedicaidMember" xlink:label="asth_MedicaidMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherThirdPartiesMember" xlink:label="asth_OtherThirdPartiesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_CommercialMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_MedicareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_MedicaidMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_OtherThirdPartiesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueLineItems" xlink:label="asth_AccountsReceivableAndNetRevenueLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AccountsReceivableAndNetRevenueTable" xlink:label="asth_AccountsReceivableAndNetRevenueTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="us-gaap_ConcentrationRiskBenchmarkDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain" xlink:label="srt_NameOfMajorCustomerDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorAMember" xlink:label="asth_PayorAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="us-gaap_ConcentrationRiskTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorBMember" xlink:label="asth_PayorBMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorCMember" xlink:label="asth_PayorCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorDMember" xlink:label="asth_PayorDMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorFMember" xlink:label="asth_PayorFMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PayorEMember" xlink:label="asth_PayorEMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="asth_AccountsReceivableAndNetRevenueLineItems" xlink:to="asth_AccountsReceivableAndNetRevenueTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskBenchmarkDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskTypeDomain" xlink:to="us-gaap_CustomerConcentrationRiskMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_NameOfMajorCustomerDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_AccountsReceivableAndNetRevenueLineItems" xlink:to="us-gaap_ConcentrationRiskPercentage1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_SalesRevenueNetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="srt_MajorCustomersAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorBMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="us-gaap_AccountsReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_AccountsReceivableAndNetRevenueTable" xlink:to="us-gaap_ConcentrationRiskByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorDMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorFMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_NameOfMajorCustomerDomain" xlink:to="asth_PayorEMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillPeriodIncreaseDecrease" xlink:label="us-gaap_GoodwillPeriodIncreaseDecrease"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AirlineCompleteHealthcareOfTexasLtdMember" xlink:label="asth_AirlineCompleteHealthcareOfTexasLtdMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedHealthManagementSystemsLPMember" xlink:label="asth_AdvancedHealthManagementSystemsLPMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfMedicareMembers" xlink:label="asth_NumberOfMedicareMembers"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareOfCentralValleyIncMember" xlink:label="asth_PrimeCommunityCareOfCentralValleyIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EstimatedWorkingCapitalAdjustments" xlink:label="asth_EstimatedWorkingCapitalAdjustments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ReplacementOfRestrictedStockAwards" xlink:label="asth_ReplacementOfRestrictedStockAwards"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ContingentConsideration" xlink:label="asth_ContingentConsideration"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ConsiderationOfAcquisitionInCashFunded" xlink:label="asth_ConsiderationOfAcquisitionInCashFunded"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="us-gaap_GoodwillImpairmentLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillPeriodIncreaseDecrease" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AirlineCompleteHealthcareOfTexasLtdMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedHealthManagementSystemsLPMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_NumberOfMedicareMembers" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_PrimeCommunityCareOfCentralValleyIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_EstimatedWorkingCapitalAdjustments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ReplacementOfRestrictedStockAwards" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ContingentConsideration" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_ConsiderationOfAcquisitionInCashFunded" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_GoodwillImpairmentLoss" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalPurchaseConsiderationAbstract" xlink:label="asth_TotalPurchaseConsiderationAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedHealthManagementSystemsLPMember" xlink:label="asth_AdvancedHealthManagementSystemsLPMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OtherAcquisitionsMember" xlink:label="asth_OtherAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentsToAcquireBusinessCashPayable" xlink:label="asth_PaymentsToAcquireBusinessCashPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TotalAcquisitionsMember" xlink:label="asth_TotalAcquisitionsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="asth_TotalPurchaseConsiderationAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedHealthManagementSystemsLPMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_OtherAcquisitionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="asth_PaymentsToAcquireBusinessCashPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_TotalAcquisitionsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_TotalPurchaseConsiderationAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_Goodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkRelationshipsMember" xlink:label="asth_NetworkRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksMember" xlink:label="us-gaap_TrademarksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ManagementContractsMember" xlink:label="asth_ManagementContractsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MemberRelationshipsMember" xlink:label="asth_MemberRelationshipsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PatientManagementPlatformMember" xlink:label="asth_PatientManagementPlatformMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember" xlink:label="us-gaap_TrademarksAndTradeNamesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DevelopedTechnologyRightsMember" xlink:label="us-gaap_DevelopedTechnologyRightsMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_NetworkRelationshipsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_ManagementContractsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_LicenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_MemberRelationshipsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="asth_PatientManagementPlatformMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_TrademarksAndTradeNamesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_DevelopedTechnologyRightsMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LasalleMedicalAssociatesIpaMember" xlink:label="asth_LasalleMedicalAssociatesIpaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsRollForward" xlink:label="asth_EquityMethodInvestmentsRollForward"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PacificMedicalImagingAndOncologyCenterIncMember" xlink:label="asth_PacificMedicalImagingAndOncologyCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentAdditionalInvestment" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiveThreeOneW.CollegeLLCMember" xlink:label="asth_FiveThreeOneW.CollegeLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OneMSOLLCMember" xlink:label="asth_OneMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentSoldCarryingAmount" xlink:label="us-gaap_EquityMethodInvestmentSoldCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CAIPAMSOLLCMember" xlink:label="asth_CAIPAMSOLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentsContribution" xlink:label="asth_EquityMethodInvestmentsContribution"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherInvesteesMember" xlink:label="us-gaap_OtherInvesteesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_LasalleMedicalAssociatesIpaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_PacificMedicalImagingAndOncologyCenterIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_EquityMethodInvestmentsRollForward" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="asth_EquityMethodInvestmentAdditionalInvestment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_FiveThreeOneW.CollegeLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_OneMSOLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="us-gaap_EquityMethodInvestmentSoldCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CAIPAMSOLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EquityMethodInvestmentsRollForward" xlink:to="asth_EquityMethodInvestmentsContribution" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="us-gaap_OtherInvesteesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:label="us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EquityMethodInvestmentAdditionalInvestment" xlink:label="asth_EquityMethodInvestmentAdditionalInvestment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:label="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:label="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_ScheduleOfEquityMethodInvestmentsTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_CallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_EquityMethodInvestmentAdditionalInvestment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableMember" xlink:label="us-gaap_NotesReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IntraCareConvertiblePromissoryNoteReceivableMember" xlink:label="asth_IntraCareConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SeniorSecuredPromissoryNoteMember" xlink:label="asth_SeniorSecuredPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BassMedicalGroupMember" xlink:label="asth_BassMedicalGroupMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DwgasConvertiblePromissoryNoteReceivableMember" xlink:label="asth_DwgasConvertiblePromissoryNoteReceivableMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetCurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_NotesReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_IntraCareConvertiblePromissoryNoteReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_SeniorSecuredPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_BassMedicalGroupMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_DwgasConvertiblePromissoryNoteReceivableMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_NotesAndLoansReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems" xlink:label="us-gaap_LineOfCreditFacilityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable" xlink:label="us-gaap_LineOfCreditFacilityTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanMember" xlink:label="asth_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesPayableToBanksMember" xlink:label="us-gaap_NotesPayableToBanksMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LineOfCreditFacilityTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_NotesPayableToBanksMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LongTermDebtCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LineOfCreditFacilityTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLineItems" xlink:to="us-gaap_LongTermDebtNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember" xlink:label="us-gaap_RevolvingCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditAgreementMember" xlink:label="asth_AmendedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecuredOvernightFinancingRateMember" xlink:label="asth_SecuredOvernightFinancingRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember" xlink:label="us-gaap_LetterOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TruistBankMember" xlink:label="asth_TruistBankMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherExpenseMember" xlink:label="us-gaap_OtherExpenseMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" xlink:label="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanAMember" xlink:label="asth_TermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedAndRestatedCreditAgreementMember" xlink:label="asth_AmendedAndRestatedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember" xlink:label="us-gaap_BaseRateMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NewTermLoanMember" xlink:label="asth_NewTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PreferredBankMember" xlink:label="asth_PreferredBankMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AsOfLastDayEachFiscalQuarterThereafterMember" xlink:label="asth_AsOfLastDayEachFiscalQuarterThereafterMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DelayedDrawTermLoanMember" xlink:label="us-gaap_DelayedDrawTermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount" xlink:label="us-gaap_DebtInstrumentCarryingAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CreditAgreementMember" xlink:label="asth_CreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember" xlink:label="us-gaap_LineOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DelayedDrawTermLoanAMember" xlink:label="asth_DelayedDrawTermLoanAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubordinatedLoanAgreementMember" xlink:label="asth_SubordinatedLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TermLoanMember" xlink:label="asth_TermLoanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcBusinessLoanAgreementMember" xlink:label="asth_ApcBusinessLoanAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthPromissioryNoteMember" xlink:label="asth_IHealthPromissioryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ForYourBenefitPromissoryNoteMember" xlink:label="asth_ForYourBenefitPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditFacilityMember" xlink:label="asth_AmendedCreditFacilityMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:label="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LineOfCreditFacilityAmountFundedAtClosing" xlink:label="asth_LineOfCreditFacilityAmountFundedAtClosing"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" xlink:label="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentNumberOfKeyFinancialRatios" xlink:label="asth_DebtInstrumentNumberOfKeyFinancialRatios"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtCovenantAggregatePurchasePriceMaximum" xlink:label="asth_DebtCovenantAggregatePurchasePriceMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" xlink:label="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" xlink:label="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" xlink:label="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnamortizedDeferredFinancingCosts" xlink:label="asth_UnamortizedDeferredFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtFinancingExpense" xlink:label="asth_DebtFinancingExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationPeriod" xlink:label="us-gaap_LineOfCreditFacilityExpirationPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts" xlink:label="us-gaap_PaymentsOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" xlink:label="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansPayable" xlink:label="us-gaap_NotesAndLoansPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:label="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:label="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_RevolvingCreditFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="asth_SecuredOvernightFinancingRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LetterOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_TruistBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_OtherExpenseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedAndRestatedCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_BaseRateMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="asth_NewTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_PreferredBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="asth_AsOfLastDayEachFiscalQuarterThereafterMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_DelayedDrawTermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentCarryingAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_CreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_LineOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_DelayedDrawTermLoanAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_SubordinatedLoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_TermLoanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_ApcBusinessLoanAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_IHealthPromissioryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_ForYourBenefitPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditFacilityMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_LineOfCreditFacilityAmountFundedAtClosing" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_RepaymentsOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromRepaymentsOfBankOverdrafts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentNumberOfKeyFinancialRatios" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtCovenantAggregatePurchasePriceMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_UnamortizedDeferredFinancingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DeferredFinanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="25" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtFinancingExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="26" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="27" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="28" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="29" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_PaymentsOfFinancingCosts" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="30" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="31" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="32" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_NotesAndLoansPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="33" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="34" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="35" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloMedicalHoldingsIncMember" xlink:label="asth_ApolloMedicalHoldingsIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember" xlink:label="us-gaap_SeriesAPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockIssuedDuringPeriodSharesMerger" xlink:label="asth_StockIssuedDuringPeriodSharesMerger"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CDSCMember" xlink:label="asth_CDSCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesBPreferredStockMember" xlink:label="us-gaap_SeriesBPreferredStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CompanyAndAPCMember" xlink:label="asth_CompanyAndAPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares" xlink:label="us-gaap_TreasuryStockCommonShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired" xlink:label="us-gaap_TreasuryStockSharesAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepurchaseAgreementDate" xlink:label="us-gaap_RepurchaseAgreementDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DistributionOfShares" xlink:label="asth_DistributionOfShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionPayable" xlink:label="us-gaap_DistributionPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" xlink:label="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_ApolloMedicalHoldingsIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesAPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="asth_StockIssuedDuringPeriodSharesMerger" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_CDSCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_SeriesBPreferredStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_CompanyAndAPCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TreasuryStockCommonShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TreasuryStockSharesAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_RepurchaseAgreementDate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="asth_DistributionOfShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DistributionPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_StockAwardsAndUnitsMember" xlink:label="asth_StockAwardsAndUnitsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EsppMember" xlink:label="asth_EsppMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_StockAwardsAndUnitsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EsppMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApcStockOptionMember" xlink:label="asth_ApcStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PerformanceBasedRestrictedStockMember" xlink:label="asth_PerformanceBasedRestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EmployeeStockPurchasePlanMember" xlink:label="asth_EmployeeStockPurchasePlanMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" xlink:label="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentage" xlink:label="asth_CommonStockDiscountedPricePercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommonStockDiscountedPricePercentageMaximum" xlink:label="asth_CommonStockDiscountedPricePercentageMaximum"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="asth_ApcStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_PerformanceBasedRestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="asth_EmployeeStockPurchasePlanMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_CommonStockDiscountedPricePercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="asth_CommonStockDiscountedPricePercentageMaximum" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesLineItems" xlink:label="asth_CommitmentsAndContingenciesLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommitmentsAndContingenciesTable" xlink:label="asth_CommitmentsAndContingenciesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis" xlink:label="us-gaap_LineOfCreditFacilityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain" xlink:label="us-gaap_LineOfCreditFacilityLenderDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AmendedCreditAgreementMember" xlink:label="asth_AmendedCreditAgreementMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:label="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:label="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SuretyBondMember" xlink:label="us-gaap_SuretyBondMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:label="us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNatureDomain" xlink:label="us-gaap_LossContingencyNatureDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TruistBankMember" xlink:label="asth_TruistBankMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaHealthManagementIncMember" xlink:label="asth_AstranaHealthManagementIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityExpirationDate1" xlink:label="us-gaap_LineOfCreditFacilityExpirationDate1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="asth_CommitmentsAndContingenciesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LineOfCreditFacilityAxis" xlink:to="us-gaap_LineOfCreditFacilityLenderDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_AmendedCreditAgreementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LossContingencyNatureDomain" xlink:to="us-gaap_SuretyBondMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="us-gaap_LossContingencyNatureDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="asth_TruistBankMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AstranaHealthManagementIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCreditFacilityExpirationDate1" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_CommitmentsAndContingenciesLineItems" xlink:to="us-gaap_LineOfCredit" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LineOfCreditFacilityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_LossContingenciesByNatureOfContingencyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_CommitmentsAndContingenciesTable" xlink:to="us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCareOtherMember" xlink:label="us-gaap_HealthCareOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AHMCMember" xlink:label="asth_AHMCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProviderServicesMember" xlink:label="asth_ProviderServicesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdWayHealthIncMember" xlink:label="asth_ThirdWayHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrivateEquityFundsMember" xlink:label="us-gaap_PrivateEquityFundsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_OwnershipDomain" xlink:label="srt_OwnershipDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LmaMember" xlink:label="asth_LmaMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PmiocMember" xlink:label="asth_PmiocMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_OfficeLeaseMember" xlink:label="asth_OfficeLeaseMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ArroyoVistaMember" xlink:label="asth_ArroyoVistaMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SongPCMember" xlink:label="asth_SongPCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NetworkMedicalManagementMember" xlink:label="asth_NetworkMedicalManagementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" xlink:label="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SunnyVillageCareCenterMember" xlink:label="asth_SunnyVillageCareCenterMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProfessionalMedicalCorporationMember" xlink:label="asth_ProfessionalMedicalCorporationMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstCommonwealthPropertyLLCMember" xlink:label="asth_FirstCommonwealthPropertyLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyExpensesPayable" xlink:label="asth_RelatedPartyExpensesPayable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AstranaMedicalMember" xlink:label="asth_AstranaMedicalMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersMember" xlink:label="asth_BoardMembersMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BoardMembersWhoAreAlsoOfficersMember" xlink:label="asth_BoardMembersWhoAreAlsoOfficersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificHoldingsInvestmentManagementLLCMember" xlink:label="asth_AlliedPacificHoldingsInvestmentManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_PaymentsForRepurchaseOfCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCreditsAndOtherLiabilities" xlink:label="us-gaap_DeferredCreditsAndOtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="us-gaap_OperatingCostsAndExpenses"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_HealthCareOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AHMCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_ProviderServicesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_OwnershipDomain" xlink:to="asth_ThirdWayHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_PrivateEquityFundsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_LmaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_PmiocMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_OfficeLeaseMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_ArroyoVistaMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_SongPCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_NetworkMedicalManagementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_SunnyVillageCareCenterMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_ProfessionalMedicalCorporationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_FirstCommonwealthPropertyLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="asth_RelatedPartyExpensesPayable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AstranaMedicalMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_BoardMembersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_BoardMembersWhoAreAlsoOfficersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AlliedPacificHoldingsInvestmentManagementLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_OwnershipAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentsForRepurchaseOfCommonStock" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_DeferredCreditsAndOtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_OperatingCostsAndExpenses" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:label="us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueRecognizedMember" xlink:label="asth_RelatedPartyTransactionRevenueRecognizedMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AHMCMember" xlink:label="asth_AHMCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionExpensesIncurredMember" xlink:label="asth_RelatedPartyTransactionExpensesIncurredMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_HSMSOMember" xlink:label="asth_HSMSOMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_RelatedPartyTransactionRevenueExpenseNetMember" xlink:label="asth_RelatedPartyTransactionRevenueExpenseNetMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AurionMember" xlink:label="asth_AurionMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionAmountsOfTransaction" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionRevenueRecognizedMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AHMCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionExpensesIncurredMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_HSMSOMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="asth_RelatedPartyTransactionRevenueExpenseNetMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="asth_AurionMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareLineItems" xlink:label="asth_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareTable" xlink:label="asth_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AlliedPacificOfCaliforniaIPAMember" xlink:label="asth_AlliedPacificOfCaliforniaIPAMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember" xlink:label="us-gaap_PerformanceSharesMember"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="asth_EarningsPerShareLineItems" xlink:to="asth_EarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AlliedPacificOfCaliforniaIPAMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_EarningsPerShareTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_PerformanceSharesMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails">
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareLineItems" xlink:label="asth_EarningsPerShareLineItems"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_EarningsPerShareTable" xlink:label="asth_EarningsPerShareTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="asth_EarningsPerShareLineItems" xlink:to="asth_EarningsPerShareTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="asth_EarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="asth_EarningsPerShareLineItems" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityOwnershipPercentage" xlink:label="us-gaap_VariableInterestEntityOwnershipPercentage"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_VariableInterestEntityOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityLineItems" xlink:label="us-gaap_VariableInterestEntityLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:label="us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonrelatedPartyMember" xlink:label="us-gaap_NonrelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:label="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_ScheduleOfVariableInterestEntitiesTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_NonrelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_MarketableSecuritiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="asth_FiduciaryAccountsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AccountsReceivableNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_Goodwill" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_DividendsPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableInterestEntityLineItems" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherReceivablesNetCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquityMethodInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_TaxesPayableCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherLongTermInvestments" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_RestrictedCash" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrent" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" xlink:label="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseRenewalTerm" xlink:label="asth_LesseeOperatingAndFinanceLeaseRenewalTerm"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" xlink:label="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeFinanceLeaseRemainingLeaseTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="asth_LesseeOperatingAndFinanceLeaseRenewalTerm" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems" xlink:label="us-gaap_SegmentReportingInformationLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember" xlink:label="us-gaap_OperatingSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis" xlink:label="srt_ConsolidationItemsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain" xlink:label="srt_ConsolidationItemsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain" xlink:label="us-gaap_SegmentDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsAxis" xlink:label="us-gaap_SubsegmentsAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="us-gaap_SubsegmentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsegmentsDomain" xlink:label="us-gaap_SubsegmentsDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthCarePatientServiceMember" xlink:label="us-gaap_HealthCarePatientServiceMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CarePartnersMember" xlink:label="asth_CarePartnersMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntersegmentEliminationMember" xlink:label="us-gaap_IntersegmentEliminationMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductAndServiceOtherMember" xlink:label="us-gaap_ProductAndServiceOtherMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareDeliveryMember" xlink:label="asth_CareDeliveryMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember" xlink:label="us-gaap_CorporateNonSegmentMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CareEnablementMember" xlink:label="asth_CareEnablementMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember" xlink:label="us-gaap_AllOtherSegmentsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_OperatingSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidationItemsAxis" xlink:to="srt_ConsolidationItemsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_SegmentDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_StatementBusinessSegmentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsegmentsAxis" xlink:to="us-gaap_SubsegmentsDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsegmentsDomain" xlink:to="us-gaap_HealthCarePatientServiceMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CarePartnersMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_IntersegmentEliminationMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="srt_ConsolidationItemsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsegmentsDomain" xlink:to="us-gaap_ProductAndServiceOtherMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CareDeliveryMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidationItemsDomain" xlink:to="us-gaap_CorporateNonSegmentMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="us-gaap_SubsegmentsAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="asth_CareEnablementMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentDomain" xlink:to="us-gaap_AllOtherSegmentsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_CostsAndExpenses" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SegmentReportingInformationLineItems" xlink:to="us-gaap_OperatingIncomeLoss" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AAMGMember" xlink:label="asth_AAMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InterestRateCollarMember" xlink:label="asth_InterestRateCollarMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_VOMGMember" xlink:label="asth_VOMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthCallOptionMember" xlink:label="asth_IHealthCallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DmgMember" xlink:label="asth_DmgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloSunLabsManagementLLCMember" xlink:label="asth_ApolloSunLabsManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets" xlink:label="us-gaap_DerivativeAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ADSCMember" xlink:label="asth_ADSCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CFCMember" xlink:label="asth_CFCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PrimeCommunityCareMember" xlink:label="asth_PrimeCommunityCareMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMember" xlink:label="asth_CHSMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_AAMGMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_InterestRateCollarMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_VOMGMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_IHealthCallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_DmgMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_ApolloSunLabsManagementLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeAssets" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_ADSCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_CFCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_PrimeCommunityCareMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="asth_CHSMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeLiabilities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FinancialLiabilitiesFairValueDisclosure" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="srt_EquityMethodInvesteeNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DMGAndSunLabsMember" xlink:label="asth_DMGAndSunLabsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationByTypeAxis" xlink:label="us-gaap_ContingentConsiderationByTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContingentConsiderationTypeDomain" xlink:label="us-gaap_ContingentConsiderationTypeDomain_default"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesMember" xlink:label="us-gaap_OtherLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CertificatesOfDepositMember" xlink:label="us-gaap_CertificatesOfDepositMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis" xlink:label="us-gaap_DerivativeInstrumentRiskAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain" xlink:label="us-gaap_DerivativeContractTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CallOptionMember" xlink:label="us-gaap_CallOptionMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ApolloSunLabsManagementLLCMember" xlink:label="asth_ApolloSunLabsManagementLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" xlink:label="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InterestRateCollarMember" xlink:label="asth_InterestRateCollarMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023MetricMember" xlink:label="asth_A2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DmgMember" xlink:label="asth_DmgMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_VOMGMember" xlink:label="asth_VOMGMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_MarketableSecuritiesCurrentMaturityPeriod" xlink:label="asth_MarketableSecuritiesCurrentMaturityPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024TargetAndGrowthMetricsMember" xlink:label="asth_A2024TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IHealthIncMember" xlink:label="asth_IHealthIncMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AAMGMember" xlink:label="asth_AAMGMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023TargetAndGrowthMetricsMember" xlink:label="asth_A2023TargetAndGrowthMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_Met2023MetricMember" xlink:label="asth_Met2023MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CommunityFamilyCareMedicalGroupIPAInc.Member" xlink:label="asth_CommunityFamilyCareMedicalGroupIPAInc.Member"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NumberOfEquitySecuritiesSold" xlink:label="asth_NumberOfEquitySecuritiesSold"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2024MetricMember" xlink:label="asth_A2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CollaborativeHealthSystemsLLCMember" xlink:label="asth_CollaborativeHealthSystemsLLCMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_DerivativeCeilingInterestRate" xlink:label="asth_DerivativeCeilingInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_A2023And2024MetricMember" xlink:label="asth_A2023And2024MetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PCCCVMember" xlink:label="asth_PCCCVMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFloorInterestRate" xlink:label="us-gaap_DerivativeFloorInterestRate"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FirstMetricMember" xlink:label="asth_FirstMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:label="us-gaap_DerivativeFairValueOfDerivativeAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondMetricMember" xlink:label="asth_SecondMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ThirdMetricMember" xlink:label="asth_ThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:label="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondThirdFourthAndFifthMeasurementPeriodMember" xlink:label="asth_SecondThirdFourthAndFifthMeasurementPeriodMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" xlink:label="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" xlink:label="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SecondAndThirdMetricMember" xlink:label="asth_SecondAndThirdMetricMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ValueOfCallOption" xlink:label="asth_ValueOfCallOption"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_DMGAndSunLabsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ContingentConsiderationByTypeAxis" xlink:to="us-gaap_ContingentConsiderationTypeDomain_default" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherLiabilitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CertificatesOfDepositMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DerivativeInstrumentRiskAxis" xlink:to="us-gaap_DerivativeContractTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="us-gaap_CallOptionMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_ApolloSunLabsManagementLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DerivativeContractTypeDomain" xlink:to="asth_InterestRateCollarMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="srt_EquityMethodInvesteeNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023MetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_DmgMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_VOMGMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_MarketableSecuritiesCurrentMaturityPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2024TargetAndGrowthMetricsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_DerivativeInstrumentRiskAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_EquityMethodInvesteeNameDomain" xlink:to="asth_IHealthIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AAMGMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023TargetAndGrowthMetricsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquitySecuritiesFvNi" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_Met2023MetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_NumberOfEquitySecuritiesSold" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2024MetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_CollaborativeHealthSystemsLLCMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_DerivativeCeilingInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_A2023And2024MetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_ContingentConsiderationByTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_PCCCVMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeFloorInterestRate" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_FirstMetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_DerivativeFairValueOfDerivativeAsset" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondMetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_ThirdMetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondThirdFourthAndFifthMeasurementPeriodMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSMemberEnrollmentMetricsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ContingentConsiderationTypeDomain" xlink:to="asth_SecondAndThirdMetricMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="asth_ValueOfCallOption" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SeniorSecuredPromissoryNoteMember" xlink:label="asth_SeniorSecuredPromissoryNoteMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="us-gaap_SubsequentEventTypeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BassMedicalGroupMember" xlink:label="asth_BassMedicalGroupMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_AdvancedDiagnosticAndSurgicalCenterIncMember" xlink:label="asth_AdvancedDiagnosticAndSurgicalCenterIncMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventTable" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="asth_SeniorSecuredPromissoryNoteMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="asth_BassMedicalGroupMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsequentEventTypeDomain" xlink:to="us-gaap_SubsequentEventMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTypeAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_BusinessAcquisitionAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" priority="2" use="optional"/>
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/srt/role/srt-eedm/ExtensibleEnumerationLists">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember"/>
          <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefExecutiveOfficerMember" priority="2" use="optional"/>
          <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_ChiefFinancialOfficerMember" priority="2" use="optional"/>
        </link:definitionLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquity" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesNoncurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IncomeTaxesReceivable" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_MinorityInterest" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DividendsPayableCurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LongTermDebtNoncurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_Goodwill" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_NotesAndLoansReceivableNetNoncurrent" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_EquityMethodInvestments" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="asth_FiduciaryAccountsPayableCurrent" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" order="7" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent" order="8" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="8" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" order="9" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:label="us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" xlink:label="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_LongTermDebtNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:label="us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" xlink:label="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="1" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_ProfitLoss" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InterestExpenseNonoperating" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_UnrealizedGainLossOnInvestments" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense" order="5" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="us-gaap_InterestExpenseNonoperating"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrealizedGainLossOnInvestments" xlink:label="us-gaap_UnrealizedGainLossOnInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest" order="0" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_UnrealizedGainLossFromInvestmentInEquitySecurities" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfOtherLongTermDebt" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromPaymentsToMinorityShareholders" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromLoansReceivable" order="2" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_ProceedsPaymentsFromOtherOperatingActivities" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="3" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_ChangeInFairValueOfContingentConsiderationLiabilities" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" order="4" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts" order="5" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable" order="9" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" order="10" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" order="10" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" order="11" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables" order="12" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="13" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" order="14" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" order="15" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="15" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_AmortizationOfFinancingCosts" order="16" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="16" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccountsPayable" order="17" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" order="18" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_IncreaseDecreaseInMedicalLiabilities" order="19" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties" order="20" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DepreciationDepletionAndAmortization" order="21" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="23" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_DeferredIncomeTaxesAndTaxCredits" order="24" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="25" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="26" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="27" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="asth_NoncashLeaseExpense" order="28" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt" order="29" weight="-1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_UnrealizedGainLossFromInvestmentInEquitySecurities" xlink:label="asth_UnrealizedGainLossFromInvestmentInEquitySecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfOtherLongTermDebt" xlink:label="us-gaap_RepaymentsOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" xlink:label="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsToMinorityShareholders" xlink:label="us-gaap_ProceedsFromPaymentsToMinorityShareholders"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromLoansReceivable" xlink:label="us-gaap_PaymentsForProceedsFromLoansReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ProceedsPaymentsFromOtherOperatingActivities" xlink:label="asth_ProceedsPaymentsFromOtherOperatingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_ChangeInFairValueOfContingentConsiderationLiabilities" xlink:label="asth_ChangeInFairValueOfContingentConsiderationLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:label="us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" xlink:label="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:label="us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" xlink:label="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="us-gaap_IncreaseDecreaseInIncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInOtherAccountsPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_IncreaseDecreaseInMedicalLiabilities" xlink:label="asth_IncreaseDecreaseInMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:label="us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_NoncashLeaseExpense" xlink:label="asth_NoncashLeaseExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" order="1" weight="-1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="asth_PaymentsToAcquireBusinessCashPayable" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" order="7" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" order="10" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="us-gaap_Goodwill" order="11" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" xlink:label="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_PaymentsToAcquireBusinessCashPayable" xlink:label="asth_PaymentsToAcquireBusinessCashPayable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" xlink:label="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" order="5" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" xlink:label="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="asth_SpecialtyCapitationPayableCurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="asth_SubcontractorIPAPayable" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_RelatedPartyDepositLiabilities" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="6" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="7" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SpecialtyCapitationPayableCurrent" xlink:label="asth_SpecialtyCapitationPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_SubcontractorIPAPayable" xlink:label="asth_SubcontractorIPAPayable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RelatedPartyDepositLiabilities" xlink:label="us-gaap_RelatedPartyDepositLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" order="2" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:label="us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" xlink:label="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:label="us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LineOfCredit" xlink:to="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" order="5" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit" xlink:label="us-gaap_LineOfCredit"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" xlink:label="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" order="2" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares" xlink:label="us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesNoncurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_MarketableSecuritiesCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="asth_FiduciaryAccountsPayableCurrent" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxLiabilitiesNet" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_Goodwill" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" order="2" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_IncomeTaxesReceivableNoncurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_IncomeTaxesReceivable" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_DividendsPayableCurrent" order="3" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_EquityMethodInvestments" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherReceivablesNetCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_TaxesPayableCurrent" order="4" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OtherLongTermInvestments" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedIncomeTaxesNoncurrent" order="5" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="6" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_RestrictedCash" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="7" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="8" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilities" order="9" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="10" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsNoncurrent" xlink:label="us-gaap_AssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent" xlink:label="us-gaap_MarketableSecuritiesCurrent"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FiduciaryAccountsPayableCurrent" xlink:label="asth_FiduciaryAccountsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:label="us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:label="us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivableNoncurrent" xlink:label="us-gaap_IncomeTaxesReceivableNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable" xlink:label="us-gaap_IncomeTaxesReceivable"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrent" xlink:label="us-gaap_DividendsPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherReceivablesNetCurrent" xlink:label="us-gaap_OtherReceivablesNetCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLongTermInvestments" xlink:label="us-gaap_OtherLongTermInvestments"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesNoncurrent" xlink:label="us-gaap_AccruedIncomeTaxesNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue" xlink:label="us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseRightOfUseAssetAmortization" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_FinanceLeaseInterestExpense" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_SubleaseIncome" order="3" weight="-1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:label="us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense" xlink:label="us-gaap_FinanceLeaseInterestExpense"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome" xlink:label="us-gaap_SubleaseIncome"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="3" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="4" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="asth_FinanceLeaseLiabilityToBePaidAfterYearFour" order="5" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" order="5" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:label="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="us-gaap_FinanceLeaseLiability" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_CostsAndExpenses" order="0" weight="-1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses" xlink:to="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" order="1" weight="1" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:label="us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" xlink:label="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization"/>
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails">
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" order="0" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_DerivativeLiabilities" order="0" weight="1" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" order="1" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_EquitySecuritiesFvNi" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" order="2" weight="1.0" use="optional"/>
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_DerivativeAssets" order="3" weight="1.0" use="optional"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:label="us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesFvNi" xlink:label="us-gaap_EquitySecuritiesFvNi"/>
          <link:loc xlink:type="locator" xlink:href="asth-20250331.xsd#asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" xlink:label="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeAssets" xlink:label="us-gaap_DerivativeAssets"/>
        </link:calculationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="asth_RestructuringSpinoffTransactionNumberOfMembershipUnits" name="RestructuringSpinoffTransactionNumberOfMembershipUnits" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_NoncashLeaseExpense" name="NoncashLeaseExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_A2024TargetAndGrowthMetricsMember" name="A2024TargetAndGrowthMetricsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_OfficeLeaseMember" name="OfficeLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TruistBankMember" name="TruistBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CareDeliveryMember" name="CareDeliveryMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AccountsReceivableAndNetRevenueLineItems" name="AccountsReceivableAndNetRevenueLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CommitmentsAndContingenciesLineItems" name="CommitmentsAndContingenciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EstimatedWorkingCapitalAdjustments" name="EstimatedWorkingCapitalAdjustments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_MedicaidMember" name="MedicaidMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_HSMSOMember" name="HSMSOMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_IHealthIncMember" name="IHealthIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" name="ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_MezzanineEquityAbstract" name="MezzanineEquityAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_RelatedPartyExpensesPayable" name="RelatedPartyExpensesPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" name="InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent" name="BusinessCombinationEquityInterestPurchaseObligationNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_EquityMethodInvestmentsContribution" name="EquityMethodInvestmentsContribution" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_DebtInstrumentCovenantLeverageRatioIncrementalChange" name="DebtInstrumentCovenantLeverageRatioIncrementalChange" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_DrawOnLetterOfCreditThroughRevolverLoan" name="DrawOnLetterOfCreditThroughRevolverLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_PayorAMember" name="PayorAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_RelatedPartyTransactionRevenueExpenseNetMember" name="RelatedPartyTransactionRevenueExpenseNetMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_RelatedPartyTransactionRevenueRecognizedMember" name="RelatedPartyTransactionRevenueRecognizedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PerformanceBasedRestrictedStockMember" name="PerformanceBasedRestrictedStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PreferredBankMember" name="PreferredBankMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CashPaidForLeaseLiabilitiesAbstractAbstract" name="CashPaidForLeaseLiabilitiesAbstractAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_FinanceLeaseLiabilityToBePaidAfterYearFour" name="FinanceLeaseLiabilityToBePaidAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities" name="PaymentForRepurchaseOfTreasuryStockFinancingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_StockIssuedDuringPeriodSharesMerger" name="StockIssuedDuringPeriodSharesMerger" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_CAIPAMSOLLCMember" name="CAIPAMSOLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_FirstMetricMember" name="FirstMetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AccountsReceivableAndNetRevenueTable" name="AccountsReceivableAndNetRevenueTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_UnamortizedDeferredFinancingCosts" name="UnamortizedDeferredFinancingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_EquityMethodAndOtherEquityInvestmentsTextBlock" name="EquityMethodAndOtherEquityInvestmentsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_ContingentConsideration" name="ContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_DebtFinancingExpense" name="DebtFinancingExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller" name="BusinessCombinationConsiderationPurchasePriceDueToFromSeller" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_AcquisitionOfNonControllingInterestShares" name="AcquisitionOfNonControllingInterestShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_CFCMember" name="CFCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_RestructuringSpinoffTransactionPercentage" name="RestructuringSpinoffTransactionPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" name="CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DmgMember" name="DmgMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PayorEMember" name="PayorEMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TaxesAssociatedWithExcludedAssetsSpinOffMember" name="TaxesAssociatedWithExcludedAssetsSpinOffMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_IntraCareConvertiblePromissoryNoteReceivableMember" name="IntraCareConvertiblePromissoryNoteReceivableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AsOfLastDayEachFiscalQuarterThereafterMember" name="AsOfLastDayEachFiscalQuarterThereafterMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_MezzanineMember" name="MezzanineMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" name="BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_LmaMember" name="LmaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AccountsPayableAndAccruedExpensesMember" name="AccountsPayableAndAccruedExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ForYourBenefitPromissoryNoteMember" name="ForYourBenefitPromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SecondMetricMember" name="SecondMetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" name="NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_ApcBusinessLoanAgreementMember" name="ApcBusinessLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CommunityFamilyCareMedicalGroupIPAInc.Member" name="CommunityFamilyCareMedicalGroupIPAInc.Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DebtInstrumentNumberOfKeyFinancialRatios" name="DebtInstrumentNumberOfKeyFinancialRatios" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_TermLoanAMember" name="TermLoanAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EquityMethodInvestmentsRollForward" name="EquityMethodInvestmentsRollForward" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_SecuredOvernightFinancingRateMember" name="SecuredOvernightFinancingRateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_Met2023MetricMember" name="Met2023MetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TemporaryEquityTransferOfCommonControlEntities" name="TemporaryEquityTransferOfCommonControlEntities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_DistributionOfShares" name="DistributionOfShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_A2023And2024MetricMember" name="A2023And2024MetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CommercialMember" name="CommercialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_A2023MetricMember" name="A2023MetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_VOMGMember" name="VOMGMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ApolloSunLabsManagementLLCMember" name="ApolloSunLabsManagementLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PmiocMember" name="PmiocMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SpecialtyCapitationPayableCurrent" name="SpecialtyCapitationPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ADSCMember" name="ADSCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AirlineCompleteHealthcareOfTexasLtdMember" name="AirlineCompleteHealthcareOfTexasLtdMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PayorBMember" name="PayorBMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NonCashDividendPaidInFormOfStock" name="NonCashDividendPaidInFormOfStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_AstranaMedicalMember" name="AstranaMedicalMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" name="GeneralAndAdministrativeExpensesAndDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_AstranaHealthManagementIncMember" name="AstranaHealthManagementIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EmployeeStockPurchasePlanMember" name="EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CHSMemberEnrollmentMetricsMember" name="CHSMemberEnrollmentMetricsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_A2023TargetAndGrowthMetricsMember" name="A2023TargetAndGrowthMetricsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AmendedCreditFacilityMember" name="AmendedCreditFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ApolloMedicalHoldingsIncMember" name="ApolloMedicalHoldingsIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" name="ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_IncreaseDecreaseInMedicalLiabilities" name="IncreaseDecreaseInMedicalLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_SunnyVillageCareCenterMember" name="SunnyVillageCareCenterMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CarePartnersMember" name="CarePartnersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LeaseWeightedAverageDiscountRateAbstract" name="LeaseWeightedAverageDiscountRateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PayorDMember" name="PayorDMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SharesIssuedForVestingOfRestrictedStockAwards" name="SharesIssuedForVestingOfRestrictedStockAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_NewTermLoanMember" name="NewTermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_MarketableSecuritiesCurrentMaturityPeriod" name="MarketableSecuritiesCurrentMaturityPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_FiveThreeOneW.CollegeLLCMember" name="FiveThreeOneW.CollegeLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AlliedPacificHoldingsInvestmentManagementLLCMember" name="AlliedPacificHoldingsInvestmentManagementLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LasalleMedicalAssociatesIpaMember" name="LasalleMedicalAssociatesIpaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum" name="DebtInstrumentCovenantLeverageRatioAdjustedMaximum" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_InterestRateCollarMember" name="InterestRateCollarMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BoardMembersMember" name="BoardMembersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember" name="EmployeeStockOptionAndEmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_FinanceLeaseCostsAbstract" name="FinanceLeaseCostsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" name="BusinessAcquisitionInAccountsPayableAndAccruedLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_CHSMember" name="CHSMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DebtInstrumentIncreaseInOriginalPrincipalAmount" name="DebtInstrumentIncreaseInOriginalPrincipalAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BassMedicalGroupMember" name="BassMedicalGroupMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TaxImpactFromDividends" name="TaxImpactFromDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_CreditAgreementMember" name="CreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ProceedsPaymentsFromOtherOperatingActivities" name="ProceedsPaymentsFromOtherOperatingActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_LeaseWeightedAverageRemainingLeaseTermAbstract" name="LeaseWeightedAverageRemainingLeaseTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PatientManagementPlatformMember" name="PatientManagementPlatformMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CareEnablementMember" name="CareEnablementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" name="NoncontrollingInterestIncreaseDecreaseFromBusinessCombination" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_AmendedCreditAgreementMember" name="AmendedCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DebtInstrumentCovenantLeverageRatioMaximum" name="DebtInstrumentCovenantLeverageRatioMaximum" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_EquityMethodInvestmentAdditionalInvestment" name="EquityMethodInvestmentAdditionalInvestment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_TotalAcquisitionsMember" name="TotalAcquisitionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_A2024MetricMember" name="A2024MetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AHMCMember" name="AHMCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LineOfCreditFacilityAmountFundedAtClosing" name="LineOfCreditFacilityAmountFundedAtClosing" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" name="NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_AurionMember" name="AurionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_PrimeCommunityCareMember" name="PrimeCommunityCareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ApcStockOptionMember" name="ApcStockOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EarningsPerShareTable" name="EarningsPerShareTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" name="AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EarningsPerShareLineItems" name="EarningsPerShareLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" name="BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_IHealthCallOptionMember" name="IHealthCallOptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TermLoanMember" name="TermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DelayedDrawTermLoanAMember" name="DelayedDrawTermLoanAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SongPCMember" name="SongPCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_AAMGMember" name="AAMGMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_IHealthPromissioryNoteMember" name="IHealthPromissioryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SecondAndThirdMetricMember" name="SecondAndThirdMetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DMGAndSunLabsMember" name="DMGAndSunLabsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PayorCMember" name="PayorCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ThirdMetricMember" name="ThirdMetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_RelatedPartyTransactionExpensesIncurredMember" name="RelatedPartyTransactionExpensesIncurredMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_MedicareMember" name="MedicareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TemporaryEquityTaxImpactFromDividends" name="TemporaryEquityTaxImpactFromDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_AlliedPacificOfCaliforniaIPAMember" name="AlliedPacificOfCaliforniaIPAMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DwgasConvertiblePromissoryNoteReceivableMember" name="DwgasConvertiblePromissoryNoteReceivableMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PayorFMember" name="PayorFMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ProfessionalMedicalCorporationMember" name="ProfessionalMedicalCorporationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_SeniorSecuredPromissoryNoteMember" name="SeniorSecuredPromissoryNoteMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NetworkRelationshipsMember" name="NetworkRelationshipsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CommonStockDiscountedPricePercentageMaximum" name="CommonStockDiscountedPricePercentageMaximum" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_LesseeOperatingAndFinanceLeasesTextBlock" name="LesseeOperatingAndFinanceLeasesTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_ProviderServicesMember" name="ProviderServicesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_HealthCareCapitationRevenueMember" name="HealthCareCapitationRevenueMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_UnrealizedGainLossFromInvestmentInEquitySecurities" name="UnrealizedGainLossFromInvestmentInEquitySecurities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" name="ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" name="PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_ConsiderationOfAcquisitionInCashFunded" name="ConsiderationOfAcquisitionInCashFunded" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" name="LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" name="CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_OtherAcquisitionsMember" name="OtherAcquisitionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_StockAwardsAndUnitsMember" name="StockAwardsAndUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_SubordinatedLoanAgreementMember" name="SubordinatedLoanAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CommonStockDiscountedPricePercentage" name="CommonStockDiscountedPricePercentage" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_MemberRelationshipsMember" name="MemberRelationshipsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TotalPurchaseConsiderationAbstract" name="TotalPurchaseConsiderationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NetworkMedicalManagementMember" name="NetworkMedicalManagementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PrimeCommunityCareOfCentralValleyIncMember" name="PrimeCommunityCareOfCentralValleyIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_EsppMember" name="EsppMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CDSCMember" name="CDSCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PCCCVMember" name="PCCCVMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" name="FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" name="IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_CompanyAndAPCMember" name="CompanyAndAPCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DerivativeCeilingInterestRate" name="DerivativeCeilingInterestRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_OneMSOLLCMember" name="OneMSOLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_CollaborativeHealthSystemsLLCMember" name="CollaborativeHealthSystemsLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_NumberOfEquitySecuritiesSold" name="NumberOfEquitySecuritiesSold" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" name="NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_AdvancedHealthManagementSystemsLPMember" name="AdvancedHealthManagementSystemsLPMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_BoardMembersWhoAreAlsoOfficersMember" name="BoardMembersWhoAreAlsoOfficersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" name="LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_LesseeOperatingAndFinanceLeaseRenewalTerm" name="LesseeOperatingAndFinanceLeaseRenewalTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_Rule10B51ArrModifiedFlag" name="Rule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_DebtCovenantAggregatePurchasePriceMaximum" name="DebtCovenantAggregatePurchasePriceMaximum" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_LoanReceivableTextBlock" name="LoanReceivableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_OtherThirdPartiesMember" name="OtherThirdPartiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" name="LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ValueOfCallOption" name="ValueOfCallOption" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_ThirdWayHealthIncMember" name="ThirdWayHealthIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" name="RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_AdvancedDiagnosticAndSurgicalCenterIncMember" name="AdvancedDiagnosticAndSurgicalCenterIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ChangeInFairValueOfContingentConsiderationLiabilities" name="ChangeInFairValueOfContingentConsiderationLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="asth_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PaymentsToAcquireBusinessCashPayable" name="PaymentsToAcquireBusinessCashPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_SubcontractorIPAPayable" name="SubcontractorIPAPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_SecondThirdFourthAndFifthMeasurementPeriodMember" name="SecondThirdFourthAndFifthMeasurementPeriodMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" name="TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ArroyoVistaMember" name="ArroyoVistaMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NumberOfMedicareMembers" name="NumberOfMedicareMembers" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="asth_FirstCommonwealthPropertyLLCMember" name="FirstCommonwealthPropertyLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_PacificMedicalImagingAndOncologyCenterIncMember" name="PacificMedicalImagingAndOncologyCenterIncMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_DebtInstrumentCovenantInterestCoverageRatioMinimum" name="DebtInstrumentCovenantInterestCoverageRatioMinimum" type="xbrli:pureItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_ReplacementOfRestrictedStockAwards" name="ReplacementOfRestrictedStockAwards" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_FiduciaryAccountsPayableCurrent" name="FiduciaryAccountsPayableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_CommitmentsAndContingenciesTable" name="CommitmentsAndContingenciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_NonRule10B51ArrModifiedFlag" name="NonRule10B51ArrModifiedFlag" type="xbrli:booleanItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics" name="NumberOfOperatingSegmentsThatShareSimilarCharacteristics" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="asth_AmendedAndRestatedCreditAgreementMember" name="AmendedAndRestatedCreditAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="asth_ManagementContractsMember" name="ManagementContractsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 05, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Astrana Health, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ASTH<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,061,712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 258,517<span></span>
</td>
<td class="nump">$ 288,455<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,802<span></span>
</td>
<td class="nump">19,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,919<span></span>
</td>
<td class="nump">29,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,711<span></span>
</td>
<td class="nump">22,861<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">613,270<span></span>
</td>
<td class="nump">638,496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,849<span></span>
</td>
<td class="nump">14,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">111,916<span></span>
</td>
<td class="nump">118,179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">416,386<span></span>
</td>
<td class="nump">419,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">48,134<span></span>
</td>
<td class="nump">51,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,005<span></span>
</td>
<td class="nump">39,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,896<span></span>
</td>
<td class="nump">8,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">647<span></span>
</td>
<td class="nump">646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,698<span></span>
</td>
<td class="nump">32,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,512<span></span>
</td>
<td class="nump">16,021<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">717,986<span></span>
</td>
<td class="nump">716,398<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,331,256<span></span>
</td>
<td class="nump">1,354,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,559<span></span>
</td>
<td class="nump">106,142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">8,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">204,101<span></span>
</td>
<td class="nump">209,039<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">471<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,500<span></span>
</td>
<td class="nump">9,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,180<span></span>
</td>
<td class="nump">26,287<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">361,268<span></span>
</td>
<td class="nump">365,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,197<span></span>
</td>
<td class="nump">4,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">543<span></span>
</td>
<td class="nump">607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,963<span></span>
</td>
<td class="nump">30,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion and deferred financing costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">403,894<span></span>
</td>
<td class="nump">425,299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,685<span></span>
</td>
<td class="nump">14,003<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">452,282<span></span>
</td>
<td class="nump">475,118<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">813,550<span></span>
</td>
<td class="nump">840,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MezzanineEquityAbstract', window );"><strong>Mezzanine deficit</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends', window );">Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation ("APC")</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(232,733)<span></span>
</td>
<td class="num">(202,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value per share; 100,000,000 shares authorized, 49,028,624 and 47,929,872 shares issued and outstanding, excluding 9,903,953 and 10,603,849 treasury shares, as of March 31,2025 and December 31, 2024, respectively</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">452,439<span></span>
</td>
<td class="nump">426,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">292,880<span></span>
</td>
<td class="nump">286,283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">745,368<span></span>
</td>
<td class="nump">712,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,071<span></span>
</td>
<td class="nump">4,006<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">750,439<span></span>
</td>
<td class="nump">716,726<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine deficit, and stockholders' equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,331,256<span></span>
</td>
<td class="nump">1,354,894<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241,078<span></span>
</td>
<td class="nump">225,733<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 56,846<span></span>
</td>
<td class="nump">$ 50,257<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">212.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively. These VIE balances do not include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of March 31, 2025, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of December 31, 2024, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further details.</span><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of Investment in privately held entity that does not report net asset value per share .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MezzanineEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MezzanineEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Net of Dividends</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,028,624<span></span>
</td>
<td class="nump">47,929,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,028,624<span></span>
</td>
<td class="nump">47,929,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,903,953<span></span>
</td>
<td class="nump">10,603,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 1,331,256<span></span>
</td>
<td class="nump">$ 1,354,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">813,550<span></span>
</td>
<td class="nump">840,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">678,100<span></span>
</td>
<td class="nump">712,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">212,100<span></span>
</td>
<td class="nump">207,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">190,200<span></span>
</td>
<td class="nump">224,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Amount due to affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="nump">$ 48,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">212.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively. These VIE balances do not include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of March 31, 2025, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of December 31, 2024, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further details.</span><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 620,390<span></span>
</td>
<td class="nump">$ 404,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services, excluding depreciation and amortization</a></td>
<td class="nump">549,061<span></span>
</td>
<td class="nump">330,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="nump">43,897<span></span>
</td>
<td class="nump">38,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,849<span></span>
</td>
<td class="nump">5,096<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">599,807<span></span>
</td>
<td class="nump">374,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">20,583<span></span>
</td>
<td class="nump">30,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Loss) income from equity method investments</a></td>
<td class="num">(867)<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(7,308)<span></span>
</td>
<td class="num">(7,585)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,312<span></span>
</td>
<td class="nump">3,996<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized (loss) gain on investments</a></td>
<td class="num">(44)<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other loss</a></td>
<td class="num">(5,072)<span></span>
</td>
<td class="num">(4,277)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(10,979)<span></span>
</td>
<td class="num">(6,135)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">9,604<span></span>
</td>
<td class="nump">24,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">3,383<span></span>
</td>
<td class="nump">7,142<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">6,221<span></span>
</td>
<td class="nump">16,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net (loss) income attributable to non-controlling interest</a></td>
<td class="num">(471)<span></span>
</td>
<td class="nump">2,027<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Astrana Health, Inc.</a></td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 14,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember', window );">Capitation, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 583,963<span></span>
</td>
<td class="nump">$ 365,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">14,491<span></span>
</td>
<td class="nump">17,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,310<span></span>
</td>
<td class="nump">4,078<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Fee-for-service, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">14,890<span></span>
</td>
<td class="nump">15,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,736<span></span>
</td>
<td class="nump">$ 1,054<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=asth_HealthCareCapitationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock&#160;Outstanding</div></th>
<th class="th"><div>Additional Paid-in&#160; Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Non-controlling Interest</div></th>
<th class="th">
<div>Non-controlling Interest </div>
<div>Mezzanine</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (205,883)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205,557)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,843,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 616,651<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 371,037<span></span>
</td>
<td class="nump">$ 243,134<span></span>
</td>
<td class="nump">$ 2,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net income</a></td>
<td class="nump">16,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,835<span></span>
</td>
<td class="nump">1,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of non-controlling interest</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SharesIssuedForVestingOfRestrictedStockAwards', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(2,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">5,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of shares for business acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of shares for business acquisition</a></td>
<td class="nump">21,952<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">21,951<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AcquisitionOfNonControllingInterestShares', window );">Acquisition of non-controlling interest (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,340)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination', window );">Acquisition of non-controlling interest</a></td>
<td class="num">(535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,458,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2024</a></td>
<td class="nump">$ 657,975<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">395,473<span></span>
</td>
<td class="nump">257,969<span></span>
</td>
<td class="nump">4,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, beginning balance at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202,558)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,564)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Temporary Equity, Repurchase of subsidiary's shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionOfDividends', window );">Temporary Equity, Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27,295)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, carrying amount, ending balance at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (232,733)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="nump">47,929,872<span></span>
</td>
<td class="nump">47,929,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2024</a></td>
<td class="nump">$ 716,726<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">426,389<span></span>
</td>
<td class="nump">286,283<span></span>
</td>
<td class="nump">4,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity', window );">Net income</a></td>
<td class="nump">7,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,692<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of non-controlling interest</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Shares issued for vesting of restricted stock awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SharesIssuedForVestingOfRestrictedStockAwards', window );">Shares issued for vesting of restricted stock awards</a></td>
<td class="num">(4,052)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(4,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 7,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of shares for Employee Stock Purchase Plan ("ESPP") (in shares)</a></td>
<td class="nump">10,683<span></span>
</td>
<td class="nump">10,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of shares for Employee Stock Purchase Plan ("ESPP")</a></td>
<td class="nump">$ 301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares', window );">Dividends (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">699,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares', window );">Dividends</a></td>
<td class="nump">$ 21,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,935<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="nump">49,028,624<span></span>
</td>
<td class="nump">49,028,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 750,439<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 452,439<span></span>
</td>
<td class="nump">$ 292,880<span></span>
</td>
<td class="nump">$ 5,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_AcquisitionOfNonControllingInterestShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition of Non-Controlling Interest, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_AcquisitionOfNonControllingInterestShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) from Business Combination</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SharesIssuedForVestingOfRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issued for vesting of restricted stock awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SharesIssuedForVestingOfRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity during the period due to unpaid dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 6,221<span></span>
</td>
<td class="nump">$ 16,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">6,849<span></span>
</td>
<td class="nump">5,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">691<span></span>
</td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">7,811<span></span>
</td>
<td class="nump">5,748<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ChangeInFairValueOfContingentConsiderationLiabilities', window );">Change in fair value of contingent consideration liabilities</a></td>
<td class="nump">1,407<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="nump">375<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_UnrealizedGainLossFromInvestmentInEquitySecurities', window );">Unrealized loss (gain) on investments</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(1,099)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Loss (income) from equity method investments</a></td>
<td class="nump">867<span></span>
</td>
<td class="num">(632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred tax</a></td>
<td class="num">(358)<span></span>
</td>
<td class="num">(7,248)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ProceedsPaymentsFromOtherOperatingActivities', window );">Other</a></td>
<td class="num">(557)<span></span>
</td>
<td class="nump">6,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of business combinations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Receivables, net</a></td>
<td class="num">(10,368)<span></span>
</td>
<td class="num">(26,128)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Receivables, net - related parties</a></td>
<td class="num">(6,589)<span></span>
</td>
<td class="num">(3,374)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">3,688<span></span>
</td>
<td class="num">(1,403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,674<span></span>
</td>
<td class="num">(4,255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(314)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable', window );">Fiduciary accounts payable</a></td>
<td class="num">(3,383)<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_IncreaseDecreaseInMedicalLiabilities', window );">Medical liabilities</a></td>
<td class="nump">3,319<span></span>
</td>
<td class="num">(808)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">3,514<span></span>
</td>
<td class="nump">14,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(1,090)<span></span>
</td>
<td class="num">(3,083)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">16,627<span></span>
</td>
<td class="nump">5,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments for business acquisition, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(50,649)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties', window );">Proceeds from repayment of promissory notes, including those with related parties</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromLoansReceivable', window );">Issuance of loan receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(20,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,070)<span></span>
</td>
<td class="num">(369)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distribution from investment - equity method</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(2,394)<span></span>
</td>
<td class="num">(71,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(5,455)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt', window );">Borrowings on long-term debt</a></td>
<td class="nump">412,000<span></span>
</td>
<td class="nump">110,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(428,232)<span></span>
</td>
<td class="num">(3,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payment of finance lease obligations</a></td>
<td class="num">(147)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Deferred financing cost</a></td>
<td class="num">(17,241)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from ESPP purchases</a></td>
<td class="nump">301<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid from net share settlement of restricted stock</a></td>
<td class="num">(4,052)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities', window );">Repurchase of subsidiary's shares</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders', window );">Proceeds from sale of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Purchase of non-controlling interest</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(44,170)<span></span>
</td>
<td class="nump">106,351<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(29,937)<span></span>
</td>
<td class="nump">41,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">289,101<span></span>
</td>
<td class="nump">294,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">259,164<span></span>
</td>
<td class="nump">335,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">4,338<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">7,360<span></span>
</td>
<td class="nump">6,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities', window );">Business acquisition in accounts payable and accrued liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">63,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">5,729<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Common stock issued in business combination</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,952<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities', window );">Purchase of investments - equity method in accounts payable and accrued liabilities and other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DrawOnLetterOfCreditThroughRevolverLoan', window );">Draw on letter of credit through Revolver Loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NonCashDividendPaidInFormOfStock', window );">Dividend paid in the form of common stock</a></td>
<td class="nump">21,935<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">258,517<span></span>
</td>
<td class="nump">334,796<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">647<span></span>
</td>
<td class="nump">645<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash shown in the statement of cash flows</a></td>
<td class="nump">$ 259,164<span></span>
</td>
<td class="nump">$ 335,441<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition in accounts payable and accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ChangeInFairValueOfContingentConsiderationLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value of contingent consideration liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ChangeInFairValueOfContingentConsiderationLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DrawOnLetterOfCreditThroughRevolverLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Draw On Letter Of Credit Through Revolver Loan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DrawOnLetterOfCreditThroughRevolverLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_IncreaseDecreaseInMedicalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_IncreaseDecreaseInMedicalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NonCashDividendPaidInFormOfStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non cash dividend paid in form of stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NonCashDividendPaidInFormOfStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment For Repurchase Of Treasury Stock, Financing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from repayment of promissory notes including related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ProceedsPaymentsFromOtherOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds (payments) from other operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ProceedsPaymentsFromOtherOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of investments equity method in accounts payable and accrued liabilities and other liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation Of Cash Cash Equivalents And Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_UnrealizedGainLossFromInvestmentInEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized (Gain) Loss from Investment in Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_UnrealizedGainLossFromInvestmentInEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInIncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInIncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478600/954-210-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 6,692<span></span>
</td>
<td class="nump">$ 14,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_Rule10B51ArrModifiedFlag', window );">Rule 10b5-1 Arr Modified Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NonRule10B51ArrModifiedFlag', window );">Non Rule 10b5-1 Arr Modified Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NonRule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Rule 10b5-1 Arr Modified Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NonRule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_Rule10B51ArrModifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rule 10b5-1 Arr Modified Flag</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_Rule10B51ArrModifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Description of Business</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">1.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Description of Business</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Overview</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unless the context dictates otherwise, references in these notes to the financial statements to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; and similar words are references to Astrana Health, Inc. (&#8220;Astrana&#8221;) and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#8220;VIEs&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#8217;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based Care Enablement services and Care Delivery with its consolidated Care Partners to serve patients of whom the majority are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#8220;HMOs&#8221;), with a small portion of its revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#8217;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Segments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segments are Care Partners, Care Delivery, and Care Enablement, which are described as follows:</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Partners</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#8217;s unique Care Enablement platform and ability to recruit, empower, and incentivize physicians to manage total cost of care effectively, the Company is able to organize partnered providers into successful multi-payer, risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare Advantage, Medicaid, Commercial, Exchange, and Medicare fee for service (&#8220;FFS&#8221;). The Company&#8217;s healthcare delivery entities consist of a network of risk-bearing organizations (&#8220;RBOs&#8221;) that encompass independent practice associations (&#8220;IPAs&#8221;), accountable care organizations (&#8220;ACOs&#8221;), and state-specific entities such as Restricted Knox-Keene licensed health plans in California. These entities are tasked with coordinating and providing high-quality care to patients within Astrana&#8217;s ecosystem. This helps provide a seamless continuity of care among patients in different age groups, stages of life, and life circumstances. The Company participates in the Accountable Care Organization Realizing Equity, Access, and Community Health Model (&#8220;ACO REACH&#8221;), and in the Medicare Shared Savings Program (&#8220;MSSP&#8221;). The MSSP was created to promote accountability and improve care coordination  for Medicare beneficiaries.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Delivery</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#8217;s Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:</span></p><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Primary care clinics, including post-acute care services;</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Specialty care clinics and inpatient services, including cardiac care, endocrinology, and ophthalmology, as well as hospitalist and intensivist services; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Care Enablement</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information, all powered by the Company&#8217;s proprietary technology suite.  This platform enhances the delivery of high-quality, value-based care to patients and helps lead to superior clinical and financial outcomes. The Company provides solutions to payers and providers, including independent physicians, provider and medical groups, and ACOs.  The Company&#8217;s platform meets providers and payers wherever they are on the spectrum of total cost of care, offering solutions for fee-for-service entities to providers open to taking upside and downside risks on professional and institutional spending, and across all patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#8217;s wholly owned subsidiaries that operate as management services organizations (&#8220;MSOs&#8221;), which enter into long-term management and/or administrative services agreements with RBOs and other providers. By leveraging the Company&#8217;s Care Enablement platform, providers and payers can improve their ability to deliver high-quality patient care and achieve better patient outcomes.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">2.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basis of Presentation and Summary of Significant Accounting Policies</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying condensed consolidated balance sheet at December 31, 2024, has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited condensed consolidated financial statements as of March 31, 2025, and for the three months ended March 31, 2025 and 2024, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025. In the opinion of management, all material adjustments (consisting of normal recurring adjustments as well as intercompany accounts and transactions, which have been eliminated) considered necessary for a fair presentation have been made to make the condensed consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or any future periods.</span></p></div><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, and the condensed consolidated statements of income for the three months ended March 31, 2025 and 2024, include Astrana&#8217;s wholly owned subsidiaries and consolidated VIEs. All intercompany transactions and balances have been eliminated in consolidation.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The unaudited condensed consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read, or have access to, our audited consolidated financial statements for the fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment assessment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including estimations of affiliated hospitals&#8217; claims costs which involves assumptions for IBNR, such as utilization of healthcare services, historical payment patterns, cost trends, seasonality, changes in membership, and other factors), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combinations</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination which are expensed as incurred.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains its cash in deposit accounts with several banks, which at times may exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents and restricted cash. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">266.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">332.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></div><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Receivables, Receivables &#8211; Related Parties, Other Receivables, and Loan Receivables</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables are comprised of accounts receivable, capitation and fee-for-service receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated in the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s loan receivables consist of promissory notes that accrue interest per annum and are recorded and stated at amortized cost plus accrued interest. Interest income is accrued based on the outstanding principal amounts. As of March 31, 2025, promissory notes are expected to be collected by their maturity dates.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation receivables relate to each health plan&#8217;s capitation revenue and are usually received by the Company in the month following the month of service. Capitation receivables also include receivables from the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) related to the Company&#8217;s participation in the ACO REACH model. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months after the risk pool performance year is completed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other receivables consist of amounts due from the seller associated with acquisitions, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains reserves for potential credit losses on the receivables. Management reviews the composition of the Company&#8217;s receivables and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected, and adjustments are recorded when necessary. Reserves are recorded based on historical trends. Any change in such an estimate of reserves is recorded in the period when such change is identified.</span></p></div><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided, and collection is reasonably likely to occur. The Company continuously monitors its receivables collections, and it expects that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></div><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risks</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts, as used by our chief operating decision makers (&#8220;CODMs&#8221;). The condensed consolidated statements of income present disaggregated revenue by service type. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents disaggregated revenue generated by each payer type </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands): <br/></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,081</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49,512</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicare</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">389,352</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">246,564</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicaid</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173,158</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,263</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other third parties</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,799</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,017</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div></div><div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.0</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer B</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer C</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer D</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Less than 10% of total net revenues</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers that contributed to the following percentages of receivables, net, receivables &#8211; related parties, and other receivables:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:64.527%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of March 31,<br/>2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,<br/>2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer F</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.6</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
         </table></div></div><div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company receives payments from the following sources for services rendered:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial insurers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal government under the Medicare program administered by CMS;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State governments under Medicaid and other programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other third-party payers (e.g., hospitals and IPAs); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual patients and clients.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue primarily consists of the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation revenue;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk pool settlements and incentives;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management fee income; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FFS revenue.</span></div></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related collection risk for such services may vary by type of revenue and the customer.</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses a recognition threshold of &#8220;more-likely-than-not&#8221; and a measurement attribute on all tax positions taken, or expected to be taken, in a tax return in order to be recognized in the condensed consolidated financial statements. Once the recognition threshold is met, the tax position is measured to determine the actual amount of benefit to recognize in the condensed consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Not Yet Adopted</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221; to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a significant impact on its consolidated financial statements and related disclosures.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03 &#8220;Income Statement &#8212; Reporting Comprehensive Income &#8212; Expense Disaggregation Disclosures (Subtopic 220-40)&#8221; to provide disaggregated information about certain income statement costs and expenses. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the new standards discussed above, there have been no other recent accounting pronouncements not yet adopted that are expected to have significance, or potential significance, to the Company&#8217;s financial position, results of operations, and cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations and Goodwill</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">3.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Combinat</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ions and Goodwill</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, the Company finalized the purchase price allocation for Advanced Health Management Systems, L.P. (&#8220;AHMS&#8221;) and is in the process of finalizing Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks (collectively, &#8220;CHS&#8221;). Therefore, the balances were subject to change as a result of any working capital adjustments, primarily for the finalization of medical liabilities and CHS&#8217; participation in government savings programs for the 2024 performance year. As of March 31, 2025, measurement period adjustments impacted receivables, net, other receivables, accounts payable and accrued expenses, and medical liabilities with a net decrease </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million to </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">goodwill.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AHMS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On March 31, 2024, the Company, through its wholly owned subsidiary, purchased all of the outstanding general and limited partnership interests of AHMS. AHMS&#8217;s wholly owned subsidiary operates a Restricted Knox-Keene licensed health plan in Los Angeles, California. The total consideration for the acquisition was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, consisting of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash funded upon the close date and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due from the seller based on estimated working capital adjustments. The consideration is subject to changes based on working capital adjustments, which are settled within one year from the close date as per the purchase agreement.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,935</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due from seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,995</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">60,940</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,950</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,007</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,600</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,571</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,464</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,001</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,093</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,430</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,524</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">60,940</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CHS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On October 4, 2024, the Company and its affiliated professional entity acquired all of the outstanding membership interest relating to CHS. CHS partners with independent providers in caring for over </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">129,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Medicare members across </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> states. CHS provides comprehensive support for its physician partners by providing management services, risk contracting, and population health capabilities, including actionable data and other tools, to deliver care coordination and closure of gaps in care. CHS provides additional services to secure and deliver favorable value-based contracts with commercial and other health plans. Total consideration for the acquisition was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, consisting of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million cash funded upon the close date, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million due to the seller based on estimated working capital adjustments, contingent consideration fair valued at $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of replacement restricted stock awards. The consideration is subject to changes based on working capital adjustments, which are settled December 31 of the year following the year in which the closing occurs as per the purchase agreement. See Note 19 &#8212; &#8220;Fair Value Measurements of Financial Instruments&#8221; for additional information on contingent consideration.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CHS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,322</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due to seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,944</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent consideration</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,154</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issued and replacement awards</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47,538</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,556</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92,393</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,336</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">357</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,200</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,444</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">168,064</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,276</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,328</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-controlling interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,526</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47,538</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Factors leading to goodwill being recognized are the Company&#8217;s expectation of synergies from combining the operations of entities acquired and the Company, as well as the value of intangible assets that are not separately recognized, such as the assembled workforce. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. Transaction costs associated with business acquisitions are expensed as they are incurred.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impairment of its goodwill or indefinite-lived intangible assets during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the carrying value of goodwill for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">419,253</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">416,386</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unaudited Pro Forma Financial Information</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.34%;box-sizing:content-box;"></td>
         <td style="width:1.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678,640</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Astrana Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,171</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.41</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">4.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Intangible Assets, Net</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:12.803%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.802000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">171,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,499</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,418</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,832</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,259</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,573</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,893</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,184</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,011</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">371</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">275,054</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163,138</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,916</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:12.803%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.802000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">171,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,046</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,871</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,832</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,953</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,879</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,406</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,671</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,011</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">358</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">275,054</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">156,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, the Company recognized amortization expenses of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in depreciation and amortization in the accompanying condensed consolidated statements of income. The Company determined that ther</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> impai</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">rment of its finite-lived intangible or long-lived assets during the three months ended March 31, 2025 and 2024.</span></p><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.76%;box-sizing:content-box;"></td>
         <td style="width:2.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,395</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,295</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,808</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,397</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,866</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodAndOtherEquityInvestmentsTextBlock', window );">Investments in Other Entities</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">5.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Investments in Other Entities</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method</span></p><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, the Company&#8217;s equity method investment activity and balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.11%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:11.044%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.464%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>(Loss) Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">343</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,785</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,660</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,664</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,612</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">264</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,842</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">347</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">843</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,552</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,319</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">347</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,005</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments including those from the CHS acquisition.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:0.575;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.115%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:11.047%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.447999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,866</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,225</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,691</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,718</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,660</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">186</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,846</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">557</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">617</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,774</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">632</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,893</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments.</span></p></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company records its investments in certain non-consolidated VIEs within investments in other entities &#8211; equity method in the accompanying condensed consolidated balance sheets. These entities were determined to be VIEs but are not consolidated because despite providing financial support to these entities, the Company lacks a controlling financial interest and is not the primary beneficiary. Thus, these VIEs are accounted for under the equity method of accounting. The Company recognizes its share of the investee&#8217;s earnings or losses under the &#8220;hypothetical-liquidation-at-book-value&#8221; method. As of  March 31, 2025, the Company&#8217;s maximum exposure to loss was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> which represents the carrying value of the Company&#8217;s investments in the non-consolidated VIEs.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity method investments are subject to impairment evaluation. </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">No</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">mpairment loss was recorded related to equity method investments for the three months ended March 31, 2025 and 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Privately Held Entities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company accounts for certain equity investments using the cost basis, adjusted for observable price changes and impairments, when there is no readily determinable fair value. Observable price changes and impairments are recognized in net income. As of both March 31, 2025, and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, our investments in privately held entities was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, for which a fair value is not readily determinable and we do not have significant influence. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, there were no observable price changes to these investments.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodAndOtherEquityInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method And Other Equity Investments [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodAndOtherEquityInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LoanReceivableTextBlock', window );">Loans Receivable</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">6.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loans Receivable</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Loans receivable</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">IntraCare</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In July 2023, the Company entered into a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> convertible promissory note with IntraCare as the borrower. The principal on the note is $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.81</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">July 27, 2028</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of both </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the related note balance of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, was included in loan receivable &#8211;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> non-current in the accompanying condensed consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">BASS Medical Group</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 29, 2024, the Company provided BASS Medical Group (&#8220;BASS&#8221;) with a $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million senior secured promissory note (&#8220;BASS secured promissory note&#8221;). The promissory note is secured by certain assets of BASS. The BASS secured promissory note matures on </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 11, 2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and has an interest rate per annum equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.21</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, compounded annually. The principal on the note, including unpaid interest, is due and payable on the maturity date. On April 24, 2025, the BASS secured promissory note was amended and restated to update the terms of the note to include terms of repayment, whereby the principal balance shall be payable in monthly installments of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> until </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 11, 2031</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the maturity date. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the related non-current portion of the note balance of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, respectively, was included in loan receivable, non-current in the accompanying condensed consolidated balance sheets. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the related current portion of the note of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was included in loan receivable in the accompanying condensed consolidated balance sheets.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company assessed the outstanding loans receivable under the CECL model by assessing the party&#8217;s ability to pay by reviewing their interest payment history quarterly, financial history annually, the value of any collateral, and reassessing any identified insolvency risk.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LoanReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loan Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LoanReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">7.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accounts Payable and Accrued Expenses</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and other accruals</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,911</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,168</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitation payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,703</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,639</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subcontractor IPA payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,845</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,486</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,512</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,809</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due to related parties</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,111</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,924</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contract liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">686</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,606</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,752</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,409</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other provider payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,039</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,101</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105,559</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,142</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">Medical Liabilities</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">8.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Medical Liabilities</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, beginning of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209,039</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,657</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,256</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,645</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Components of medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">384,479</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,735</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">658</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,419</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total medical care costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">383,821</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">233,316</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments for medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">229,701</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,014</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">145,938</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,335</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims paid for acquired balance</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,864</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,775</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">380,503</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,124</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, end of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">204,101</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">136,494</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Credit Facility, Bank Loans, and Lines of Credit</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">9.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Credit Facility, Bank Loans, and Lines of Credit</span></div></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s debt balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revolver Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,000</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">146,732</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438,107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Current portion of debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,375</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Unamortized financing costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,481</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,433</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">425,299</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The estimated fair value of the Company's long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of March 31, 2025, and December 31, 2024, the carrying value was not materially different from fair value, as the interest rates on the Company&#8217;s debt approximated rates currently available to the Company.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are the future commitments, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,375</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,063</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,750</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,437</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,750</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Credit Facility</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Second Amended and Restated Credit Agreement</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On February 26, 2025, the Company entered into the Second Amended and Restated Credit Agreement (the &#8220;Second Amended and Restated Credit Agreement&#8221; and the credit facility thereunder, the &#8220;Second Amended and Restated Credit Facility&#8221;) with Truist Bank, in its capacities as administrative agent for the lenders, issuing bank, swingline lender and a lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain amended credit agreement, dated June 16, 2021, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Second Amended and Restated Credit Agreement provides for (a) a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> revolving credit facility (&#8220;Revolver Loan&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, which includes a letter of credit sub-facility of up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and a swingline loan sub-facility of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, (b) a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> term loan A credit facility (&#8220;Term Loan&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million and (c) a </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">five-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> delayed draw term loan credit facility (&#8220;DDTL A&#8221;) to the Company of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">745.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. The term loan A and revolving credit facilities are intended to be used to, among other things, refinance certain existing indebtedness of the Company and certain subsidiaries, pay transactions costs and expenses arising in connection with the Second Amended and Restated Credit Agreement, and provide for working capital needs and other general corporate purposes, and, in addition to the foregoing, the revolving credit facility will also be used to finance certain future permitted acquisitions and permitted investments and capital expenditures. The delayed draw term loan facility will be used to finance the purchase of all of the outstanding equity interests of Prospect Health Services RI, Inc. (d/b/a Prospect ACO Rhode Island), Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical Center), and Prospect Health Plan, Inc., and substantially all the assets of certain direct and indirect subsidiaries of PHP Holdings, LLC (&#8220;PHPH&#8221;), subject to customary adjustments, plus the assumption of certain identified liabilities of the sellers party thereto, (the &#8220;Transaction&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amounts borrowed under the Second Amended and Restated Credit Agreement bear interest at an annual rate equal to either, at the Company&#8217;s option, (a) the rate for term Secured Overnight Financing Rate (&#8220;SOFR&#8221;) published by the CME Group Benchmark Administration Limited two days prior to the first day of the applicable interest period, plus a spread of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio, or (b) a base rate, plus a spread of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%, as determined on a quarterly basis based on the Company&#8217;s leverage ratio. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the Company had outstanding borrowings under the Revolver Loan and Term Loan of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the interest rate on both loans was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.82</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Second Amended and Restated Credit Agreement, requires the Company to pay a commitment fee of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.175</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.35</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% multiplied by the daily amount of the unused revolving commitments during the availability period, with such fee determined on a quarterly basis based on the Company&#8217;s leverage ratio, and a ticking fee on the delayed draw term loan facility of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.175</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.35</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% multiplied by the average daily unused portion of delayed draw term loan commitments, with such fee determined on a quarterly basis based on the Company&#8217;s leverage ratio. The Company is also required to comply with two financial ratios, each calculated on a consolidated basis. The Company must maintain (commencing with the fiscal quarter ending June 30, 2025) (x) a maximum consolidated total net leverage ratio of not greater than (a) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.00</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day of each fiscal quarter ending prior to March 31, 2027, and (b) </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day each fiscal quarter thereafter and (y) a minimum consolidated interest coverage ratio of not less than </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to 1.00 as of the last day of each fiscal quarter. The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with various affirmative covenants, including, without limitation, furnishing updated financial and other information, preserving existence and entitlements, maintaining properties and insurance, complying with laws, maintaining books and records, requiring any new subsidiary meeting a materiality threshold specified in the Second Amended and Restated Credit Agreement to become a guarantor thereunder and paying obligations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with, and to use commercially reasonable efforts to the extent permitted by law to cause certain material associated practices of the Company to comply with, restrictions on liens, indebtedness and investments (including restrictions on acquisitions by the Company), subject to specified exceptions. The Second Amended and Restated Credit Agreement also contains certain negative covenants binding the Company and its subsidiaries, including restrictions on fundamental changes, dividends and distributions, dispositions, sales and leasebacks, transactions with affiliates, restrictive agreements, use of proceeds, amendments of organizational documents, accounting changes and prepayments and modifications of subordinated debt.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and its subsidiary, Astrana Health Management, Inc. (&#8220;AHM&#8221;), have granted the lenders a security interest in all of their assets, including stock and other equity issued by their subsidiaries, pursuant to the Amended and Restated Guaranty and Security Agreement, dated as of February 26, 2025, by and among the Company, as borrower, and AHM, as guarantor, in favor of Truist Bank, which amends and restates that certain guaranty and security agreement dated as of September 11, 2019, in its entirety. The Second Amended and Restated Credit Agreement contains certain customary events of default. If any event of default occurs and is continuing under the Second Amended and Restated Credit Agreement, the lenders may terminate their commitments, and may require the Company and its guarantors to repay outstanding debt and/or to provide a cash deposit as additional security for outstanding letters of credit. In addition, the agent, on behalf of the lenders, may pursue other remedies, including, without limitation, transferring pledged securities of the Company&#8217;s subsidiaries in the name of the agent and exercising all rights with respect thereto (including the right to vote and to receive dividends), collect on pledged accounts, instruments and other receivables, and other rights provided by law.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">I Health, Inc. Promissory Note Payable &#8211; Related Party</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On April 1, 2024, the Company issued a promissory note in the amount of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million as a promissory note (the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8220;I Health Promissory Note&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) with a maturity date of March 31, 2027. On March 31, 2024, the Company entered into a purchase agreement for </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health, Inc. (&#8220;I Health&#8221;) that included a call option to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest on each of the first, second, and third anniversaries from when certain triggering events occur (&#8220;I Health Call Option&#8221;). I Health may accelerate the maturity date if the Company does not exercise the I Health Call Option</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The promissory note has an interest rate of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> per annum on the principal amount. Accrued interest is payable on each anniversary of the promissory note payable. I Health is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held by the Company (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Equity Method&#8221;). On July 1, 2024, an amendment was made to the I Health Promissory Note that, among other things, increased the original principal amount by an additional $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the total amount payable under the I Health Promissory Note is </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Deferred Financing Costs</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company paid debt financing costs of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million related to the issuance of the Second Amended and Restated Credit Agreement. Of the $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million debt financing, the Company expensed $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million within other expense on the accompanying condensed consolidated statements of income, and the remaining $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was deferred and amortized over the life of the amended credit facility. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, unamortized deferred financing costs for the Revolver Loan, DDTL A, and Term Loan, were $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. As of December 31, 2024, unamortized deferred financing costs for the Revolver Loan and Term Loan were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Deferred financing costs associated with the Term Loan are presented as a direct reduction against the amounts borrowed on the Term Loan and amortized over the life of the loan using the effective interest rate method. D</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">eferred financing costs associated with the Revolver Loan and the DDTL A are recognized in other assets in the accompanying condensed consolidated balance sheets and amortized over the life of the loans using the straight-line method. The deferred financing costs associated with the DDTL A will be presented as a direct reduction against the amounts borrowed and amortized using the effective interest rate method when the draw is made. Interest expense in the condensed consolidated statements of income includes amortization of deferred debt issuance costs.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Effective Interest Rate</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s average effective interest rate on its total debt during the three months ended March 31, 2025 and 2024, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.51</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Interest expense in the condensed consolidated statements of income included amortization of deferred debt issuance costs for the three months ended March 31, 2025 and 2024 of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">,  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Lines of Credit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC Business Loan</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On September 10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#8220;APC Business Loan Agreement&#8221;) was amended to, among other things, decrease loan availability to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#8217;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Standby Letters of Credit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company established irrevocable standby letters of credit with Truist Bank under the Second Amended and Restated Credit Agreement for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of CMS and certain health plans as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> periods from the present or any future expiration date.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of certain health plans as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The standby letters of credit are automatically extended without amendment for additional </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one-year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine Deficit and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Mezzanine Deficit and Stockholders' Equity</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">10.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mezzanine Deficit and Stockholders&#8217; Equity</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Mezzanine Deficit</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As the redemption feature of APC&#8217;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#8217;s shares were not redeemable, and it was not probable that the shares would become redeemable as of March 31, 2025 and December 31, 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, APC repurchased $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of its common stock from its shareholders. There was no similar type of repurchase during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Stockholders&#8217; Equity</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,048</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 merger of Astrana with AHM, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro rata </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">portion of Astrana common stock as contemplated under the 2017 merger agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 merger. The condensed consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory, and the Company is legally obligated to issue these shares in connection with the 2017 merger.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Treasury Stock</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, APC owned </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,132,802</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,132,698</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of Astrana&#8217;s common stock, respectively. While such shares of Astrana&#8217;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the condensed consolidated financial statements. APC&#8217;s ownership in Astrana was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11.13</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.96</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of the Company&#8217;s common stock from APC, pursuant to a stock repurchase agreement dated </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 17, 2025</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for an aggregate purchase price of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of March 31, 2025 and December 31, 2024, the Company had repurchased </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,771,151</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,471,151</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares, respectively, of its common stock. These are included as treasury stock.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#8217;s stock held by APC, was </span><span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;">9,903,953</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,603,849</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Dividends</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, certain consolidated subsidiaries of the Company paid distributions of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to the shareholders who own the non-controlling interests in the entities.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the APC board approved the distribution of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">699,896</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of the Company&#8217;s shares and a cash distribution of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to its shareholders. During the three months ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> dividends were declared to the APC shareholders.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">11.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock-Based Compensation</span></div></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, and associated with the issuance of restricted shares of common stock and restricted stock units and vesting of stock options that are included in general and administrative expenses in the accompanying condensed consolidated statements of income (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.391%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.424%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.424%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options and ESPP</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,399</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,811</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,748</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Unrecognized compensation expense related to total share-based payments outstanding as of March 31, 2025, was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Restricted Stock Awards and Units</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company grants restricted stock awards and units to officers and employees, which are earned based on service and/or performance conditions. The awards will vest over a period of </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">four years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in accordance with the terms of those plans. The grant date fair value of the restricted stock awards and units are the grant date&#8217;s closing market price of the Company&#8217;s common stock. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025, the Company granted </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">417,787</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of restricted stock awards and units with performance-based conditions and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,516</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of restricted stock awards and units without performance-based conditions. During the three months ended March 31, 2025, the weighted average grant date fair value of restricted stock awards and units with and without performance-based conditions was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27.61</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Shares of restricted stock awards and units with performance-based conditions are recognized to the extent that the performance conditions are probable of being achieved.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s ESPP is a shareholder-approved plan that allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#8217;s common stock at a discounted price equal to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">85</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% up to </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">90</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the fair market values of the stock on the exercise date, subject to a maximum number of shares that can be purchased during any single offering period as well as an annual maximum dollar amount of shares during any single calendar year. A maximum of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,000,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares were authorized for issuance at the time the ESPP was approved. There were </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,683</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares issued for the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">12.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commitments and Contingencies</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Regulatory Matters</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As a risk-bearing organization, the Company is required to follow the regulations of the Department of Managed Health Care (&#8220;DMHC&#8221;). The Company must comply with a minimum working capital requirement, a tangible net equity (&#8220;TNE&#8221;) requirement, a cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Many of the Company&#8217;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Standby Letters of Credit and Surety Bonds</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company established irrevocable standby letters of credit with Truist Bank for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of CMS and certain health plans as of March 31, 2025 (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> for the benefit of certain health plans as of March 31, 2025 (see Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit &#8212; Standby Letters of Credit&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company currently has several surety bonds as required by CMS. The bonds total approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the aggregate, as of March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The bonds expire on various dates through </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2030</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Litigation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. Currently, management does not believe the Company is a party to any legal proceedings that would have a material adverse effect on its operations. The Company continuously evaluates potential contingencies and will accrue liabilities as necessary. However, the resolution of any claim or litigation is inherently uncertain and could impact the Company&#8217;s financial condition, cash flows, or results of operations.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Liability Insurance</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company believes that its insurance coverage is appropriate based upon the Company&#8217;s claims experience and the nature and risks of the Company&#8217;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#8217;s affiliated professional organizations or the Company&#8217;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims &#8212;  including liabilities in excess of the Company&#8217;s insurance coverage &#8212; will not have a material adverse effect on the Company&#8217;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#8217;s business. Contracted physicians are required to obtain their own insurance coverage.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Although the Company currently maintains liability insurance policies on a claims-made basis which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may not continue to be available to the Company in future years at acceptable costs and on favorable terms.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-Party Transactions</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">13.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Related-Party Transactions</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Equity Method Investments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Pacific Medical Imaging &amp; Oncology Center, Inc. (&#8220;PMIOC&#8221;) for provider services. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PMIOC provides covered services on behalf of the Company&#8217;s RBOs to enrollees of the plans. PMIOC is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During each of the three months ended March 31, 2025, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for provider services to an equity method investment in which the Company has a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership. (see Note 5 &#8212; &#8220;Investments in Other Entities &#8211; Equity Method&#8221;).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company incurred expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in management fees and interest expense to I Health. The Company has a management service agreement and promissory note payable</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> with I Health. I Health is accounted for under the equity method based on the </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity ownership interest held (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025, the Company recognized approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in management fee income from equity method investments acquired through the CHS acquisition. The Company owns </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> - </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in these investments. These investments are accounted for under the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">equity method (see Note 5 &#8212; &#8220;Investments in Other Entities </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8211; Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Astrana Board Members and Officers</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company recognized approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in expenses and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, in revenue, net of expenses, from Arroyo Vista Family Health Center (&#8220;Arroyo Vista&#8221;), respectively. Revenue consisted of management fees and surplus from shared risk arrangements. Expenses consisted of fees for provider services. Arroyo Vista&#8217;s chief executive officer is a member of the Company&#8217;s board of directors. Arroyo Vista is a non-profit network of community health centers serving Greater Northeast Los Angeles. Arroyo Vista provides certain primary care services to enrollees of certain healthcare service plans, the providers of which have contracted with our affiliates.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company incurred rent expenses of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, from certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. As of March 31, 2025, and December 31, 2024, the Company&#8217;s operating right-of-use asset balance included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the Company&#8217;s operating lease liabilities included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. The chief executive officer of Allied Pacific Holdings Investment Management, LLC is a member of the Company&#8217;s board of directors.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has a Simple Agreement for Future Equity ("SAFE") with Third Way Health (see Note 5 &#8212; &#8220;Investments in Other Entities"). As of March 31, 2025 and December 31, 2024 the investment was $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. During the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, the Company incurred approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in expenses payable to Third Way Health for call center and credentialing services. One of Astrana&#8217;s officers is a board member of Third Way Health.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">45,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Sunny Village Care Center for services as a provider. The Company has provider contracts with Sunny Village Care Center. Sunny Village Care Center shares common ownership with certain Astrana board members.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company incurred rent expense of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to First Commonwealth Property, LLC for an office lease. First Commonwealth Property, LLC shares common ownership with certain board members of APC and AHM. As of March 31, 2025 and December 31, 2024, the Company&#8217;s operating right-of-use asset balance included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and the Company&#8217;s operating lease liabilities included </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, for certain properties owned by </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">First Commonwealth Property, LLC.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has agreements with Health Source MSO Inc., a California corporation (&#8220;HSMSO&#8221;), Aurion Corporation (&#8220;Aurion&#8221;), and AHMC Healthcare Inc. (&#8220;AHMC&#8221;) for services provided to the Company. One of the Company&#8217;s board members is an officer of AHMC, HSMSO and Aurion and is the sole owner of Aurion. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees, and expenses consisting of claims expenses, management fees, and consulting fees.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth revenue recognized and fees incurred related to AHMC, HSMSO, and Aurion for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.667%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,771</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,920</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">301</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,680</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,557</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,909</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,363</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">301</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended March 31, 2025 and 2024, the Company had recognized risk pool revenues of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. As of March 31, 2025 and December 31, 2024,  </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> remained in outstanding risk pool receivables, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">APC Board Members</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the three months ended March 31, 2025 and 2024, the Company paid an aggregate of approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to board members for provider services and repurchase of APC shares of common stock, which included approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, to Astrana board members and officers who are also board members and officers of APC.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition, affiliates wholly owned by the Company&#8217;s key personnel are reported in the accompanying condensed consolidated statements of income on a consolidated basis, together with the Company&#8217;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#8217;s subsidiaries as related-party transactions.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Intercompany Transactions</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#8217;s key personnel, to engage in certain transactions and make intercompany loans from time to time.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For equity method investments and promissory note payable with related parties, see Note 5 &#8212; &#8220;Investments in Other Entities  &#8212; Equity Method&#8221; and Note 9 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit,&#8221; respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">14.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income Taxes</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the liability method of accounting for income taxes as set forth in ASC 740 Income Taxes. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#8217;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#8217;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s effective income tax rate for the three months ended March 31, 2025 and 2024, was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The tax rate for the three months ended March 31, 2025, differed from the U.S. federal statutory rate primarily due to non deductible expenses, state income taxes and income from flow-through entities.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If recognized, $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million of the unrecognized tax benefits as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, would reduce the annual effective tax rate. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes in the Company&#8217;s consolidated financial statements. For the period ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. the Company had recognized $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of interest and penalties related to unrecognized tax benefits on its consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company is subject to U.S. federal income tax as well as state income tax in certain U.S. states. The Company and its subsidiaries&#8217; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2020 through December 31, 2024, and for the years ended December 31, 2021 through December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">15.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Earnings Per Share</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Basic earnings per share are calculated using the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during a certain period and are calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#8217;s common stock issued and outstanding during such period. Diluted earnings per share are calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes and preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana's income from APC&#8217;s ownership of Astrana common stock, and this is included in the net income (loss) attributable to non-controlling interest on the condensed consolidated statements of income, therefore, none of the shares of Astrana held by APC are considered outstanding for the purpose of basic or diluted earnings per share computation.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#8217;s stock held by APC was </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,903,953</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,603,849</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. These are treated as treasury shares for accounting purposes, and not included in the number of shares of common stock outstanding used to calculate earnings per share.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and 2024, restricted stock of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">409,736</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,142</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, stock options of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">125,707</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">168,207</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the three months ended March 31, 2025 and 2024, contingently issuable shares of </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,120,899</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">973,461</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of March 31, 2025 and 2024, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.2%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.419999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.14</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.31</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.14</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.31</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,470,682</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,260,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,850,666</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,699,537</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the shares included in the diluted earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.187%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.737%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.877%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,470,682</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,260,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">112,858</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">188,083</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,055</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingently issuable shares</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,071</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,975</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,850,666</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,699,537</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities (VIEs)</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">16.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Variable Interest Entities (VIEs)</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#8217;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Some states have laws that prohibit business entities with non-physician owners&#8212;such as Astrana and its subsidiaries&#8212;from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements&#8212;such as fee-splitting&#8212;with physicians.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#8217;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholders of professional corporations that hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder, the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition, these entities are managed by the Company&#8217;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations and their consolidated medical corporations are consolidated by the Company in the accompanying condensed financial statements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Astrana Medical and Astrana Care Partners Medical were formed as designated shareholder professional corporations in May 2019 and July 2021, respectively, as designated shareholder professional corporations. The Company&#8217;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Care Partners Medical. Via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and Astrana Care Partners Medical. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Care Partners Medical. Therefore, Astrana Medical and Astrana Care Partners Medical are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs.</span></p><div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolida</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tion, are included in the accompanying condensed consolidated balance sheets (in thousands).</span></p></div><div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,013</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158,922</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in marketable securities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,283</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,259</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,820</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,977</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net &#8211; related party</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54,873</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,251</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,303</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,161</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">285,928</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318,873</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,528</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,582</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87,840</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,531</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">243,283</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable, non-current</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,943</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,943</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,063</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,442</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in a privately held entity</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">405</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">405</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190,178</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,033</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,585</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,055</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,019</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">582,358</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">618,326</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">868,286</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">937,199</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;">
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,804</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,800</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiduciary accounts payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,840</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,223</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,547</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105,486</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">638</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">638</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,140</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,041</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">520</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,076</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,348</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amount due to affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,548</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,142</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173,392</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,688</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,905</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,237</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">520</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,006</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,012</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,890</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">619</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,252</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,388</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">216,644</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,076</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Investment in affiliates includes the Company&#8217;s VIEs&#8217; investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingAndFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">17.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leases</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company has operating and finance leases for corporate offices, physicians&#8217; offices, and certain equipment. These leases have remaining lease terms ranging from </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> month</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">21</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> years, some of which may include options to extend the leases for up to </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ten years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, and some of which may include options to terminate the leases within </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">one year</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as the Consumer Price Index. As of March 31, 2025 and December 31, 2024, finance lease assets, net of depreciation, were </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and accumulated depreciation associated with finance leases was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets.</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,611</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,159</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of lease expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">147</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sublease income</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,730</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,136</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to leases was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental Cash Flow Information</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,017</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,837</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">147</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.343%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.343%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Lease Term</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.22</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.39</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.96</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Discount Rate</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.75</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.79</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.53</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,269</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">443</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,851</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">345</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,246</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">267</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,973</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,882</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future minimum lease payments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,097</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,091</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,155</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,942</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,014</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,979</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">471</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,963</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">543</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingAndFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating and finance leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingAndFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text"><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">18.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Segments</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company determined its operating segments in accordance with ASC 280, &#8220;Segment Reporting&#8221; (&#8220;ASC 280&#8221;). Factors used in determining the reportable business segments include the nature of operating activities and the type of information presented to the Company's CODMS to evaluate all results of operations. The Company currently has </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">three</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#8212;&#8220;Description of Business&#8221;).</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Partners segment, revenue is primarily comprised of capitation and risk pool settlements and incentives. Cost of service for this segment is primarily capitation and claims expenses.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Delivery segment, revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives. Cost of service for this segment is primarily medical supplies costs and salaries expense related to medical staff and clinic employees.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the Company&#8217;s Care Enablement segment, revenue for is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis. Cost of service for this segment is primarily MSO salaries expense.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company's CODMs are its</span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_85a7fb24-2a46-4162-beeb-ab37e6433db9;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Chief Executive Officer and Chief Financial Officer.</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> The CODMs evaluate the performance of the Company&#8217;s operating segments based on segment revenue growth and operating income. The CODMs use revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. The CODMs do not evaluate the Company&#8217;s segments using asset information. The significant segment expenses that comprise operating income as a measure used by the CODMs in evaluating operating segment performance do not differ from the operating expenses as presented on the consolidated statements of income.</span></span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the normal course of business, the Company&#8217;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs, and corporate shared costs, such as finance, human resources, legal, and executives.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain amounts disclosed in prior period have been recast to conform to the current period presentation. Specifically, segments are presented net of intrasegment eliminations for the three months ended March 31, 2024. The following table presents information about our segments (in thousands):</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about the Company&#8217;s segments (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,951</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,690</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,749</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,698</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,813</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,511</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,951</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,388</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,562</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,511</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">512,668</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,139</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,818</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,564</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">549,061</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,068</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,357</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,209</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,950</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,746</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">556,736</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,496</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,027</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,514</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">599,807</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,215</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,108</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,535</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,583</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,318</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,878</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,160</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,841</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,114</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,955</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,318</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,719</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,274</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,955</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300,189</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,794</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,373</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,957</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,399</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,933</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,163</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,397</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,818</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">339,122</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,957</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,770</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,032</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">374,217</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,196</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">238</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,504</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,139</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balance includes general and administrative expenses, and depreciation and amortization. </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income that is not presented in the table. </span></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements of Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19. Fair Value Measurements of Financial Instruments</span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,755</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,755</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call option</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,152</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,019</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,309</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,309</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,170</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,170</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,450</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,450</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,037</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,133</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,673</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,673</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,289</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,289</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call options</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,051</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,848</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,285</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,285</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,949</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,949</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,643</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,643</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,595</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,705</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p></div><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the fair value of Level 3 </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a6133d98-7b94-492e-8834-b1b4530ae2ee;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">liabilities is recognized in unrealized loss on investments, other income, or general and administrative expenses</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the accompanying condensed consolidated statements of income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,595</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of existing Level 3 liabilities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,442</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,037</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Marketable Securities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ninety days</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, certificates of deposit amounted to approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></p></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the equity securities were approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, in the accompanying condensed consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying condensed consolidated statements of income as other income. </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value on equity securities held are as follows (in thousands) for the periods listed below and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> securities had been sold in the respective periods:</span></span></p><div style="font-size:12pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gains (losses) recognized on equity securities held at end of period</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivative Financial Instruments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Rate Collar Agreements</span></p></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company enters into agreements designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan, including the collar agreement. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on the Company&#8217;s debt. Under the terms of the agreement, the ceiling is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and the floor is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.  The collar agreement is not designated as a hedging instrument. Changes in the fair value of this contract are recognized as unrealized gain or loss on investments in the accompanying condensed consolidated statements of income and reflected in the accompanying condensed consolidated statements of cash flows as unrealized (gain) loss on investments. The estimated fair value of the collar was determined using Level 2. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the fair value of the collar was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and presented within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> other liabilities in the accompanying condensed consolidated balance sheets.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, the fair value of the collar was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and presented within prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">I Health Call Option</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company acquired a </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health, which included a call option that allows the Company to purchase an additional </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest on each of the first, second, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> third anniversaries from when certain triggering events occur. The Company determined the fair value of the call option using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of the purchase price based on EBITDA and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the value of the call option was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The I Health call option is presented within other assets in the accompanying condensed consolidated balance sheet. The </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% equity interest in I Health</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> is accounted for under the equity method (see Note 5 &#8212; &#8220;Investments in Other Entities &#8212;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> Equity Method&#8221;).</span></p><p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Remaining equity interest purchase</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Sun Clinical Laboratories (&#8220;Sun Labs&#8221;) within </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three years</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> from the date the Company consolidated Sun Labs. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> As the financing obligation is embedded in the non-controlling interest, the non-controlling interest is recognized in other liabilities in the accompanying condensed consolidated balance sheets.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Contingent consideration</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">All American Medical Group</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> (&#8220;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">AAMG&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#8220;AAMG stock contingent consideration&#8221;) in the form of the Company&#8217;s common stock. The additional consideration is contingent on AAMG meeting certain revenue and capitated member targets in 2023 (&#8220;2023 target metric&#8221;) and in 2024 (&#8220;2024 target metric&#8221;). Additional shares would be further issued for exceeding the revenue targets in 2023 (&#8220;2023 growth metric&#8221;) and in 2024 (&#8220;2024 growth metric&#8221;). The total amount of stock that can be issued for the 2023 target and growth metrics and 2024 target and growth metrics is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">157,059</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">184,357</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. At the end of the earnout periods, the Company concluded on the achievement of the 2023 target and growth metrics and the 2024 target and growth metrics based on actual revenue and the value of the Company stock (Level 1) to calculate payment, representing the fair value of the contingent consideration.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The 2023 and 2024 growth metrics were considered variable and were presented within other liabilities in the accompanying consolidated balance sheet. As of March 31, 2025 and December 31, 2024, the AAMG stock contingent consideration for the 2024 growth metric had a fair value of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Changes in the AAMG stock contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">During the year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the Company had concluded that both the 2023 target metric and the 2023 growth metric were met and issued </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">157,059</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> shares of common stock to the sellers in 2024.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Advanced Diagnostic and Surgical Center (&#8220;ADSC&#8221;)</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">95</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest of ADSC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent on ADSC achieving revenue and EBITDA metrics for fiscal years 2023 (&#8220;ADSC 2023 Metric&#8221;) and 2024 (&#8220;ADSC 2024 Metric&#8221;) (collectively, &#8220;ADSC contingent consideration&#8221;). The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the ADSC 2023 Metric and the 2024 Metric were valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and were included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the ADSC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In April 2025, the Company paid $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million in cash to the sellers of ADSC for the contingent consideration that was achieved. As a result, the contingent liabilities are no longer outstanding.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring certain assets of CFC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent upon CFC maintaining or exceeding the target member month amount for the first, second, and third measurement period (&#8220;CFC contingent consideration&#8221;). The first measurement period means the period commencing on the first day of the month immediately following the close of AHMS and ending on the one-year anniversary thereof. The second measurement period is for one year after the first measurement period, and the third measurement period is for one year after the second measurement period. The contingent liability will be paid after achieving the metric in each measurement period. The Company will pay $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each metric achieved for each measurement period, or a total of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million. In the event that the CFC first and/or second contingent consideration metrics are not achieved during the first and/or the second measurement period, if the metric is met within the second and/or third measurement period, there is a catch-up payment that shall be paid concurrently with the payments of the CFC second contingent consideration and/or CFC third contingent consideration. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31,</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2024, the first metric was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively, and was included in other liabilities in the accompanying condensed consolidated balance sheets. As of March 31, 2025 and December 31, 2024, the second and third metrics were valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in aggregate, and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CFC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring certain assets of PCCCV in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash, contingent upon PCCCV meeting certain metrics related to financial ratios and member months for the first and second measurement periods (&#8220;PCCCV contingent consideration&#8221;). The first measurement period is the first day of the month immediately following the close and ending on June 30, 2024. The second measurement period is for one year after the first measurement period. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, the first metric had been met, and $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million was paid in the fourth quarter of 2024. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the second metric was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively and was included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the PCCCV contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">CHS</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Upon acquiring </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% of the equity interest of CHS in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled i</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">n cash, contingent upon CHS achieving a gross profit per total member months metric for fiscal year 2025 (&#8220;CHS 2025 Gross Profit PMPM Metric&#8221;) and member enrollment metrics (&#8220;CHS Member Enrollment Metrics&#8221;</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">) measured over four measurement periods and an additional fifth measurement period contingent upon acquisition of an entity (the &#8220;earnout period&#8221;) (collectively, &#8220;CHS contingent consideration&#8221;). For the CHS Member Enrollment Metrics, the first measurement period means the period commencing on the first day immediately following the closure of CHS and ending on the one-year anniversary thereof. The second, third, fourth, and fifth measurement periods are for one year after each of the previous respective measurement periods. If the metrics are achieved, the contingent liability will be paid after the end of the earnout period. The Company will pay up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for the CHS 2025 Gross Profit PMPM Metric, and up to $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million for each metric achieved for each measurement period, or up to a total of $</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million, for the CHS Member Enrollment Metrics. T</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">he Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the CHS contingent consideration was valued at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The CHS 2025 Gross Profit PMPM Metric was included in other liabilities and the CHS Member Enrollment Metrics were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CHS contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Basis of Presentation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying condensed consolidated balance sheet at December 31, 2024, has been derived from the Company&#8217;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;). The accompanying unaudited condensed consolidated financial statements as of March 31, 2025, and for the three months ended March 31, 2025 and 2024, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025. In the opinion of management, all material adjustments (consisting of normal recurring adjustments as well as intercompany accounts and transactions, which have been eliminated) considered necessary for a fair presentation have been made to make the condensed consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, or any future periods.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Principles of Consolidation</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, and the condensed consolidated statements of income for the three months ended March 31, 2025 and 2024, include Astrana&#8217;s wholly owned subsidiaries and consolidated VIEs. All intercompany transactions and balances have been eliminated in consolidation.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The unaudited condensed consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read, or have access to, our audited consolidated financial statements for the fiscal year ended December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment assessment, accrual of medical liabilities (incurred but not reported (&#8220;IBNR&#8221;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including estimations of affiliated hospitals&#8217; claims costs which involves assumptions for IBNR, such as utilization of healthcare services, historical payment patterns, cost trends, seasonality, changes in membership, and other factors), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Business Combinations</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination which are expensed as incurred.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Cash and Cash Equivalents</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains its cash in deposit accounts with several banks, which at times may exceed the insured limits of the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents and restricted cash. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, the Company&#8217;s deposit accounts with banks exceeded the FDIC&#8217;s insured limit by approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">266.7</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">332.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#8217;s concentration of risk exposure.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock', window );">Receivables, Receivables &#8211; Related Parties, Other Receivables and Loan Receivables</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Receivables, Receivables &#8211; Related Parties, Other Receivables, and Loan Receivables</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables are comprised of accounts receivable, capitation and fee-for-service receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s receivables &#8211; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#8211; related parties are recorded and stated in the amount expected to be collected.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s loan receivables consist of promissory notes that accrue interest per annum and are recorded and stated at amortized cost plus accrued interest. Interest income is accrued based on the outstanding principal amounts. As of March 31, 2025, promissory notes are expected to be collected by their maturity dates.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation receivables relate to each health plan&#8217;s capitation revenue and are usually received by the Company in the month following the month of service. Capitation receivables also include receivables from the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;) related to the Company&#8217;s participation in the ACO REACH model. Risk pool settlements and incentive receivables mainly consist of the Company&#8217;s hospital shared-risk pool receivable, which is recorded quarterly based on reports received from the Company&#8217;s hospital partners and management&#8217;s estimate of the Company&#8217;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> months after the risk pool performance year is completed.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other receivables consist of amounts due from the seller associated with acquisitions, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company maintains reserves for potential credit losses on the receivables. Management reviews the composition of the Company&#8217;s receivables and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected, and adjustments are recorded when necessary. Reserves are recorded based on historical trends. Any change in such an estimate of reserves is recorded in the period when such change is identified.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided, and collection is reasonably likely to occur. The Company continuously monitors its receivables collections, and it expects that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#8220;CECL&#8221;) model.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risks</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Concentrations of Credit Risks</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts, as used by our chief operating decision makers (&#8220;CODMs&#8221;). The condensed consolidated statements of income present disaggregated revenue by service type. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents disaggregated revenue generated by each payer type </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands): <br/></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div style="font-size:10pt;font-family:Times New Roman;">
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,081</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49,512</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicare</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">389,352</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">246,564</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicaid</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173,158</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,263</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other third parties</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,799</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,017</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.0</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer B</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer C</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer D</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Less than 10% of total net revenues</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers that contributed to the following percentages of receivables, net, receivables &#8211; related parties, and other receivables:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:64.527%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of March 31,<br/>2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,<br/>2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer F</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.6</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
         </table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Revenue Recognition</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company receives payments from the following sources for services rendered:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commercial insurers;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal government under the Medicare program administered by CMS;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">State governments under Medicaid and other programs;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other third-party payers (e.g., hospitals and IPAs); and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Individual patients and clients.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue primarily consists of the following:</span></p><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Capitation revenue;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Risk pool settlements and incentives;</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Management fee income; and</span></div></div><div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">&#8226;</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FFS revenue.</span></div></div><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related collection risk for such services may vary by type of revenue and the customer.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Income Taxes</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company uses a recognition threshold of &#8220;more-likely-than-not&#8221; and a measurement attribute on all tax positions taken, or expected to be taken, in a tax return in order to be recognized in the condensed consolidated financial statements. Once the recognition threshold is met, the tax position is measured to determine the actual amount of benefit to recognize in the condensed consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="font-size:10pt;font-family:Times New Roman;"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Recent Accounting Pronouncements Not Yet Adopted</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In December 2023, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update (&#8220;ASU&#8221;) 2023-09 &#8220;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#8221; to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#8217;s annual periods beginning January 1, 2025, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a significant impact on its consolidated financial statements and related disclosures.</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In November 2024, the FASB issued ASU 2024-03 &#8220;Income Statement &#8212; Reporting Comprehensive Income &#8212; Expense Disaggregation Disclosures (Subtopic 220-40)&#8221; to provide disaggregated information about certain income statement costs and expenses. ASU 2024-03 is effective for the Company&#8217;s annual periods beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other than the new standards discussed above, there have been no other recent accounting pronouncements not yet adopted that are expected to have significance, or potential significance, to the Company&#8217;s financial position, results of operations, and cash flows.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"></span></p></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Derivative Financial Instruments</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Interest Rate Collar Agreements</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From time to time, the Company enters into agreements designed to limit the interest rate risk associated with the Company&#8217;s Revolver Loan, including the collar agreement. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#8217;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#8212; &#8220;Credit Facility, Bank Loans, and Lines of Credit&#8221; for further information on the Company&#8217;s debt. Under the terms of the agreement, the ceiling is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">% and the floor is </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">%.  The collar agreement is not designated as a hedging instrument. Changes in the fair value of this contract are recognized as unrealized gain or loss on investments in the accompanying condensed consolidated statements of income and reflected in the accompanying condensed consolidated statements of cash flows as unrealized (gain) loss on investments. The estimated fair value of the collar was determined using Level 2. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the fair value of the collar was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and presented within</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> other liabilities in the accompanying condensed consolidated balance sheets.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Investments in Marketable Securities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Investments in Marketable Securities</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ninety days</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025 and December 31, 2024, certificates of deposit amounted to approximately </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.</span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Receivables and receivables from related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue by Each Payor Type</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents disaggregated revenue generated by each payer type </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(in thousands): <br/></span>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.62%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commercial</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">46,081</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">49,512</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicare</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">389,352</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">246,564</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medicaid</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173,158</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">81,263</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other third parties</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,799</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,017</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
           <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Schedule of Contributions to Revenue and Receivables by Payor</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:66.993%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.16%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:13.343%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">34.0</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer B</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer C</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.5</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer D</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;word-break:break-word;">
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">*</span></p></td>
           <td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Less than 10% of total net revenues</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company had major payers that contributed to the following percentages of receivables, net, receivables &#8211; related parties, and other receivables:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
         <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
          <tr style="visibility:collapse;">
           <td style="width:64.527%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:1.1%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
           <td style="width:14.637%;box-sizing:content-box;"></td>
           <td style="width:1%;box-sizing:content-box;"></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of March 31,<br/>2025</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">As of December 31,<br/>2024</span></p></td>
           <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer A</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer F</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17.6</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16.1</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
          <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payer E</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12.9</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
           <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18.3</span></p></td>
           <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
          </tr>
         </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions, by Acquisition</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">63,935</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due from seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,995</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">60,940</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,950</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,007</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,600</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,571</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,464</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,001</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,093</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,430</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,524</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">60,940</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:74.1%;box-sizing:content-box;"></td>
         <td style="width:1.8%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">CHS</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total purchase consideration:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,322</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Purchase price due to seller</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,944</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingent consideration</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,154</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common stock issued and replacement awards</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47,538</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,556</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">92,393</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,336</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">357</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,200</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,444</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">168,064</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">68,276</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52,328</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Non-controlling interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">78</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities assumed</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">120,526</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total net assets acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">47,538</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Unaudited Pro Forma Financial Information</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">pro forma </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.34%;box-sizing:content-box;"></td>
         <td style="width:1.84%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;">(in thousands, except per share amounts)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678,640</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income attributable to Astrana Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19,171</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.41</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net income per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Change in Carrying Value of Goodwill</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the carrying value of goodwill for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">419,253</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Adjustments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">416,386</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets, Net</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:12.803%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.802000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">171,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116,499</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55,418</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,832</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,259</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,573</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,893</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,184</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,011</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">371</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">640</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">56</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">275,054</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">163,138</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">111,916</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">At December 31, 2024, intangible assets, net, consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:43.869%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:12.803%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.802000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.24%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.782%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Useful<br/>Life<br/>(Years)</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Gross<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Accumulated<br/>Amortization</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Net<br/>December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Indefinite lived assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,150</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Licenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">N/A</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,900</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortized intangible assets:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Network relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">171,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">114,046</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">57,871</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Management contracts</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,832</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,953</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,879</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Member relationships</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">-</span><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">73,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,406</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,671</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Patient management platform</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,060</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Tradename/trademarks</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,011</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">358</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">653</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Developed technology</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6</span></span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">52</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">55</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">275,054</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">156,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">118,179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:75.76%;box-sizing:content-box;"></td>
         <td style="width:2.14%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:20.099999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,395</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,295</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,808</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,397</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">107,866</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments Activity</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">For the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, the Company&#8217;s equity method investment activity and balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.11%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:11.044%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.464%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.2%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.044%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>(Loss) Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">343</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,785</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,660</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,664</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,612</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">264</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,077</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">% - </span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">51</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,842</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">347</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">843</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,552</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,319</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">347</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,005</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments including those from the CHS acquisition.</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:0.575;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:25.115%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:11.047%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:10.447999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.201%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.046999999999999%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">% of<br/>Ownership</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2023</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Initial<br/>Investment</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Allocation<br/>of Net<br/>Income</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Distribution</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">LaSalle Medical Associates &#8211; IPA line of business</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,866</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">359</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,225</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Pacific Medical Imaging &amp; Oncology Center, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,691</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,718</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CAIPA MSO, LLC</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,660</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">186</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,846</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health, Inc.</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">557</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">60</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">617</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,774</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">632</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">35,893</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Other consists of smaller equity method investments.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s accounts payable and accrued expenses consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and other accruals</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,911</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,168</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Capitation payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,703</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,639</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Subcontractor IPA payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,845</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,486</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Professional fees</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,512</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,809</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Due to related parties</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,111</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,924</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contract liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">686</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,606</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accrued compensation</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">13,752</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22,409</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other provider payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,039</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40,101</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105,559</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,142</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Medical Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s medical liabilities consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, beginning of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">209,039</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">106,657</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Acquired</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,256</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,645</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Components of medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">384,479</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,735</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">658</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,419</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total medical care costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">383,821</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">233,316</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Payments for medical care costs related to claims incurred:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Current period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">229,701</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,014</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prior periods</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">145,938</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">94,335</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Claims paid for acquired balance</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,864</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,775</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total paid</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">380,503</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">234,124</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Medical liabilities, end of period</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">204,101</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">136,494</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Credit Facility</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s debt balance consisted of the following (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31,<br/>2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31,<br/>2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Term Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">250,000</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">281,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revolver Loan</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">162,000</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">146,732</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Promissory Note Payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">438,107</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Current portion of debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,375</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: Unamortized financing costs</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,481</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,433</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term debt</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">403,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">425,299</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Commitments of Credit Facility</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are the future commitments, as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, of the Company&#8217;s debt for the years ending December 31 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,375</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,500</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,063</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">18,750</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">23,437</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,750</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">421,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expense</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table summarizes the stock-based compensation expense recognized under all of the Company&#8217;s stock plans for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024, and associated with the issuance of restricted shares of common stock and restricted stock units and vesting of stock options that are included in general and administrative expenses in the accompanying condensed consolidated statements of income (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:55.391%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.424%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.88%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:18.424%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended<br/>March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options and ESPP</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">70</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">349</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,399</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total stock-based compensation expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,811</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,748</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock', window );">Schedule of Fees Incurred and Revenue Earned from Related Party Transactions</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following tables set forth revenue recognized and fees incurred related to AHMC, HSMSO, and Aurion for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">three months ended March 31, 2025 and 2024 (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:32.667%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:8.122%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">AHMC</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">HSMSO</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Aurion</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Revenue</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,771</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,920</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">301</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">31,680</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,557</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,909</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,363</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">301</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share Computations</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.2%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.26%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.419999999999998%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.14</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.31</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Earnings per share &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.14</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">0.31</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,470,682</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,260,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,850,666</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,699,537</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Shares Included in the Diluted Earnings Per Share Computations</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Below is a summary of the shares included in the diluted earnings per share computations:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:64.187%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.737%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:16.877%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three months ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; basic</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,470,682</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,260,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Stock options</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">112,858</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">188,083</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted stock awards and units</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">130,055</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">225,128</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Contingently issuable shares</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">137,071</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,975</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Weighted average shares of common stock outstanding &#8211; diluted</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,850,666</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">47,699,537</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Assets and Liabilities, Variable Interest Entities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table includes assets that can only be used to settle the liabilities of the Company&#8217;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#8217;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolida</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">tion, are included in the accompanying condensed consolidated balance sheets (in thousands).</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash and cash equivalents</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">150,013</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">158,922</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in marketable securities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,283</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,259</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">71,820</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,977</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Receivables, net &#8211; related party</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">54,873</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,251</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other receivables</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">22</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,303</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Prepaid expenses and other current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,917</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,161</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">285,928</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">318,873</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Property and equipment, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,528</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,875</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intangible assets, net</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">83,582</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">87,840</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Goodwill</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">241,531</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">243,283</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income taxes receivable, non-current</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,943</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,943</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investments in other entities &#8211; equity method</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,063</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15,442</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in a privately held entity</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">405</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">405</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Investment in affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190,178</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224,894</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Restricted cash</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">40</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease right-of-use assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">26,033</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,585</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,055</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,019</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">582,358</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">618,326</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">868,286</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">937,199</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
         <td style="width:46.451%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:2.36%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:22.416%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">December 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Accounts payable and accrued expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">37,804</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,800</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Fiduciary accounts payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,840</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8,223</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Medical liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">100,547</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">105,486</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dividend payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">638</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">638</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income tax payable</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,140</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,041</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">520</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,076</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,487</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,348</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amount due to affiliates*</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,548</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48,142</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">173,392</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">222,688</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Deferred tax liability</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,905</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,237</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">451</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">520</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease liabilities, net of current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,006</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21,012</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Other long-term liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,890</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">619</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total non-current liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,252</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,388</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">216,644</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">256,076</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">*Investment in affiliates includes the Company&#8217;s VIEs&#8217; investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#8217;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#8217;s condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Information Related to Lease Costs</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The components of lease expense were as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,611</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,159</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance lease cost</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Amortization of lease expense</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">147</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest on lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sublease income</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">226</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease cost</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,730</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,136</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other information related to leases was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Supplemental Cash Flow Information</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cash paid for amounts included in the measurement of lease liabilities:</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,017</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,837</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Financing cash flows from finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">147</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">179</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.343%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:13.343%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Remaining Lease Term</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7.22</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">8.39</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.34</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2.96</span></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;years</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Weighted Average Discount Rate</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Operating leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.75</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6.15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Finance leases</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.79</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5.53</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">%</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments Under Non-cancelable Leases</a></td>
<td class="text"><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Operating<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Finance<br/>Leases</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2025 (excluding the three months ended March 31, 2025)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,269</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">443</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2026</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,851</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">345</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2027</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,246</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">267</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2028</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,973</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2029</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,882</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thereafter</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">14,876</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total future minimum lease payments</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,097</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,091</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: imputed interest</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,155</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,942</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,014</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Less: current portion</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,979</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">471</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Long-term lease liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,963</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">543</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating and finance lease, liability, maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Information about our Segments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The following table presents information about the Company&#8217;s segments (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,951</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,690</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,749</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,698</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,813</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,511</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">600,951</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,388</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">39,562</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,511</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">620,390</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">512,668</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">27,139</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">25,818</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,564</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">549,061</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,068</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,357</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10,209</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,950</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">50,746</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">556,736</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,496</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">36,027</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">53,514</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">599,807</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">44,215</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,108</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,535</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,062</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">20,583</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:31.16%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.7%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.44%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:7.72%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.56%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31, 2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Partners</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Delivery</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Care<br/>Enablement</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Intersegment<br/>Elimination</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Corporate<br/>Costs</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Consolidated<br/>Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Third-Party</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,318</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,878</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,160</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Intersegment</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,841</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,114</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,955</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total revenues</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">382,318</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,719</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">33,274</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">41,955</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">404,356</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cost of services</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">300,189</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">24,794</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">17,373</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,957</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">330,399</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">General and administrative</span><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(1)</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">38,933</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,163</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">12,397</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,818</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total expenses</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">339,122</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,957</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">29,770</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">42,032</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">374,217</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:9pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Income (loss) from operations</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">43,196</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">238</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,504</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">77</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;">(2)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;">(</span><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">16,400</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,139</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(1)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Balance includes general and administrative expenses, and depreciation and amortization. </span></div></div><div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(2)</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income that is not presented in the table. </span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Carrying Amounts and Fair Values of Financial Instruments</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,755</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,755</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,313</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">84</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call option</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,152</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,867</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,019</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,309</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,309</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,170</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">11,170</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,450</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,450</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,741</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,075</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">21</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,037</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">32,133</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The carrying amounts and fair values of the Company&#8217;s financial instruments as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">December 31, 2024, are presented below (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:50.38%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.22%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:9.184000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Fair Value Measurements</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 1</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 2</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Level 3</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Total</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Assets</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Money market accounts*</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,673</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,673</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; certificates of deposit</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,289</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,289</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Marketable securities &#8211; equity securities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">89</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">I Health call options</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Interest rate collar</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total assets</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">6,051</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">19</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">3,778</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,848</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Liabilities</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">AAMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">VOMG contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">15</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sun Labs remaining equity interest purchase</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">7,352</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">ADSC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,285</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4,285</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CFC contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,949</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">9,949</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">PCCCV contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,351</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">CHS contingent consideration</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,643</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5,643</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Total liabilities</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">2,110</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#8212;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,595</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,705</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">* Included in cash and cash equivalents</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Change in Fair Value of Level 3 Liabilities</a></td>
<td class="text"><p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in the fair value of Level 3 </span><span style="font-size:10pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_a6133d98-7b94-492e-8834-b1b4530ae2ee;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">liabilities is recognized in unrealized loss on investments, other income, or general and administrative expenses</span></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> in the accompanying condensed consolidated statements of income. As of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">March 31, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):</span></p><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:80.24%;box-sizing:content-box;"></td>
         <td style="width:1.94%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:15.82%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Amount</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at January 1, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">28,595</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Change in fair value of existing Level 3 liabilities</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">1,442</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Balance at March 31, 2025</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">30,037</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Schedule of Change in Fair Value on Equity Securities Held</a></td>
<td class="text"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The change in fair value on equity securities held are as follows (in thousands) for the periods listed below and </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> securities had been sold in the respective periods:</span><p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
       <table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;">
        <tr style="visibility:collapse;">
         <td style="width:66.993%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:1.62%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
         <td style="width:12.883000000000001%;box-sizing:content-box;"></td>
         <td style="width:1%;box-sizing:content-box;"></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Three Months Ended March 31,</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;">
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"> </span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2025</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">2024</span></p></td>
         <td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
        </tr>
        <tr style="height:10pt;background-color:#cff0fc;word-break:break-word;">
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Unrealized gains (losses) recognized on equity securities held at end of period</span></p></td>
         <td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"><p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">5</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">$</span></p></td>
         <td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">116</span></p></td>
         <td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;font-kerning:none;min-width:fit-content;">)</span></p></td>
        </tr>
       </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Amount deposit accounts exceeded FDIC insured limit</a></td>
<td class="nump">$ 266,700<span></span>
</td>
<td class="nump">$ 332,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear', window );">Risk pool surplus or deficits, settlement period after performance year</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">$ 686<span></span>
</td>
<td class="nump">$ 1,606<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Risk Pool Surplus Or Deficits, Settlement Period After Performance Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 620,390<span></span>
</td>
<td class="nump">$ 404,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_CommercialMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">46,081<span></span>
</td>
<td class="nump">49,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">389,352<span></span>
</td>
<td class="nump">246,564<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">173,158<span></span>
</td>
<td class="nump">81,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=asth_OtherThirdPartiesMember', window );">Other third parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 11,799<span></span>
</td>
<td class="nump">$ 27,017<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_CommercialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_CommercialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_OtherThirdPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_OtherThirdPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">33.10%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">15.30%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">10.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Net Revenue | Payer E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">10.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables, Net and Receivables-Related Parties and Other Receivables | Payer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">44.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables, Net and Receivables-Related Parties and Other Receivables | Payor F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">17.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables, Net and Receivables-Related Parties and Other Receivables | Payer E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_AccountsReceivableAndNetRevenueLineItems', window );"><strong>Accounts Receivable And Net Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_AccountsReceivableAndNetRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_AccountsReceivableAndNetRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=asth_PayorFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=asth_PayorFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Goodwill - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 04, 2024 </div>
<div>USD ($) </div>
<div>State </div>
<div>Member</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Decrease in goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Impairment of goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember', window );">AHMS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,940,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,935,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EstimatedWorkingCapitalAdjustments', window );">Estimated working capital adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 47,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NumberOfMedicareMembers', window );">Number of medicare members | Member</a></td>
<td class="nump">129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states | State</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">$ 35,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EstimatedWorkingCapitalAdjustments', window );">Estimated working capital adjustments</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ReplacementOfRestrictedStockAwards', window );">Replacement of restricted stock awards</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">Community Family Care Medical Group IPA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">47,538,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">$ 35,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EstimatedWorkingCapitalAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated working capital adjustments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EstimatedWorkingCapitalAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NumberOfMedicareMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of medicare members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NumberOfMedicareMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ReplacementOfRestrictedStockAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Replacement of restricted stock awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ReplacementOfRestrictedStockAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Oct. 04, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 416,386<span></span>
</td>
<td class="nump">$ 419,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">CFC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TotalPurchaseConsiderationAbstract', window );"><strong>Total purchase consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="nump">$ 35,322<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller', window );">Purchase price due to (from) seller</a></td>
<td class="nump">6,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Contingent consideration</a></td>
<td class="nump">5,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Common stock issued and replacement awards</a></td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">47,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">4,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="nump">92,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other receivables</a></td>
<td class="nump">44,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="nump">14,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod', window );">Investments in other entities - equity method</a></td>
<td class="nump">2,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">168,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">68,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities', window );">Medical liabilities</a></td>
<td class="nump">52,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest', window );">Non-controlling interest</a></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">120,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="nump">$ 47,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember', window );">AHMS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_TotalPurchaseConsiderationAbstract', window );"><strong>Total purchase consideration:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,935<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller', window );">Purchase price due to (from) seller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,995)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities', window );">Medical liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,524<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Total net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Consideration Purchase Price due to (from) Seller</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business combination recognized identifiable assets acquired and liabilities assumed current assets investments in other entities equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Accounts Payable And Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Medical Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_TotalPurchaseConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Purchase Consideration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_TotalPurchaseConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AdvancedHealthManagementSystemsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Goodwill - Schedule of Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 419,253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillPurchaseAccountingAdjustments', window );">Adjustments</a></td>
<td class="num">(2,867)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 416,386<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 16<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479405/805-10-25-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Total revenue | $</a></td>
<td class="nump">$ 678,640<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income attributable to Astrana Health, Inc. | $</a></td>
<td class="nump">$ 19,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net income per share - basic (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net income per share - diluted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -SubTopic 10<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (163,138)<span></span>
</td>
<td class="num">$ (156,875)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">107,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible Assets, Gross</a></td>
<td class="nump">275,054<span></span>
</td>
<td class="nump">275,054<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">111,916<span></span>
</td>
<td class="nump">118,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived assets</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember', window );">Licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived assets</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">171,917<span></span>
</td>
<td class="nump">171,917<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(116,499)<span></span>
</td>
<td class="num">(114,046)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 55,418<span></span>
</td>
<td class="nump">$ 57,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember', window );">Network relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">21 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember', window );">Management contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 22,832<span></span>
</td>
<td class="nump">$ 22,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(18,259)<span></span>
</td>
<td class="num">(17,953)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">4,573<span></span>
</td>
<td class="nump">4,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">73,077<span></span>
</td>
<td class="nump">73,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(25,893)<span></span>
</td>
<td class="num">(22,406)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 47,184<span></span>
</td>
<td class="nump">$ 50,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember', window );">Member relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember', window );">Patient management platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 2,060<span></span>
</td>
<td class="nump">$ 2,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (2,060)<span></span>
</td>
<td class="num">$ (2,060)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Tradename/trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">20 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 1,011<span></span>
</td>
<td class="nump">$ 1,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(371)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="nump">$ 653<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Amortized intangible assets, Gross</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(56)<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 51<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_NetworkRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_ManagementContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_MemberRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=asth_PatientManagementPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of finite-lived intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2025 (excluding the three months ended March 31, 2025)</a></td>
<td class="nump">$ 18,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2026</a></td>
<td class="nump">20,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2027</a></td>
<td class="nump">16,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2028</a></td>
<td class="nump">14,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2029</a></td>
<td class="nump">11,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour', window );">Thereafter</a></td>
<td class="nump">26,894<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">$ 107,866<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Asset, Expected Amortization, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Schedule of Equity Method Investments Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 39,319<span></span>
</td>
<td class="nump">$ 25,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="num">(347)<span></span>
</td>
<td class="nump">9,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="num">(867)<span></span>
</td>
<td class="nump">632<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 38,005<span></span>
</td>
<td class="nump">$ 35,893<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember', window );">LaSalle Medical Associates - IPA Line of Business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 13,128<span></span>
</td>
<td class="nump">$ 9,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="num">(343)<span></span>
</td>
<td class="nump">359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 12,785<span></span>
</td>
<td class="nump">$ 10,225<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember', window );">Pacific Medical Imaging &amp; Oncology Center, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 1,660<span></span>
</td>
<td class="nump">$ 1,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 1,664<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOLLCMember', window );">CAIPA MSO, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 14,612<span></span>
</td>
<td class="nump">$ 13,660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 14,876<span></span>
</td>
<td class="nump">$ 13,846<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">$ 6,077<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">6,128<span></span>
</td>
<td class="nump">$ 9,487<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Beginning Balance</a></td>
<td class="nump">3,842<span></span>
</td>
<td class="nump">$ 557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="num">(347)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Allocation of Net Income (Loss)</a></td>
<td class="num">(843)<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount', window );">Distribution</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Ending Balance</a></td>
<td class="nump">$ 2,552<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Other | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember', window );">Other | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentAdditionalInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentAdditionalInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentSoldCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the entity's equity method investment which has been sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentSoldCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_LasalleMedicalAssociatesIpaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PacificMedicalImagingAndOncologyCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CAIPAMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=us-gaap_OtherInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Other Entities - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="num">$ (347,000)<span></span>
</td>
<td class="nump">$ 9,487,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="nump">8,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,896,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum exposure to loss amount</a></td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EquityMethodInvestmentAdditionalInvestment', window );">Initial Investment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 9,487,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EquityMethodInvestmentAdditionalInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Additional Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EquityMethodInvestmentAdditionalInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of Investment in privately held entity that does not report net asset value per share .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 24, 2025</div></th>
<th class="th"><div>Jan. 29, 2024</div></th>
<th class="th"><div>Jul. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,134,000<span></span>
</td>
<td class="nump">$ 51,266,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember', window );">IntraCare Convertible Promissory Note Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,300,000<span></span>
</td>
<td class="nump">28,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember', window );">IntraCare Convertible Promissory Note Receivable | Convertible Secured Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.81%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Mature Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 27,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_BassMedicalGroupMember', window );">BASS Medical Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loans receivable, non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,200,000<span></span>
</td>
<td class="nump">$ 21,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Loans receivable, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_BassMedicalGroupMember', window );">BASS Medical Group | Senior Secured Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt, principal sum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Mature Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_BassMedicalGroupMember', window );">BASS Medical Group | Senior Secured Promissory Note | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal balance payable in monthly installments</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Mature Date</a></td>
<td class="text">Jan. 11,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_IntraCareConvertiblePromissoryNoteReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_BassMedicalGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_BassMedicalGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_SeniorSecuredPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_SeniorSecuredPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accruals</a></td>
<td class="nump">$ 14,911<span></span>
</td>
<td class="nump">$ 15,168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SpecialtyCapitationPayableCurrent', window );">Capitation payable</a></td>
<td class="nump">15,703<span></span>
</td>
<td class="nump">10,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_SubcontractorIPAPayable', window );">Subcontractor IPA payable</a></td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">2,486<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">3,512<span></span>
</td>
<td class="nump">5,809<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyDepositLiabilities', window );">Due to related parties</a></td>
<td class="nump">7,111<span></span>
</td>
<td class="nump">7,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract liabilities</a></td>
<td class="nump">686<span></span>
</td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">13,752<span></span>
</td>
<td class="nump">22,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other provider payable</a></td>
<td class="nump">48,039<span></span>
</td>
<td class="nump">40,101<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued expenses</a></td>
<td class="nump">$ 105,559<span></span>
</td>
<td class="nump">$ 106,142<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SpecialtyCapitationPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of specialty capitation payable current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SpecialtyCapitationPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_SubcontractorIPAPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subcontractor IPA Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_SubcontractorIPAPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyDepositLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deposits held by the entity for a related party (entity, shareholder, employee).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyDepositLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Medical Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Medical Liabilities [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, beginning of period</a></td>
<td class="nump">$ 209,039<span></span>
</td>
<td class="nump">$ 106,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquired</a></td>
<td class="num">(8,256)<span></span>
</td>
<td class="nump">30,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Components of medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current period</a></td>
<td class="nump">384,479<span></span>
</td>
<td class="nump">234,735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior periods</a></td>
<td class="num">(658)<span></span>
</td>
<td class="num">(1,419)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total medical care costs</a></td>
<td class="nump">383,821<span></span>
</td>
<td class="nump">233,316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Payments for medical care costs related to claims incurred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current period</a></td>
<td class="num">(229,701)<span></span>
</td>
<td class="num">(130,014)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior periods</a></td>
<td class="num">(145,938)<span></span>
</td>
<td class="num">(94,335)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance', window );">Claims paid for acquired balance</a></td>
<td class="num">(4,864)<span></span>
</td>
<td class="num">(9,775)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(380,503)<span></span>
</td>
<td class="num">(234,124)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities, end of period</a></td>
<td class="nump">$ 204,101<span></span>
</td>
<td class="nump">$ 136,494<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for unpaid claims and claims adjustment expense claims paid for acquired balance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 421,875<span></span>
</td>
<td class="nump">$ 438,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of debt</a></td>
<td class="num">(12,500)<span></span>
</td>
<td class="num">(9,375)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized financing costs</a></td>
<td class="num">(5,481)<span></span>
</td>
<td class="num">(3,433)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">403,894<span></span>
</td>
<td class="nump">425,299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">162,000<span></span>
</td>
<td class="nump">146,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">281,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Less: Unamortized financing costs</a></td>
<td class="num">(5,500)<span></span>
</td>
<td class="num">(3,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember', window );">Promissory Note Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt</a></td>
<td class="nump">$ 9,875<span></span>
</td>
<td class="nump">$ 9,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableToBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2025 (excluding the nine months ended March 31, 2025)</a></td>
<td class="nump">$ 9,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2026</a></td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2027</a></td>
<td class="nump">27,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2028</a></td>
<td class="nump">18,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2029</a></td>
<td class="nump">23,437<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour', window );">Thereafter</a></td>
<td class="nump">330,750<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total</a></td>
<td class="nump">$ 421,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt maturities repayments of principal after year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th">
<div>Feb. 26, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 01, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 10, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstsnding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 421,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 438,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.96%<span></span>
</td>
<td class="nump">6.51%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Loan from company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 421,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember', window );">Other Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtFinancingExpense', window );">Debt financing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=asth_DelayedDrawTermLoanAMember', window );">DDTL A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstsnding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of debt financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantLeverageRatioMaximum', window );">Maximum consolidated leverage ratio (not greater than)</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | As of last day each fiscal quarter thereafter</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantLeverageRatioMaximum', window );">Maximum consolidated leverage ratio (not greater than)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum', window );">Minimum consolidated interest coverage ratio (not less than)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Secured Overnight Financing Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Revolver Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstsnding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Delayed Draw Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Revolving credit facility term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 745,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Amount outstsnding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Average effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_IHealthPromissioryNoteMember', window );">I Health Promissiory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Payments on promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DebtInstrumentIncreaseInOriginalPrincipalAmount', window );">Additional Principal Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansPayable', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditFacilityMember', window );">Amended Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | APC Business Loan Agreement | Preferred Bank | Allied Pacific Of California IPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Allied Pacific Of California IPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit | Amended Credit Agreement | Truist Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationPeriod', window );">Term of facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtFinancingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt financing expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtFinancingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantInterestCoverageRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Interest Coverage Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantInterestCoverageRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DebtInstrumentIncreaseInOriginalPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument increase in original principal amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DebtInstrumentIncreaseInOriginalPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_DelayedDrawTermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_DelayedDrawTermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=asth_AsOfLastDayEachFiscalQuarterThereafterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=asth_AsOfLastDayEachFiscalQuarterThereafterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=asth_SecuredOvernightFinancingRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=asth_SecuredOvernightFinancingRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=asth_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=asth_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_DelayedDrawTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_DelayedDrawTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_IHealthPromissioryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_IHealthPromissioryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_ApcBusinessLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_PreferredBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_PreferredBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Mezzanine Deficit and Stockholders' Equity - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_StockIssuedDuringPeriodSharesMerger', window );">Holdback shares not issued to former shareholders (in shares)</a></td>
<td class="nump">41,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Shares repurchased</a></td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="nump">9,903,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,603,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Treasury stock repurchased (in shares)</a></td>
<td class="nump">3,771,151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,471,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepurchaseAgreementDate', window );">Stock repurchase agreement date</a></td>
<td class="text">Jan. 17,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="nump">$ 5,455,000<span></span>
</td>
<td class="nump">$ 95,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Aggregate purchase price</a></td>
<td class="nump">$ 10,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="nump">6,132,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,132,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Aggregate purchase price</a></td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DistributionOfShares', window );">Distribution of shares</a></td>
<td class="nump">699,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionPayable', window );">Cash distribution</a></td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Apollo Medical Holdings, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">% of Ownership</a></td>
<td class="nump">11.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.96%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CDSCMember', window );">CDSC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Payments of ordinary dividends common stock</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CompanyAndAPCMember', window );">Company And APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, common, shares (in shares)</a></td>
<td class="nump">9,903,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,603,849<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DistributionOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Distribution of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DistributionOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_StockIssuedDuringPeriodSharesMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to merger.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_StockIssuedDuringPeriodSharesMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution payable to ownership interest holder from investment income and return of capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478790/946-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepurchaseAgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date of repurchase agreement, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-12A(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.12-12(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column A)(Footnote 2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepurchaseAgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_ApolloMedicalHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_ApolloMedicalHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CDSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CDSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CompanyAndAPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CompanyAndAPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 7,811<span></span>
</td>
<td class="nump">$ 5,748<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember', window );">Stock options and ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember', window );">Restricted stock awards and units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 7,741<span></span>
</td>
<td class="nump">$ 5,399<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_StockAwardsAndUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation expense | $</a></td>
<td class="nump">$ 44.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Number of shares issued under stock purchase plan</a></td>
<td class="nump">10,683<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards and Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares)</a></td>
<td class="nump">417,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance', window );">Contingent on performance (in shares)</a></td>
<td class="nump">234,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 27.61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember', window );">Performance Based Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 27.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=asth_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommonStockDiscountedPricePercentage', window );">Common stock, discounted price, percentage</a></td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommonStockDiscountedPricePercentageMaximum', window );">Common stock, discounted price, percentage (up to)</a></td>
<td class="nump">90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized for issuance (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards and Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">1 month<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards and Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CommonStockDiscountedPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Discounted Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CommonStockDiscountedPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CommonStockDiscountedPricePercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Discounted Price, Percentage, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CommonStockDiscountedPricePercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_PerformanceBasedRestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=asth_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=asth_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Feb. 26, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Amount outstanding</a></td>
<td class="nump">$ 421,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_SuretyBondMember', window );">Surety Bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="nump">$ 46,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityExpirationDate1', window );">Bonds expiration period</a></td>
<td class="text">Dec. 31,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember', window );">Amended Credit Agreement | Truist Bank | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum loan availability</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the credit facility terminates, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_SuretyBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_SuretyBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=asth_AmendedCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=asth_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 620,390,000<span></span>
</td>
<td class="nump">$ 404,356,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">30,698,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,601,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_RelatedPartyExpensesPayable', window );">Expenses payable</a></td>
<td class="nump">2,200,000<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="nump">8,896,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,896,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">33,942,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">4,979,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,350,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of shares</a></td>
<td class="nump">10,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=asth_ThirdWayHealthIncMember', window );">Third Way Health | Agreement for Future Equity Fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue', window );">Investments in privately held entities</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">14,491,000<span></span>
</td>
<td class="nump">17,377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember', window );">First Commonwealth Property, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AlliedPacificHoldingsInvestmentManagementLLCMember', window );">Allied Pacific Holdings Investment Management, LLC | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AHMCMember', window );">AHMC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCreditsAndOtherLiabilities', window );">Amount outstanding under agreement</a></td>
<td class="nump">53,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AHMCMember', window );">AHMC | Related Party | Risk pool settlements and incentives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">8,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AHMCMember', window );">AHMC | Arroyo Vista | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of shares</a></td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Sunny Village Care Center | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Board Members | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">6,500,000<span></span>
</td>
<td class="nump">4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC | Board Members Who Are Also Officers | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember', window );">AMG | First Commonwealth Property, LLC | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">42,000<span></span>
</td>
<td class="nump">38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember', window );">AMG | Allied Pacific Holdings Investment Management, LLC | Office Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc. | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Incurred expenses</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember', window );">PMIOC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember', window );">PMIOC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember', window );">Song PC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember', window );">Song PC | Provider Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS | Related Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Incurred expenses</a></td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of Investment in privately held entity that does not report net asset value per share .</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_RelatedPartyExpensesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party, Expenses Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_RelatedPartyExpensesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCreditsAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCreditsAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=asth_ThirdWayHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=asth_ThirdWayHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_PrivateEquityFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_FirstCommonwealthPropertyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AlliedPacificHoldingsInvestmentManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AlliedPacificHoldingsInvestmentManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_ArroyoVistaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_ArroyoVistaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_SunnyVillageCareCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_ProviderServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_ProviderServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_BoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_BoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_BoardMembersWhoAreAlsoOfficersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_BoardMembersWhoAreAlsoOfficersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ProfessionalMedicalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_OfficeLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_OfficeLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_PmiocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_SongPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CollaborativeHealthSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_CollaborativeHealthSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">$ 6,771<span></span>
</td>
<td class="nump">$ 9,920<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">31,680<span></span>
</td>
<td class="nump">7,557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AHMCMember', window );">AHMC | Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="num">(24,909)<span></span>
</td>
<td class="nump">2,363<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_HSMSOMember', window );">HSMSO | Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">Aurion | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">Aurion | Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=asth_AurionMember', window );">Aurion | Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Related party transaction, amount of transaction</a></td>
<td class="num">$ (100)<span></span>
</td>
<td class="num">$ (50)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AHMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AHMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueRecognizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueRecognizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionExpensesIncurredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionExpensesIncurredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=asth_RelatedPartyTransactionRevenueExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_HSMSOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_HSMSOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=asth_AurionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=asth_AurionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">35.20%<span></span>
</td>
<td class="nump">29.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would reduce annual effective tax rate</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Interest and penalties related to unrecognized tax benefits</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Additional Information (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">409,736<span></span>
</td>
<td class="nump">118,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">125,707<span></span>
</td>
<td class="nump">168,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">1,120,899<span></span>
</td>
<td class="nump">973,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember', window );">APC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities not included in the calculation of earnings per share (in shares)</a></td>
<td class="nump">9,903,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,603,849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Earnings Per Share [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AlliedPacificOfCaliforniaIPAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Earnings Per Share Computations (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share &#8211; basic (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share &#8211; diluted (in dollars per share)</a></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">48,470,682<span></span>
</td>
<td class="nump">47,260,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">48,850,666<span></span>
</td>
<td class="nump">47,699,537<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares of common stock outstanding &#8211; basic (in shares)</a></td>
<td class="nump">48,470,682<span></span>
</td>
<td class="nump">47,260,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares', window );">Contingently issuable shares (in shares)</a></td>
<td class="nump">137,071<span></span>
</td>
<td class="nump">25,975<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares of common stock outstanding &#8211; diluted (in shares)</a></td>
<td class="nump">48,850,666<span></span>
</td>
<td class="nump">47,699,537<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">112,858<span></span>
</td>
<td class="nump">188,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards and Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Adjustments to weighted average shares of common stock (in shares)</a></td>
<td class="nump">130,055<span></span>
</td>
<td class="nump">225,128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Earnings Per Share [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 44<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-44<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-51<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-52<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-53<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 54<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-54<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 48<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 258,517<span></span>
</td>
<td class="nump">$ 288,455<span></span>
</td>
<td class="nump">$ 334,796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,397<span></span>
</td>
<td class="nump">2,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,802<span></span>
</td>
<td class="nump">19,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,919<span></span>
</td>
<td class="nump">29,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,711<span></span>
</td>
<td class="nump">22,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">613,270<span></span>
</td>
<td class="nump">638,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">111,916<span></span>
</td>
<td class="nump">118,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">416,386<span></span>
</td>
<td class="nump">419,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,005<span></span>
</td>
<td class="nump">39,319<span></span>
</td>
<td class="nump">35,893<span></span>
</td>
<td class="nump">$ 25,774<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,698<span></span>
</td>
<td class="nump">32,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,512<span></span>
</td>
<td class="nump">16,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">717,986<span></span>
</td>
<td class="nump">716,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,331,256<span></span>
</td>
<td class="nump">1,354,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,559<span></span>
</td>
<td class="nump">106,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">8,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">204,101<span></span>
</td>
<td class="nump">209,039<span></span>
</td>
<td class="nump">$ 136,494<span></span>
</td>
<td class="nump">$ 106,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">471<span></span>
</td>
<td class="nump">554<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">5,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,180<span></span>
</td>
<td class="nump">26,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">361,268<span></span>
</td>
<td class="nump">365,608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,197<span></span>
</td>
<td class="nump">4,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">543<span></span>
</td>
<td class="nump">607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,963<span></span>
</td>
<td class="nump">30,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,685<span></span>
</td>
<td class="nump">14,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">452,282<span></span>
</td>
<td class="nump">475,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">813,550<span></span>
</td>
<td class="nump">840,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember', window );">Nonrelated Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241,078<span></span>
</td>
<td class="nump">225,733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">56,846<span></span>
</td>
<td class="nump">50,257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">150,013<span></span>
</td>
<td class="nump">158,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Investment in marketable securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,283<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,820<span></span>
</td>
<td class="nump">83,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22<span></span>
</td>
<td class="nump">15,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,917<span></span>
</td>
<td class="nump">10,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">285,928<span></span>
</td>
<td class="nump">318,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,528<span></span>
</td>
<td class="nump">5,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83,582<span></span>
</td>
<td class="nump">87,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241,531<span></span>
</td>
<td class="nump">243,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivableNoncurrent', window );">Income taxes receivable, non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,943<span></span>
</td>
<td class="nump">15,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in other entities &#8211; equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,063<span></span>
</td>
<td class="nump">15,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue', window );">Investment in a privately held entity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">405<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Investment in affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">190,178<span></span>
</td>
<td class="nump">224,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">26,033<span></span>
</td>
<td class="nump">21,585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">3,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Total non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">582,358<span></span>
</td>
<td class="nump">618,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">868,286<span></span>
</td>
<td class="nump">937,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,804<span></span>
</td>
<td class="nump">43,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FiduciaryAccountsPayableCurrent', window );">Fiduciary accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">8,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Medical liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,547<span></span>
</td>
<td class="nump">105,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">638<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Income tax payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">14,140<span></span>
</td>
<td class="nump">11,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">451<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,076<span></span>
</td>
<td class="nump">3,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,348<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Amount due to affiliates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">48,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">173,392<span></span>
</td>
<td class="nump">222,688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,905<span></span>
</td>
<td class="nump">11,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">451<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, net of current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,006<span></span>
</td>
<td class="nump">21,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,890<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">43,252<span></span>
</td>
<td class="nump">33,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">216,644<span></span>
</td>
<td class="nump">256,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Related Party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 54,873<span></span>
</td>
<td class="nump">$ 48,251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#8217;s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#8217;s consolidated VIEs totaling </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of the Company&#8217;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">212.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively. These VIE balances do not include </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190.2</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of March 31, 2025, and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of December 31, 2024, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 &#8212; &#8220;Variable Interest Entities (VIEs)&#8221; for further details.</span><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></p></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FiduciaryAccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FiduciaryAccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivableNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivableNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-7<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 9E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-9E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_NonrelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingAndFinanceLeaseRenewalTerm', window );">Lease option to extend (up to)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable', window );">Lease, termination period, if applicable</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Assets recorded under finance leases. net of depreciation</a></td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation associated with finance leases</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease term, finance</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm', window );">Remaining lease term, finance</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingAndFinanceLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating and finance lease, renewal term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingAndFinanceLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, operating and finance lease, termination period, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 3,611<span></span>
</td>
<td class="nump">$ 3,159<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FinanceLeaseCostsAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of lease expense</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(44)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost, net</a></td>
<td class="nump">$ 3,730<span></span>
</td>
<td class="nump">$ 3,136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FinanceLeaseCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FinanceLeaseCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Other Information Related to Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_CashPaidForLeaseLiabilitiesAbstractAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="nump">$ 2,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 179<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LeaseWeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">7 years 2 months 19 days<span></span>
</td>
<td class="text">8 years 4 months 20 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">2 years 4 months 2 days<span></span>
</td>
<td class="text">2 years 11 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LeaseWeightedAverageDiscountRateAbstract', window );"><strong>Weighted Average Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.75%<span></span>
</td>
<td class="nump">6.15%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">5.79%<span></span>
</td>
<td class="nump">5.53%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_CashPaidForLeaseLiabilitiesAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_CashPaidForLeaseLiabilitiesAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LeaseWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LeaseWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LeaseWeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LeaseWeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Operating leases, 2025 (excluding the three months ended March 31, 2025)</a></td>
<td class="nump">$ 5,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Operating leases, 2026</a></td>
<td class="nump">6,851<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Operating leases, 2027</a></td>
<td class="nump">6,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Operating leases, 2028</a></td>
<td class="nump">5,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Operating leases, 2029</a></td>
<td class="nump">4,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Operating leases, Thereafter</a></td>
<td class="nump">14,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Operating leases, Total future minimum lease payments</a></td>
<td class="nump">44,097<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Operating leases, Less: imputed interest</a></td>
<td class="nump">10,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating leases, Total lease liabilities</a></td>
<td class="nump">33,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases, Less: current portion</a></td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">$ 5,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases, Long-term lease liabilities</a></td>
<td class="nump">28,963<span></span>
</td>
<td class="nump">30,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Finance leases, 2025 (excluding the three months ended March 31, 2025)</a></td>
<td class="nump">443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Finance leases, 2026</a></td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">Finance leases, 2027</a></td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">Finance leases, 2028</a></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">Finance leases, 2029</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">Finance leases, Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Finance leases, Total future minimum lease payments</a></td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Finance leases, Less: imputed interest</a></td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Finance leases, Total lease liabilities</a></td>
<td class="nump">1,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance leases, Less: current portion</a></td>
<td class="nump">471<span></span>
</td>
<td class="nump">554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance leases, Long-term lease liabilities</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 607<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, To Be Paid, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription', window );">Segment Reporting, Expense Information Used by CODM, Description</a></td>
<td class="text">The Company&#8217;s operations are based in the United States. All revenues of the Company are derived from the United States. The CODMs do not evaluate the Company&#8217;s segments using asset information. The significant segment expenses that comprise operating income as a measure used by the CODMs in evaluating operating segment performance do not differ from the operating expenses as presented on the consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</a></td>
<td class="text">The Company's CODMs are its Chief Executive Officer and Chief Financial Officer. The CODMs evaluate the performance of the Company&#8217;s operating segments based on segment revenue growth and operating income. The CODMs use revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">Chief Executive Officer [Member], srt:ChiefFinancialOfficerMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of nature of expense information used by chief operating decision maker (CODM) to manage operation when segment expense information by category is not disclosed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Schedule of Information about our Segments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 620,390<span></span>
</td>
<td class="nump">$ 404,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">549,061<span></span>
</td>
<td class="nump">330,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">50,746<span></span>
</td>
<td class="nump">43,818<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">599,807<span></span>
</td>
<td class="nump">374,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">20,583<span></span>
</td>
<td class="nump">30,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember', window );">Third-Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">620,390<span></span>
</td>
<td class="nump">404,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(53,511)<span></span>
</td>
<td class="num">(41,955)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="num">(16,564)<span></span>
</td>
<td class="num">(11,957)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="num">(36,950)<span></span>
</td>
<td class="num">(30,075)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="num">(53,514)<span></span>
</td>
<td class="num">(42,032)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">77<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="num">(53,511)<span></span>
</td>
<td class="num">(41,955)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">24,062<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">24,062<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="num">(24,062)<span></span>
</td>
<td class="num">(16,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">600,951<span></span>
</td>
<td class="nump">382,318<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">512,668<span></span>
</td>
<td class="nump">300,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">44,068<span></span>
</td>
<td class="nump">38,933<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">556,736<span></span>
</td>
<td class="nump">339,122<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">44,215<span></span>
</td>
<td class="nump">43,196<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments | Third-Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">600,951<span></span>
</td>
<td class="nump">382,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember', window );">Care Partners | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">33,388<span></span>
</td>
<td class="nump">30,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">27,139<span></span>
</td>
<td class="nump">24,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">9,357<span></span>
</td>
<td class="nump">6,163<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">36,496<span></span>
</td>
<td class="nump">30,957<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="num">(3,108)<span></span>
</td>
<td class="num">(238)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments | Third-Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16,690<span></span>
</td>
<td class="nump">17,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember', window );">Care Delivery | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">16,698<span></span>
</td>
<td class="nump">12,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">39,562<span></span>
</td>
<td class="nump">33,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">25,818<span></span>
</td>
<td class="nump">17,373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization', window );">General and administrative</a></td>
<td class="nump">10,209<span></span>
</td>
<td class="nump">12,397<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">36,027<span></span>
</td>
<td class="nump">29,770<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,535<span></span>
</td>
<td class="nump">3,504<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments | Third-Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,749<span></span>
</td>
<td class="nump">4,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember', window );">Care Enablement | Operating Segments | Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 36,813<span></span>
</td>
<td class="nump">$ 29,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General and Administrative Expenses and Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CarePartnersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CareDeliveryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=asth_CareEnablementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">$ 2,755<span></span>
</td>
<td class="nump">$ 3,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,313<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">9,019<span></span>
</td>
<td class="nump">9,848<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">32,133<span></span>
</td>
<td class="nump">30,705<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_AAMGMember', window );">AAMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">2,075<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_VOMGMember', window );">VOMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember', window );">Sun Labs remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">7,352<span></span>
</td>
<td class="nump">7,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_ADSCMember', window );">ADSC contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">4,309<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CFCMember', window );">CFC contingent considerations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">11,170<span></span>
</td>
<td class="nump">9,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_PrimeCommunityCareMember', window );">PCCCV contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=asth_CHSMember', window );">CHS contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember', window );">Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_IHealthCallOptionMember', window );">I Health call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">3,867<span></span>
</td>
<td class="nump">3,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">2,755<span></span>
</td>
<td class="nump">3,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">2,313<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">5,152<span></span>
</td>
<td class="nump">6,051<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">2,075<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | AAMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">2,075<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | VOMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Sun Labs remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | ADSC contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | CFC contingent considerations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | PCCCV contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | CHS contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | I Health call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | AAMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | VOMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Sun Labs remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | ADSC contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | CFC contingent considerations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | PCCCV contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | CHS contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | I Health call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">3,867<span></span>
</td>
<td class="nump">3,778<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">30,037<span></span>
</td>
<td class="nump">28,595<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | AAMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | VOMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Sun Labs remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="nump">7,352<span></span>
</td>
<td class="nump">7,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | ADSC contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">4,309<span></span>
</td>
<td class="nump">4,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | CFC contingent considerations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">11,170<span></span>
</td>
<td class="nump">9,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | PCCCV contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">1,450<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | CHS contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">5,741<span></span>
</td>
<td class="nump">5,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | I Health call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative assets</a></td>
<td class="nump">$ 3,867<span></span>
</td>
<td class="nump">$ 3,778<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-12<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 30: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5C<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-5B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 28: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-10<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_VOMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_VOMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_ADSCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_ADSCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CFCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CFCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_PrimeCommunityCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_PrimeCommunityCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=asth_CHSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=asth_CHSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_IHealthCallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_IHealthCallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at January 1, 2025</a></td>
<td class="nump">$ 28,595<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value of existing Level 3 liabilities</a></td>
<td class="nump">1,442<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balace at March 31, 2025</a></td>
<td class="nump">$ 30,037<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 04, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>Securities </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList', window );">Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">General and Administrative Expense, Other Nonoperating Income (Expense), Unrealized Gain (Loss) on Investments<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,313,000<span></span>
</td>
<td class="nump">$ 2,289,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Marketable securities &#8211; equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,000<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_NumberOfEquitySecuritiesSold', window );">Number of equity securities sold | Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember', window );">Apollo-Sun Labs Management, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent', window );">Remaining equity interest purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG contingent consideration | 2024 Target ang Growth Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity interest issued, number of shares (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG contingent consideration | 2023 Target and Growth Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity interest issued, number of shares (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG contingent consideration | Other Noncurrent Liabilities | 2024 Target ang Growth Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember', window );">AAMG contingent consideration | Other Noncurrent Liabilities | 2023 Target and Growth Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Equity interest issued, number of shares (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember', window );">Advanced Diagnostic and Surgical Center, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember', window );">Advanced Diagnostic and Surgical Center, Inc | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember', window );">Advanced Diagnostic and Surgical Center, Inc | Other Noncurrent Liabilities | 2023 Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember', window );">Advanced Diagnostic and Surgical Center, Inc | Other Noncurrent Liabilities | 2024 Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">Community Family Care Medical Group IPA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid contingent consideration</a></td>
<td class="nump">$ 35,322,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">Community Family Care Medical Group IPA, Inc. | Other Liabilities | First Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">Community Family Care Medical Group IPA, Inc. | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod', window );">Contingent consideration, liability, each measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member', window );">Community Family Care Medical Group IPA, Inc. | Other Noncurrent Liabilities | Second and Third Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid contingent consideration</a></td>
<td class="nump">$ 35,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember', window );">CHS | Other Liabilities | CHS 2025 Gross Profit PMPM Metric and CHS Member Enrollment Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_PCCCVMember', window );">PCCCV | Other Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=asth_PCCCVMember', window );">PCCCV | Other Noncurrent Liabilities | First Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember', window );">DMG And Sun Labs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase', window );">Business combination, equity interest purchase obligation, period to purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember', window );">I Health, Inc. | Call Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_ValueOfCallOption', window );">Call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember', window );">Interest Rate Collar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_DerivativeCeilingInterestRate', window );">Derivative, ceiling interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFloorInterestRate', window );">Derivative, floor interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="nump">19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | CHS | CHS 2025 Gross Profit PMPM Metric</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod', window );">Contingent consideration, liability, each measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | CHS | Other Noncurrent Liabilities | Second Third Fourth and Fifth Measurement Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod', window );">Contingent consideration, liability, each measurement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | CHS | Other Noncurrent Liabilities | CHS Member Enrollment Metrics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_asth_MarketableSecuritiesCurrentMaturityPeriod', window );">Short-term marketable securities, maturity period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities &#8211; certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability, Each Measurement Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Equity Interest Purchase Obligation, Period to Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_DerivativeCeilingInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Ceiling Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_DerivativeCeilingInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_MarketableSecuritiesCurrentMaturityPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketable Securities, Current, Maturity Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_MarketableSecuritiesCurrentMaturityPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_NumberOfEquitySecuritiesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of equity securities sold.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_NumberOfEquitySecuritiesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_asth_ValueOfCallOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of call option.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">asth_ValueOfCallOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>asth_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483444/210-20-55-7<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFloorInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFloorInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from liability measured at fair value using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_ApolloSunLabsManagementLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AAMGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AAMGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2024TargetAndGrowthMetricsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2024TargetAndGrowthMetricsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2023TargetAndGrowthMetricsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2023TargetAndGrowthMetricsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_AdvancedDiagnosticAndSurgicalCenterIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2023MetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2023MetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_A2024MetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_A2024MetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CommunityFamilyCareMedicalGroupIPAInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_FirstMetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_FirstMetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_SecondAndThirdMetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_SecondAndThirdMetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_CollaborativeHealthSystemsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=asth_PCCCVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=asth_PCCCVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_DMGAndSunLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=asth_IHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=asth_InterestRateCollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_SecondThirdFourthAndFifthMeasurementPeriodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_SecondThirdFourthAndFifthMeasurementPeriodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=asth_CHSMemberEnrollmentMetricsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=asth_CHSMemberEnrollmentMetricsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gains (losses) recognized on equity securities held at end of period</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (116)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>90
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $:(J5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $:(J5HDNM\.\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( $:(J5H$A,=&[04  ,8?   8
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M.U]-KNZN)W9W&3:13XE/(K\?_JV"'J%TY" ')EL(?.=VW\LJ_3ZOBHR+6K=
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M%/XK%EN-6JD+L0FW7I!:Z&HJS72JH3/[L-H'DQAB31*SM@/3_?5[[(2$-"'
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M"S7'S7+^_E865X6Z,FM-)F7@A8KC9AG?!_RX-@I7];D"NLFD#+H0;]RLPOM
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M^[S&2F1GGCUY:_+<VLXVEQUOCSYU:0SKT_96K\;*MCR_8^S)8H*:BXEOC!U
MA7^PWOSLU&&SFYU#TI.W)FE9=U#S!K=IZ/5:;_3EK<E3UAO4O(Y_>^BI:W0H
MM95C!IV9$]"NQ"?K!&JN$^I]!A,^8_N=H]&3MR9;67-0_\.CKM>RHB]O39ZR
MK*#OV2DW1350CZT\ZK8'G6J%+:>]L3'<.LI-63ZK3K@+-.'+3-1'H)NG]2GZ
M&3X:5X?-K>>G^.BT.E,>2C?UT?Q5F,_BK$ )FX)+Z]"#>9#7I]WUC>"+ZL#X
MB0O!T^IRSL*(Y:4!O)]R+EYOR@]L_N=@]!]02P,$%     @ 1HBI6JM3CU3
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MU:[6&U5M<_U2JATLFM H\G22%\[\N_FY/5](V/4%L H=GK1H.?)Z\IU+&2B
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M\YFW,H]\ %((Q ?DZYY!7A^7!SE$:V-B>YG^T)T^*-*_ZVC><VM7.Q;=%V"
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M@/=K@_-;]4 ;--^G+_X+4$L#!!0    ( $:(J5IF<MD2RP0  .L+   9
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M8]":"-ZA/8DM83N)N-WAG(TXV7=P<KA0TJX-_"([[+[6C\FGO6/9K6-GV:.
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M=1F"'D?+<6/5QH]S"V5I./3+-4WCJ)T _;]4RMYNG(']?#_[!U!+ P04
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MJ_2)]!<L9V7"(9'8"K1!(W)IX98RQYXBRA7LH\>(46N4UV\.]UZ1R"5/>+'
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M7<_=W"4E5+3G^HO8?82QGM3P%8(K^R2[(3;&X*)76C0C&!4TK!W>]'$\AR-
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MR-C.Y4^4=EL#"V,4.'P'GO3,[ 9/"TH""^2OM=3IQ!4,CYQ!BC:&MC0<81E
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M>V/$>8_%;2<O:\=I 6IH^0M'C/=4K)$9Q,'O9;O/3$ZC5?C*7RM@^-I3=-X
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MXMS9G7"T&M&HP:ZR-!JG#&W*=7 XJU N+*Z#S6[?7J%?N7AG2]QK+RE<Y\.
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M]W52N7SL9"PA/93% .D%^%,T410;T%,;O'3.N U.B:$8*8-7UO5W5F/A9T*
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MPX\D( 5/)9A?B0ELA<9\V HS1/G%FXQ>]H^-]R:ECXG@@! D@.<3 \H77_"
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MDP$6Z$X@725LT#28+&8>4^X:[AZ,;.S5=RT-7J3ML "."DD+<'XC\6NU>Z
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MVGT,DEAE"+:+Z\M3^M.Z#4Z**:%2-1)!6'.I9.V7)9&W598 :0TF0??\2'C
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M:G8AN$9-2?]9:$N6>MTU@VQGFWP/)3[L)#1:%G'=]38W/<@N%FB/N97NHOR
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M)^U?]GYB5>->TPME\39WGSG^#$G- MA?*F4?)WS YN_5V7]02P,$%     @
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MDL<^5Q6VT2ZN[MD'V2+-$DS[9]ZA<S,4#V)Y) J"?(SX(\5WT& ?44\/R'H
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M!HKB<R;3Z_*=D]$6H9-1YS5[)7B<KD!!<<S4AA"Q/FX8G!Q/[&N'! (*0('
M[L9!?SRH[-<.OL=.@U[_M/-&\KF,B8/.:] +J"=E&O;) *!BKJNBZM>^=J;3
M\Y<P,DG!=$!/^-'(2  !Y',0]";C!O' U<['WW?-K,_IC^%?YR)+V!L^-Q!4
M,&RAN3HY2L_Z)@.; [#?HC )AB (>NU,GU_,;K_V*!CV3NUK9W:VQ\1^/^A/
M>NZM\W8VFWW<8W(P&O?L:V?VZN+V$\?!9-2WK\X8XD+'9.^H%*?,82_H#=$:
MAH.@/QRR7P$8PC@#O >1@LV9%0$!?4!1 QC\J9#Q7(1B/1?:H\;H+E%C&!Q/
MABVH0?>^&C4&)Z<-;@%7]T>-;4) I0DU3 -L3"8G]K79]W-;/"U]K"/,<= ;
MHRG!H'N.)(++R>BD BZ[D0+-LM_OM4(TW/N?0HS!R=B^[H<8I\'IZ-2^[H\7
M0U #O>Z+%\>CH7UMP8NZ8@8GP?AT;-%CTAOO!QHK#DPQ\E]10@OT#^^=Y?4E
MJBY4RT3^QY+/$BAA8OH&"1_X50)7+T&1Y/$!4T!7PZ50K05\TPQ$ %N/B24>
M028N,3O$DH*)+U B&5S%LH/.3UB%=@)2B_!N1/)3L8PX I!)X2U/J.PZ739M
M3'B0)G(/: =[(NG#*)7IQJU><4+!!?B>NC);&#<EE.T\XS&@)_":LM]XDD$]
MQMQZN68ZLUS(50&++[!WW%O3\A!J1H,R^>INBF#QNA W+E%"K(L"EV8MV(=H
MKN&S1EG"(AON^ O8)LX,JD!GI&GKG@&458!C4,4AY6L6$<$EV #<!_GPA(%7
M"[IS;5BS)DCW#:&E#:!M0 ,N4L7X9J/5%PD,B/@:1=P=0CD7QU29 MGJE0 V
M9S:"*M;XNEN75>N"()4P!DB%FR@7PWSDDE4"-:=923!MV"FL]&(K--1%7<SK
MHBL:41_<Q@&MBA.M">>+@F[ UP3[G"E<PD70C98A$%QHM<;E,VL:Z4KJZ %H
M&WB<:_5):+LFO^0RIA$2Y>F*_3P:@X"SA$=_0#TMHOV4BTQOQ\LK9+BNTUZW
M7]-I^4I5I\$^8#%WWD1EONFREQ"#;)Z$V"4JV 8K;;,+I"*GR#((?@M84:95
M LEN#9?+D-'$TDHXEEJQ"BYK8G$CM%21 9@Q1>Z&NT]4A2+'>R*QNW7;*V3N
MR3SLO%]I(2I=B<(6.F0+J/K.AR)$+$G@]ZVT#V\4M]U;R@3P" *S"V,5!?_O
M0R)_S [!U#1$-&*LN9S.4ZEWF$K-;"HU!<ARFCA#ST@E: +@!=^#<IK,,,_5
MZ.P(/L6L2!BY3"PFQ7(-H(&39"5MT])\PL1, 4\H<(+.IA3\G;A4\268P!O%
M$[1H#-]H1SC8)7_YVM9 P*UAJQO8JYK_X13C$OSZ! S:P*5 -A/D"\Q!BR@+
MA4,2[<+.=4X!4X4%F9),2JD9O_;%P<U[@ND<@]L#$D4DYBG*-3-V:;\Y"9/"
MU'I#)>,E^Z=T8I%!K!%;7)28[(( %QA^%/L'0!^KYN"#WJ,9K D:.N,A;3-@
MSWCRB80-&0HZP!N(6>23=B1-@_P>'6>1:>>=MG-+64/2N&7<9)=] $>P_@8,
MK_.R*U>'-:]0 "L@!-#-N-MC/Q,;%$YB!:O"98AC(_:S@X,&E28J=59(BL!L
M!1PF6A+5W/Z[;.9$V9CC01PPE)MB@ZZ.;$ RJ_HNFDY#FO?M& B;UV*!+>9O
M0=22W59YOX_,'S:Q;N4+WRC\1%OBR66/Z6 D4*42W3XS1>(VV)5P[B2(97_0
MZ_5( $55C4Z%PB;#JZ3?7Q_KIFT%_2V8[)^V,PD7-EQ&1?*.HRSG@.,:C=75
MIM_ ?%Y S[" _MVVW=Z74)J'$#PTVBR#L//S5E4):WL:F"9)4)/T11*O-/,@
MAP6.;1PMQP$ E[PTQ<0H IR \0# C0MB/..PBA/G0FI,G@U6'U'@G!U2,/B4
M '1K R#LLS3(XFQJB@Z7:KE<0HC#2OG2VGD(<NU6=E^RRQ9MEC9H+9>#XM3<
MX?Z#*SITP:1116#0) ,G'TAZ &(H2P959HF:8QO>I8B03D(X=^7+89==0(Y
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MT2?>7O(=T?O@3XT!(4[S+[4PPJ_^<3HU5@-$?V[+0W-,NOT81ZQ#L^ Y'??
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M0A\[=6F6G%T0+^T\!"+S X?P23C _;6A^'CFFLR8PT4.V>@@_1?)0I2U]:R
M;,1VC%M9-VYEWSQNG<_1H<BE^)QKO7+H_;2^0=9=:MNTM?.$EZ>MO#O.,VY]
M9'=IW:T;X[K2UI>U:LK:T DC=#[O9FBVY*Z[M)>G^7J"\D4.SGB)EN!*^(QA
MF6LWJ%B<)<%I\5>][L-N2!H/1VAF&ZK/CG::PS 9#[=6I;_QIJE(W_F7FV&^
M!S?/FVZU>QR>-F^B1_'F98ES[P3H4-(,JM'!".G7S6NM^;!JX5](4V7QWO(_
MYWC@DG8"V)\I9=<?[H#NR7SR#U!+ P04    " !&B*E:\[W1N%8$    "P
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M\%(W8H&O*"JT JZO.%?[@7;0O<LF_P)02P,$%     @ 1HBI6B0M)R\< P
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MS1K_,B!- .Y70NC]PA <_EN+OU!+ P04    " !&B*E:-2I%]V #  !S!P
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M#6\GF0>Z&_'=QJJF':L[96E(M\N*7D743H#N]TK9\\89&-[9U3]02P,$%
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MDY'3<R#"F!69GHOM ^[J:1N^4&3*/F%;QG:[#H2%TB+?@4E!GO)R92^[<S@
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M04K0=;:BJ0>L6Y9%.?W?ES[4Q:\L7B+$BQ(Y0A*7&5*.@I85)=<S+HOP%WQ
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MU1&U50#*/[;\QLC&/7!FTM!SR7V6]#Y%907H?B&E66^L@<V+=_H?4$L#!!0
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M14#\+HJB^HZ! _,KW6QE^_3I0\;#],(2.VJH:L% [ZQL2SLY/[G?&*6>J8/
MV1:;\7!/KJ0!O/'GNG7*]' 0QL!Y28<!6ZOKJH1Y":"5*7^XD<8]D8\D88SF
M<0BS,*%)SF#":1KE,'I^_.+9+.&,BIR=/ LT;'N$C(B$9J$@IR06- Y#,AD-
M^O'D7CM90TMZ4.U.V9&#$%1DX)_3..''_(?H5]HZ/& \@JH A#CD-$DRPE,:
MBISP&!AD@ ",XB0Z0(BCG+(D//E%M<H !R@TD27TA0KUC V.G(83$D5@E9&<
MBC@E(:.<Y8 &B>4Q S2.VYS$#"J5]-FH1^CS%KG$"4U%@M91[@?&TR&;Z, [
MSVG&4BAEH1L(6VMK)V1E=$/@+\-XT5@H.7#A80P3($!#E@'"1YC% K]!F?G$
M[_6HN( JQ9EX5SW1_U>/R#@54&E03TJS%"<1A9O\BGHB%D%%DU?4PVD6A83G
M-(0RG9(HA&K'[ZMGX"#@-,(<1<33H_Y#]._4(T!_899C"=,\PE1$BOH-$2$]
M0! "]9>_IQZ1T5P(DD E!*8E<CQ_\&4I\@%11HR12*!(7ZI'@/I#SM$:8T,U
MTI1A-IPRP;]YBQ1E\1_4 YH!%7J%B%$[+((Q34?Q]*!^E_DKA'E<REJVA8(N
M5M2[$LBM7\][2(#ZS5)!"RRJOO&A=8/_'/_X#V<^;$_\)6/HE[Y'5H<2474%
MP3HTH\;N:G?0;.%%@001:ZG<7JEV[*=GY.Z%166'W@R785^Y#31<#>',8. V
MTJ%5J]V!I6_+JFON9^38O]3TX 71*+/V[R1+"KUK7?>8&+^.3['/W0ODFWGW
MCH,[NJZ@$K5:@2L[2^. F.YMU"V<WOKWR%([>-WXZ0:>D\J@ >ROM';# @.,
M#]3%OU!+ P04    " !&B*E:J,%Z-[D%  "X$0  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6S56%MOVS84?M>O(-RB: LAUL7R)1<#CM,T&1HL:-+L
M8=@#+1W;1"G1):DXV:_?(6G+<B*[R89A&&#S?NZ''TD=+X7\KN8 FCSDO% G
MK;G6B\-V6Z5SR*DZ$ LH<&8J9$XU=N6LK182:&:)<MZ.@J#;SBDK6L-C.W8M
MA\>BU)P5<"V)*O.<RL=3X&)YT@I;ZX&O;#;79J ]/%[0&=R _K:XEMAK5UPR
MED.AF"B(A.E):Q0>GG;->KO@CL%2U=K$6#(1XKOI7&8GK< H!!Q2;3A0K.YA
M#)P;1JC&CQ7/5B72$-;;:^[GUG:T94(5C 7_C65Z?M+JMT@&4UIR_54L+V!E
M3V+XI8(K6Y*E6]L+6B0ME1;YBA@UR%GA:OJP\D.-H+^+(%H11%9O)\AJ>48U
M'1Y+L232K$9NIF%-M=2H'"M,4&ZTQ%F&='IX3IDD=Y270*Z JE(">EPK(J;D
MG!6T2!GEY+)06I9NXOTMG7!0'X[;&L4;)NUT)>K4B8IVB(K)E2CT7)%/10;9
M-GT;U:YTC]:ZGT9[&5Y1>4#BT"=1$"5[^,65+V+++_ZY+\Z82KDP[E#D]]$$
MS<?T^:/)9L>RT\S2;*E#M: IG+1PSRB0]] :OGL3=H.C/0IW*H4[^[@/;W"+
M9B4'$ZTQE?*1%3,RRD5I D6+C&PLVAW1)J/VB[V= TG7XFA-W-2(NZ_$:5PW
M%OF"%H_OWO2CL'>DR+12@=62BMKU&,]T7@74)U0"L5XK-&1D8@"$O&<%\A6E
M0GGJPZ&W(W^]+W /G(3$U=&JCLFMT)1[(Z4 %V$^PB/N)OD=T8^FJ;7D(WE+
M(K^7)%A;M:.CK9:=\ZXLD=D*1$%:2J89&FU7A4<D!:G9E*54.T]DL!"*::2-
MP[CBM:[MZ$\XPH^2Z<?Z3+_SC%&_XUV2"Z!<SS% G!.QL-#W=%WL][L]5WK6
M(1@ XQ"T+O'#)-JRURU^2P9^$ Z\+XQ.&+<:>)<8%PR/)A+M)(A$G,IM5X5/
MNMYH=/495Q8:4P?C9)J*98 ,C)Z1'_22!O?@J'?WZS[*IS1A@C_OIBS(%SI1
M>'J8\\FDZ\J/;*WZHL2<0U1_QJ'GQ^@(6WJCLYOQRV5W_#@8N-(;G[^", S]
ML!>L*N]Z/![?O8+8[R2!*[WQQ<W+"1._UPE=N4H&OHFQS7<3E%4PX\ /8I,-
M<>2'<4P^(I*DO$0\1Y=BSJFY!0+;,*Y&,+ ;_-^"C#-((9^ 7*-&Y[]$C=CO
M]N(=J&'G_C9J1/U!P[; T=>CQG-&R*4)-50#;/1Z?5<V[_TJ%P>UYE.$Z?I!
M8E()%[U=L33@TN_TM\!E/U*8M S#8"=$X]S_"C&B?N+*UR'&P!]T!JY\/5[$
M& 9;OA8ONIW8E3OPXFE@HKZ?#!*''KT@>2EH[+D@)=4%*7GY!6E.T3PCL;;[
M<7R]QVO)UW0EVBNH^9YG0:^2:J!M@W9UR77_,9-ZJ9@5[$_GGK+ MQ:W/;R0
M(BX4.'J/B6@1RR<"^4H<2D4.V),$0XBAX]:E-,,G S.W5_/V(?" ;SEEI#AU
M#'A9K#5YCE'/S&QFXR\XRZ@!4*6QJMX$3LX!&35>V Q/HSVB-=IDLP=7B5(V
MFKJD%L6GB!UBJ9YAM+O'>J>4(_JCKIK\0HL2'XYD):_*+&\3VFT'PP/:;FQK
M$H]'92>JL]^V9G/8[<G#;I6'W7^8AP7YY'#F9H/5%\"SIE3<+VL[Z^H.*1K.
M@SG*L$?FSDC@L+2178!D(E/H1+4Y64V6%6*+(S5S4!#,H6R=:;@G%F ?X&LV
MA][M7 )LO0DW(?!L",R![GW;;( 90C*J9_8!OD#K&V6/;9H ZHB.=X+-'1?_
M[_&:U24?FF+;KKVF<Y S^\U $7O.NX=U-5I]EABYU_AFN?NF@?;,C,H<ID@:
M'/001:3[3N Z6BSLVWPB-+[T;7,.%+'7+,#YJ1!ZW3$"JH\UP[\ 4$L#!!0
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MVMUV$(_]_ G_F#=3G+KDFNH-!*[(-3H=4-'H9C(V"ZLJ/UR6RM*H\J\;^IA
M[0SH?*64W2_<!>WG2?8;4$L#!!0    ( $:(J5HVY*)%L ,  "\0   9
M>&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;+5888^;.!#]*Q:M3JUT73 $DNPE
MD3;95JUTJT:;]N[#Z3YX80)6P::VDW3_?6T@!!(6=2OV2X+-O)>9YR>8R>S
MQ3>9 "CT(TN9G%N)4OFU;<LP@8S(*YX#TW>V7&1$Z:6(;9D+(%$!RE+;=9S
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M'A>+RT1/]"!,@+Z_Y5P=%^8'ZO\(%C\!4$L#!!0    ( $:(J5JH/Q*/U00
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M0>L$4%H(1=/EK4L%U[A>OM>\0:MYF_=2<U^=E7G$2M^ME_JN>:W?9MY/K>(
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M8PLE9(WWJ;QGAUM2-2C0O)BEHOB-#N6S(\="\5Y(EE7!J@89S<N_^&LEQ%&
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MR;+B<$NP>F_T ^K^FC'Y<J(+J#<$S?X'4$L#!!0    ( $:(J5H!9H%RR@<
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MQ-WHPQXG.K43G7W6DSMEF:!F7: L$7[!P3:"E8FN-^&&QB+I]DZZG:@?+K9
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M\4@!<UIS\RC7GV'K9VCKY9)K]T_6V]C (WFMC:RVR:B@8J)YTLUV'782PO!
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MX7S/O&D<+ O'KX-X_0%=\R&/TN5/-.&3DV;OBCEPHNT%>)6C2X<A-3DGXC;
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MQO;= 4O7Y=[PNY2Q-"X_KFBPH%D1P+^_3U/V>%!<8/_?"T;_ U!+ P04
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M2U.#BJI*K1J*YV7=]LB5K@++QT17]BC, /U^S;G:-TR YK^"Q?]02P,$%
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M R&J$V&U4'Q='JKF7.DC6GFYTJ=H$,9 /U]PG:WUPIS3FG-Y\B]02P,$%
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ML%_+OBO7:DTRG#CF95 H-^BDGS\-(N_K$:=!YS0XII[6P<_Q+6-53OD*=('
M30V4@NM" ?(<<[/X,BNZA;KH"]%@HAICW\]-.@[B,'$W/>:&G;GA*7-1'ZOI
M"G=8 S_TO'Y8V,'"4["X#Q;NP?S8BX)^6-3!HE.P41\LVD\VBL,#R>(.%I^"
MC?M@\7ZR8!C$_;!1!QL=A3T7:([LI4;9AQSM(8/ .QAPW#''QYE"$]:'&^]M
MRJ%O%_0_G+MSJMD/A-GN*\H5,%R:1N\J-H9E<^@V RW6]4&W$-H<F_5M8;Y3
M*&V!>;X40G\,[-G9??G2OU!+ P04    " !&B*E:] 9+.^81  !O# $ &0
M 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6RUW5MSVTABAN&_@E(VJ=FJ68OG
M@V.KRC;ZE+)C[=B37*1R 9--"S4DH 4@R4K-CP] P6HU";4$U;M[L2/)Q-.0
M]8ELXV,WWMSDQ1_EA;55]&.WS<JW)Q=5=?GZ]+1<7=A=4K[*+VU6_\DF+W9)
M57]:?#\M+PN;K/<'[;:GH\%@=KI+TNSD[,W^:^?%V9O\JMJFF3TOHO)JMTN*
MV_=VF]^\/1F>_/S";^GWBZKYPNG9F\ODN_UBJ]\OSXOZL]-[99WN;%:F>185
M=O/VY-WPM5G.FP/VC_BOU-Z4#SZ.FF_E6Y[_T7QBUF]/!LT9V:U=50V1U/^Y
MMA_L=MM(]7G\HT5/[L=L#GSX\4]=[K_Y^IOYEI3V0[[][W1=7;P]69Q$:[M)
MKK;5;_F-MNTW-&V\5;XM]_\?W;2/'9Q$JZNRRG?MP?49[-+L[K_)C_8OXL$!
MP\DC!XS: T8'!XQ&CQPP;@\8/_> 27O Y+D'3-L#IL\]8-8>,'ON ?/V@/ES
M#UBT!RR>>\"R/6"YC\/=SV__PX^3*CE[4^0W4=$\NM::#_8)VA]=_\S3K G[
MEZJH_S2MCZO./A1VG5:13%;I-JUN?XW>)]D?T<<\R<I?HR1;1Q_K \HHWT3M
M(_\6O5O7_ZV#FFPCD]W]NC6Q_26V59)NR[]&?XG2+/IZD5^5-5"^.:WJ\VQ&
M.UVUYR3NSFGTR#F-HT]Y5EV4D<C6=NT??UI_?_??Y.CG-_E^% 3_XRI[%8T'
MOT:CP6C:<3X?PH=+^^U5-)K='1[]_B6.?OG+7SN8.,R\NRQ>18/AGID$&!%F
M/B4U,QX^>3;R^4SH;%28B>WJ68Q^ZB>T?=;?C0DS7^SEJVBX_T$/E]V,%Z#Q
M_6_)>.^.'_TNOU5UV,NJN*J?Z*OH?YK?BLA4=E?^;\=9OK_3)MU:\_KUNKQ,
M5O;M2?T"5=KBVIZ<_=N_#&>#?^\*)XG%)"9(3)*8(C%-8@;"O!A/[F,\">EG
M[W;Y59W>>LY35F6V3K/O7>$-&GW#2V(QB8D[;+;'FBGA]=ED-%S,Z]>'ZX>Q
M),=4'6..%\/!W!]3DV,:"/,"-[T/W#0<N&M;U%/FR&XV=C^KK6<&E:W'J:(B
MJ6Q7^H)@W_216$QBX@Y;/DC"X-5@MIP=I*_[8=/AX,'_AOXQBCQ/36(&PKPH
MSNZC. M&L9G21ILBWT6K?'>99+==X0L2?<-'8C&)B=GSGOK(,16):1(S$.:E
M<GZ?RGDPE?N)Y2;-DFQ5OQK7T:Q?F+N"&53Z!I/$8A(3=]CT03!'H]%@<)!+
M<DA%8IK$#(1YN5S<YW(1S.7O6;++BRK]/[MN+AW9HO['_W-R&E3[YI3$8A(3
MBZ.<3B>+@]=A28ZHCD<<3\;C@WDC.:*!,"]^R_OX+8/Q^UQ=V"(2/RYM5G;.
M$H.']\T9B<4D)DA,DI@B,4UB!L*\W X'[G+J +U2U')0DE$M1C6!:A+5%*II
M5#.4Y@?Z03\P[#-#M8\_)X>AWE$FM1C51*MYK_^#HVDJ.J9"-8UJAM+\B(Y<
M1$?!B/YFK_/M=3UA:/Z-WYG,X/&]DTEJ,:H)5).HIE!-HYJA-#_!KEX:LOW2
M$"V84"U&-8%J$M44JFE4,Y3F!]H53<-PT_32ZP=AMG>PT?8)U42K/9Q#S(;'
M<PBT?NH8<WDXI$:'-)3FY]#U3\-P 17'7S]&[SJ3AA9-J!:CFD UB6H*U32J
M&4KSH^OZJN&,G1.@Y16JQ:@F4$VBFD(UC6J&TOQ NZIK&.ZZ7CPG0,LO5(M1
M30R/^Z_%T0NT1,=4J*91S5":'UC7@0W#)=A76^P>OZ: 5EVH%J.:0#6):@K5
M-*H92O/3ZRJTX9*=/Z"=&JK%J"903:*:0C6-:H;2_/?PNVIM%&PZGOGNU3#2
M-\:H%J.::#7OW3)-#7$X7T!'55VC+H;3H\L(Z*B&TOSHN1)L%"[!7CIU#;.]
MPXA68J@F6NWA>PJG1Z&0Z)BJ8\SQY#B(:-5%:7X07=4U"E==)M(VV587O]:O
M[*M7G9%#NRY4BU%-H)I$-85J&M4,I?D1=EW7B.VZ1FC7A6HQJ@E4DZBF4$VC
MFJ$T/]"NZQJ%NZY_;5;'?K[);%%>I)>=$49;+52+44VT6O.>I<JM6!D=KBQX
MWL,4>FX:U0RE^:%SQ=;HB955]7/GNIZ$MJNRWWTOK&V>3COCAU9=J!:CFD U
MB6H*U32J&4KSP^RJKA%;=8W0J@O58E03J"913:&:1C5#:7Z@7=4U"E==GY(?
MZ>YJ%VV;18?)=9)NDV_[_34ZTXSV6ZWV\!_%H^,WI\;HH +5)*HI5-.H9BC-
MCZDKN$;A@NL\N6V>;_?;NZR?N1(Q3/9.*]I[H9IH->\WJ6,U(CJH0C6-:H;2
M_+2Z0FL47A3VV)0W^C-ZMX_PQZ2LHCBY;3X6R>HBDFFY2K;1WZ^2HFK6D^U+
M@^B\2/,BJO+H4U+4#_IZD1;5;?2YGG%\O<GO]RVJ/ZGMV^B+O;:=!7#X;'O_
M(J!]&:H)5).HIE!-HYJA-'_+(M>7C=FE:&.T.4.U&-4$JDE44ZBF4<U0FA]H
MU\*-PRW<SUGU*L_*?)NNDZI^-=C:=H^9HMF&+OHERZNH?F5(FB?\ZB+)NG81
M>S_N6,#EOZQ_")]+[_RB91NJ2513J*91S5":GU]7WHW#Y=V3$YAM,X%9UQ,8
MV\Q>-G>SEW^TLY=F2;Q--O6'G8E&:S]4BU%-H)I$-85J&M4,I?GA?["#(KR%
M(KN'(KN)(KN+(KN-(KN/(KN1(KN3XC^C]AN[VF\<KOW V4C;AHT>3$<FKXXF
M)&CMAVH"U22J*533J&8HS8^P*Q''X1+Q4YH=1_A^A\95?ISEK2W+0)"GQT$>
M'0<9+1!13:":1#6%:AK5#*7Y078%XCB\N6-@9MUFO#.N:(V(:C&J"523J*90
M3:.:H30_UJY&',_9.3/:)*):C&H"U22J*533J&8HS0^T*QS'X<)QG]]\$ZWN
MGJ<W]W>=N,JNROKY>Y74@]=?:/;HW:75/O0;:Z-+6ZSJC^O)2&?LT4JRU89C
M[[UI@\'P<'_<&!U7H)I$-85J&M4,I?F1=JWD^,6MY,_I]9_1%[NZ:I:,?*YG
MU%ES^YU(WC?MOSVR$7IXW-ZI1OM%5!.H)E%-H9I&-4-I_KTD7+\X8?O%"=HO
MHEJ,:@+5)*HI5-.H9BC-#[3K%R?A?O%]4J9E='?3N"C/HNND2)-O6_OHO2K"
M7N]$WVD'-WL8'KXK/D9'%:@F44VAFD8U0VE^5EV7.'EQE^BF'76@[:/SB_
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M_%\*5\PM%NQL!"WF4"U&-8%J$M44JFE4,Y3F!]KU=XMP?]=O-H*V=Z@6HYI
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M!G7]@3'Y?) GJ+>^SOX'4$L#!!0    ( $:(J5HB*H?@(0,  ,@+   9
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M-G 5@-\7C,GM1&U0F7?_'U!+ P04    " !&B*E:#]Y3AGP$  !%$P  &0
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MY/?+-,U?#PH#^U]]N/H_4$L#!!0    ( $:(J5H?MQ5.>@0  * <   9
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M@E?!/&$!:T;^RC.Y7S@3!V6PQ161#^SP"9J 1IHO94287W1H;#T'I960K&C
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MVV)7=9_KAW^(PPDQY6]15VW_;_1PL(TOHL6N[>KUH;",8%UN]O\77P]"G!1
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MX@GJO_\NQ0B]Z4&G>XS6HEO52U!A8DE'TCAFIL* F1R&6E<[8,;2S*B(.8(
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M:W-H965T<R]S:&5E=#<W+GAM;)U676_;.!#\*PL5Z+6 :SEVG!2I;2!QTFN
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M4L/##LQ#;8=M"$.A[W?<7E.E_K3OF8>A#I8:=@<H;B_2&J.\CGG)E E@ TQ
M3QWMM[#VDXPM):[0FBE1+H!-Z0*84Q?@"JV9"N4"V(DN@.GR+HMENP@8HHCD
MV#%WE0=@IWN  1;6?I;1(S:%)6#*$K I+0%S:@E<H353H2P!.]$2U.U90R$"
MV'XDSA"&0@C;I7=^]$K2EN</U9M:!5AENU3L7^$Y'-V_#78%SY?52U.MX^_@
M^;OJW:BY@MF_8O8QRA_BM  )OY>0WEM?,LOW;VWMOXCLL7KQZ2X3(MM6'S<\
M6O.\#)"_WV>9>/E2GN#P[MSB?U!+ P04    " !&B*E:W[5EU8H,  !$@P
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MMU)>8Q;'7L<G?@>8S,&9[/-BL?AJYB\J:+QM1&KR\H'O'&]:.4\*A%1J<O
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MI28'#_ P&*O/*U ;N-I)CYK(#@.2!3B20=(/;0/ !8WW:XPSN   +YA6@U=
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MHP-T9IW/#F#"!'C6,P(>W@?&#08]TN;;.,J#?H2I\LR95C,9HYU*3R;7"J"
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M_T3V0OV@4S]XCSVYE>1-@O_"#'+R) /[5 "#-$$:4Y5+?T(#A\W F>>!*]S
M,0LH,S>I%6JNLEVU:A(8^@2<Z:T2ZOIJNP!_1ASV>L,NJ!$6;EW"$G7NO<E
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M8?T>W'D?^:OWE+_^[^?P+U!+ P04    " !&B*E:EXJ[',     3 @  "P
M %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=
MOZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'
MTD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+,P[P
MS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T
M>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( $:(J5J[40*0$@8
M ",V   /    >&PO=V]R:V)O;VLN>&ULQ9M=3^,X%(;_BM4K5AJV-,U'9S2,
M5&C9K<27IHC;E4E<:I'8R$Y@AE^_)RD='*:\VINSO2IQT_3IB>/G'-M\?;;N
MX<[:!_&C*HT_'JSK^O'+<.CSM:JD_],^*D/OK*RK9$V'[G[H'YV2A5\K55?E
M,#HZ2H>5U&;P[>OV6M=N&![86N6UMH8:VX9;K9[]V_OMH7C27M_I4M<_CP?=
MWZ4:B$H;7>D751P/C@;"K^WSW];I%VMJ62YS9\OR>##:O'&K7*WSWYJ7+>2-
MO/-=2RWOODL".1ZD1W3!E7:^[L[HKB^)\4G1R9NCIK9GNJR5F\E:_>5L\ZC-
M?7L9^A7#X&=T<=B^;H+XQ?V7,-K52N=J9O.F4J;>Q-&IL@4T?JT?_4 86:GC
MP:E]4J[]/?0%BV+SVVJ""B+EOFAZPRV*#H\1Y>IR-K]<SF>"_EI>G2]FTQLZ
M.)F>3R]/YR* C !DM$?(?Z( <@P@QWN!7-[0R\7\,H", 62\1\A>)!, F>P3
M<AQ I@ RY86\EC_%DQ?7RG4?-[D2,^WSTOK&J0 Q X@9+^+">%TH)VZ<+&BH
M$U/GI+E7[:=\0#@!A!->PIGRN=./;;NP*W'2>&V4#^$^ [C/O' GTFO?8ET[
MY>G4[@PA32&6357)</P^0@/X$3/F:]#$J:WNM-F<T&'^96WQ'&)"SS"+9D$!
M-/?MEXJI]R383^)2U2$=$LR(V3 +\Z1\W3T90AMQ5:_IN9F;6M=:A=UQA 0S
M8C;,N95T9[^K7.DGV7WU&Q=RRHA9*M,\MTT;.1H36ZZN\U&C:U0AYC]"3&25
M$;-6+E31)I3B7,LN,7UW9Y%+1LPR.77$5HLSF7<9\R=Q(LV#Z.[W)XIFB(E\
M,F(6RH5Z>9&&1ALQ4_01(NY&P]KF#VM;%B$FDLJ(V2H=T"$-W]3]:%"D*_GN
MI) />67$+!9BJO3K8-,&\)3J'_*S,GF_2T9(*Q&S5KZWC:HXO):N_MFF$!3$
MKN;K$2*C1.Q&R6VEQ(W\T8\:+%28/3*7CIZ/^RXO%,NU[*6"$9)'Q"R/6^ET
M-SB3B!4E-/4OO8F#V\4\Q$0NB9A=<J[HL>W=3J2,B%D92W7_/EN.D"<B9D^<
M2>W$K2P;)2XH4%1I;$812E+/*/4+,9$G(F9/P,RY5V5&R!,1LR<P9EAG1D@7
M$7<=@A+\_NP'$L:861B[$WQQ<-...OZ/$!-98\QN#9#IBX,0$XEDS"P2F%/W
M;SJ<\V*VRHZ<>N<=1TH9<\]YH>2Z'TKDFC&W:S[(6E_C&6(B!8V9%?1Q7MB!
MAIA(06-F!?V>B.WLET@_8V;]P(RLWR^1?L;,^MED9+NB%R/=Q,RZV:9F.\&0
M8&)FP< <K7=;8R28F%DP'TR]BH.9JJ4N0TPDF)A9,#A'BT-,N*S"[!B,F828
MR#$QLV,P9AIB(L?$S([!&6^8F,?(,3%WF0,Q>WT3>2;F+G,@9J]O(L_$>RUS
MPKZ9(.\D^RES#L62+EXT(2:R4+*7Y1;"G!:4#.L0$UDH85]W ='LKT<C"R7,
M%L)%XV&(B2R4,%L(8O:C"9?WF2WT?AUKFW/T<K@$"2AA%A"NOD,!)4A "?MZ
MS([J>U<LD7X29OW@\KL72Z2?A'M1!F*&,D^1?E)F_6#,4.8ITD_*K!^X4M@;
MB5*DGY19/Q_.N6P$%&(B_:3,^@&8K<Y#3*2?E'NB#:UK]BR9(OVDS/H!,UAM
M/$-,N+]L?Q-M;>\,,9&#4O9-9F^KL#OEDR+YI,SRV3$-N$V!K9'A+$>*Y),R
MRV<GYJ:@H.3#AML)D7PR9OE S-ZHGB'Y9,SRP1.K8<:1(?EDS/)YG5@-^R-E
M[9M+]7>K9$@^&?>NLRWF6W]<=1:RYMW2>(;DD_TO&P?>86XJH 4%-<1$\LFX
M:Y]=F&=-W="S=*%[-QW))V.6SZ_9]5[O7&Q[9X@)-S@SRR? #..YY0PQD84R
M9@OA)8'>@(0LE#%;"&.&)= $66C";"&,&99 $V2AR5[7@<+YS FRT*2ST+ [
MV7_[6E Y951Q25_AJ9VJ__S:B?:EV]88Q4F[M7'5E.4IM5T9J@R+[?\X;?\_
MZ]N_4$L#!!0    ( $:(J5IFS1$Z= (  &TP   :    >&PO7W)E;',O=V]R
M:V)O;VLN>&UL+G)E;'/-VDUNHT 0AN&K6!P@N*NJJ\@HSFHVV8YR >2T?Q3;
M6,!HDMN/Y2SL#\UB-A'?"C6(XI60'B'@Z5<YM..^.PV[_7E8?!P/IV%5[<;Q
M_*.NA_6N'-OAH3N7T^7(INN/[7A9]MOZW*[?VVVI9;GTNK^?43T_W<]<O'Z>
MR_],[#:;_;K\[-:_C^4T_F-P_:?KWX==*6.U>&W[;1E75?UQN.T>ZNLF/5PF
M5XN7MU75O[REJIX[2"!(Y@]2"-+Y@PR";/Z@#$%Y_B"'()\_*" HY@]J(*B9
M/^@1@A[G#TI+E'%)D#3!FD#KA%PG J\3@IT(Q$Y(=B(P.R':B4#MA&PG K<3
MPIT(Y$Y(=R*P.R'>B4!O0;V%0&]!O85 ;YD\;!/H+:BW$.@MJ+<0Z"VHMQ#H
M+:BW$.@MJ+<0Z"VHMQ#H+:BW$.BMJ+<2Z*VHMQ+HK:BW$NBMDY<E!'HKZJT$
M>BOJK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'H;ZFT$>AOJ;01Z&^IM!'H;ZFT$
M>MOD93>!WH9Z&X'>AGH;@=Z&>AN!WH9Z&X'>AGH;@=X9]<X$>F?4.Q/HG5'O
M3*!W1KTS@=X9]<X$>N?)QTH"O3/JG0GTSJAW)M [H]Z90.^,>F<"O1WU=@*]
M'?5V KT=]78"O1WU=@*]'?5V KT=]78"O7WRLPF!WHYZ.X'>CGH[@=Z.>CN!
MWH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>,?E9D$#O0+V#
M0.] O8- [P;U;@CT;E#OAD#O!O5NOE/O8?P\E.'6\[7&ZW\GU>/EW'*[_'7Y
MM7-R7ZXXU_<5P_-?4$L#!!0    ( $:(J5H2 6)0(0(  " O   3    6T-O
M;G1E;G1?5'EP97-=+GAM;,W:WT[;,!0&\%>I<HL:U__+1+G9N-VXV MXR2F-
MFL26;:"\_9P4D#:Q"E2D?3>-6MOG._&1?E>]^OD4*"T.0S^F3;7+.7QA+#4[
M&ERJ?:"QK&Q]'%PN7^,="Z[9NSMB8K4RK/%CIC$O\U2CNK[Z1EMWW^?%S:'\
MG#H_;JI(?:H67X\;IZQ-Y4+HN\;ELLX>QO:OE.5S0EU.SGO2K@OIHFRHV)L)
MT\J_ Y[/_7B@&+N6%K<NYN]N*+O8H6<I/_64ZM,EWNC1;[==0ZUO[H=RI$XA
MDFO3CB@/?7TL>G$Z.9<;IN,G/SM_+G,JL.R\C3ZD,K%('X][&<ET>AE*(8JY
M._V*KXFE]-GO1].T6VK?F5VN]]''_3R/Q.;'^7?\YXQ?ZW^P#P'2AP3I0X'T
MH4'Z,"!]6) ^UB!]7(+TP5<HC:"(RE%(Y2BF<A14.8JJ'(55CN(J1X&5H\@J
M4&05*+(*%%D%BJP"15:!(JM D56@R"I09!4HLDH4626*K!)%5HDBJT215:+(
M*E%DE2BR2A19)8JL"D56A2*K0I%5H<BJ4&15*+(J%%D5BJP*15:%(JM&D56C
MR*I19-4HLFH4636*K!I%5HTBJT:15:/(:E!D-2BR&A19#8JL!D56@R*K09'5
MH,AJ4&0U*+):%%DMBJP615:+(JM%D=6BR&I19+4HLEH462V*K&L46=<HLJ[_
MIZR_O-]_<OS\K ?7C2_Y;/YC_/5O4$L! A0#%     @ 1HBI6D;'34B5
MS0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " !&B*E:)+K?#O(    K @  $0              @ '#    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " !&B*E:F5R<(Q &  "<)P  $P
M        @ 'D 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( $:(
MJ5H$A,=&[04  ,8?   8              " @24(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " !&B*E:$,7V[=$+   -.   &
M        @(%(#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%
M  @ 1HBI6L8ZG>QX!@  ]!D  !@              ("!3QH  'AL+W=O<FMS
M:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( $:(J5KN[$ \H08  '\@   8
M              " @?T@  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"
M% ,4    " !&B*E:JU./5, )  "05   &               @('4)P  >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 1HBI6@OL^$\4"P
MZS,  !@              ("!RC$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM
M;%!+ 0(4 Q0    ( $:(J5JM]!M&2P(  * %   8              " @10]
M  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !&B*E:) M?
MDF@"  "\!P  &               @(&5/P  >&PO=V]R:W-H965T<R]S:&5E
M=#@N>&UL4$L! A0#%     @ 1HBI6DAUC2$R"@  JQH  !@
M ("!,T(  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( $:(
MJ5H+"F%-RQ,  $ Y   9              " @9M,  !X;"]W;W)K<VAE971S
M+W-H965T,3 N>&UL4$L! A0#%     @ 1HBI6L[STB2#"P  JQX  !D
M         ("!G6   'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4
M    " !&B*E:9G+9$LL$  #K"P  &0              @(%7;   >&PO=V]R
M:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( $:(J5K],TR3508   \0
M   9              " @5EQ  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL
M4$L! A0#%     @ 1HBI6AAZ2Q<J!0  :@T  !D              ("!Y7<
M 'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !&B*E:M,?!
M$1 #  #7!@  &0              @(%&?0  >&PO=V]R:W-H965T<R]S:&5E
M=#$U+GAM;%!+ 0(4 Q0    ( $:(J5H_4A6Y50,  '4'   9
M  " @8V   !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @
M1HBI6B2T.<8L$@  B#<  !D              ("!&80  'AL+W=O<FMS:&5E
M=',O<VAE970Q-RYX;6Q02P$"% ,4    " !&B*E:C393.G@&  !M$0  &0
M            @(%\E@  >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4
M Q0    ( $:(J5K+^YT1PP4  *D.   9              " @2N=  !X;"]W
M;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 1HBI6E<&0"G&"
M&Q8  !D              ("!):,  'AL+W=O<FMS:&5E=',O<VAE970R,"YX
M;6Q02P$"% ,4    " !&B*E:LBA68% *   )(@  &0              @($B
MK   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( $:(J5KC
MT==7?P4  .@-   9              " @:FV  !X;"]W;W)K<VAE971S+W-H
M965T,C(N>&UL4$L! A0#%     @ 1HBI6N.W&9" !0  %Q$  !D
M     ("!7[P  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $:(J5J05.QPPQ8  /Y&   9              "
M@3;M  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 1HBI
M6L*]I;[E P  [0@  !D              ("!, 0! 'AL+W=O<FMS:&5E=',O
M<VAE970R.2YX;6Q02P$"% ,4    " !&B*E:[<\K%A<&   ^#P  &0
M        @(%," $ >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0
M   ( $:(J5KSO=&X5@0    +   9              " @9H. 0!X;"]W;W)K
M<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 1HBI6D>T!@H*!   HPD
M !D              ("!)Q,! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q0
M2P$"% ,4    " !&B*E:)"TG+QP#  ##!@  &0              @(%H%P$
M>&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( $:(J5HU*D7W
M8 ,  ','   9              " @;L: 0!X;"]W;W)K<VAE971S+W-H965T
M,S0N>&UL4$L! A0#%     @ 1HBI6N=8L#&E P  ' @  !D
M ("!4AX! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !&
MB*E:M38V($<#   U!P  &0              @($N(@$ >&PO=V]R:W-H965T
M<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( $:(J5I2205(]0(  *8&   9
M          " @:PE 0!X;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#
M%     @ 1HBI6J=O"EH@ P  O0@  !D              ("!V"@! 'AL+W=O
M<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " !&B*E:WZ1(A'L&   S
M#P  &0              @($O+ $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM
M;%!+ 0(4 Q0    ( $:(J5J5;)MEBP0  /T*   9              " @>$R
M 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @ 1HBI6F@0
MY!^2!   K H  !D              ("!HS<! 'AL+W=O<FMS:&5E=',O<VAE
M970T,2YX;6Q02P$"% ,4    " !&B*E:J,%Z-[D%  "X$0  &0
M    @(%L/ $ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    (
M $:(J5IQ<U$W0P(  -,$   9              " @5Q" 0!X;"]W;W)K<VAE
M971S+W-H965T-#,N>&UL4$L! A0#%     @ 1HBI6DY\'60Q P  J@@  !D
M             ("!UD0! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"
M% ,4    " !&B*E:-N2B1; #   O$   &0              @($^2 $ >&PO
M=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( $:(J5JH/Q*/U00
M .(B   9              " @25, 0!X;"]W;W)K<VAE971S+W-H965T-#8N
M>&UL4$L! A0#%     @ 1HBI6OS=E2])!0  '"0  !D              ("!
M,5$! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !&B*E:
M 6:!<LH'  !N0@  &0              @(&Q5@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;%!+ 0(4 Q0    ( $:(J5K"J1_3;P(  +$%   9
M      " @;)> 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%
M  @ 1HBI6G( :"CU @  +@<  !D              ("!6&$! 'AL+W=O<FMS
M:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " !&B*E:-;@L;>,&   $,@
M&0              @(&$9 $ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+
M 0(4 Q0    ( $:(J5I!"\T+F0(  '\&   9              " @9YK 0!X
M;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 1HBI6J3.M"BW
M @  %P<  !D              ("!;FX! 'AL+W=O<FMS:&5E=',O<VAE970U
M,RYX;6Q02P$"% ,4    " !&B*E:8:>N;T4'  !J,   &0
M@(%<<0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( $:(
MJ5JQ4@G(J ,  #<0   9              " @=AX 0!X;"]W;W)K<VAE971S
M+W-H965T-34N>&UL4$L! A0#%     @ 1HBI6FF*8SSN!0  US$  !D
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M=#8P+GAM;%!+ 0(4 Q0    ( $:(J5KT!DL[YA$  &\, 0 9
M  " @3*1 0!X;"]W;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @
M1HBI6CQXB!='!@  !BL  !D              ("!3Z,! 'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6Q02P$"% ,4    " !&B*E:(BJ'X"$#  #("P  &0
M            @('-J0$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4
M Q0    ( $:(J5H/WE.&? 0  $43   9              " @26M 0!X;"]W
M;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%     @ 1HBI6O4(''2U P
M.A(  !D              ("!V+$! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX
M;6Q02P$"% ,4    " !&B*E::PK_RG\*   !8@  &0              @('$
MM0$ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( $:(J5H?
MMQ5.>@0  * <   9              " @7K  0!X;"]W;W)K<VAE971S+W-H
M965T-C<N>&UL4$L! A0#%     @ 1HBI6JP;/9^Y @  A <  !D
M     ("!*\4! 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6Q02P$"% ,4
M" !&B*E:O%\B1[X#  #'$P  &0              @($;R $ >&PO=V]R:W-H
M965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( $:(J5I8ZNU6Y (  '((   9
M              " @1#, 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L!
M A0#%     @ 1HBI6OKT-JV7 P  6 T  !D              ("!*\\! 'AL
M+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"% ,4    " !&B*E:F1$KX/T.
M  "\=   &0              @('YT@$ >&PO=V]R:W-H965T<R]S:&5E=#<R
M+GAM;%!+ 0(4 Q0    ( $:(J5J*7#?V@ ,   X.   9              "
M@2WB 0!X;"]W;W)K<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ 1HBI
M6A=P\JX( P  +0D  !D              ("!Y.4! 'AL+W=O<FMS:&5E=',O
M<VAE970W-"YX;6Q02P$"% ,4    " !&B*E:C]3SIXT#  "!#   &0
M        @($CZ0$ >&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0
M   ( $:(J5K!B''"C@0  + 7   9              " @>?L 0!X;"]W;W)K
M<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @ 1HBI6AN<!;L !   5@H
M !D              ("!K/$! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q0
M2P$"% ,4    " !&B*E:3E5+.+T'  !'-P  &0              @('C]0$
M>&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( $:(J5K?M675
MB@P  $2#   9              " @=?] 0!X;"]W;W)K<VAE971S+W-H965T
M-SDN>&UL4$L! A0#%     @ 1HBI6D;;_NS3 @  =@8  !D
M ("!F H" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX;6Q02P$"% ,4    " !&
MB*E:H Q)/4H0   =T@  &0              @(&B#0( >&PO=V]R:W-H965T
M<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( $:(J5ICJ>%XK@(  #@&   9
M          " @2,> @!X;"]W;W)K<VAE971S+W-H965T.#(N>&UL4$L! A0#
M%     @ 1HBI6I)]C8E- P  "A4   T              ( !""$" 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !&B*E:EXJ[',     3 @  "P
M    @ & ) ( 7W)E;',O+G)E;'-02P$"% ,4    " !&B*E:NU$"D!(&   C
M-@  #P              @ %I)0( >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 1HBI6F;-$3IT @  ;3   !H              ( !J"L" 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 1HBI6A(!8E A @  ("\
M !,              ( !5"X" %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ %H 6@"M&   IC "

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>416</ContextCount>
  <ElementCount>426</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>149</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995455 - Disclosure - Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness</Role>
      <ShortName>Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995475 - Disclosure - Business Combinations and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill</Role>
      <ShortName>Business Combinations and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995485 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995495 - Disclosure - Investments in Other Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities</Role>
      <ShortName>Investments in Other Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995505 - Disclosure - Loans Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable</Role>
      <ShortName>Loans Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995515 - Disclosure - Accounts Payable and Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses</Role>
      <ShortName>Accounts Payable and Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995525 - Disclosure - Medical Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities</Role>
      <ShortName>Medical Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995535 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995545 - Disclosure - Mezzanine Deficit and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity</Role>
      <ShortName>Mezzanine Deficit and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995555 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995565 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995575 - Disclosure - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions</Role>
      <ShortName>Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995585 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995595 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>995605 - Disclosure - Variable Interest Entities (VIEs)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs</Role>
      <ShortName>Variable Interest Entities (VIEs)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>995615 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995625 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995635 - Disclosure - Fair Value Measurements of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments</Role>
      <ShortName>Fair Value Measurements of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995675 - Disclosure - Business Combinations and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables</Role>
      <ShortName>Business Combinations and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995685 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995695 - Disclosure - Investments in Other Entities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables</Role>
      <ShortName>Investments in Other Entities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>995705 - Disclosure - Accounts Payable and Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>995715 - Disclosure - Medical Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables</Role>
      <ShortName>Medical Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>995725 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995735 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995745 - Disclosure - Related-Party Transactions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables</Role>
      <ShortName>Related-Party Transactions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>995755 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>995765 - Disclosure - Variable Interest Entities (VIEs) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables</Role>
      <ShortName>Variable Interest Entities (VIEs) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>995775 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/Leases</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>995785 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/Segments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>995795 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value Measurements of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>995805 - Disclosure - Description of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails</Role>
      <ShortName>Description of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>995815 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>995825 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>995835 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>995845 - Disclosure - Business Combinations and Goodwill - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails</Role>
      <ShortName>Business Combinations and Goodwill - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>995855 - Disclosure - Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>995865 - Disclosure - Business Combinations and Goodwill - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails</Role>
      <ShortName>Business Combinations and Goodwill - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>995875 - Disclosure - Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails</Role>
      <ShortName>Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>995885 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>995895 - Disclosure - Intangible Assets, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>995905 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets, Net - Schedule of Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>995915 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails</Role>
      <ShortName>Investments in Other Entities - Schedule of Equity Method Investments Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>995925 - Disclosure - Investments in Other Entities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails</Role>
      <ShortName>Investments in Other Entities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>995935 - Disclosure - Loans Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails</Role>
      <ShortName>Loans Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>995945 - Disclosure - Accounts Payable and Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails</Role>
      <ShortName>Accounts Payable and Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>995955 - Disclosure - Medical Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails</Role>
      <ShortName>Medical Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>995965 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>995975 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>995985 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails</Role>
      <ShortName>Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>995995 - Disclosure - Mezzanine Deficit and Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Mezzanine Deficit and Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>996005 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>996015 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>996035 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>996045 - Disclosure - Related-Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related-Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>996055 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails</Role>
      <ShortName>Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>996065 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>996075 - Disclosure - Earnings Per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails</Role>
      <ShortName>Earnings Per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>996085 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Earnings Per Share Computations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>996095 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>996115 - Disclosure - Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>996125 - Disclosure - Leases - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails</Role>
      <ShortName>Leases - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>996135 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Schedule of Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>996145 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails</Role>
      <ShortName>Leases - Schedule of Other Information Related to Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>996155 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>996175 - Disclosure - Segments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails</Role>
      <ShortName>Segments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>996185 - Disclosure - Segments - Schedule of Information about our Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails</Role>
      <ShortName>Segments - Schedule of Information about our Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>996195 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>996205 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>996215 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="asth-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>996225 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails</Role>
      <ShortName>Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="asth-20250331.htm">asth-20250331.htm</File>
    <File>asth-20250331.xsd</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img124443625_0.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1107">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>96
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "asth-20250331.htm": {
   "nsprefix": "asth",
   "nsuri": "http://www.astranahealth.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "asth-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "asth-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    }
   },
   "keyStandard": 360,
   "keyCustom": 66,
   "axisStandard": 39,
   "axisCustom": 0,
   "memberStandard": 50,
   "memberCustom": 90,
   "hidden": {
    "total": 9,
    "http://fasb.org/us-gaap/2024": 4,
    "http://xbrl.sec.gov/dei/2024": 5
   },
   "contextCount": 416,
   "entityCount": 1,
   "segmentCount": 149,
   "elementCount": 945,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1107,
    "http://xbrl.sec.gov/dei/2024": 30,
    "http://xbrl.sec.gov/ecd/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/Cover",
     "longName": "100000 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
     "longName": "100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "100030 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited",
     "longName": "100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity",
     "longName": "100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF MEZZANINE DEFICIT AND STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "C_8ada5766-cd70-45e8-a299-c4904c89c0e1",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8ada5766-cd70-45e8-a299-c4904c89c0e1",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
     "longName": "100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness",
     "longName": "995455 - Disclosure - Description of Business",
     "shortName": "Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NatureOfOperations",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "longName": "995465 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill",
     "longName": "995475 - Disclosure - Business Combinations and Goodwill",
     "shortName": "Business Combinations and Goodwill",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet",
     "longName": "995485 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities",
     "longName": "995495 - Disclosure - Investments in Other Entities",
     "shortName": "Investments in Other Entities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable",
     "longName": "995505 - Disclosure - Loans Receivable",
     "shortName": "Loans Receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:LoanReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:LoanReceivableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses",
     "longName": "995515 - Disclosure - Accounts Payable and Accrued Expenses",
     "shortName": "Accounts Payable and Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities",
     "longName": "995525 - Disclosure - Medical Liabilities",
     "shortName": "Medical Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1",
     "longName": "995535 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity",
     "longName": "995545 - Disclosure - Mezzanine Deficit and Stockholders' Equity",
     "shortName": "Mezzanine Deficit and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation",
     "longName": "995555 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies",
     "longName": "995565 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions",
     "longName": "995575 - Disclosure - Related-Party Transactions",
     "shortName": "Related-Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes",
     "longName": "995585 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare",
     "longName": "995595 - Disclosure - Earnings Per Share",
     "shortName": "Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs",
     "longName": "995605 - Disclosure - Variable Interest Entities (VIEs)",
     "shortName": "Variable Interest Entities (VIEs)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/Leases",
     "longName": "995615 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:LesseeOperatingAndFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:LesseeOperatingAndFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/Segments",
     "longName": "995625 - Disclosure - Segments",
     "shortName": "Segments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments",
     "longName": "995635 - Disclosure - Fair Value Measurements of Financial Instruments",
     "shortName": "Fair Value Measurements of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "longName": "995655 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "longName": "995665 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables",
     "longName": "995675 - Disclosure - Business Combinations and Goodwill (Tables)",
     "shortName": "Business Combinations and Goodwill (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables",
     "longName": "995685 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables",
     "longName": "995695 - Disclosure - Investments in Other Entities (Tables)",
     "shortName": "Investments in Other Entities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables",
     "longName": "995705 - Disclosure - Accounts Payable and Accrued Expenses (Tables)",
     "shortName": "Accounts Payable and Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables",
     "longName": "995715 - Disclosure - Medical Liabilities (Tables)",
     "shortName": "Medical Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables",
     "longName": "995725 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables",
     "longName": "995735 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables",
     "longName": "995745 - Disclosure - Related-Party Transactions (Tables)",
     "shortName": "Related-Party Transactions (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables",
     "longName": "995755 - Disclosure - Earnings Per Share (Tables)",
     "shortName": "Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables",
     "longName": "995765 - Disclosure - Variable Interest Entities (VIEs) (Tables)",
     "shortName": "Variable Interest Entities (VIEs) (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:VariableInterestEntityDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables",
     "longName": "995775 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables",
     "longName": "995785 - Disclosure - Segments (Tables)",
     "shortName": "Segments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables",
     "longName": "995795 - Disclosure - Fair Value Measurements of Financial Instruments (Tables)",
     "shortName": "Fair Value Measurements of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails",
     "longName": "995805 - Disclosure - Description of Business (Details)",
     "shortName": "Description of Business (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "U_Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "longName": "995815 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "U_Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:CashUninsuredAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails",
     "longName": "995825 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Each Payer Type (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_1dbcd7f4-15f4-485f-84c9-42d3bbcb06e1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails",
     "longName": "995835 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details)",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Contributions to Revenue and Receivables by Payer (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "C_5fb914a7-0520-41f4-83cf-9c07f5e46feb",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5fb914a7-0520-41f4-83cf-9c07f5e46feb",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
     "longName": "995845 - Disclosure - Business Combinations and Goodwill - Additional Information (Details)",
     "shortName": "Business Combinations and Goodwill - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:GoodwillPeriodIncreaseDecrease",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:BusinessCombinationDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
     "longName": "995855 - Disclosure - Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details)",
     "shortName": "Business Combinations and Goodwill - Summary of Purchase Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:Goodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e",
      "name": "asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails",
     "longName": "995865 - Disclosure - Business Combinations and Goodwill - Schedule of Goodwill (Details)",
     "shortName": "Business Combinations and Goodwill - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "C_9ac0c6d0-4628-4820-9917-37da7e90084b",
      "name": "us-gaap:Goodwill",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:GoodwillPurchaseAccountingAdjustments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails",
     "longName": "995875 - Disclosure - Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)",
     "shortName": "Business Combinations and Goodwill - Schedule of Business Acquisition, Pro Forma Information, Nonrecurring Adjustments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "C_8f134208-f6d5-4c50-a680-3e055aa91882",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8f134208-f6d5-4c50-a680-3e055aa91882",
      "name": "us-gaap:BusinessAcquisitionsProFormaRevenue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
     "longName": "995885 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "div",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails",
     "longName": "995895 - Disclosure - Intangible Assets, Net - Additional Information (Details)",
     "shortName": "Intangible Assets, Net - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
     "longName": "995905 - Disclosure - Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "shortName": "Intangible Assets, Net - Schedule of Future Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
     "longName": "995915 - Disclosure - Investments in Other Entities - Schedule of Equity Method Investments Activity (Details)",
     "shortName": "Investments in Other Entities - Schedule of Equity Method Investments Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "C_9ac0c6d0-4628-4820-9917-37da7e90084b",
      "name": "us-gaap:EquityMethodInvestments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquityMethodInvestmentSoldCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "div",
       "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
     "longName": "995925 - Disclosure - Investments in Other Entities - Additional Information (Details)",
     "shortName": "Investments in Other Entities - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:EquityMethodInvestmentAdditionalInvestment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "div",
       "asth:EquityMethodAndOtherEquityInvestmentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails",
     "longName": "995935 - Disclosure - Loans Receivable (Details)",
     "shortName": "Loans Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:NotesAndLoansReceivableNetNoncurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0e5954be-95e4-4557-b760-60d9a28d9308",
      "name": "us-gaap:NotesAndLoansReceivableNetNoncurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "asth:LoanReceivableTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails",
     "longName": "995945 - Disclosure - Accounts Payable and Accrued Expenses (Details)",
     "shortName": "Accounts Payable and Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails",
     "longName": "995955 - Disclosure - Medical Liabilities (Details)",
     "shortName": "Medical Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "C_9ac0c6d0-4628-4820-9917-37da7e90084b",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails",
     "longName": "995965 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Credit Facility Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_2a253766-549b-48d9-804a-32af249a20f3",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails",
     "longName": "995975 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Schedule of Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
     "longName": "995985 - Disclosure - Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)",
     "shortName": "Credit Facility, Bank Loans, and Lines of Credit - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
     "longName": "995995 - Disclosure - Mezzanine Deficit and Stockholders' Equity - Additional Information (Details)",
     "shortName": "Mezzanine Deficit and Stockholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:StockIssuedDuringPeriodSharesMerger",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:StockIssuedDuringPeriodSharesMerger",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
     "longName": "996005 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
     "longName": "996015 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "longName": "996035 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:LineOfCredit",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "div",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4fbc38e4-4839-4ebf-a373-b96ad86a302b",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
     "longName": "996045 - Disclosure - Related-Party Transactions - Additional Information (Details)",
     "shortName": "Related-Party Transactions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:RelatedPartyExpensesPayable",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails",
     "longName": "996055 - Disclosure - Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)",
     "shortName": "Related-Party Transactions - Schedule of Fees Incurred and Revenue Earned from Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails",
     "longName": "996065 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "U_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
     "longName": "996075 - Disclosure - Earnings Per Share - Additional Information (Details)",
     "shortName": "Earnings Per Share - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "C_0ac128eb-5a33-4975-905f-b556a96e2c4d",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_0ac128eb-5a33-4975-905f-b556a96e2c4d",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
     "longName": "996085 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share Computations (Details)",
     "shortName": "Earnings Per Share - Schedule of Earnings Per Share Computations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EarningsPerShareBasic",
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R71": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
     "longName": "996095 - Disclosure - Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)",
     "shortName": "Earnings Per Share - Schedule of Shares Included in the Diluted Earnings Per Share Computations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares",
      "unitRef": "U_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
     "longName": "996115 - Disclosure - Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details)",
     "shortName": "Variable Interest Entities (VIEs) - Schedule of Assets and Liabilities, Variable Interest Entities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails",
     "longName": "996125 - Disclosure - Leases - Additional information (Details)",
     "shortName": "Leases - Additional information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "asth:LesseeOperatingAndFinanceLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "asth:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "asth:LesseeOperatingAndFinanceLeaseRenewalTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "asth:LesseeOperatingAndFinanceLeasesTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails",
     "longName": "996135 - Disclosure - Leases - Schedule of Components of Lease Expense (Details)",
     "shortName": "Leases - Schedule of Components of Lease Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails",
     "longName": "996145 - Disclosure - Leases - Schedule of Other Information Related to Leases (Details)",
     "shortName": "Leases - Schedule of Other Information Related to Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
     "longName": "996155 - Disclosure - Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details)",
     "shortName": "Leases - Schedule of Future Minimum Lease Payments Under Non-cancelable Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "asth:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "asth:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails",
     "longName": "996175 - Disclosure - Segments - Additional Information (Details)",
     "shortName": "Segments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "U_Segment",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
     "longName": "996185 - Disclosure - Segments - Schedule of Information about our Segments (Details)",
     "shortName": "Segments - Schedule of Information about our Segments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
     "longName": "996195 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Carrying Amounts and Fair Values of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails",
     "longName": "996205 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value of Level 3 Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "C_9ac0c6d0-4628-4820-9917-37da7e90084b",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_9ac0c6d0-4628-4820-9917-37da7e90084b",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
     "longName": "996215 - Disclosure - Fair Value Measurements of Financial Instruments - Additional Information (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "C_99ea2791-355d-432f-b116-de8fe51581b6",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "asth:NumberOfEquitySecuritiesSold",
      "unitRef": "U_Securities",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "span",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "span",
       "p",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails",
     "longName": "996225 - Disclosure - Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details)",
     "shortName": "Fair Value Measurements of Financial Instruments - Schedule of Change in Fair Value on Equity Securities Held (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_5866792a-f02f-4281-bb96-b527c6b93742",
      "name": "us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss",
      "unitRef": "U_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-3",
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "asth-20250331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "asth_A2023And2024MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "A2023And2024MetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 and 2024 Metric",
        "label": "A2023 and 2024 Metric [Member]",
        "documentation": "2023 and 2024 metric."
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2023MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "A2023MetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2023 Metric",
        "label": "2023 Metric [Member]",
        "terseLabel": "2023 Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2023TargetAndGrowthMetricsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "A2023TargetAndGrowthMetricsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 2023 Target and Growth Metrics [Member]",
        "documentation": "A 2023 target and growth metrics.",
        "terseLabel": "2023 Target and Growth Metrics"
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2024MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "A2024MetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2024 Metric",
        "label": "2024 Metric [Member]",
        "terseLabel": "2024 Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_A2024TargetAndGrowthMetricsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "A2024TargetAndGrowthMetricsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 2024 Target and Growth Metrics [Member]",
        "documentation": "A 2024 target and growth metrics.",
        "terseLabel": "2024 Target ang Growth Metrics"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AAMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AAMGMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AAMG",
        "label": "AAMG [Member]",
        "terseLabel": "AAMG contingent consideration",
        "verboseLabel": "AAMG"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ADSCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ADSCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ADSC",
        "label": "ADSC [Member]",
        "terseLabel": "ADSC contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AHMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AHMCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "AHMC [Member]",
        "terseLabel": "AHMC",
        "verboseLabel": "AHMC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r1149"
     ]
    },
    "asth_AccountsPayableAndAccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AccountsPayableAndAccruedExpensesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Payable and Accrued Expenses",
        "label": "Accounts Payable And Accrued Expenses [Member]",
        "documentation": "Accounts payable and accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Total accounts payable and accrued expenses",
        "verboseLabel": "Accounts payable and accrued expenses",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accounts Payable and Accrued Expenses",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r104",
      "r109",
      "r1213"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "verboseLabel": "Accounts payable and other accruals",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "asth_AccountsReceivableAndNetRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AccountsReceivableAndNetRevenueLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable And Net Revenue [Line Items]",
        "terseLabel": "Accounts Receivable And Net Revenue [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AccountsReceivableAndNetRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AccountsReceivableAndNetRevenueTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable And Net Revenue [Table]",
        "terseLabel": "Accounts Receivable And Net Revenue [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable [Member]",
        "verboseLabel": "Receivables, Net and Receivables-Related Parties and Other Receivables",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Receivables, net",
        "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total",
        "terseLabel": "Receivables, net - related parties",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1148"
     ]
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income tax payable",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r170"
     ]
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "asth_AcquisitionOfNonControllingInterestShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AcquisitionOfNonControllingInterestShares",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition of Non-Controlling Interest, Shares",
        "label": "Acquisition of Non-Controlling Interest, Shares",
        "negatedTerseLabel": "Acquisition of non-controlling interest (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1031"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r973",
      "r1302"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Paid-in Capital [Member]",
        "verboseLabel": "Additional Paid-in\u00a0 Capital",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r791",
      "r1133",
      "r1134",
      "r1135",
      "r1137",
      "r1220",
      "r1303"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AdvancedDiagnosticAndSurgicalCenterIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AdvancedDiagnosticAndSurgicalCenterIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Diagnostic and Surgical Center, Inc",
        "label": "Advanced Diagnostic and Surgical Center, Inc [Member]",
        "terseLabel": "Advanced Diagnostic and Surgical Center, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AdvancedHealthManagementSystemsLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AdvancedHealthManagementSystemsLPMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advanced Health Management Systems, L.P.",
        "label": "Advanced Health Management Systems, L.P. [Member]",
        "terseLabel": "AHMS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1013",
      "r1023",
      "r1055"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1016",
      "r1026",
      "r1058"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "asth_AirlineCompleteHealthcareOfTexasLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AirlineCompleteHealthcareOfTexasLtdMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Airline Complete Healthcare of Texas, Ltd",
        "label": "Airline Complete Healthcare of Texas, Ltd [Member]",
        "terseLabel": "Airline"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1051",
      "r1059",
      "r1063",
      "r1071"
     ]
    },
    "us-gaap_AllOtherSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllOtherSegmentsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Segments [Member]",
        "terseLabel": "Other",
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r320",
      "r922",
      "r923"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "asth_AlliedPacificHoldingsInvestmentManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AlliedPacificHoldingsInvestmentManagementLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allied Pacific Holdings Investment Management, LLC",
        "label": "Allied Pacific Holdings Investment Management, LLC [Member]",
        "terseLabel": "Allied Pacific Holdings Investment Management, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AlliedPacificOfCaliforniaIPAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AlliedPacificOfCaliforniaIPAMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allied Pacific Of California IPA",
        "label": "Allied Pacific Of California IPA [Member]",
        "terseLabel": "Allied Pacific Of California IPA",
        "verboseLabel": "APC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r540",
      "r544"
     ]
    },
    "asth_AmendedAndRestatedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AmendedAndRestatedCreditAgreementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended and Restated Credit Agreement",
        "label": "Amended and Restated Credit Agreement [Member]",
        "terseLabel": "Credit Agreement Amendment"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AmendedCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AmendedCreditAgreementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Credit Agreement",
        "label": "Amended Credit Agreement [Member]",
        "terseLabel": "Amended Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AmendedCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AmendedCreditFacilityMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amended Credit Facility [Member]",
        "documentation": "Amended credit facility.",
        "terseLabel": "Amended Credit Facility"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance cost",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r461",
      "r1123",
      "r1240"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r391",
      "r398",
      "r933"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities not included in the calculation of earnings per share (in shares)",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r276"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "asth_ApcBusinessLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ApcBusinessLoanAgreementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC Business Loan Agreement [Member]",
        "terseLabel": "APC Business Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApcStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ApcStockOptionMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "APC Stock Option [Member]",
        "terseLabel": "APC Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApolloMedicalHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ApolloMedicalHoldingsIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Apollo Medical Holdings, Inc [Member]",
        "terseLabel": "Apollo Medical Holdings, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ApolloSunLabsManagementLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ApolloSunLabsManagementLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Apollo-Sun Labs Management, LLC",
        "label": "Apollo-Sun Labs Management, LLC [Member]",
        "terseLabel": "Apollo-Sun Labs Management, LLC",
        "verboseLabel": "Sun Labs remaining equity interest purchase"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ArroyoVistaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ArroyoVistaMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arroyo Vista",
        "label": "Arroyo Vista [Member]",
        "terseLabel": "Arroyo Vista"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AsOfLastDayEachFiscalQuarterThereafterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AsOfLastDayEachFiscalQuarterThereafterMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As of last day each fiscal quarter thereafter",
        "label": "As of Last Day Each Fiscal Quarter Thereafter [Member]",
        "documentation": "As of Last Day Each Fiscal Quarter Thereafter."
       }
      }
     },
     "auth_ref": []
    },
    "asth_AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven [Member]",
        "documentation": "As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven [Member]",
        "terseLabel": "As of Last Day of Each Fiscal Quarter Ending Prior to March Thirty One Two Thousand Twenty Seven"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets",
        "verboseLabel": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r182",
      "r205",
      "r235",
      "r280",
      "r289",
      "r315",
      "r319",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r586",
      "r590",
      "r627",
      "r721",
      "r835",
      "r922",
      "r923",
      "r973",
      "r994",
      "r1200",
      "r1201",
      "r1247"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets",
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r214",
      "r235",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r586",
      "r590",
      "r627",
      "r973",
      "r1200",
      "r1201",
      "r1247"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r960"
     ]
    },
    "us-gaap_AssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent",
        "totalLabel": "Total non-current assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r586",
      "r590",
      "r627",
      "r1200",
      "r1201",
      "r1247"
     ]
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsNoncurrentAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current assets",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AstranaHealthManagementIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AstranaHealthManagementIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Astrana Health Management, Inc [Member]",
        "documentation": "Astrana Health Management, Inc.",
        "verboseLabel": "Astrana Health, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "asth_AstranaMedicalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AstranaMedicalMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Astrana Medical",
        "label": "Astrana Medical [Member]",
        "terseLabel": "Astrana Medical"
       }
      }
     },
     "auth_ref": []
    },
    "asth_AurionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "AurionMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xxx_Aurion [Member]",
        "label": "Aurion [Member]",
        "verboseLabel": "Aurion"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable securities \u2013 certificates of deposit",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r372",
      "r604",
      "r714",
      "r960",
      "r964",
      "r1150",
      "r1224",
      "r1225",
      "r1226"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]",
        "documentation": "Information by location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]",
        "documentation": "Location in statement of financial position where disaggregated cumulative balance has been reported."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r86",
      "r414",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "asth_BassMedicalGroupMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BassMedicalGroupMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bass Medical Group",
        "label": "Bass Medical Group [Member]",
        "terseLabel": "BASS Medical Group"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BoardMembersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BoardMembersMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Members",
        "label": "Board Members [Member]",
        "terseLabel": "Board Members"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BoardMembersWhoAreAlsoOfficersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BoardMembersWhoAreAlsoOfficersMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Members Who Are Also Officers",
        "label": "Board Members Who Are Also Officers [Member]",
        "terseLabel": "Board Members Who Are Also Officers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r578",
      "r951",
      "r952"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r578",
      "r951",
      "r952"
     ]
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Equity interest issued, number of shares (shares)",
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity."
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "asth_BusinessAcquisitionInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessAcquisitionInAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business acquisition in accounts payable and accrued liabilities",
        "label": "Business Acquisition In Accounts Payable And Accrued Liabilities",
        "documentation": "Business acquisition in accounts payable and accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Interest acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Basic",
        "terseLabel": "Net income per share - basic (in dollars per share)",
        "documentation": "The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Earnings Per Share, Diluted",
        "terseLabel": "Net income per share - diluted (in dollars per share)",
        "documentation": "The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r1090",
      "r1091"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaNetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income attributable to Astrana Health, Inc.",
        "label": "Business Acquisition, Pro Forma Net Income (Loss)",
        "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577"
     ]
    },
    "us-gaap_BusinessAcquisitionsProFormaRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionsProFormaRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfBusinessAcquisitionProFormaInformationNonrecurringAdjustmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Acquisition, Pro Forma Revenue",
        "terseLabel": "Total revenue",
        "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period."
       }
      }
     },
     "auth_ref": [
      "r576",
      "r577"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationConsiderationPurchasePriceDueToFromSeller": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationConsiderationPurchasePriceDueToFromSeller",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination Consideration Purchase Price due to (from) Seller",
        "documentation": "Business Combination Consideration Purchase Price due to (from) Seller",
        "verboseLabel": "Purchase price due to (from) seller"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred",
        "totalLabel": "Consideration transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r14"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "verboseLabel": "Common stock issued and replacement awards",
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Contingent consideration",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r66",
      "r581"
     ]
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of contingent consideration",
        "label": "Contingent considerations fair value",
        "verboseLabel": "Value of the contingent consideration for 2023 and 2024 metric",
        "totalLabel": "Contingent consideration cash paid",
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r157",
      "r582",
      "r606",
      "r607",
      "r608"
     ]
    },
    "asth_BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability, Each Measurement Period",
        "label": "Business Combination, Contingent Consideration, Liability, Each Measurement Period",
        "terseLabel": "Contingent consideration, liability, each measurement period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwill"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations and Goodwill",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r579"
     ]
    },
    "asth_BusinessCombinationEquityInterestPurchaseObligationNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationEquityInterestPurchaseObligationNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Noncurrent",
        "label": "Business Combination, Equity Interest Purchase Obligation, Noncurrent",
        "verboseLabel": "Remaining equity interest purchase",
        "terseLabel": "Remaining equity interest purchase"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase",
        "label": "Business Combination, Equity Interest Purchase Obligation, Period to Purchase",
        "terseLabel": "Business combination, equity interest purchase obligation, period to purchase"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired",
        "terseLabel": "Aggregate purchase price",
        "documentation": "Amount of assets acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAmountsDueFromAffiliates",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Amounts Due From Affiliates",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Amounts Due From Affiliates",
        "terseLabel": "Amounts due from affiliates"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsIncomeTaxReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax receivable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Income Tax Receivable",
        "documentation": "Business combination, recognized identifiable assets acquired and liabilities assumed, current assets, income tax receivable."
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Investments in Other Entities Equity Method",
        "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current assets investments in other entities equity method.",
        "terseLabel": "Investments in other entities - equity method"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Investment in marketable securities",
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other receivables",
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Receivables",
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Restricted Cash",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets",
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Accounts Payable And Accrued Expenses",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Accounts Payable And Accrued Expenses",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAmountsDueToAffiliates",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Amounts Due To Affiliates",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Amounts Due To Affiliates",
        "terseLabel": "Amounts due to affiliates"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesIncomeTaxesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Income Taxes Payable",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Medical Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Medical Liabilities",
        "terseLabel": "Medical liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Noncontrolling Interest",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed, Liabilities, Noncontrolling Interest",
        "terseLabel": "Non-controlling interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Total net assets acquired",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Land, property and equipment",
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155"
     ]
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Description and Basis of Presentation [Text Block]",
        "verboseLabel": "Basis of Presentation and Summary of Significant Accounting Policies",
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r138",
      "r139"
     ]
    },
    "asth_CAIPAMSOLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CAIPAMSOLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAIPA MSO, LLC",
        "label": "CAIPA MSO, LLC [Member]",
        "terseLabel": "CAIPA MSO, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CDSCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CDSCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CDSC",
        "label": "CDSC [Member]",
        "terseLabel": "CDSC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CFCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CFCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CFC",
        "label": "CFC [Member]",
        "terseLabel": "CFC contingent considerations"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CHSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CHSMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHS [Member]",
        "documentation": "CHS.",
        "terseLabel": "CHS contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CHSMemberEnrollmentMetricsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CHSMemberEnrollmentMetricsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C H S Member Enrollment Metrics [Member]",
        "documentation": "CHS member enrollment metrics",
        "terseLabel": "CHS Member Enrollment Metrics"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C H S Two Thousand Twenty Five Gross Profit P M P M Metric and C H S Member Enrollment Metrics [Member]",
        "documentation": "C H S Two Thousand Twenty Five Gross Profit P M P M Metric and C H S Member Enrollment Metrics.",
        "terseLabel": "CHS 2025 Gross Profit PMPM Metric and CHS Member Enrollment Metrics"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "C H S Two Thousand Twenty Five Gross Profit P M P M Metric [Member]",
        "documentation": "CHS two thousand twenty five gross profit PMPM metric.",
        "terseLabel": "CHS 2025 Gross Profit PMPM Metric"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CallOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CallOptionMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Call Option",
        "label": "Call Option [Member]",
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r879"
     ]
    },
    "asth_CareDeliveryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CareDeliveryMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Delivery",
        "label": "Care Delivery [Member]",
        "terseLabel": "Care Delivery"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CareEnablementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CareEnablementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Enablement",
        "label": "Care Enablement [Member]",
        "terseLabel": "Care Enablement"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CarePartnersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CarePartnersMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Care Partners",
        "label": "Care Partners [Member]",
        "terseLabel": "Care Partners"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r201",
      "r907"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Money market accounts",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1222",
      "r1223"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash shown in the statement of cash flows",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r134",
      "r232"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r134"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "verboseLabel": "Supplemental disclosures of non-cash investing and financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CashPaidForLeaseLiabilitiesAbstractAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CashPaidForLeaseLiabilitiesAbstractAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid For Lease Liabilities [Abstract]",
        "verboseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Amount deposit accounts exceeded FDIC insured limit",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CertificatesOfDepositMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CertificatesOfDepositMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of Deposit",
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r988",
      "r989",
      "r990",
      "r991"
     ]
    },
    "asth_ChangeInFairValueOfContingentConsiderationLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ChangeInFairValueOfContingentConsiderationLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Contingent Consideration Liabilities",
        "documentation": "Change in fair value of contingent consideration liabilities.",
        "terseLabel": "Change in fair value of contingent consideration liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "auth_ref": [
      "r1147"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r210",
      "r211",
      "r212",
      "r235",
      "r261",
      "r264",
      "r273",
      "r275",
      "r282",
      "r283",
      "r364",
      "r428",
      "r431",
      "r432",
      "r433",
      "r437",
      "r438",
      "r469",
      "r470",
      "r473",
      "r476",
      "r483",
      "r627",
      "r778",
      "r779",
      "r780",
      "r781",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r822",
      "r844",
      "r866",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r1081",
      "r1127",
      "r1138"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r211",
      "r212",
      "r282",
      "r469",
      "r470",
      "r471",
      "r473",
      "r476",
      "r481",
      "r483",
      "r778",
      "r779",
      "r780",
      "r781",
      "r940",
      "r1081",
      "r1127"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of warrant, number of securities called by each warrant (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "asth_CollaborativeHealthSystemsLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CollaborativeHealthSystemsLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "CHS",
        "label": "Collaborative Health Systems, LLC [Member]",
        "documentation": "Collaborative Health Systems, LLC."
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommercialMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommercialMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:CommercialMember",
        "label": "Commercial [Member]",
        "terseLabel": "Commercial"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies",
        "verboseLabel": "Commitments and contingencies (Note 12)",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r173",
      "r725",
      "r821"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r418",
      "r419",
      "r899",
      "r1186",
      "r1191"
     ]
    },
    "asth_CommitmentsAndContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommitmentsAndContingenciesLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommitmentsAndContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommitmentsAndContingenciesTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommonStockDiscountedPricePercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommonStockDiscountedPricePercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Discounted Price, Percentage",
        "label": "Common Stock, Discounted Price, Percentage",
        "terseLabel": "Common stock, discounted price, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "asth_CommonStockDiscountedPricePercentageMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommonStockDiscountedPricePercentageMaximum",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Discounted Price, Percentage, Maximum",
        "label": "Common Stock, Discounted Price, Percentage, Maximum",
        "terseLabel": "Common stock, discounted price, percentage (up to)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "verboseLabel": "Common\u00a0Stock\u00a0Outstanding",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r984",
      "r985",
      "r986",
      "r988",
      "r989",
      "r990",
      "r991",
      "r1133",
      "r1134",
      "r1137",
      "r1220",
      "r1299",
      "r1303"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r822"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value per share; 100,000,000 shares authorized, 49,028,624 and 47,929,872 shares issued and outstanding, excluding 9,903,953 and 10,603,849 treasury shares, as of March 31,2025 and December 31, 2024, respectively",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r727",
      "r973"
     ]
    },
    "asth_CommunityFamilyCareMedicalGroupIPAInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CommunityFamilyCareMedicalGroupIPAInc.Member",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Community Family Care Medical Group IPA, Inc.",
        "label": "Community Family Care Medical Group IPA, Inc. [Member]",
        "terseLabel": "Community Family Care Medical Group IPA, Inc.",
        "verboseLabel": "CFC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "asth_CompanyAndAPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CompanyAndAPCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company And APC",
        "label": "Company And APC [Member]",
        "terseLabel": "Company And APC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r93",
      "r94",
      "r326",
      "r898"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r93",
      "r94",
      "r326",
      "r775",
      "r898"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r93",
      "r94",
      "r326",
      "r898",
      "r1089"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risks",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r188"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r93",
      "r94",
      "r326"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38",
      "r93",
      "r94",
      "r326",
      "r898"
     ]
    },
    "asth_ConsiderationOfAcquisitionInCashFunded": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ConsiderationOfAcquisitionInCashFunded",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consideration of Acquisition in Cash Funded",
        "label": "Consideration of Acquisition in Cash Funded",
        "terseLabel": "Consideration of acquisition in cash funded"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r586",
      "r587",
      "r590",
      "r591",
      "r669",
      "r900",
      "r1199",
      "r1202",
      "r1203"
     ]
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r586",
      "r587",
      "r590",
      "r591",
      "r669",
      "r900",
      "r1199",
      "r1202",
      "r1203"
     ]
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r242",
      "r280",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r922",
      "r923",
      "r1200",
      "r1201"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "auth_ref": [
      "r180",
      "r242",
      "r280",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r428",
      "r429",
      "r430",
      "r431",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r922",
      "r923",
      "r1200",
      "r1201"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r912"
     ]
    },
    "asth_ContingentConsideration": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ContingentConsideration",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationByTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]",
        "documentation": "Information by type of contingent consideration."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContingentConsiderationTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]",
        "documentation": "Description of contingent payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract with Customer, Liability, Current",
        "verboseLabel": "Contract liabilities",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r487",
      "r498"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Costs",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r314",
      "r315",
      "r316",
      "r317",
      "r320",
      "r1143"
     ]
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "terseLabel": "Cost of services, excluding depreciation and amortization",
        "verboseLabel": "Cost of services",
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization."
       }
      }
     },
     "auth_ref": [
      "r1094",
      "r1095"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost, Depreciation and Amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service."
       }
      }
     },
     "auth_ref": [
      "r1114"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses",
        "totalLabel": "Total expenses",
        "verboseLabel": "Total expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r443",
      "r471",
      "r667",
      "r692",
      "r719",
      "r909",
      "r911"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "asth_CreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "CreditAgreementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r1197"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r1197",
      "r1198"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r326"
     ]
    },
    "asth_DMGAndSunLabsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DMGAndSunLabsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DMG And Sun Labs",
        "label": "DMG And Sun Labs [Member]",
        "terseLabel": "DMG And Sun Labs"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtCovenantAggregatePurchasePriceMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtCovenantAggregatePurchasePriceMaximum",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Covenant, Aggregate Purchase Price, Maximum",
        "label": "Debt Covenant, Aggregate Purchase Price, Maximum",
        "terseLabel": "Debt covenant, aggregate purchase price, maximum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCredit1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Credit Facility, Bank Loans, and Lines of Credit",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r233",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r426",
      "r427",
      "r439",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r455",
      "r462",
      "r463",
      "r465",
      "r637"
     ]
    },
    "asth_DebtFinancingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtFinancingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Financing Expense",
        "documentation": "Debt financing expense.",
        "terseLabel": "Debt financing expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r103",
      "r104",
      "r169",
      "r172",
      "r242",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r971",
      "r1128",
      "r1187",
      "r1188",
      "r1189",
      "r1239",
      "r1241"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amount outstsnding",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total debt",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r172",
      "r466"
     ]
    },
    "asth_DebtInstrumentCovenantInterestCoverageRatioMinimum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentCovenantInterestCoverageRatioMinimum",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Interest Coverage Ratio, Minimum",
        "terseLabel": "Minimum consolidated interest coverage ratio (not less than)"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioAdjustedMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentCovenantLeverageRatioAdjustedMaximum",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Adjusted Maximum",
        "terseLabel": "Debt instrument, covenant, leverage ratio, adjusted maximum"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioIncrementalChange": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentCovenantLeverageRatioIncrementalChange",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Incremental Change",
        "terseLabel": "Consolidated leverage ratio, annual decrease"
       }
      }
     },
     "auth_ref": []
    },
    "asth_DebtInstrumentCovenantLeverageRatioMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Maximum consolidated leverage ratio (not greater than)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "secured convertible promissory note",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt, principal sum",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r440",
      "r637",
      "r638",
      "r936",
      "r937",
      "r971"
     ]
    },
    "asth_DebtInstrumentIncreaseInOriginalPrincipalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentIncreaseInOriginalPrincipalAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument increase in original principal amount",
        "label": "Debt Instrument Increase in Original Principal Amount",
        "terseLabel": "Additional Principal Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Average effective interest rate",
        "documentation": "The average effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r458",
      "r1239"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r441"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r464",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r971",
      "r1128",
      "r1239",
      "r1241"
     ]
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentMaturityDate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mature Date",
        "label": "Debt Instrument, Maturity Date",
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r935",
      "r1225",
      "r1226"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r242",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r971",
      "r1128",
      "r1187",
      "r1188",
      "r1189",
      "r1239",
      "r1241"
     ]
    },
    "asth_DebtInstrumentNumberOfKeyFinancialRatios": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DebtInstrumentNumberOfKeyFinancialRatios",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number Of Key Financial Ratios",
        "label": "Debt Instrument, Number Of Key Financial Ratios",
        "terseLabel": "Number of key financial ratios"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Principal balance payable in monthly installments",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r51",
      "r54",
      "r98",
      "r146",
      "r147",
      "r242",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r446",
      "r451",
      "r452",
      "r453",
      "r454",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r464",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r971",
      "r1128",
      "r1239",
      "r1241"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Term",
        "terseLabel": "Revolving credit facility term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "terseLabel": "Unamortized deferred financing costs",
        "negatedTerseLabel": "Less: Unamortized financing costs",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r451",
      "r467",
      "r636",
      "r637",
      "r638",
      "r936",
      "r937",
      "r971"
     ]
    },
    "us-gaap_DeferredCreditsAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCreditsAndOtherLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Credits and Other Liabilities",
        "terseLabel": "Amount outstanding under agreement",
        "documentation": "Total carrying amount as of the balance sheet date of unearned revenue or income, not otherwise specified in the taxonomy, which is expected to be taken into income in future periods and obligations not separately disclosed in the balance sheet (other liabilities)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt financing costs",
        "label": "Debt Issuance Costs, Net",
        "totalLabel": "Debt Issuance Costs, Net, Total",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r1205",
      "r1238",
      "r1239",
      "r1241"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred tax liability",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred tax liability",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r549",
      "r550",
      "r722"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Taxes and Tax Credits",
        "verboseLabel": "Deferred tax",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "asth_DelayedDrawTermLoanAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DelayedDrawTermLoanAMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed Draw Term Loan A [Member]",
        "documentation": "Delayed Draw Term Loan A.",
        "terseLabel": "DDTL A"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DelayedDrawTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DelayedDrawTermLoanMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed Draw Term Loan (DDTL) [Member]",
        "terseLabel": "Delayed Draw Term Loan",
        "documentation": "Term loan allowing borrower to withdraw predefined amount of preapproved loan within predetermined period."
       }
      }
     },
     "auth_ref": [
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r280",
      "r294",
      "r319",
      "r922",
      "r923"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative assets",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r604",
      "r605",
      "r617",
      "r626",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r828",
      "r829",
      "r879",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r911",
      "r960",
      "r964",
      "r986",
      "r1224",
      "r1225",
      "r1226",
      "r1300"
     ]
    },
    "asth_DerivativeCeilingInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DerivativeCeilingInterestRate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Ceiling Interest Rate",
        "label": "Derivative Ceiling Interest Rate",
        "terseLabel": "Derivative, ceiling interest rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r812",
      "r827",
      "r828",
      "r829",
      "r831",
      "r832",
      "r833",
      "r834",
      "r836",
      "r837",
      "r838",
      "r839",
      "r854",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r879",
      "r880",
      "r883",
      "r885",
      "r984",
      "r986",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset, fair value",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r122",
      "r163",
      "r164",
      "r215",
      "r911"
     ]
    },
    "us-gaap_DerivativeFloorInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeFloorInterestRate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative, Floor Interest Rate",
        "terseLabel": "Derivative, floor interest rate",
        "documentation": "Floor rate on an interest rate derivative such as an interest rate floor or collar. If market rates falls below the floor rate, a payment or receipt is triggered on the contract."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r87",
      "r88",
      "r165",
      "r810",
      "r812",
      "r827",
      "r828",
      "r829",
      "r831",
      "r832",
      "r833",
      "r834",
      "r836",
      "r837",
      "r838",
      "r839",
      "r854",
      "r855",
      "r856",
      "r857",
      "r860",
      "r861",
      "r862",
      "r863",
      "r879",
      "r880",
      "r883",
      "r885",
      "r911",
      "r984",
      "r986",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_FinancialLiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Liability",
        "terseLabel": "Derivative liability",
        "verboseLabel": "Derivative liabilities",
        "totalLabel": "Derivative Liability, Total",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r604",
      "r605",
      "r617",
      "r626",
      "r803",
      "r804",
      "r805",
      "r806",
      "r808",
      "r809",
      "r810",
      "r811",
      "r812",
      "r836",
      "r838",
      "r839",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r911",
      "r1224",
      "r1225",
      "r1226",
      "r1300"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r81",
      "r82",
      "r83",
      "r89",
      "r241",
      "r256"
     ]
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DevelopedTechnologyRightsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology",
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1177",
      "r1179",
      "r1182",
      "r1183"
     ]
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "verboseLabel": "Board [Member]"
       }
      }
     },
     "auth_ref": [
      "r1147",
      "r1301"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r497",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Table Text Block]",
        "verboseLabel": "Schedule of Disaggregated Revenue by Each Payor Type",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1207"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r510",
      "r513",
      "r541",
      "r542",
      "r543",
      "r954"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DistributionMadeToLimitedPartnerCashDistributionsDeclared": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DistributionMadeToLimitedPartnerCashDistributionsDeclared",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution Made to Limited Partner, Cash Distributions Declared",
        "terseLabel": "Cash distribution",
        "documentation": "Amount of equity impact of cash distribution declared to unit-holder of limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "asth_DistributionOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DistributionOfShares",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution Of Shares",
        "documentation": "Distribution of shares.",
        "terseLabel": "Distribution of shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DistributionPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DistributionPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution Payable",
        "terseLabel": "Cash distribution",
        "documentation": "Amount of distribution payable to ownership interest holder from investment income and return of capital."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r888"
     ]
    },
    "us-gaap_DividendsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable",
        "verboseLabel": "Dividend payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "asth_DmgMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DmgMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "DMG [Member]",
        "terseLabel": "DMG remaining equity interest purchase"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r998"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1030"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "asth_DrawOnLetterOfCreditThroughRevolverLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DrawOnLetterOfCreditThroughRevolverLoan",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Draw On Letter Of Credit Through Revolver Loan",
        "label": "Draw On Letter Of Credit Through Revolver Loan",
        "terseLabel": "Draw on letter of credit through Revolver Loan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "asth_DwgasConvertiblePromissoryNoteReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "DwgasConvertiblePromissoryNoteReceivableMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DWGAS Convertible Promissory Note Receivable",
        "documentation": "DWGAS Convertible Promissory Note Receivable [Member]",
        "label": "DWGAS Convertible Promissory Note Receivable [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Earnings per share \u2013 basic (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r259",
      "r261",
      "r273",
      "r274",
      "r275",
      "r279",
      "r574",
      "r584",
      "r601",
      "r602",
      "r716",
      "r740",
      "r913"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Earnings per share \u2013 diluted (in dollars per share)",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r261",
      "r273",
      "r274",
      "r275",
      "r279",
      "r574",
      "r584",
      "r601",
      "r602",
      "r716",
      "r740",
      "r913"
     ]
    },
    "asth_EarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EarningsPerShareLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Earnings Per Share [Table]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EarningsPerShareTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r276",
      "r277",
      "r278"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r957"
     ]
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1212"
     ]
    },
    "asth_EmployeeStockOptionAndEmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EmployeeStockOptionAndEmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options and ESPP",
        "label": "Employee Stock Option And Employee Stock Purchase Plan [Member]",
        "documentation": "Employee stock option and employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Stock options and ESPP",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "asth_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r195",
      "r221",
      "r222",
      "r223",
      "r243",
      "r244",
      "r245",
      "r247",
      "r252",
      "r254",
      "r256",
      "r281",
      "r365",
      "r366",
      "r406",
      "r485",
      "r563",
      "r564",
      "r571",
      "r572",
      "r573",
      "r575",
      "r583",
      "r584",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r639",
      "r641",
      "r660",
      "r738",
      "r769",
      "r770",
      "r771",
      "r791",
      "r866"
     ]
    },
    "asth_EquityMethodAndOtherEquityInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EquityMethodAndOtherEquityInvestmentsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method And Other Equity Investments [Text Block]",
        "label": "Equity Method And Other Equity Investments [Text Block]",
        "verboseLabel": "Investments in Other Entities"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r570",
      "r1083",
      "r1084",
      "r1085",
      "r1216",
      "r1217",
      "r1218",
      "r1219"
     ]
    },
    "asth_EquityMethodInvestmentAdditionalInvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EquityMethodInvestmentAdditionalInvestment",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Additional Investment",
        "label": "Equity Method Investment, Additional Investment",
        "terseLabel": "Initial Investment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of investments",
        "documentation": "Amount of other-than-temporary decline in value that has been recognized against investment accounted for under equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r1157"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity interest (as a percent)",
        "verboseLabel": "% of Ownership",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r361"
     ]
    },
    "us-gaap_EquityMethodInvestmentSoldCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentSoldCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investment, Amount Sold",
        "negatedTerseLabel": "Distribution",
        "documentation": "Amount of the entity's equity method investment which has been sold."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Purchase price of equity investment",
        "label": "Equity Method Investments",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Investments in other entities \u2013 equity method",
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r300",
      "r319",
      "r359",
      "r1104",
      "r1159"
     ]
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentsContribution": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EquityMethodInvestmentsContribution",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity method investments contribution",
        "label": "Equity Method Investments Contribution",
        "terseLabel": "Funding"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EquityMethodInvestmentsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EquityMethodInvestmentsRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments [Roll Forward]",
        "label": "Equity Method Investments [Roll Forward]",
        "terseLabel": "Equity Method Investments [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments [Table Text Block]",
        "verboseLabel": "Schedule of Equity Method Investments Activity",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNi",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity securities",
        "verboseLabel": "Marketable securities \u2013 equity securities",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r625",
      "r908"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value",
        "verboseLabel": "Investment in a privately held entity",
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r625"
     ]
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsOfFinancialInstrumentsScheduleOfChangeInFairValueOnEquitySecuritiesHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedTerseLabel": "Unrealized losses recognized on equity securities held at end of period",
        "terseLabel": "Unrealized gains (losses) recognized on equity securities held at end of period",
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)."
       }
      }
     },
     "auth_ref": [
      "r741",
      "r1156"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1013",
      "r1023",
      "r1055"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1010",
      "r1020",
      "r1052"
     ]
    },
    "asth_EsppMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EsppMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP",
        "label": "ESPP [Member]",
        "documentation": "ESPP [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_EstimatedWorkingCapitalAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "EstimatedWorkingCapitalAdjustments",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Estimated Working Capital Adjustments",
        "documentation": "Estimated working capital adjustments",
        "terseLabel": "Estimated working capital adjustments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r617",
      "r960"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r604",
      "r605",
      "r617",
      "r960"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Carrying Amounts and Fair Values of Financial Instruments",
        "documentation": "Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r960",
      "r1222",
      "r1223",
      "r1234"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r616",
      "r617",
      "r619",
      "r676",
      "r677",
      "r678",
      "r936",
      "r937",
      "r948",
      "r949",
      "r950",
      "r960",
      "r964"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements of Financial Instruments",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r612",
      "r614",
      "r615",
      "r616",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r712",
      "r960",
      "r965"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r501",
      "r506",
      "r605",
      "r617",
      "r676",
      "r948",
      "r949",
      "r950",
      "r960"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r501",
      "r506",
      "r605",
      "r606",
      "r617",
      "r677",
      "r936",
      "r937",
      "r948",
      "r949",
      "r950",
      "r960"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r605",
      "r606",
      "r607",
      "r608",
      "r617",
      "r678",
      "r936",
      "r937",
      "r948",
      "r949",
      "r950",
      "r960",
      "r964"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Change in Fair Value of Level 3 Liabilities",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r613",
      "r618"
     ]
    },
    "asth_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditions",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability, Additions",
        "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability, Additions",
        "terseLabel": "Additions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value of existing Level 3 liabilities",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r618"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements",
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r611",
      "r618"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofChangeinFairValueofLevel3LiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodStartLabel": "Balance at January 1, 2025",
        "periodEndLabel": "Balace at March 31, 2025",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r609",
      "r618"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r603",
      "r605",
      "r606",
      "r607",
      "r608",
      "r616",
      "r617",
      "r619",
      "r676",
      "r677",
      "r678",
      "r936",
      "r937",
      "r948",
      "r949",
      "r950",
      "r960",
      "r964"
     ]
    },
    "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from liability measured at fair value using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r610",
      "r618"
     ]
    },
    "asth_FiduciaryAccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FiduciaryAccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fiduciary accounts payable, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Fiduciary Accounts Payable Current",
        "terseLabel": "Fiduciary accounts payable",
        "verboseLabel": "Fiduciary accounts payable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_FinanceLeaseCostsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FinanceLeaseCostsAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Costs",
        "label": "Finance Lease Costs [Abstract]",
        "terseLabel": "Finance lease cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r650",
      "r972"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from finance leases",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r646",
      "r653"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance leases, Total lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r643",
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Finance leases, Less: current portion",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities",
        "verboseLabel": "Finance lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases, Long-term lease liabilities",
        "label": "Finance Lease, Liability, Noncurrent",
        "verboseLabel": "Finance lease liabilities, net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Finance leases, Total future minimum lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "Finance leases, 2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Finance leases, 2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Finance leases, 2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Finance leases, 2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Finance leases, 2025 (excluding the three months ended March 31, 2025)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "asth_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases, Thereafter",
        "documentation": "Finance Lease, Liability, To Be Paid, After Year Four",
        "label": "Finance Lease, Liability, To Be Paid, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance leases, Less: imputed interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Principal Payments",
        "verboseLabel": "Financing cash flows from finance leases",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r645",
      "r653"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Assets recorded under finance leases. net of depreciation",
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "terseLabel": "Accumulated depreciation associated with finance leases",
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1087",
      "r1092"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of lease expense",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r650",
      "r972"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Finance leases",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r972"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Finance leases",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r972"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r373",
      "r374",
      "r375",
      "r464",
      "r481",
      "r598",
      "r624",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r690",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r739",
      "r931",
      "r960",
      "r962",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r974",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1221",
      "r1224",
      "r1225",
      "r1226",
      "r1233",
      "r1236"
     ]
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Liabilities Fair Value Disclosure",
        "totalLabel": "Total liabilities",
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities."
       }
      }
     },
     "auth_ref": [
      "r1222",
      "r1223",
      "r1233"
     ]
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialSupportToNonconsolidatedLegalEntityAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Support to Nonconsolidated Legal Entity [Axis]",
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Axis]",
        "documentation": "Information by financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r784",
      "r785"
     ]
    },
    "us-gaap_FinancialSupportToNonconsolidatedLegalEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialSupportToNonconsolidatedLegalEntityDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Support to Nonconsolidated Legal Entity [Domain]",
        "terseLabel": "Financial Support to Nonconsolidated Legal Entity [Domain]",
        "documentation": "Financial support arrangement provided to a nonconsolidated legal entity that is required to comply with or operate in accordance with requirements that are similar to those included in Rule 2a-7 of the Investment Company Act of 1940 for registered money market funds."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r784",
      "r785"
     ]
    },
    "asth_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r203",
      "r376",
      "r397",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2026",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r904",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2025 (excluding the three months ended March 31, 2025)",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1305"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2029",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r904",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2028",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r904",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2027",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r904",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r401",
      "r402",
      "r710",
      "r711",
      "r904"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Amortized intangible assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r397",
      "r711",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r397",
      "r401",
      "r402",
      "r404",
      "r710",
      "r904",
      "r933"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r401",
      "r402",
      "r904"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsDetails2": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofFutureAmortizationExpenseDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r710",
      "r1179"
     ]
    },
    "asth_FirstCommonwealthPropertyLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FirstCommonwealthPropertyLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Commonwealth Property, LLC",
        "label": "First Commonwealth Property, LLC [Member]",
        "terseLabel": "First Commonwealth Property, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_FirstMetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FirstMetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Metric",
        "label": "First Metric [Member]",
        "terseLabel": "First Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_FiveThreeOneW.CollegeLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "FiveThreeOneW.CollegeLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Five Three One W. College LLC [Member]",
        "verboseLabel": "531 W. College, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ForYourBenefitPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ForYourBenefitPromissoryNoteMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For Your Benefit Promissory Note",
        "label": "For Your Benefit Promissory Note [Member]",
        "terseLabel": "FYB Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1059"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1059"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1059"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1059"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1059"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestmentsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Schedule of Change in Fair Value on Equity Securities Held",
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1117"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gain (Loss) on Extinguishment of Debt, Total",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss on debt extinguishment",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r46",
      "r47"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative expenses",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r846"
     ]
    },
    "asth_GeneralAndAdministrativeExpensesAndDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "GeneralAndAdministrativeExpensesAndDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General and Administrative Expenses and Depreciation and Amortization",
        "label": "General and Administrative Expenses and Depreciation and Amortization",
        "terseLabel": "General and administrative"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r377",
      "r713",
      "r923",
      "r932",
      "r961",
      "r973",
      "r1162",
      "r1169"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Impairment of goodwill",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r378",
      "r384",
      "r388",
      "r932",
      "r961"
     ]
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillPeriodIncreaseDecrease",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease in goodwill",
        "label": "Goodwill, Period Increase (Decrease)",
        "totalLabel": "Goodwill, Period Increase (Decrease), Total",
        "documentation": "Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "us-gaap_GoodwillPurchaseAccountingAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillPurchaseAccountingAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, Purchase Accounting Adjustments",
        "terseLabel": "Adjustments",
        "documentation": "Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r1168"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillScheduleOfGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "asth_HSMSOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "HSMSOMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xxx_HSMSO [Member]",
        "label": "HSMSO [Member]",
        "verboseLabel": "HSMSO"
       }
      }
     },
     "auth_ref": []
    },
    "asth_HealthCareCapitationRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "HealthCareCapitationRevenueMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh_HealthCareCapitationRevenueMember",
        "label": "Health Care Capitation Revenue [Member]",
        "verboseLabel": "Capitation, net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthCareOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCareOtherMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Care, Other [Member]",
        "terseLabel": "Risk pool settlements and incentives",
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthCarePatientServiceMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fee-for-service, net",
        "verboseLabel": "Third-Party",
        "label": "Health Care, Patient Service [Member]",
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "asth_IHealthCallOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IHealthCallOptionMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I Health call option.",
        "label": "I Health Call Option [Member]",
        "terseLabel": "I Health call option"
       }
      }
     },
     "auth_ref": []
    },
    "asth_IHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IHealthIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I Health, Inc.",
        "label": "I Health, Inc. [Member]",
        "terseLabel": "I Health, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "asth_IHealthPromissioryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IHealthPromissioryNoteMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "I Health Promissiory Note",
        "label": "I Health Promissiory Note [Member]",
        "terseLabel": "I Health Promissiory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "terseLabel": "Impairment of finite-lived intangible assets",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r1123",
      "r1184"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r177",
      "r181",
      "r717",
      "r734",
      "r915",
      "r922",
      "r1140",
      "r1142",
      "r1144",
      "r1145",
      "r1146"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Allocation of Net Income (Loss)",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "(Loss) income from equity method investments",
        "negatedLabel": "Loss (income) from equity method investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r124",
      "r176",
      "r280",
      "r296",
      "r319",
      "r359",
      "r733"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Statement of Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r407",
      "r414",
      "r415",
      "r610",
      "r613",
      "r618",
      "r766",
      "r768",
      "r851",
      "r904",
      "r963",
      "r1264"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r415",
      "r610",
      "r613",
      "r618",
      "r766",
      "r768",
      "r851",
      "r904",
      "r963",
      "r1264"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r236",
      "r546",
      "r552",
      "r553",
      "r554",
      "r555",
      "r558",
      "r561",
      "r565",
      "r567",
      "r568",
      "r569",
      "r783",
      "r957"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r191",
      "r255",
      "r256",
      "r280",
      "r297",
      "r319",
      "r551",
      "r552",
      "r566",
      "r742",
      "r957"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "Income Taxes",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r547",
      "r548",
      "r558",
      "r559",
      "r560",
      "r562",
      "r777"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r136",
      "r1125",
      "r1214",
      "r1215"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r1111"
     ]
    },
    "us-gaap_IncomeTaxesReceivableNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesReceivableNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes receivable",
        "label": "Income Taxes Receivable, Noncurrent",
        "verboseLabel": "Income taxes receivable, non-current",
        "documentation": "Carrying amount due after one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r1106"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receivables, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInDueFromRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDueFromRelatedParties",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Receivables, net - related parties",
        "label": "Increase (Decrease) in Due from Related Parties",
        "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInIncomeTaxesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Income Taxes Receivable",
        "negatedLabel": "Income taxes receivable",
        "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "asth_IncreaseDecreaseInMedicalLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IncreaseDecreaseInMedicalLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of medical liabilities.",
        "label": "Increase (Decrease) In Medical Liabilities",
        "verboseLabel": "Medical liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of business combinations:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1093",
      "r1122"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Accounts Payable",
        "verboseLabel": "Fiduciary accounts payable",
        "documentation": "Amount of increase (decrease) in obligations classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities",
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedTerseLabel": "Other assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Receivables",
        "negatedLabel": "Other receivables",
        "documentation": "Amount of increase (decrease) in receivables classified as other."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "asth_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the value of prepaid expenses and other current assets.",
        "label": "Increase (Decrease) In Prepaid Expenses And Other Current Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToContingentlyIssuableShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToContingentlyIssuableShares",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares",
        "terseLabel": "Contingently issuable shares (in shares)",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of contingently issuable shares. Contingently issuable shares are those shares that are issuable for little or no cash contingent on certain conditions being met."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r275"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r395",
      "r400",
      "r933"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Intangible Assets, Net",
        "terseLabel": "Indefinite lived assets",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r400",
      "r933"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r395",
      "r400",
      "r933"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1051",
      "r1059",
      "r1063",
      "r1071"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1075"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1075"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1075"
     ]
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets, Net",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r403",
      "r405",
      "r903",
      "r904"
     ]
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Intangible Assets, Gross",
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill."
       }
      }
     },
     "auth_ref": [
      "r202"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible Assets, Net",
        "verboseLabel": "Intangible assets, net",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r1179",
      "r1181"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expense",
        "terseLabel": "Interest expense",
        "negatedLabel": "Interest expense",
        "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r289",
      "r293",
      "r299",
      "r319",
      "r635",
      "r922",
      "r923"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Nonoperating, Total",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r1118"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r230",
      "r231"
     ]
    },
    "asth_InterestRateCollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "InterestRateCollarMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Rate Collar",
        "label": "Interest Rate Collar [Member]",
        "terseLabel": "Interest Rate Collar"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntersegmentEliminationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntersegmentEliminationMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination",
        "documentation": "Eliminating entries used in operating segment consolidation."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r280",
      "r291",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r922"
     ]
    },
    "asth_IntraCareConvertiblePromissoryNoteReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "IntraCareConvertiblePromissoryNoteReceivableMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IntraCare Convertible Promissory Note Receivable",
        "label": "IntraCare Convertible Promissory Note Receivable [Member]",
        "terseLabel": "IntraCare Convertible Promissory Note Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of Investment in privately held entity that does not report net asset value per share .",
        "label": "Investment In Privately Held Entity That Does Not Report Net Asset Value",
        "verboseLabel": "Investments in privately held entities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r292",
      "r319",
      "r922",
      "r1115"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Investments in affiliates",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r1107"
     ]
    },
    "asth_LasalleMedicalAssociatesIpaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LasalleMedicalAssociatesIpaMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LaSalle Medical Associates IPA [Member]",
        "terseLabel": "LaSalle Medical Associates - IPA Line of Business"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost, net",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r972"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Information Related to Lease Costs",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1243"
     ]
    },
    "asth_LeaseWeightedAverageDiscountRateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LeaseWeightedAverageDiscountRateAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Weighted Average Discount Rate [Abstract]",
        "verboseLabel": "Weighted Average Discount Rate"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LeaseWeightedAverageRemainingLeaseTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LeaseWeightedAverageRemainingLeaseTermAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Weighted Average Remaining Lease Term [Abstract]",
        "verboseLabel": "Weighted Average Remaining Lease Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeFinanceLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Finance Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term, finance",
        "documentation": "Remaining lease term of finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r1242"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r659"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r659"
     ]
    },
    "asth_LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating and finance lease, liability, maturity.",
        "label": "Lessee, Operating and Finance Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments Under Non-cancelable Leases"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LesseeOperatingAndFinanceLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LesseeOperatingAndFinanceLeaseRenewalTerm",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating and finance lease, renewal term.",
        "label": "Lessee, Operating and Finance Lease, Renewal Term",
        "terseLabel": "Lease option to extend (up to)"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating and finance lease, termination period, if applicable.",
        "label": "Lessee, Operating and Finance Lease, Termination Period, If Applicable",
        "terseLabel": "Lease, termination period, if applicable"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LesseeOperatingAndFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LesseeOperatingAndFinanceLeasesTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, operating and finance leases.",
        "label": "Lessee, Operating and Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating leases, Total future minimum lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Operating leases, 2026",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Operating leases, 2029",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Operating leases, 2028",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Operating leases, 2027",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Operating leases, 2025 (excluding the three months ended March 31, 2025)",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1244"
     ]
    },
    "asth_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases, Thereafter",
        "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four",
        "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases, Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term, operating",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r1242"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r103",
      "r104",
      "r105",
      "r108",
      "r109",
      "r110",
      "r111",
      "r235",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r587",
      "r590",
      "r591",
      "r627",
      "r820",
      "r914",
      "r994",
      "r1200",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, mezzanine deficit, and stockholders' equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r175",
      "r730",
      "r973",
      "r1129",
      "r1160",
      "r1237"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "Liabilities, Mezzanine Deficit, and Stockholders' Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r200",
      "r235",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r587",
      "r590",
      "r591",
      "r627",
      "r973",
      "r1200",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total non-current liabilities",
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r108",
      "r109",
      "r110",
      "r111",
      "r235",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r587",
      "r590",
      "r591",
      "r627",
      "r1200",
      "r1247",
      "r1248"
     ]
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesNoncurrentAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Medical liabilities, end of period",
        "periodStartLabel": "Medical liabilities, beginning of period",
        "terseLabel": "Medical liabilities",
        "verboseLabel": "Medical liabilities",
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date."
       }
      }
     },
     "auth_ref": [
      "r978",
      "r982",
      "r1256",
      "r1268"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "terseLabel": "Medical Liabilities",
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments."
       }
      }
     },
     "auth_ref": [
      "r760",
      "r761"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquired",
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Payments for medical care costs related to claims incurred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedLabel": "Current period",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r763",
      "r978"
     ]
    },
    "asth_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Claims paid for acquired balance",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense Claims Paid for Acquired Balance",
        "documentation": "Liability for unpaid claims and claims adjustment expense claims paid for acquired balance.",
        "negatedLabel": "Claims paid for acquired balance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedLabel": "Prior periods",
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r763",
      "r978"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total medical care costs",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process."
       }
      }
     },
     "auth_ref": [
      "r978",
      "r1266"
     ]
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Components of medical care costs related to claims incurred:"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Medical Liabilities [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpensePeriodIncreaseDecrease",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Period Increase (Decrease)",
        "terseLabel": "Adjustments",
        "documentation": "Amount, after effects of reinsurance, of increase (decrease) in the liability for unpaid claims and claims adjustment expense."
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "us-gaap_LicenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LicenseMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Licenses",
        "label": "License [Member]",
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Line of Credit",
        "terseLabel": "Drew down on revolver loan",
        "totalLabel": "Total",
        "verboseLabel": "Amount outstanding",
        "netLabel": "Loan from company",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r172",
      "r1257"
     ]
    },
    "asth_LineOfCreditFacilityAmountFundedAtClosing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LineOfCreditFacilityAmountFundedAtClosing",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Amount Funded At Closing",
        "label": "Line Of Credit Facility, Amount Funded At Closing",
        "terseLabel": "Amount funded at closing"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107",
      "r1128",
      "r1197",
      "r1198"
     ]
    },
    "us-gaap_LineOfCreditFacilityCurrentBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityCurrentBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Line of Credit Facility, Current Borrowing Capacity",
        "documentation": "Amount of current borrowing capacity under the credit facility considering any current restrictions on the amount that could be borrowed (for example, borrowings may be limited by the amount of current assets), but without considering any amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationDate1": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationDate1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Expiration Date",
        "verboseLabel": "Bonds expiration period",
        "documentation": "Date the credit facility terminates, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_LineOfCreditFacilityExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityExpirationPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Expiration Period",
        "terseLabel": "Term of facility",
        "documentation": "Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "documentation": "The effective interest rate at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility interest rate",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "documentation": "The effective interest rate during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107",
      "r1128",
      "r1197"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r1128",
      "r1197"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum loan availability",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Outstanding borrowings",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107",
      "r427"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107",
      "r427",
      "r1128",
      "r1197"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Line of credit facility, unused capacity commitment fee percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "asth_LmaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LmaMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "LMA [Member]",
        "terseLabel": "LMA"
       }
      }
     },
     "auth_ref": []
    },
    "asth_LoanReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LoanReceivableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Receivable",
        "label": "Loan Receivable [Text Block]",
        "verboseLabel": "Loans Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt",
        "negatedTerseLabel": "Less: Current portion of debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "asth_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Long Term Debt Maturities Repayments of Principal After Year Four",
        "documentation": "Long term debt maturities repayments of principal after year four."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2026",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r242",
      "r457"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2029",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r242",
      "r457"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2028",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r242",
      "r457"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2027",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r242",
      "r457"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails": {
       "parentTag": "us-gaap_LineOfCredit",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "terseLabel": "2025 (excluding the nine months ended March 31, 2025)",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion and deferred financing costs",
        "verboseLabel": "Long-term debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r209"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r1187",
      "r1188",
      "r1189"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r45",
      "r1187",
      "r1188",
      "r1189"
     ]
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency Nature [Axis]",
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r425",
      "r545",
      "r774",
      "r934",
      "r1192",
      "r1193"
     ]
    },
    "us-gaap_LossContingencyNatureDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyNatureDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency, Nature [Domain]",
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability."
       }
      }
     },
     "auth_ref": [
      "r420",
      "r421",
      "r422",
      "r425",
      "r545",
      "r774",
      "r934",
      "r1192",
      "r1193"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r326",
      "r943",
      "r976",
      "r981",
      "r1207",
      "r1261",
      "r1269",
      "r1270",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "asth_ManagementContractsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ManagementContractsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management Contracts",
        "label": "Management Contracts [Member]",
        "verboseLabel": "Management contracts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManagementServiceMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Service [Member]",
        "terseLabel": "Management fee income",
        "documentation": "Contractually stipulated right to receive compensation for operating and managing business."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Current",
        "terseLabel": "Investment in marketable securities",
        "verboseLabel": "Investment in marketable securities",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "asth_MarketableSecuritiesCurrentMaturityPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MarketableSecuritiesCurrentMaturityPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketable Securities, Current, Maturity Period",
        "label": "Marketable Securities, Current, Maturity Period",
        "terseLabel": "Short-term marketable securities, maturity period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Investments in Marketable Securities",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r508",
      "r545",
      "r608",
      "r708",
      "r765",
      "r767",
      "r774",
      "r811",
      "r812",
      "r874",
      "r875",
      "r876",
      "r877",
      "r887",
      "r901",
      "r902",
      "r930",
      "r940",
      "r953",
      "r964",
      "r965",
      "r969",
      "r970",
      "r977",
      "r1204",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "asth_MedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MedicaidMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:MedicaidMember",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MedicareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MedicareMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:MedicareMember",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MemberRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MemberRelationshipsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Member Relationships",
        "label": "Member Relationships [Member]",
        "terseLabel": "Member relationships"
       }
      }
     },
     "auth_ref": []
    },
    "asth_Met2023MetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "Met2023MetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Met 2023 Metric.",
        "label": "Met 2023 Metric [Member]",
        "terseLabel": "Met 2023 Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MezzanineEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MezzanineEquityAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MEZZANINE EQUITY [Abstract]",
        "verboseLabel": "Mezzanine deficit"
       }
      }
     },
     "auth_ref": []
    },
    "asth_MezzanineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "MezzanineMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine",
        "label": "Mezzanine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r508",
      "r545",
      "r608",
      "r708",
      "r765",
      "r767",
      "r774",
      "r811",
      "r812",
      "r874",
      "r875",
      "r876",
      "r877",
      "r887",
      "r901",
      "r902",
      "r930",
      "r940",
      "r953",
      "r964",
      "r965",
      "r969",
      "r977",
      "r1204",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r174",
      "r235",
      "r364",
      "r428",
      "r431",
      "r432",
      "r433",
      "r437",
      "r438",
      "r627",
      "r729",
      "r824"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Purchase of non-controlling interest",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r148",
      "r160"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r326",
      "r943",
      "r976",
      "r981",
      "r1207",
      "r1261",
      "r1269",
      "r1270",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_NatureOfOperations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NatureOfOperations",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Description of Business",
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r192"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r229"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r135",
      "r137"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "totalLabel": "Net income attributable to Astrana Health, Inc.",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r137",
      "r178",
      "r198",
      "r218",
      "r219",
      "r223",
      "r235",
      "r246",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r255",
      "r256",
      "r272",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r574",
      "r584",
      "r602",
      "r627",
      "r737",
      "r843",
      "r864",
      "r865",
      "r992",
      "r1200"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "verboseLabel": "Net (loss) income attributable to non-controlling interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r161",
      "r218",
      "r219",
      "r252",
      "r255",
      "r256",
      "r736",
      "r1113"
     ]
    },
    "asth_NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income",
        "documentation": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity",
        "label": "Net Income (Loss), Including Portion Attributable To Noncontrolling Interest And Temporary Equity"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NetworkMedicalManagementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NetworkMedicalManagementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Network Medical Management [Member]",
        "terseLabel": "NMM"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NetworkRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NetworkRelationshipsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Network Relationships",
        "label": "Network Relationships [Member]",
        "terseLabel": "Network relationships"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements Not Yet Adopted",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "asth_NewTermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NewTermLoanMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Term Loan",
        "label": "New Term Loan [Member]",
        "terseLabel": "New Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NonCashDividendPaidInFormOfStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NonCashDividendPaidInFormOfStock",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Cash Dividend Paid In Form Of Stock",
        "documentation": "Non cash dividend paid in form of stock.",
        "terseLabel": "Dividend paid in the form of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1017",
      "r1027",
      "r1051",
      "r1059"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "asth_NonRule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NonRule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Rule 10b5-1 Arr Modified Flag",
        "documentation": "Non Rule 10b5-1 Arr Modified Flag"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "asth_NoncashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NoncashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "verboseLabel": "Non-cash lease expense"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares",
        "label": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Shares, Release Of Hold Back Shares",
        "terseLabel": "Dividends (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Dividends",
        "terseLabel": "Dividends",
        "label": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares",
        "documentation": "Noncontrolling Interest, Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period, Value, Release Of Hold Back Shares"
       }
      }
     },
     "auth_ref": []
    },
    "asth_NoncontrollingInterestIncreaseDecreaseFromBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NoncontrollingInterestIncreaseDecreaseFromBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisition of non-controlling interest",
        "terseLabel": "Acquisition of non-controlling interest",
        "label": "Noncontrolling Interest, Increase (Decrease) from Business Combination",
        "documentation": "Noncontrolling Interest, Increase (Decrease) from Business Combination"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale of non-controlling interest",
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r55",
      "r160"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Member]",
        "verboseLabel": "Non-controlling Interest",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r485",
      "r1133",
      "r1134",
      "r1135",
      "r1137",
      "r1303"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonrelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonrelatedPartyMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonrelated Party [Member]",
        "terseLabel": "Nonrelated Party",
        "documentation": "Party not related to reporting entity."
       }
      }
     },
     "auth_ref": [
      "r1130",
      "r1131"
     ]
    },
    "us-gaap_NotesAndLoansPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansPayable",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Notes and Loans Payable, Total",
        "label": "Notes and Loans Payable",
        "terseLabel": "Notes payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of all notes and loans payable (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r172",
      "r1257"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Loans receivable, current",
        "verboseLabel": "Loan receivable",
        "documentation": "Amortized cost, after allowance for credit loss, of financing receivable classified as current. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r715",
      "r1148"
     ]
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Loans receivable, non-current",
        "totalLabel": "Financing Receivable, after Allowance for Credit Loss, Noncurrent, Total",
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesPayableToBanksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesPayableToBanksMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable to Banks [Member]",
        "terseLabel": "Promissory Note Payable",
        "documentation": "A written promise to pay a note to a bank."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Receivable [Member]",
        "terseLabel": "Convertible Secured Promissory Note",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "asth_NumberOfEquitySecuritiesSold": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NumberOfEquitySecuritiesSold",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of equity securities sold",
        "label": "Number of Equity Securities Sold",
        "documentation": "Number of equity securities sold."
       }
      }
     },
     "auth_ref": []
    },
    "asth_NumberOfMedicareMembers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NumberOfMedicareMembers",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of medicare members",
        "label": "Number of Medicare Members",
        "documentation": "Number of medicare members."
       }
      }
     },
     "auth_ref": []
    },
    "asth_NumberOfOperatingSegmentsThatShareSimilarCharacteristics": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "NumberOfOperatingSegmentsThatShareSimilarCharacteristics",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Operating Segments That Share Similar Characteristics",
        "label": "Number Of Operating Segments That Share Similar Characteristics",
        "terseLabel": "Number of operating segments that share similar characteristics"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DescriptionofBusinessDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r916",
      "r928",
      "r1141"
     ]
    },
    "us-gaap_NumberOfStatesInWhichEntityOperates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfStatesInWhichEntityOperates",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of states",
        "label": "Number of States in which Entity Operates",
        "documentation": "The number of states the entity operates in as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "asth_OfficeLeaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "OfficeLeaseMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Office Lease",
        "label": "Office Lease [Member]",
        "terseLabel": "Office Lease"
       }
      }
     },
     "auth_ref": []
    },
    "asth_OneMSOLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "OneMSOLLCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One MSO, LLC",
        "label": "One MSO, LLC [Member]",
        "terseLabel": "One MSO, LLC"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingCostsAndExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incurred expenses",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Operating Costs and Expenses, Total",
        "verboseLabel": "Expenses recognized",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Income (Loss)",
        "verboseLabel": "Income (loss) from operations",
        "totalLabel": "Income from operations",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r915",
      "r1140",
      "r1142",
      "r1144",
      "r1145",
      "r1146"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Cost",
        "verboseLabel": "Operating lease cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r972"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofFutureMinimumPaymentsUnderNoncancelableLeasesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating leases, Total lease liabilities",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases, Less: current portion",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Operating lease liabilities",
        "netLabel": "Operating lease liabilities",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureLeasesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableLeasesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases, Long-term lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Operating lease liabilities, net of current portion",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Payments",
        "verboseLabel": "Operating cash flows from operating leases",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r653"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r642"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Operating leases",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r972"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofOtherInformationRelatedtoLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Operating leases",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r972"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r320",
      "r922",
      "r923"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r91",
      "r92",
      "r166"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other provider payable",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "asth_OtherAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "OtherAcquisitionsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Acquisitions",
        "label": "Other Acquisitions [Member]",
        "terseLabel": "Other Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "verboseLabel": "Other assets",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r204"
     ]
    },
    "us-gaap_OtherExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherExpenseMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expense [Member]",
        "terseLabel": "Other Expense",
        "documentation": "Primary financial statement caption encompassing other expense."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_OtherInvesteesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherInvesteesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonconsolidated Investees, Other [Member]",
        "terseLabel": "Other",
        "documentation": "Investment in group of nonconsolidated investees classified as other."
       }
      }
     },
     "auth_ref": [
      "r1158"
     ]
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities",
        "terseLabel": "Amount due to affiliates",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r723",
      "r816",
      "r817",
      "r994",
      "r1258",
      "r1301"
     ]
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities",
        "netLabel": "Other liabilities",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r973"
     ]
    },
    "us-gaap_OtherLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities [Member]",
        "terseLabel": "Other Liabilities",
        "documentation": "Primary financial statement caption encompassing other liabilities."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r90"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities",
        "verboseLabel": "Other long-term liabilities",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_OtherLongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Long-Term Investments",
        "terseLabel": "Investment in affiliates",
        "documentation": "Amount of long-term investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r719",
      "r720",
      "r1105"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncurrentLiabilitiesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities",
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other loss",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "us-gaap_OtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables",
        "terseLabel": "Due from affiliates",
        "documentation": "Amount due from parties in nontrade transactions, classified as other."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r830",
      "r923",
      "r1260"
     ]
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherReceivablesNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables",
        "verboseLabel": "Other receivables",
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "asth_OtherThirdPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "OtherThirdPartiesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ameh:OtherThirdPartiesMember",
        "label": "Other Third Parties [Member]",
        "terseLabel": "Other third parties"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1015",
      "r1025",
      "r1057"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1018",
      "r1028",
      "r1060"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1018",
      "r1028",
      "r1060"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PCCCVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PCCCVMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCCCV",
        "label": "PCCCV [Member]",
        "terseLabel": "PCCCV"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PacificMedicalImagingAndOncologyCenterIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PacificMedicalImagingAndOncologyCenterIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pacific Medical Imaging and Oncology Center, Inc [Member]",
        "terseLabel": "Pacific Medical Imaging &amp; Oncology Center, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "asth_PatientManagementPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PatientManagementPlatformMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Management Platform",
        "label": "Patient Management Platform [Member]",
        "terseLabel": "Patient management platform"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PaymentForRepurchaseOfTreasuryStockFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PaymentForRepurchaseOfTreasuryStockFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment For Repurchase Of Treasury Stock, Financing Activities",
        "label": "Payment For Repurchase Of Treasury Stock, Financing Activities",
        "negatedTerseLabel": "Repurchase of subsidiary's shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total paid",
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r978",
      "r1267"
     ]
    },
    "us-gaap_PaymentsForProceedsFromLoansReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromLoansReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for (Proceeds from) Loans Receivable",
        "totalLabel": "Payments for (Proceeds from) Loans Receivable, Total",
        "negatedLabel": "Issuance of loan receivable",
        "documentation": "The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r29"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments for Repurchase of Common Stock",
        "terseLabel": "Payments for repurchase of shares",
        "verboseLabel": "Aggregate purchase price",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Deferred financing cost",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Payments of ordinary dividends common stock",
        "negatedTerseLabel": "Dividends paid",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividendsMinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedTerseLabel": "Purchase of non-controlling interest",
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of Financing Costs",
        "totalLabel": "Payments of Financing Costs, Total",
        "terseLabel": "Payments of debt financing costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Taxes paid from net share settlement of restricted stock",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r225"
     ]
    },
    "asth_PaymentsToAcquireBusinessCashPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PaymentsToAcquireBusinessCashPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Business, Cash Payable",
        "label": "Payments to Acquire Business, Cash Payable",
        "terseLabel": "Cash payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails": {
       "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Aggregate amount",
        "terseLabel": "Cash paid",
        "totalLabel": "Cash paid contingent consideration",
        "label": "Cash paid contingent consideration",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r580"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Payments for business acquisition, net of cash acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireMarketableSecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable securities",
        "documentation": "Amount of cash outflow for purchase of marketable security."
       }
      }
     },
     "auth_ref": [
      "r1151"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "asth_PayorAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorAMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor A [Member]",
        "label": "Payor A [Member]",
        "terseLabel": "Payer A"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorBMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor B [Member]",
        "label": "Payor B [Member]",
        "terseLabel": "Payer B"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor C [Member]",
        "label": "Payor C [Member]",
        "terseLabel": "Payer C"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorDMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor D.",
        "label": "Payor D [Member]",
        "terseLabel": "Payer D"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorEMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payor E [Member]",
        "terseLabel": "Payer E",
        "documentation": "Payor E Member"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PayorFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PayorFMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payor F",
        "label": "Payor F [Member]",
        "terseLabel": "Payor F"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1033"
     ]
    },
    "asth_PerformanceBasedRestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PerformanceBasedRestrictedStockMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Based Restricted Stock",
        "label": "Performance Based Restricted Stock [Member]",
        "terseLabel": "Performance Based Restricted Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "asth_PmiocMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PmiocMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PMIOC [Member]",
        "terseLabel": "PMIOC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1035"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r1034"
     ]
    },
    "asth_PreferredBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PreferredBankMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Bank [Member]",
        "terseLabel": "Preferred Bank"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (in dollars per share)",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r469"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r822"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Shares Issued",
        "verboseLabel": "Preferred stock, shares issued (in shares)",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r469"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r822",
      "r841",
      "r1303",
      "r1304"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock, Value, Issued",
        "verboseLabel": "Preferred stock",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r726",
      "r973"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "verboseLabel": "Prepaid expenses and other current assets",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1112"
     ]
    },
    "asth_PrimeCommunityCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PrimeCommunityCareMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prime Community Care",
        "label": "Prime Community Care [Member]",
        "terseLabel": "PCCCV contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PrimeCommunityCareOfCentralValleyIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PrimeCommunityCareOfCentralValleyIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prime Community Care of Central Valley, Inc",
        "label": "Prime Community Care of Central Valley, Inc [Member]",
        "terseLabel": "Prime Community Care of Central Valley, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivateEquityFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivateEquityFundsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement for Future Equity Fund",
        "label": "Private Equity Funds [Member]",
        "documentation": "Investments held in private equity funds."
       }
      }
     },
     "auth_ref": [
      "r960",
      "r962",
      "r1209"
     ]
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement",
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distribution from investment - equity method",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r1119"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Drawdowns",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r1120"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfOtherLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Issuance of Other Long-Term Debt",
        "terseLabel": "Borrowings on long-term debt",
        "documentation": "Amount of cash inflow from issuance of long-term debt classified as other."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ProceedsFromPaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsToMinorityShareholders",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Payments to) Noncontrolling Interests",
        "terseLabel": "Proceeds from sale of non-controlling interest",
        "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Proceeds from promissory note",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "asth_ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from repayment of promissory notes, including those with related parties",
        "label": "Proceeds from Repayment of Promissory Notes Including Related Parties",
        "documentation": "Proceeds from repayment of promissory notes including related parties."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromRepaymentsOfBankOverdrafts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromRepaymentsOfBankOverdrafts",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from (Repayments of) Bank Overdrafts",
        "terseLabel": "Proceeds from (repayments of) bank overdrafts",
        "documentation": "The net cash inflow or outflow from the excess drawing from an existing cash balance, which will be honored by the bank but reflected as a loan to the drawer."
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1121",
      "r1124"
     ]
    },
    "us-gaap_ProceedsFromStockPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from ESPP purchases",
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "asth_ProceedsPaymentsFromOtherOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ProceedsPaymentsFromOtherOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds (Payments) From Other Operating Activities",
        "documentation": "Proceeds (payments) from other operating activities.",
        "terseLabel": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductAndServiceOtherMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other revenue",
        "verboseLabel": "Intersegment",
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1208"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r709",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r764",
      "r906",
      "r941",
      "r975",
      "r977",
      "r979",
      "r982",
      "r983",
      "r1194",
      "r1195",
      "r1207",
      "r1261",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r323",
      "r709",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r764",
      "r906",
      "r941",
      "r975",
      "r977",
      "r979",
      "r982",
      "r983",
      "r1194",
      "r1195",
      "r1207",
      "r1261",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "asth_ProfessionalMedicalCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ProfessionalMedicalCorporationMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Professional Medical Corporation",
        "label": "Professional Medical Corporation [Member]",
        "terseLabel": "AMG"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r218",
      "r219",
      "r227",
      "r235",
      "r246",
      "r252",
      "r255",
      "r256",
      "r364",
      "r428",
      "r429",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r437",
      "r438",
      "r574",
      "r584",
      "r585",
      "r588",
      "r589",
      "r602",
      "r627",
      "r717",
      "r735",
      "r790",
      "r843",
      "r864",
      "r865",
      "r958",
      "r959",
      "r993",
      "r1113",
      "r1200"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Land, property and equipment, net",
        "verboseLabel": "Property and equipment, net",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1092",
      "r1185"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r658",
      "r718",
      "r732",
      "r973"
     ]
    },
    "asth_ProviderServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ProviderServicesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Services",
        "label": "Provider Services [Member]",
        "terseLabel": "Provider Services"
       }
      }
     },
     "auth_ref": []
    },
    "asth_PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Of Investments Equity Method In Accounts Payable And Accrued Liabilities And Other Liabilities",
        "documentation": "Purchase of investments equity method in accounts payable and accrued liabilities and other liabilities.",
        "terseLabel": "Purchase of investments - equity method in accounts payable and accrued liabilities and other liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r1032"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r500",
      "r508",
      "r536",
      "r537",
      "r538",
      "r545",
      "r608",
      "r679",
      "r691",
      "r708",
      "r765",
      "r767",
      "r774",
      "r811",
      "r812",
      "r874",
      "r875",
      "r876",
      "r877",
      "r887",
      "r901",
      "r902",
      "r930",
      "r940",
      "r953",
      "r964",
      "r965",
      "r969",
      "r970",
      "r977",
      "r986",
      "r1190",
      "r1204",
      "r1225",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesAdditionalinformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424",
      "r500",
      "r508",
      "r536",
      "r537",
      "r538",
      "r545",
      "r608",
      "r679",
      "r691",
      "r708",
      "r765",
      "r767",
      "r774",
      "r811",
      "r812",
      "r874",
      "r875",
      "r876",
      "r877",
      "r887",
      "r901",
      "r902",
      "r930",
      "r940",
      "r953",
      "r964",
      "r965",
      "r969",
      "r970",
      "r977",
      "r986",
      "r1190",
      "r1204",
      "r1225",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "us-gaap_ReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Receivables and receivables from related parties.",
        "label": "Receivables, Receivables \u2013 Related Parties, Other Receivables And Loan Receivables [Policy Text Block]",
        "verboseLabel": "Receivables, Receivables \u2013 Related Parties, Other Receivables and Loan Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ReconciliationOfCashCashEquivalentsAndRestrictedCashAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation Of Cash Cash Equivalents And Restricted Cash",
        "label": "Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1010",
      "r1020",
      "r1052"
     ]
    },
    "us-gaap_RelatedPartyDepositLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDepositLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Deposit Liabilities",
        "verboseLabel": "Due to related parties",
        "documentation": "Amount of deposits held by the entity for a related party (entity, shareholder, employee)."
       }
      }
     },
     "auth_ref": [
      "r1130"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Domain]",
        "terseLabel": "Related Party [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r507",
      "r664",
      "r665",
      "r724",
      "r731",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r840",
      "r842",
      "r873"
     ]
    },
    "asth_RelatedPartyExpensesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RelatedPartyExpensesPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenses payable",
        "label": "Related Party, Expenses Payable",
        "documentation": "Related Party, Expenses Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "terseLabel": "Related Party",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r664",
      "r665",
      "r666",
      "r667",
      "r724",
      "r731",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r840",
      "r842",
      "r873"
     ]
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Related party transaction, amount of transaction",
        "documentation": "Amount of transactions with related party during the financial reporting period."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r664"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r664",
      "r665",
      "r1246"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": []
    },
    "asth_RelatedPartyTransactionExpensesIncurredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RelatedPartyTransactionExpensesIncurredMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Expenses Incurred",
        "label": "Related Party Transaction, Expenses Incurred [Member]",
        "terseLabel": "Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r847",
      "r848",
      "r851"
     ]
    },
    "asth_RelatedPartyTransactionRevenueExpenseNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RelatedPartyTransactionRevenueExpenseNetMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Revenue (Expense), Net",
        "label": "Related Party Transaction, Revenue (Expense), Net [Member]",
        "terseLabel": "Net"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RelatedPartyTransactionRevenueRecognizedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RelatedPartyTransactionRevenueRecognizedMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Revenue Recognized",
        "label": "Related Party Transaction, Revenue Recognized [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party, Type [Axis]",
        "terseLabel": "Related Party [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r507",
      "r664",
      "r665",
      "r724",
      "r731",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r840",
      "r842",
      "r873",
      "r1246"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions Disclosure [Text Block]",
        "verboseLabel": "Related-Party Transactions",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r662",
      "r663",
      "r665",
      "r668",
      "r786",
      "r787",
      "r788",
      "r849",
      "r850",
      "r851",
      "r870",
      "r872"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Debt",
        "terseLabel": "Repayments",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Payment of finance lease obligations",
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfOtherLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfOtherLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Other Long-Term Debt",
        "negatedTerseLabel": "Repayment of long-term debt",
        "documentation": "Amount of cash outflow for the payment of debt classified as other, maturing after one year or the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of Related Party Debt",
        "terseLabel": "Payments on promissory note",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "asth_ReplacementOfRestrictedStockAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ReplacementOfRestrictedStockAwards",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Replacement of Restricted Stock Awards",
        "documentation": "Replacement of restricted stock awards.",
        "terseLabel": "Replacement of restricted stock awards"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r239",
      "r240",
      "r443",
      "r471",
      "r667",
      "r692",
      "r719",
      "r910",
      "r911"
     ]
    },
    "us-gaap_RepurchaseAgreementDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepurchaseAgreementDate",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase Agreement, Date",
        "terseLabel": "Stock repurchase agreement date",
        "documentation": "Date of repurchase agreement, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": [
      "r874",
      "r875",
      "r877",
      "r887"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1011",
      "r1021",
      "r1053"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1012",
      "r1022",
      "r1054"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1019",
      "r1029",
      "r1061"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1103",
      "r1126",
      "r1255",
      "r1259"
     ]
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r896",
      "r897",
      "r1106",
      "r1126"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_AssetsNoncurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r1106",
      "r1126"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Stock [Member]",
        "verboseLabel": "Restricted Stock Awards and Units",
        "terseLabel": "Restricted Stock Awards",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "asth_RestructuringSpinoffTransactionNumberOfMembershipUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RestructuringSpinoffTransactionNumberOfMembershipUnits",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Spinoff Transaction, Number Of Membership Units",
        "label": "Restructuring, Spinoff Transaction, Number Of Membership Units",
        "terseLabel": "Spinoff transaction, number of membership units per common share"
       }
      }
     },
     "auth_ref": []
    },
    "asth_RestructuringSpinoffTransactionPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RestructuringSpinoffTransactionPercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring, Spinoff Transaction, Percentage",
        "label": "Restructuring, Spinoff Transaction, Percentage",
        "terseLabel": "Spinoff transaction, ownership percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r148",
      "r728",
      "r772",
      "r773",
      "r782",
      "r823",
      "r973"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings [Member]",
        "verboseLabel": "Retained Earnings",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r243",
      "r244",
      "r245",
      "r247",
      "r252",
      "r254",
      "r256",
      "r365",
      "r366",
      "r406",
      "r563",
      "r564",
      "r571",
      "r572",
      "r573",
      "r575",
      "r583",
      "r584",
      "r592",
      "r594",
      "r595",
      "r597",
      "r600",
      "r639",
      "r641",
      "r769",
      "r771",
      "r791",
      "r1303"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 0.0
      },
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofDisaggregatedRevenuebyEachPayerTypeDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r280",
      "r290",
      "r291",
      "r313",
      "r319",
      "r323",
      "r325",
      "r326",
      "r496",
      "r497",
      "r709"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r193",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r905"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolver Loan",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r654",
      "r972"
     ]
    },
    "asth_RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year",
        "label": "Risk Pool Surplus Or Deficits, Settlement Period After Performance Year",
        "terseLabel": "Risk pool surplus or deficits, settlement period after performance year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_Rule10B51ArrModifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "Rule10B51ArrModifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arr Modified Flag",
        "documentation": "Rule 10b5-1 Arr Modified Flag"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofContributionstoRevenueandReceivablesbyPayerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Benchmark [Member]",
        "verboseLabel": "Net Revenue",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r1088"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r257",
      "r509",
      "r1082",
      "r1136"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r121",
      "r328",
      "r1149"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62",
      "r578"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share Computations",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Share-Based Compensation Expense",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r570",
      "r1083",
      "r1084",
      "r1085",
      "r1216",
      "r1217",
      "r1218",
      "r1219"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r361",
      "r362",
      "r363",
      "r364",
      "r627"
     ]
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureInvestmentsInOtherEntitiesScheduleOfEquityMethodInvestmentsActivityDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]",
        "documentation": "Disclosure of information about equity method investment. Includes, but is not limited to, name of investee or group of investees, percentage ownership, difference between investment and value of underlying equity in net assets."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r235",
      "r361",
      "r362",
      "r363",
      "r364",
      "r627"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r390",
      "r397",
      "r401",
      "r402",
      "r404",
      "r710",
      "r904",
      "r933"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets, Net",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r1178"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Change in Carrying Value of Goodwill",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r932",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1169",
      "r1170",
      "r1171"
     ]
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Medical Liabilities",
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Credit Facility",
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r107"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Future Commitments of Credit Facility",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsScheduleofFeesIncurredandRevenueEarnedfromRelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r96",
      "r847",
      "r848",
      "r851"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Related Party Transactions [Table Text Block]",
        "verboseLabel": "Schedule of Fees Incurred and Revenue Earned from Related Party Transactions",
        "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "verboseLabel": "Schedule of Contributions to Revenue and Receivables by Payor",
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/SegmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Information about our Segments",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43",
      "r44"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r512",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Transactions Under Stock Option Plans",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r149"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r144",
      "r146",
      "r147",
      "r148",
      "r210",
      "r211",
      "r212",
      "r282",
      "r469",
      "r470",
      "r471",
      "r473",
      "r476",
      "r481",
      "r483",
      "r778",
      "r779",
      "r780",
      "r781",
      "r940",
      "r1081",
      "r1127"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Disclosure of information about variable interest held, whether or not such variable interest entity (VIE) is included in consolidated financial statements."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r76",
      "r78",
      "r586",
      "r587",
      "r590",
      "r591",
      "r687",
      "r688",
      "r689"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities, Variable Interest Entities",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r73",
      "r74",
      "r76",
      "r78"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "verboseLabel": "Schedule of Shares Included in the Diluted Earnings Per Share Computations",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Schedule of Future Amortization Expense",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r1180"
     ]
    },
    "asth_SecondAndThirdMetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SecondAndThirdMetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Second and Third Metric",
        "label": "Second And Third Metric [Member]",
        "documentation": "Second and Third metric."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SecondMetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SecondMetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second Metric",
        "label": "Second Metric [Member]",
        "terseLabel": "Second Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SecondThirdFourthAndFifthMeasurementPeriodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SecondThirdFourthAndFifthMeasurementPeriodMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Second Third Fourth and Fifth Measurement Period [Member]",
        "documentation": "Second third fourth and fifth measurement period.",
        "terseLabel": "Second Third Fourth and Fifth Measurement Period"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SecuredOvernightFinancingRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SecuredOvernightFinancingRateMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate",
        "label": "Secured Overnight Financing Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r995"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182",
      "r280",
      "r285",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r326",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r404",
      "r416",
      "r417",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r918",
      "r922",
      "r923",
      "r932",
      "r980",
      "r1261",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r921",
      "r929"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r312",
      "r918",
      "r926"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Segments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segments",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r182",
      "r280",
      "r284",
      "r285",
      "r286",
      "r287",
      "r289",
      "r302",
      "r304",
      "r305",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r323",
      "r324",
      "r326",
      "r916",
      "r919",
      "r920",
      "r922",
      "r924",
      "r927",
      "r928"
     ]
    },
    "us-gaap_SegmentReportingExpenseInformationUsedByCodmDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingExpenseInformationUsedByCodmDescription",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Expense Information Used by CODM, Description",
        "verboseLabel": "CODM Description",
        "documentation": "Description of nature of expense information used by chief operating decision maker (CODM) to manage operation when segment expense information by category is not disclosed."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r305",
      "r319"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "verboseLabel": "Reportable Segments",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r322",
      "r325",
      "r917",
      "r918",
      "r925"
     ]
    },
    "asth_SeniorSecuredPromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SeniorSecuredPromissoryNoteMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Secured Promissory Note",
        "label": "Senior Secured Promissory Note [Member]",
        "terseLabel": "Senior Secured Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A Preferred Stock",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1110",
      "r1206"
     ]
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesBPreferredStockMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B Preferred Stock",
        "documentation": "Series B preferred stock."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1110",
      "r1206"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Vesting period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r954"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Contingent on Performance",
        "terseLabel": "Contingent on performance (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock awards granted (in shares)",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value granted (in dollars per share)",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r512",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of shares authorized for issuance (in shares)",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value (in millions)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable (in shares)",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Options exercised",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r532"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options canceled, forfeited or expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total",
        "negatedLabel": "Options canceled, forfeited or expired (in shares)",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1210"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Options canceled, forfeited or expired (in dollars per share)",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1210"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Options forfeited (in shares)",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "totalLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures, Total",
        "documentation": "Net number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r1211"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "verboseLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Options outstanding, beginning balance (in dollars per share)",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r518"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "verboseLabel": "Options exercisable (in dollars per share)",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageExercisePriceAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Exercise Price [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Exercise Price [Abstract]",
        "verboseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Contractual Term (Years)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (in dollars per share)",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Options forfeited (in dollars per share)",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Options granted (in dollars per share)",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "verboseLabel": "Options exercisable",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "asth_SharesIssuedForVestingOfRestrictedStockAwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SharesIssuedForVestingOfRestrictedStockAwards",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued for Vesting of Restricted Stock Awards",
        "documentation": "Shares issued for vesting of restricted stock awards.",
        "terseLabel": "Shares issued for vesting of restricted stock awards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares, Outstanding",
        "periodEndLabel": "Equity, ending balance (in shares)",
        "periodStartLabel": "Equity, beginning balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Shares withheld from issuance upon exercise of options",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SongPCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SongPCMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Song PC",
        "label": "Song PC [Member]",
        "terseLabel": "Song PC"
       }
      }
     },
     "auth_ref": []
    },
    "asth_SpecialtyCapitationPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SpecialtyCapitationPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the amount of specialty capitation payable current.",
        "label": "Specialty Capitation Payable Current",
        "verboseLabel": "Capitation payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StandbyLettersOfCreditMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit",
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r1196",
      "r1297",
      "r1298"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r182",
      "r197",
      "r280",
      "r285",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r300",
      "r301",
      "r303",
      "r304",
      "r305",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r326",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r404",
      "r408",
      "r416",
      "r417",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r918",
      "r922",
      "r923",
      "r932",
      "r980",
      "r1261",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r210",
      "r211",
      "r212",
      "r235",
      "r261",
      "r264",
      "r273",
      "r275",
      "r282",
      "r283",
      "r364",
      "r428",
      "r431",
      "r432",
      "r433",
      "r437",
      "r438",
      "r469",
      "r470",
      "r473",
      "r476",
      "r483",
      "r627",
      "r778",
      "r779",
      "r780",
      "r781",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r822",
      "r844",
      "r866",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r1081",
      "r1127",
      "r1138"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r114",
      "r118",
      "r119",
      "r195",
      "r221",
      "r222",
      "r223",
      "r243",
      "r244",
      "r245",
      "r247",
      "r252",
      "r254",
      "r256",
      "r281",
      "r365",
      "r366",
      "r406",
      "r485",
      "r563",
      "r564",
      "r571",
      "r572",
      "r573",
      "r575",
      "r583",
      "r584",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r639",
      "r641",
      "r660",
      "r738",
      "r769",
      "r770",
      "r771",
      "r791",
      "r866"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r281",
      "r641",
      "r709",
      "r776",
      "r802",
      "r813",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r822",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r831",
      "r832",
      "r833",
      "r834",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r842",
      "r845",
      "r846",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r866",
      "r987"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r257",
      "r509",
      "r1082",
      "r1086",
      "r1136"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r245",
      "r281",
      "r327",
      "r641",
      "r709",
      "r776",
      "r802",
      "r813",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r822",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r831",
      "r832",
      "r833",
      "r834",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r842",
      "r845",
      "r846",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r866",
      "r987"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1014",
      "r1024",
      "r1056"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "asth_StockAwardsAndUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "StockAwardsAndUnitsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Awards And Units",
        "label": "Stock Awards And Units [Member]",
        "terseLabel": "Restricted stock awards and units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued",
        "terseLabel": "Common stock issued in business combination",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of shares for business acquisition (in shares)",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued under stock purchase plan",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "verboseLabel": "Issuance of shares for Employee Stock Purchase Plan (\"ESPP\") (in shares)",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148"
     ]
    },
    "asth_StockIssuedDuringPeriodSharesMerger": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "StockIssuedDuringPeriodSharesMerger",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to merger.",
        "label": "Stock Issued During Period, Shares, Merger",
        "terseLabel": "Holdback shares not issued to former shareholders (in shares)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with the Company's equity award programs (in shares)",
        "terseLabel": "Number of shares purchased by related party (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148",
      "r778",
      "r866",
      "r890"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Shares issued for vesting of restricted stock awards (in shares)",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationScheduleofStockOptionTransactionsUnderStockOptionPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Shares issued for exercise of options and warrants (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "verboseLabel": "Shares issued for cash and exercise of options (in shares)",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148",
      "r522"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of shares for business acquisition",
        "documentation": "Value of stock issued pursuant to acquisitions during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r114",
      "r118",
      "r119",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of shares for Employee Stock Purchase Plan (\"ESPP\")",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Shares issued for vesting of restricted stock awards",
        "negatedLabel": "Shares issued for vesting of restricted stock awards",
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Share-based compensation",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r113",
      "r114",
      "r148"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Purchase price adjustment from merger",
        "verboseLabel": "Shares issued for cash and exercise of options",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r114",
      "r118",
      "r119",
      "r148"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Shares repurchased",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148",
      "r781",
      "r866",
      "r892"
     ]
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased, value",
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r113",
      "r114",
      "r148",
      "r791",
      "r866",
      "r892",
      "r993"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r118",
      "r119",
      "r141",
      "r824",
      "r841",
      "r867",
      "r868",
      "r973",
      "r994",
      "r1129",
      "r1160",
      "r1237",
      "r1303"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "totalLabel": "Total equity",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69",
      "r79",
      "r195",
      "r196",
      "r222",
      "r243",
      "r244",
      "r245",
      "r247",
      "r252",
      "r254",
      "r365",
      "r366",
      "r406",
      "r485",
      "r563",
      "r564",
      "r571",
      "r572",
      "r573",
      "r575",
      "r583",
      "r584",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r600",
      "r628",
      "r629",
      "r633",
      "r640",
      "r660",
      "r770",
      "r771",
      "r789",
      "r824",
      "r841",
      "r867",
      "r868",
      "r894",
      "r993",
      "r1129",
      "r1160",
      "r1237",
      "r1303"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "verboseLabel": "Stockholders\u2019 equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Text Block]",
        "terseLabel": "Mezzanine Deficit and Stockholders' Equity",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r234",
      "r468",
      "r470",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r482",
      "r485",
      "r599",
      "r869",
      "r871",
      "r895"
     ]
    },
    "asth_SubcontractorIPAPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SubcontractorIPAPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/AccountsPayableandAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subcontractor IPA Payable",
        "label": "Subcontractor IPA Payable",
        "verboseLabel": "Subcontractor IPA payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/LeasesScheduleofComponentsofLeaseExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sublease Income",
        "negatedLabel": "Sublease income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r972"
     ]
    },
    "asth_SubordinatedLoanAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SubordinatedLoanAgreementMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subordinated Loan Agreement",
        "label": "Subordinated Loan Agreement [Member]",
        "terseLabel": "Subordinated Loan Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]",
        "documentation": "Information by business subsegments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsegmentsDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSegmentsScheduleOfInformationAboutOurSegmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]",
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r671"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r671"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event [Table]",
        "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r671"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r671"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/LoansReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r634",
      "r671"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Text Block]",
        "verboseLabel": "Subsequent Events",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r670",
      "r672"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary Of Significant Accounting Policies [Table]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "asth_SunnyVillageCareCenterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "SunnyVillageCareCenterMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sunny Village Care Center",
        "label": "Sunny Village Care Center [Member]",
        "terseLabel": "Sunny Village Care Center"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current period",
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r762",
      "r978"
     ]
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails": {
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/MedicalLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior periods",
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs."
       }
      }
     },
     "auth_ref": [
      "r762",
      "r978"
     ]
    },
    "us-gaap_SuretyBondMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SuretyBondMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Surety Bond [Member]",
        "terseLabel": "Surety Bonds",
        "documentation": "An obligation arising from a three-party agreement that legally binds together a principal who needs the bond, an obligee who requires the bond and a surety company that sells the bond."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "asth_TaxImpactFromDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TaxImpactFromDividends",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Tax impact from dividends",
        "terseLabel": "Tax impact from dividends",
        "label": "Tax Impact From Dividends",
        "documentation": "Tax impact from dividends."
       }
      }
     },
     "auth_ref": []
    },
    "asth_TaxesAssociatedWithExcludedAssetsSpinOffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TaxesAssociatedWithExcludedAssetsSpinOffMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Taxes Associated with Excluded Assets Spin-off",
        "label": "Taxes Associated With Excluded Assets Spin-off [Member]",
        "documentation": "Taxes associated with excluded assets spin-off."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes Payable, Current",
        "totalLabel": "Taxes Payable, Current, Total",
        "terseLabel": "Income tax payable",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r104"
     ]
    },
    "us-gaap_TemporaryEquityAccretionOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityAccretionOfDividends",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary Equity, Dividends",
        "label": "Temporary Equity, Accretion of Dividends",
        "documentation": "Value of accretion of temporary equity during the period due to unpaid dividends."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, carrying amount, ending balance",
        "periodStartLabel": "Temporary equity, carrying amount, beginning balance",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r235",
      "r364",
      "r627"
     ]
    },
    "asth_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Net of Dividends",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests, Net of Dividends",
        "terseLabel": "Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation (\"APC\")"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TemporaryEquityNetIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net (loss) income",
        "documentation": "The portion of net income or loss attributable to temporary equity interest."
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityTaxImpactFromDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TemporaryEquityTaxImpactFromDividends",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary equity, Tax impact from dividends",
        "negatedLabel": "Temporary equity, Tax impact from dividends",
        "label": "Temporary Equity Tax Impact From Dividends",
        "documentation": "Temporary equity tax impact from dividends."
       }
      }
     },
     "auth_ref": []
    },
    "asth_TemporaryEquityTransferOfCommonControlEntities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TemporaryEquityTransferOfCommonControlEntities",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Transfer Of Common Control Entities",
        "label": "Temporary Equity, Transfer Of Common Control Entities",
        "terseLabel": "Temporary Equity, Transfer Of Common Control Entities"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TermLoanAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TermLoanAMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term Loan A",
        "label": "Term Loan A [Member]",
        "documentation": "Term Loan A."
       }
      }
     },
     "auth_ref": []
    },
    "asth_TermLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TermLoanMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCreditFacilityBankLoansAndLinesOfCreditScheduleOfCreditFacilityInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ThirdMetricMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ThirdMetricMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Metric",
        "label": "Third Metric [Member]",
        "terseLabel": "Third Metric"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ThirdWayHealthIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ThirdWayHealthIncMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Way Health",
        "label": "Third Way Health Inc [Member]",
        "documentation": "Third way health inc."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1147",
      "r1245"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StockBasedCompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TotalAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TotalAcquisitionsMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Acquisitions",
        "label": "Total Acquisitions [Member]",
        "terseLabel": "Total Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "asth_TotalPurchaseConsiderationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TotalPurchaseConsiderationAbstract",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureBusinessCombinationsAndGoodwillSummaryOfPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Purchase Consideration",
        "label": "Total Purchase Consideration [Abstract]",
        "terseLabel": "Total purchase consideration:"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksAndTradeNamesMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trademarks and Trade Names [Member]",
        "terseLabel": "Tradename/trademarks",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1179",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "us-gaap_TrademarksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IntangibleAssetsNetScheduleofIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks",
        "label": "Trademarks [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r933",
      "r1172",
      "r1173",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1179",
      "r1181",
      "r1182",
      "r1183"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/RelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r464",
      "r481",
      "r598",
      "r624",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r690",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r739",
      "r960",
      "r962",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969",
      "r970",
      "r974",
      "r1096",
      "r1097",
      "r1098",
      "r1099",
      "r1100",
      "r1101",
      "r1102",
      "r1152",
      "r1153",
      "r1154",
      "r1155",
      "r1221",
      "r1224",
      "r1225",
      "r1226",
      "r1233",
      "r1236"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury shares (in shares)",
        "verboseLabel": "Treasury stock, common, shares (in shares)",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureMezzanineDeficitAndStockholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Shares, Acquired",
        "verboseLabel": "Treasury stock repurchased (in shares)",
        "negatedTerseLabel": "Purchase of treasury shares (in shares)",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r114",
      "r148"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineDeficitAndStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Temporary Equity, Repurchase of subsidiary's shares",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r56",
      "r148"
     ]
    },
    "asth_TruistBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "TruistBankMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Truist Bank",
        "label": "Truist Bank [Member]",
        "terseLabel": "Truist Bank"
       }
      }
     },
     "auth_ref": []
    },
    "asth_UnamortizedDeferredFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "UnamortizedDeferredFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unamortized Deferred Financing Costs",
        "label": "Unamortized Deferred Financing Costs",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "asth_UnrealizedGainLossFromInvestmentInEquitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "UnrealizedGainLossFromInvestmentInEquitySecurities",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrealized (Gain) Loss from Investment in Equity Securities",
        "label": "Unrealized (Gain) Loss from Investment in Equity Securities",
        "negatedLabel": "Unrealized loss (gain) on investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrealizedGainLossOnInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfIncomeUnaudited"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized (loss) gain on investments",
        "label": "Unrealized Gain (Loss) on Investments",
        "documentation": "Amount of unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and penalties related to unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r556",
      "r956"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would reduce annual effective tax rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r956"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "verboseLabel": "Use of Estimates",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41",
      "r186",
      "r187",
      "r189",
      "r190"
     ]
    },
    "asth_VOMGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "VOMGMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsScheduleofCarryingAmountsandFairValuesofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "VOMG",
        "label": "VOMG [Member]",
        "terseLabel": "VOMG contingent consideration"
       }
      }
     },
     "auth_ref": []
    },
    "asth_ValueOfCallOption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.astranahealth.com/20250331",
     "localname": "ValueOfCallOption",
     "crdr": "debit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/FairValueMeasurementsofFinancialInstrumentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Call option",
        "label": "Value Of Call Option",
        "documentation": "Value of call option."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEs"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "verboseLabel": "Variable Interest Entities (VIEs)",
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss."
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum exposure to loss amount",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r162"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r587",
      "r590",
      "r591",
      "r687",
      "r688",
      "r689"
     ]
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/InvestmentsinOtherEntitiesAdditionalInformationDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityOwnershipPercentage",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Variable interest entity, ownership percentage",
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly)."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/DisclosureVariableInterestEntitiesViesScheduleOfAssetsAndLiabilitiesVariableInterestEntitiesDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/VariableInterestEntitiesVIEsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r586",
      "r587",
      "r590",
      "r591"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/CreditFacilityBankLoansandLinesofCreditAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment",
        "terseLabel": "Adjustments to weighted average shares of common stock (in shares)",
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation."
       }
      }
     },
     "auth_ref": [
      "r1139"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares of common stock outstanding \u2013 diluted (in shares)",
        "verboseLabel": "Weighted average shares of common stock outstanding \u2013 diluted (in shares)",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r275"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 0.0
      }
     },
     "presentation": [
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofEarningsPerShareComputationsDetails",
      "http://www.astranahealth.com/20250331/taxonomy/role/EarningsPerShareScheduleofSharesIncludedintheDilutedEarningsPerShareComputationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Weighted average shares of common stock outstanding \u2013 basic (in shares)",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r275"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "12",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481410/810-10-15-12"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "12",
   "Subparagraph": "(f)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481410/810-10-15-12"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "16",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-16"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478353/942-405-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4D"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-8"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "63",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-63"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-37"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-24"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-5A"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-6"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-9"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-4"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-7"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-4"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21D"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "44",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-44"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "48",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-48"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-51"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-52"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-53"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "54",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-54"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "36",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482736/825-10-45-1A"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-1A"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(d)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-40/tableOfContent"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-15"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-16"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-12"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5A"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478790/946-405-45-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-4"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478600/954-210-50-2"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-7"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "SubTopic": "10",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-9"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481664/323-10-45-1"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(cc)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-15"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-16"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>97
<FILENAME>0000950170-25-068198-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-25-068198-xbrl.zip
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M*Y)U(^R7&FK-J5%6:T@%'9!-R<8<&>EV"4NNZC7Z]?DMTBC\I3N-6'MTB)I
MR<B@5E;&+CI4\-$%C<BPQG1G\.Y'FIB?O"%C%4CI. Q%6R!844&ZK(5!YQ1U
M-]K<U=+IF[##=J0%U);A8%N^%AAP%-5F-14H357Z$((M.U3"W=]*M:X',VGX
M<CE+/JRQM@IOY1!/\XVH:&U6.EO=W9!3I_'7EI)Z1A9-5#BD+ZWH9C4$9250
M8.M:%5H7NO-C=\O:,\+JS,/Y[/7!?3WPQ3E4#1>UE;V)+(32#'\0A-55*7)W
M'9HC2?64HNIT)/7I6WS-]F!O5EZP?9C.7Y]LNB-Z5P5/P39*]%3#RI!8P!P"
M7[W&MMO%1M=M=:"+ZOVWS,>?.IG&#+X:--O"F.N6W(U3OF"C1@Z"S0,)P> =
M!;!V5"M,"::_Y2%C[4O>:X1UAR]V:,MV=EI8EQN1H#8<Y-J6FP\,#G*(?+B1
MJNT6'/1 9-U#RMQ'+VM-4*)L<5);)QH+VWU50JBYH@O=9;FZ7"?ZB8N5 L1&
M>X,_>>O-9)F"$VU 29!G%UO9V489(0E=4#N%)7=['.^W5PNEK':/N*(TF&H,
MQ!01HE'6D&RK1>]U2FJ+#:R[E)**(9OUX@_IP%@VM5'Q!P192#0"N*R[.YYW
M2[M[U:ZPW9X%RJB2=-Y %98M@I<28DRL%8Z$0G+*=5RI[B%)_=?P&VA,3H@0
M5EO%.'*&)*,&2;XFC(0&NP5GO?0S]("QT91:1(*0VO:2F@J@T!E$"2[EM@RH
MW\TRW]ZR_ALMW\^'/[[WK'^B \'8Z 3H6-O8@E(,RS&TX95L& $HC-TV1W<7
M*M]1!A/1I5H]M!D#]MF,YP/'5QQC949NQ1E;NVM'_%9:K$/B[UQ6+>A/YL?#
M\LW>K#R9U.6;YX2+XV&E!0>K9S:6 _].D[7C-%D9219I"420#%*(KQV=XP,2
M$EH;0DJ^.[:X[WU2W6"CI(0UFC%MXVDQ,3B.AZV#MC>W2%=RP>[*0M]W:HT/
MCU(2T@8)Q1(R1*Z1?:O,X%V.50<IM>TVTNDJ#7U9/!<SRS<2#T<J4;>F;09!
M8!3CGY1-;;QI)AE1$7-WT.<.N0_&/!B$E#))(&RD,2:Q=PTJ@$9R.AGT4O<;
M._:0*/JZ&OS^8H>:6JOW0<9& :Y:^,CX*GA'()-.1)Y?C-WUR7W?'#V^-:B>
MQ:XT..EMJ_ IB"@0$J((I4AO^B,_Z'7R?<33680.6A0'>;50L>C&29$T%!=4
M+3Z84+M#+U_?IG6GA/EWD]KA^#5;YRMH'3U[63:T@44*%)PN7K, H^Y-@-^;
MTV[]F$N7L&&Q[&/;N!8\!)L2AZY()NJD=;]T9%\=$7^(B\7%+2D[(PQMHZZ9
MP&>CP'C+$2.#(.##JHV66>3^.@6_?:)T+^?F.A<O*1,?K#0=;7J\]Z'2+2Q#
M_?..YA* NY&C,293XS"@E:.I#<=CBN!$(HNVDHK=F9 =ZV_5X\'M8JQ-4D0P
M+INV8M-#S%C!%739L2A]["[M\7T%4Q^(TAIK"GG&"F>;!I(5!()0LT:1H]QM
MWN:[>[I[]W0WU9AB@Y8QJ]9AQ A7F *QD .50ZTB4XS4W7365<3'\TIMR<T,
MIZ<0=W\^',V'4:S==37$B_V1O\[Y6K/7BW.'N96%J]?7&E]4OAMZ1KBXGTNQ
MBPM%DV<,@)KQ58BMPZ8D()6\1D<<&W3IL3?D$F/X]2F;V.-9TZP#_I7AU?QY
M"_I;]\;RY,6,7KV?OWHS/U[@K+QZS]<^.6PEY?%"_7M).E9<-2WG S)YQGQ6
MB+96G1TW^MIH##%BMRM:;X-?MIM<.,NH*)4=Q,3"-PI;.=(FP"0)H[5*^NX8
M'C[BIO<XE$]:KQZ_/9K.3XA6#70'QWR0V4@?3'&[RXW'S,AXS)JH@E55MD:@
M#*$X \'*K'U[J;\6QSNL#HYY%$)E@XL.$D8.5F5JJU[;BGJ?DFSYA6J[M5E?
MP2QLL"Z^\AFEQG#AQ9T1$T9ALD]MXTOF/V*%I+( M#XHX7/RMKOJW=T, (V4
M<MH[FD^G\U/H?X[!=X91N2#*FKWERS5F7)06H@PK,CI?J$87:G<38YW"PXM+
M &\FDD0^U%;T28U=+#/J2"D#%6]-5%7;VJVI_1ADK%#@B[I"&I],U?&CH,7#
M@X$JM?W66^KFW])Q2=:R(V33BL&"28%-:RB^\4I'5%%I/D"]RN831'CN'1=M
M*?5R,TEL9%=OJ]N\AVQ <L*M%M^+U?Q<8(3D&*!B%1:%]H)2=TG8*U./K4^&
MAC95=S^3YBD6Q^84O*^E[5UKP1T#I-*XH:K6V;GNY/7I#KS6UG#Y##_D.*[]
M:Y^)ES]E,R:SV[$9=[#EMR0.HA1&8$5L*? 6P!;24&VTY VC]M@=2/^^(KH7
MAY.]"B*7%M+%M@*G43SPCSHYAA_).TW=E?>OE=_37\_Z,M].6C5E./EM?JTU
M&\$!F<T=T,6WWDQ^H3@R",JT"3;G/$24"93RSE1K9:%N<XJ=$[7L[A;2DJNN
MTA,4-!SRZ6):[[V%BC&$Z(KPH;L!Q^^["SJIX]\1D"Y).VO3*6LOI0QH&-.4
M8JM7R%XH=-O/_)3!0OV60M;Y(O/<)F5WQJP0(P6&FN"U+FUH0$*H.4)*&EVM
M+N9=*I?\5>B@>@"953'*K!6HM!X'10F"U!:<D2I5)YSVW<V"W:3:\_*V2CUC
MUD)KT%6X##*U%:4H H<$$8&C2U&$2,+8;C,9FW*%[#5[^ J'U]0Z.G\9YN\;
M34A+5]Z8%6.ST>KM;"7IXH1'G5O3":;6):Z"A(0*(04O<PED?7\]*'?K&NZ&
MZO^*]K^'<QQ..7(6__%FOC?0WG0Q7[??#=O>XWE'H),#HJA= BN#:VS0"H)A
MZ^=BS!*M-DEW!SI'*C0_>OY+:VH_GCW#=#^7M)+T1K3NDLC>"TP4"F)I1>GB
MM" L[-*Z$^[.[P$Y>#N9W\]M$*1D5*$(**$QQ[LL('HL4$-0-;L:G.HN^+G&
MXO]Z^/SPQ>WYLZ^\XY0NJG6Y-*ZRZVC:=M08*78Q*G/<PR$0F :2D%@]2>I4
M.&RN)+L;4[C--&TW.0[23MA4"Q02%HQI!=U6@+=\_H,R59=RKT+5VVQ,'#%:
M)1-M]5&#MXUDJ,@"(;46>,VG3.=2:^ANEOJ[->[&E]M<BDH)G$#7DLVI;9RH
MH$14WLOBL#]NHN]%LVV;%%=,<-*"U6Z5 *N 1;-=<8450J147'< [[,^R;/T
MT^&E:>9U)Q;+XO&L-?R,U6-SW=#VBZ-5(F[V^NQNQK)NW\>U65V]0^\D:VJR
MC:(]Z[:/H0"C2NNTEM;D[AB<KF_<:*74IJBL6N\:VSYKZVD7QVD3Q_ASVU>W
M(+7/W'Q8_*:JI$'X#55I]=:Q5*E(]G\)<@QMUXN7$'-RD+1)HOJL*':K2M\S
M)?W%NAA%44:#S<V1"M* EG^4T=ID@J]$W:I39QN2NY!F]<'F!$5:#H@U>YQ0
M@P#%8,DH':K+W?82[1S1W+IO<1^GTQ='&S ^](.=L:*V:!B"M%TAIAA 1PFD
M:"/HVA93NLVU][LO9EL]ZUO*G"41V1K8MFRDI3CYVDC60$&DB-[$K+J=9?HF
M'3@_T&P>YD=47E%^,ULMQ'XY>?WFVC"G'XGE4+W@Z"&OMF\&EEUJ_5PY&V%S
MM-K&[I)H7Q]>.=L&<SQ0><'!PZS)XG2GU^SU/1MGN:T1N#L89Z$2T26!H*J2
MC=&)O4IV!+:X2E*F(G.WR;G.X.,ELS&>LR?A7:D>_(I45B:"H"J"#]'97%5*
M_7;S=8$([VXW[)C.@X))11303K<-P:P J:4/@H_>>?2Y8'?]@B.%[L]PP0B=
M3ED:&";,\X3/_>+I$=[/5",%1Z:-(A.U(5<1&PM(:']45Y!TE=V&@%]-%9^%
M6@,=,(KGUT_S0[N=&-^P#O"(IHQUARV4>SO(6%1!%:7T#&M+;?FG"#&Y#,KK
MD$744IMNU;4+_]1MQF)$]U5%15L$JUU$:@ON"\1@(F#&@-(5Z4MWU;ZM-"QW
MDT.J4DF4NH*O3K&7D1*PF@RY9&^*3UYB=RU2UT_K/1[K,-Y[BN-;Q4:CT>-7
M%9,UF*!FL9J_9A-"' N7X&60PF9C=V]^?CMYC$V&XM;3<-L;AML.Q595Q=2@
M,M3(]LLXS=A8MPE6I47-"E.4IC<EV+$="2/F+ZH6.1%FCE?YW)I0V?6[MI;%
M8K7%D4BU.[Z4*U(&\[='.#O9FY6]@YU9/U9-]%4Z!]4)/C ^:$C6!W;]69+0
MTKK2K=7\WFMUA[U6=Q11FJI\RW,*;!G/S/8=BT&.+4LNJI(VNCMH^HTIZ?4^
MP^V3)XZXZZ;:4*NSOO%GBP:]$D=OBJ,&ZY(P*H4:J%>IW.O0VAE+R590-:XF
MI=H"X"Q!-B;25&MVHKM9X*X6 /\EE"1X-#Y5T*K-V2 1A.I"6WM19/!6JGXI
MBK9,"?&->(#*"A-.Z!.+?E8A/RLOKI%CZ\_'H:4.J/+5<1LYX"UI3$S$X54%
MBX' L#6!$!0"->I-5;*(.S> >9L;=]JMO)HL6[#W=%8F[R;E&*?G'07[;R94
M'W^@?-SLS>G4_^ZH1IO.<QZLMHP$B"*D-KI!RA/6&+R7W5:D-^4NV?_U\+/M
M.$]85+\,\\6B[8V:+ ^>'SQ?TYF,Y8&N9C-9[<)-J^54[VCMB Y/%BTV&4E?
M;ZOK94M!+LHBC,T0HN98H9*!5!L?G[<B2RFC+5UFA:X+-?_<+L8=C?R2=JFJ
M!-D'MBR85,OL!2C:699A2;9T2Z^Y#6[=?DQ^,M%H05!5ZQ)3M7 8J HHB<IB
M\<6G+M' GS)I&UWY9LG<CWFDEL0Y>WF[G:QCFMJ4=/9.0TVU,;RP(J2D!#B1
M/18R*$IWG:Q75'-72V#.N'F^ 01V=#JSEL5;D%(4/IVV0*R6I5V"L9*E86*W
MO>";1-VG(55K*EZ!H.TBY5$/2L9(%"!(/BW&: >HB)U:)F%M3E[T-^0\4J7J
M-%6R0\N4:DZN)L>PT64&D)+_AC7Y1F@5O'.!9']SF5=8M5^?[TY]JI@&)!*4
MLK)?K:!K0INPY@A3V8"[WX/^DI;(L5UYC,.LI1UVYE 49UC6$J(D/A0Y\WE@
M;P*U]7-Y$VI2W2+RSKD[]AX=[@S"$-)6Z87AX)H<JP$??:Q(( .K@58Y:-U=
M!;G+;K%=9-'?S5R"D#Z[Y E8/65C[! M2&'/DFQ2FDSIL.7T6[.43R9#&V0:
M-0>)4V3U.'Q#M'PVSWB>A+P4LSZ;8&H9C,G-&1XVS7Z>DAP]P;>3Z2G5T6HB
MY)=A?GST]&"/H>:/.V-/E;8<HCE(RICUIM=@T4&.4JE,NBCLSI[NBEN]FW!^
M1#@L5&9$W/AFM&+,E;!"##X#M6TR/D?K5;=P^$\SX9WZQ)>4YZ]GDW]>2X6W
MD?N_JABXE?BH@_$QH0FKE@*J*0S5DLD0B3R0U:X4+:*C;DO]7<SCW.'*]S&-
MB(F5V)6 4SJW1>\!HEWU;"5+T3C/>+Y7-=@=(W(\;+\4=T=FQ!(:G360EJVM
MC"\<2JB 3B2C(O\U=)M3_G:.F7.<T*#WP-JT,\48$?C_+0GPLL;6ETDM;U98
M;L6C\%$GVRT9T%W&.=N/-NXNYNI(.7V)60O(S@OV0L5#TCF##%HFJ<B0Z&[X
MXQLSNWNEK+0'IP<X87NSCT>3Y3;V;V^GK5L$E#$%A)@;7!32,4ZP'E0@$[SP
M1*F[MID1^9"[@J;]I"="$A4K07(^<0Q1(D0T;6#(9%NE#HFZ8QOI9DWQY3&Z
MBP2S-Q))##$6P994%K:D-3E@V^H@B22SEMH*V5TZ<[=*R6.Z/40=2K1 PJPX
M60L@D@2?/58A2TBF7_#<>7IOVU6S4=4@2_:C"2PVTJ;H+41A*R1K'4;'X;GI
MUHSN\17*9+KJ3U_1_*UPY^,/>7I<J#QA(]H T?%R!5;Y<)_6M0]H.'S#;O?A
MR9<O\&E5?-$P/4?R6QJ%ZZ$.Q3C7HFH0>$7G9!O11C"04C6AR%"$[@Y@[4@^
M;CO[/;=D"Y+4M>TR(VI\*]I)"&03N$ <I:/VI+H+TZ\8@W^R.ZT+*5?3$B+5
MY=AZRCU@+@&0(U(^F4:%VNWYZV/T[>OISV&8G\Q_G[!PMGC(MU^HN2O'4,A$
MU%!#DFP1*J.#-NR@T%3E0N0 K#N+<&V0]6TD-KLJN%J3]PK(H^7H6+(Q\5ZP
M9==4G:M9Y6Y+*W^*>IM-3Z'6R[38FY75#\T0[$X2,D=?!!8HRE<P?/&V?TP#
M1B7YK!7I^FM>VQ$$MFT<,*H65 Z]LV-DD3DFKSI <":!2*EQWK$R]#<DT0L%
M80?,;Z+$D'P4(-@SLOBBA5"]AZ1J#(SGK,S=><O=F1/KP:N69*7%"BH(WZPT
MRS8T_^I,L!0]:]-]37">'N/3"N/3M_AZ,GO-KO;%+*_V7.Q30^"[E/\DR8>S
M"$A8"B,D'R"ZE,%88TQLC".^8ZZ@.Z%IO'I\^!$'=2=4'@WX_A6_Z=D<;V$
M_ ZV40A2,1?K09*5;;-18906<XN.DDK5HNYWV4%GU%]CIE#(1FL20;1D^!"S
M?))W;=ZW1%2A1"VZ'0*ZC>67'=G=*-JX+U1OV'.R9  58]QL0[(Z9V'-[@GJ
M=E,*=]1M5U4RWCCPSA(85!H:7PGH8"M)XUW.W3K,+DC<[K!I=TQ#6YT-D4^M
M<"*==OZ+UH8A%*-C2OQBM^YOAY:ZC6EQ:\,KR;)#%.P:E6.)2:U ZL9N;)1*
M_;(O?M7B/F0Y76QWW"[&/=TD-YO,A]-]<I?=\&T8?!4W-/@7WWHS@Y\<Q=B(
M[-$TH-LX;K4'+]H^7Q]<IFYSR!NL\#[ DX:;7LT?XNR/G1EV%RP,Y7*%%#.;
M7V2A1+1\MK%J(:4NI+L5RE..3>O-DON[8G/;T\O514A!^993( B:?W1%UZRE
M*35W9W-W<1?:=O8!2"F%S$J D0WJJB A*)9C17[B63N4_6VRVY%JS-;[84:T
MM5*%4"DHP#8>8%!8!D[!02R%P:_77O?'MG.#^:+5M;:^PGJW&#NE=A9C6W//
MRM!66#,&$BE!UA:SL:&XT&UGSM7C0WOE71OH*8\F^'HV7RPGN>UM.!Y>-ZM]
M.]E\#D'$6')RB*;ME]>UD8=;GR$XF<$9775V3CNY0W1_?8^(7)<(Z>?P>@YX
MJW.L#VE5XLF E4\PFV\3T%;%>M*;4C0;>;I'Y<5PND;E@F:<[RA=SW!=F"B^
METE'Z1.;6J\XR$DLQ]K.-?\,/@53HTDIBGZ9 G:ECVE,R!2"3B9[R*GQ@JC4
M=D ["X0JL&661?MNAREO8ZJD']L80V0S:$"EML"HR )8DH40HQ&ER%1EMX*Z
ME;D/?G>=#V_70\_\6_>SHZ4U%WH4&80/"8Q+&K"96V-41/(EV]1M-G_#8O9O
M\UG[SL-\.F4M."/JW9ESFJS520A0C1W.8)80%0;PF2-3_C]I3;>+QO;>XU ^
M3:*WIH+5"\W!_3M[R&T?K#L"+JERX.'9\]70>D-R@)"+8>R9M)0ZQ-3ORO%K
M L=M9W#&# L9/%J51&NFQM85PN9-Q0S1)V%$M2[&[FK66VFHW2CN&"'YNV:V
M.\W]GN\OVIFN0%EL3&02),U_&*\:+[HBL,2:E*C:K+M+^6VRH65_/ARUM3S$
MWO!T'^C]Q#,EY>(K1S26_S#!5@BFS=2IHE/*273(+'<E"7#+ M&0)]M@:^E"
M7AQY-.YN&5,%DPM'(&@+.&%MTD+K$+K+VWTK,]1>8\-YA<-K:JMQ?QGF[Y=O
MUD11X_'2;L;.U*#P\3#P'=\Z-^YV4$,'0Q^2+*)J&2K->FNJYK^EFMIRAJRD
M#^2PVT!Z4PWF&'D^*RTA]68RE#LA<[Y#U;U?M,Z2H@R8#7B!;=]+S9",#^",
M+4II+*EVZ2%W8TAI2_T(A,XH)$!MV]H7&1L^K9!%5EY:ZS1V6<BX*2WIQ@?X
MIFRLCS\<\24WV':PHRBK>N=)<53C)'NFC*+MW_9 6EB&6V1+OV/\3R8S]@^,
M?S]M _V8J%TMYZ+U^7]R/"NCM"V\>#]C(/YF<G1!AU;>[S_P9.>XOF2-&$TM
M0(($R]](0-_^<"4SRO9*JV[[F6YYUNU++2N3V79:5CH89E/2K.C>P$;=UB3Z
M"$CL7G2H'K,3&G5W";+=H5 >$;:IQL@G7& (H%IB@P/E&!R"0UF<RRXJVGH=
MX)OM5_O/2%^^B-;T'$LCBM>%8ZP8!!#_F6UU5>1NBR OCE8I.395'ZB\FC]=
M+([9L:R]U1?V'^%TNOZ-3A*ZM[8C<31GIY1*Q=D$,F0%AB0UDY8@IYRSK":6
M>*^I5+9(;+E#E&I*.22M&6RGU@"FVFJMUL=M.%@JM1+*NG7'MAL)+*4*/PM"
MR-[RDW*!STN6&D1%9*="F'VW+:X?6P#.,CBGM8U+&70<Z/&LC?J,A0^O*[:\
M.%HETF:OS^ZFI\3G:$&E4M78RM8UY%;A=M+P"5,$,J+SR5L917>ELEVQL[\>
M[HR=U2YG3)%#$HX=C&9]B$%6"%%@4#[)C-T-.FTV)/B2WLVG[_@4KR/,)YA;
MUOG&?)7;B6MOG&JX&%#>3!_0%:H2*H-S,#$:"*)(B%YFE;1"7[HMAWST)JNX
M\45=]RI=WHW*CX(6>P<#51J&K7%";^NLUI"=-J!=]6!,"Z@T2\DG)87#R"+K
M-@WX3<76VUS#,\H<S>;WLKUJ63?92L5HW=:*$!N?CQ%10Y0"08CHR2B&[Z([
M%L2/:GK)5XSA4/JQ'HSJ*%&$4ELOG3:A.7D)H660#5%(V)U8KBE",<PZ?/&7
MJT'=4;C T:46)D,A!AL&.69(4B806$W;%U.]ZC9<.#Q.BTN!Y=D+Y^-8!VR*
M^?73B:T>H\S1@^I'-)V\HV$+!JP+=45=13: 2NE6&"% XQ&\4!2MD[;H;@<C
MOKTP<JJ]Y_61 [94;?QE9YQ3D(8D*L#D6%PR%."_$)14%$M*!B&[JW!^?=3S
MO+2]>K4!RO7+*W!W+UL4%$JT'"*R4^"C9H(N'#<F]A&)2"54,:KNXL81![C[
M =^HK/;.@34QK>D9@S ('+E792(JT6^K2&_@>U2Q%*S21XZ)^&08HQKIK$0H
MK=<TFRJ*[C;-]I?B'% Y^AS0@W>M3H]&0G39035MW1ZA*?VN\KF"^VY[C,[;
M$D.J+JH$7E(;_"*QAF].83:B&AM=MQT#.[-:?I/P>4?1/UE+166(*#,8+RND
MX"I4F902Q=@0NH.3/2WDNAK6GD?-F^#9&\"P>[N72]4@R'C6^)@MPX'8^L*L
M %5$R)1+S?W"@0W']E_2$B<S*F?L#;OB>;2L*JO8"F!MKVY>K='4!JS/R<ND
MG>R/L687F1\[.(5:":D<HXK2BFI&.HZ5E"L00['5"\_GL+OFV2N'3=>2FUR'
M&W956C(&:3-[\K8A HD@>M\HX@SF&*JRM<OE/5<-T5SOW[:/.D_K%FW*OY4<
MMZT\=P,(M4*R7FJP&B,#0DH,#05!3D9)=L8B4G?5B]W?_-2#U;!6IL!.7)82
MP"CM(9BJP*?H756:5.[.:OSY.L!OM'P_'_[X3@+[B0Y0D8UDG73KD+7&02K%
M TD=0O"1-:&[E35WPR*SN3/A"/%=Z^(Y#1!'T;(K/.7#.0ZGGNE^=N-JY[-'
M:_AR$L'4UIVA0H9:!=584BS]K0Z]53O5CS5Q47K=B#&I4=1DEED,T8&3J9I&
M6!M,=Y0G(T&)_;UF8PY?/'MV/],R+%J7@@LMV&^QOU404IL_\D;$0D$H[+9X
MUOF*K!T:/=*.I!,,$HHKME$VLBGV%2&T>:3*FJ'M#I6RG],__XFSR6PT"O+.
M:#M[\-W>^I)4@JQ:S=VTNH.@ ,G*D%PMI%)W^/*ZS,1%D'G. WCF*\X;C:YW
M!1O=RJO)LGFFI[,R85AYC-/S8&/_S83JXP^45W2_+RK?T#9Z:+8$%GPDAUZS
M+5GO)EXEK1"HDDO:*)=JIZIQUKQ(9652/N-7_AV'21O*.SO9:\/SVWS9>F=P
M.'E(,V)137 ;#89;,OS!%,9T$HR0!8S6"9 ?*RC&X$4Z+9#N]>3Q=6N#^CE5
MP08G.)8O$45C^=30F"%;>@>S]VWU]PYYZ%U:J:1#H!Q* 3*"$;)'#H-"2-#6
M,SM7I,W]E4R^L^7M&%O>J)8B1J?YBB0T8_E(',RYG,#7G#F.=[Y#?=V@Q+>-
M?M0>@'2T*HM,X'-DNZ[9N(<@VA)XGUR,27KLKNOK[D+>,8])+%Y(TB!<6Q5;
MZFKQI8(L:JXUH52JNRK)GV;ZVNC*.T=7.:8VH**48Z-.9RM@<E5M@#. J3;J
MK$H(ICNZROYK9MMBH=N6#FCGBS?@BVTTLT6W40X$K2F:A$H9T5W@^GW<[ZIQ
MOU;,FVV_?'9'F7O,6>8000OOP!!90,418319N$0V9-\=SON^/W+;P6HRQOK
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MMQH91XSJK=/*M&79"9$/GA010E(18O4^NB2=[0]3[DB?R\=JT@Z87V=K]E)
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MO2MPZC"U7]-E7I;CNU86<L+MH>'-<6Z,B0BEJ>*(*TVR)(LB%;>T;XECX>P
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M6=G?V:7]W2+6R=EOAY_\NO[.&@*/\=N$\9Z:'D.\,]DQU9C;;W<X79.4,':
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M5KTZK$8>5KO)G1,[F.#H>C =X5,WH;13K(L?>="@=UW;T5_S[2*7^>ONN.%
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M*6JX+!C:<\P"1PY49&A2S<X\ZC"B=T''O O2"Q3KAL!NKPN2"I-R&2ND:*+
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M^#C6)[)Z87->XHBV,$Q9B!62F92(Q9@C0;5 -.(8QZ$021:U4<!94PXK(<F
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M9@/R-)@2(V,2HE1)"(%BJ5&JP>T@C'&EL2$)7LK3/-^-]'D:K[8;0DYO9[S
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M:;P6V7U2$>&A<AO+#!-%4J0TC1!C:80X3 LE1*0A)5HQ1=J8U7/SY<OS87R
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MXWR%R\@J7X7WMO95._!4*PR!Z,[TKWO\W*WNSOE6F.K<S)02MCMM:^"/W-C
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M@$KZASY0I .$Z@Q"\9+,HWOKLV5G%S;SE MMX,MVC2FZU#2P0\H+$@9X '@
MY04)/^=FGFUO RFC!6G=$=2B):UR,4VFL;J<3II*^&3<M)I='Z96S>S'N-*(
MNKZLT,[T!1<KX6YV_7:)';;1<<L%]D(FQ#TGB,=(D6,A(DR5B8[[Z&1:SP%I
M#6PUHW!?3R<7+_/?&X[G^9[?+MIP)^/ZYQ;M%I\[:]#MZ.-L:C/U#,=V>G4\
MBQ?UR63<W,ET,LIB_WW-9]Z8@<0PSKVO"%"".(&R0&&!LAZF+.PQB3(B3:)
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M1^VNA(&C=HFC$LG<1#(I,1)XYAOB<GCD3?X?:A+F-FFN[W*4) X3Q1726.=
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M<&LG@*@,A05N!97>,94N09R P:"P@,& P7U5Z1+$"1@,"@L8#!C<5Y4N09R
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M%B5EZ2Z5T:1QY(HC;+S(09S)'V<"(QJP]M&'Y!DNFLJHH0.MR^PF*A89@,J
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M3'LQBN-P<#FIA^U?G\:1G0T_Q ,W^=@\>?,TGW8;?7RD!A*:?U[78GV&YE5
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M+_<HUNUG;P=_QR>O'XC^Q(!P _%?3\VZ!'$"#X'" @]!+-!7E2Y!G(#!H+"
MP06,0,FQ@8D>4V1D2#GD< Y9JO.KY)-7)LH0EP[%Y='RE"A!)A*%\D\!:<\M
M4M218!1WQ)@O#AM<Q!2+6./U9/J/13;[;;HOROB&*2AU7IK\ZJ%Q* ..%00<
M,/CK^>4*K >L!ZP'D4=?5;H$<0(&@\("!@,&]U6E2Q G8# H+&!P =F?*+V4
M1CID@N*(&VJ1ULH@K+7W@07'R5*M^5NZCB'[TT'L@'FX75VK=?0=(V?K&++-
M7US&<6T;<RF8'$I8 _!FP)L!;P8BRKZJ= GB! P&A04,!@SNJTJ7($[ 8%!8
MP&# X+ZJ= GB! P&A04,?K#N(3BG'G.%DI<&<>8%<H839!@C45@I<5@ZW_9;
MNEX?V&/W#SN:QS;;^G.3;'UY*]>ZIADK8J"XAK)'3PV[!'$"$X'" A-!--!7
ME2Y!G(#!H+" P8#!?57I$L0)& P*"QC\\$1V0R*FC"!EG$7<$(8T9AHY2A-/
M. DK\3KFWT)&IF>&#7-O.]-_VIBE'?O8C+E=C!9KA]^Z>9V?H*XKZ_\]']9#
M:$D%I^/9)0Q.1Z><#@C\>J72)8@3,!@4%C#XX0%46KID*4-"BAS$19V0)EXC
M$8F)44B7?[OQ<;>'GSW+IT^XE8P,%*$0Z_74EDL0)Y /*"R0SR.RCB:8) BR
MU$O$76A>)8VBL#@:8RE6<8/DTV8=O\H]3SAA"[BGIZ9<@CB!>T!A@7L>Y)X@
M$B4N*J1]; (?ZY%F.)-)"";PJ+A@2[-7UMV#O 'NH61@!!!07^VY!'$" 8'"
M @%!]:.O*EV". &#06$!@P&#^ZK2)8@3,!@4%C#XP42,5M@8HADRFG+$J91(
MJ^@1#MI@':B@/FRZ]7A3B1BH0G>BXQ@FWCY/Q_$MLVN:CO-GVU].)Z/\"+]7
MPP8'8STK&+9+6!+P,SJ!2V4H;!_\#(CU>J72)8@3,!@4%C"X@"-5C+'1&YR0
M%2Y'D]QBI)E52$:GC*<R!K%4UO^6EK+V2)5;?NO;=#(9O_SLM!Y?^ZRGUYW+
M3VQFIG3 .(8H<O40Y?$*!<?G L<!QP''09P!*EVJ. &#06$!@PN(,RS'E)AH
M$&8R(*ZC0%8Y@3Q+44I)8O)+^R:_I7VXC3-R:'$K'WX36AR/_33:.KZ*BW]?
M3R<7/U\/Z7@YN7##\3H'YV@A(?R \./YY0K4!]0'U ?A1U]5N@1Q @:#P@(&
M/Q@<4!PLD88@QB1#W/" G,$!"1IY8(03BNG=X, XKI1E&@G/!>(B<N2PPDC9
M&+1+W@?*GR,X>-PY[XS"GL.^VGD)X@1B H4%8BH@+R:4I"9ZCXQ*-M.8T4B'
MH%'"V#"G>"!,/J6;NYB\F& "&._Y\F(P5[HS7=ZOAA^&(8Y#73 EE"#TG?%A
M7#:H./W\IKB<5?5D- S5C485NP;=]')6%'@?_*""DJ1@%N68Q6+'%V;EBAS8
MX/G78.?4'M@ V #, M@ U![4'M@ V #, M@ U![4'M@ V #, M@ U![4'M@
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M.>H%RJ%J"I990HU[2HQKZWPCS=G.&;]^;>#K:(%>Z]K4/Z!:@;_14[,M09S
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MV:<FD='!(\.9\Y+P*,.3!J1]99_:-9ZM/^F?(V "\\C[:L<EB!.(!Q06B*>
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ML%)6VX@PP3E*U\(@K:Q#6@O)DX]4___LO7MSXSBR)_K_^12,VNG=[@W!39
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MCSIR.N=O?UV3SOE[=!1VXL$Q[\$R[[.CL(L-/9/8D($/752H%^KCJ4S9X"1
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M-O_,'5[^&(E,VM=Q2CFAS"2$R4B31#-)TDQ2&K$X]+7<B_]@/DZQC>=GVW,
M=4K+0BLQU^;#;K3UW8>W*^%64AF%(5>+7LWDQ7^"]#?FVEAK'UBCZ;10E^-O
MIFT5W8J&'*PJU<%2SRZ5,"BE80[*H1;^:-RFH&P 2-=-(JJ[-D XT VYH]1:
M(??SH-1=1=?_JM9@6\.O:!=DA9HC, 3AD<[SD849R*/PLAK<K\!=JV'Q P#N
M=OMV(%O9ZOG*8KSZ7?@$A%R##KJN-T$^N023SYH/2*NRZ)@F[=VPH9"T]?
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MP8H*$L*2P"="T)B$L9:Q$;Z?L/3Q]DH8!B>!VRMWSD-M=+:MB+H*!O"<0H,
M&L>OMA!@5%15G?IM(:L]B5B7I*T6/F2S\'&W&*7J9HEW3IW:!]4*;YLBA:':
M"DP+][U%&Q:4  MM+7GX>-2[3?S\1\<E=W5MA+NY-MB+&U*(N0E%)CDB?182
MQGE*4A.!QC0F""EG+!+W*EXN*R#AYV4H:.57ZZW",LFYJ3YB<*'S[=E$_U[(
M2>>3N_DT;C.Q0S1AGL"G\;D;]^S\89LC4?K2:U;2:Y9RX-G%]%;N0YF!"]K]
MU/E$;O2)=".H;3,@D(6FZQ+O7C4 JPHCJ(OX\7HQ@>ZE5JA.BV($QNAL-FH/
ME;4%MLUJM+N3@X#EH>O(9C?JV;GZI#V/VAU;TR.K=;"WA91UFS]0^T^6QSL:
M3T@=@U]S0CM6N9%5VEW91@.F]:[<9*%K6.!N:[U-'FQ[\[:U;TZ)N;6_U]J/
M4*IV&:#C)\6"TWE58>VDYO2>=6IB DFG$=S4UD<!?%W'N:_?J;!2L*)_-B$F
M;SJ:5\W#].)I>/:N>6Z3 )$O+UJ6N\?#>?,9!OMUY]@I'L>K/:FM<VC]Z-C&
MC-JXU3;6:8KCY&7MB\5$'02PM_&H7@ONW)&&@SG2D+@C#>Y(0^^.-+#=S#B^
M_^'>TD;:R;0*#L^TVC<#OUJB\:YZKM'1HDEA)Y>R$PWMW+E,J415-Z_F-DVM
M?N)&_;<64]D3A\ORS9W/0*<V]L")=\T(Y:@J%GFPW2^692OJ HRKK2F6761R
M[9VW9;+:$-2K]XOV,0N V-02V"B\MN@ 4M>YKEN M'TZ8![:C !Y;H.O*UV"
M5@>/DF(UBKSMW5MS7NU;NM93DXU:+8%2TQ\67K# .'7:;;5<JFNK?BQ>NNS$
MU#:%LM-:]FQI,A*O&WVGQ29^W5ZNNUA_7EK<ADMGZ\AUFTOA.1: 7N<+@J[9
M"<V]<*NV74@P'JG4O*QN$;>Z?TZ-43I5F8A)(GB&TC$APDA!:)RD+)'2T/1>
MY]UK9Q7,]A-,]KR>Z\?R=3/3)5$^V33S,X0 GY;$^[] N\TV>WI>VGW7$YG4
MP43KL+<_+NKVO+0%676*_X(%U[D5-R%:M2/3-15[,0MGMRYH\7'=<;#2#ZS)
MG=&@YA8BLC)@PY6+5EYM/G<GW1$;,&.JI>T+V>BP?)R",&K/Z+7/ZO;@M?9L
M,248TEAIA&S&.1C JX]PKH<?Y;I@49H2TT=0G4P+O!:C/4V>2!,W:NS]%;]1
MY\P"0)S<?*N:5-IQ"]2OTW$K2,6VM9"CJS^QEL'RY$(J-6BH%-U9"LA8@(Q;
MC2NM?&$'^PW8:-ATT]LXS- >!;&I+<L3((M'K)\@L>BN.8I1^[BT 82@KI:A
ML99RJQ$X"[U*6W<'L<1B;O@,;.QAE?_FT:0MWN!&>F)*G+0]']M.;#69[1.0
MRNH*ZU+59S\DK%CQE:12?:U?C<=";$G1)C>YZZ];/1%E"U/ '($*%F0U'IBV
MEG&G;%+7O61/@"S*':$WL6&GE:L6B*JSPO6*G'AGF-%7UYK%6=H#0),5G+1@
MT2Y<:T!E?6"L'H:]MWT47(VUA/,LWY(!?<?@GK.7[AQGVL(EUW3N7+)FJT8Z
M6Z ^-@[0= 0\8QOO%"@ V@-'G0J^"Q;KU-EN:^\V3-S9,Y:3[*&PU.:.?D7,
MBVU$$0MO9)LB/Q3S"BX!7)/CX2F;*[>J#=MG-T(F;_WA;1M15&-+[N_(U]5@
M?5V_>?7QUBH 4S O<."=HTY5#BL&$*I)]%M(O=:;NBK%[3B^M?7EEJ;%\FS^
M#QZPL 3?O/I]80K6QEPO<=OSRS#@N[FFHILR#+(P$2DUB@@,1[(@ J/-!SE(
M62@H$TK30.VI2-E2O:,1]\HR'_[V@U2!VXS0I0K<SN6U@K%LJ;):!. RN'C_
M=C2M\TI>@"JZL,<66H>?M5Z6^BI=-E7!BOS+:O#VSZ:\OFTN71]\ - W6O92
MF%<&.U>O*+<:&%KG8 $FTK<5#5L7B>V.)UW-!&\_K@"(R3IPB)Y('!J^WX;
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M>W?U=WN\71Z?\*[^KI-4O9%4K\'@&J=@>76$E2O+V\,=XPY<'G (WI7E[4?
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M0GU]X1F0TU.X?U;.S<:T;S/HWNS0G8\#W8$A[:M.\QD,1-V!19M%\3X;55R
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M(^J'<2;\\%[Y_P\)=QH!V?ED7_B&#7P1.GQS:/C&>7H."=^\-G4_,6\FOR]
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MC5_E$T_)$N\$Y.@5 ->\=D4WT,WMZ/48Y](HH'>=AH0)+0B+?$ZDCA7V$I8
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MD%KQP+R+C'Z!")2 99J!8-$#.@\1'.,^9,.UCEM;8+O5M3L-]S V,IPU_^+
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M2-* 24&#E%:I2'Q@<JN!]A-9&R7NO"M[0XR(KO?8IY<OYFUW8XCVAJU<;==
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MP;OLYCFTIK-?0L#^4:_'Z,Z,PP-(NE8(W5I+W-!==Q#O<T-Y=;N^$Y(PKTF
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ME=!2T:V#+77DQ 5K021=#AAP#K%1&6#<>1<=#2G>LZYE9\<#C*1L\=F:-<$
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M?G+-4VJH-!"9;D#5@.K%,?53 )5CTD4K('&?0)AH$&_0>4HD^)1B#M2$_:4
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M[H7IM+;S43GW_M?:5+YS>Z8W-XMJ7Q[/4^I.\,;':!].R_77C;C>ML47XFC
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M=?E&]L7HG.G7%N0E_.,,<YH7T[)/[5I<BQ;41*P!1BX*_<^#I;UR.5]4I.\
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M6YV.7XZ_MM%1M+?>.1V$RU;\CF-74K NG;#A[EHEQ[6C#G6D+5O^);G&2T'
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M90?.DR(5E6 .LY? M-$35?&0<\5495(OU-)!&;GOPCVJ)E-1'3,'!P9=&9K
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M[#\X^N/->/1F&HY&W\4?_ ]N<^&KUV]'?QS/8*G>-!-X\O?CT:O)PJ&0P&+
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M[^G.,/ .ALUV5=*YK<.V=TH\!+Z!Y5?6Y$R$=IE 0*>)Q49[G@:=0HQ6Z;V
M4#H)*HUB\S[LAVPDZ*=H%,G:54K;4&EG]P+"M5KZN:7.'7',H70'*MO2]715
M3]O28)6,Q/QE89W6NH%F*NRS<UJUZ*AUS38$T+.3M($[G*>3[C3< ?"<C3[0
M5"%V%I[>=\(1+X3"+K*RBIE+3_?07:S+UH*7"3R'Z+AX!-MD9C!0$I1SI:.U
M#ZNKF#X47?6I8%EW;F=7/3U?P-OB" _MMF6L==X4CNYV@U]!!QWU*JYODRCG
M$Q?+Z69NZRF?]QSS[ +\ZO&H[00WW@6R'H\^I?E!> !41IMEBD3PD(BL J+:
M2 I2Y3/+NLHA['F:4D>IF<=&NURA=QK!.]6XGR>H488&4>VU^][-[OUC0_"?
MZJ9LP[P#950O3UY-8[FT<\#N6/JJ(W80PC<^!-;QIHH&F^HFRR"\3TX3IZ,C
M2D1A#:/.TCTX%2^YSM8;HI(Q"&;'B*F$)0)BEVS!F6!6]I-US('DJL8#(/A-
MD# B:#[D0Y<+_@6PI8G@U!IOI8W S&;/M^#!ZF" Z77%)?@CDA%;A0JTH!,F
M)B=C[BDKJZ-^[Z7V,>VZBQB^VHWY*87VL-:F&O3FOL2Y7AC%@^@3"0Y!C@W-
MT>I,%(T@DUAD;B'2)"EPQH+@*>\WO\E>5#YS3X+&<B3G.<058*&BJ%1@+'H5
M]RH%^R'']$!,4J_&-%C'ZV=[J 99J )Q 1T]*1VQV3,2,\TB14Y#VLL22NMD
M#D(2[1SV2A2>6,\A>)?1Q*@,N'I?*=A[+*D21W*0JEM:QY\N,WQ; !)KI,J-
MR</6U@4%:MH=B':K5KWPK&7+DNX#'F1>;)V7VFKMVF7&MI[X];Q%P0M=-JNS
MJRGG=A[G2FO;<D"86I_H?ATR[_L:^&F;OBB41QRL#]-"J'7*L>N=7%\]X^C=
MI.R<-,<I=0=WK[  S=8*()(!;DX2W*A<T[UM@'V-^78S6S7%OA5?[<[BJLS2
MUKP7>&U$IZW;&C,\)=Y=NTKH=N2]1@YW=<RC60W+;0!Q.QJ5O8;U1E:ATP 7
M]L3@PM@ %S; A?4.+DS=K!*H&BJ!KL T/Z]-SMJ,X)&6H1!H3:&M0J UZLD*
M1OXR@SUK(7;:ZM5B.;>Z="#()]AT>,$QHO#@)M?N#E+Q#]KTSV%TB9-6::%Q
M+S[12*2VCCBI(K':.P,!6T[2[C5 -%6E+7<D4XCC)#>,>&\KXA77H?)6:'F-
M(UCWT3FM.K+]+N;NU_&KRS(A_6)58:,Q*GF2E<3>U'@&D E'@HV*R<2M8'LI
M/9.9D)P:DJN(]RA*7&4H$8DJY9QEQCPZJZI^[T3VBE7/IQ?N,("*UPJ@UHG[
MJYN$OAW:.(!\H^*)&LU T%,R1*9*$).])"PZ5AE)N>=\[[B1CV"SG"#9>$:D
MR(I8S.)S)S.OC,TN[[6P7['1W=:6T2/=:\GN8_YPR,K? *(E*64S&,9*)XL0
M+6#DM VDRBPRD(3(G=J3DF2IPZVQK-&8F@@A&)>>!&6\$B%0)??VNNY+2H8]
MZ.N;P5[)R(Y-[NNII.IFN0@]Y"*NP '8U*[X5.T9B.>1@[@AK5Z]>SWZ$7<.
M$.\<MV">![6NBIJXA7M,5[C'!0[Z/-FV4(W+5L^[^<I?1TSF%@QOA75]^;UK
MS"S,UZPJEQ>SBX_V@]$J9]';K<*=GJV+V2%4:DI$8U1:D9""(U)S1KS*FCA1
M"8O]*YG<<ZA=4JER*1*FJ"#2&D^<,H%HIUB4.5G0DU=I<MDU'ONQ;*7A^;*N
MW>4=^1'R8"IZ"W9SBTZSG)_.FO7^YTXGA,U1^2]Q_@7'U HL-:(>GT>E'G?=
M%4JXVR%(KCL^8#.&5M"^!/A>MUNLN)];,.9P:&O8^!E"IG?C=A> LW?PYAA<
MPP4>8:PO CEOWP^R!P]?IVVW6AWMOJC%!S]9H]R/2N<H[$9Q,:SZ"ON#66L+
MO'LG\[WU6P8'Y"K2];YC^E\W3/^<7)%KGXO&,ZL@4LTQUGC,L3UY*  =ERJ/
MUL9N-3VX(=9_29RY;G]ER(A=VX ',+@N<>*9PDZ-DA)K*D9R-)6H*J]MVL-:
M5C9RH1#"53-&9,J4^!P=R9)&5WENX+X>&'!^*&<Q>S6F51[:IVF"KXKB^^U]
MD<$5QN9Q"[1S.L'J*G?!N;<^3>AH](]IUSHUE<8/]:)T.%HU="BPG>MV0:T7
MTM:*7:ZXVKJO=4^1N&DGW#:_.JWG[=/045@U(VD?L[H9BV*P/64HG;1*OZS8
MU9BA'[,!$"OJ[<XP===JX/?E29K7H=,"1IJD*Q9(5$Z"X^ "<14SQ.1*!FN"
M%BGM;86E2C!OP8.GV*N>1D&,X+AK"W=Z7_&T@>'ZDA;X>4VNU4;8EE03<-Y>
MQ.7\$_;13-.>&#[XCIPE-U_[ CLT[9>..2U$[:!R6P3+4JY8?&8PW'FY6,[W
MF'9HD+4AX>M.[;UY]ZHY5Y&ZB[QX0Q_H7)[A:G':X/7<RNNA5&<)&BNX[!#J
M%_P?"JZ/HCH)$ZV*:6_K'_6@%!8! EA%I*JPPP17Q+"8J$LQ!J'ZX/4<2-JB
M5V.ZP.DY4&?GSR^Z+EB,WR_/(RF#96&&6,8C8K=$\#R4)"KQ8$64SN7]7B_)
MT.! $K5 U/XH&#@JP1+OA:MRKFRP>UB#@^=Q()X'GG,M_GKKEF^L[+;OC@G$
M^'$;1^O<4S9^?"L$%SCM]YZ@V^-UGJI*>+ Z.9M I 0V=UP%4DD-?K:2BGIW
M%[61[[%;)K:.!^%O08L1:1./NDUF#9#\3WC\CQ.XYAMP68([A5L7\V7:V\^\
MRGC_'^M*P;N:<N"N$P(^T(*D2?%4"H>=;I65[YSH^*H+>>%1CG+<X&5Q%@F^
ML'F!6.IX[YY;N>%.<22$^+8G6<E+)*@;(^J<]K#$B[]2.H7A3M8'8;J#%85Z
M7R#.-W]G=,WA6US<OH=1^NVY)_:("N>P@-.__N6F>&#K)[#-H6Y;2&[S>)?4
M[P"ZUV*].7-T:!',-DW+4\&[F[7:[44)#\KYM1*'/%0^?&\5#CA ?(3M! CE
M#IA@]X"5U8+$Q732-I'*R15G *SY]BY=<^SF;1T(-NR=X<"Q$73=]MH! 4A=
M,_A-F>YB/IMTCQEO-]UH/]HTZOGG$DB3S]"EQTU+-T7/I+L6%0QVP?$).PNA
M86L]$8>WMD>FX"T3W%-<[6F6DZPG:R'!> +F!D*+C9#+4X\NFEF!XL#A("W2
M":8+NEW5MG4 ?G4ZG_F21]CD)KN;9TML_Y!*U?'F 1=&*>6A>Z B0YIG"PCY
M&L=R^N1GCPM?S].J"=M!P'QFRF)DM"+96PS[G"$F:4FLBZZR-,C(]Q"^1-)5
M$HJ2Y*3$A',FOK*)>&ZXD+126K++8(A_F<W_6%,(XL"B38H/<6?='@ZDT6=7
M=+&C3TN$AI\6Q=)Y5267 -JI54.CIH8G.%!K9Z=%36\8;OM 6Y^F_#4IEGT:
M[%XTNA/5WT>QR!6CNQL%A?RP:TQZXG-?(<89S/;%N*O]MX"2FV1=QM8JF-BQ
M\,-2*XB1CE/G6:6KO79JUTD&%:#KPD%O2F_P[;.&[XO_^%N:?\"\S);]:QW+
M;</WYO=?OE8GR<94FGX;/Q0B[\#2=9[SL?O8NMW%P^^:IR]FZZ0_3AC<9*P*
MW#:)HT_'L]9EW_NF\\P7,,82KDQF!<JERTYRRC1$!TCO$H@@$,W4M=M_\*A2
M-PC7G;4#.TNE#K-9>JSK!/<? A2(<Q A9Y)*;>4FL8\/:K#DTDU*'6/W9(39
MF9=]Q!FB[R0\E]Y6-C[0NMQ0Y<%D\=B\ZY4C<8K'.%O7:47?'??)-:V<PO*4
M;>'-#N[VNKM-&X=WX(T@=S1+4%IE>4ZQV2W^=1GG%<8H03,J\*UE':]W;E:A
MZ+A;Z34MRX/* =0:*UZFL<'X--8PE]HOVQK8KDLY(C7-8YM"+S@MNV!$92=Z
MGZ?;;:=+SLAVB$K GUNG9=OIS%-[BA8G?DFHC['L<E%VM$I?@P\XBBY[4.BV
MQGIJ\_SG1*)N=^QAUKB_#G*4E].PF,W/-E#UJ]U[N'22/I1-L:XXN-4)13O@
ME<TZ\ ;I@J=.6Z2B#2[4-D4&/*2GA8?$!SRD 0_I(?&0KAAGW2@\$X<=GCV0
M+_(G'LU:SL_:O:8AY/IBR'5Q?KG-36+CXD, A)$IL6@K2I+'/F>10S3F'/9&
M\S*;J#+7>_OSF6:G(E6$6D2CS3(2:Z0E+CCC6!69CGNU*"O&*GS5I2*[P.N6
ML5@U9H*/#>UY(Y@#P0=BE<G"!A(L!7;0GL*JYDAD)2I8Z,H8L<<.UD86HU)$
MI,I 5*\L\<Z"W<\0LIM@J,U[#4SNCQUT88?*]CPZW[C^77BUWB7;#@7.0_7\
MYW&-M;6[L<.7'E"JWU8N?A?S(R?NQ!<E"L<+5\$)1N8K0]"]IQ3&A8(;C5%<
M=^BR1:1-GSOPGY)3OR2HV7KC5P"&+@J>=C<2M[O";Q(+!X$59W(,V5-)3, .
MX,PK8K*5A#*6H[+,4+^',\*"4(J#*'HJ')%*"?!O0$:MQ@+>K"IKTWD!:W.F
M;=_V-]./$"(C'=^N"/<NS3'8 (?\KC"X&#MB_=X.ZA4(UX'8@P JG7IA"9<:
MV%54FCCK(DF1\NBU8";DO5)59ZD,V &3HCL.ZA^;:H,A4=IPJH/7RCT^N_(!
MWO!:['H-__=2*)MG'D-<I]IBMYOI=J5#_Y4&B'ABE$:P;-C3-C-!?%*:>"&I
MH$XS+?=LW(UK?C<E#A=L]]S:FQ24CH%.O5846Q[7%L]<[ X6#ZV4B0'5$.ZB
MI-5=]^U6?<-YX(?[.0EA$Y7>.0@W,@0,$L'3O&.9Z,IS*1E5*N]!J=R$4S9,
MLCY-]A-,:W?Q<:*DB"3>3*([*\<.2&\.0OQ?-UUB;1W3NQ59?3X04>(&[ <!
M=,?MA=&:PTYAK&6'QIV>SF>?0=X66-G8I]$?0%%9997VECJBG<G8<]Q!P.XE
MB94+X+A5K-)W(D$/5U1&C_KME_7Q,-^J@][5_+-MS^+8Q0/S+E02)E24$B'1
M9M"($71(Q!L)O)NYLM5>M_2;</Q.BJIU)UX%"%/F*=[>K1AKS<:LYZC5!Q*C
MLJ09CXX3B$D1AA7<">N\)2+J&'1"Q..]NEK.*Y>$8(3ZJ@*&P$;-R!5252+F
MG, )V4NIW"]#R$-@B'9JNQ'>^*+RVE(=@6[D?!L;?#NM6*X:@L,;;3"5"++
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M$*\RBT.&0+SH6-Y3P3]D3P/_L"A64KAWM,W@%^$<7BS!_(82C!T]'1,DN23
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M!S[+YW:;BRZ/JH%+VV[7M#QQFI7!!%3/<MX=V<H'3=VRS5Y[>]:\65E@(WA
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M!.1RGC-P^LJ.R\O^M-7>T<\N12*72Y^/X[2K_-BIH4T:2<[':F]+3=EHII]
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M[/F6S1Y":! TEVCP.6N(QXPV/"!!>1"!1Z/C7M905($XS!SR1@-"647@;@>
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M.O12SM>-Z[/#[>F[V;!#F'8]27Q8K/]:XN.T[*Z'DD,T;;MX0#6LO^5\!]:
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MK[)N!M:Q5WEKIM/WO2)MLB(MZKV-L?DE7R::OGU+^9?B5S]M/1>6K^S)-3^
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M$0"Z*#!!5 N 0,]!_^7J/BI0JCW5 9N]OD?$:!,PY^!;Y%JH@00$3D4N!6=
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M=\A(/0\#L4(8'F$AJA7RS.5[""2MP%09MP+3W8N["I:8"@D%F6.PW.=&*3+
M;YK3)'&RBEX')G"IO;-*(AS 1^9, # 9$Y @R6,*8!4I&P8P42I&@*$5F$[-
M/:X[Q8_G'K^!W^ B^&-RU8S;=MF=IB["-W ]/H2U>%(&R F?X3U=$^7;3^X\
M,R-&86UD<!99QL$@L58@30Q!/":ON)8>IW2,S.N?IGX>LUEB)V_*(9/.<GF]
M6,S';EG*2+R?;:O/GWKM^:ZW7+[1RU8CK(:;]E9UQ;!T13T,6]G_&;-_A<J;
MH-(FS2QF"BG)*0"D=\@H $!%<#2$A>!4.$9*^.-");C]1@TW'EU51=TW/\'
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M<A^"I#TIJ\2!>,;YYD-QN6C:V60<FA6G#78=3M=N.9#HS]>R 6J8R(U!RIJ
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MJ%\#3)L<TY8"E[5I&2^HZ6G!W)A,3I)*0[WZ L_S'^DBO7>3 X',\L]B2 ]
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M?UV-V=^OSM-L',K?<?QN\6F]\/CBRBV'LO^\_W'ONZ4Z$\E]"DX#XY&"B,R
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M,\M 1(EG>6"))KDVCZPST5H1B*KN12HI Z>4@"A*R!RILR3L-^[MROB5W_Z
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M=W!?R'TTZ7D][>:C:1YU:?9N'#9OTX.CU>*L,M978$'5 1=4!>.S4"F#9,Z
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MKL IHT!YE9@EQ,J\MN_#)BW"=A?J\A/),=+%2!<Y$SD3.1,Y<P]M-464CML
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MI3Q'I5U*P!*U(*S28(F@8 B+44079 Q/64K0#I<*?F*H02YM%SN>M37XONO
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MZ[^\*!"X(^GN>"'*$3EO. R#'@9<IH@0=1A#@L-PI,. $(40=1A#@L-PI,.
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M8>PF/]Y@X_=N//LO-[E*WXZ[,)EV5[.T)=^&G1 M#\2W.3"8&$H,=$_LF!=
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M=NV^!N-F[(9V].L2&U_;X>2?=C0+OPPK-RJKV23LR;;A \9H3VR;GL'$L?A
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M -V9POR-*HX[,&S]JF?#*0S$W8&%WRRK=V/X=;D>R7)![EC6><SUY"^CNBI
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M9M5P<?@5[WYOQ\'6M5^;7)<&WX-=]D)(:0)H26>X(3(KP.>U6A(J.9.B* K
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M1Z:[4V,&FG9B#PF*17?$ CTY9/L39/M3UP8BDP/.4!N@6* V0+8_=;8_=6W
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MFD_ET:N#18Z8]T9;,)TS'KD]U9N=T<TA@H?YD$\/!^9D+\<%J(2*0O07OE=
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M\JB30;L5^R_8,8:$H^G_^<^NZW2.I#*" Q[FL?Y(!I2A4,@-/-(P)-/)W@)
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M+,FEO7;:;C4%!I,Y0:!R!2#.9A>_Z/  '9:@X '$2_@6N3MX5P03?V8*-XD
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MGMUNH49[79^)!$Z"+^ZM'$LXME,*D196ER LFK\D#@&_1OX/$&L/IA2ZKBV
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M-\+@;I O(//+O26*' BO928Q0$81>0 J%*7*1+%"=)X>*CZ/29B\"W<V'@^
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MY!O&T#BW\$S/VJ?SSWWV04B@*=5))Q+C6<, W0H8>IPC2-H)BBU\2&S FE<
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M_&9%U$%6:E/\^3B O&GV;+>73MRH='GRD02$36HRY4EZR+,T/IK_ 8BN'D]
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M$GD[U3\;-JYI0,EALZQ$EI3WS-#*L'4MHTP..V@SR$'>R*:-]?OY+U5[3J.
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M]=&!L.'PU* 7-KQ-H!EB Y837>ETRK_3&1T.64=]J@#K/ME!_FXCR70E8SA
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MY(-3%))4TC@,?/"0G7HAF*4?EAAGZ<<R@V2(Y;&@2IGH0FM:+-YY"89PN0S
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M]78S=3O;8GNMD"QB8,%E?1ZDN=*0JJ3JSRR'"QY73?(G1[<-::+D OJ<>B*
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M[P0T-#/$@8\WC_M7[4NSOLY9*ZI&:LZ8HO&$[*V/>+6.$R_9L@-T'X<A^0)
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M<^J?!]YS%*=9,(?L@$WR3"O)89!ZB:QLY]CPH5 Q%H=A8Z,A-AP5SO>69W$
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M!TGS&;@<M]-5XQ_Z8;6ZF%AJ?0>E2HP8%F<E+<ZP:?>JQ2E0C*Y\L,LMJ.V
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ME-AHZ516F"@!+^YP,C@#.#OSTB5Y:T#V\D^W7U*HS9-CNYW,,R*5]0CH 2!
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MP?"RMG5'JH*CT<P]3%H%Q(HX OFRAX6$*T %K9&L"U9Y*7WT(S-47%@GOI^
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MM6H(96]6.8?F;5D9_#82YN$WW1/QP,35Y!V?C_>'.2'J=DJ-OJ=^K MQ!6U
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M.QY&6'ZZ95:ZQ>=OKBXFD1+"' 9KI>#"B,,Z^C4-$_#XJ#[C[.QUJ<4QV9V
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M.>_GU>45_Y%> Y=QBU4TF/%N,Q2$W1K/DJI@9G%]0SD9[656T(N&+EU].[^
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MDWG>& 7L$IVT_S"*$?^'B-&(E^PMSYQ]\DC<JRBX%8E+64E>%^!S:5UB]ZV
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M]4@+AMAFVNC]^?KBOH&VPC1E!@;<-&?(804_,C+N6IEY9\+[Q>9@=@C$0QP
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MO\_L_C.[;<6&F];PR?S<CR^\J=@-ZYJZE:M!CV#N%L?[2XP&6YY@Y 8"()U
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M;.3<"Q8K>=QY\"UZ/!3W[__V\4\?_HY"^9<128EOV6.O,K \H+9Z[\(9*82
ME,,>LYTVK08^BS#PR[)X %)<L*ZODF9=H8?[EJY$OLQD?E-ES!I>)?E%X9@W
MQ%0=@2Z\;(V(4+>)F"$4 6S+9@R6%*2X= 5#@'#UL(L2^TFUIF; 0C,&N2:X
M2VW2FX5W9Z'0"O68)$41O2B19L.*VKPT)>(V,JBD MC!1)W88Y([G.VA@H=
MX"IKZL0(OZWYM1Q\<C;@M,!\@L!3 K:YK-F8S'G0_8HVBS+5%MOV3RF]3I9T
M_)SMGY4OA8\(B"*_@+"@-Y"8*.WJY:A0\5+[T^3J!R\^!!!TH",5*PD$Q/$4
M[#]4<SG@>&>2 K"!+^LLI=RE'SF[!LXURELNG6:/;!1%ZK34MQ.'E-@!(LMW
M@5+"P6<:#>&.-@MN92AVTX@CW30BVH77*ZQ6C<86.G[[C=48XT>:Y,T">B?>
ML+?;9SWX.:5'\[(ZJKG $2G"Q[;\HK&?%# CID<W214N.34,#/$><:%0\,J>
MA9 ;G7= 6K5HKO("SINJ/"^K92(9.FYH)3->LIGK/<#0,P*:#(*J-+<)4\9S
MAT8$]0T=?SNEE.>2ZN0<<D3N06X?J3M([F@ ]Q-!0JGF<PX;1O($0I[;6X./
M8R9Z0F'957&?0_MMF7K( MO>%0150MB'X06*6%!#AF"U'(F.0^[0T) 7"2K*
MI#"(2=AF>ET6,R>"SG.5YJ'EC@AOKS'.\_(),X&@1Y#(F(+(U(AHO4/$;C=,
M97))98 ORN)HR. ,5F/GIQN)_EC[F'Y**O0@2NZZ,W;A!Z^ARP9D<JM(^9H"
M4&J(]3('PKJ+3*9_P$;'IVD)_F*V(G&-\PHE6'+3$AN?527X!-+CS><:TILT
MO<>LR1ZM)FA[W]O54* X7PW&*-22L7?V:]X33@P*,OK?P;B8_?K>)$!18XM8
MP',(4VKWG;3FM5+S6FA[G_T<OD,'_<J85*--K!I3\.J?TPSBR_=KO.PXI;B;
MDD)GMWL<_5;P)#5DAF4866*.(#OU(,@/B:C\[!D_5!3+2_S0WW M&!.2>N0A
MIS0-$:?<R5Z#+Q(;3AB@U@IM T.=,=@U^8:*K+R@[K*<X0([+2&Q=E][1$J#
M\UF<.E+P2'9S)[]P'6&?W2W-D6\8/(C(7P9[,$1U'VFQIB)NS\X5+^^D4$90
M&S'403@<%9)W0N7[H&4'$:"+1_W5D..\LF&QMQQ^A\)X=$V?F^D3S1_I%>:J
MQR1^FA3!C8)8T_!%!J@_!5ZZW+;,$AZF!.,%_F\DDHB32&<B[FOB;NU?IFI.
MS%8O^'\,]60LSN0(F9?1IT3M:WM/1:QV?3%GI<7X:TX-.^)GV)*IG9G$&=&K
MN(FNR&_)L[.<78><*U-R/L?S"'K!L-UJ)2SII]?!MVK@HW&6KLH\+^_6!5-<
M:VIU7^1J7/P1DT]  =$:PK.M^88F;VDO0XIT/_.,S7+\O*%GUJ[W%Y#ZIZFZ
MHP\ S.W.R674P:^57@9MLT5&'OD-K>:0_, NX1CE<PNG&])XT#!>\QI/0"QV
MH"TTL3JY0 6S"&9AW;MKJQK-H<_>[),8)>Z^D)@!OA?@1 K=>4-EKC(#5=I#
ME]P?RC)]RO*<W0_:1?;>.KM+'7@+:-,.]-3:/2AN\P$?$GCH"X$AT8U10\KW
M-J/<<]_<%Q1,S)+8D3P&(A23AL%F)<6\#B#F]F$^7QV\]1Q;/<G#0P4D)WCQ
M%U[-RZR@%PU=[GMRV&)A:Y(>W%] -$'9X?M9>@9GD;(>!$*='R%K"C%+!E-D
MV,:D3AF=T>(K-T3J V=&@WV8,3<(N^]T)-+$3Q@).B&[$D@.=%:NLJ*$NFF9
MUK+O!BUK4QH>_48(38GN+*![8U=,P">U'#HJ*_0">6P&ABPP!N%U!1JK&525
M%P]W*P9G/C<B3/LW-MWRQ1MZV(G#-=D1MO#]7,-"5K[VMP_5VGP$P,8$6#X5
M[".+;"4[V$;HTHLMWM2NRQ!S/D3^7U<. 11N[*_X;/LC7@R#U:)XDH!OV%#D
MBQRVHL"N;<2%.@<N-&ZMGO"]4:9#NM9\;)4[2GT8'>/VL5"I4C '#%\LXV\-
M]LMEN[UCK]99W1PGQ9XD2.TUC>((R#OH8<NUJ(<;J63)<=S68@H_U_MQ2'I*
MF]F/9C-6\DS<*6FQ(P5+F.'T';1(JJS\7-1LAK-Y1E.W0)*0%SP< X.?9@W<
M>R^*%-@"UDG^<]8L,'D-BOF8-3@MN0/*"1)JX;F84L];0&?M+CU ;$4">4]<
M9EF*E^BBP$@28(7:A./-29DN3VD]JS(D]7<+=!*E;B3IIXBAD6 EQ_V&G$Q.
MKZ +EE+[1F:C16?(4,8 R;N_+:!1Q$6A&FR#Z25Y6TY,VA;WKFA<%WNR1G]L
M;GPIHAA+8XP69_$FH=V=D$]&5I Y3,8C3@;DG^U@S5&=S9CJ/PQ_-JR" 8>I
MB&!K0/S<3M ]^<I,,$7EWEPJ^PJC\C(1ES.ZBP0S@IM-^,W-"[2N F7:D61]
M$B?=T"<FBXO&?&"#6W^=QTQOD*;0%7Y=;3#^B!N,Y!Z\2?B&P_GI]KY8<O$R
MOHD21XJD$:AKY-G#]0P.[^[.$-M.#F:ZB,0WV%'K]3W;1C/V@?^H180W;-8?
MNS#]T6,#:! 7HQ6Q\[AS=5_\8]3>S\X#;]UV0\^V;JI298_L(3_2\[PL*QE1
MNV4+?.^..E+BB*!,75,/4@<$R.YUJU'-$95*<*TBH#(24W#C\D ZKS9H:)1#
M@V_&K@CL1E4(H^8P_I\/?_CPX2-9)=*"5:Q8?R<?/WP8?>#_%]LN2=9LSZ^
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MD.V/H4KRX]YUG_=0\B7E0XM&H#+D*@C#JGHLQRD##0-VFZNQ5@ ?)< 8%:$
M4&?GN_IY\>&9A/(1?;>>D'1T0CU/9N(:@FQW2,G,&XK!:X<N?O[)T!#-Y%:
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MR3E'#1#=:#2Z&_WPO5WJ>9.K^\H!*%"26_9?8[(Y^(_>1I8SI1V')(%OSM1
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MD->1H3\Q1U5>FE <GMEZL/4DY/QY]85*-JJCA*)\="&0_5V:[=>E:%#9,X
M",7)$I59X1)8=(;DT-:?B;,>>'>?ZRT4+(5F/?778A&,?09:SN?S;S)-M_C-
M^B$MWGIG;]2<@Y,XAPA!$NWAQ@-BB@L'& ]$<2($MT/J;U;XU[2#[+,95&(N
M7@.RRD3_38YY[<1G4#&;-XGI0!2[!UZ6>;GW],TQ\V\5_WR4&3KFHU$@F]^(
M9<U-:L3)@*V+[D?RYOAI.F%M\8*?45#^L53+0FX0-*%0+#YW;A:EK-0.).4
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M:7>?5'L)6-('X67/91Z1\ZT !=%YU$08O$$X9TFPRB,LFK H$*F7[U&6(9'
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M*! M@L5-2E2U"3YO/Q\*@HC4I7*E\').CZFZ)1N/ V%J-R>IW:RJ%RB"0X%
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M8N!3UVN;+D*G3FO_%-^$5 !QA456Y[ )8G79,;6]GRCI=X==<\&-'U$PX->
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MH/.>>X.2NLW3KQITIN6SW@I@4=[[CFBEU=_/;! 7C4/OZ;^(#I(,TLI"N?/
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M03U^Z*&JW0P)L$5#B_?RN',B:"X05YX)6$,@J>&E'6CO0H.&.@6OQUI%3C$
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M;4KDFJ]-+3W:C+=^%Y<"T>H%+,U#V!HC,7$=D+Z()^GB0U!,@4WQU=]P'2;
MF@"JR]!3]\\0I;[UVG $;SIR]W2Y,DG+^6?3ZM2BR&6KU%GM0.:)- +KGDU7
MX<!6Z6D3.=PM4]EJ0K*:)C:)8]U7MEE>8..$O*Y)$'S(O*\R.YNE28V:Y+WE
M7U7Z5YIE,HV:L.W5:).+3)9+-.#5=0%UOT[3\R6)3+WVB<*K#?2CZ@\CL2?1
MJJLGHT&I&4^"D*>9#'TD#$Z"S">9#[4\Q$D0K$_S(0]G/25%<A)4/Y<-H<[2
M'#6I![$=C))%1TW6GBT'TRS52="T;]NAF1([8'=%3(3LQVQHDXX[2%/&$!)
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M#%06.WT0?_P2J$";QZC?.VM&M!LG^(-I[Y1,C^!]S*I%_7A9$@KJ(1A[UB3
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M^00.^7ARCZE.W#:)JZ<WTO;#T5.P<.2=OB[QSKJL?E]#H:NMRJ(;AD,:G-
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M\A$$16@(2!6(./0]%_3(_""+PY6EH-87+-UM!3#>@.)K5/P%1L5_<R(/2/\
M#QET38S;CE_"9!EY.R<ZWI" ;+RU1_^H#-9I/X\UE.>.[_,[08E1 PQ;T-<U
M<\%>YL+(0J+!S^V\AA%5;-\)O]=?CC%02!U&:C ,V:EAFO]JZP0KLMO3E4?'
MHK9:JX.CG B9..?_FX;:/;+6"'N>,:R*8.XV5]^::$[PAX!>)>]4(_*/OQ*?
MJT5'N@');4AB>M$\$[H-"50(A:SF;XY_J"LC/4R(XW6FC9U7L?T-S:BQAA_V
MZ8H;;XR,SK3*HAA4%LU8.>@:P'IFQI,[,CM8+J.F8#=?69FB3<-H$@2[QDPC
M#_E21BZ-DY;7P%_+S_LF!O%$>D-VCP4SLU.N(; =<DB4;HQ1!W6>IH++C9LA
MHNG&PX8='4NCCO"T$BP[SE#&'G3'$SV%YRR$:BL&YC%T@OB9K FE#N7(BXQQ
M>0R#-\JVNUORFFA#/R3 UMSSE/E(:0.4[X]B6'LMG-9K$.DQ6Q:UC6N\I'N3
M,QYN#4'@D8> 'J4#R) 5Y1H)*@) >V^EA]>8_.L UN [+$8=Y"6#QK1\Y7F6
MPR-A&VD,EQ:\]W<S>B?,Z7U+%5YZ#250[G=)KUHOCL,(O*1$(X:ZSF)M(XJ5
MZ"(A1) (HATJ(I+)1RHG[[W "=9>\%8LVBS.JMUL6"2 \D84PUI;>EVY4 A>
M(2@2D:58M@"P9S'U0@*J;+^0-;49W:IDD4LE_2 DI+UWUNH0"REXSV2^<>(X
M+6+P2Q0>]G+:2B"1$#3S/CQ3X^XE 1^.ML1KBPEZ)OKMQYL3GW3]MIS!KEG3
M5.JIA?TE#.@IC>3!549#$2(V[XC5W#9*U?.P9 E-WGKI'-E?(X^J!WOP=!@<
M)NE@),@].<D!'#FW])P;(509@,,AIG9WE'V)$M_"J%_VNCHGJFW6FW;_)(BF
M\1U4_-1R.WWLD5XZ^[[D?VYO<4^"SQ2&N?@MI*4A/ DB:CUEBN,Z*6Y36>5E
M&LDNUDD0Z42GD_SZG$"DJKEF9NKAF$2X1G\J6MFK,@G2&:L@,C?/)*C4HTP3
MWR&3H*+<-RP_D() TI^^'[?P[T^:J5V:DXB?,I9O;3VJDZ!>CW)/ZA$8>VSD
M*<?9S/D]L>B]DUG1?$<F0=EA&'1>X\YQ%N#K_\Z6OYJ,NDY?_X2LOM",OPA=
M1CG*.$ I)W#IOT0'XD*?^R F\46&Y*;8 "LP=!Q?%X&E&F$]PC5='+1Y@"R;
M=(<>/>?5\UF^B/KMM_4T?8?4[,G:HXQXG#M[C_-,NA3QN@T'];W*P^L::L#2
M'0^CA^4L_9IP;1)0FXP"6TFMCPV)8R:6[HD!6Z@&60R;])G1Z414#)-]&'M)
MB4>E$93*0?9*>Z5\\IN7;.>'. EW),H6=E3OC]%0>\6,=GL_/!*2$MY8&.G'
MV>T$V5:X#B1*![@[3K\V6J%I00TTN/9%%IWY]3KRGF@MZ6AZN4\D*[T5U63*
MQL@[:'0_J4K]YIRIDI=#-9TB-82/Y?*I9J:Q#>%6N7S:&2B%0[A4+I]PAHK'
MWT?MQ3M9?=,3\!^]$C!,'!^-)R\-LR@A?Y&NNUS4WH?1UV#O>.[<=[P=,$7Z
M!_?_#FFY*>ZBA+():N?>:7/:2^<K+5NW8 /,M5.@0-1L?Q[X.V;V<]_;+YG>
M8D[J?N\36&"E)0S%AZK$>Q*!]14?P I[".(#E1=K\I6>XNB#"CHJY5,I^+_$
MZ<I'9US !7$A_^<EA>R= P537R1A2CO_XP#$J4QOSV-=M 1["-JCHRL.T-/L
M%\0_-X?8"ZBE/UO_Z^#%K-2F-)&]G\DO5;0O09NU)]C-/W]!W%>(EQR]> CA
M59[]@LA358[Z(TQ]WI[?=T_9*3J$20NZNAO'AT,@>A;N^0O66"(-(HKIFJ""
M8AI1$QO+%//Q%\3U/,**\FA$G)C<$O[?WIA?,CT* IW!]OS]9R0^J%[<#Y7,
MC5:$'.*!D;>(?4F<*,'D[>O;Z*^&C9_/7IY&:F&/MK'L=)QF6O:Z#=6N\)@V
MHF=3\[2]J(B^ZSDX]7HXQ3:>1"H@XBNCA1U^W2I+%T;%FN]U%_#>%P@$ENP,
M3B(7<DB1U8/K9I ]$#Z+7]0>J&71(.ZD7G?B*H]:;NXD4C:'NI-;^ M[I7.5
MRU>7+W9Z9W69TW(2V;5677F__SQ,C"AWYMT%3:%N*^[LUHO7/FNQ-*=(>% ,
MB1'IQ@G^R/+L'\%B76PX0)&37QU0LKHN,W+-8A\8R9L7U Z%/9 7=*Y!6'QO
M"!H,\:CIX*(>@Z3D[]R)HJ,7O+6HNEX;8B]WL4)9)3L+02UFD+Z'_CNE8'59
MRE8.ZC%6F:F0L)I((0DPJD.MZA4BA[^VU#CM\"J6+0"T6]T^C>=?A:!!Q/J.
M9$)XJPRS2KE G5\K@D1R:7T-G%T8)=Z?Q 5Y M?0,B([[["CRAP#C>,#^"WF
M89S$5&TVNM?:SXIB%[4=(R3 2*P@LZ*P=4UQ(J]Y!DJGO%907;6;!,U42F$U
M^52I@TV"5FKEK>I:D&I*DZ"45E,T+H8[<CI=:\FW%5$R$HD%V20(U+*%CU@A
MGT@80TL-0:C^#QAKL+H$BDDEN>BD7OE*KWEVL,\&?%^^;![4;,5$HE1.$'-#
M%Y665?>XP >OM+KLI=9FN&QG=(EEBWUX)OLT>F&QR:LF/Q/0AR@G+S;W% /'
MAZ!! ^=/IVDO@2 /P1?*?*L/XK^3IS!(MBH?>/<Y+X,4L&NKC[ /"F1371#B
M],/2YYMNDUT.\O?AH0<Q4)JK[Q17\T7,-E0)D>!TVEPH7AL-'AB1J%XM?(0G
M7V"3<&X,0E#1!3@)0W4@:N9WZ"3,JR&)R._C2<0O#TA&?@M.(BQ63\43=8E)
M=)SI]K0W4$<95'4H)4X1)W6*A"DI9J[K<72O<;_74,FAH@U5X7HR<%0(/ )O
M1VJ6T@WK%Z$X2DK(T+\5B-"__'[WKP/CA60+B2?O)$X(:3;03%$P&-"SB?SP
M*Q-@#\%:'A/?@$$2E=?PR"NC[1ZQ1<*#-F&T<@;8RZ)CLO[^+7S_P24>7R_]
M0[%,^I??[X)$%MO>^+EG5ISYO@?5^=?>QEO3 ^SX'KT( \]Y6,[DS&DP"LE^
M2T^]%KQO0N^8@I#J'6_48&*=_N0D5L%;(^XW)_+@#1/:,BO)*@#LNU4:65.E
MUUV\$\IX;]ND:*-*/RFGJ\FPL]Y5ST[P)EYO_=>S+NO)"[S=82==6/7W\U-,
MH%15?[-V1NB5'>YXTW)V!<)'P":4:X&J$=C04)YZ]1@D5X(J^4<$><V>F42^
MWB-)$GBKX*M2VIY"4!1WLH))&F!GE=FY3'A9DX"N))3(;S'<>9>:?OEK$$-;
MN0W5=*5VHQSVFJQY29F.LM3UZ.#%";@/%<GK=9@S,VL6UM5T8;!*$!+'ANSX
MG3*=W9ZI:<T+I> 6 /9MYL6+S2/]TZUSI#1TUEO^]/T_!R>BS'H7N-328"7@
M5N&3$ZVWJZT7)<=%0%8?X6H;'L!%O?J@E#Z^D'>BJ)DPS(<&*OV@<"7405 Y
M/I^<3S!R;L(H"C_ U^SLZ2_)L8435#K%,/Z%6> ^TU,)$=%M70W:H=:VYL:)
MB=2JEP"=UUCFFRPWEBN_([&#%'>K +!G=OU"/O1U89I /:]BF3UQJJ]X$=AP
M]T9#F*_HI44<>-\VN@[TXRTRH.\<J8H<.>K=U\,C.4/V"NM(^,A8Z",3\>6K
M4VU[-P'/]$KS2-X<G[_%"$2G"*+GO16<!H5BI8!&<GCHC>W%+WLJF]Q%4'9/
MR-KY& _O^ZGA\!I&5*%F=4R!COKCI1MBK]570A7_UR-W8<5&1TXY9++%XI91
MN";$C>^C<%=M<OXJNPB40_I6*/;KK$B_(<MJ1EB,#BK"_0P)K1PR3# 'W=N=
M%\?4X#Y"OKHVL$,,;XW(8G?/XB.@)W[K[9<D6D/TVYOLX<1\?,_DOP^C_PT/
MT0T)R,9+4JIJ-\%@% I5*/,BI%G\IS@BI%,,&>B@#.73@J/:@H> WGZ4K]G[
M2;+,2N"VV '9#+WW&!3$%#)CX_[ _#S)W ^IG'\3;8?Y8!3W@>$=<)+<[UE3
M*%8%W@2(0W$C:IS+7#&&@Y&H]&469T]YKO;F:#$!BAW,JEHHF4\Q .%.W1XB
M>"U@ JGU+E4&]V[Q5H+S#G K+#;_38YIU);C/T. 2?WLM!L[Z)KGX3NAGTL>
M"3VKE(?9-U-WL'[5RM$#K#O[WNR-*O]05F5YB-9;)R;+R%L3S;+-!I^?VJSS
M .^I-=]">%A'NC?G.3\NO,0_<4_CH/HL9\$CDQGP]X*7>12A.1[*65#HBP8*
M(98[@"IXI(7GN@3>,\>42TFE3RUY7"ZK'B5B$/T@BV0NKT=?H%@,/<"QS DD
M[IHLAT/"L9.O"9W)/W77ZSH4"L&8F9-T45[$XH*5&J?14'L606Z(*065%MQ>
M3$6S@VMA:2TVW\*$KC'CHSCK%">+O>@VV:!Z1]9PZB%81-X;I;I?Y(J+[KQ.
M4]AM4L!:G#E!5AM5LCE"4%02@5>*H2QRBG]3,0DJ9%L:WJVF0(7HU^ 0$S?;
MA'FXVWGL4>">$*U3J/M\."HSF!<WOI:HUR?-:RNE5O+31TTR\^SVO(A*,]M\
MU!02J_B/YG6->8KXJ&DD2SK/><8D+7S4%!*SAN*4J?.[)T$K>7)X3B6CI.U1
M$TN2\@T4$J1=3X,4];N^0:-1DZ%PVFCSQLN7EB8_>PB2^8BHI<CI-FSN,&YN
M,FV1)4Y[G@2)9(G39?*([K11$T>;K)T):$6:]!1DCUG=1:&4&C7_R#P@UR9A
MAHX/4;&]HD-F(R%]U'3J*\,]DUDZS\G8!9=139_RZ11EUD^ XS0%0 JC?YAL
M_U%36*69Z_3W:5T.[9HFU_URXV\)8.C=%5VR\L(.$Z2>WJNIKRHQ";*I'9QY
M,$2M6L6H2:-S9U8+8XR:%"T]4Z)B').@C\XS):L/,@GBM+8(A25,1DVJSBJZ
M06&541-.)7ET\DE@)?_T_=3U[X)4TK(VDVDMU2G4HEX^9PAJR3KWHJ&70OU6
M*]M38JJ&&G6Z:W (*F)R]AF_  I*+XV:PQ3%G( NS>"HZX57%DJJ,E23:0'8
MZ;I3%;R:(.44%Y^VXM8$R27U)(B?6B=!(=,[3EWU;!*D:OF<4*/-^-N1&DIT
M==FW"5)+]7J@J4$W06H)[9A2$.P$2:(\;NKB?Y/I\FMTW-25""=(*ZG&U(S\
MG"!UE.>N13W((;I)7[+3SJ0BY2 =N'&SF]B#)XXT'H(\F%QS)T:OR*N!IH3[
M^X3XRC0G3Y)9/252R3T(T@3L"5*I]7&45H9-B?>/"1&OP6)"9_L$"2/DJK;U
M>E.Z_7-"=)/*+&6ZY!"$NE %HEDN.0MR&?=K5J<PO!(EITBE%IY/>1GKC'!3
M"J)2$JY-B>R,>.-\>3^1Z^JEMS-BC?OAIA=.JU8:RP@W>3=SRRKC&=TF[R9L
M7>D\H]R4/%YJRAG66L\(-WD+_(1R[QD-K_9FUS+S&06G9'FVI:"ZP'T60W@U
M)P2>M((\_1@-_^3D"4ARH<21U^G/"#5Y \&T<4!&L*N1D(-*FA-DE+I:!?)V
M"1F-)F\!B$$[]&?(*#IYRZ!P;-=:/&04FKP)H'J$:W:5R,@V>:T_=Z5)>U9D
MI)J\>I_7<.C8'2.+))^\EM^M(4=&ONO300HJ;O.1D6GR-D#7IB(9 :\V0:=&
M)1GY)F\H]-#^)*/E&0R*__BA04JZ\#]* ,+?4WP;='6@[&G@;%G0^??K</=#
MUI+IA\3Y#(-P=^2K*4JE/I$__W3HF234!O4H6:AD>TG"]1_;T*=4B'G0\<QU
M/8[V0[ )HQTO44@2Q_,+XGL)K*:^U.\J?$$^$Q;_]YVMKCA%?CK#\N8X]YTX
M7BEZ-:E&6&ON\W)XC3W7<Z+CBY,OK9PU74=""M\O"G&4E)9/_U8LW;Q-2KIV
M@P$]=RN;[4/?#Y^HR%@[_J_T % !&Y>:M%269S+"'G\4NPSD6FQ65"[$SIJ=
M6Q&Q6PRTV/+;>X='.=]95W+6A(A(@'M9?$S6W[^%[S^XQ./KIG\HEBOKY)(N
ML/%SWTQLT"=&P,CZ4=;VG0G<E"F5S"L M'<"J6)&[82\%AA;E))C52/LH='0
M!<#^J==7KV.B'H2"D1K*HX*7"MB>SRJ;'?ROQ"VK\R];J@G'3R1Z$Q]6DV%G
MO=?[* A>NO5/FL[B44GCGLNLH]+)I/ ]<]G\]F4NE_RE7RT+RYO6PE(\PK9\
M^<V)J-*4+*)GZ*>5!:^Q/EO4BB(QO5Q]XMZPXH=56+4L.F'>,ZD]DA).)<VG
M#M$WJX>[O1,<J1$[6ZIX7@"&BVON/DFT]M+(L_S'./TU_K$-IVCGLJC1EX\O
MO[]F!RK6(WBNE&KVRD&HD%D<DACJW+!4(6-LRJ/L:GXR)>,+^6 _R>\VH\%V
MD7LF^S2^4[!(%6+J@2B1^N;X!ZF'2SO.&DHK>)XZ1$>V1'#8AH%R>^3PUE!H
M4;9!B)+Y>!R[E KD_/U5OT^U$=;0*(Y 7A;IEJKH$A1DT/;NGR*GT'OW7!*X
M<7H"@,BRZT<]R#HR]V%4$'JQ,4=(,;!GG?/6BY/(>SW\_^R]69/C.)(_^%WF
M?:JV[^ZU^3\HKJS8C0C%1BBS;)[*&"0DH8LBU3PB4_7I%^ ADB).$B  4F8]
M4YDI  1^<+@[''Y@$RE2QTGLB=[.&,#MV9Q?L8F(DEI:,>UG+P";^ D>8)6"
M"K'$6R_=M]ND=\ //3HC&CZ>'2^B N]9G:2+]'>CN19:$W]W:B7)8[\#+:+6
ME?@34C<VE/Q&,VO(:"\^#4$)O,GH0,C"G%WTQYP.GV*]GLR:EH1?^#MP"9S5
MN?)WN9>J#FHLV;D((F,^B#69OT5>J6:-UQR*WEH#YE#5E?Z\IJ-$E VLC:M7
MM%_V%E$G2T9[H#PG+@XG(F-7^&2Y"$ %F14KM=X\0P/X/(KT)#MK2-0<0OX+
M\") Y'K5$(#LB <]E:)L40^N1;,&\VIEY>KF';(DS,5XSAR+0$OR4D,!=Q$E
M1T815L>QY@I7]Z(LYKBSB/H:<JAQ/((642)""6*5N]$B4M4+ \9P9M*1?=WR
MQQ\F5/*U;I3FR7 9.J8SEI8,VBZC1?7Y6D;*;'$=C.-<MHPDV=)PL=S7M*3*
M=O$L,KSHEI$56YBLB$Y[R\B /0@C20_!"3-BFTK\45HEL+J.[?(@2HNA:ZM%
M7!Z\WN]5WCLW,WX05[3"UO1=(>]O3DV3BF^OOGM)T*.RR[")\0,;<Z-=A<6X
M(&#N-V7A@IW-Q<$T-CC>%J6T/1+,"#-R?'/[7\SA7)B>O,V=-B8]OJM4187^
M=$:Y*CU<I$LL,/YH89QR,A2,'-0<:0\FN&8WH^ U]")JVAVMGU(<>G%_.(;Q
M"8!"JJT+ 8V^V?G7<PD'-!%Z0/"P@71D@RC P_D%OT8P2^DSIC=6C7%Z/#*
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MM-YW^M^Q%S*>".E1A DY)C<).Z/:G4H5-J%(:AV6+I_1)6(8'W3WF#[$R1;
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MOZ\@\?$KR(YV%1;OOZC\"_:'</+NJZ4K./V^VOE=\=Z6I_()>"GY)D]I-"E
M=S !/AJ*BM!% ]7DGR3Q*?X&TXPA^_N-%,_B/8YVKPS#7^=WVP3WZH"MM4BM
M;_V;I#Y"&D$QQ"\@^QXGOS^# /I>V/BBTD'G]%!]R?1^@'25IC%2 Q!$^ &E
M?,0" 7[#RM+W(XS0667</>5&4$W">12=OL$P1"CA-Y-;@"WX#))FM5>>H@!]
MYB/&?K.?H+R:OY]2_!3Z],0X=2+=C!W&]1'@B46[@G._X8R#Z^W7%!1;33E^
M[#[J+8Q;D*:%ETAUAF[CY!B7WLM,>R._G^*Y/L DS;#33QQ]+_8930)AE9V8
M]"'02_$\V_P39UV.4I"^>B=:F@U6<SU)!VIFR4LTT&VG>"XWL9=4L60,NS:A
ME6IGD[,>_QA5]J+P] L(@U(9W>R]["X&Z4N<O0'LJH<$3G$2J^)#_2F/&U C
MRK_NXU4"5F$:5Q=!0=RI_2QAJT_0^RC<EX48:M-:YQWMESC$CBUI0PR-:L)D
M5P-&L6T;;O,$.WK*[4;=R9QIN4J8^A GC:]#D6D528ZB0 _-R,SO:#"!2>G5
M6KKY8]M_X253HPX!/:$)MZ-YLBM2WE:E#;#4Y%%<K[U9KV>>ERMV=.8XF,XZ
M<%'<4_7L$M[W')TU0K(NJ.T0A$%>GK-&D^L06A](:5?,V</&]8%O4Q[%O7/V
M(+'\1&O2DG#1G#5>_*#UE@_FK)%0XM)9D]<X1\E9XTQQIZR1NW!IG'MF$B'7
MR/-AI/DI+H-@B'R\34E+(A:ZV">Y,LZ>0"AND4U"'YK7XJR1T>GWV"8YNKO@
MK.&E.AW6W*E'E4OB4"S?QD[&NV$*U^PI2SJ*[,SL6JZ;LT9)PA64)B ).M>2
M(6.XG=(07!1L'$?6-D9J9>Y<!8>JJ,):XO+LV+.FTA'AZS5^3+?GV8,G^0K2
M<<5>1#J](0\@$L[@L\9093F!N2:X5&:$9:6)GB=Y\>RJ7==['5#8H$\,LZL2
M0@-F32MB!D520,+,^<^X>S<A?&+69#1 9>K&=LPZ ^HXIQ&)X))9H\C5FGBA
M++-&1^FC-=EO8A'XR:D+LM%)LX9PG,AD!TK-&KAKANS1VH10*)N.I-@6J:QC
MU Q.V)P.Y*PA-ZYB(1:R-VN,E*D70YZ=9HWL.*DI$J$Y:_B&,#U^S.BL<_^+
MEJ>Z"%J=-293\;<%E)88Q]!(0<JSAFLP QL91JVC2H>%RK 2>P@Y9G"Z.B=.
MGV)Z$/RL 51W&VM%VU>(_7W6B"DYLI2PPED#./+-:D VA5G#J>$$GQ,U5,#]
M0PEP_RJ!BT!F$VQ*CO&%4[U2V-QQ5F"2FD@:C0JW?\[ZG"J[NU%]>W7 Z#KY
MB20\J7#[UY7\>/RN%=ZH S37B8V1B*;VKYGGD]A4]JFG7AG/*0"UK8YGC7*\
M?0  Z< ^5ML"+PJJ%"[W7A*! .\,;01[BGZ.3V3;.Y$7V9YLKJOH0F9>\C*O
M)? F+X%WK?LVKV)>E(]53/P-^/$N@G^ @)X;4G($V[;"MDHR]I=QM*.6C!P]
MUSIPK:=(DS-E ,6S_^7]^7U-GUO[YTGY0+7Z%\#(>2\Y@NICDR>0E1J\\[L=
M]Y2I7-WG>=N[YJZSU?E]WOC).;_+JE=+AO":]V;:MTS-N2HM='2YIKZQSIBZ
M@%ASI9*#=I&9-8+C&%WG4C7SD&QS;R#S##O3H?7U+].SAG"DEM*YU^L BG9Z
M33VX(<X>'T 1->OD"]EY_G<P]<,XS1/ ,;&R>IBKRKO= A]'2IYG]X;.-"Y*
M :,<)Z<KG]D1)Z6L2F( 8XO\&B7G*RB:X V(P!9F*?:+_S7.P^#Q<$2;<%Y)
MM0;*@@<.9MOBS]OU"A WP<XYJRAXQ+P*I-G*]Y,<!'(("(UHAYP3.+R=;&42
MAV01UR5)_(:>OUEK^VJQ%#O.TVE@IM0*[(^#O=5?0?*^1]BO@@"6ZWJ,MG%R
M*+[DI,*Q0MPF@&&1@_,=H&MQX5%)=9H0[F;P@15M*O31#:)P328^:K';*IEZ
M"OR?=O'GSP& Y:S1'YK)TB)DJ_GU?M99UY*2_I'P"LCO96S7R?18I\HI*Z(=
MCGEY#-?;R_-\<R(/P'B6U_E%Q=M]^>TGBK\=I[&KFUN^[^K9QFIL<Q>MR_FP
M+XO4YIHICN24QF@X$0>FI$1J,>'+%N;V^7 ,XQ, A9Q:%SH54[+1VYNKQ@N2
M0E6*?%!L-;E4-:^U'=JUJ-;4-083%9-9W^Q4)J*>^_OJ!"I,FQSY)#QKRA13
MC/B 26LALT955"TYGW^*HC!KD/@:$B^M_#QQ&2-<&?K1K,U]8K0TB8B9-<YC
M:).J^,[ZY?J:<W;(2>6I)<LSM3>ALI>_M'B5FX_]IHTWRA=PXZ70%YQ]V=::
MJ=]AIDY]FZ:U-C;]7P'.H R"%;K(>COPDF.)LMZ6\F6=9VGF13B_$FM'Y,:P
M;:G5%O1F*[=8ZBAVJ!LB]RC.85R(]60,4N>SOQ#_5AFL)!G-E#Z&;B-(YU]3
M5A&P3\LK 7F,RCLIC+)]?3YGI__-SO=B!J]45T>"&3L2+$AK-GVWM-@QP&&O
M,F5$3],^5L&_\S(=KPSY"XQF;/E(DTB*F!E<4Z?(6%K,<I6A/?I 7!61U28N
MG:YWJ%5X>DS3'/]KV8X>=3%J5+NH82&W:3T/2_,T5U^]$DR@+N^5,.Q^?K4&
M7?T/+'HSGB?.^IP%YVJ@5,3^1)3;67LK*'UK7A!$3%(;?9&8M;N',LUE6KMX
M%J/MM,8J_LU+(*:8.L*R<)!!LN+;XWUJ><@A-YMTE,8A#'!FCWI5U(S2E*83
MI[_NSX*:1IK1V-A%GTA+I]<$'KSD5,;W^A#]D6G*DAS$LL72S-.BO2Q;SKE4
M$6*O/C[?.UHR"?'^QI:X3G9>!/\H>%1S?+"<BH+7%O]:;\_%<M[1OQ0"F)=U
M6LW8%F1\I\D#L1SO[-[F\QKQ9$*3+Y7.BF=]@1230VV=2I;ISQH^2>' QY'(
M@!<!H5)N3<Y,R^%UBX!9DO.S&.2"[&L#4!-F#=/90$S=.9O\0-3;)_J_!N.B
MQ#=. ]0JP$?K:<_U5,8#J%A@54B5HVF2VQK3'&^]=(]V!O_G_C\Y_/3"@O]F
MMUZ2G&"TJRJS$Y<BUM?X'?QJ-)BJ.HUPF273DWZ)HZ0U':9!@]S6V-1;/%2,
MX3 ZF'.9]/VB@,JK=\)" #&1*C-<?[(T-BHQ@KEE%KP>$9 O(1H(S<TE8$GB
M(T!$_QIZ:#I1@-G\$6OH+X"V"&87R\QC,S5MMHZ ,.VQ^QA;2EW)^9Q5LCU/
M*@WR>EDA+.G)X>4KNY$&L.RL.6M9KVXO(JS;_'FYVLCMLY%/L[QG+_D=%"X%
MC<,06X5B];""0W)<YI7IY)3 @P<8Y(4\O] UR:@*=3'HTIYYT0YB3;E4,D%6
M^N.A:_J7. Z^PS"D^JT+=#6VL)+5@"?@I:"6\J=&@Z&LB=?+^,7H#?@ ?F+2
M07"+W82(78SKH*>'.+D-/7C ]K_J#V>?NJHR"T<E%1K"V$(YI\?\":EJ D0[
MR3/"[V=8)6.J8D:CA^IZ,LV1I,<$$=J:NVW!3QB *&!+.EYKNY#GTCFOE[F#
MF^U!0KR7TTXLO8-Q.0"I<7'M%F:Q;K8_Y4I=1@>3R@.V@+8(FDLRS"[F(I'_
MDT.LU6?[&$WM$Y2BGEKXB=+:!IKG;H!EQQ7=XX\>#"JM"NE;!9UWWBRI=E]^
M3V/+*BA;2*B16AH^!\WM_.'S!2)D?X6(U//L#7@!#$]W( /) 5UHT(P?/)BP
M7FQ'#&A8V>/<@>P@,^*UDCUS9A?#JD<<[3:($O@<F-K<MDL/1Z:S.UF020*[
M6E#M89U&UFBM FJ434^V71IXP_%&Z^W7M+1]"='-91]K=D)P"PQ/^/(1G#7K
M7EL;5#XVP=M$ZX)0BZ!L(D::Y737]M@4='&;>9Z#:_C$P/+C]- )BA?9(A#B
MNZ%U,D+(^'O-_"#2V"H+/[8?UJP)[AK1I/J\BI$<U_-J$;#).VQU4[+TQ<@B
M8!L0/W?I9K4H*<"4G60]=Q%T= TBM#4<[AI$*'X!9;KFS3IEDMQ]BN3[MPAX
MQ"Y38DZ),\_W-N3V).;\N#1*$\..ZU^Y$'H;H-&R3O4BB$U4MR51XB( &I&&
M0.9BN@@LA;4QMHOU0JH1R9EOY9RY%P*AC ;2TS+F#HZTGB'@I;X0Z,9I&@Q9
M.L\LLK+*AB8XB$EAW50M1#,<+8&>!(0C)=Y#2^IAVT"24R.HX253EB\T3E*B
M-@M.+,M",)-7)!A1,PO!;)P&,676=..'48!KL4*#*J3^>F7R8A%%RP!,AL]3
M0YT6@90T=V<S=K5@.<NQA(*X*LC^-G-9*,>\B'%B.I"R[B3*\ZQA86D+(3MQ
M:S3Q5/Y]UHQ,[DRR@^IT &8M/<G<@$C!>UJHRS9.)D==O$#!"K)_7.F+%FFH
M!2+7J8H6!%EA]<]98R7%K-CQEHO :QQMG4'ZUZQ!DI: _>C&1> T[&6?Y)&J
MUGO7-B54AIZHI#0%1J:J?!0,N55#$MI80U(F1!N@72RO$7<@]1-8[!(KYRNK
MQZ1%(MZ\: <H92R:WZ:?$C%!Z^6ODT[K&4;PD!^H$^O^;BY= )&R>B\T0O3X
M9#Y%=CFQ"U4.8#?_^F_X*LI<%;>SP<45?)"3/K_;:%J:]WZP:;[SNV$B:5MS
M)$F$TU5Q]N<+LEQ%0??[$?CNA80Y2W:>=-:;TB*+N<8K0&I+\+A='8\A] E"
M</1P5F3A$DO@P^IAXS)6OI\?\L+->W6(DZR*D)1?'6T@.U1T 8VM#D5L:4BS
MCCVDJ%XU#!?JSS*@(&6PZ6 T:Q@D5<K.Y5]0;5L(?B0UKP\7A1TM!",AABQ,
MDK,.3.*QZJ[6/FLH1O,HWJWABEX7/=D;S"(\^M7BQ[E++</]7_X\,R]GR_!Y
M5 H:]2HXG=>:V0>*.M IWM[&AV,<84^7>%O\5CE .OI:8=KJ*#'9[A7B-D[%
M,B47#947;6N."AZ?!B&GL956GW&F'HY]9_KEG<-3F%7 6#W,U9+,D9 O)H2C
M'"@SOVAD]@&#<2B99]'*FSB)W\P\7Z 8<Q-5&DB:PMQ-%S2BXB$[Z[OE.++J
M<?!98R7.GR[%@]+K];]*6"*PPTJ_6\#T^?4$0::VW$\*K\3'QHNJ2M24Q65#
M$]<4ZBLRFM"O  L-=*U$4M#;@3N8%GF3WM"<63JU<%]+;BN,J;Z"Q >"U8($
MAE'^U-__;-\V*KM5C!'LW+#^A/\T9,-(PRS"Y8A"73BTX]6#P4.<=")C8/-)
M%FG)=+>$KEZ]$[/&&;FQ%3?IP3Q,<A ;%RM^_B4'L6*QM89=T=LZ.D>H29A+
M")VM6-QK B,?'KV0<_38?2RX0,GJ2W1;ALA)7H*E8YAR(XPKD6G,'%=!2XB4
MX)\Y9$,U(3H=-IQN"="-X8NR^LW,\Y KXHJRBM3,417DB;*XSQPU%6Q15,E=
MN$59DHW./$6R:L(C7$"F1-"481K33ABG>0*Z)NKU]B'/T+]6400=A>5KA'#!
M$= 8O!#[N)FS6BN]A+;(IU[K74ZS< \8P(J;]IFAUC,LI1?:4EPY+?6]\'^!
M=QD[.&*@15A.%=L?!Q&BU!!6Q0>/(LD1 ]IY'M$VO2"VN/D.PD_P'$?97L08
M)C2,W;LNOO#!PUF[XY@>-]_C@1M=][9^?]G+E!W%[MU$WQ)Q9&3W=V-'&4N5
M'\?J77V(\T&Z4;N[$WO*6*CT,!K]NL_?W<0W %\%5UMTI:<L0+:WWH0, ^<_
M8!1K3]3 DV3_"1IY<BS;,73AKTQ,(+C_X:-%K [X;S+;1QW#SKV47/*PL>S:
M99G=M.VB3)L\K;5=R)_3+8IO0-W%MGU@+X73R:Y=:>=X%-^85B_;]H:[('X_
M.]Y(Y&VVW"3R',O3PN-BAEDI%P':$,,M+_'.E2JG.>Q$@^/"7YF'P+X(R"8Y
MZ,NE2+W'_&QW7D1VFZE(=5FH3D"AI1U]$?F")J71!>&JGTI+P_0B\C--2:0+
M@G48C4J__2RB6.-0$AW\(K4(5/5RT874=IR*>RX$3@TT27_E6D0A/ZT$NG!L
M-5"KIA* MIWSL51)?2%=!'H:Z.ZR&IZ:HH'GW$V93?!I(CX]$"Z(]^DO.&@;
MB)HHT1"0YN.[WL&N@*VIXOCH>!7':D5OX(A36$8[3GP,M;DQ/XV7'!=\6&_+
M*>% NGJ3*$M@=#"7__8"UBH!9(NXOJ8@N#G=QL&AE>1<<)-$1[-F^7ABKTF\
MA=E3G*;/B/>@L_=+_!U/6W[YHJ-9M?Q'=//YA$'NA1O,1U91\!JG!<]9)U^2
M.#^ND]OX<(!9!L"+=P#WF)&D$%'S?90?"JXM!9":[REV]JZ/ZED,U2=UL_>R
M]ST2?^_P $,ON45_1EP()##-H']Y\L>-I7A-;P!QS-S/\@3/X0BC>+O=(#F4
MHF^6M2]P_@UO1ZP?*-YYVEG7X);5=](]/'Z-8(\#CQG)#GV*)RW;NA-+,"W"
MZ4@&K,$"4(=?1S@3$(7%J [7@SF!J$@8ZW@[=PWFD7)=Q].NDQ!*J!$Z'AOG
MB!E5B='Q,M8#T![C1I.^IB5^5Q]QGJWSI&YDC[&#4\W]-H[2.(1!,:>B(MA=
MC!W!+W139E/S02@U[,2B]+S6UEQLG3,N-4?A<FZMHW%SJG[<$,J^CQE)[;*E
MSTF[#C3SE!0-S>T18C< @W:3IS ":7HVTO;G+];']'DA,BAR&Y,5NU(!G"]:
MV3!=-KJ]=L:F_$LANF^1^O.*CAJ:T3M(/J$/F"* TTEY40/\G22+D+I$G!:M
ME>D31F*^3Y<50SG2B=C5V,+>P">(<O" -&/$H NQ^2M$E)"G68QNH/<__# /
ML$Q-4^QP$VR\'Y1U#AG)V+*+5*?5B;T/85U!F'E&V'V,+>4UB0-T.5E%075F
MB_I&S)4PNV@XZW<@A)\@.;'/^D4K8X#BNECK[9<X#M(&H3/YW@%T6?%A]7)[
M#$%QRXD"@:J@"@8V"$J"^!?2?E[BJ.)H3!*CM]= 7_<1UGNI<Z*W4SR7+P#)
M*B_$FQ8@]@#Q-21#-%U9I?&NMW>9334J1C1&+JLP+'B*T/V3TM@H \#(UB S
MCG.GF?GK?EGH$%OM>5?]5DNSUC@16PO1M>B2M*YO8Y<O$D.,$+-&D6^OP/BQ
M*7+6 $G91@BO7\L":;B1KP,=&^ME0$FV"EW4\KVTQ"P-&KI0Y-E\9E[DB&D'
M;574ZEN=ED%"$L:K-E4-L@W-G-1DU56.H6D1Z65&"DJ6UK8,_$1$ -L,./-*
M6.("X-(4N0P"&B@ 5%A"9TYYLO* 84==1"(G59>FRPO#,L#CLK>^)7Q)P @S
M."76^F4@J^B\"FW0(I*$40\Q[^UD2>@,4E6Z;S9:X+(MX\)0N(@O1EKRGQ$1
M,^6T_.#!Y)L7YJ *:BG.5[PMH_XACLK&GMX=;^9XB^1J<L)FCB*%3.I%P7D8
M2E][G)PE'A'/B\+FG.(LM>+^*[R"=?0&< @_AB,*D Z;U'^]\5*8LCQ9U8UO
MKE1!O82;T_F/OT!TDA)_?WH"GR!D^#0*=C:_N/;9Z,^4Z08I-X:2I:; _VD7
M?_X< %BN$OVA61SZRV_W$3J Y'GW?E;L$+):/7^ANZ2T?C6_ZTT\!Z]L*[.+
ML87<@01^%OI[PXC?8/H[XT0RNUBPD-KHOD%?8QX[9A?SI/48'?,L+5C<GYB.
M0*P>YI<Q0F[U=#$-LO')O#,Q+@F/IH;_<_^?')%DV.'_#;^@>50)]U?,IXM7
M&I!F;UZ&CE 8>F3_679;Q7/ZMF;)CM:OYD]&Z[C^6?J _]GT,E:?2%G'BN5#
MG+Q[.-T".E;%R;L#'UGS-YKWHFAWU31;/_J'X?I(=5YG-IU( 7L".R\LU2R"
M-":U4 S5W6%'!Z?YT:J#]!?I@_07T\O /#L[-13_\/D"*?,G-E6M?!\1=X[?
M\^C)^TB?O<C;%?>1IZ=;ADK.ZV.!6ECJ"%Q5L&JF&M2[=Q9\S:_FV'FQ;G&E
M@]Y>=:3" P.YYD=CP-7^A[?QX:-R4\'7":1?HA. WSAA4*4DX57^'#*28K!?
M$W@ .+E*'N$4J%Y"CG]DMU4\)P(L)1^L5<K7//'W7@K6'R'<%;]3RT8J&% U
M>?_RSB#O\X\6,-#6W8K+1=MM#9=(A5[8FHTX@Q/M;<>+AG(S=">]KZ !=Q%N
MH7+6;"*,8J;B6:-)LS"?W0S:-N!9(R%C4B92T_@3OPA\12S=;7S9!N5%0#;H
M;8M(HR1;]K(@5&D&[WAPB!N/%P&XR#O06<C0#=B+P$JKTLCFM[-V(.<J-^U'
MBEDCH562_'F9$.J2).(/.HO 6TZ0T%Z5%@&5%CE"? *;M?,X5VRT'N1F#P3E
M];.FC"Y.-1H_+41?4RE%_[((DII,BI)?<W5@:U$XW[16:#5;-^NX$+YYE?O*
MKP.?F9(LDR'T/1 63GDM5P@MH3.V(#'=Q8WNNC%=;)*-I-9R'=%1E6-YE#;(
MUV76T'-ID.Y1HZ/.B36X:"=)%:Y!.G; (A6'SQ\;WZ,*BG]<B5&-KM=QEKJ"
MJP)<87>N"NY_7@.RNP'9>P_):1B=.\?;T@#4PM/M$&PVP144]C6*/U*0?&(C
M0V$$0S\CB8!ZE=J,%_IY6/SQ#5V0'^+DNY><"9X63:#MN^9#*UH$AI,8]I:1
M=M>1OEV<YTH++,;BP:CT6^:A,QP:3/$W'HHV!>Q5$!25.8G%A[5]R_SFJEG1
M%Z25X20BCQ%.#@>"Q^C>2R+4C!OQJOW[<X'X'619F=IK(DS;'W0.1&OX]V]_
MM4VMU:U<\#S%%6R?#J>V([KRQ,%[YB69E;<166]J?=N\+)?"*8Z+9H5F6;X[
M+O"W 6K4LKP:'-[$CJ*F](GT7^6N16#G957;Z[ZIU]>T/#:6ZL5]U-\V!VQO
MM2S!_WA.,.FVB>V:Y9 ;;=P0 "NM(:6UP6)XF/0>$97] ,$F?DS3'$FY\C4-
M.SXSUB+4U=J%,5/$"7:>M'1\^?5GD.UCI.E\@C0#X,4[D!<BT$%UUJ#G+[CJ
M0>591L\?1&AFME[Y?W)T".\_T?_CT#NMM4W3YY==)[:?E)#?\'L4D4(N?YUT
M6L_>#WC(#]2)=7\W6&Z5Z'ASP^/6_'ZV+8E+S_Q^YK(#>2&2\^!]#T#VA+^
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M L?AE(T4Z(1A,XAT/K"(D1K7B]]J0" Z%"GZV'\''3Y+T4IHGOT=(4T07XY
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M@7V;^KR\2L^_H@MAF8;G:^3E 40_7=U*9^M6^@8^092#7C*R7KW2BV:F)_R
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M,"?H9HN#0O*HK N*6-]M<2L-OWEA"'"Y/L;[LWAO8]N!=/$B*\LFKOA?S3-
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M0;'7C";&CY!V[TI.R(Y2_\.9Y N9A^)"<GF<R0:-"%%3?<CFAZC-*7(F0&:
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M.E";$5'-)YC!)5K>->V,#NUG4]6R>#N=FD0SLVJ!Q(47378^5RVPV/E\P<H
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M]5P[=QR5!P--%?:C"L3%Q%Y,F$U&T^F=[%W?\22):N$WY1S@>()&M\^ @-.
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M,3*TUF:XIKT?DJ.8;,9GDG-%#VC6 <W?[3QIW)AHF[&8]AA18IUL!DB??7I
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MPZ/W#LP.9W<<NH'77OV,257Y)$L8$]5GRF;L-'$F@=P'CJ.BER%Q<C(XCMW
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MWZ!)QMI!\/OW[S^A'4Z\R-L7#]X_^?'AYSH=X,^9]R..XL/IYP+5.YCB;4'
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M?\OG"9C6[@$914'(F=5__(&MBLWDO23<E/,??]A[89%_1XX'[EB3O-:SQA5
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MSY"<,$\)T3S?LB:40'"'^];!;OZ&<ME**G*%>!3U&XN [*6HO-M*G]!S$$K
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M B_/7UOP$/CO*H]M$)DSW^I'UNG[0N?*401YIE"'WHZ(T!!M[4*;GNXPV(?
MSW8!6U[+X)S;QZHC;>CF#L2#ZWR(Z[@B]"0W1'E17@&DTF)644U[+<6@VW\8
MWW,L7 N!B!N"#)+%PCO)Y,W]!F@_-\P@;WKRT'9!^.I1""KE,^&&'(3^]NJE
MG&PWP3$(/<JT>YB2?1\L&QU!I_]XA#X@>3Y[1IC _R%.PB;]O;D[2KF@\H&8
MY_IK.^Y W6%2@/[^SP!/LGLE1^\__Q]02P,$%     @ 1HBI6F&TS$UJ"0
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M:177'945C)A$" ]C1"&/@Y$\-= R^49Y<2"*6I]0C';I\Z2C58J74B@6W@Y
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MQ/&KE@)[KGGW4RE_3U=DBN%18KUA-_^*RV1:&V1B5J!Z_.E#I>*.SWH4&KE
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MPQF$+](;<,Y?(_<YA%.-@Z$W#,*3[PW8^=+,^'^_1W)H\!,F8M&(DL-K=$6
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M[UZ(]#V-N^B3VGB23O>HD>Z2"'K 0/<E\/5<4H[[JHS(D[IP:(TCO:E6I:W
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MSJA)])HEIWRXHEFR%#,GM&7AJ.(\Y"<V7JPM8=4KX>&/P(K'U!##L* <'J\
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M<-Z^^&EOFC&XF:R<&?NMHDT=7;<4+60?ULXHQKY9IV37OSB?-?9Q,)"Y0[[
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M &N3W)P[ %42":T01%O7##^F%HG+?_L;#1(A ']W3^WO7CH\6*'S-Z8X2N)
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M"&[^L[BDOM*/*8T:,U6(Q'GP&Y[<?&(1"9<UU@LO57F:C;R<".D.0(@;U]<
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M>=A-,QC>H. .I?G%8Z@4AA.$]3 P[0P6OLL&@VZO2]'DS4;4H45Q3AE+Q73
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MK?J[6(RUP?BS.3D"T]<*MW#GA\1J,UA9WE3B,R9CQ9QG;'5'"B*0[[;0*G1
M@#,>23T@-T&F WCH 'ZT=4K\!R/A!9Q=G\GGF(CI89XZ^.'YBH& +)A7;G53
MPL(+_F^7U;7%]^_;?^E%2YYG)Y>^HX.CF$$BQ*/2WP,2[,M,LFY4W-S*\_+*
M/=LY'6!XXD(JZR$BL\P+$B:[1S7*^*!B8=H:BT4S&)NH+$('7#_J1J,#FNB
MYIP2D@M^6PM_!-(SWS=Q6XJ/7[=8L>3*'.]P#G7*-(QA,.+3<IQ=/_)BNO/>
MF7LO?W)3#L)Q[*>PJ9&0"\4A8:HGBC1N-N4&)0><2EA]0,S'(6R+LR6/QR@X
MJ0\E_>XCQDF'2;+8"59WQ(AAG^2FH61>@[]QL(6E4G16*RN'VI)9G+J\ NA3
M0=-@Y O'O1<B*F'OA>@@,+]*=T<T#BVYGM@NF4MI*Q?SN;]Y;Y55;@ITCII
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M,S,Q+GAS9%!+ 0(4 Q0    ( $:(J5IAM,Q-:@D  /=$   /
M  "  <U3!0!A<W1H+65X,S%?,2YH=&U02P$"% ,4    " !&B*E:K=&7=$H)
M  !F0P  #P              @ %D704 87-T:"UE>#,Q7S(N:'1M4$L! A0#
M%     @ 1HBI6BAG^)K7!0  534   T              ( !VV8% &%S=&@M
M97@S,BYH=&U02P$"% ,4    " !&B*E:G"H>2CUQ  "*BP  $@
M    @ '=; 4 :6UG,3(T-#0S-C(U7S N:G!G4$L%!@     &  8 <P$  $K>
$!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>asth-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:asth="http://www.astranahealth.com/20250331"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="asth-20250331.xsd" xlink:type="simple"/>
    <context id="C_80446148-a401-4cce-89ac-14f1418b9966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_80e76537-df9f-428c-93ad-7da9d13bb50d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockOptionAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_820936f1-0951-4659-b917-23fcb1da4cbf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_8243a6ab-ccef-4b27-a5e5-fc7c8cc5d6bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8297f21e-2dac-46a3-bf2e-4b0c2ff5c175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_83766bc6-44a6-4789-9671-394dba982518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_84a45b5b-15c0-41fe-adf1-ca456ce3cf0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_84fa31dd-5a86-4282-8662-e45fc242151e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_86a4c592-7bab-4c59-bf8a-cfdcf0ecc6d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_88dd1103-5401-475c-b0d3-88c0af26a48e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8ada5766-cd70-45e8-a299-c4904c89c0e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_8b0919d3-15a4-433c-a537-c7cf98fef70b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8b9280f1-8e3e-4e01-b2b8-0697e6c860d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8c0c24cf-629d-468f-990d-739224e84719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_8d32a733-9808-4cd7-b7c0-f21ceeb7f902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_8e1fbaba-ca27-4783-9682-64643b46acf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_8e22a9c3-e9e2-4f67-87cc-739826df0ebc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8e631b93-40e7-40d3-8326-b5618bb62eed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_8ef40c99-631c-434b-8193-71f59194c695">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_8f134208-f6d5-4c50-a680-3e055aa91882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_8f301b9f-cd6b-4eac-bd0f-1c2f7c9543f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_8f4dfe63-7e3c-4550-a1aa-0d1885663f72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_90d6d0bb-c95e-4885-bab2-bba445ae396a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_91422e50-b35a-4ab8-a125-5f4472712612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-04</instant>
        </period>
    </context>
    <context id="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_92e5a4d9-669c-445f-ae84-87c0d970533d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_93eb1e59-ba73-4807-8847-1e31de1feffc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_952ec1b4-0412-4990-a574-cf7524a67b4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_95410889-f77a-49be-96bd-dcaa6e56cd80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_95571c44-ac25-407c-a11f-70a6547c78ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_973e57e5-b73d-4cc7-94b0-6463141b31dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_98479280-cc4c-40f7-b636-b708537e9e1c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_985081e2-9a89-4282-bea5-465c5a88d3d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-01</instant>
        </period>
    </context>
    <context id="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_99d1dd55-3e68-4959-ba9e-eff028c809f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_99ea2791-355d-432f-b116-de8fe51581b6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_9a8924e1-57f9-410e-b002-cadf956446e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9ac0c6d0-4628-4820-9917-37da7e90084b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9adc0920-b8bd-47d0-97bd-354c3679c0f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_9af99720-afab-41bf-8f18-b88302257d99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9b477a38-5c45-45e4-b070-7aed8bfccd24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_9bb5d082-e558-46fe-93e8-c3308bb50e45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_9c3af7b7-7fc8-4c10-9520-574b3555c4e0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9d156022-37ae-4ca3-ad28-343a96df50ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_9d87bcf2-94d1-468d-bf39-ab8853daaa29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_9da713da-4bde-499d-850b-07a0b56f32e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_9e031983-8e48-4e18-a080-9ef7b798c5c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9e346eab-38d7-402b-bf8f-0d60cb0107a1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_9e7792f7-702f-4f53-bc31-698f8ce0df84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9e921ba2-6ad9-43f7-bb6e-25d335ac8af4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_9f0059b7-fc7c-4e0a-9e5b-a7e9d0745aaa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9fa5f4aa-a01c-4fb8-b531-d0b936d239ba">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_9feee836-d0ff-463c-b3e6-a83e692c0715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_a0af827e-2073-40a4-9366-c1c611fcf2e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_a0be7500-06cf-4f7d-a434-0f961d061842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_a0db209d-d0ac-4fda-b0be-cbfb62c51851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="C_a103be58-2da8-49dd-aac7-8114b8e1d475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_a1674af8-635b-46ac-b060-061caa2787f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_a2bea5f5-db89-471f-9592-a236454f04a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_a319aa70-1ce6-4734-8031-6b09d4cddad6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-24</startDate>
            <endDate>2025-04-24</endDate>
        </period>
    </context>
    <context id="C_a38c3842-fb3a-4695-9d09-f0d2fbf7975a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_a5fa8d3f-8630-436e-bb55-37a26df286f9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_a7e4265c-f495-4ea8-9abe-63aa02dd47c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_ab1680b4-76ea-4b15-86a6-421050cb834d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_abd1bb36-649a-4b3f-b313-b8879975169d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_acc8f0ee-cf35-491f-b1bc-f32657bd0a84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ae5e6aed-1503-498b-a58c-7a51d4fe9172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:ApcBusinessLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:PreferredBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-10</instant>
        </period>
    </context>
    <context id="C_af039a31-ee84-42a7-82dd-8c7deb252ff1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_af055ce3-c87f-4637-a806-c95905a23203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_afa4f934-11e5-4c39-b49b-0cb4a0e75483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_b046e187-8392-4a7d-a3ab-f5065c36bf0b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b0e202af-bc90-4be3-a147-eec79b8a2bef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b1bd11cd-8dd6-4de9-a5ed-b6ef0413b392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b1c3604a-49e6-44ea-82e9-36f2015f5d4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b3af013b-f74c-4b68-9ba2-7e9a3065d0ca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_b3b64b0e-4eb5-45d0-b5f9-2d703131e99a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_b427f9b8-5e88-4171-8639-300cf97af194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:DelayedDrawTermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b4ca8ae3-3bfd-4c53-99ad-240c6fa58860">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_b57351e9-49af-4f6a-a532-91fd8bca805e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_b6707bb2-894d-4ef5-b67b-4a9d78165cd2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:PerformanceBasedRestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_b672f703-aedd-4bf1-94c4-160d381f1498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_b6dd06dd-3e1a-4e3d-bd37-70d3a5857d75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b75ed518-5871-4767-8792-56c29fff2189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_b7aa5384-1c58-4d97-a748-b46442622060">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b7f07760-d62f-4512-a664-d49bed1a90cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_b83becec-a8a7-4250-98f0-8f5ba29d2848">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_b899ab26-e619-4d58-a07b-38bf2016ab41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSMemberEnrollmentMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b8b87b9c-e6a0-406d-818f-112b6825b4cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_b929ea35-4d57-4309-9729-8e223f59f4b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_b959fdf1-fcd8-4458-9fe1-8862724296dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_baa505f3-0b22-4c7d-97da-d429c4957dac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedHealthManagementSystemsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_bbf6403d-9162-483c-8776-b0ea02605c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_bca3f795-036a-486d-b7b3-5bde30763876">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_bce624dd-14dc-4bb3-b213-4088492584ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_beaa67cb-6b14-49ee-84da-6671434aed28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_beafc79c-c290-4d5a-b082-1dafd30fba26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_beef7b88-15ad-4fab-977d-5bf2e6bb0e4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_bf6be12f-f3ab-4aa9-a56c-870966b9a04a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c0084b72-06a0-4ae0-91de-1a477153763a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c16d7a21-9458-4b38-a8c0-cfb657c898ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_c1a29941-265e-47ee-bfab-5f1290b6297b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayEachFiscalQuarterThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_c24d9fbe-5f15-4c99-b3b6-14bc8e5f8a34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_c2e67330-5049-40a7-b292-d46f9324eb05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c3a02d13-ffcb-4213-bda6-e5bb59c91eeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c3a3893e-219e-41f0-a38f-79683aa82945">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_c3a4e452-1161-4a5d-850f-16c304a662ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_c3edf28a-a238-40d2-bd32-23ef178885d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CDSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c4024cc1-119f-4d5f-ae31-02955c23c53f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c41d3eed-30db-4a53-8251-e8161f2a5685">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_c4e85806-bf8b-4a55-ac88-31f987995966">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c627daaf-b808-4e00-85a0-596f504d8472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_c63056ce-4e34-415d-bc81-ec89ac8aef55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-04</startDate>
            <endDate>2024-10-04</endDate>
        </period>
    </context>
    <context id="C_c7b860f3-00e7-4af6-b919-b03da362adc5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_c8ddf934-6d23-4f44-9b9a-94254e17fd2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_c98c4392-4a16-456e-9225-81de0aeddc35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_ca2b1674-f053-4711-99b6-46e02ae62634">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ca44cbaa-887f-4bf8-b193-1e7fba9ea4ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_ca4dfd0b-8bd6-4fbd-a03c-0d86bc0e20dd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ca845960-39f0-4a22-b0a8-870c481d2a9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_caa6bff7-c546-4734-8b91-b9cc35d645f7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondThirdFourthAndFifthMeasurementPeriodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_cae1d15e-081f-4e25-9666-48ba5588bb71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_cb205433-1776-4986-8156-9590d16dcda6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-04</instant>
        </period>
    </context>
    <context id="C_cd8693a7-bcaa-4246-bc4f-8864b40faac7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ceaebce1-eadc-44b5-9828-3ae63b4a713d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_cf778192-a620-4a66-876e-1b3bee77789f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_cf787623-6175-4af2-9a0a-baa08dd1743a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_d03830d6-ceb5-4d30-91b3-d682fd7848fb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_d15c567f-3397-4492-8383-e863d7384893">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_d16bace1-c79d-4e87-85bb-17ae493b3326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_d3593fce-7c42-4759-889f-3843431c0c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_d44cee9d-e397-4f66-8ab9-60be5a5fe296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_d455b109-46c4-4ef7-9caf-6da6c644c797">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_d5454de7-c7d8-4458-b50e-0ea3109e6ecd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_d58319c2-1e7d-404d-9de6-2c8ff0ce99e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_d68d3e73-1a37-4898-87db-e2b73a6e4347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayOfEachFiscalQuarterEndingPriorToMarchThirtyOneTwoThousandTwentySevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d73d22c6-9b06-42af-885b-ab1ea9552178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_d7ac3eef-52f1-4e2c-8d64-851c37c3ee9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_d8fdeda6-ba99-41b0-8f1a-47bb18ab9f50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_da904c7b-408c-409f-b2c0-a578207cb75a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_daa1fc75-315e-4a15-918b-4217def968f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_db55fdec-4a85-4b80-a8d7-2659a2923a15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_db6068f0-807f-4b86-b6ef-af05a0370ebd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_db9d68bb-77fd-49e6-9bc0-d0eaff33c66d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_dbba92a9-68bd-4064-8de3-f595e744099a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_dc7280cd-a579-4b3e-92cd-3b6923b763e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-04-01</endDate>
        </period>
    </context>
    <context id="C_dc8d6e4a-2466-4667-9a1b-22764f551de8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_dcf3f17e-da41-43d4-8765-fa98896d0781">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_de80ca92-733d-4d31-8fc9-bb3a6ff69c9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_df2728ff-ed37-42eb-8135-6412bf60637f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_df83f06c-1bd7-4a08-a59a-dbb0d00b045d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_df93c67e-ab97-4281-ba2a-b871cd8e57a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_dfa9936b-5186-4152-84d7-699c1a534b33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:DMGAndSunLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_e1740a99-900b-4902-9d5e-4d630ead0b03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_e21928d0-d834-46c0-97ad-f882fc6f862c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_e3605bfd-de05-44e6-96ef-5e21824f3ddf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:NonrelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_e495f793-75dc-4d1d-8b73-1382c3cdff82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_e5cdd2bb-60a6-4ebb-b03f-2092771d6a9f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_e6d48615-5367-4a0f-ad3d-86dd6a0bbd6c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_e76a7617-4b56-4fc3-99bd-e245633154cb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-07-31</endDate>
        </period>
    </context>
    <context id="C_e7d1b03b-c982-4a71-9cb6-b34b0f7c2e9b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_ea90d243-5c67-40e3-a543-1955b487feeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_eaf785cb-d155-4317-8f80-24864238f6c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_eafa35a4-99f0-44d4-a6eb-107f2d35d4d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_eb098f65-c543-4b24-ae54-daae9a749c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ec8f7056-c0e7-4865-bfc9-cc405c953592">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">asth:SecuredOvernightFinancingRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_ed9a6b0a-2f21-4044-9c6e-5d6fe11bd1cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_ee076df7-779d-41be-82fa-78965cf2bb7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_ee84bd0d-3633-4ffa-b982-879767a7cdad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_ee86e486-beed-4909-b2c8-b2cf6dae3f11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_f0efa117-c0df-40e9-9b6c-2738c0931341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_f121a13f-7f62-4911-af4c-cdc74d7b71a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_f29b54ab-fc06-4669-ae02-d8718105c456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_f30cbeac-b9ab-48fd-96ce-75af5d6e0bfa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CompanyAndAPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_f497f166-f60f-4783-b578-7fc1e03156d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_f58ff657-ab10-466b-ac21-a56b042b8f8e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f645eb5f-2f94-46c5-98c1-1dabebffc600">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f87a47bf-3205-4aee-8f68-e2bd18751281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_f9e21867-5350-4ee9-bd3d-e27eaf98771f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_fa1d045c-893a-4fe4-bf41-4750c11195d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_fb36bf2b-c780-4ab2-b3b8-d365c11db5d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fb49430e-f221-42fd-ab2d-21a25ad7d7bc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_fbb3c763-fbfe-4d2d-bb20-60c7ade4a0d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fbc31d75-110d-425d-9f53-3d8451a0d495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_fbca9ee8-8163-4436-a2e2-bce055cb706c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fcb6fb64-b6ca-4164-afb7-90087668e19b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_fd421a2b-dd0d-4238-b483-99535258a1cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_fd640251-91ea-4cc7-9495-ffa5d748fb28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_015f1704-89e6-4c03-afae-18a5d32c8336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_017c6b7e-32c1-4fc0-bb28-bb5b23e4d7dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_02359f56-b244-409f-85a6-c9122ce3d2a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_02cfd407-332a-4baf-987c-e88967c9572f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_03eaf310-f4d6-4b4c-9ee7-e536dd3096e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_049fe2ce-623c-47b8-956b-acb5e9467f17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_05ea43c3-e314-4603-8d8f-a60b429d8f85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_080805e0-71f9-466e-995d-e3d7a0793b53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:FirstMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_087d9c30-c670-47d7-b3cc-1831b12e4e0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_08a19b8a-9cd6-4016-9557-28e48707eeb4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_08b0fafe-b67b-4bd9-9a48-7f4c5f138bed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IHealthPromissioryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-01</instant>
        </period>
    </context>
    <context id="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0aa38d95-e047-40ed-aae1-7c7af01d8b45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0ac128eb-5a33-4975-905f-b556a96e2c4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_0b125a20-c6ed-4951-af84-bbf48d18d034">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0b13f834-ee62-4361-8e5b-68ea07a37e23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0bcf495d-f6c9-4ab7-acd8-a670125428f4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_0bde49a3-f8b1-43f5-93b8-2a4f2689faf3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0c97d0ad-d27f-4202-b033-a921a4fd1636">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0cff01c6-12c7-4f38-864b-0bbcdc7a9295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_0d98b790-089f-4f95-8f77-b2f98cd851c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_0db515af-2807-4207-b8a5-46485e97024c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0e18f7d0-badd-4b78-96bc-454449d1877e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DelayedDrawTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0e5954be-95e4-4557-b760-60d9a28d9308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0e90a0d4-f745-48d9-a24b-c58b53cc0548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_0f2b4746-765e-4a23-95d4-385fe1476cce">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0f6589d9-060b-4baf-90fe-b02db5eb589f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_0f9cd5b5-b704-426f-9132-13af5d422b00">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-29</startDate>
            <endDate>2024-01-29</endDate>
        </period>
    </context>
    <context id="C_0fb6e99b-fca4-44d8-ad37-70ea90786ce7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1083cf69-b827-454e-8369-6d3fc314dfc0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_11101c20-415e-4281-8227-fa000c36a1ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1288fe82-ac30-4a05-9186-9dd06073739b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1365a955-4128-4b28-a0bb-c35ac458d684">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_16aa46eb-3f05-457c-861c-643f3c663612">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_17704f66-45bd-4b7c-af28-dd048a5f2457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">asth:HealthCareCapitationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1989d044-2b9d-4d1d-adb5-89940dd1bf1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_1a4f7a0c-078b-46b3-a572-4429ae7dc5bf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1b553b00-2fc0-4ac1-92a8-7cfe88881549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_1bff3c75-ef8c-43c8-8cd4-ddb311389b41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_1c3552b0-b03a-4553-a29c-97b040f5699e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:ApolloMedicalHoldingsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_1dbcd7f4-15f4-485f-84c9-42d3bbcb06e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:CommercialMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_1dd1d251-19bf-4cd5-8a5d-6055b3033882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023TargetAndGrowthMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_1e5aa272-935d-4f32-9bfb-416c2178e6aa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondAndThirdMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_1e918ac4-70a3-44fc-b478-645d223adbf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_1ea642ae-a35a-4119-b34f-c0c2715563a7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_1f767e2b-b61b-4ca0-98c7-e3058a5e5df3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">asth:ThirdWayHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PrivateEquityFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_2147af01-593e-4d79-ae19-38f7ac603a3e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:ManagementContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_21d8b068-a324-48d5-986a-6a1d66c692e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2025-05-05</instant>
        </period>
    </context>
    <context id="C_21dd06cf-9d3c-43d2-9980-e998c5f6f0c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_222bd65b-18c2-4e1e-ae1b-cbccc1f49d96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_226ae331-0b66-42c0-b281-4563dffea1fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_22d1feea-c756-468e-ac13-0faa2e9eac74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_22f45f1e-8c8c-4614-b22e-19a67b75190b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_236ccab9-0279-431e-981f-890a827b1ca0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="C_23a6def1-fe99-4994-80d1-971c2b32a7da">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_23f8c634-36f7-44cf-9399-7b2106a9fe93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023MetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_242c5ffa-94be-4093-910a-0097e423df05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_267bebe9-df3a-4348-8901-8b3074ee8ba5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_2756304c-de02-4a8c-b11b-0af4c1d0f72b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_2814e1a2-ab63-418d-b63e-dbd2d3f1801d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_2a1a51c2-b17e-483d-80bc-bbee2ba2992a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_2a253766-549b-48d9-804a-32af249a20f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_2cbf692b-71ea-45e0-a47a-62ac40f45969">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_2e55ed2c-9a1c-471f-b86f-f1b220d4588d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_2f80e474-09c5-4498-a350-2d08cecdfc30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_31f2c291-fe47-4c84-bb34-57cb71b36101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3201267a-d634-4169-826d-98d5f707cdfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3219815c-b8e4-4aee-977c-644ac98f25fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3551b884-1dd8-4237-84f2-7b976f23e2cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_35ed1a55-e356-4546-bdd7-e13888799768">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_367c7a54-311a-4f48-828c-ff0ef9db9d95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_369173ba-bef4-4c54-9896-61bf4704f842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3696b868-57c7-4c52-8b1e-a7409de802a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_36e16046-d6d5-4ac8-87fa-8e331f7c735a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_3757db2b-c29b-442c-90e8-b518b6fde2b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AlliedPacificHoldingsInvestmentManagementLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_379e6a73-d6bc-454e-977a-efe6b3426bf8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_384def41-401d-433b-a083-2f0ed1630ae6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_38586056-d9a0-4723-b06e-423ac77877ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AAMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_388ec8dd-e407-47aa-b88b-930866d15cfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:SecondAndThirdMetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_38996325-e035-49ee-a6cb-7fcc69167cfe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_3952c0ce-7c90-43a0-8800-607b699b17a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_39d701e3-06a4-4df9-b822-c0fcffba122c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3a2ebc98-8101-4cf2-9108-4f593c2d8847">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:NetworkRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3a367d74-7d53-44d3-bbea-33e94ba22408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3acc1c89-3076-4ee5-a26e-94c06be58c7e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3b445780-6235-4a8f-ba3b-abd685c6ec2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3b49047f-ac09-4d40-b78d-73c4e56f102a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3b9afbd5-4210-4cba-a0f1-a98c07823a3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3bad1aa8-8683-4fde-8415-afca6a2c5cdb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_3bc8f5ef-23a9-4f96-bc10-a52d7a540f3d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_3bd97afb-8c37-43d8-b09f-783073d2929a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3d384b8a-36f4-49d6-9e03-2c663c6f6dae">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_3d79f704-e8f9-4c16-8574-e530d4eb0e3c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AurionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_3e76e350-ea44-40df-b69e-b28234065741">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_3f74b900-fc5b-4144-b943-471127db7623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_3ff71d2b-ebbc-4683-8c33-29859e53eefe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_40132981-89ba-4e41-815e-8b46af618908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_40324dab-ee91-438e-8fee-dd30b551fea0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_4103c318-abec-4453-8eb0-b888e91d21a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_4119ea9a-9b96-42d3-bd3c-d9d8cc88b66c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:InterestRateCollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_423ede0d-20f9-4418-b336-259b500c9fd8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_42bb4ed7-33be-47af-988b-992e494c103d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_43074c34-b768-45ea-9ed8-9013bbb22b45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_439f009f-2b98-4cfc-ba9d-62cbb1adf7e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_43ba0bc5-d5da-4f73-96ca-7e4df5bc7e92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:MemberRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_44dfee64-65b5-496e-98a1-6b501aa3532a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_455ccf48-8afa-43f7-9084-96bed70ceb5b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_4620cbd3-1893-4a0c-9d80-94c7c2d51650">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_47d471b9-bc25-4bfd-ba7e-f4308580c360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_47dc46dc-5dad-4a5f-967c-32e72a07d19c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_48d15767-6248-4bb8-9a0c-0543b84f6436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_48e4959b-0f1f-4be5-ab14-031e03179f1a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:VOMGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_48fdb53a-c0dd-414d-8bd9-069c2eded400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedHealthManagementSystemsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-31</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_495d4051-3ab2-4ec4-aac2-eb89210fcf3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CollaborativeHealthSystemsLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:CHSTwoThousandTwentyFiveGrossProfitPMPMMetricAndCHSMemberEnrollmentMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4a4c4fe5-1018-477c-a9b5-a907e028c99f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_4a4ecf0b-afe3-484c-ad85-f7a6579c67a9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_4a8637ec-690d-4853-a3e3-abf4a49d231a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_4aad3ec6-80fd-4602-9c7b-59c3596c2d22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_4b85094b-d44b-4343-9073-a47a57dcafe2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableToBanksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_4bbeb5ac-5579-4bec-887a-12754b13daa5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_4c0af0d9-a715-49c1-818f-7bd0aa182dbe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:OtherThirdPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_4fbc38e4-4839-4ebf-a373-b96ad86a302b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_51568cb6-3f1a-4554-92a1-e0a87a63611a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_51d37c62-bd92-4b36-bda5-66bf4ab5d0f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_5632426d-baaa-4109-8b29-9f7796b165df">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">asth:PatientManagementPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_56bfe089-97e1-4466-af03-ff2f279f2e29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:MezzanineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:SeniorSecuredPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-29</instant>
        </period>
    </context>
    <context id="C_56f15d39-f30a-4cdd-8e2e-7558823519b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="C_577be10c-71a6-4648-8164-b2570291e50e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_57ab083d-904e-4e53-978c-f5c3da6822ed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:IntraCareConvertiblePromissoryNoteReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-31</instant>
        </period>
    </context>
    <context id="C_57c79a78-9732-4080-9239-22b71e33c266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PmiocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_5866792a-f02f-4281-bb96-b527c6b93742">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_58fba134-3b96-4623-9e04-19f42b73f4cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_598d420b-fa2c-4abf-b7c7-2b099761021d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_59d235ce-9711-4ef0-bfda-f40da6b2866b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">asth:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_5ab8feca-ce17-4204-bc5e-2c50a0f3326e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:FirstCommonwealthPropertyLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:OfficeLeaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ProfessionalMedicalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_5b31a718-c1c9-490e-911d-86d1062a0eeb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:EmployeeStockOptionAndEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_5b43a6c1-a998-439d-ba82-792676c6568d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:PCCCVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_5edf9e77-4494-4d12-9667-31e210c6227e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">asth:IHealthCallOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_5f9b3463-0249-4f81-a7e3-f5f9afa4f5c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_5fb914a7-0520-41f4-83cf-9c07f5e46feb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_608c6900-ee56-4405-ae5d-6fc0640fc6b5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_60a42d76-6c9a-4f99-93d9-4550f317d0fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:BassMedicalGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_60dd78d1-64db-4a8b-924c-509710d8f2d8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:LasalleMedicalAssociatesIpaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_60fac651-18d8-44ed-9d9c-07d7f1f63e2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareDeliveryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_6177be07-fab5-40c9-821f-deabcadf9b27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_61b01747-808d-4a48-a5cf-a6bdc4b2b455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_625b04f5-8205-44a5-ae85-4037620ce1b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_6399433e-def4-4d84-b6b6-f762bf6ee833">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CarePartnersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_63adb938-c888-47f6-afd0-8fa1a58390b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_6400c1e2-a6bb-49bc-af77-e72305173422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_651b11d9-1f6c-4cc8-af5e-b6decb5bd381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_6576bf12-444e-4d4e-b361-dc0763d5edca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_65d1d249-71f7-46a2-a28a-9474d27d86f3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CFCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_65e86fd8-187a-4fa5-8ef5-554371a711f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:SunnyVillageCareCenterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_660533f2-bb98-4221-8734-e0be6ba384e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024TargetAndGrowthMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_66914d11-6398-4518-9398-8ccb5e2da66d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:IHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6876888c-242a-4666-a5ca-046144b65e95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">asth:PayorFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="C_69535d23-6b5a-4866-b0c2-b2062e9d8bed">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:ArroyoVistaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AHMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_697ba52d-2244-440b-9f20-87f75a1b40f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">asth:StockAwardsAndUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_69d8a835-e946-435c-8b6b-b394071da012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:SuretyBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_6a8368f0-8774-4b22-a45d-899d1800a379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6aa69ca0-0134-44c6-9a4c-dfef95103988">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6afa4315-6042-4fb4-bfdb-562cff61568e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">asth:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-26</startDate>
            <endDate>2025-02-26</endDate>
        </period>
    </context>
    <context id="C_6c8bf174-59c7-4577-a615-168c7e390b79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:CAIPAMSOLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_6ce72f59-77e8-4dbe-aae6-f5d7f9f30d70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ApolloSunLabsManagementLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_6d80e85a-168e-4e9b-80f3-ccebe319846c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialSupportToNonconsolidatedLegalEntityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_6ecdd9eb-4e61-4714-82a4-da270a6dfb36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_70877b65-4861-4b51-a656-f2212a0647a5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_7111af93-0249-4601-b68b-7488d9494f44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AAMGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2023TargetAndGrowthMetricsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_71250632-5809-4877-9e5a-4ea18f63b9b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:CHSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_713fe850-c7c0-4c74-bb89-374b329bb348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:ADSCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_71a445c4-c7ab-4d90-a288-fe1fead886c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:AdvancedDiagnosticAndSurgicalCenterIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">asth:A2024MetricMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="C_71fe0c76-45fe-453d-84d9-fa9e245de91b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:PacificMedicalImagingAndOncologyCenterIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="C_7207eb90-6e38-4c0b-adf2-11627269267f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_72cdfcac-2740-4878-88ae-2ceba95c47c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:HSMSOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_74ff5438-7469-415e-827f-4df6603c37f5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:BoardMembersWhoAreAlsoOfficersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:ProviderServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:AlliedPacificOfCaliforniaIPAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_766601e2-a6b4-4052-99ed-c5eca3f68c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">asth:PrimeCommunityCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_77dce955-a90f-4883-84a3-2ecf12cbb7b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">asth:CareEnablementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_782cba76-0dc6-4355-999d-51fc02a33e23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="C_787cb7d7-ebc8-4665-80e3-627cd2d9a92c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">asth:AsOfLastDayEachFiscalQuarterThereafterMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="C_7a198c7b-7dd4-4175-ba0f-59cc0ec75af0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionExpensesIncurredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_7acb6b6e-5f3d-4e08-a797-82f25588ef01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">asth:SongPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_7d30ac99-4e7f-46aa-b268-23abada1cedd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">us-gaap:OtherInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="C_7d764929-a2f0-4c7b-b54b-eba37cf55e23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">asth:AmendedCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:DelayedDrawTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-26</instant>
        </period>
    </context>
    <context id="C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">asth:AHMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">asth:RelatedPartyTransactionRevenueRecognizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">asth:CommunityFamilyCareMedicalGroupIPAInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-04</startDate>
            <endDate>2024-10-04</endDate>
        </period>
    </context>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_Segment">
        <measure>asth:Segment</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_State">
        <measure>asth:State</measure>
    </unit>
    <unit id="U_Member">
        <measure>asth:Member</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Securities">
        <measure>asth:Securities</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_b1fc9651-f5ca-44a4-8059-556f18fc56fe">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_5cecff7a-c2bd-4114-aba6-4e1323305fcd">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_dcdc880e-faf8-4a27-b899-3843ae3b99cd">2025</dei:DocumentFiscalYearFocus>
    <dei:AmendmentFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_161eb69e-b5ec-47ae-8742-313e4ab92d94">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_e704d9e9-2112-42cb-afad-0db5ccf1a00b">0001083446</dei:EntityCentralIndexKey>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      id="F_6c1492df-fbc9-403e-b36b-cbe2a6c35037"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      id="F_942d33bd-6fea-48e0-9338-60f3d993553a"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_85a7fb24-2a46-4162-beeb-ab37e6433db9">http://fasb.org/srt/2024#ChiefExecutiveOfficerMember http://fasb.org/srt/2024#ChiefFinancialOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_a6133d98-7b94-492e-8834-b1b4530ae2ee">http://fasb.org/us-gaap/2024#GeneralAndAdministrativeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#UnrealizedGainLossOnInvestments</us-gaap:FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList>
    <dei:DocumentType
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_e66ec606-a86b-4e11-9e9e-e7c96f45fe18">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_59a1c554-db7b-4d2d-9b09-554078bcfa5c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_09016c9f-34a4-4b15-a0b3-fada2b98d568">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_6f521797-31ef-458e-ba85-ddf0981447fa">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_6de5a79c-ace9-4c68-ada3-f4763991bf32">001-37392</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_a51ec7c0-e62f-40f3-a901-c7ae7ba73246">Astrana Health, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_a4390608-ef56-4b87-9f0a-974eb59ab183">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_e74fe11c-8b14-4ce3-9ea4-01b0a080d839">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_41dfa5d0-c8fc-43e9-90fa-4f055e364ae3">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_97894742-5671-4b77-ab46-71264e6eef1f">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_538afcd9-3a05-4d74-a982-c623cd1349f3">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_26b60af4-5390-4a95-8301-e3842f23cf22">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_cc37e990-8de1-41b3-8c0a-013b7b76ade0">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_6a9c0483-93a1-49ae-b3be-b682da72524b">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_fe7ec2d4-1423-4004-bc41-61d8dfa8eb30">282-0288</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_c4a01ad9-7107-4b41-bdae-128081af1b2f">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_058e906d-44b1-4188-ad8f-cb7cd142beef">ASTH</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_572b76ad-96c6-45d0-91a4-a524af1b0f72">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_8bb1f784-64b8-446b-85af-80b6a7252f8b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_7d99915b-bb19-43d9-bcd2-45f34462d109">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_8096676f-5ab0-4b60-9a27-eb700d3dc3d9">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_69197fae-4e11-44a5-88c9-9cd1f7f55c6f">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_75dc0749-63fd-4365-ac00-bceb3a180974">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_554d3289-b4b7-4225-8f75-36151f2ab91b">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_21d8b068-a324-48d5-986a-6a1d66c692e9"
      decimals="INF"
      id="F_e01a8480-12bb-4470-ab29-48597d335861"
      unitRef="U_shares">56061712</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc"
      decimals="INF"
      id="F_d3885bf4-48e6-4ebd-a475-db286490724a"
      unitRef="U_shares">6132802</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_e518f6eb-82b8-44ae-9bcb-3bc6da604ac6"
      unitRef="U_USD">258517000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_07dbebfd-87a3-4fcf-92a7-182bd3a64a08"
      unitRef="U_USD">288455000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_dcbf9fc5-2fec-41f6-a8a4-eba063fac7b3"
      unitRef="U_USD">2397000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_25af7667-d63e-4b72-b057-ad382405a1e6"
      unitRef="U_USD">2378000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_e3605bfd-de05-44e6-96ef-5e21824f3ddf"
      decimals="-3"
      id="F_2bc2ec2d-7ecf-49fb-8c34-05a54c330a92"
      unitRef="U_USD">241078000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_d8fdeda6-ba99-41b0-8f1a-47bb18ab9f50"
      decimals="-3"
      id="F_1bef5b65-486a-45f0-9002-0573c668d4a4"
      unitRef="U_USD">225733000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_df2728ff-ed37-42eb-8135-6412bf60637f"
      decimals="-3"
      id="F_3cbccbe8-1618-4e99-9e72-5d2161484799"
      unitRef="U_USD">56846000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_577be10c-71a6-4648-8164-b2570291e50e"
      decimals="-3"
      id="F_653daef8-45b0-49c3-aa64-ae00c41bd875"
      unitRef="U_USD">50257000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a8084a98-cb79-4591-8fa0-aaa79dbb6afd"
      unitRef="U_USD">15802000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_27a9102f-859d-4fc8-bc4b-795ed17ba55e"
      unitRef="U_USD">19316000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_20aa0a3d-eb0f-4d1c-93c3-f46e4f614e50"
      unitRef="U_USD">14919000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_6232204b-1747-4491-a831-c00593315356"
      unitRef="U_USD">29496000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_6ac8c1ed-f8dc-43b0-83de-3db962d2d788"
      unitRef="U_USD">23711000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_fdbc39ea-e322-4489-b9aa-0f846b870478"
      unitRef="U_USD">22861000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_be842bf5-efc3-4142-9de0-b175ed6cc2e8"
      unitRef="U_USD">613270000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_0df681b0-16f1-4647-be1f-e3c8fb0eea13"
      unitRef="U_USD">638496000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5f66ac01-fa77-48e6-88be-3b6c929d72f5"
      unitRef="U_USD">16849000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_3a4a3ab5-c7d3-4e1a-b7dc-c3f25b1f97e5"
      unitRef="U_USD">14274000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_d12fafbc-0811-4ce1-8168-e95e160bd7ba"
      unitRef="U_USD">111916000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_539be4ca-5787-4d76-9ade-2323becec9d2"
      unitRef="U_USD">118179000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_9dd2ddfa-9d05-41ff-b339-c54c31cd39fb"
      unitRef="U_USD">416386000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_87c69b49-dfb8-47e5-a04b-d008e69a9d9f"
      unitRef="U_USD">419253000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_350d1403-6ae7-4b31-8c63-b19e94e7ac90"
      unitRef="U_USD">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_ea8bbdf3-43b8-4c2f-b5f6-44b735268d07"
      unitRef="U_USD">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_c29ef843-b966-4a00-bc35-af8a46f7d592"
      unitRef="U_USD">48134000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_fbf38fda-30dd-4adc-b735-b3977cc98bc3"
      unitRef="U_USD">51266000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_fc3607b7-7862-4457-826e-2d1e9b6e50f8"
      unitRef="U_USD">38005000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_35814182-735f-4384-9e0a-f3c0a8d753d1"
      unitRef="U_USD">39319000</us-gaap:EquityMethodInvestments>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_456e1764-a239-4b5e-8949-6feef8ec401b"
      unitRef="U_USD">8896000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_20d4f7f4-686d-4d18-88df-57105af1bc3b"
      unitRef="U_USD">8896000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_80227941-7fa2-4522-9c2a-e48046f126c0"
      unitRef="U_USD">647000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_f701c9fe-8ee0-478b-a2cb-c32a7af3f191"
      unitRef="U_USD">646000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_8ae89b6c-c27c-47b0-abf3-730293b13367"
      unitRef="U_USD">30698000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_fc4e1d05-044d-4323-84ff-a7979287ae6c"
      unitRef="U_USD">32601000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_64b5aaf6-9415-4732-b8cb-106c292ceb63"
      unitRef="U_USD">30512000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_bc62453c-6a5e-4cd9-b467-90e44b1a8abb"
      unitRef="U_USD">16021000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_e338430c-bfbb-4609-a2da-2590063aa7f5"
      unitRef="U_USD">717986000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_88d661d9-4542-4160-b004-ad4da3b6e1c8"
      unitRef="U_USD">716398000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_b5a02926-a7d8-4244-8588-e131eb0d1fca"
      unitRef="U_USD">1331256000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_eeaffbef-52aa-44cf-b09d-2ce37173ba27"
      unitRef="U_USD">1354894000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_f2c43a0e-813b-4304-ad88-31ca23dfdf79"
      unitRef="U_USD">105559000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_fa03b55f-18d1-4a1f-873e-4bfceafaf2cf"
      unitRef="U_USD">106142000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <asth:FiduciaryAccountsPayableCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_0d01f442-f697-403d-b7b4-41746ba434a2"
      unitRef="U_USD">4840000</asth:FiduciaryAccountsPayableCurrent>
    <asth:FiduciaryAccountsPayableCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_0223541e-1455-4546-9121-3297b4271ec9"
      unitRef="U_USD">8223000</asth:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_bb7cbc9c-812f-4a5f-b4d0-a2283e80494d"
      unitRef="U_USD">204101000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_ceaa528e-934d-40f5-92bf-870150bcd8cf"
      unitRef="U_USD">209039000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DividendsPayableCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_8df352fe-7499-40e0-91ce-bb02e57e654f"
      unitRef="U_USD">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_0977e7c9-6bcf-4db8-b19a-c921922a4d29"
      unitRef="U_USD">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_1de03bc3-456a-40c9-ae1d-aa97044175e5"
      unitRef="U_USD">471000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_45e91e13-a7b0-4761-bae3-bdea3fa9ba51"
      unitRef="U_USD">554000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_584581ed-fbe8-46b7-a24b-c1a2bb5eeea2"
      unitRef="U_USD">4979000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_0b48de3e-5c7e-42b3-9b05-2306c2577969"
      unitRef="U_USD">5350000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5972006b-64dd-415e-9f0e-ac9cb033e567"
      unitRef="U_USD">12500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_41f1c66e-05b4-4e53-9161-549417a2e96b"
      unitRef="U_USD">9375000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_10945a85-6dd5-48bc-9bdd-3229bd8502a0"
      unitRef="U_USD">28180000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_ee9095a4-f2e8-4a5b-9713-7386941cc0be"
      unitRef="U_USD">26287000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_19521661-654b-4495-b5a7-a9e01740d299"
      unitRef="U_USD">361268000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_8a761e03-8176-4289-912c-1f33ee052d15"
      unitRef="U_USD">365608000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_251a7457-81c9-44a8-baf2-3acb4003995d"
      unitRef="U_USD">4197000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_f26aa95d-e7fe-44d5-bae8-07813936aec6"
      unitRef="U_USD">4555000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_1320d07a-d7bb-4bee-b88a-27dd7b2c458f"
      unitRef="U_USD">543000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_d3828661-9b32-40a8-8a7c-2cd4197999b2"
      unitRef="U_USD">607000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_b5724fe8-d628-49a0-a77b-ed0f48e233bc"
      unitRef="U_USD">28963000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_e902c8d6-6417-4bd2-8436-fe1db07d3a6b"
      unitRef="U_USD">30654000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_513ad74e-a03b-4708-ae6d-138b154b9d77"
      unitRef="U_USD">403894000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_ecc3d465-2b52-4767-8d13-bc81b823b03a"
      unitRef="U_USD">425299000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_51d8d986-9a95-404b-8363-563618c7da00"
      unitRef="U_USD">14685000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_4f073789-2e40-4cc5-bf07-54df584e1249"
      unitRef="U_USD">14003000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_e7775fd5-8f7b-4490-aa68-63209620eb90"
      unitRef="U_USD">452282000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_070ad8a6-6584-4c80-bda3-b628154e9467"
      unitRef="U_USD">475118000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_3caa0f8b-7e96-491f-8b69-dc963eefb25d"
      unitRef="U_USD">813550000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_c7e2d019-0bd5-48b6-9f3d-aa213600f006"
      unitRef="U_USD">840726000</us-gaap:Liabilities>
    <asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_9705f259-420b-4f56-b5c8-a9dc4f0019f7"
      unitRef="U_USD">-232733000</asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends>
    <asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_3e60c789-7d97-4e76-84d7-40064315af0a"
      unitRef="U_USD">-202558000</asth:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsNetOfDividends>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_b90614e5-eb39-4456-88f6-6ec371a61e85"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_c6da3999-b94a-4a67-8476-19607c1eb099"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_4b162b64-8153-4c05-b2e7-de57737ae44f"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_4954dd91-b0b0-47fc-b17a-0e7c559bb4ae"
      unitRef="U_shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0"
      decimals="INF"
      id="F_4236a83b-7259-4faa-90dd-36229bbc6724"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0"
      decimals="INF"
      id="F_af074ac7-570f-4bb2-ae44-4e37285caa3f"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0"
      decimals="INF"
      id="F_7cd03142-78f6-4c81-9a97-2b0c9b4e116a"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da"
      decimals="INF"
      id="F_5d3ad465-05a1-4090-aae0-8c6b603b45ac"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da"
      decimals="INF"
      id="F_420ab9cd-ea24-4ea1-862b-4f4f4ae09ebd"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da"
      decimals="INF"
      id="F_966e7f8f-aa46-4267-a880-24e93b3b37db"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_aaf3dbb5-a8b2-46fb-a22e-6df7287f75c0"
      decimals="-3"
      id="F_569ff054-86d6-4c31-a192-cab952160733"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_23a6def1-fe99-4994-80d1-971c2b32a7da"
      decimals="-3"
      id="F_b0465b7b-92b6-44f4-8209-c304bb6695b3"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd"
      decimals="INF"
      id="F_2eb9ce43-5b94-4749-88ad-5bf5015db94e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd"
      decimals="INF"
      id="F_8f80f3a8-1a07-4a65-aa2d-f0175b0f9a69"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd"
      decimals="INF"
      id="F_3b968a1f-d3d0-463e-b187-b6071f37d87a"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0"
      decimals="INF"
      id="F_133e7aa6-ff66-43d9-991e-d32ba04117ab"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0"
      decimals="INF"
      id="F_470d6220-06a8-4c41-95d1-5c3e333219c8"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0"
      decimals="INF"
      id="F_d9bf2076-9560-4a30-930e-5a5fee7b5b19"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_b189d5da-c79c-4b4d-bdcb-527aff0bacdd"
      decimals="-3"
      id="F_021eb613-8cb4-46bd-8da6-1449cd0e1703"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_dabe78fb-17b1-4acf-8bbc-ed75492f35f0"
      decimals="-3"
      id="F_addea7bb-81ab-4716-ab54-c40060356418"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_8687e98d-c4f0-424a-a772-0be17b80353d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_b456d799-7f89-4b78-a566-069bda6a9edd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_e3a5d2d1-c2a9-4b36-9645-f1088c30ce5c"
      unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_a4deac46-b7a1-4388-8748-5c2eab97010e"
      unitRef="U_shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_6bb010a6-9fe8-4c51-bc66-f4689ad1bc86"
      unitRef="U_shares">49028624</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_6bf01c18-cd25-4485-9bc6-71a8321dc4c1"
      unitRef="U_shares">49028624</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_5da71b9c-4490-4e87-9ccb-dd8c6140ef0a"
      unitRef="U_shares">47929872</us-gaap:CommonStockSharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_52815004-8bbb-46b6-b3a5-6195b088e9ba"
      unitRef="U_shares">47929872</us-gaap:SharesOutstanding>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="INF"
      id="F_f95ecb98-58b1-40be-8e34-f2da72054f0a"
      unitRef="U_shares">9903953</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="INF"
      id="F_94981375-3481-47e5-a974-c3575fc768ce"
      unitRef="U_shares">10603849</us-gaap:TreasuryStockCommonShares>
    <us-gaap:CommonStockValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_98ad39fe-8c14-4a37-8b15-6d9012ad8aa3"
      unitRef="U_USD">49000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_95e74ecb-e31b-487a-bcf5-e02d078af154"
      unitRef="U_USD">48000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_89071e54-7460-4cf3-92f8-2211f2cc04e9"
      unitRef="U_USD">452439000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_0b36cb54-8c22-4ea9-ade6-047ee62aed3e"
      unitRef="U_USD">426389000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_d91f967a-8214-4270-83da-f62d97f8b55c"
      unitRef="U_USD">292880000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_e9d24088-f2cf-4e37-96c6-e2df73a56eac"
      unitRef="U_USD">286283000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_249aa5ab-d480-4480-8dfc-09aad8ca9ee9"
      unitRef="U_USD">745368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_f9bf5180-9f15-4086-9782-7603d5aadce4"
      unitRef="U_USD">712720000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_fa0de7f6-ae67-424f-a511-aeb904d8d40f"
      unitRef="U_USD">5071000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_c2f938eb-f4a0-411c-9822-a0dc57af9dd7"
      unitRef="U_USD">4006000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_6fb4b890-c859-4730-9834-20f099b39bb3"
      unitRef="U_USD">750439000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_4262560f-8e13-4ab9-87b8-dfb5cb84cf3b"
      unitRef="U_USD">716726000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a7b520a0-adc7-4eb2-8cac-da9c4ce0c114"
      unitRef="U_USD">1331256000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_31ddb3db-10a7-4967-9c40-dc57ddfd4b0f"
      unitRef="U_USD">1354894000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Assets
      contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4"
      decimals="-5"
      id="F_e774d8a6-1ca0-454d-8a66-2f6b6094debf"
      unitRef="U_USD">678100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8"
      decimals="-5"
      id="F_d919e4d3-907a-42df-ae53-171315784140"
      unitRef="U_USD">712300000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4"
      decimals="-5"
      id="F_e82bc556-6036-4ed3-8f2f-80e0d59fdf99"
      unitRef="U_USD">212100000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8"
      decimals="-5"
      id="F_b6f34696-9301-4469-bcf7-1257e936f6f6"
      unitRef="U_USD">207900000</us-gaap:Liabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4"
      decimals="-5"
      id="F_bc209b8d-0e7f-41ff-b3e5-b4a6e4cd4d37"
      unitRef="U_USD">190200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherLiabilities
      contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4"
      decimals="-5"
      id="F_e3ce3138-139a-4408-89c3-29049931c274"
      unitRef="U_USD">4500000</us-gaap:OtherLiabilities>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8"
      decimals="-5"
      id="F_a846b54e-7d99-4da5-876e-cb5325d45219"
      unitRef="U_USD">224900000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:OtherLiabilities
      contextRef="C_379e6a73-d6bc-454e-977a-efe6b3426bf8"
      decimals="-5"
      id="F_931f02f0-4b30-448d-b9ca-605b2b0001a0"
      unitRef="U_USD">48100000</us-gaap:OtherLiabilities>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b57351e9-49af-4f6a-a532-91fd8bca805e"
      decimals="-3"
      id="F_ab539edf-c6d6-4f3b-bcd6-e2053e45809f"
      unitRef="U_USD">583963000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_17704f66-45bd-4b7c-af28-dd048a5f2457"
      decimals="-3"
      id="F_b0d2c6ba-4f37-467b-83ca-d665125c5f9e"
      unitRef="U_USD">365910000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8c0c24cf-629d-468f-990d-739224e84719"
      decimals="-3"
      id="F_c00c6cb2-e2a9-455e-b002-a08e7c184137"
      unitRef="U_USD">14491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a7e4265c-f495-4ea8-9abe-63aa02dd47c3"
      decimals="-3"
      id="F_26514644-2f83-463e-9c8d-e9a613295e99"
      unitRef="U_USD">17377000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_abd1bb36-649a-4b3f-b313-b8879975169d"
      decimals="-3"
      id="F_3c8c4132-cf70-438f-913b-0ceb6dd95625"
      unitRef="U_USD">2310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_625b04f5-8205-44a5-ae85-4037620ce1b3"
      decimals="-3"
      id="F_f03f5d97-7123-47fc-aaa5-f4ed77484d47"
      unitRef="U_USD">4078000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_70877b65-4861-4b51-a656-f2212a0647a5"
      decimals="-3"
      id="F_390ba0c2-9526-44af-8da8-13eb42b24a22"
      unitRef="U_USD">14890000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_43074c34-b768-45ea-9ed8-9013bbb22b45"
      decimals="-3"
      id="F_ab29764b-9e1f-4c95-b565-d4f0aeafa91b"
      unitRef="U_USD">15937000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2814e1a2-ab63-418d-b63e-dbd2d3f1801d"
      decimals="-3"
      id="F_9621a4cc-9247-42c5-b9a6-c8ec73054593"
      unitRef="U_USD">4736000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d03830d6-ceb5-4d30-91b3-d682fd7848fb"
      decimals="-3"
      id="F_99dadea4-7a00-4b2f-9b82-10ebea3794d0"
      unitRef="U_USD">1054000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_1d025724-1ad5-49d8-96d2-fb579a5ff686"
      unitRef="U_USD">620390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_5ec336ea-82a4-44b7-a392-d2c08303ce63"
      unitRef="U_USD">404356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_e7d4f16c-f517-4fd0-8642-6745c2d2bd13"
      unitRef="U_USD">549061000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_06c28cda-a894-4c5b-b2dd-77be42e3ee2b"
      unitRef="U_USD">330399000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_1f050e36-f5c9-4bf1-8757-5f382f49e0ef"
      unitRef="U_USD">43897000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_21f25613-2e1e-44b0-aa11-e3cd9adc20c4"
      unitRef="U_USD">38722000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_001755b0-38ca-41d5-b6b8-cd608489c8c1"
      unitRef="U_USD">6849000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_3220a1f0-b109-40c2-94a9-5f83e8f84647"
      unitRef="U_USD">5096000</us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7f5ca191-f4e5-49dd-b59f-8eaa5aed83ad"
      unitRef="U_USD">599807000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2fce7af5-db64-4776-b8a5-07e899ba50de"
      unitRef="U_USD">374217000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_420d21e7-8dd6-4e50-89e8-816194fd9fda"
      unitRef="U_USD">20583000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e9167dee-b33f-4b2b-98fe-d87a78e0cba5"
      unitRef="U_USD">30139000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_cf906f49-1cc2-4d59-b2ae-dde1e262e72e"
      unitRef="U_USD">-867000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_15c67ade-6adc-41f1-8034-42db7e4eb252"
      unitRef="U_USD">632000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InterestExpenseNonoperating
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_31559849-f1ea-43db-891a-8d5168cc8725"
      unitRef="U_USD">7308000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_69d0dd95-d404-46f2-a4ae-40d397b8e7c1"
      unitRef="U_USD">7585000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_32766688-4969-45d5-917c-9c198e547639"
      unitRef="U_USD">2312000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_8867c887-bda0-4fc8-bbaf-ef9df6f6adbc"
      unitRef="U_USD">3996000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_9fb11999-ba86-4c6a-9500-6b86f4e7c4b8"
      unitRef="U_USD">-44000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_53f69cb7-0c68-4b74-9186-7fc1b9c6dad5"
      unitRef="U_USD">1099000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_09623a5f-5906-4328-b09e-c0621c3c46c3"
      unitRef="U_USD">-5072000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_b5551a82-7018-42bb-9731-d7c5deca0c67"
      unitRef="U_USD">-4277000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_25dac64d-9e40-4d83-9aff-81f313609df2"
      unitRef="U_USD">-10979000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_1cfec470-9f03-47cf-9fd2-fd9abaec24dd"
      unitRef="U_USD">-6135000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_1450c56f-4c41-4ee2-b3de-0279eb4ceb6f"
      unitRef="U_USD">9604000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_10c01e6e-81e5-43d8-9461-9922e1becee0"
      unitRef="U_USD">24004000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_58264a1b-aee5-4602-afd8-1efd612770de"
      unitRef="U_USD">3383000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_5de1b1b8-a430-4967-b397-210ab8bfd7a6"
      unitRef="U_USD">7142000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_138d3184-c9a7-47e6-9d94-7795af279a53"
      unitRef="U_USD">6221000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_bdae3e93-c549-487a-8101-7f2b77922537"
      unitRef="U_USD">16862000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_49b9ef3c-1cdf-4c7e-ba7d-0ca8c6d5e068"
      unitRef="U_USD">-471000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e5963a77-7fa7-4b7d-a95c-dbff10b4e920"
      unitRef="U_USD">2027000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_35c555c2-51f9-4068-a585-bfd0a602f1f4"
      unitRef="U_USD">6692000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_543d0035-8567-4e5f-a5a4-08aa0c2ee1af"
      unitRef="U_USD">14835000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="2"
      id="F_1544e84c-5a9b-4ba1-9a8f-b9bd77192304"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_a94f5a43-33ce-493f-a66c-9adb99d44390"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="2"
      id="F_3f52787d-9a4d-418d-95dd-848bb9557000"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_5259718d-9a7a-4dee-a7ce-73fd3a54bd5e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_8243a6ab-ccef-4b27-a5e5-fc7c8cc5d6bf"
      decimals="-3"
      id="F_351abcc8-ca9e-4b74-b195-82ce5aab6aa0"
      unitRef="U_USD">-202558000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f"
      decimals="INF"
      id="F_d3bdb4bc-937d-4b52-b073-f72df8ebd940"
      unitRef="U_shares">47929872</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0e29cd57-1e51-44dd-a99c-43fb2bf5a37f"
      decimals="-3"
      id="F_3883d049-f7f7-4f3c-b20e-bcdeae0962ae"
      unitRef="U_USD">48000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_61b01747-808d-4a48-a5cf-a6bdc4b2b455"
      decimals="-3"
      id="F_f17f710e-31d4-441b-93c9-9329f04af848"
      unitRef="U_USD">426389000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_fd421a2b-dd0d-4238-b483-99535258a1cf"
      decimals="-3"
      id="F_eae452ba-3691-47b8-8b57-481aea20ad58"
      unitRef="U_USD">286283000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_c4024cc1-119f-4d5f-ae31-02955c23c53f"
      decimals="-3"
      id="F_b0219b2d-16f4-4e32-92d7-9c386139dcc3"
      unitRef="U_USD">4006000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_04f7c596-9d84-489f-9815-5f75469f918a"
      unitRef="U_USD">716726000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7"
      decimals="-3"
      id="F_0a3be08a-9e24-493a-8992-ea84b635884f"
      unitRef="U_USD">-1564000</us-gaap:TemporaryEquityNetIncome>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e"
      decimals="-3"
      id="F_2b0968b9-1a55-4763-8075-c779f18853a1"
      unitRef="U_USD">6692000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_ea90d243-5c67-40e3-a543-1955b487feeb"
      decimals="-3"
      id="F_6fff54f8-5c34-470f-8562-8d2e34712b66"
      unitRef="U_USD">1093000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_0e2528d0-0c3f-4e22-9fbf-631cc28fbf2e"
      unitRef="U_USD">7785000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="C_ea90d243-5c67-40e3-a543-1955b487feeb"
      decimals="-3"
      id="F_3bf0fde8-703d-42c7-8fcb-2009509fd14e"
      unitRef="U_USD">28000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_3d85dcf1-cc72-4c3b-b62c-b1a8bcabf7c9"
      unitRef="U_USD">28000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55"
      decimals="INF"
      id="F_0ebeb762-cc96-441a-96be-17db233cdc1d"
      unitRef="U_shares">388173</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <asth:SharesIssuedForVestingOfRestrictedStockAwards
      contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55"
      decimals="-3"
      id="F_a692072d-30c3-476e-8f02-c61ee7d9671d"
      unitRef="U_USD">1000</asth:SharesIssuedForVestingOfRestrictedStockAwards>
    <asth:SharesIssuedForVestingOfRestrictedStockAwards
      contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f"
      decimals="-3"
      id="F_487f3faa-b817-4ad3-aa6f-f390d287fb79"
      unitRef="U_USD">-4053000</asth:SharesIssuedForVestingOfRestrictedStockAwards>
    <asth:SharesIssuedForVestingOfRestrictedStockAwards
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_0adf4ec9-50a0-4379-9b6f-b7889285c3cc"
      unitRef="U_USD">-4052000</asth:SharesIssuedForVestingOfRestrictedStockAwards>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7"
      decimals="-3"
      id="F_019a2bd2-a217-499e-aa3f-0e9636ad3526"
      unitRef="U_USD">1316000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f"
      decimals="-3"
      id="F_0cb56820-6891-4cdc-9706-635a429eec1d"
      unitRef="U_USD">7867000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_26bec014-6ede-411f-a80e-4582cd50e1bc"
      unitRef="U_USD">7867000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55"
      decimals="INF"
      id="F_41844e05-e020-4bfc-bafb-024a62a6efd6"
      unitRef="U_shares">10683</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f"
      decimals="-3"
      id="F_2ad7a852-1ba0-45b9-a112-1377b6b2dd24"
      unitRef="U_USD">301000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_849370d3-3196-42e4-ac33-0ed07de33f59"
      unitRef="U_USD">301000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:TemporaryEquityAccretionOfDividends
      contextRef="C_c1ce8299-59df-40e0-ae9d-bc415c0cfae7"
      decimals="-3"
      id="F_88e8823f-d43c-41a0-a6a2-347cbd9b22e9"
      unitRef="U_USD">-27295000</us-gaap:TemporaryEquityAccretionOfDividends>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares
      contextRef="C_c63056ce-4e34-415d-bc81-ec89ac8aef55"
      decimals="INF"
      id="F_b3d166fc-71e8-4b56-9740-19f5968eb9a0"
      unitRef="U_shares">699896</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodSharesReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares
      contextRef="C_7207eb90-6e38-4c0b-adf2-11627269267f"
      decimals="-3"
      id="F_888cd53d-a87f-4a80-9b3d-52793fa06533"
      unitRef="U_USD">-21935000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares
      contextRef="C_5f0b2113-0a70-4397-8c31-1fb2c721da4e"
      decimals="-3"
      id="F_01efa4de-a956-4c15-8c3a-7a14044e763a"
      unitRef="U_USD">95000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_01592a62-ddf3-4276-932e-1234b6bf9965"
      unitRef="U_USD">-21840000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_56bfe089-97e1-4466-af03-ff2f279f2e29"
      decimals="-3"
      id="F_5b87abc3-412d-41fc-89f7-8b4f11d93917"
      unitRef="U_USD">-232733000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3"
      decimals="INF"
      id="F_3cd50716-bc1c-453d-b239-63565757502a"
      unitRef="U_shares">49028624</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_6d1a5d79-d5ca-4fe0-8439-4247e1116dd3"
      decimals="-3"
      id="F_e36b74de-a5de-4424-b4cf-dc42d54811d5"
      unitRef="U_USD">49000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_af055ce3-c87f-4637-a806-c95905a23203"
      decimals="-3"
      id="F_5c078ef6-edd1-4dae-a651-4783682d46de"
      unitRef="U_USD">452439000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_2f80e474-09c5-4498-a350-2d08cecdfc30"
      decimals="-3"
      id="F_0c808bdc-b6af-4fa6-bd18-a22c1e3e623f"
      unitRef="U_USD">292880000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_1a4f7a0c-078b-46b3-a572-4429ae7dc5bf"
      decimals="-3"
      id="F_07f0594f-2c21-4ecf-9c23-9484afc7686d"
      unitRef="U_USD">5071000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_b79ab2ea-9ef2-4121-ad0b-4ad7d2b81d33"
      unitRef="U_USD">750439000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_8ada5766-cd70-45e8-a299-c4904c89c0e1"
      decimals="-3"
      id="F_63f7abd1-116a-414f-b79e-c0345e851e5a"
      unitRef="U_USD">-205883000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439"
      decimals="INF"
      id="F_6f641717-abd7-4809-a1f5-5fe1df85b1e3"
      unitRef="U_shares">46843743</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_f4f271be-0a9d-4c38-ad4a-40dcd2fe3439"
      decimals="-3"
      id="F_41fb4278-975a-4ac3-b8de-e58ca25f9650"
      unitRef="U_USD">47000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_087d9c30-c670-47d7-b3cc-1831b12e4e0a"
      decimals="-3"
      id="F_3530213b-6bce-4ea4-88e3-c60a07395330"
      unitRef="U_USD">371037000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_6ecdd9eb-4e61-4714-82a4-da270a6dfb36"
      decimals="-3"
      id="F_b29fb42b-c40d-4e9d-a84e-0b045f5ade2f"
      unitRef="U_USD">243134000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_3ff71d2b-ebbc-4683-8c33-29859e53eefe"
      decimals="-3"
      id="F_55b7f2b2-e835-41f1-afdd-42de9b39afe8"
      unitRef="U_USD">2433000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0"
      decimals="-3"
      id="F_4987ebf6-1121-4184-9ac3-0b8f28f2bd01"
      unitRef="U_USD">616651000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="C_36e16046-d6d5-4ac8-87fa-8e331f7c735a"
      decimals="-3"
      id="F_329ea8b8-d243-49a2-a6f0-db668ba440e4"
      unitRef="U_USD">326000</us-gaap:TemporaryEquityNetIncome>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_86a4c592-7bab-4c59-bf8a-cfdcf0ecc6d0"
      decimals="-3"
      id="F_2bf617bc-1c9e-4d3e-99e6-71391666aca1"
      unitRef="U_USD">14835000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"
      decimals="-3"
      id="F_98e39c72-9a58-4458-83b5-0c2b1336bd49"
      unitRef="U_USD">1701000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_972ed63f-f913-4c21-aba8-c949038b5b3f"
      unitRef="U_USD">16536000</asth:NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"
      decimals="-3"
      id="F_e6595aab-897c-46e1-9d50-f54e9c076ea8"
      unitRef="U_USD">25000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_6698b1d6-ec3c-414a-90c6-83043bfea434"
      unitRef="U_USD">25000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"
      decimals="-3"
      id="F_9aa24410-db75-4d44-b905-5eb406a007dc"
      unitRef="U_USD">150000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_b9670550-35fd-4edc-9899-045ec75f2d8f"
      unitRef="U_USD">150000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c"
      decimals="INF"
      id="F_4bc13b81-45cd-47d8-998d-da21aa4d710b"
      unitRef="U_shares">5149</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <asth:SharesIssuedForVestingOfRestrictedStockAwards
      contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199"
      decimals="-3"
      id="F_1d29ec02-96df-45bb-a28f-4fcfc79e6de9"
      unitRef="U_USD">-2407000</asth:SharesIssuedForVestingOfRestrictedStockAwards>
    <asth:SharesIssuedForVestingOfRestrictedStockAwards
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e6c6696b-9d74-492a-8879-088ccd3db41b"
      unitRef="U_USD">-2407000</asth:SharesIssuedForVestingOfRestrictedStockAwards>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199"
      decimals="-3"
      id="F_5442c047-fc69-43c5-b941-9331e5a660d8"
      unitRef="U_USD">5748000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_991e0231-79ba-4913-8038-b22f4f0f5a60"
      unitRef="U_USD">5748000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c"
      decimals="INF"
      id="F_186bfa23-5655-4e8f-81c8-5e19ee56bbfa"
      unitRef="U_shares">631712</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c"
      decimals="-3"
      id="F_999d9f51-a2c6-4bd1-a2f8-e5a0e99a207e"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199"
      decimals="-3"
      id="F_d5f21be7-8ce5-4eac-8302-bdd9d4e7453b"
      unitRef="U_USD">21951000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_87099183-9824-4266-87ec-0d8908d252cd"
      unitRef="U_USD">21952000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <asth:AcquisitionOfNonControllingInterestShares
      contextRef="C_ca845960-39f0-4a22-b0a8-870c481d2a9c"
      decimals="INF"
      id="F_99aec90f-a5b4-44a0-83a7-6eb79c26ed5b"
      unitRef="U_shares">22340</asth:AcquisitionOfNonControllingInterestShares>
    <asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination
      contextRef="C_4ea4ff21-9e17-4ead-8c4a-72b1d974b199"
      decimals="-3"
      id="F_a40219e9-036d-48e5-a7b5-c3fe6661efca"
      unitRef="U_USD">856000</asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination>
    <asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination
      contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"
      decimals="-3"
      id="F_20da1691-3363-494d-b90d-52e4d3141202"
      unitRef="U_USD">-321000</asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination>
    <asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_57629ecc-97fa-4598-8dd8-f0093b74d136"
      unitRef="U_USD">535000</asth:NoncontrollingInterestIncreaseDecreaseFromBusinessCombination>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares
      contextRef="C_9b477a38-5c45-45e4-b070-7aed8bfccd24"
      decimals="-3"
      id="F_3a75b707-72b9-4da7-9d51-b9fb54d9051a"
      unitRef="U_USD">95000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_1ed08265-51ef-4f32-b345-c0e834ac8f25"
      unitRef="U_USD">95000</asth:NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="C_3bad1aa8-8683-4fde-8415-afca6a2c5cdb"
      decimals="-3"
      id="F_8163bbf0-7c3a-4db5-94ab-afa060ddf8a2"
      unitRef="U_USD">-205557000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:SharesOutstanding
      contextRef="C_b0e202af-bc90-4be3-a147-eec79b8a2bef"
      decimals="INF"
      id="F_dc0d8638-ae0e-4019-b679-9019d167243b"
      unitRef="U_shares">47458264</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_b0e202af-bc90-4be3-a147-eec79b8a2bef"
      decimals="-3"
      id="F_438703b3-e967-406a-a61c-f695477b8ea4"
      unitRef="U_USD">48000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_9bb5d082-e558-46fe-93e8-c3308bb50e45"
      decimals="-3"
      id="F_8cb139f3-6623-47a7-9b7a-6301a5d4faaf"
      unitRef="U_USD">395473000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_4620cbd3-1893-4a0c-9d80-94c7c2d51650"
      decimals="-3"
      id="F_4e90929a-b2e0-4211-a752-786dd67d2cfe"
      unitRef="U_USD">257969000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_ed9a6b0a-2f21-4044-9c6e-5d6fe11bd1cf"
      decimals="-3"
      id="F_0f4ce85a-cdee-4eab-9c66-dff6ccc76db0"
      unitRef="U_USD">4485000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_57a6ead4-feb0-45b4-9af1-cd3730f7a3cc"
      unitRef="U_USD">657975000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_3dd80437-6ca6-4655-a2b2-b9e1ccff94d4"
      unitRef="U_USD">6221000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_135286d0-7ebd-4636-8607-509c8c2518df"
      unitRef="U_USD">16862000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_a7d2a5c0-8ee3-4f3f-81ce-ecf41b7c7ccf"
      unitRef="U_USD">6849000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_fc947375-f4db-4974-8d1d-bf9511e517d7"
      unitRef="U_USD">5096000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_b05e5666-0948-479c-bbcf-50bf52fa0ca8"
      unitRef="U_USD">691000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_d686d418-0394-486f-832b-cc0b1cdaf7df"
      unitRef="U_USD">458000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ShareBasedCompensation
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_a8b4fe80-eb5e-42a5-9ced-31de73f694ef"
      unitRef="U_USD">7811000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_32dff704-e81c-432e-9a34-15d54aa9e72a"
      unitRef="U_USD">5748000</us-gaap:ShareBasedCompensation>
    <asth:NoncashLeaseExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_8ad83b54-1dbe-4554-b2c5-6b9fda3a129b"
      unitRef="U_USD">1287000</asth:NoncashLeaseExpense>
    <asth:NoncashLeaseExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_0800c566-6133-4976-8096-dd33e0a45b60"
      unitRef="U_USD">3155000</asth:NoncashLeaseExpense>
    <asth:ChangeInFairValueOfContingentConsiderationLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_685e33e1-f1c4-43b5-a9cf-f89e6992be01"
      unitRef="U_USD">1407000</asth:ChangeInFairValueOfContingentConsiderationLiabilities>
    <asth:ChangeInFairValueOfContingentConsiderationLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_5c1893f7-4ca2-4906-b60d-940900a19983"
      unitRef="U_USD">0</asth:ChangeInFairValueOfContingentConsiderationLiabilities>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_59cf6c1f-ce5a-41bc-bdd4-436835654ee8"
      unitRef="U_USD">-375000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_228e181e-911a-4faa-83c3-d3e72b7e12c4"
      unitRef="U_USD">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <asth:UnrealizedGainLossFromInvestmentInEquitySecurities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_5593dc2d-613e-48d2-8b90-290e312d673f"
      unitRef="U_USD">-44000</asth:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <asth:UnrealizedGainLossFromInvestmentInEquitySecurities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_d4934c1f-ae3c-4d4d-bb9f-d6c42ca7347d"
      unitRef="U_USD">1099000</asth:UnrealizedGainLossFromInvestmentInEquitySecurities>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_9835e312-80f3-447a-977f-f7f53802264f"
      unitRef="U_USD">-867000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_032a3426-59e2-4a6f-b872-3741965b9217"
      unitRef="U_USD">632000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_a5632009-5ed1-4cdd-ae0d-1226904d23b1"
      unitRef="U_USD">-358000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_4a46794e-042d-4250-9e0f-d444889a8853"
      unitRef="U_USD">-7248000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <asth:ProceedsPaymentsFromOtherOperatingActivities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_aed32e12-b45c-41ea-a2b7-2176ce73dbfe"
      unitRef="U_USD">-557000</asth:ProceedsPaymentsFromOtherOperatingActivities>
    <asth:ProceedsPaymentsFromOtherOperatingActivities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_a5a5c52b-9c7f-4a0f-9b5d-3e4414d6aef5"
      unitRef="U_USD">6795000</asth:ProceedsPaymentsFromOtherOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_36c341dd-c083-47aa-b131-70dfc4809012"
      unitRef="U_USD">10368000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_b0b90830-26e3-41eb-8993-f78d14795e3c"
      unitRef="U_USD">26128000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2fc1b011-30a6-40be-ad33-acf13b65f301"
      unitRef="U_USD">6589000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_29f4c2a5-1ce8-4cf4-ba99-1947bd6b142e"
      unitRef="U_USD">3374000</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_dc6aa8ea-4304-45ed-90e6-2c1760562608"
      unitRef="U_USD">-3688000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_a98fb2cb-f034-47c8-bf33-971732fc1911"
      unitRef="U_USD">1403000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_486d67a7-dd5c-48c5-9b1e-1cf15978a66f"
      unitRef="U_USD">-2674000</asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2b61d482-8233-4650-a346-8240c11f9526"
      unitRef="U_USD">4255000</asth:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_fff54b26-fea4-4573-a714-8d3ecee9c0f5"
      unitRef="U_USD">314000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_ef1d8e34-6739-418c-afb2-c79e053027a9"
      unitRef="U_USD">-92000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_bea2f10a-0eb6-446e-8c52-cf2c45c7aeb0"
      unitRef="U_USD">8000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_6758377e-b79e-44f3-b249-7e2dc33dd22f"
      unitRef="U_USD">905000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_c2860cd1-4282-4459-b97d-f044eef029ea"
      unitRef="U_USD">-3383000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherAccountsPayable
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_72fb776f-074d-4481-ae4b-20247aefb1a6"
      unitRef="U_USD">56000</us-gaap:IncreaseDecreaseInOtherAccountsPayable>
    <asth:IncreaseDecreaseInMedicalLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_d7c8eb39-92d8-4656-98dc-943bc614e6d8"
      unitRef="U_USD">3319000</asth:IncreaseDecreaseInMedicalLiabilities>
    <asth:IncreaseDecreaseInMedicalLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_d9268c9e-1c8f-4ece-b59f-d46d440b5c2d"
      unitRef="U_USD">-808000</asth:IncreaseDecreaseInMedicalLiabilities>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2b2aac2f-662f-4031-b628-7489715727ad"
      unitRef="U_USD">-3514000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInIncomeTaxesReceivable
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_f84dc559-3387-4fd8-8560-6725672cdc4b"
      unitRef="U_USD">-14542000</us-gaap:IncreaseDecreaseInIncomeTaxesReceivable>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_c6431c84-07c9-4be1-8dd0-57175a8113df"
      unitRef="U_USD">-1090000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_17496f33-f939-4fa9-b8ee-dc341ef622f1"
      unitRef="U_USD">-3083000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_887f37f5-105b-4a62-aeb6-f75a12b85860"
      unitRef="U_USD">531000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_d08ea1a6-ec48-4c36-8857-e630165eac83"
      unitRef="U_USD">298000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_d9c84a5b-8919-41d2-a76b-dfd34876f2f1"
      unitRef="U_USD">16627000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_c5f1b48b-31c9-4088-9122-43a1b9f940e8"
      unitRef="U_USD">5977000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_9fde0019-959a-48e9-b63f-8d64afbd2cd6"
      unitRef="U_USD">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_36e1fe20-c793-44cf-bec0-3cf87c524be5"
      unitRef="U_USD">50649000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_b9c5642a-0ed5-4b74-8f0a-705237a43792"
      unitRef="U_USD">600000</asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties>
    <asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_065d5acf-c2f3-4787-ba52-848ea920a938"
      unitRef="U_USD">6000</asth:ProceedsFromRepaymentOfPromissoryNotesIncludingRelatedParties>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_6359b168-2f1c-4f55-a47a-2624d6876def"
      unitRef="U_USD">24000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_efecc4fd-3eaa-42da-bec0-e7a506a704d8"
      unitRef="U_USD">27000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsForProceedsFromLoansReceivable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_9299c484-e3e1-4be0-8210-754ef95c3d7d"
      unitRef="U_USD">0</us-gaap:PaymentsForProceedsFromLoansReceivable>
    <us-gaap:PaymentsForProceedsFromLoansReceivable
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e8a96ff7-2388-43be-9b0b-2cee8267f1ba"
      unitRef="U_USD">20000000</us-gaap:PaymentsForProceedsFromLoansReceivable>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_e077a8ae-010f-4859-87ab-88564fce28de"
      unitRef="U_USD">3070000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_6efa31e3-7ad8-4662-844d-9d3f9aa7b3fd"
      unitRef="U_USD">369000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_259f69b4-f508-4458-8b57-456c29f8f603"
      unitRef="U_USD">100000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_9fe1317b-39e9-463f-90ff-887b3ce1c601"
      unitRef="U_USD">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_cf6cdcf0-3a78-4cd1-80f3-2cee0ad199be"
      unitRef="U_USD">-2394000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_99e01cda-dd29-4169-84fe-e6043e258ec5"
      unitRef="U_USD">-71039000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_155f2347-1c00-4b56-8585-99f07634bf5c"
      unitRef="U_USD">5455000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_d371c1d6-e54f-4754-9e71-b9b46ac21e05"
      unitRef="U_USD">95000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_ce3ce7cb-9ea9-4d68-8e6b-e20706a5896f"
      unitRef="U_USD">412000000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_41ee47c6-37e3-401b-a473-4194a9421096"
      unitRef="U_USD">110000000</us-gaap:ProceedsFromIssuanceOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2a965e19-c398-425d-a906-8a4d6fe82537"
      unitRef="U_USD">428232000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_c625852a-635c-483c-aa02-bb1974fbcc9b"
      unitRef="U_USD">3500000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_62eafb1f-eaa7-48e4-af0d-bd314a908635"
      unitRef="U_USD">147000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_6858e9aa-2e85-456a-9671-556a5a05ff15"
      unitRef="U_USD">179000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_bd800177-3921-46c8-87ed-1ab456b2e18e"
      unitRef="U_USD">17241000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_7d81e7f0-63f7-491d-9aa1-65b3ba31762c"
      unitRef="U_USD">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_227b0ba0-c60a-4b20-9d5e-2bf0e14e05e2"
      unitRef="U_USD">301000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_c8987854-8dde-40e0-b447-bd9841de9b2e"
      unitRef="U_USD">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_68fce2b4-eb02-41b5-9eef-888f846eecf4"
      unitRef="U_USD">4052000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_7b45ab5d-be3c-435e-8c68-02156a1d416b"
      unitRef="U_USD">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_33e49205-8035-4345-8068-bfdd7d32e181"
      unitRef="U_USD">1316000</asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities>
    <asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_9adb03b8-82ca-49fb-9003-1ffd0fd23ba7"
      unitRef="U_USD">0</asth:PaymentForRepurchaseOfTreasuryStockFinancingActivities>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_1a5cb29d-a621-4b47-ae55-284c97ebe12e"
      unitRef="U_USD">0</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromPaymentsToMinorityShareholders
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_4e977f82-10cf-48c0-ab6f-08c2e578720d"
      unitRef="U_USD">150000</us-gaap:ProceedsFromPaymentsToMinorityShareholders>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_0f628ca1-6148-4e9d-952c-a608d4347390"
      unitRef="U_USD">28000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_8ef0a426-b212-46bc-9ba8-373e9704649f"
      unitRef="U_USD">25000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_dd881de1-fbe5-4282-a6b5-7e5c0c1f0ee9"
      unitRef="U_USD">-44170000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_273b3e13-50f1-4e68-a8e8-c54c440775bb"
      unitRef="U_USD">106351000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_b6a0b891-c064-4562-bced-1f8aca610c3c"
      unitRef="U_USD">-29937000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_8b3e095b-6656-4ee7-8418-778b19bf873f"
      unitRef="U_USD">41289000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_6739108b-4670-4490-9c06-129c86ef0a73"
      unitRef="U_USD">289101000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0"
      decimals="-3"
      id="F_0e82728d-a2aa-43d0-94d5-7d95296aa7ee"
      unitRef="U_USD">294152000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_4509f15e-c81d-43ad-b495-b55fc16f09c2"
      unitRef="U_USD">259164000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_d4631b88-67e0-4517-94d3-3d613410344f"
      unitRef="U_USD">335441000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_8952804f-eeb2-4edf-8115-750a04dc9b4a"
      unitRef="U_USD">4338000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2849a4d0-3ed6-49d8-af34-2469252a014e"
      unitRef="U_USD">194000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_b2d53ac4-f978-499f-ad13-5d0a6f67d559"
      unitRef="U_USD">7360000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_eaa1755f-1816-496f-872b-3a71140483fc"
      unitRef="U_USD">6430000</us-gaap:InterestPaidNet>
    <asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_6b78c700-6b2f-4bf9-b0ec-1ade89251f7f"
      unitRef="U_USD">0</asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities>
    <asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e62aa25a-429a-4ff2-baf7-23f8ea103e5f"
      unitRef="U_USD">63935000</asth:BusinessAcquisitionInAccountsPayableAndAccruedLiabilities>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_5a7741e2-19ad-4537-b15d-854525b1a5a5"
      unitRef="U_USD">5729000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_ceec2258-4db5-4736-8906-1bad3b1bac29"
      unitRef="U_USD">4910000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:StockIssued1
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_22c16f3b-cfd6-436c-86c1-122ce74464ca"
      unitRef="U_USD">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_9f7518c5-73ac-4924-a221-8f3583a63f87"
      unitRef="U_USD">21952000</us-gaap:StockIssued1>
    <asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_0861ee15-5152-450a-8ead-89bb4bd114c6"
      unitRef="U_USD">0</asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities>
    <asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_48485bdb-1b20-4364-ac0a-dd7c5ded8106"
      unitRef="U_USD">9487000</asth:PurchaseOfInvestmentsEquityMethodInAccountsPayableAndAccruedLiabilitiesAndOtherLiabilities>
    <asth:DrawOnLetterOfCreditThroughRevolverLoan
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_3314681d-9914-400a-8415-d2bf9d9f55a8"
      unitRef="U_USD">0</asth:DrawOnLetterOfCreditThroughRevolverLoan>
    <asth:DrawOnLetterOfCreditThroughRevolverLoan
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2efda3d4-5fcb-4286-b46c-34b1d16de714"
      unitRef="U_USD">4759000</asth:DrawOnLetterOfCreditThroughRevolverLoan>
    <asth:NonCashDividendPaidInFormOfStock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_11a7279e-d921-48a3-b6cf-9fc314bcb2a4"
      unitRef="U_USD">21935000</asth:NonCashDividendPaidInFormOfStock>
    <asth:NonCashDividendPaidInFormOfStock
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_7e505729-d69f-4b55-86a8-933b15972742"
      unitRef="U_USD">0</asth:NonCashDividendPaidInFormOfStock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5a811968-73ea-4efe-bbac-152703f2960f"
      unitRef="U_USD">258517000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_2ca09f3d-f86f-489c-99fe-943c4a446d6c"
      unitRef="U_USD">334796000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_6ccfa33c-1742-4f30-ae3f-3d019ffa8016"
      unitRef="U_USD">647000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_fe30c004-5b98-4d7a-85a4-e2d3ca413ca9"
      unitRef="U_USD">645000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_d3b8a69b-4054-4085-8854-d576a0306346"
      unitRef="U_USD">259164000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_b9a7c2b4-8209-43ca-aed3-18cd74cb290f"
      unitRef="U_USD">335441000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NatureOfOperations
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_ea7cf9fe-215c-42bc-af29-b4685c284920">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;1.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Overview&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unless the context dictates otherwise, references in these notes to the financial statements to the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; and similar words are references to Astrana Health, Inc. (&#x201c;Astrana&#x201d;) and its consolidated subsidiaries and affiliated entities, as appropriate, including its consolidated variable interest entities (&#x201c;VIEs&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Headquartered in Alhambra, California, Astrana is a leading provider-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner. Together with Astrana&#x2019;s affiliated physician groups and consolidated subsidiaries and VIEs, the Company provides value-based Care Enablement services and Care Delivery with its consolidated Care Partners to serve patients of whom the majority are covered by private or public insurance provided through Medicare, Medicaid, and health maintenance organizations (&#x201c;HMOs&#x201d;), with a small portion of its revenue coming from non-insured patients. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company&#x2019;s physician network consists of primary care physicians, specialist physicians, physician and specialist extenders, and hospitalists.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segments are Care Partners, Care Delivery, and Care Enablement, which are described as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Care Partners&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's Care Partners segment is focused on building and managing high-quality and high-performance provider networks by partnering with, empowering, and investing in strong provider partners aligned on a shared vision for coordinated care delivery. By leveraging the Company&#x2019;s unique Care Enablement platform and ability to recruit, empower, and incentivize physicians to manage total cost of care effectively, the Company is able to organize partnered providers into successful multi-payer, risk-bearing organizations that take on varying levels of risk based on total cost of care across membership in all lines of business, including Medicare Advantage, Medicaid, Commercial, Exchange, and Medicare fee for service (&#x201c;FFS&#x201d;). The Company&#x2019;s healthcare delivery entities consist of a network of risk-bearing organizations (&#x201c;RBOs&#x201d;) that encompass independent practice associations (&#x201c;IPAs&#x201d;), accountable care organizations (&#x201c;ACOs&#x201d;), and state-specific entities such as Restricted Knox-Keene licensed health plans in California. These entities are tasked with coordinating and providing high-quality care to patients within Astrana&#x2019;s ecosystem. This helps provide a seamless continuity of care among patients in different age groups, stages of life, and life circumstances. The Company participates in the Accountable Care Organization Realizing Equity, Access, and Community Health Model (&#x201c;ACO REACH&#x201d;), and in the Medicare Shared Savings Program (&#x201c;MSSP&#x201d;). The MSSP was created to promote accountability and improve care coordination  for Medicare beneficiaries.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Care Delivery&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s Care Delivery segment is a patient-centric, data-driven care delivery organization focused on delivering high-quality and accessible care to all patients. The Company&#x2019;s Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. This segment includes the following:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Primary care clinics, including post-acute care services;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Specialty care clinics and inpatient services, including cardiac care, endocrinology, and ophthalmology, as well as hospitalist and intensivist services; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:3.333%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.447919145106397%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Ancillary service providers, such as urgent care centers, outpatient imaging centers, ambulatory surgery centers, and full-service labs.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Care Enablement&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information, all powered by the Company&#x2019;s proprietary technology suite.  This platform enhances the delivery of high-quality, value-based care to patients and helps lead to superior clinical and financial outcomes. The Company provides solutions to payers and providers, including independent physicians, provider and medical groups, and ACOs.  The Company&#x2019;s platform meets providers and payers wherever they are on the spectrum of total cost of care, offering solutions for fee-for-service entities to providers open to taking upside and downside risks on professional and institutional spending, and across all patient types, including Medicare, Medicaid, Commercial, and Exchange patients. This segment includes the Company&#x2019;s wholly owned subsidiaries that operate as management services organizations (&#x201c;MSOs&#x201d;), which enter into long-term management and/or administrative services agreements with RBOs and other providers. By leveraging the Company&#x2019;s Care Enablement platform, providers and payers can improve their ability to deliver high-quality patient care and achieve better patient outcomes.&lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_dd0d7b15-14e8-4a6d-8d4a-bfa1164730da"
      unitRef="U_Segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_64333d48-f05e-467c-bc66-4dbf06bcaf8e">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;2.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying condensed consolidated balance sheet at December 31, 2024, has been derived from the Company&#x2019;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying unaudited condensed consolidated financial statements as of March 31, 2025, and for the three months ended March 31, 2025 and 2024, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025. In the opinion of management, all material adjustments (consisting of normal recurring adjustments as well as intercompany accounts and transactions, which have been eliminated) considered necessary for a fair presentation have been made to make the condensed consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, or any future periods.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, and the condensed consolidated statements of income for the three months ended March 31, 2025 and 2024, include Astrana&#x2019;s wholly owned subsidiaries and consolidated VIEs. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The unaudited condensed consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read, or have access to, our audited consolidated financial statements for the fiscal year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment assessment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including estimations of affiliated hospitals&#x2019; claims costs which involves assumptions for IBNR, such as utilization of healthcare services, historical payment patterns, cost trends, seasonality, changes in membership, and other factors), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Combinations&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination which are expensed as incurred.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains its cash in deposit accounts with several banks, which at times may exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents and restricted cash. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the Company&#x2019;s deposit accounts with banks exceeded the FDIC&#x2019;s insured limit by approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;266.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;332.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#x2019;s concentration of risk exposure.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Receivables, Receivables &#x2013; Related Parties, Other Receivables, and Loan Receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and fee-for-service receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated in the amount expected to be collected.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s loan receivables consist of promissory notes that accrue interest per annum and are recorded and stated at amortized cost plus accrued interest. Interest income is accrued based on the outstanding principal amounts. As of March 31, 2025, promissory notes are expected to be collected by their maturity dates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitation receivables relate to each health plan&#x2019;s capitation revenue and are usually received by the Company in the month following the month of service. Capitation receivables also include receivables from the Centers for Medicare and Medicaid Services (&#x201c;CMS&#x201d;) related to the Company&#x2019;s participation in the ACO REACH model. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s hospital shared-risk pool receivable, which is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months after the risk pool performance year is completed.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other receivables consist of amounts due from the seller associated with acquisitions, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains reserves for potential credit losses on the receivables. Management reviews the composition of the Company&#x2019;s receivables and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected, and adjustments are recorded when necessary. Reserves are recorded based on historical trends. Any change in such an estimate of reserves is recorded in the period when such change is identified.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided, and collection is reasonably likely to occur. The Company continuously monitors its receivables collections, and it expects that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risks&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts, as used by our chief operating decision makers (&#x201c;CODMs&#x201d;). The condensed consolidated statements of income present disaggregated revenue by service type. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents disaggregated revenue generated by each payer type &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(in thousands): &lt;br/&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicare&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;389,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;246,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicaid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;173,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other third parties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Less than 10% of total net revenues&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers that contributed to the following percentages of receivables, net, receivables &#x2013; related parties, and other receivables:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:64.527%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company receives payments from the following sources for services rendered:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Commercial insurers;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Federal government under the Medicare program administered by CMS;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;State governments under Medicaid and other programs;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other third-party payers (e.g., hospitals and IPAs); and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue primarily consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Risk pool settlements and incentives;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Management fee income; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;FFS revenue.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related collection risk for such services may vary by type of revenue and the customer.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses a recognition threshold of &#x201c;more-likely-than-not&#x201d; and a measurement attribute on all tax positions taken, or expected to be taken, in a tax return in order to be recognized in the condensed consolidated financial statements. Once the recognition threshold is met, the tax position is measured to determine the actual amount of benefit to recognize in the condensed consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d; to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning January 1, 2025, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a significant impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03 &#x201c;Income Statement &#x2014; Reporting Comprehensive Income &#x2014; Expense Disaggregation Disclosures (Subtopic 220-40)&#x201d; to provide disaggregated information about certain income statement costs and expenses. ASU 2024-03 is effective for the Company&#x2019;s annual periods beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other than the new standards discussed above, there have been no other recent accounting pronouncements not yet adopted that are expected to have significance, or potential significance, to the Company&#x2019;s financial position, results of operations, and cash flows.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_85b98b65-6f9e-43ce-8578-aedd2d023d7e">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The accompanying condensed consolidated balance sheet at December 31, 2024, has been derived from the Company&#x2019;s audited consolidated financial statements, but does not include all annual disclosures required by generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;). The accompanying unaudited condensed consolidated financial statements as of March 31, 2025, and for the three months ended March 31, 2025 and 2024, have been prepared in accordance with U.S. GAAP for interim financial statements and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes to the financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024, as filed with the SEC on March 14, 2025. In the opinion of management, all material adjustments (consisting of normal recurring adjustments as well as intercompany accounts and transactions, which have been eliminated) considered necessary for a fair presentation have been made to make the condensed consolidated financial statements not misleading, as required by Regulation S-X, Rule 10-01. Operating results for the three months ended March 31, 2025, are not necessarily indicative of the results that may be expected for the year ending December 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, or any future periods.&lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_3402a905-6eb8-4a8f-a437-def8d21aa4af">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Principles of Consolidation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, and the condensed consolidated statements of income for the three months ended March 31, 2025 and 2024, include Astrana&#x2019;s wholly owned subsidiaries and consolidated VIEs. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The unaudited condensed consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read, or have access to, our audited consolidated financial statements for the fiscal year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_45a400fc-8904-46df-95ce-aaded9ba3da9">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the condensed consolidated financial statements as well as the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include collectability of receivables, recoverability of long-lived and intangible assets, business combination and goodwill valuation and impairment assessment, accrual of medical liabilities (incurred but not reported (&#x201c;IBNR&#x201d;) claims), determination of hospital shared-risk and health plan shared-risk revenue and receivables (including estimations of affiliated hospitals&#x2019; claims costs which involves assumptions for IBNR, such as utilization of healthcare services, historical payment patterns, cost trends, seasonality, changes in membership, and other factors), income tax-valuation allowance, share-based compensation, and right-of-use assets and lease liabilities. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ materially from those estimates and assumptions.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_3a81edac-6ce1-48bf-8324-8804a2add196">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Business Combinations&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the acquisition method of accounting for all business combinations, which requires assets and liabilities of the acquiree to be recorded at fair value, to measure the fair value of the consideration transferred, including contingent consideration, to be determined on the acquisition date, and to account for acquisition-related costs separately from the business combination which are expensed as incurred.&lt;/span&gt;&lt;/p&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_de13ce27-c4e9-43bb-a968-05bf6c06ced6">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s cash and cash equivalents primarily consist of money market funds and certificates of deposit. The Company considers all highly liquid investments that are both readily convertible into known amounts of cash and mature within 90 days from their date of purchase to be cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains its cash in deposit accounts with several banks, which at times may exceed the insured limits of the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;). The Company believes it is not exposed to any significant credit risk with respect to its cash and cash equivalents and restricted cash. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the Company&#x2019;s deposit accounts with banks exceeded the FDIC&#x2019;s insured limit by approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;266.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;332.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The Company has not experienced any losses to date and performs ongoing evaluations of these financial institutions to limit the Company&#x2019;s concentration of risk exposure.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashUninsuredAmount
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_1022cd4b-56e1-4f5d-8c90-1bc59bca9ec9"
      unitRef="U_USD">266700000</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-5"
      id="F_e33d6aa3-928d-40aa-8f18-3367e82decad"
      unitRef="U_USD">332200000</us-gaap:CashUninsuredAmount>
    <asth:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_5e39fa57-c443-455b-be60-1ee23154469a">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Receivables, Receivables &#x2013; Related Parties, Other Receivables, and Loan Receivables&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s receivables are comprised of accounts receivable, capitation and fee-for-service receivable, risk pool settlements, incentive receivables, management fee income, and other receivables. Accounts receivable are recorded and stated at the amount expected to be collected.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s receivables &#x2013; related parties are comprised of risk pool settlements, management fee income, and other receivables. Receivables &#x2013; related parties are recorded and stated in the amount expected to be collected.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s loan receivables consist of promissory notes that accrue interest per annum and are recorded and stated at amortized cost plus accrued interest. Interest income is accrued based on the outstanding principal amounts. As of March 31, 2025, promissory notes are expected to be collected by their maturity dates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitation receivables relate to each health plan&#x2019;s capitation revenue and are usually received by the Company in the month following the month of service. Capitation receivables also include receivables from the Centers for Medicare and Medicaid Services (&#x201c;CMS&#x201d;) related to the Company&#x2019;s participation in the ACO REACH model. Risk pool settlements and incentive receivables mainly consist of the Company&#x2019;s hospital shared-risk pool receivable, which is recorded quarterly based on reports received from the Company&#x2019;s hospital partners and management&#x2019;s estimate of the Company&#x2019;s portion of the estimated risk pool surplus for open performance years. Settlement of risk pool surplus or deficits occurs approximately &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;18&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; months after the risk pool performance year is completed.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other receivables consist of amounts due from the seller associated with acquisitions, transportation reimbursements from the hospitals, and stop-loss insurance premium reimbursements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company maintains reserves for potential credit losses on the receivables. Management reviews the composition of the Company&#x2019;s receivables and analyzes historical bad debts, customer concentrations, customer creditworthiness, current economic trends, and changes in customer payment patterns to evaluate the adequacy of these reserves. The Company also regularly analyzes the ultimate collectability of accounts receivable after certain stages of the collection cycle using a look-back analysis to determine the amount of receivables subsequently collected, and adjustments are recorded when necessary. Reserves are recorded based on historical trends. Any change in such an estimate of reserves is recorded in the period when such change is identified.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Receivables are recorded when the Company is able to determine amounts receivable under applicable contracts and agreements based on information provided, and collection is reasonably likely to occur. The Company continuously monitors its receivables collections, and it expects that the historical credit loss experienced across its receivable portfolio is materially similar to any current expected credit losses that would be estimated under the current expected credit losses (&#x201c;CECL&#x201d;) model.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;</asth:ReceivablesReceivablesRelatedPartiesOtherReceivablesAndLoanReceivablesPolicyTextBlock>
    <asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_ecdbcf97-895f-4db8-9ea9-178b48aae1bf">P18M</asth:RiskPoolSurplusOrDeficitsSettlementPeriodAfterPerformanceYear>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_f389b1ec-9fee-4268-9043-1439149cd12c">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Concentrations of Credit Risks&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company disaggregates revenue from contracts by service type and payer type. This level of detail provides useful information pertaining to how the Company generates revenue by significant revenue stream and by type of direct contracts, as used by our chief operating decision makers (&#x201c;CODMs&#x201d;). The condensed consolidated statements of income present disaggregated revenue by service type. &lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents disaggregated revenue generated by each payer type &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(in thousands): &lt;br/&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicare&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;389,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;246,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicaid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;173,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other third parties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Less than 10% of total net revenues&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers that contributed to the following percentages of receivables, net, receivables &#x2013; related parties, and other receivables:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:64.527%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_bc3d38a6-a9e0-44ab-a8b3-88cee3ea1cd3">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents disaggregated revenue generated by each payer type &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;(in thousands): &lt;br/&gt;&lt;/span&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Commercial&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46,081&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;49,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicare&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;389,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;246,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medicaid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;173,158&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;81,263&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other third parties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_1dbcd7f4-15f4-485f-84c9-42d3bbcb06e1"
      decimals="-3"
      id="F_6b7029f5-8635-430d-be7b-46aadc21e749"
      unitRef="U_USD">46081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_db6068f0-807f-4b86-b6ef-af05a0370ebd"
      decimals="-3"
      id="F_78bbd81b-dd08-4303-9748-878fbdbf1b5c"
      unitRef="U_USD">49512000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_9feee836-d0ff-463c-b3e6-a83e692c0715"
      decimals="-3"
      id="F_5ebdf9ef-b18a-486e-8d89-13209640d661"
      unitRef="U_USD">389352000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_38996325-e035-49ee-a6cb-7fcc69167cfe"
      decimals="-3"
      id="F_f0003559-4ac2-42e9-b353-629066a5b762"
      unitRef="U_USD">246564000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3201267a-d634-4169-826d-98d5f707cdfe"
      decimals="-3"
      id="F_7390d03a-d8e4-42e1-9705-0bd57873f4cd"
      unitRef="U_USD">173158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b672f703-aedd-4bf1-94c4-160d381f1498"
      decimals="-3"
      id="F_7ab08718-dcec-4dea-9f5c-7cfa770093c0"
      unitRef="U_USD">81263000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4a4c4fe5-1018-477c-a9b5-a907e028c99f"
      decimals="-3"
      id="F_723d30cb-59d5-4698-9f48-bee25395503b"
      unitRef="U_USD">11799000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4c0af0d9-a715-49c1-818f-7bd0aa182dbe"
      decimals="-3"
      id="F_e26ff5d0-ada6-4dfa-b629-a6412489411f"
      unitRef="U_USD">27017000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2d6598b3-30f5-4bd6-8014-c2a1453b67ab"
      unitRef="U_USD">620390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_c5f9fe47-934c-4445-bf0e-0dfa44ca4025"
      unitRef="U_USD">404356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_d63aa031-fd9c-46da-8454-0f707b5e218e">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers from its Care Partners segment that contributed the following percentages of net revenue&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;34.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer B&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer C&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer D&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;word-break:break-word;"&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#ffffff;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="background-color:#cff0fc;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Less than 10% of total net revenues&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had major payers that contributed to the following percentages of receivables, net, receivables &#x2013; related parties, and other receivables:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
         &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
          &lt;tr style="visibility:collapse;"&gt;
           &lt;td style="width:64.527%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:14.637%;box-sizing:content-box;"&gt;&lt;/td&gt;
           &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;As of December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer F&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
          &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payer E&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
           &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;/tr&gt;
         &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_5fb914a7-0520-41f4-83cf-9c07f5e46feb"
      decimals="3"
      id="F_2022384a-224f-451f-8676-809b6847efc8"
      unitRef="U_pure">0.331</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_dcf3f17e-da41-43d4-8765-fa98896d0781"
      decimals="3"
      id="F_647d974c-0189-4516-9286-ffd801c04799"
      unitRef="U_pure">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_95571c44-ac25-407c-a11f-70a6547c78ed"
      decimals="3"
      id="F_03442894-e77f-40de-94a4-759ea4ffb4e1"
      unitRef="U_pure">0.153</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_c2e67330-5049-40a7-b292-d46f9324eb05"
      decimals="3"
      id="F_7527b08b-fdf8-4956-95e8-19272107893a"
      unitRef="U_pure">0.135</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_598d420b-fa2c-4abf-b7c7-2b099761021d"
      decimals="3"
      id="F_a0971660-79b0-44b9-80b1-ce99adb33610"
      unitRef="U_pure">0.105</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_9adc0920-b8bd-47d0-97bd-354c3679c0f5"
      decimals="3"
      id="F_c03b85f9-6a2e-4306-a0fe-a4efabcaeaa1"
      unitRef="U_pure">0.103</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_015f1704-89e6-4c03-afae-18a5d32c8336"
      decimals="3"
      id="F_b8321e09-9c66-40b3-94a6-79259dcb066b"
      unitRef="U_pure">0.101</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d5454de7-c7d8-4458-b50e-0ea3109e6ecd"
      decimals="3"
      id="F_23f1ae0f-0862-44a0-8b9a-a966304bfd16"
      unitRef="U_pure">0.443</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_d3593fce-7c42-4759-889f-3843431c0c72"
      decimals="3"
      id="F_ddb6972f-1632-4a43-9d8d-cf89519b375c"
      unitRef="U_pure">0.389</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_40324dab-ee91-438e-8fee-dd30b551fea0"
      decimals="3"
      id="F_26ff32f9-a107-43e1-a3f1-36245b02e73d"
      unitRef="U_pure">0.176</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_6876888c-242a-4666-a5ca-046144b65e95"
      decimals="3"
      id="F_7718f0cf-eea8-4b54-96b1-25a71a4e7872"
      unitRef="U_pure">0.161</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_9d87bcf2-94d1-468d-bf39-ab8853daaa29"
      decimals="3"
      id="F_5f527da7-3c89-4c2d-aa73-c0e08236d150"
      unitRef="U_pure">0.129</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="C_f121a13f-7f62-4911-af4c-cdc74d7b71a9"
      decimals="3"
      id="F_c2e4941a-62fa-4152-a4fb-3f4e2fa66c0a"
      unitRef="U_pure">0.183</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_7531d51c-a766-47c8-ac94-557e03bb8e14">&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Revenue Recognition&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company receives payments from the following sources for services rendered:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Commercial insurers;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Federal government under the Medicare program administered by CMS;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;State governments under Medicaid and other programs;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other third-party payers (e.g., hospitals and IPAs); and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Individual patients and clients.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue primarily consists of the following:&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Capitation revenue;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Risk pool settlements and incentives;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Management fee income; and&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="margin-left:4.537%;display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.491405046981553%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;&#x2022;&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;FFS revenue.&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Revenue is recorded in the period in which services are rendered or the period in which the Company is obligated to provide services. The form of billing and related collection risk for such services may vary by type of revenue and the customer.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_6d6f019d-6c7e-4daa-ae5e-31b848e9efe7">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Federal and state income taxes are computed at currently enacted tax rates less tax credits using the asset and liability method. Deferred taxes are adjusted for both items that do not have tax consequences and for the cumulative effect of any changes in tax rates from those previously used to determine deferred tax assets or liabilities. Tax provisions include amounts that are currently payable, changes in deferred tax assets and liabilities that arise because of temporary differences between the timing of when items of income and expense are recognized for financial reporting and income tax purposes, changes in recognition of tax positions, and any changes in the valuation allowance caused by a change in judgment about the realizability of the related deferred tax assets. A valuation allowance is established when necessary to reduce deferred tax assets to amounts expected to be realized.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses a recognition threshold of &#x201c;more-likely-than-not&#x201d; and a measurement attribute on all tax positions taken, or expected to be taken, in a tax return in order to be recognized in the condensed consolidated financial statements. Once the recognition threshold is met, the tax position is measured to determine the actual amount of benefit to recognize in the condensed consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_59597c4e-9c15-4b97-89b1-cf5c79ab79ed">&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In December 2023, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-09 &#x201c;Income Taxes (Topics 740): Improvements to Income Tax Disclosures&#x201d; to expand the disclosure requirements for income taxes, specifically related to the rate reconciliation and income taxes paid. ASU 2023-09 is effective for the Company&#x2019;s annual periods beginning January 1, 2025, with early adoption permitted. The Company does not expect the adoption of ASU 2023-09 to have a significant impact on its consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In November 2024, the FASB issued ASU 2024-03 &#x201c;Income Statement &#x2014; Reporting Comprehensive Income &#x2014; Expense Disaggregation Disclosures (Subtopic 220-40)&#x201d; to provide disaggregated information about certain income statement costs and expenses. ASU 2024-03 is effective for the Company&#x2019;s annual periods beginning January 1, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on its financial statement disclosures.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other than the new standards discussed above, there have been no other recent accounting pronouncements not yet adopted that are expected to have significance, or potential significance, to the Company&#x2019;s financial position, results of operations, and cash flows.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_f24239d7-ddec-4a83-a5cd-3a5eca4fab86">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;3.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Business Combinat&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ions and Goodwill&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025, the Company finalized the purchase price allocation for Advanced Health Management Systems, L.P. (&#x201c;AHMS&#x201d;) and is in the process of finalizing Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks (collectively, &#x201c;CHS&#x201d;). Therefore, the balances were subject to change as a result of any working capital adjustments, primarily for the finalization of medical liabilities and CHS&#x2019; participation in government savings programs for the 2024 performance year. As of March 31, 2025, measurement period adjustments impacted receivables, net, other receivables, accounts payable and accrued expenses, and medical liabilities with a net decrease &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million to &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;goodwill.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;AHMS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On March 31, 2024, the Company, through its wholly owned subsidiary, purchased all of the outstanding general and limited partnership interests of AHMS. AHMS&#x2019;s wholly owned subsidiary operates a Restricted Knox-Keene licensed health plan in Los Angeles, California. The total consideration for the acquisition was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, consisting of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million cash funded upon the close date and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million due from the seller based on estimated working capital adjustments. The consideration is subject to changes based on working capital adjustments, which are settled within one year from the close date as per the purchase agreement.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMS&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total purchase consideration:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchase price due from seller&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;60,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,007&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;60,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;CHS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On October 4, 2024, the Company and its affiliated professional entity acquired all of the outstanding membership interest relating to CHS. CHS partners with independent providers in caring for over &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;129,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Medicare members across &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; states. CHS provides comprehensive support for its physician partners by providing management services, risk contracting, and population health capabilities, including actionable data and other tools, to deliver care coordination and closure of gaps in care. CHS provides additional services to secure and deliver favorable value-based contracts with commercial and other health plans. Total consideration for the acquisition was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, consisting of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million cash funded upon the close date, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million due to the seller based on estimated working capital adjustments, contingent consideration fair valued at $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of replacement restricted stock awards. The consideration is subject to changes based on working capital adjustments, which are settled December 31 of the year following the year in which the closing occurs as per the purchase agreement. See Note 19 &#x2014; &#x201c;Fair Value Measurements of Financial Instruments&#x201d; for additional information on contingent consideration.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;CHS&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total purchase consideration:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,322&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchase price due to seller&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock issued and replacement awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;47,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;168,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,276&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-controlling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,526&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;47,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The acquisitions were accounted for under the acquisition method of accounting. The fair value of the consideration for the acquired companies was allocated to acquired tangible and intangible assets and liabilities based on their fair values. The excess of the purchase consideration over the fair value of the net tangible and identifiable intangible assets acquired was recorded as goodwill. Factors leading to goodwill being recognized are the Company&#x2019;s expectation of synergies from combining the operations of entities acquired and the Company, as well as the value of intangible assets that are not separately recognized, such as the assembled workforce. The determination of the fair value of assets and liabilities acquired requires the Company to make estimates and use valuation techniques when market value is not readily available. Transaction costs associated with business acquisitions are expensed as they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At the time of acquisition, the Company estimates the amount of the identifiable intangible assets based on a valuation and the facts and circumstances available at the time. The Company determines the final value of the identifiable intangible assets as soon as information is available, but not more than one year from the date of acquisition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company had &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impairment of its goodwill or indefinite-lived intangible assets during the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the carrying value of goodwill for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at January 1, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;419,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;416,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;pro forma&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;pro forma &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:75.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;678,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Astrana Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-5"
      id="F_b179c983-bdb7-4bd5-b554-d1e5e7545a62"
      unitRef="U_USD">2900000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-5"
      id="F_0e20d289-f488-4a43-9b1b-96fcdc06d1b2"
      unitRef="U_USD">60900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-5"
      id="F_308dc7b7-4a7a-42b5-9598-e032bd7457f5"
      unitRef="U_USD">63900000</us-gaap:PaymentsToAcquireBusinessesGross>
    <asth:EstimatedWorkingCapitalAdjustments
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-5"
      id="F_84f9e23c-4b44-4dee-a665-1d03184aea3f"
      unitRef="U_USD">3000000</asth:EstimatedWorkingCapitalAdjustments>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_504affeb-419c-49da-bdb9-2f46220b95ee">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMS&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total purchase consideration:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;63,935&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchase price due from seller&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;60,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,007&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,600&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,571&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,464&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,001&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,524&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;60,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:74.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.8%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;CHS&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total purchase consideration:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,322&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Purchase price due to seller&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,944&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,154&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Common stock issued and replacement awards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;47,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,556&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;92,393&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,200&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,444&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;168,064&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;68,276&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52,328&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Non-controlling interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;78&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities assumed&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;120,526&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total net assets acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;47,538&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Unaudited Pro Forma Financial Information&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;pro forma&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; financial information in the table below presents the combined results of the Company and the acquisitions that occurred during the year ended 2024, as if the acquisitions had occurred on January 1, 2024. The &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;pro forma &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company, or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:75.34%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.84%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;(in thousands, except per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;678,640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income attributable to Astrana Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,171&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.41&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net income per share &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-3"
      id="F_609ae028-5de7-4f59-a67e-1f95b13c2dc3"
      unitRef="U_USD">63935000</us-gaap:PaymentsToAcquireBusinessesGross>
    <asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-3"
      id="F_ced17487-f340-4037-bd44-4825f73ad4e9"
      unitRef="U_USD">-2995000</asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_48fdb53a-c0dd-414d-8bd9-069c2eded400"
      decimals="-3"
      id="F_a1a6876c-0be0-48d2-97e8-b995d770b321"
      unitRef="U_USD">60940000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_1071428c-366a-4731-b697-362430e3b204"
      unitRef="U_USD">33950000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_ad5f0473-5c7e-42cd-a0ee-ae164cff2c2e"
      unitRef="U_USD">11007000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_38e87820-4dc9-415b-a6fc-d5dc910750ef"
      unitRef="U_USD">36000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_be5715e0-1219-4a08-a94b-fb0cb2b85c40"
      unitRef="U_USD">23600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_1253393b-dcd6-416b-b134-f8083805d4d0"
      unitRef="U_USD">25571000</us-gaap:Goodwill>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_cabcef0c-d89c-4c26-b5a9-c66a77d62ca8"
      unitRef="U_USD">300000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsRestrictedCash>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_6c3502e0-4769-40f6-8447-0e9ebdaec58e"
      unitRef="U_USD">94464000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_7baac5ff-2973-4fe7-bf4d-f8ce8c229f8b"
      unitRef="U_USD">13001000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_8c305bc2-c924-4f92-8459-0361037f9030"
      unitRef="U_USD">14093000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_2cbe6560-a7f4-4d39-a3ef-5b941c25426b"
      unitRef="U_USD">6430000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_d37ac325-4809-4d50-8991-c955dc5bb2fb"
      unitRef="U_USD">33524000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="C_baa505f3-0b22-4c7d-97da-d429c4957dac"
      decimals="-3"
      id="F_d5f2e955-db52-42c7-a416-6b0ec899f617"
      unitRef="U_USD">60940000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <asth:NumberOfMedicareMembers
      contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b"
      decimals="INF"
      id="F_71b52db3-49d9-4605-ad7c-ae1a95518a05"
      unitRef="U_Member">129000</asth:NumberOfMedicareMembers>
    <us-gaap:NumberOfStatesInWhichEntityOperates
      contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b"
      decimals="INF"
      id="F_e47116e6-63f1-4fa4-bc35-000d7d7b0e77"
      unitRef="U_State">17</us-gaap:NumberOfStatesInWhichEntityOperates>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b"
      decimals="-5"
      id="F_2cbb6f08-e440-478f-9c03-3391415c4909"
      unitRef="U_USD">47500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b"
      decimals="-5"
      id="F_aac2c3da-e47c-431d-91fa-b506e8a2db32"
      unitRef="U_USD">35300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <asth:EstimatedWorkingCapitalAdjustments
      contextRef="C_c7971ffb-d918-406e-b9d4-02d88fcfa68b"
      decimals="-5"
      id="F_c9a05571-e8e0-4df9-ae7d-fdacbaabc705"
      unitRef="U_USD">6900000</asth:EstimatedWorkingCapitalAdjustments>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b"
      decimals="-5"
      id="F_e41e7f11-875f-478e-9fb7-57ebccc05048"
      unitRef="U_USD">5200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:ReplacementOfRestrictedStockAwards
      contextRef="C_cbb01581-d5ea-4ff9-8b1c-76c9f381135b"
      decimals="-5"
      id="F_44ec5872-1e0c-45b4-9117-864a912c20af"
      unitRef="U_USD">100000</asth:ReplacementOfRestrictedStockAwards>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"
      decimals="-3"
      id="F_8a58def1-c26e-403b-91ae-514bf4fdbaf7"
      unitRef="U_USD">35322000</us-gaap:PaymentsToAcquireBusinessesGross>
    <asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller
      contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"
      decimals="-3"
      id="F_780c163d-65db-44a9-b6b4-03c44b25ed95"
      unitRef="U_USD">6944000</asth:BusinessCombinationConsiderationPurchasePriceDueToFromSeller>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"
      decimals="-3"
      id="F_538a7b6f-f657-480b-81d9-39da32d3bc67"
      unitRef="U_USD">5154000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"
      decimals="-3"
      id="F_061930a5-f911-4e74-9809-b1bc2935b0ee"
      unitRef="U_USD">118000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="C_7f2b9b72-299a-4da3-9ed5-2c3187faec6e"
      decimals="-3"
      id="F_b9ff3f30-d4d7-48a9-8ffa-9f9904dfe51a"
      unitRef="U_USD">47538000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_21dfe2d8-9137-4e1b-bda6-bb8bbd1d7bdd"
      unitRef="U_USD">4556000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_82be8699-dd04-409e-bc28-010379de9f5c"
      unitRef="U_USD">92393000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_53c48cca-d272-4809-881b-dda178481b43"
      unitRef="U_USD">44336000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_12dea3c3-5302-4958-aa96-cdd5a7c928ca"
      unitRef="U_USD">357000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_b008672f-5678-4cf1-a376-324875f7c67a"
      unitRef="U_USD">14200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_bc0ec777-10da-40c8-be21-28606415459f"
      unitRef="U_USD">9444000</us-gaap:Goodwill>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_be9a279e-f099-41c5-82c0-c25e8727c863"
      unitRef="U_USD">2778000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsInvestmentsInOtherEntitiesEquityMethod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_7d0ed6be-3ca6-46b0-8824-37b93edacda6"
      unitRef="U_USD">168064000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_7547163b-2686-491b-b54a-eed65326f0e3"
      unitRef="U_USD">68276000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAccountsPayableAndAccruedExpenses>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_db07eece-9eda-45bc-b640-bca06e22417c"
      unitRef="U_USD">52328000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesMedicalLiabilities>
    <asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_2be0bb95-51e4-44d1-9350-1b5ee9adb897"
      unitRef="U_USD">-78000</asth:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesNoncontrollingInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_648920aa-62f4-4837-a4a5-e40ab323669e"
      unitRef="U_USD">120526000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="C_91422e50-b35a-4ab8-a125-5f4472712612"
      decimals="-3"
      id="F_42257018-1de9-4ae9-88b7-28dd23e2f9a5"
      unitRef="U_USD">47538000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_75c8506b-dd13-4d9e-a35c-91764806afdb"
      unitRef="U_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="INF"
      id="F_9af223da-5360-41e6-9fe1-acc9b71045c5"
      unitRef="U_USD">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_2dccd72a-d6ce-46e7-854e-f206a7279890">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the carrying value of goodwill for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at January 1, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;419,253&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Adjustments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;416,386&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_333b8719-8ef5-410c-ac66-d7b1c1e6708f"
      unitRef="U_USD">419253000</us-gaap:Goodwill>
    <us-gaap:GoodwillPurchaseAccountingAdjustments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_e7812cae-c87c-4232-b812-c5049c55a954"
      unitRef="U_USD">-2867000</us-gaap:GoodwillPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_cac6f7fe-bca9-4871-9531-fae83c76a54c"
      unitRef="U_USD">416386000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionsProFormaRevenue
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_3036d997-ef0d-4319-9c88-2470f10e3637"
      unitRef="U_USD">678640000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_b2695732-9b2e-4ffe-8dc1-bbe5b36ac937"
      unitRef="U_USD">19171000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_274f183f-7f0b-4f63-85c7-ce77bff1fb0b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.41</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_35ffe610-b7a8-4cfb-9b90-678794a94677"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.4</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_64207ddc-c761-428b-96d6-c1ba75c0179b">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;4.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Intangible Assets, Net&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.869%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.803%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.802000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;br/&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Licenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Network relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;171,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,418&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Management contracts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Member relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Patient management platform&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tradename/trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Developed technology&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;275,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;163,138&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At December 31, 2024, intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.869%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.803%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.802000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;br/&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Licenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Network relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;171,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Management contracts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Member relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Patient management platform&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tradename/trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Developed technology&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;275,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;156,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the three months ended March 31, 2025 and 2024, the Company recognized amortization expenses of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, in depreciation and amortization in the accompanying condensed consolidated statements of income. The Company determined that ther&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;e was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; impai&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;rment of its finite-lived intangible or long-lived assets during the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:75.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,395&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_abfaeab9-80fd-48f0-9f0f-3131d173cfbc">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.869%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.803%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.802000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;br/&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Licenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Network relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;171,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55,418&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Management contracts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,573&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Member relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Patient management platform&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tradename/trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;371&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;640&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Developed technology&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;275,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;163,138&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;111,916&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.02in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;At December 31, 2024, intangible assets, net, consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:43.869%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.803%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.802000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.782%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Useful&lt;br/&gt;Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Gross&lt;br/&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Net&lt;br/&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Indefinite lived assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,150&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Licenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;N/A&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,900&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortized intangible assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Network relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;171,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;114,046&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;57,871&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Management contracts&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,832&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,953&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,879&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Member relationships&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;-&lt;/span&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;73,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,406&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Patient management platform&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Tradename/trademarks&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,011&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;653&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Developed technology&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;275,054&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;156,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37"
      decimals="-3"
      id="F_a927dde2-4b00-4849-b479-376325fc4e63"
      unitRef="U_USD">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_0fca26cf-b9cb-4ad8-9a55-baf30113de37"
      decimals="-3"
      id="F_a610ba96-a4b3-444f-a7e7-8411e7f8cc5f"
      unitRef="U_USD">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_92e5a4d9-669c-445f-ae84-87c0d970533d"
      decimals="-3"
      id="F_322f2540-6eeb-4116-9ead-f404b0835c9a"
      unitRef="U_USD">1900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_92e5a4d9-669c-445f-ae84-87c0d970533d"
      decimals="-3"
      id="F_0fa3de7d-88a2-436d-8734-65ed43f89175"
      unitRef="U_USD">1900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_3a2ebc98-8101-4cf2-9108-4f593c2d8847"
      id="F_763dd215-6bd5-4c47-90d8-7ec4fecb0a9e">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_3551b884-1dd8-4237-84f2-7b976f23e2cc"
      id="F_8b0ce2b7-6d98-45aa-a79e-af95334cbf64">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95"
      decimals="-3"
      id="F_5e8c7121-b867-4327-b648-64f587eb77dc"
      unitRef="U_USD">171917000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95"
      decimals="-3"
      id="F_6a11e9fa-2f94-46a6-82be-75e61e30510b"
      unitRef="U_USD">116499000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_367c7a54-311a-4f48-828c-ff0ef9db9d95"
      decimals="-3"
      id="F_ecdfac41-1e97-4245-937a-179b985b82b1"
      unitRef="U_USD">55418000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85"
      id="F_7fd7b083-04d8-4d07-b2d8-12ad5ba145d1">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85"
      decimals="-3"
      id="F_018cfd56-744a-4b05-acd4-8b7a6f1f004d"
      unitRef="U_USD">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85"
      decimals="-3"
      id="F_e6f2c47e-158a-4252-8b33-a08291917dbc"
      unitRef="U_USD">18259000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_05ea43c3-e314-4603-8d8f-a60b429d8f85"
      decimals="-3"
      id="F_c9d4f5af-3259-4296-9e8b-4a0fced21488"
      unitRef="U_USD">4573000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_43ba0bc5-d5da-4f73-96ca-7e4df5bc7e92"
      id="F_25f4a7e6-66ae-41ae-80b8-913419d073b5">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_1288fe82-ac30-4a05-9186-9dd06073739b"
      id="F_94b7b890-f6de-4311-a5cf-830903c03978">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4"
      decimals="-3"
      id="F_88f674c6-06c8-4a3b-8672-381f336c2c4c"
      unitRef="U_USD">73077000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4"
      decimals="-3"
      id="F_9bdb8f78-48da-437f-a4e4-0bff0df4bf63"
      unitRef="U_USD">25893000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_9e031983-8e48-4e18-a080-9ef7b798c5c4"
      decimals="-3"
      id="F_104f1c58-7fbb-4756-bdb4-b2cf8f94cd2f"
      unitRef="U_USD">47184000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd"
      id="F_e0a217e8-e0c9-44e6-a3c4-da8b743487fe">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd"
      decimals="-3"
      id="F_57f04868-1ad2-4c33-b90c-d4c82d318747"
      unitRef="U_USD">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_565fc710-9190-4f9c-a4ba-2cc66a76b9bd"
      decimals="-3"
      id="F_2f4977da-5196-4a8d-b598-cf2025f5bcf7"
      unitRef="U_USD">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7"
      id="F_afd4432a-c167-407e-a697-a3d7b9545e4c">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7"
      decimals="-3"
      id="F_a0b2d3de-268f-4b51-b3d5-71a63d629491"
      unitRef="U_USD">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7"
      decimals="-3"
      id="F_f51b3301-e0b8-4735-b0f4-d498ead6a817"
      unitRef="U_USD">371000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0bffb772-e7a5-4b18-a770-ee3ef66fc2c7"
      decimals="-3"
      id="F_2ff27e0e-76f4-4232-87d2-393f944d2e0f"
      unitRef="U_USD">640000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f"
      id="F_c82f2e43-663a-4356-87a3-c0ae10ad3f04">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f"
      decimals="-3"
      id="F_bc9c53c5-89ab-4a35-af4d-fa02f63530eb"
      unitRef="U_USD">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f"
      decimals="-3"
      id="F_ce3170ed-61b9-4b02-9ac6-3bdb95356404"
      unitRef="U_USD">56000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_0f6589d9-060b-4baf-90fe-b02db5eb589f"
      decimals="-3"
      id="F_20c751b6-7be6-47c5-91b0-237da50cad24"
      unitRef="U_USD">51000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_9ae69c67-0b25-4c98-a08a-8b9ade76ba20"
      unitRef="U_USD">275054000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_7b2aad18-ab82-4a80-85da-db7e95b1c00c"
      unitRef="U_USD">163138000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ed74e884-c045-46a3-a366-71e6a4cbaf2b"
      unitRef="U_USD">111916000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_4a8637ec-690d-4853-a3e3-abf4a49d231a"
      decimals="-3"
      id="F_fa787aee-01c8-4462-ad23-c44d0bd83699"
      unitRef="U_USD">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_4a8637ec-690d-4853-a3e3-abf4a49d231a"
      decimals="-3"
      id="F_8ceb046b-575b-4233-a1e6-310c89be6bd3"
      unitRef="U_USD">2150000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683"
      decimals="-3"
      id="F_ce64accc-bfbd-49f7-8142-4b938ae7a660"
      unitRef="U_USD">1900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="C_ddb3655b-30db-4ebc-a4a9-dd5f72a3e683"
      decimals="-3"
      id="F_b12fcb0e-847b-40bb-b29e-8d1093a36211"
      unitRef="U_USD">1900000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_eafa35a4-99f0-44d4-a6eb-107f2d35d4d3"
      id="F_bf64b945-a88a-4da8-9d5b-59188ea40a55">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_ca4dfd0b-8bd6-4fbd-a03c-0d86bc0e20dd"
      id="F_9cea3c8e-cce5-48a3-9e4f-bbbe56ff5671">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad"
      decimals="-3"
      id="F_4d3f8907-6905-42f7-bffd-0449724830b6"
      unitRef="U_USD">171917000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad"
      decimals="-3"
      id="F_9abeda93-ee41-4bf1-8ee3-f0b9ff81a75d"
      unitRef="U_USD">114046000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_9d156022-37ae-4ca3-ad28-343a96df50ad"
      decimals="-3"
      id="F_0278720f-701e-489c-910b-e50288a67b09"
      unitRef="U_USD">57871000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e"
      id="F_6f8da79d-1d1f-4bfc-a333-fe8df356e8fc">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e"
      decimals="-3"
      id="F_fad24c10-9272-42db-9d1d-a23bcf8377dd"
      unitRef="U_USD">22832000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e"
      decimals="-3"
      id="F_80a81a7d-8044-4feb-94b4-d39e6f524365"
      unitRef="U_USD">17953000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_2147af01-593e-4d79-ae19-38f7ac603a3e"
      decimals="-3"
      id="F_37ef78eb-f329-46d2-bea0-cd986803465a"
      unitRef="U_USD">4879000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_42bb4ed7-33be-47af-988b-992e494c103d"
      id="F_12421ec0-f1d9-4dd1-9120-f64f2f1aa178">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_c0084b72-06a0-4ae0-91de-1a477153763a"
      id="F_5786ffff-8214-4ebc-99b4-6527b12a3ffb">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0"
      decimals="-3"
      id="F_be956af6-8186-4abb-a2f2-309eac25c727"
      unitRef="U_USD">73077000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0"
      decimals="-3"
      id="F_8850ab0d-c40a-453a-981b-99739901ae7f"
      unitRef="U_USD">22406000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_d6f43d73-1b74-4500-b67e-0a7f2d8ca9a0"
      decimals="-3"
      id="F_844b66ee-a601-4bdb-aff3-acc8d91ae67c"
      unitRef="U_USD">50671000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f"
      id="F_9e02151a-7254-4798-b2b2-d7eb7afa0ba8">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f"
      decimals="-3"
      id="F_e678e9c7-d6da-4d5f-9e0a-3b4a8ecc5d19"
      unitRef="U_USD">2060000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_27a3f0c4-a223-4d7e-a47a-702e95615d3f"
      decimals="-3"
      id="F_7778a1a6-6aae-43f4-82e7-b8817b24a9c6"
      unitRef="U_USD">2060000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901"
      id="F_a32ae3c5-99e5-4ae4-83de-160ee82196d1">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901"
      decimals="-3"
      id="F_f8163ad3-8981-41b7-841a-f6f0102bf78b"
      unitRef="U_USD">1011000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901"
      decimals="-3"
      id="F_a6b9cad1-16ce-441a-90ae-74c461e4aff9"
      unitRef="U_USD">358000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_17bc3572-9ab6-4f7c-8357-7b84f94bb901"
      decimals="-3"
      id="F_a00f7812-35c4-4691-b8c4-dc70283df9a5"
      unitRef="U_USD">653000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25"
      id="F_d11aca15-9c64-48db-aff8-ad834f20af90">P6Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25"
      decimals="-3"
      id="F_d614662c-5d90-4822-b4cf-27070ec077ae"
      unitRef="U_USD">107000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25"
      decimals="-3"
      id="F_c188572a-929e-40ba-8900-b88bee7e19bd"
      unitRef="U_USD">52000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_eb098f65-c543-4b24-ae54-daae9a749c25"
      decimals="-3"
      id="F_beef100d-b38f-4adc-a92e-8372f8b31691"
      unitRef="U_USD">55000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_ec4286a7-ce2c-4086-9959-4f4073c38815"
      unitRef="U_USD">275054000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_e7bdb68f-c827-4ad2-aa1a-eddb97ffb14d"
      unitRef="U_USD">156875000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_2a1bb747-5ff4-42bc-ba1d-45b49ccb7d02"
      unitRef="U_USD">118179000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-5"
      id="F_03076d9c-fe5f-41ea-bc8d-79d847bd9bda"
      unitRef="U_USD">6300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-5"
      id="F_734a7596-b75b-45b9-856a-8042f938424e"
      unitRef="U_USD">4400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_f1d16382-3b56-437c-a777-a4b81a41ef24"
      unitRef="U_USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="INF"
      id="F_14ff1a44-79a8-46c6-ae85-39e43dfa82ae"
      unitRef="U_USD">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_cb9fcfbd-8639-4b54-9cd5-a65f74b71f0b">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Future amortization expense is estimated to be as follows for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:75.76%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.14%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:20.099999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,395&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,295&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,808&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;107,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_fb2a5b7e-0b9a-498b-bd4e-75d4b041da65"
      unitRef="U_USD">18395000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_eed8792b-1281-4bf0-9f42-76292a9f153f"
      unitRef="U_USD">20295000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_8f31cba3-fa32-4ce3-b8f5-8a923061bf15"
      unitRef="U_USD">16808000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_7fddfb89-047f-4e58-8ec7-55966d0bc251"
      unitRef="U_USD">14077000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ba4a0ac1-663a-453d-ba3d-e3344140ba63"
      unitRef="U_USD">11397000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <asth:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_014de97e-3e2f-4b8f-a4f5-9d5c84e7d3b9"
      unitRef="U_USD">26894000</asth:FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_1d9036ff-0938-4b2d-9268-0544dd27d273"
      unitRef="U_USD">107866000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <asth:EquityMethodAndOtherEquityInvestmentsTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_f84cfc71-7ce0-48dd-aac0-d50c1ce9aa7d">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;5.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Investments in Other Entities&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Method&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024, the Company&#x2019;s equity method investment activity and balance consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.11%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.464%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;% of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial&lt;br/&gt;Investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Allocation&lt;br/&gt;of Net&lt;br/&gt;(Loss) Income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Distribution&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;LaSalle Medical Associates &#x2013; IPA line of business&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;343&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,005&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Other consists of smaller equity method investments including those from the CHS acquisition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:0.575;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.115%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.047%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.447999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;% of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial&lt;br/&gt;Investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Allocation&lt;br/&gt;of Net&lt;br/&gt;Income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Distribution&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;LaSalle Medical Associates &#x2013; IPA line of business&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;632&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Other consists of smaller equity method investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company records its investments in certain non-consolidated VIEs within investments in other entities &#x2013; equity method in the accompanying condensed consolidated balance sheets. These entities were determined to be VIEs but are not consolidated because despite providing financial support to these entities, the Company lacks a controlling financial interest and is not the primary beneficiary. Thus, these VIEs are accounted for under the equity method of accounting. The Company recognizes its share of the investee&#x2019;s earnings or losses under the &#x201c;hypothetical-liquidation-at-book-value&#x201d; method. As of  March 31, 2025, the Company&#x2019;s maximum exposure to loss was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; which represents the carrying value of the Company&#x2019;s investments in the non-consolidated VIEs.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity method investments are subject to impairment evaluation. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;No&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; i&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;mpairment loss was recorded related to equity method investments for the three months ended March 31, 2025 and 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in Privately Held Entities&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company accounts for certain equity investments using the cost basis, adjusted for observable price changes and impairments, when there is no readily determinable fair value. Observable price changes and impairments are recognized in net income. As of both March 31, 2025, and December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, our investments in privately held entities was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, for which a fair value is not readily determinable and we do not have significant influence. During the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, there were no observable price changes to these investments.&lt;/span&gt;&lt;/p&gt;</asth:EquityMethodAndOtherEquityInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_4502b70c-ec1e-4d78-936b-96d6c1a67df8">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024, the Company&#x2019;s equity method investment activity and balance consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.11%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.464%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.044%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;% of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial&lt;br/&gt;Investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Allocation&lt;br/&gt;of Net&lt;br/&gt;(Loss) Income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Distribution&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;LaSalle Medical Associates &#x2013; IPA line of business&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;343&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,785&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,664&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,612&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;264&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,077&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;% - &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;843&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,319&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;347&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,005&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:middle;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Other consists of smaller equity method investments including those from the CHS acquisition.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:0.575;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:25.115%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:11.047%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:10.447999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.201%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.046999999999999%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;% of&lt;br/&gt;Ownership&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Initial&lt;br/&gt;Investment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Allocation&lt;br/&gt;of Net&lt;br/&gt;Income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Distribution&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;LaSalle Medical Associates &#x2013; IPA line of business&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;359&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,225&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Pacific Medical Imaging &amp;amp; Oncology Center, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CAIPA MSO, LLC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,660&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;186&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,846&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health, Inc.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;60&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,774&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;632&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35,893&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Other consists of smaller equity method investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_973e57e5-b73d-4cc7-94b0-6463141b31dd"
      decimals="2"
      id="F_724092fc-9a96-4a55-a8f7-79278f453bf5"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_8e22a9c3-e9e2-4f67-87cc-739826df0ebc"
      decimals="-3"
      id="F_b3990bb9-3f19-4397-82a6-8691dfbf76d3"
      unitRef="U_USD">13128000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101"
      decimals="-3"
      id="F_d7397fc3-3cda-464e-a523-96e48e10d33f"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101"
      decimals="-3"
      id="F_66bb4d92-d875-4226-ab4e-091ebc80ae70"
      unitRef="U_USD">-343000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_31f2c291-fe47-4c84-bb34-57cb71b36101"
      decimals="-3"
      id="F_36e6f06d-8b86-4b8e-8738-380a311bc1a3"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_973e57e5-b73d-4cc7-94b0-6463141b31dd"
      decimals="-3"
      id="F_e48a38b2-e46d-47fa-ae0c-5598ba8e2020"
      unitRef="U_USD">12785000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_0db515af-2807-4207-b8a5-46485e97024c"
      decimals="2"
      id="F_4502a0cb-e213-4343-979a-53e4c350b18f"
      unitRef="U_pure">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_3f74b900-fc5b-4144-b943-471127db7623"
      decimals="-3"
      id="F_e88d8444-f207-460f-b8cb-1ae78da30c27"
      unitRef="U_USD">1660000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb"
      decimals="-3"
      id="F_9361e581-afc9-4855-9ea8-1f483c60a0c6"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb"
      decimals="-3"
      id="F_ba7bf8d2-47d5-4ddb-b4e8-dc1616a92878"
      unitRef="U_USD">4000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_32ae5713-53a9-47eb-9a0e-cb421f8009eb"
      decimals="-3"
      id="F_43e1f35f-ebde-42cd-8723-d406c69d24a5"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_0db515af-2807-4207-b8a5-46485e97024c"
      decimals="-3"
      id="F_dbe6dcab-5c1e-4e9f-b3c5-df87c6c7cbe3"
      unitRef="U_USD">1664000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_c627daaf-b808-4e00-85a0-596f504d8472"
      decimals="2"
      id="F_4b246b3b-08eb-4060-85ca-c44d8a23b3c9"
      unitRef="U_pure">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_90d6d0bb-c95e-4885-bab2-bba445ae396a"
      decimals="-3"
      id="F_e331c887-0334-4752-a247-b3fb19207365"
      unitRef="U_USD">14612000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842"
      decimals="-3"
      id="F_a11ba0fc-41a0-4549-903c-36aa907d83fc"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842"
      decimals="-3"
      id="F_1445c75f-91ff-4618-927e-f43e3bd52ac3"
      unitRef="U_USD">264000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_369173ba-bef4-4c54-9896-61bf4704f842"
      decimals="-3"
      id="F_b0b500ad-3d12-4651-bf98-6736d016b1fe"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_c627daaf-b808-4e00-85a0-596f504d8472"
      decimals="-3"
      id="F_66ded356-aea3-4a6a-b3d8-f15f81992e37"
      unitRef="U_USD">14876000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c"
      decimals="2"
      id="F_6d1f2161-fd70-47a6-aef2-a6a8620a49c5"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_fbca9ee8-8163-4436-a2e2-bce055cb706c"
      decimals="-3"
      id="F_381e2888-b4f5-40f4-9882-710cd1e5968a"
      unitRef="U_USD">6077000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d"
      decimals="-3"
      id="F_59f5a73e-4a30-493a-b64e-ee05498f940b"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d"
      decimals="-3"
      id="F_b553fb46-eac7-4404-bc2b-48275aecd40e"
      unitRef="U_USD">51000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_952ec1b4-0412-4990-a574-cf7524a67b4d"
      decimals="-3"
      id="F_bca575ea-a829-4a95-95b3-2174cf43b558"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c"
      decimals="-3"
      id="F_4a94d530-870c-4bfe-9601-dcc3523a6342"
      unitRef="U_USD">6128000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_39d701e3-06a4-4df9-b822-c0fcffba122c"
      decimals="2"
      id="F_e0e54e62-a2f1-4ad3-9a43-2ed048d935b0"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_fb49430e-f221-42fd-ab2d-21a25ad7d7bc"
      decimals="2"
      id="F_c79f8e95-9df9-4b15-b533-b88cde738246"
      unitRef="U_pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_6aa69ca0-0134-44c6-9a4c-dfef95103988"
      decimals="-3"
      id="F_8930ec71-85cb-406e-989e-38a7ed4bc152"
      unitRef="U_USD">3842000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3"
      decimals="-3"
      id="F_36970ca6-9fc7-4394-9e3b-c22959061187"
      unitRef="U_USD">-347000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3"
      decimals="-3"
      id="F_4d6e8862-d206-48f6-8c1b-c25a5dfbae73"
      unitRef="U_USD">-843000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_0d98b790-089f-4f95-8f77-b2f98cd851c3"
      decimals="-3"
      id="F_8781e2a2-7ae1-43d7-aab4-c93412e7c0d8"
      unitRef="U_USD">100000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_7d30ac99-4e7f-46aa-b268-23abada1cedd"
      decimals="-3"
      id="F_4fecbf5a-0a7e-4426-bdfb-e97ae6475619"
      unitRef="U_USD">2552000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_1469860a-bd27-4cf8-a793-19cfd44acd6d"
      unitRef="U_USD">39319000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_f96343f4-2a38-4383-b218-f068eb6676d7"
      unitRef="U_USD">-347000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_3a5fec0c-9585-492a-9fdd-0269a885b41a"
      unitRef="U_USD">-867000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_93b50967-57a4-46e8-b912-63066064dd16"
      unitRef="U_USD">100000</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_c11bfb81-52f3-440f-af95-91d6e86c0ee8"
      unitRef="U_USD">38005000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_1083cf69-b827-454e-8369-6d3fc314dfc0"
      decimals="2"
      id="F_a1ced9e8-ec09-4656-8210-15b0380da481"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_60dd78d1-64db-4a8b-924c-509710d8f2d8"
      decimals="-3"
      id="F_18cacd6c-7525-4ca4-aec1-f3d4c8315627"
      unitRef="U_USD">9866000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad"
      decimals="-3"
      id="F_756482a8-7086-4260-8724-618f62c57e6d"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad"
      decimals="-3"
      id="F_70a948ad-2459-4d66-bfc0-915c4f6a2c06"
      unitRef="U_USD">359000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_ee84bd0d-3633-4ffa-b982-879767a7cdad"
      decimals="-3"
      id="F_046c8488-2926-4ffa-935a-c49bb84fe876"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_1083cf69-b827-454e-8369-6d3fc314dfc0"
      decimals="-3"
      id="F_0a25ad94-e3be-48d8-87c0-e0cbeedfc18c"
      unitRef="U_USD">10225000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_51568cb6-3f1a-4554-92a1-e0a87a63611a"
      decimals="2"
      id="F_e301cc56-8aa2-4721-9d3c-85a00d70c361"
      unitRef="U_pure">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_71fe0c76-45fe-453d-84d9-fa9e245de91b"
      decimals="-3"
      id="F_495eb24f-c082-430c-b6fe-4781b672d6bc"
      unitRef="U_USD">1691000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9"
      decimals="-3"
      id="F_9d254111-cfee-41f2-ad54-d2bdb04aebbf"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9"
      decimals="-3"
      id="F_83045481-d256-42e1-9548-97c3bfb5901d"
      unitRef="U_USD">27000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_c4d66a2e-21a8-4be5-8d25-080eaf6f10c9"
      decimals="-3"
      id="F_e6602d5a-ef9a-4f9b-b7f4-a3b4f05fd85a"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_51568cb6-3f1a-4554-92a1-e0a87a63611a"
      decimals="-3"
      id="F_54f7a978-4dd3-49c5-a23c-c48dc933513e"
      unitRef="U_USD">1718000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914"
      decimals="2"
      id="F_a113aea8-3ffc-439b-bd64-896ff8d59389"
      unitRef="U_pure">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_d44cee9d-e397-4f66-8ab9-60be5a5fe296"
      decimals="-3"
      id="F_557e9efd-5806-443c-977f-778d97cdb545"
      unitRef="U_USD">13660000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79"
      decimals="-3"
      id="F_bf878567-c56a-470f-97b0-6bab23b24d57"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79"
      decimals="-3"
      id="F_9aa1d70e-131d-4fc1-9c2c-52e8f9048c72"
      unitRef="U_USD">186000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_6c8bf174-59c7-4577-a615-168c7e390b79"
      decimals="-3"
      id="F_bd13bbdc-66ec-4c96-a54e-58a5be9ae717"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_f2d4f82c-f93f-4638-b3bc-a230fc2ab914"
      decimals="-3"
      id="F_82fa5879-8d95-406f-a2e9-cb600aec9a9e"
      unitRef="U_USD">13846000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="2"
      id="F_615095ad-f908-4516-adbe-b9c2a759dbc6"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_51d37c62-bd92-4b36-bda5-66bf4ab5d0f1"
      decimals="-3"
      id="F_beb2a6b4-11a2-40ca-a144-0b2e1562d871"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d"
      decimals="-3"
      id="F_608defcf-e836-49c4-810d-2a0dd78d5d19"
      unitRef="U_USD">9487000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d"
      decimals="-3"
      id="F_ca305592-5e1b-45c7-b81f-b2b4f02c75ed"
      unitRef="U_USD">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_9a5a7663-ec9f-4368-babf-a8c9150aed9d"
      decimals="-3"
      id="F_4c2bd9e9-5100-4cee-8ece-6cd90b7b4a0e"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="-3"
      id="F_7b1ce679-51cd-4c2b-8b5f-16ec73120f39"
      unitRef="U_USD">9487000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_1e918ac4-70a3-44fc-b478-645d223adbf1"
      decimals="2"
      id="F_ba447842-dd61-417b-8d27-890559ed7b64"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="C_4aad3ec6-80fd-4602-9c7b-59c3596c2d22"
      decimals="-3"
      id="F_333a7609-7fa7-4f7d-a96d-93df9177fc8f"
      unitRef="U_USD">557000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1"
      decimals="-3"
      id="F_dfec1adc-2072-455c-a57a-a5ae464086e5"
      unitRef="U_USD">0</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1"
      decimals="-3"
      id="F_85f39b37-4f70-40fe-ad78-de8182a1369a"
      unitRef="U_USD">60000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_8f0f3286-f1ee-4317-8ac0-a7b8be591ff1"
      decimals="-3"
      id="F_e0954749-26ac-4edb-b3dd-66236b87769b"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_1e918ac4-70a3-44fc-b478-645d223adbf1"
      decimals="-3"
      id="F_8db686a0-5ee7-4a42-9eef-de5b1309d95d"
      unitRef="U_USD">617000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0"
      decimals="-3"
      id="F_0c870521-1103-44d9-8f79-504718a90eeb"
      unitRef="U_USD">25774000</us-gaap:EquityMethodInvestments>
    <asth:EquityMethodInvestmentAdditionalInvestment
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_1e78af40-9aa7-481b-a22b-72a5641c05c8"
      unitRef="U_USD">9487000</asth:EquityMethodInvestmentAdditionalInvestment>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_303a28a5-7e96-48d6-aa12-48f9c2aa5693"
      unitRef="U_USD">632000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentSoldCarryingAmount
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_ead7220f-4656-4822-a9cd-bd27d97776c8"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentSoldCarryingAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_69baebfb-197d-4544-99ce-0408bb504987"
      unitRef="U_USD">35893000</us-gaap:EquityMethodInvestments>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="C_63adb938-c888-47f6-afd0-8fa1a58390b4"
      decimals="-5"
      id="F_727d16c7-8ab9-4bbf-b398-0afdb74f4532"
      unitRef="U_USD">1900000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_794de7e3-cb91-43ff-b5bc-6a64bf951820"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="INF"
      id="F_a4733265-bebc-44e6-a3ea-6501b7ae6dde"
      unitRef="U_USD">0</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_317cd4d6-ba9a-437b-8fee-de3d2fdd4029"
      unitRef="U_USD">8900000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-5"
      id="F_d9b02f73-b652-410e-b854-8bc755bf734e"
      unitRef="U_USD">8900000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:LoanReceivableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_4a27edfc-7810-40db-920e-a8d65321ff98">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;6.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Loans Receivable&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Loans receivable&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;IntraCare&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In July 2023, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; convertible promissory note with IntraCare as the borrower. The principal on the note is $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, with interest on the outstanding principal amount and unpaid interest at a rate per annum equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.81&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, compounded annually. In the event that the convertible promissory note remains outstanding on or after the maturity date of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;July 27, 2028&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the outstanding principal balance and any unpaid accrued interest shall, upon the election of the Company, convert into IntraCare preferred shares. As of both &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, and December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the related note balance of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, was included in loan receivable &#x2013;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; non-current in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;BASS Medical Group&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On January 29, 2024, the Company provided BASS Medical Group (&#x201c;BASS&#x201d;) with a $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million senior secured promissory note (&#x201c;BASS secured promissory note&#x201d;). The promissory note is secured by certain assets of BASS. The BASS secured promissory note matures on &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 11, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and has an interest rate per annum equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.21&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, compounded annually. The principal on the note, including unpaid interest, is due and payable on the maturity date. On April 24, 2025, the BASS secured promissory note was amended and restated to update the terms of the note to include terms of repayment, whereby the principal balance shall be payable in monthly installments of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; until &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 11, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the maturity date. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the related non-current portion of the note balance of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, respectively, was included in loan receivable, non-current in the accompanying condensed consolidated balance sheets. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the related current portion of the note of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was included in loan receivable in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company assessed the outstanding loans receivable under the CECL model by assessing the party&#x2019;s ability to pay by reviewing their interest payment history quarterly, financial history annually, the value of any collateral, and reassessing any identified insolvency risk.&lt;/span&gt;&lt;/p&gt;</asth:LoanReceivableTextBlock>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_e76a7617-4b56-4fc3-99bd-e245633154cb"
      id="F_8b0eb24e-4446-4037-9e43-fc6c3828bb8c">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_57ab083d-904e-4e53-978c-f5c3da6822ed"
      decimals="-5"
      id="F_c8cec016-9086-4b13-bc85-ac6e6aa1b1a2"
      unitRef="U_USD">25000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_57ab083d-904e-4e53-978c-f5c3da6822ed"
      decimals="INF"
      id="F_d3e4ea83-ad17-44e0-ac24-f89ca459a42b"
      unitRef="U_pure">0.0881</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_e76a7617-4b56-4fc3-99bd-e245633154cb"
      id="F_06a66919-1148-4c29-8ffb-abb9638fdab7">2028-07-27</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_0e5954be-95e4-4557-b760-60d9a28d9308"
      decimals="-5"
      id="F_42368efd-ddef-439a-aa73-e338b4b3486f"
      unitRef="U_USD">28300000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_3bd97afb-8c37-43d8-b09f-783073d2929a"
      decimals="-5"
      id="F_e761f1fd-898b-43de-8f95-ab42a318b59f"
      unitRef="U_USD">28300000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841"
      decimals="-5"
      id="F_2a4ad9ce-3296-4c29-a7a4-4030e3dc940c"
      unitRef="U_USD">20000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_0f9cd5b5-b704-426f-9132-13af5d422b00"
      id="F_9aea9884-a4ff-4861-b730-1c01fefcc5a4">2031-01-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_56dbfd1f-0e69-4d6e-9843-c8ed3ea04841"
      decimals="INF"
      id="F_ea37a1a9-a946-4628-b540-b8a5696879de"
      unitRef="U_pure">0.0821</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="C_a319aa70-1ce6-4734-8031-6b09d4cddad6"
      decimals="0"
      id="F_dec8e319-20e4-4950-aef8-7d499042045f"
      unitRef="U_USD">250000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_a319aa70-1ce6-4734-8031-6b09d4cddad6"
      id="F_6aa99862-ea5e-415e-9590-85924a8bd71d">2031-01-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_d16bace1-c79d-4e87-85bb-17ae493b3326"
      decimals="-5"
      id="F_78c267e7-6172-444b-a8a0-efab522f94c6"
      unitRef="U_USD">19200000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="C_60a42d76-6c9a-4f99-93d9-4550f317d0fa"
      decimals="-5"
      id="F_89742dad-c928-4909-b943-f351306ca4ed"
      unitRef="U_USD">21600000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="C_d16bace1-c79d-4e87-85bb-17ae493b3326"
      decimals="-5"
      id="F_cd0d619f-6030-4cbb-bcc2-8aaa307c3eef"
      unitRef="U_USD">2800000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_0dabe370-4ff1-47bb-bb10-73314840e1c3">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;7.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Accounts Payable and Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,911&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitation payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due to related parties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contract liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other provider payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_82c538f0-8dbf-400a-bb2b-02bf6fcbd1f2">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s accounts payable and accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and other accruals&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,911&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Capitation payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,639&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Subcontractor IPA payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,845&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,512&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,809&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Due to related parties&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,111&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contract liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accrued compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;13,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22,409&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other provider payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_6647b1f7-f12c-43df-b273-0f9da7f6d574"
      unitRef="U_USD">14911000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_1459c1cb-7428-40e6-a4cd-cde2910ca4ff"
      unitRef="U_USD">15168000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <asth:SpecialtyCapitationPayableCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_00260d79-440e-4b64-acb0-01d3e0c86c50"
      unitRef="U_USD">15703000</asth:SpecialtyCapitationPayableCurrent>
    <asth:SpecialtyCapitationPayableCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_47d30673-dade-4e8c-bada-b8389f7ee186"
      unitRef="U_USD">10639000</asth:SpecialtyCapitationPayableCurrent>
    <asth:SubcontractorIPAPayable
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_342ce3be-558a-4704-b204-94829682d91a"
      unitRef="U_USD">1845000</asth:SubcontractorIPAPayable>
    <asth:SubcontractorIPAPayable
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_b52cff7b-8bba-4aab-82d5-cd4d8dca6afd"
      unitRef="U_USD">2486000</asth:SubcontractorIPAPayable>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_949e7963-3c05-438a-9cc2-4aa24fdf0d0c"
      unitRef="U_USD">3512000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_c2cc5e4e-c4ae-4778-ab95-f65741bc5811"
      unitRef="U_USD">5809000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a85d5611-1809-42d8-98e3-ec04c21253bd"
      unitRef="U_USD">7111000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:RelatedPartyDepositLiabilities
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_04ca23f5-0748-4293-b7cb-60a269277d7c"
      unitRef="U_USD">7924000</us-gaap:RelatedPartyDepositLiabilities>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_848a817f-b9cc-472d-9a54-5f77a885e74b"
      unitRef="U_USD">686000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_6b60adbf-0c4f-477a-bdd9-2911c357f050"
      unitRef="U_USD">1606000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_f97a3189-60f9-4d93-93e2-5a87418a2618"
      unitRef="U_USD">13752000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_66c2c25b-2573-4d67-a549-28f1e2533424"
      unitRef="U_USD">22409000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_0e4044c2-923c-40da-bba8-bf94a0f57f25"
      unitRef="U_USD">48039000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_26465ccc-d0fe-4d68-a6eb-00ea592e2564"
      unitRef="U_USD">40101000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_8c56b171-3267-45e3-bf0a-6f89c96740c1"
      unitRef="U_USD">105559000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_de24f929-6fbf-4244-a55f-6c7478eb7493"
      unitRef="U_USD">106142000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_4adf916e-658b-4cc2-8c75-f3553273e206">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;8.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Medical Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities, beginning of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;384,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prior periods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total medical care costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;383,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;233,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;229,701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prior periods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;145,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Claims paid for acquired balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,775&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;380,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities, end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;204,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;136,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_26b422d3-759f-4cbb-85c6-e7fc8ac74ac4">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s medical liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities, beginning of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;209,039&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;106,657&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Acquired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,645&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Components of medical care costs related to claims incurred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;384,479&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,735&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prior periods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total medical care costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;383,821&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;233,316&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Payments for medical care costs related to claims incurred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Current period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;229,701&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prior periods&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;145,938&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;94,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Claims paid for acquired balance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,864&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,775&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:20pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:3.707%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total paid&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;380,503&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,124&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #ffffff03;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="border-top:0.5pt solid #000000;padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities, end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;204,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;136,494&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_6b852635-5695-431f-94ee-7377b75c2c0b"
      unitRef="U_USD">209039000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_988c889e-d2b3-407c-8a0f-fa1da0deabf0"
      decimals="-3"
      id="F_f2fbc662-8e02-467b-8f3b-158273879020"
      unitRef="U_USD">106657000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_37805971-03e3-4d2f-96d4-33287f9b7a56"
      unitRef="U_USD">-8256000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_cf2c5190-b31c-43dd-a7d4-eb9f9df13168"
      unitRef="U_USD">30645000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7c9fbd56-a1f1-48e0-be68-c26adb78019e"
      unitRef="U_USD">384479000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_10f787b8-abc7-4e57-a887-e673b6bdcf68"
      unitRef="U_USD">234735000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_5062960b-9ea7-4ffe-b20d-f19da2454129"
      unitRef="U_USD">-658000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2b591459-f72a-4c21-9d81-87472a05f70a"
      unitRef="U_USD">-1419000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_0b51db38-fa5b-4d1a-92ab-d2d1eb6624ed"
      unitRef="U_USD">383821000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_24bd6453-d19a-4b34-9c24-ebbee7e6ae9d"
      unitRef="U_USD">233316000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_3e7e0003-7663-4c00-8e68-4f4bdd272771"
      unitRef="U_USD">229701000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e8707f9e-860f-4e2c-aed9-278f882d20d1"
      unitRef="U_USD">130014000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_6fbcecd7-6921-49b6-a6e7-2609f2f69a99"
      unitRef="U_USD">145938000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_b07fb665-e5a6-4fb5-9a63-920263e74bc1"
      unitRef="U_USD">94335000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_d4e449cb-a366-4f23-85e9-579829a8a384"
      unitRef="U_USD">4864000</asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance>
    <asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_94f72e41-a4de-4a15-9477-ad4459baf50c"
      unitRef="U_USD">9775000</asth:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidForAcquiredBalance>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_f24eb7f7-aada-429c-8a6d-f2c11e44a454"
      unitRef="U_USD">380503000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_bc0f1e46-13d2-478f-9705-9ac3d378d6e4"
      unitRef="U_USD">234124000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_b493a640-09f5-42e5-a973-aa3d45031527"
      unitRef="U_USD">204101000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="-3"
      id="F_c327fac0-675a-4474-bb3d-beb11b33b532"
      unitRef="U_USD">136494000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_33c0a833-e870-415f-8569-a9d7356a1720">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;9.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Credit Facility, Bank Loans, and Lines of Credit&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s debt balance consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revolver Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;146,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Promissory Note Payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;421,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;438,107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;425,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The estimated fair value of the Company's long-term debt was determined using Level 2 inputs primarily related to comparable market prices. As of March 31, 2025, and December 31, 2024, the carrying value was not materially different from fair value, as the interest rates on the Company&#x2019;s debt approximated rates currently available to the Company.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following are the future commitments, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,437&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;330,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;421,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Credit Facility&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Second Amended and Restated Credit Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On February 26, 2025, the Company entered into the Second Amended and Restated Credit Agreement (the &#x201c;Second Amended and Restated Credit Agreement&#x201d; and the credit facility thereunder, the &#x201c;Second Amended and Restated Credit Facility&#x201d;) with Truist Bank, in its capacities as administrative agent for the lenders, issuing bank, swingline lender and a lender, and the banks and other financial institutions from time to time party thereto, to, among other things, amend and restate that certain amended credit agreement, dated June 16, 2021, by and among the Company, Truist Bank, and certain lenders thereto, in its entirety. The Second Amended and Restated Credit Agreement provides for (a) a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; revolving credit facility (&#x201c;Revolver Loan&#x201d;) to the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, which includes a letter of credit sub-facility of up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and a swingline loan sub-facility of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, (b) a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; term loan A credit facility (&#x201c;Term Loan&#x201d;) to the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million and (c) a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; delayed draw term loan credit facility (&#x201c;DDTL A&#x201d;) to the Company of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;745.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. The term loan A and revolving credit facilities are intended to be used to, among other things, refinance certain existing indebtedness of the Company and certain subsidiaries, pay transactions costs and expenses arising in connection with the Second Amended and Restated Credit Agreement, and provide for working capital needs and other general corporate purposes, and, in addition to the foregoing, the revolving credit facility will also be used to finance certain future permitted acquisitions and permitted investments and capital expenditures. The delayed draw term loan facility will be used to finance the purchase of all of the outstanding equity interests of Prospect Health Services RI, Inc. (d/b/a Prospect ACO Rhode Island), Alta Newport Hospital, LLC (d/b/a Foothill Regional Medical Center), and Prospect Health Plan, Inc., and substantially all the assets of certain direct and indirect subsidiaries of PHP Holdings, LLC (&#x201c;PHPH&#x201d;), subject to customary adjustments, plus the assumption of certain identified liabilities of the sellers party thereto, (the &#x201c;Transaction&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Amounts borrowed under the Second Amended and Restated Credit Agreement bear interest at an annual rate equal to either, at the Company&#x2019;s option, (a) the rate for term Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) published by the CME Group Benchmark Administration Limited two days prior to the first day of the applicable interest period, plus a spread of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, as determined on a quarterly basis based on the Company&#x2019;s leverage ratio, or (b) a base rate, plus a spread of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%, as determined on a quarterly basis based on the Company&#x2019;s leverage ratio. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the Company had outstanding borrowings under the Revolver Loan and Term Loan of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, and the interest rate on both loans was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.82&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Second Amended and Restated Credit Agreement, requires the Company to pay a commitment fee of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.175&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.35&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% multiplied by the daily amount of the unused revolving commitments during the availability period, with such fee determined on a quarterly basis based on the Company&#x2019;s leverage ratio, and a ticking fee on the delayed draw term loan facility of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.175&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.35&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% multiplied by the average daily unused portion of delayed draw term loan commitments, with such fee determined on a quarterly basis based on the Company&#x2019;s leverage ratio. The Company is also required to comply with two financial ratios, each calculated on a consolidated basis. The Company must maintain (commencing with the fiscal quarter ending June 30, 2025) (x) a maximum consolidated total net leverage ratio of not greater than (a) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to 1.00 as of the last day of each fiscal quarter ending prior to March 31, 2027, and (b) &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to 1.00 as of the last day each fiscal quarter thereafter and (y) a minimum consolidated interest coverage ratio of not less than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to 1.00 as of the last day of each fiscal quarter. The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with various affirmative covenants, including, without limitation, furnishing updated financial and other information, preserving existence and entitlements, maintaining properties and insurance, complying with laws, maintaining books and records, requiring any new subsidiary meeting a materiality threshold specified in the Second Amended and Restated Credit Agreement to become a guarantor thereunder and paying obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Second Amended and Restated Credit Agreement requires the Company and its subsidiaries to comply with, and to use commercially reasonable efforts to the extent permitted by law to cause certain material associated practices of the Company to comply with, restrictions on liens, indebtedness and investments (including restrictions on acquisitions by the Company), subject to specified exceptions. The Second Amended and Restated Credit Agreement also contains certain negative covenants binding the Company and its subsidiaries, including restrictions on fundamental changes, dividends and distributions, dispositions, sales and leasebacks, transactions with affiliates, restrictive agreements, use of proceeds, amendments of organizational documents, accounting changes and prepayments and modifications of subordinated debt.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company and its subsidiary, Astrana Health Management, Inc. (&#x201c;AHM&#x201d;), have granted the lenders a security interest in all of their assets, including stock and other equity issued by their subsidiaries, pursuant to the Amended and Restated Guaranty and Security Agreement, dated as of February 26, 2025, by and among the Company, as borrower, and AHM, as guarantor, in favor of Truist Bank, which amends and restates that certain guaranty and security agreement dated as of September 11, 2019, in its entirety. The Second Amended and Restated Credit Agreement contains certain customary events of default. If any event of default occurs and is continuing under the Second Amended and Restated Credit Agreement, the lenders may terminate their commitments, and may require the Company and its guarantors to repay outstanding debt and/or to provide a cash deposit as additional security for outstanding letters of credit. In addition, the agent, on behalf of the lenders, may pursue other remedies, including, without limitation, transferring pledged securities of the Company&#x2019;s subsidiaries in the name of the agent and exercising all rights with respect thereto (including the right to vote and to receive dividends), collect on pledged accounts, instruments and other receivables, and other rights provided by law.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Promissory Note Payable&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;I Health, Inc. Promissory Note Payable &#x2013; Related Party&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On April 1, 2024, the Company issued a promissory note in the amount of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million as a promissory note (the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x201c;I Health Promissory Note&#x201d;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) with a maturity date of March 31, 2027. On March 31, 2024, the Company entered into a purchase agreement for &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in I Health, Inc. (&#x201c;I Health&#x201d;) that included a call option to purchase an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest on each of the first, second, and third anniversaries from when certain triggering events occur (&#x201c;I Health Call Option&#x201d;). I Health may accelerate the maturity date if the Company does not exercise the I Health Call Option&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The promissory note has an interest rate of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; per annum on the principal amount. Accrued interest is payable on each anniversary of the promissory note payable. I Health is accounted for under the equity method based on the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity ownership interest held by the Company (see Note 5 &#x2014; &#x201c;Investments in Other Entities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Equity Method&#x201d;). On July 1, 2024, an amendment was made to the I Health Promissory Note that, among other things, increased the original principal amount by an additional $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the total amount payable under the I Health Promissory Note is &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Deferred Financing Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company paid debt financing costs of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million related to the issuance of the Second Amended and Restated Credit Agreement. Of the $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million debt financing, the Company expensed $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million within other expense on the accompanying condensed consolidated statements of income, and the remaining $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was deferred and amortized over the life of the amended credit facility. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025, unamortized deferred financing costs for the Revolver Loan, DDTL A, and Term Loan, were $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. As of December 31, 2024, unamortized deferred financing costs for the Revolver Loan and Term Loan were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. Deferred financing costs associated with the Term Loan are presented as a direct reduction against the amounts borrowed on the Term Loan and amortized over the life of the loan using the effective interest rate method. D&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;eferred financing costs associated with the Revolver Loan and the DDTL A are recognized in other assets in the accompanying condensed consolidated balance sheets and amortized over the life of the loans using the straight-line method. The deferred financing costs associated with the DDTL A will be presented as a direct reduction against the amounts borrowed and amortized using the effective interest rate method when the draw is made. Interest expense in the condensed consolidated statements of income includes amortization of deferred debt issuance costs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Effective Interest Rate&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s average effective interest rate on its total debt during the three months ended March 31, 2025 and 2024, was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.51&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. Interest expense in the condensed consolidated statements of income included amortization of deferred debt issuance costs for the three months ended March 31, 2025 and 2024 of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;,  &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Lines of Credit&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;APC Business Loan&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On September 10, 2019, the APC Business Loan Agreement with Preferred Bank (the &#x201c;APC Business Loan Agreement&#x201d;) was amended to, among other things, decrease loan availability to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, limit the purpose of the indebtedness under the APC Business Loan Agreement to the issuance of standby letters of credit, and include as a permitted lien, the security interest in all of its assets that APC granted to AHM under a Security Agreement dated on or about September 11, 2019, securing APC&#x2019;s obligations to AHM under their management services agreement dated as of July 1, 1999, as amended.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Standby Letters of Credit&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company established irrevocable standby letters of credit with Truist Bank under the Second Amended and Restated Credit Agreement for a total of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of CMS and certain health plans as of March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Unless the institution provides notification that the standby letters of credit will be terminated prior to the expiration date, the letters will be automatically extended without amendment for additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; periods from the present or any future expiration date.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank under the APC Business Loan Agreement for a total of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of certain health plans as of March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The standby letters of credit are automatically extended without amendment for additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one-year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; periods from the present or any future expiration date, unless notified by the institution in advance of the expiration date that the letter will be terminated.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_f9ae7a90-916a-47ef-9c29-0f4ee7cc2f0f">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s debt balance consisted of the following (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31,&lt;br/&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Term Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;250,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;281,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revolver Loan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;162,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;146,732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Promissory Note Payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;421,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;438,107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: Unamortized financing costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,481&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,433&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;403,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;425,299&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4"
      decimals="-3"
      id="F_c1c4b2ef-0c93-41e9-950d-16a09ed5608b"
      unitRef="U_USD">250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2"
      decimals="-3"
      id="F_31f97cd3-ca31-4b26-bb66-50de95ff3e0b"
      unitRef="U_USD">281500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_2a253766-549b-48d9-804a-32af249a20f3"
      decimals="-3"
      id="F_a3ced6eb-e5aa-42e0-848f-eac40c714f14"
      unitRef="U_USD">162000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_242c5ffa-94be-4093-910a-0097e423df05"
      decimals="-3"
      id="F_a70839c7-62fa-4fde-9ad2-5f6cdf57c822"
      unitRef="U_USD">146732000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_4b85094b-d44b-4343-9073-a47a57dcafe2"
      decimals="-3"
      id="F_bf414df7-b82d-4c4e-aba4-6468387d77fe"
      unitRef="U_USD">9875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_0fb6e99b-fca4-44d8-ad37-70ea90786ce7"
      decimals="-3"
      id="F_fc267d34-6d9a-4553-a832-a71e1cb72837"
      unitRef="U_USD">9875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_935481f8-3613-4960-b7a9-d27da3fd127f"
      unitRef="U_USD">421875000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_34aa8810-d8fd-47ef-871b-6150d8fb9416"
      unitRef="U_USD">438107000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_2ae4ac49-002b-4948-908e-99c6ff4d0e95"
      unitRef="U_USD">12500000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_6859543a-c65c-408a-9fc7-6276af1fd0a6"
      unitRef="U_USD">9375000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_088be745-5d6c-449b-91f2-a3dcd33be6be"
      unitRef="U_USD">5481000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_2460409f-634f-428a-9017-afbc4921abcf"
      unitRef="U_USD">3433000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ac8e650a-6fb2-4a5a-b9e7-aadf4c034c42"
      unitRef="U_USD">403894000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_53d5527b-9dc1-493a-ab76-5f0842ed8c62"
      unitRef="U_USD">425299000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_34aed7d4-f529-48f5-8c68-33387d55747d">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following are the future commitments, as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, of the Company&#x2019;s debt for the years ending December 31 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,500&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;18,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;23,437&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;330,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;421,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ac607544-8be5-4e06-bee1-bf56db669a93"
      unitRef="U_USD">9375000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_c44a48fe-6b20-4b50-a178-af87361b0839"
      unitRef="U_USD">12500000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_7bf93a68-ed17-4899-8ae3-e282d1ce10c0"
      unitRef="U_USD">27063000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_547c11b4-fdab-4630-8d02-674ce5a877e4"
      unitRef="U_USD">18750000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_f905df79-92c4-40ad-a5a2-7ed39b947017"
      unitRef="U_USD">23437000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <asth:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_7ecd4cb9-84a6-4eb5-8741-9ba29bc2bd97"
      unitRef="U_USD">330750000</asth:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour>
    <us-gaap:LineOfCredit
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_04e6d336-d876-4494-b684-705250c645e3"
      unitRef="U_USD">421875000</us-gaap:LineOfCredit>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_b959fdf1-fcd8-4458-9fe1-8862724296dc"
      id="F_929f034d-a2e3-4705-88a1-ecbcf43cb9c8">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_236ccab9-0279-431e-981f-890a827b1ca0"
      decimals="-5"
      id="F_e24d5ac1-857e-4348-8892-738417381762"
      unitRef="U_USD">300000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_f29b54ab-fc06-4669-ae02-d8718105c456"
      decimals="-5"
      id="F_e5b977a9-f379-447b-bba2-4027944b738a"
      unitRef="U_USD">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_daa1fc75-315e-4a15-918b-4217def968f5"
      decimals="-5"
      id="F_1495045d-7384-4c99-bca4-debf243f96f6"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_8297f21e-2dac-46a3-bf2e-4b0c2ff5c175"
      id="F_712b4b71-098d-417b-afd9-8f1d8bb650fd">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6afa4315-6042-4fb4-bfdb-562cff61568e"
      decimals="-5"
      id="F_d3671b86-3c63-4060-affe-dad71f194fb9"
      unitRef="U_USD">250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="C_0e18f7d0-badd-4b78-96bc-454449d1877e"
      id="F_78607df2-bb79-40ef-83f5-790d6922f339">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_7d764929-a2f0-4c7b-b54b-eba37cf55e23"
      decimals="-5"
      id="F_762da20d-fabc-43a8-8c66-2e44130bf7da"
      unitRef="U_USD">745000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_9da713da-4bde-499d-850b-07a0b56f32e7"
      decimals="INF"
      id="F_d3841c53-41c9-4b8f-89ed-b012bda71959"
      unitRef="U_pure">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_ec8f7056-c0e7-4865-bfc9-cc405c953592"
      decimals="INF"
      id="F_fd6ed1bd-95ec-4f3f-955d-7fcc70fa16dc"
      unitRef="U_pure">0.025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_db9d68bb-77fd-49e6-9bc0-d0eaff33c66d"
      decimals="INF"
      id="F_bd1a6ef2-4e6e-4aee-9dd1-dc9e8ac3e240"
      unitRef="U_pure">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_afa4f934-11e5-4c39-b49b-0cb4a0e75483"
      decimals="INF"
      id="F_fb67849d-74a7-4b4a-b55d-6c40287245d3"
      unitRef="U_pure">0.015</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_3b49047f-ac09-4d40-b78d-73c4e56f102a"
      decimals="-5"
      id="F_263b3804-04ab-4314-ba9e-05eb9a255158"
      unitRef="U_USD">162000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="C_5f9b3463-0249-4f81-a7e3-f5f9afa4f5c1"
      decimals="-5"
      id="F_4796dbd6-739c-4fd9-8934-30484230f17a"
      unitRef="U_USD">250000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_dbba92a9-68bd-4064-8de3-f595e744099a"
      decimals="4"
      id="F_07482c68-0806-4446-a19c-977312685d71"
      unitRef="U_pure">0.0582</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_6177be07-fab5-40c9-821f-deabcadf9b27"
      decimals="4"
      id="F_8a7f3dbe-8c78-4d6f-a8f6-1cf9c70a6344"
      unitRef="U_pure">0.0582</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d"
      decimals="INF"
      id="F_87843aef-2f11-45c3-a4cf-840364fa1dc7"
      unitRef="U_pure">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7"
      decimals="INF"
      id="F_33b535a0-c83e-4175-a2c2-f8c0231a8628"
      unitRef="U_pure">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="C_1f9a94fd-e0e0-4c41-a741-a6dcb307232d"
      decimals="INF"
      id="F_5f646cd2-5b8a-42f2-864e-7369ae2cd04b"
      unitRef="U_pure">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="C_6bd40b10-b1e7-4481-9c33-745a25bcadf7"
      decimals="INF"
      id="F_b176b102-347a-44d5-b0f4-5e4de6a0b09f"
      unitRef="U_pure">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <asth:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="C_d68d3e73-1a37-4898-87db-e2b73a6e4347"
      decimals="2"
      id="F_4d4e9be8-75e2-4c6e-93ec-6475c6c18a16"
      unitRef="U_pure">5</asth:DebtInstrumentCovenantLeverageRatioMaximum>
    <asth:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="C_c1a29941-265e-47ee-bfab-5f1290b6297b"
      decimals="2"
      id="F_16bd97e4-e1bf-4ff8-b397-a9bf99c963c0"
      unitRef="U_pure">4.5</asth:DebtInstrumentCovenantLeverageRatioMaximum>
    <asth:DebtInstrumentCovenantInterestCoverageRatioMinimum
      contextRef="C_787cb7d7-ebc8-4665-80e3-627cd2d9a92c"
      decimals="2"
      id="F_bdf9c76f-4eb7-4a05-8095-470029d70e50"
      unitRef="U_pure">2.5</asth:DebtInstrumentCovenantInterestCoverageRatioMinimum>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="C_dc7280cd-a579-4b3e-92cd-3b6923b763e6"
      decimals="-5"
      id="F_29d67da5-bfc5-4444-90ab-1b8a47fbd22d"
      unitRef="U_USD">8300000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="2"
      id="F_2dedd3ce-9071-45d8-80fa-0a639ea0b997"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="2"
      id="F_77776a58-be3d-4af7-86b6-6c945c6fd03f"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="C_985081e2-9a89-4282-bea5-465c5a88d3d2"
      decimals="4"
      id="F_78337b2e-f480-4082-872b-0fe53028203c"
      unitRef="U_pure">0.043</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c"
      decimals="2"
      id="F_e85e4108-cc2e-4bbc-a803-698411897fc1"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <asth:DebtInstrumentIncreaseInOriginalPrincipalAmount
      contextRef="C_08b0fafe-b67b-4bd9-9a48-7f4c5f138bed"
      decimals="-5"
      id="F_385c69c7-48a9-42b5-b9a7-6462d5d8a93c"
      unitRef="U_USD">1600000</asth:DebtInstrumentIncreaseInOriginalPrincipalAmount>
    <us-gaap:NotesAndLoansPayable
      contextRef="C_b8b87b9c-e6a0-406d-818f-112b6825b4cc"
      decimals="-5"
      id="F_7f94bcad-b2c5-466c-b881-9f0a8bc23568"
      unitRef="U_USD">9900000</us-gaap:NotesAndLoansPayable>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="C_6400c1e2-a6bb-49bc-af77-e72305173422"
      decimals="-5"
      id="F_ff9cecf1-dbbc-4bf8-baf0-7215ec6f4343"
      unitRef="U_USD">22200000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_4ac6556a-4a7b-4fcd-a557-f13951e80817"
      unitRef="U_USD">22200000</us-gaap:DeferredFinanceCostsNet>
    <asth:DebtFinancingExpense
      contextRef="C_4a4ecf0b-afe3-484c-ad85-f7a6579c67a9"
      decimals="-5"
      id="F_791598ff-37af-4c57-9dac-b0c7ecdd957c"
      unitRef="U_USD">5000000</asth:DebtFinancingExpense>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="C_9af99720-afab-41bf-8f18-b88302257d99"
      decimals="-5"
      id="F_9dbc0e6f-2fe2-4a3a-b335-f3746df24b0b"
      unitRef="U_USD">17200000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_47d471b9-bc25-4bfd-ba7e-f4308580c360"
      decimals="-5"
      id="F_04d9f4ed-32ce-46c0-b140-f3bf1f76fcc3"
      unitRef="U_USD">6100000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_b427f9b8-5e88-4171-8639-300cf97af194"
      decimals="-5"
      id="F_b86d8f2e-e910-4ea7-a7da-53d39810a906"
      unitRef="U_USD">8900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_2c97c8a7-7624-4a41-96c6-f4a38dea4df4"
      decimals="-5"
      id="F_bdd6c039-3af5-4701-88d7-98b949d8108b"
      unitRef="U_USD">5500000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_fb36bf2b-c780-4ab2-b3b8-d365c11db5d8"
      decimals="-5"
      id="F_b80fd97f-50d4-4579-9484-ec211c32efd3"
      unitRef="U_USD">900000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="C_49a4fc34-7aae-493b-9b2f-24d8dd587af2"
      decimals="-5"
      id="F_7073656c-ac10-444a-9fb1-df0f3ed20ce7"
      unitRef="U_USD">3400000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="4"
      id="F_4957370b-ae0d-479a-a45d-97ba8aaefe49"
      unitRef="U_pure">0.0696</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="4"
      id="F_39d885eb-f545-4ce2-913a-c9d514e29313"
      unitRef="U_pure">0.0651</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestExpense
      contextRef="C_0bde49a3-f8b1-43f5-93b8-2a4f2689faf3"
      decimals="-5"
      id="F_52e08712-9ee8-4e63-8fb4-1da168402b22"
      unitRef="U_USD">700000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_0e90a0d4-f745-48d9-a24b-c58b53cc0548"
      decimals="-5"
      id="F_2e559feb-67e9-45d0-a79c-6f1d19a3d2a5"
      unitRef="U_USD">500000</us-gaap:InterestExpense>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_ae5e6aed-1503-498b-a58c-7a51d4fe9172"
      decimals="-5"
      id="F_4fbd2575-ceca-4721-b5f7-a36394481142"
      unitRef="U_USD">4100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_59d235ce-9711-4ef0-bfda-f40da6b2866b"
      decimals="-5"
      id="F_4cfe9ae2-b157-4a40-9861-fd86366b79ed"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_8e631b93-40e7-40d3-8326-b5618bb62eed"
      id="F_848e761c-d5a4-41ac-a618-8f64c98c73ee">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_c98c4392-4a16-456e-9225-81de0aeddc35"
      decimals="-5"
      id="F_4007f4d3-cafa-4652-b040-507e38d95de3"
      unitRef="U_USD">2100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationPeriod
      contextRef="C_de80ca92-733d-4d31-8fc9-bb3a6ff69c9c"
      id="F_e588aae8-912d-484d-a654-5e2c93d4aafd">P1Y</us-gaap:LineOfCreditFacilityExpirationPeriod>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_2e663bd3-ff8c-4454-a25c-647f645450ba">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;10.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Mezzanine Deficit and Stockholders&#x2019; Equity&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Mezzanine Deficit&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;APC&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As the redemption feature of APC&#x2019;s shares of common stock is not solely within the control of APC, the equity of APC does not qualify as permanent equity and has been classified as non-controlling interests in mezzanine or temporary equity. APC&#x2019;s shares were not redeemable, and it was not probable that the shares would become redeemable as of March 31, 2025 and December 31, 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, APC repurchased $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of its common stock from its shareholders. There was no similar type of repurchase during the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Stockholders&#x2019; Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,048&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; holdback shares have not been issued to certain former AHM shareholders who were AHM shareholders at the time of closing of the 2017 merger of Astrana with AHM, as they have yet to submit properly completed letters of transmittal to Astrana in order to receive their &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;pro rata &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;portion of Astrana common stock as contemplated under the 2017 merger agreement. Pending such receipt, such former AHM shareholders have the right to receive, without interest, their pro rata share of dividends or distributions with a record date after the effectiveness of the 2017 merger. The condensed consolidated financial statements have treated such shares of common stock as outstanding, given the receipt of the letter of transmittal is considered perfunctory, and the Company is legally obligated to issue these shares in connection with the 2017 merger.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Treasury Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025 and December 31, 2024, APC owned &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,132,802&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,132,698&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of Astrana&#x2019;s common stock, respectively. While such shares of Astrana&#x2019;s common stock are legally issued and outstanding, they are treated as treasury shares for accounting purposes and excluded from shares of common stock outstanding in the condensed consolidated financial statements. APC&#x2019;s ownership in Astrana was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11.13&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12.96&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of March 31, 2025 and December 31, 2024, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025, the Company repurchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of the Company&#x2019;s common stock from APC, pursuant to a stock repurchase agreement dated &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;January 17, 2025&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for an aggregate purchase price of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of March 31, 2025 and December 31, 2024, the Company had repurchased &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,771,151&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,471,151&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares, respectively, of its common stock. These are included as treasury stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#x2019;s stock held by APC, was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;white-space:pre-wrap;font-kerning:none;min-width:fit-content;color:#000000;"&gt;9,903,953&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,603,849&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, certain consolidated subsidiaries of the Company paid distributions of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to the shareholders who own the non-controlling interests in the entities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025, the APC board approved the distribution of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;699,896&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of the Company&#x2019;s shares and a cash distribution of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to its shareholders. During the three months ended March 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; dividends were declared to the APC shareholders.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_3e76e350-ea44-40df-b69e-b28234065741"
      decimals="-5"
      id="F_f01dd106-fb9d-48a8-8e74-9ada690c4d26"
      unitRef="U_USD">1300000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <asth:StockIssuedDuringPeriodSharesMerger
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_428e9afc-b82f-492f-9093-84a20ab16761"
      unitRef="U_shares">41048</asth:StockIssuedDuringPeriodSharesMerger>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc"
      decimals="INF"
      id="F_4ee1d960-ebbb-4d23-8aa0-72b4f8d5f27a"
      unitRef="U_shares">6132802</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_99d1dd55-3e68-4959-ba9e-eff028c809f0"
      decimals="INF"
      id="F_3168f39c-c90b-47b0-acfd-46364f46883a"
      unitRef="U_shares">7132698</us-gaap:TreasuryStockCommonShares>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_1c3552b0-b03a-4553-a29c-97b040f5699e"
      decimals="4"
      id="F_8fdcfb04-8cc7-41b5-8f94-011fd59180b5"
      unitRef="U_pure">0.1113</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_da904c7b-408c-409f-b2c0-a578207cb75a"
      decimals="4"
      id="F_ce680b39-2477-4367-a9ad-ed02db7318cf"
      unitRef="U_pure">0.1296</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_7cbe100d-8f5d-4f13-be57-b34030a71745"
      unitRef="U_shares">300000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:RepurchaseAgreementDate
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_9e04baac-cf9e-424b-ba1f-76b2441055f2">2025-01-17</us-gaap:RepurchaseAgreementDate>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-5"
      id="F_6957b90a-7a8f-4fca-acb4-d6ac0b361672"
      unitRef="U_USD">10600000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_5e38c600-349e-40d5-8fce-b846b9f2596c"
      unitRef="U_shares">3771151</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="C_226ae331-0b66-42c0-b281-4563dffea1fe"
      decimals="INF"
      id="F_1e712da2-d025-48ac-9ab9-3d7dc7e4e636"
      unitRef="U_shares">3471151</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_f30cbeac-b9ab-48fd-96ce-75af5d6e0bfa"
      decimals="INF"
      id="F_e2ea05c8-638f-4def-a45b-58d20639cdc2"
      unitRef="U_shares">9903953</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="C_8b0919d3-15a4-433c-a537-c7cf98fef70b"
      decimals="INF"
      id="F_16653edc-388e-4e8e-8347-08bcd9b0a6fa"
      unitRef="U_shares">10603849</us-gaap:TreasuryStockCommonShares>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_8d32a733-9808-4cd7-b7c0-f21ceeb7f902"
      decimals="-5"
      id="F_cf316cb5-bc57-47a6-be1d-2024f1b80e07"
      unitRef="U_USD">100000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_c3edf28a-a238-40d2-bd32-23ef178885d8"
      decimals="-5"
      id="F_ca7a982e-da3c-4ff5-ae91-625338c16d8b"
      unitRef="U_USD">100000</us-gaap:PaymentsOfDividendsCommonStock>
    <asth:DistributionOfShares
      contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc"
      decimals="INF"
      id="F_4a4dc84c-3cdc-43d3-a170-d14a42992b43"
      unitRef="U_shares">699896</asth:DistributionOfShares>
    <us-gaap:DistributionPayable
      contextRef="C_f0fa5d05-09ae-4f4d-9849-aca8a16d17dc"
      decimals="-5"
      id="F_be45f182-a918-474d-a2be-066a070c5c06"
      unitRef="U_USD">5400000</us-gaap:DistributionPayable>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_6576bf12-444e-4d4e-b361-dc0763d5edca"
      decimals="INF"
      id="F_f92845f8-ef4d-4bab-9554-516be7727f9b"
      unitRef="U_USD">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_cb2d03f3-f0b6-4855-86da-1d4a729e3d64">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;11.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024, and associated with the issuance of restricted shares of common stock and restricted stock units and vesting of stock options that are included in general and administrative expenses in the accompanying condensed consolidated statements of income (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.391%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.424%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.424%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options and ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards and units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,748&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Unrecognized compensation expense related to total share-based payments outstanding as of March 31, 2025, was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Restricted Stock Awards and Units&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company grants restricted stock awards and units to officers and employees, which are earned based on service and/or performance conditions. The awards will vest over a period of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;four years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in accordance with the terms of those plans. The grant date fair value of the restricted stock awards and units are the grant date&#x2019;s closing market price of the Company&#x2019;s common stock. During the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025, the Company granted &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;417,787&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of restricted stock awards and units with performance-based conditions and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;234,516&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of restricted stock awards and units without performance-based conditions. During the three months ended March 31, 2025, the weighted average grant date fair value of restricted stock awards and units with and without performance-based conditions was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.30&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27.61&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. Shares of restricted stock awards and units with performance-based conditions are recognized to the extent that the performance conditions are probable of being achieved.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s ESPP is a shareholder-approved plan that allows eligible employees to contribute a portion of their eligible earnings toward the semi-annual purchase of the Company&#x2019;s common stock at a discounted price equal to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;85&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;90&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the fair market values of the stock on the exercise date, subject to a maximum number of shares that can be purchased during any single offering period as well as an annual maximum dollar amount of shares during any single calendar year. A maximum of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,000,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares were authorized for issuance at the time the ESPP was approved. There were &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,683&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares issued for the three months ended March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_c90a0a13-eae3-4d99-bc16-52653d055ee2">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table summarizes the stock-based compensation expense recognized under all of the Company&#x2019;s stock plans for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024, and associated with the issuance of restricted shares of common stock and restricted stock units and vesting of stock options that are included in general and administrative expenses in the accompanying condensed consolidated statements of income (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:55.391%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.424%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.88%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:18.424%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options and ESPP&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;349&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards and units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,811&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,748&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5b31a718-c1c9-490e-911d-86d1062a0eeb"
      decimals="-3"
      id="F_bc695b21-69e4-4db0-8f72-3660b2dad01a"
      unitRef="U_USD">70000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_80e76537-df9f-428c-93ad-7da9d13bb50d"
      decimals="-3"
      id="F_d955549a-6b9a-4007-b1af-d59c16b2bce3"
      unitRef="U_USD">349000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_697ba52d-2244-440b-9f20-87f75a1b40f6"
      decimals="-3"
      id="F_16d3632e-efdf-4835-83cc-74094780981e"
      unitRef="U_USD">7741000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_1b553b00-2fc0-4ac1-92a8-7cfe88881549"
      decimals="-3"
      id="F_a7d81105-2afb-48c2-8c64-c1ec073d478c"
      unitRef="U_USD">5399000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_735c788b-58a8-45d5-b78c-4864dd70430d"
      unitRef="U_USD">7811000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_55a932fe-b530-4d12-8990-04c37c1dcefe"
      unitRef="U_USD">5748000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_815a18b7-1463-4bcd-9316-30975c90595a"
      unitRef="U_USD">44500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_439f009f-2b98-4cfc-ba9d-62cbb1adf7e2"
      id="F_5b693fad-f92e-44a0-a212-4f3dabb62cf7">P1M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_db55fdec-4a85-4b80-a8d7-2659a2923a15"
      id="F_588234a6-710a-474f-aecb-194820de1dce">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a"
      decimals="INF"
      id="F_e8dd1e2f-28bc-4463-a4c9-589168b24c2a"
      unitRef="U_shares">417787</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance
      contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a"
      decimals="INF"
      id="F_6efeae88-1fb2-4fff-a768-75f1d19c2f15"
      unitRef="U_shares">234516</asth:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsContingentOnPerformance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_b6707bb2-894d-4ef5-b67b-4a9d78165cd2"
      decimals="2"
      id="F_5b6c5bd7-baf6-45ce-bdc0-bdc66173472e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.3</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_aa5d58aa-32bc-45e7-a457-8a3701b7fd2a"
      decimals="2"
      id="F_9af1ff7b-cd7a-4ae0-8585-11174ce89b4d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">27.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <asth:CommonStockDiscountedPricePercentage
      contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178"
      decimals="INF"
      id="F_2048a980-ae27-4936-a1f2-3695d7ed69d6"
      unitRef="U_pure">85</asth:CommonStockDiscountedPricePercentage>
    <asth:CommonStockDiscountedPricePercentageMaximum
      contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178"
      decimals="INF"
      id="F_38629d60-8ddd-4193-92bf-13a34e4d9d6d"
      unitRef="U_pure">90</asth:CommonStockDiscountedPricePercentageMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_d73d22c6-9b06-42af-885b-ab1ea9552178"
      decimals="INF"
      id="F_57480b13-1cc9-410c-9289-f5943908e779"
      unitRef="U_shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_bc706d77-b234-4219-a756-b209e89583d1"
      unitRef="U_shares">10683</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_15bae1ca-88f7-4840-8d0e-d425fe077b8e">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;12.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Regulatory Matters&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Laws and regulations governing the Medicare program and healthcare generally are complex and subject to interpretation. The Company believes it complies with all applicable laws and regulations and is unaware of any pending or threatened investigations involving allegations of potential wrongdoing. While no regulatory inquiries have been made, compliance with such laws and regulations can be subject to future government review and interpretation, as well as significant regulatory action, including fines, penalties, and exclusion from the Medicare and Medi-Cal programs.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As a risk-bearing organization, the Company is required to follow the regulations of the Department of Managed Health Care (&#x201c;DMHC&#x201d;). The Company must comply with a minimum working capital requirement, a tangible net equity (&#x201c;TNE&#x201d;) requirement, a cash-to-claims ratio, and claims payment requirements prescribed by the DMHC. TNE is defined as net assets less intangibles, less non-allowable assets (which include amounts due from affiliates), plus subordinated obligations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Many of the Company&#x2019;s payer and provider contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of medical services. Such differing interpretations may not come to light until a substantial period of time has passed following contract implementation. Liabilities for claims disputes are recorded when the loss is probable and can be estimated. Any adjustments to reserves are reflected in current operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Standby Letters of Credit and Surety Bonds&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company established irrevocable standby letters of credit with Truist Bank for a total of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of CMS and certain health plans as of March 31, 2025 (see Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain IPAs consolidated by the Company established irrevocable standby letters of credit with Preferred Bank for a total of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; for the benefit of certain health plans as of March 31, 2025 (see Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit &#x2014; Standby Letters of Credit&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company currently has several surety bonds as required by CMS. The bonds total approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;46.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the aggregate, as of March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. The bonds expire on various dates through &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2030&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Litigation&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company is involved in various legal proceedings and other matters arising in the normal course of its business. Currently, management does not believe the Company is a party to any legal proceedings that would have a material adverse effect on its operations. The Company continuously evaluates potential contingencies and will accrue liabilities as necessary. However, the resolution of any claim or litigation is inherently uncertain and could impact the Company&#x2019;s financial condition, cash flows, or results of operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Liability Insurance&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company believes that its insurance coverage is appropriate based upon the Company&#x2019;s claims experience and the nature and risks of the Company&#x2019;s business. In addition to the known incidents that have resulted in the assertion of claims, the Company cannot be certain that its insurance coverage will be adequate to cover liabilities arising out of claims asserted against the Company, the Company&#x2019;s affiliated professional organizations or the Company&#x2019;s affiliated hospitalists in the future where the outcomes of such claims are unfavorable. The Company believes that the ultimate resolution of all pending claims &#x2014;  including liabilities in excess of the Company&#x2019;s insurance coverage &#x2014; will not have a material adverse effect on the Company&#x2019;s financial position, results of operations, or cash flows; however, there can be no assurance that future claims will not have such a material adverse effect on the Company&#x2019;s business. Contracted physicians are required to obtain their own insurance coverage.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Although the Company currently maintains liability insurance policies on a claims-made basis which are intended to cover malpractice liability and certain other claims, the coverage must be renewed annually, and may not continue to be available to the Company in future years at acceptable costs and on favorable terms.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_bca3f795-036a-486d-b7b3-5bde30763876"
      decimals="-5"
      id="F_60099a85-28bb-436b-8c8c-4bac3abd7f47"
      unitRef="U_USD">25000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_6d80e85a-168e-4e9b-80f3-ccebe319846c"
      decimals="-5"
      id="F_f882104c-a9a3-47ab-a8cc-7d73386b6cb8"
      unitRef="U_USD">2100000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="C_4fbc38e4-4839-4ebf-a373-b96ad86a302b"
      decimals="-5"
      id="F_8c0fdce5-1ed7-4e24-ba69-53254485e6e2"
      unitRef="U_USD">46400000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityExpirationDate1
      contextRef="C_69d8a835-e946-435c-8b6b-b394071da012"
      id="F_b33e11f9-1307-4aad-bc0d-c586ee18130d">2030-12-31</us-gaap:LineOfCreditFacilityExpirationDate1>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_95a52cd6-ba62-4404-bcae-910a523fb911">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;13.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Related-Party Transactions&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Equity Method Investments&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company paid approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to Pacific Medical Imaging &amp;amp; Oncology Center, Inc. (&#x201c;PMIOC&#x201d;) for provider services. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;PMIOC provides covered services on behalf of the Company&#x2019;s RBOs to enrollees of the plans. PMIOC is accounted for under the equity method based on the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity ownership interest held (see Note 5 &#x2014; &#x201c;Investments in Other Entities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2013; Equity Method&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During each of the three months ended March 31, 2025, the Company paid approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, for provider services to an equity method investment in which the Company has a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity ownership. (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2013; Equity Method&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025, the Company incurred expenses of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in management fees and interest expense to I Health. The Company has a management service agreement and promissory note payable&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; with I Health. I Health is accounted for under the equity method based on the &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity ownership interest held (see Note 5 &#x2014; &#x201c;Investments in Other Entities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2013; Equity Method&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025, the Company recognized approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in management fee income from equity method investments acquired through the CHS acquisition. The Company owns &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; - &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;51&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in these investments. These investments are accounted for under the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;equity method (see Note 5 &#x2014; &#x201c;Investments in Other Entities &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2013; Equity Method&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Astrana Board Members and Officers&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company recognized approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in expenses and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, in revenue, net of expenses, from Arroyo Vista Family Health Center (&#x201c;Arroyo Vista&#x201d;), respectively. Revenue consisted of management fees and surplus from shared risk arrangements. Expenses consisted of fees for provider services. Arroyo Vista&#x2019;s chief executive officer is a member of the Company&#x2019;s board of directors. Arroyo Vista is a non-profit network of community health centers serving Greater Northeast Los Angeles. Arroyo Vista provides certain primary care services to enrollees of certain healthcare service plans, the providers of which have contracted with our affiliates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company incurred rent expenses of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, from certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. As of March 31, 2025, and December 31, 2024, the Company&#x2019;s operating right-of-use asset balance included &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, and the Company&#x2019;s operating lease liabilities included &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, for certain properties that are managed by Allied Pacific Holdings Investment Management, LLC. The chief executive officer of Allied Pacific Holdings Investment Management, LLC is a member of the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has a Simple Agreement for Future Equity ("SAFE") with Third Way Health (see Note 5 &#x2014; &#x201c;Investments in Other Entities"). As of March 31, 2025 and December 31, 2024 the investment was $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. During the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024, the Company incurred approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, in expenses payable to Third Way Health for call center and credentialing services. One of Astrana&#x2019;s officers is a board member of Third Way Health.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company paid approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;45,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to Sunny Village Care Center for services as a provider. The Company has provider contracts with Sunny Village Care Center. Sunny Village Care Center shares common ownership with certain Astrana board members.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company incurred rent expense of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to First Commonwealth Property, LLC for an office lease. First Commonwealth Property, LLC shares common ownership with certain board members of APC and AHM. As of March 31, 2025 and December 31, 2024, the Company&#x2019;s operating right-of-use asset balance included &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, and the Company&#x2019;s operating lease liabilities included &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, for certain properties owned by &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;First Commonwealth Property, LLC.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has agreements with Health Source MSO Inc., a California corporation (&#x201c;HSMSO&#x201d;), Aurion Corporation (&#x201c;Aurion&#x201d;), and AHMC Healthcare Inc. (&#x201c;AHMC&#x201d;) for services provided to the Company. One of the Company&#x2019;s board members is an officer of AHMC, HSMSO and Aurion and is the sole owner of Aurion. Revenue with AHMC and HSMSO consists of capitation, risk pool, and miscellaneous fees, and expenses consisting of claims expenses, management fees, and consulting fees.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables set forth revenue recognized and fees incurred related to AHMC, HSMSO, and Aurion for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:32.667%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;HSMSO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aurion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;HSMSO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aurion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company and AHMC have a risk-sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. Under this agreement, during the three months ended March 31, 2025 and 2024, the Company had recognized risk pool revenues of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. As of March 31, 2025 and December 31, 2024,  &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; remained in outstanding risk pool receivables, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;APC Board Members&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the three months ended March 31, 2025 and 2024, the Company paid an aggregate of approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to board members for provider services and repurchase of APC shares of common stock, which included approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, to Astrana board members and officers who are also board members and officers of APC.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In addition, affiliates wholly owned by the Company&#x2019;s key personnel are reported in the accompanying condensed consolidated statements of income on a consolidated basis, together with the Company&#x2019;s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company&#x2019;s subsidiaries as related-party transactions.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Intercompany Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Because of corporate practice of medicine laws, the Company uses designated shareholder professional corporations, of which the sole shareholder is a member of the Company&#x2019;s key personnel, to engage in certain transactions and make intercompany loans from time to time.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For equity method investments and promissory note payable with related parties, see Note 5 &#x2014; &#x201c;Investments in Other Entities  &#x2014; Equity Method&#x201d; and Note 9 &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit,&#x201d; respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_e7d1b03b-c982-4a71-9cb6-b34b0f7c2e9b"
      decimals="-5"
      id="F_112d520c-9ca3-44e4-bc4d-524d5d4e98e8"
      unitRef="U_USD">700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_e1740a99-900b-4902-9d5e-4d630ead0b03"
      decimals="-5"
      id="F_b5c13c87-d7cd-4fc7-aa09-5980afddf711"
      unitRef="U_USD">800000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_57c79a78-9732-4080-9239-22b71e33c266"
      decimals="2"
      id="F_bd0793fe-635e-400e-ab14-ab836377ffe3"
      unitRef="U_pure">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_9e346eab-38d7-402b-bf8f-0d60cb0107a1"
      decimals="-5"
      id="F_00d963bc-ff7a-448a-8ad1-9da709674d88"
      unitRef="U_USD">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_c41d3eed-30db-4a53-8251-e8161f2a5685"
      decimals="-5"
      id="F_098cda05-ff2f-471b-a75a-c03a1f1d7825"
      unitRef="U_USD">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_7acb6b6e-5f3d-4e08-a797-82f25588ef01"
      decimals="2"
      id="F_16a0deb4-cc11-4294-bf05-dd3072afa046"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_820936f1-0951-4659-b917-23fcb1da4cbf"
      decimals="-5"
      id="F_8081f128-f17c-4b2c-ab80-6fb6e8ff14db"
      unitRef="U_USD">700000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_09899d00-c1d0-4fb6-87d6-b0b1c313501c"
      decimals="2"
      id="F_10e07e34-1dda-4c02-a737-7ed1b1d9657f"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="C_a1674af8-635b-46ac-b060-061caa2787f0"
      decimals="-5"
      id="F_b30cd143-6ca9-4430-af04-54d07bc1c9c2"
      unitRef="U_USD">900000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_423ede0d-20f9-4418-b336-259b500c9fd8"
      decimals="2"
      id="F_a09fe12c-3a1f-494d-b84c-5e948a0a4918"
      unitRef="U_pure">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_a103be58-2da8-49dd-aac7-8114b8e1d475"
      decimals="2"
      id="F_a8f6de44-14da-46c6-a54b-092fbe7fe9d8"
      unitRef="U_pure">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_0bcf495d-f6c9-4ab7-acd8-a670125428f4"
      decimals="-5"
      id="F_d9248870-2432-4991-a438-f117569cb817"
      unitRef="U_USD">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_69535d23-6b5a-4866-b0c2-b2062e9d8bed"
      decimals="-5"
      id="F_75adacc9-8e7b-4cf5-b63a-7fc7e4532cb6"
      unitRef="U_USD">500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_d58319c2-1e7d-404d-9de6-2c8ff0ce99e9"
      decimals="-5"
      id="F_f10b6542-2d95-4114-a96a-bea63500d955"
      unitRef="U_USD">1100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_b3af013b-f74c-4b68-9ba2-7e9a3065d0ca"
      decimals="-5"
      id="F_c9f629b1-6431-4d7a-8879-e5e4efdd1501"
      unitRef="U_USD">900000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_3757db2b-c29b-442c-90e8-b518b6fde2b8"
      decimals="-5"
      id="F_33b0762f-4fc0-4c55-9f51-af667e6cb382"
      unitRef="U_USD">7300000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c"
      decimals="-5"
      id="F_bb452dd4-9b77-47a8-9ec1-932d814f9f21"
      unitRef="U_USD">2700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_3757db2b-c29b-442c-90e8-b518b6fde2b8"
      decimals="-5"
      id="F_0a8d6d40-792b-4198-8497-e8d8d04eb277"
      unitRef="U_USD">7500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_f9be93ff-5a8e-41da-882a-e77fd2dc092c"
      decimals="-5"
      id="F_c1d52e18-c1fa-4ae5-acf7-259fa243a8d5"
      unitRef="U_USD">2700000</us-gaap:OperatingLeaseLiability>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_c16d7a21-9458-4b38-a8c0-cfb657c898ac"
      decimals="-5"
      id="F_bc8d69f5-0b97-4aa6-8adc-8491956e8c00"
      unitRef="U_USD">6000000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue
      contextRef="C_1f767e2b-b61b-4ca0-98c7-e3058a5e5df3"
      decimals="-5"
      id="F_621a1c52-8fa1-411c-a0e6-353f1bebfb87"
      unitRef="U_USD">6000000</asth:InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue>
    <asth:RelatedPartyExpensesPayable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-5"
      id="F_d9c0b7dd-2033-43c1-aa57-c51159b519f7"
      unitRef="U_USD">2200000</asth:RelatedPartyExpensesPayable>
    <asth:RelatedPartyExpensesPayable
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-5"
      id="F_80ee7618-f3ac-4259-a2ca-bf767a535953"
      unitRef="U_USD">600000</asth:RelatedPartyExpensesPayable>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_65e86fd8-187a-4fa5-8ef5-554371a711f6"
      decimals="-5"
      id="F_00ded2d9-31f3-4bbd-95c5-8460078759fa"
      unitRef="U_USD">200000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_b3b64b0e-4eb5-45d0-b5f9-2d703131e99a"
      decimals="0"
      id="F_d1a054e0-d6ea-46c8-9e32-12251d6f78ea"
      unitRef="U_USD">45000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_5ab8feca-ce17-4204-bc5e-2c50a0f3326e"
      decimals="0"
      id="F_e81c3b77-d4ac-45c5-8170-e8824b4fdce1"
      unitRef="U_USD">42000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_95410889-f77a-49be-96bd-dcaa6e56cd80"
      decimals="0"
      id="F_e47eca2d-7f62-47e6-9a20-0e5b0b9d825b"
      unitRef="U_USD">38000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_cf787623-6175-4af2-9a0a-baa08dd1743a"
      decimals="-5"
      id="F_ff37cff4-69ed-4175-bc04-b6e8270558a6"
      unitRef="U_USD">700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec"
      decimals="-5"
      id="F_43ac1d1a-1c24-45fa-8f21-4e962c19dbc0"
      unitRef="U_USD">700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_cf787623-6175-4af2-9a0a-baa08dd1743a"
      decimals="-5"
      id="F_d8ab5b0e-81c2-4a02-9874-1540a1c23844"
      unitRef="U_USD">700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_c008ac1f-27d7-411c-b48e-6a6dc546ecec"
      decimals="-5"
      id="F_2842121c-5e99-4426-9390-5590a17769e5"
      unitRef="U_USD">700000</us-gaap:OperatingLeaseLiability>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_099a465c-4f6f-437d-a0f2-6b565bc21854">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following tables set forth revenue recognized and fees incurred related to AHMC, HSMSO, and Aurion for the &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three months ended March 31, 2025 and 2024 (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:32.667%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:8.122%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;HSMSO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aurion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;AHMC&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;HSMSO&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Aurion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,771&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,920&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;31,680&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,557&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,909&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;301&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_7da3de8e-3c1b-47dc-b803-dfadb1036f0a"
      decimals="-3"
      id="F_d2d3b8ae-fa32-4979-aa01-88d39ca7fb20"
      unitRef="U_USD">6771000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_72cdfcac-2740-4878-88ae-2ceba95c47c8"
      decimals="-3"
      id="F_4710c306-ad26-4bfb-bf5d-969ea83d2888"
      unitRef="U_USD">105000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_84fa31dd-5a86-4282-8662-e45fc242151e"
      decimals="-3"
      id="F_1ece673d-f04c-4565-9ba5-4b91f6d7456b"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_02cfd407-332a-4baf-987c-e88967c9572f"
      decimals="-3"
      id="F_bcbfec0a-8a33-49b7-aed4-1a6da3953c5c"
      unitRef="U_USD">9920000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_2cbf692b-71ea-45e0-a47a-62ac40f45969"
      decimals="-3"
      id="F_a9c3bbb7-da15-4d2d-833b-81b9e006ce47"
      unitRef="U_USD">301000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_049fe2ce-623c-47b8-956b-acb5e9467f17"
      decimals="-3"
      id="F_a0cd2a22-e455-4bfe-b9b2-c0d8b6d51c5a"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_7a198c7b-7dd4-4175-ba0f-59cc0ec75af0"
      decimals="-3"
      id="F_b52be53b-bccf-4850-995b-418a426fd3da"
      unitRef="U_USD">31680000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_e21928d0-d834-46c0-97ad-f882fc6f862c"
      decimals="-3"
      id="F_68714bb7-c7df-4149-b86b-3fdb6acc49d2"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_b83becec-a8a7-4250-98f0-8f5ba29d2848"
      decimals="-3"
      id="F_1af263df-0434-495d-8000-3045e4f75f3a"
      unitRef="U_USD">100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_3219815c-b8e4-4aee-977c-644ac98f25fc"
      decimals="-3"
      id="F_affce970-c3f4-4d9a-9c00-4374ec80c026"
      unitRef="U_USD">7557000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_e495f793-75dc-4d1d-8b73-1382c3cdff82"
      decimals="-3"
      id="F_30325793-c926-4921-a33e-b14f32398e68"
      unitRef="U_USD">0</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_3d79f704-e8f9-4c16-8574-e530d4eb0e3c"
      decimals="-3"
      id="F_737d9cac-e1f4-49ad-bdf1-4425f616558f"
      unitRef="U_USD">50000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_cae1d15e-081f-4e25-9666-48ba5588bb71"
      decimals="-3"
      id="F_844301bc-723f-4903-a2a7-75f9f9e5caf3"
      unitRef="U_USD">-24909000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_9e921ba2-6ad9-43f7-bb6e-25d335ac8af4"
      decimals="-3"
      id="F_8b0bb609-f20c-413c-8a71-7ed117824a91"
      unitRef="U_USD">105000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_1ea642ae-a35a-4119-b34f-c0c2715563a7"
      decimals="-3"
      id="F_74b97c19-5e4f-4d40-9a71-4c98af7d31d3"
      unitRef="U_USD">-100000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_c3a02d13-ffcb-4213-bda6-e5bb59c91eeb"
      decimals="-3"
      id="F_408dad59-8e3e-4545-8f87-81d74b6824e6"
      unitRef="U_USD">2363000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_267bebe9-df3a-4348-8901-8b3074ee8ba5"
      decimals="-3"
      id="F_b3cb2504-4b1d-4990-b2fe-d17ede4571c4"
      unitRef="U_USD">301000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_b929ea35-4d57-4309-9729-8e223f59f4b8"
      decimals="-3"
      id="F_f7b419d9-571c-4176-862a-7a0504913116"
      unitRef="U_USD">-50000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2e55ed2c-9a1c-471f-b86f-f1b220d4588d"
      decimals="-5"
      id="F_2ad57161-36c2-47a3-980e-5b86a1c5ad30"
      unitRef="U_USD">5000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8e1fbaba-ca27-4783-9682-64643b46acf8"
      decimals="-5"
      id="F_f15f93d1-cdf7-4bbb-9625-481a186b6bb6"
      unitRef="U_USD">8100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DeferredCreditsAndOtherLiabilities
      contextRef="C_fcb6fb64-b6ca-4164-afb7-90087668e19b"
      decimals="-5"
      id="F_14ccc010-3f6d-40f5-b96e-7f750b53a5f7"
      unitRef="U_USD">53900000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:DeferredCreditsAndOtherLiabilities
      contextRef="C_608c6900-ee56-4405-ae5d-6fc0640fc6b5"
      decimals="-5"
      id="F_257d1910-4b97-48f0-9678-946362818ad6"
      unitRef="U_USD">47700000</us-gaap:DeferredCreditsAndOtherLiabilities>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_651b11d9-1f6c-4cc8-af5e-b6decb5bd381"
      decimals="-5"
      id="F_ad3f244c-7a0f-41b0-8f8a-969737535e7f"
      unitRef="U_USD">6500000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_35ed1a55-e356-4546-bdd7-e13888799768"
      decimals="-5"
      id="F_39128955-4a9d-4579-8563-b2779a51db11"
      unitRef="U_USD">4700000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_74ff5438-7469-415e-827f-4df6603c37f5"
      decimals="-5"
      id="F_c101b162-53da-4643-9882-61e12ed07e42"
      unitRef="U_USD">1000000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="C_df93c67e-ab97-4281-ba2a-b871cd8e57a0"
      decimals="-5"
      id="F_0e6a4130-7b66-4917-8f95-89ed3cefd252"
      unitRef="U_USD">800000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_7d799574-4cb4-4c73-a183-52b5a1ffada1">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;14.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company uses the liability method of accounting for income taxes as set forth in ASC 740 Income Taxes. Under the liability method, deferred taxes are determined based on differences between the financial statement and tax bases of assets and liabilities using enacted tax rates.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;On an interim basis, the Company estimates what its anticipated annual effective tax rate will be and records a quarterly income tax provision in accordance with the estimated annual rate, plus the tax effect of certain discrete items that arise during the quarter. As the fiscal year progresses, the Company refines its estimates based on actual events and financial results during the quarter. This process can result in significant changes to the Company&#x2019;s estimated effective tax rate. When this occurs, the income tax provision is adjusted during the quarter in which the estimates are refined so that the year-to-date provision reflects the estimated annual effective tax rate. These changes, along with adjustments to the Company&#x2019;s deferred taxes and related valuation allowance, may create fluctuations in the overall effective tax rate from quarter to quarter.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s effective income tax rate for the three months ended March 31, 2025 and 2024, was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;35.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The tax rate for the three months ended March 31, 2025, differed from the U.S. federal statutory rate primarily due to non deductible expenses, state income taxes and income from flow-through entities.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;If recognized, $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million of the unrecognized tax benefits as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, would reduce the annual effective tax rate. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in the provision for income taxes in the Company&#x2019;s consolidated financial statements. For the period ended March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. the Company had recognized $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; of interest and penalties related to unrecognized tax benefits on its consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company is subject to U.S. federal income tax as well as state income tax in certain U.S. states. The Company and its subsidiaries&#x2019; state and federal income tax returns are open to audit under the statute of limitations for the years ended December 31, 2020 through December 31, 2024, and for the years ended December 31, 2021 through December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="3"
      id="F_de2181fb-ddf4-48d8-a77b-56445ff4f8b9"
      unitRef="U_pure">0.352</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="3"
      id="F_a39acf4f-4863-4376-a506-068fd289042f"
      unitRef="U_pure">0.298</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-6"
      id="F_c93bec00-b04b-42b2-b0c9-96eda39622eb"
      unitRef="U_USD">1000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="0"
      id="F_8bafe606-37eb-42e4-9e69-04b822b1beb8"
      unitRef="U_USD">40000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_bea29491-0b40-4236-a9a1-1d4e7d307fa4">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;15.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Basic earnings per share are calculated using the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during a certain period and are calculated by dividing net income attributable to Astrana by the weighted average number of shares of the Company&#x2019;s common stock issued and outstanding during such period. Diluted earnings per share are calculated using the weighted average number of shares of common stock and potentially dilutive shares of common stock outstanding during the period, using the as-if converted method for secured convertible notes and preferred stock, and the treasury stock method for options and common stock warrants. The non-controlling interests in APC are allocated their share of Astrana's income from APC&#x2019;s ownership of Astrana common stock, and this is included in the net income (loss) attributable to non-controlling interest on the condensed consolidated statements of income, therefore, none of the shares of Astrana held by APC are considered outstanding for the purpose of basic or diluted earnings per share computation.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;As of March 31, 2025 and December 31, 2024, the total treasury stock, including the Company&#x2019;s stock held by APC was &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,903,953&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,603,849&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. These are treated as treasury shares for accounting purposes, and not included in the number of shares of common stock outstanding used to calculate earnings per share.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the three months ended March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and 2024, restricted stock of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;409,736&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;118,142&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the three months ended March 31, 2025 and 2024, stock options of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;125,707&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;168,207&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, were excluded from the computation of diluted weighted average common shares outstanding because the assumed proceeds, as calculated under the treasury stock method, resulted in these awards being antidilutive.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the three months ended March 31, 2025 and 2024, contingently issuable shares of &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,120,899&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;973,461&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, were excluded from the computation of diluted weighted average common shares outstanding because these conditions were not achieved as of March 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.419999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three months ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,470,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,260,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,850,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,699,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Below is a summary of the shares included in the diluted earnings per share computations:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.187%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.737%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.877%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three months ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,470,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,260,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;112,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;188,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards and units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,055&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingently issuable shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,850,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,699,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_3e76e350-ea44-40df-b69e-b28234065741"
      decimals="0"
      id="F_55d9c34b-1768-40d5-bcae-c8716e924aef"
      unitRef="U_shares">9903953</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0cff01c6-12c7-4f38-864b-0bbcdc7a9295"
      decimals="0"
      id="F_985e9c46-a1ca-4f48-9736-21478c3c424f"
      unitRef="U_shares">10603849</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_0ac128eb-5a33-4975-905f-b556a96e2c4d"
      decimals="0"
      id="F_ec88d6f6-bc64-4f4f-94a6-83d88fbcc9c4"
      unitRef="U_shares">409736</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_782cba76-0dc6-4355-999d-51fc02a33e23"
      decimals="0"
      id="F_b9db4447-2bb3-430c-bc45-33adb6afae0d"
      unitRef="U_shares">118142</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_a0af827e-2073-40a4-9366-c1c611fcf2e7"
      decimals="0"
      id="F_e470dedd-e58c-4e62-8d6b-5a57af96906b"
      unitRef="U_shares">125707</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece"
      decimals="0"
      id="F_d6ace12c-8e80-4258-bff7-22d40d287484"
      unitRef="U_shares">168207</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_1989d044-2b9d-4d1d-adb5-89940dd1bf1a"
      decimals="0"
      id="F_1611e501-2853-4c48-b404-7d228c28d090"
      unitRef="U_shares">1120899</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_9a8924e1-57f9-410e-b002-cadf956446e6"
      decimals="0"
      id="F_84c4aa94-70ea-43fd-b70b-dda49d32b156"
      unitRef="U_shares">973461</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_fc4f1e80-f948-45b7-b472-a123b02c15f9">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Below is a summary of the earnings per share computations:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.2%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.26%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.419999999999998%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three months ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Earnings per share &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.14&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.31&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,470,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,260,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,850,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,699,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="2"
      id="F_11eee6d5-3d25-467b-991a-f892b6d01c77"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.14</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_6908bc5d-c32b-477e-b2f5-ab8c42115814"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.31</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="2"
      id="F_b2fd700e-938a-4eb3-ad59-84c9039cadb9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="2"
      id="F_509e21c2-812e-4c52-b28c-1d519a868210"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_9ba627a0-7d8f-4ea0-80c1-a90d0f5299ba"
      unitRef="U_shares">48470682</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="0"
      id="F_0c57b267-2e20-40d0-857d-1490b91a40a4"
      unitRef="U_shares">47260351</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_22c93660-503f-4438-8411-2a38ebcb4147"
      unitRef="U_shares">48850666</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="0"
      id="F_76356ef1-b47d-4cfb-8f80-d0220e2f1995"
      unitRef="U_shares">47699537</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_311be12e-d493-46f9-8d48-59cdf299a147">&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Below is a summary of the shares included in the diluted earnings per share computations:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:64.187%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.737%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:16.877%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three months ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; basic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,470,682&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,260,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;112,858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;188,083&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted stock awards and units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;130,055&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;225,128&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Contingently issuable shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;137,071&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,975&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Weighted average shares of common stock outstanding &#x2013; diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,850,666&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;47,699,537&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_3e8fa4e2-380e-47b3-a73b-40c76ff454d8"
      unitRef="U_shares">48470682</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="0"
      id="F_f7234ee8-f3d3-4e5d-af7d-d39be0baff47"
      unitRef="U_shares">47260351</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="C_a0af827e-2073-40a4-9366-c1c611fcf2e7"
      decimals="0"
      id="F_7bc8d74e-cff2-4f7e-9304-55facca17b19"
      unitRef="U_shares">112858</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="C_5b4d9ac6-b6e1-4b0c-b380-34aea8ccaece"
      decimals="0"
      id="F_7822b5dd-c892-48ce-9979-1c0cabd119bb"
      unitRef="U_shares">188083</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="C_0ac128eb-5a33-4975-905f-b556a96e2c4d"
      decimals="0"
      id="F_26c976b8-41a9-4d1f-bc61-9db4d6a97ce4"
      unitRef="U_shares">130055</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="C_782cba76-0dc6-4355-999d-51fc02a33e23"
      decimals="0"
      id="F_953f37df-d673-44c3-ad6d-44842f60fa72"
      unitRef="U_shares">225128</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_70896dba-a346-4aa5-8191-4efc7486c0ff"
      unitRef="U_shares">137071</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="0"
      id="F_af83a037-7642-4ecb-972f-710e913ddb7d"
      unitRef="U_shares">25975</us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_61e32883-4208-4beb-ba58-a9f0cef347da"
      unitRef="U_shares">48850666</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="0"
      id="F_3de3f91e-af4d-4e9c-958b-ac85498a72fe"
      unitRef="U_shares">47699537</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_0df1d274-e2a8-4b97-b1ba-c6f83eaf4b9c">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;16.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Variable Interest Entities (VIEs)&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s condensed consolidated financial statements include its subsidiaries and consolidated VIEs. A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb losses, or the right to receive the expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity&#x2019;s economic performance and the obligation to absorb expected losses or the right to receive benefits from the entity that could potentially be significant to the VIE.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Some states have laws that prohibit business entities with non-physician owners&#x2014;such as Astrana and its subsidiaries&#x2014;from practicing medicine, employing physicians to practice medicine, or exercising control over medical decisions by physicians. These laws are generally referred to as corporate practice of medicine laws. States that have corporate practice of medicine laws permit only physicians to practice medicine, exercise control over medical decisions, or engage in certain arrangements&#x2014;such as fee-splitting&#x2014;with physicians.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Due to these laws, the Company operates by maintaining long-term MSAs with its affiliated IPAs and medical groups, each of which is owned and operated by physicians only, and employs or contracts with additional physicians to provide medical services. AHM is a wholly owned subsidiary of the Company and has entered into MSAs with several affiliated IPAs, including APC. APC arranges for the delivery of healthcare services by contracting with physicians or professional medical corporations for primary care and specialty care services. The physicians in the IPA are exclusively in control of, and responsible for, all aspects of the practice of medicine for enrolled patients. In accordance with relevant accounting guidance, APC has been determined to be a VIE of AHM, as AHM is its primary beneficiary with the ability, through majority representation on the APC Joint Planning Board and otherwise, to direct the activities (excluding clinical decisions) that most significantly affect APC&#x2019;s economic performance. Therefore, APC and its wholly owned subsidiaries and VIEs are consolidated in the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain state laws prohibit a professional corporation that has more than one shareholder from being a shareholder in another professional corporation. As a result, the Company cannot directly own shares in other professional corporations. However, an exception to this regulation permits a professional corporation that has only one shareholder to own shares in another professional corporation. In reliance on this exception, the Company designated certain key personnel as the nominee shareholders of professional corporations that hold controlling and non-controlling ownership interests in several medical corporations. Via a Physician Shareholder Agreement with the nominee shareholder, the Company has the ability to designate another person to be the equity holder of the professional corporation. In addition, these entities are managed by the Company&#x2019;s wholly owned MSOs via MSA. In accordance with relevant accounting guidance, the professional corporations and their consolidated medical corporations are consolidated by the Company in the accompanying condensed financial statements.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Astrana Medical and Astrana Care Partners Medical were formed as designated shareholder professional corporations in May 2019 and July 2021, respectively, as designated shareholder professional corporations. The Company&#x2019;s Vice Chairman is the sole shareholder of Astrana Medical and Astrana Care Partners Medical. Via a Physician Shareholder Agreement, Astrana makes all the decisions on behalf of Astrana Medical and Astrana Care Partners Medical. Astrana has the obligation to absorb losses of, or the right to receive benefits from, Astrana Medical and Astrana Care Partners Medical. Therefore, Astrana Medical and Astrana Care Partners Medical are controlled by and consolidated by Astrana as the primary beneficiary of the VIEs.&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table includes assets that can only be used to settle the liabilities of the Company&#x2019;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#x2019;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolida&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;tion, are included in the accompanying condensed consolidated balance sheets (in thousands).&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;"&gt;
         &lt;td style="width:46.451%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158,922&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,977&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;54,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,303&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;285,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,528&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241,531&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;243,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income taxes receivable, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in a privately held entity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in affiliates*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;190,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;224,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,055&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total non-current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;582,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;618,326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;868,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;937,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;"&gt;
         &lt;td style="width:46.451%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,547&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;173,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,688&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,890&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;216,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Investment in affiliates includes the Company&#x2019;s VIEs&#x2019; investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#x2019;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#x2019;s condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_c4913c3e-d2c2-4a51-988c-bddcf516ad76">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table includes assets that can only be used to settle the liabilities of the Company&#x2019;s VIEs, and to which the creditors of Astrana have no recourse, and liabilities to which the creditors of the Company&#x2019;s VIEs have no recourse to the general credit of Astrana, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of investments in affiliates and amounts due to, or from, affiliates, which are eliminated upon consolida&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;tion, are included in the accompanying condensed consolidated balance sheets (in thousands).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;"&gt;
         &lt;td style="width:46.451%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;150,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;158,922&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,259&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;71,820&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,977&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Receivables, net &#x2013; related party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;54,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,251&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other receivables&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,303&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,917&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;285,928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;318,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,528&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,875&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intangible assets, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;83,582&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;87,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Goodwill&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;241,531&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;243,283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income taxes receivable, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,943&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investments in other entities &#x2013; equity method&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,063&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in a privately held entity&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;405&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Investment in affiliates*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;190,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;224,894&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;26,033&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,585&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,055&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total non-current assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;582,358&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;618,326&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;868,286&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;937,199&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;"&gt;
         &lt;td style="width:46.451%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:2.36%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:22.416%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;37,804&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,800&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Fiduciary accounts payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8,223&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Medical liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100,547&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;105,486&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Dividend payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;638&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income tax payable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,140&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,487&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amount due to affiliates*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;48,142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;173,392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;222,688&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Deferred tax liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,905&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,237&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;451&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;520&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease liabilities, net of current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,012&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Other long-term liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,890&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;619&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total non-current liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,252&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;216,644&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;256,076&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;*Investment in affiliates includes the Company&#x2019;s VIEs&#x2019; investment in Astrana, which is reflected as treasury shares and eliminated upon consolidation. Amounts due to, or from, affiliates are receivables with Astrana&#x2019;s subsidiaries. As a result, these balances are eliminated upon consolidation and are not reflected on Astrana&#x2019;s condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_e7c93819-c0d3-480a-bee5-2ca3c977e7b5"
      unitRef="U_USD">150013000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_1a159a5b-8602-483f-a15b-cc7164283226"
      unitRef="U_USD">158922000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_e330875f-0c60-42ef-9ebd-99226b9782e8"
      unitRef="U_USD">2283000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_7f40fdbb-fe3a-4c04-8fd3-2c9b3d7b1392"
      unitRef="U_USD">2259000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_d7c3aa76-d15a-48a4-8f21-bcbdc51ba401"
      unitRef="U_USD">71820000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_40396c0b-4fc7-4407-8100-5cc17150714f"
      unitRef="U_USD">83977000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_ab1680b4-76ea-4b15-86a6-421050cb834d"
      decimals="-3"
      id="F_4de946df-94c8-4f16-bbaf-b94c1e520773"
      unitRef="U_USD">54873000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="C_f87a47bf-3205-4aee-8f68-e2bd18751281"
      decimals="-3"
      id="F_ee3a1b01-b29c-47ea-8f03-410fd873340a"
      unitRef="U_USD">48251000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_78b1de1d-bde0-4342-ad13-446923e53059"
      unitRef="U_USD">22000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_d10ce613-b587-494e-9cab-f449348112e5"
      unitRef="U_USD">15303000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_346b3aa5-bb26-4995-93d2-356de7739bb7"
      unitRef="U_USD">6917000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_b50787e0-a070-4290-aa13-b83b1ae85377"
      unitRef="U_USD">10161000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_b046980b-905c-4054-b524-36419a25d6b6"
      unitRef="U_USD">285928000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_fb173afc-25a2-426b-a820-5704c37e9284"
      unitRef="U_USD">318873000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_9663d342-c06f-4108-b46e-13ec48ad89bf"
      unitRef="U_USD">6528000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_11907088-a39c-410f-b87c-775c07122a12"
      unitRef="U_USD">5875000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_265f7135-340c-4ada-b627-a0284eb098cd"
      unitRef="U_USD">83582000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_be3d8676-ffbf-4b69-b0e7-dbb0eaae9c25"
      unitRef="U_USD">87840000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_8dc3f870-c74e-4652-aacf-5535304ab1d4"
      unitRef="U_USD">241531000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_e4527d9b-60ac-4b9b-ab98-918c52866620"
      unitRef="U_USD">243283000</us-gaap:Goodwill>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_9c914a24-1f19-4420-ada8-bfe24ef9a318"
      unitRef="U_USD">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:IncomeTaxesReceivableNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_e7a28b07-bd0c-4442-8302-1273c40319d8"
      unitRef="U_USD">15943000</us-gaap:IncomeTaxesReceivableNoncurrent>
    <us-gaap:EquityMethodInvestments
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_33f119ca-dc58-4740-8a4a-c7d4739e4298"
      unitRef="U_USD">15063000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_840ea6c7-0fb8-4871-bd14-321ecae26d77"
      unitRef="U_USD">15442000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_0fae14f2-42a1-419e-be59-f1c1fad5e9eb"
      unitRef="U_USD">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_4a8b4864-85be-40bb-a37a-3401c0cd8239"
      unitRef="U_USD">405000</us-gaap:EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue>
    <us-gaap:OtherLongTermInvestments
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_c007ca24-ef72-426b-a491-9166747072c5"
      unitRef="U_USD">190178000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_0b5118e4-4bcd-4458-8758-8de1a93deb81"
      unitRef="U_USD">224894000</us-gaap:OtherLongTermInvestments>
    <us-gaap:RestrictedCash
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_e1e40417-4687-4dd0-9a93-fd8bd727d63e"
      unitRef="U_USD">40000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_043e2139-7049-4d80-ab2d-e95f5869a394"
      unitRef="U_USD">40000</us-gaap:RestrictedCash>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_d7d66579-cff8-473c-9e2b-06f12f9b2e24"
      unitRef="U_USD">26033000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_ebf13ef7-741b-4b8c-9740-8630d62cff32"
      unitRef="U_USD">21585000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_eeaa41cf-153f-4f9c-8650-11da53755b94"
      unitRef="U_USD">3055000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_fdc86ac7-3460-46b7-ae8a-cbee078c4d00"
      unitRef="U_USD">3019000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_8a2828f7-cdd4-4c29-9cf4-c778e646f558"
      unitRef="U_USD">582358000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_13ad72d8-a7f8-4e49-8d91-719750ca5672"
      unitRef="U_USD">618326000</us-gaap:AssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_a80c2310-7a63-46d9-b7da-0346411a3a66"
      unitRef="U_USD">868286000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_981330aa-c810-48fd-b6c4-a5be4c3755eb"
      unitRef="U_USD">937199000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_ead77e1a-349b-484a-8bb5-ffbec82f4cea"
      unitRef="U_USD">37804000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_beed38ec-8701-443a-ac20-d4c312399e83"
      unitRef="U_USD">43800000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <asth:FiduciaryAccountsPayableCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_b0ac2d87-458a-440e-ab40-4f2b9d315079"
      unitRef="U_USD">4840000</asth:FiduciaryAccountsPayableCurrent>
    <asth:FiduciaryAccountsPayableCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_810a34de-50ea-46e9-98f4-9ef33cc14f14"
      unitRef="U_USD">8223000</asth:FiduciaryAccountsPayableCurrent>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_c543b331-10e7-4bec-8aa3-4f34a5161cd4"
      unitRef="U_USD">100547000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_381b4ff7-8e0c-4c10-967a-f99dca31c419"
      unitRef="U_USD">105486000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:DividendsPayableCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_8c4c0a75-0ce9-43f0-9389-b65afa149321"
      unitRef="U_USD">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_1680d1e0-3813-4680-9c2c-47ff413e57ed"
      unitRef="U_USD">638000</us-gaap:DividendsPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_ddea73ea-e20c-49d5-87da-5bf476ed692d"
      unitRef="U_USD">14140000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_b56b1b8a-10d3-4e82-a423-40f83fc13d76"
      unitRef="U_USD">11041000</us-gaap:TaxesPayableCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_6a50ceac-eb5e-4067-9453-af2860554bfe"
      unitRef="U_USD">451000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_20fdf0bb-8851-4d1e-a1bb-1bfe624c8302"
      unitRef="U_USD">520000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_6a1cbce5-180a-418f-9cf0-99b017c95e28"
      unitRef="U_USD">4076000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_81c967ac-fc21-4e3b-b4bf-a191c4d41a78"
      unitRef="U_USD">3487000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_aa054d76-bb24-48dd-801b-e3a6a2082a8e"
      unitRef="U_USD">6348000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_3eb2acbd-cb61-4143-b71a-8ec51885bf04"
      unitRef="U_USD">1351000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilities
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_add9e499-7a9d-4f75-9902-9928dea7a7e3"
      unitRef="U_USD">4548000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_884d4621-f5ef-4d67-9bb2-8eed00849949"
      unitRef="U_USD">48142000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_0c63d670-d137-4fc3-94fe-25abdf7fc372"
      unitRef="U_USD">173392000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_eba5d9e8-0890-494f-b330-1cefbdc54764"
      unitRef="U_USD">222688000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_87d394c7-3d6e-4151-b311-b73fa5e21693"
      unitRef="U_USD">10905000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_bcbe4545-ed38-46d0-bc96-db3330c4316a"
      unitRef="U_USD">11237000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_f25f4479-1c74-49ed-8ad1-8a4e2edb1c30"
      unitRef="U_USD">451000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_df678977-c277-4ff5-96df-7b48475d1e35"
      unitRef="U_USD">520000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_d7df6c0e-f0c0-4e9a-bb9c-01d482db866f"
      unitRef="U_USD">25006000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_2f5c85e7-8369-49de-989f-46eaa367dde0"
      unitRef="U_USD">21012000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_f61cfab8-365d-46cf-b711-a81ff6854bc7"
      unitRef="U_USD">6890000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_c867673f-6e3e-40fe-aa3a-9f7bb3487787"
      unitRef="U_USD">619000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_a3339d6d-3d8a-490f-bf12-a458fcc3f631"
      unitRef="U_USD">43252000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_d215972a-21ce-4512-8692-96a6c7195f88"
      unitRef="U_USD">33388000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_4f6aee3c-ffd4-4e4b-8f52-e34c294df83b"
      decimals="-3"
      id="F_62c6106a-d2b6-4fba-9ba0-ca45351a7563"
      unitRef="U_USD">216644000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_bce624dd-14dc-4bb3-b213-4088492584ea"
      decimals="-3"
      id="F_01d0d94f-66ed-41ca-a71f-38879a095ce8"
      unitRef="U_USD">256076000</us-gaap:Liabilities>
    <asth:LesseeOperatingAndFinanceLeasesTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_312c7e30-34e2-448e-a0e3-d825f0525f2e">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:12pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;17.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company has operating and finance leases for corporate offices, physicians&#x2019; offices, and certain equipment. These leases have remaining lease terms ranging from &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; month&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; years, some of which may include options to extend the leases for up to &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, and some of which may include options to terminate the leases within &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. These leases consist of payments that are fixed or variable. Variable lease payments are based on an index or a rate such as the Consumer Price Index. As of March 31, 2025 and December 31, 2024, finance lease assets, net of depreciation, were &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, and accumulated depreciation associated with finance leases was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Leases with an initial term of 12 months or less are not recorded on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of lease expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sublease income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.22&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.39&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.34&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;267&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,882&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;</asth:LesseeOperatingAndFinanceLeasesTextBlock>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="C_9e7792f7-702f-4f53-bc31-698f8ce0df84"
      id="F_f6ed1b16-3f9f-4124-b53b-b3c02236a4c5">P1M</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <us-gaap:LesseeFinanceLeaseRemainingLeaseTerm
      contextRef="C_80446148-a401-4cce-89ac-14f1418b9966"
      id="F_561ca5a8-cf06-4f2c-875a-727d4c5f926c">P21Y</us-gaap:LesseeFinanceLeaseRemainingLeaseTerm>
    <asth:LesseeOperatingAndFinanceLeaseRenewalTerm
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      id="F_2eac3fb4-b3c1-42a1-85dd-1227392eb21b">P10Y</asth:LesseeOperatingAndFinanceLeaseRenewalTerm>
    <asth:LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_9c3297bc-8167-427c-af2f-32d831dc0c5d">P1Y</asth:LesseeOperatingAndFinanceLeaseTerminationPeriodIfApplicable>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_421e2b95-1e32-4542-9d24-af6e9e8cfc5a"
      unitRef="U_USD">1200000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-5"
      id="F_99270987-f52d-4eeb-baea-541b7f7e4d8a"
      unitRef="U_USD">1300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_7e7cf9b8-d783-4f20-b709-33e2a32e3015"
      unitRef="U_USD">1600000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-5"
      id="F_ba59242d-ed11-44f4-b745-ab31ae6fb37b"
      unitRef="U_USD">2200000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_ff5ac3ff-6d3a-4a4c-84e3-2c0f91a2229e">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,611&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Amortization of lease expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sublease income&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;226&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,730&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,136&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Other information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Supplemental Cash Flow Information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,837&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;147&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;179&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:13.343%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.22&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;8.39&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.34&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.96&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Finance leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.53&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_5c345c80-167a-4067-961e-50d7040f76be"
      unitRef="U_USD">3611000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_3dd1b9f5-64cf-41fa-8cdd-1aba228033f4"
      unitRef="U_USD">3159000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7592f42f-a994-43d9-85b6-a8811440725f"
      unitRef="U_USD">147000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_053dd4ee-f0e5-409c-8fce-f52f80ba8224"
      unitRef="U_USD">179000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_684074c5-c4e2-4001-a91e-6f8af5b33cfb"
      unitRef="U_USD">16000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_a2b05c52-27db-4e3b-9bb6-01ee78f56323"
      unitRef="U_USD">24000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:SubleaseIncome
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7ffb02a7-1fa1-4e1b-99cc-4376ac71032d"
      unitRef="U_USD">44000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_fc86c6cc-a13d-4abf-ac7c-08d19075e8cf"
      unitRef="U_USD">226000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_6992f974-0b75-488e-ab8e-376ecb468b2c"
      unitRef="U_USD">3730000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_0726aaf3-db77-4fd0-8c0d-b51d19a9b140"
      unitRef="U_USD">3136000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2f56881b-d25e-4bac-95df-3e854f9ca326"
      unitRef="U_USD">3017000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_1dfafdd1-7b9b-48e8-9cb2-9774a9bd60e9"
      unitRef="U_USD">2837000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7ad97928-b53a-40d4-95b7-12d6d4dce640"
      unitRef="U_USD">16000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_459743f2-271a-49f4-9867-8d491eeda93f"
      unitRef="U_USD">24000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_35df48be-1d0b-4f3a-930b-10fc03597c63"
      unitRef="U_USD">147000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_3a5db5e6-5327-4d06-8550-0d778ed07e9a"
      unitRef="U_USD">179000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      id="F_e386ce0b-3496-4723-ae99-4f555dd088f8">P7Y2M19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      id="F_82ec6fca-2ce1-464f-bd12-f72e131b0f96">P8Y4M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      id="F_44767ff6-3faf-421b-ad4b-aa572abeda59">P2Y4M2D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      id="F_4758ddca-087e-4f7c-883f-8c7bdbd258fb">P2Y11M15D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="4"
      id="F_a54665ad-cfaf-44fa-9d6c-72e0a9e4af9e"
      unitRef="U_pure">0.0675</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="4"
      id="F_1b81f726-e1c9-440c-8ff0-f2a994629844"
      unitRef="U_pure">0.0615</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="4"
      id="F_3b41bf37-7ee5-4bc6-9c25-a3a1e3b8bf77"
      unitRef="U_pure">0.0579</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="C_56f15d39-f30a-4cdd-8e2e-7558823519b4"
      decimals="4"
      id="F_b873e9a5-70c6-40ec-8369-6889e1fc917f"
      unitRef="U_pure">0.0553</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <asth:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_053beca7-23d1-4d28-b4eb-5d903c0d7f47">&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following are future minimum lease payments under non-cancellable leases for the years ending December 31 (in thousands) below:&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:left;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2025 (excluding the three months ended March 31, 2025)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;443&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;345&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,246&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;267&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2028&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,973&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2029&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,882&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;14,876&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,091&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,155&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,942&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,014&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Less: current portion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,979&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Long-term lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,963&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;543&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</asth:LesseeOperatingAndFinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_08a4581b-e8cb-4407-a5b6-c4bd8c344e85"
      unitRef="U_USD">5269000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_4986c7a3-63ae-47f4-8bbe-b3f7fa930dc4"
      unitRef="U_USD">443000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a05ef301-ccbe-497b-9c08-53897b3b7d8c"
      unitRef="U_USD">6851000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_be7f85f5-2f6d-47e9-86a2-0e1c939e05c9"
      unitRef="U_USD">345000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ff905574-8cf6-4c88-ba0a-9f83818be948"
      unitRef="U_USD">6246000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_11396775-54d6-4602-9295-2473038b375e"
      unitRef="U_USD">267000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_0ded160b-7567-4985-bfa3-6c49b6d509a7"
      unitRef="U_USD">5973000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_2732d0f8-f481-429f-bcf6-29c3453b56c6"
      unitRef="U_USD">27000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_dde6e7d8-4ff2-43f9-b500-e1267e17d7a1"
      unitRef="U_USD">4882000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_4f731153-1781-4478-8eb9-eabe7e02f5b5"
      unitRef="U_USD">9000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <asth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_fc70a263-c21a-460d-9942-1f7bcd2cf806"
      unitRef="U_USD">14876000</asth:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <asth:FinanceLeaseLiabilityToBePaidAfterYearFour
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_7290341d-1683-4fc4-9569-3678cbf38775"
      unitRef="U_USD">0</asth:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_1c65c418-e083-4a9d-bb4e-c04d9152b357"
      unitRef="U_USD">44097000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_abba8679-816d-43bb-802f-04af4c96cf54"
      unitRef="U_USD">1091000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5da13df7-f51a-4d32-a5c3-338ce672e799"
      unitRef="U_USD">10155000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5cebf15f-d9e7-4f43-8f36-d30adaaaa116"
      unitRef="U_USD">77000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5b071c86-1481-4816-a34e-77042ac93396"
      unitRef="U_USD">33942000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a085f478-bb60-4288-aa54-b0b13d2aa470"
      unitRef="U_USD">1014000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_4ecef208-fc15-472d-9815-a6ae89f49d08"
      unitRef="U_USD">4979000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_fd5f0112-2850-46ce-a488-84c7f2287707"
      unitRef="U_USD">471000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_98ab2829-e722-4a32-b13b-9ce4a460ae0d"
      unitRef="U_USD">28963000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_faeba382-cdb9-43fb-b11e-99e613bcc11c"
      unitRef="U_USD">543000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_fbb0a7ea-a0e5-442a-970e-dde087f0ef00">&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;18.&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company determined its operating segments in accordance with ASC 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;). Factors used in determining the reportable business segments include the nature of operating activities and the type of information presented to the Company's CODMS to evaluate all results of operations. The Company currently has &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;three&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; reportable segments consisting of: 1) Care Partners; 2) Care Delivery; and 3) Care Enablement (See Note 1 &#x2014;&#x201c;Description of Business&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Company&#x2019;s Care Partners segment, revenue is primarily comprised of capitation and risk pool settlements and incentives. Cost of service for this segment is primarily capitation and claims expenses.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Company&#x2019;s Care Delivery segment, revenue is primarily earned based on fee-for-service reimbursements, capitation, and performance-based incentives. Cost of service for this segment is primarily medical supplies costs and salaries expense related to medical staff and clinic employees.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;For the Company&#x2019;s Care Enablement segment, revenue for is primarily comprised of management and software fees, charged as a percentage of gross revenue or on a per-member-per-month basis. Cost of service for this segment is primarily MSO salaries expense.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company's CODMs are its&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_85a7fb24-2a46-4162-beeb-ab37e6433db9;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Chief Executive Officer and Chief Financial Officer.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; The CODMs evaluate the performance of the Company&#x2019;s operating segments based on segment revenue growth and operating income. The CODMs use revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company&#x2019;s operations are based in the United States. All revenues of the Company are derived from the United States. The CODMs do not evaluate the Company&#x2019;s segments using asset information. The significant segment expenses that comprise operating income as a measure used by the CODMs in evaluating operating segment performance do not differ from the operating expenses as presented on the consolidated statements of income.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In the normal course of business, the Company&#x2019;s reportable segments enter into transactions with each other. While intersegment transactions are treated like third-party transactions to determine segment performance, the revenues recognized by a segment and expenses incurred by the counterparty are eliminated in consolidation and do not affect consolidated results.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Corporate costs are unallocated and primarily include corporate initiatives, corporate infrastructure costs, and corporate shared costs, such as finance, human resources, legal, and executives.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certain amounts disclosed in prior period have been recast to conform to the current period presentation. Specifically, segments are presented net of intrasegment eliminations for the three months ended March 31, 2024. The following table presents information about our segments (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s segments (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:31.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Partners&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Delivery&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Enablement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;br/&gt;Elimination&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Corporate&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Consolidated&lt;br/&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Third-Party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,690&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,562&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;512,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;549,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,068&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;556,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;599,807&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:31.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Partners&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Delivery&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Enablement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;br/&gt;Elimination&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Corporate&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Consolidated&lt;br/&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Third-Party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;382,318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;382,318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,794&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;330,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;339,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;374,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Balance includes general and administrative expenses, and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(2)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income that is not presented in the table. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="0"
      id="F_9afeaaba-0a58-4f7c-8056-d326edc9144b"
      unitRef="U_Segment">3</us-gaap:NumberOfReportableSegments>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_43064779-aba2-4426-ac3f-35387bad1512">The Company's CODMs are its Chief Executive Officer and Chief Financial Officer. The CODMs evaluate the performance of the Company&#x2019;s operating segments based on segment revenue growth and operating income. The CODMs use revenue growth and total segment operating income as a measure of the performance of operating businesses separate from non-operating factors.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_3adbc4db-8514-4f38-836a-a52389f5cf2d">The Company&#x2019;s operations are based in the United States. All revenues of the Company are derived from the United States. The CODMs do not evaluate the Company&#x2019;s segments using asset information. The significant segment expenses that comprise operating income as a measure used by the CODMs in evaluating operating segment performance do not differ from the operating expenses as presented on the consolidated statements of income.</us-gaap:SegmentReportingExpenseInformationUsedByCodmDescription>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_5830cbee-0d7a-4269-83c2-96fcca832466">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The following table presents information about the Company&#x2019;s segments (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:31.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Partners&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Delivery&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Enablement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;br/&gt;Elimination&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Corporate&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Consolidated&lt;br/&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Third-Party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,690&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,749&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,813&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;600,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;39,562&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;620,390&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;512,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;27,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,564&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;549,061&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,068&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,357&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;10,209&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,950&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;50,746&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;556,736&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,496&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;36,027&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;53,514&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;599,807&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;44,215&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,535&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;20,583&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:31.16%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.7%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.44%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:7.72%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.56%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="23" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31, 2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Partners&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Delivery&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Care&lt;br/&gt;Enablement&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;br/&gt;Elimination&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Corporate&lt;br/&gt;Costs&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Consolidated&lt;br/&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Third-Party&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;382,318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Intersegment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,841&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,114&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total revenues&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;382,318&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;33,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;41,955&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;404,356&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Cost of services&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;300,189&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;24,794&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;17,373&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;330,399&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;General and administrative&lt;/span&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;38,933&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,163&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;12,397&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,818&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;339,122&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,957&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;29,770&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;42,032&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;374,217&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:9pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Income (loss) from operations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;43,196&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,504&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;top:-4.221pt;white-space:pre-wrap;font-size:6.03pt;position:relative;font-kerning:none;min-width:fit-content;"&gt;(2)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:9pt;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;16,400&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="font-size:9pt;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,139&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:9pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:0;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(1)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Balance includes general and administrative expenses, and depreciation and amortization. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div class="item-list-element-wrapper" style="display:flex;margin-top:6pt;line-height:1.38;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"&gt;&lt;span style="transform:scale(0.67);color:#000000;white-space:pre-wrap;vertical-align:super;font-size:10pt;font-family:Times New Roman;transform-origin:top left;font-kerning:none;min-width:3.333%;word-break:keep-all;display:inline-flex;justify-content:flex-start;"&gt;(2)&lt;/span&gt;&lt;div style="width:100%;display:inline;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Income from operations for the intersegment elimination represents sublease income between segments. Sublease income is presented within other income that is not presented in the table. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3a367d74-7d53-44d3-bbea-33e94ba22408"
      decimals="-3"
      id="F_af03fec4-ea44-4d66-af14-3cfc86f44b4c"
      unitRef="U_USD">600951000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_ee86e486-beed-4909-b2c8-b2cf6dae3f11"
      decimals="-3"
      id="F_f168ec89-8576-482f-bf06-2559203c134e"
      unitRef="U_USD">16690000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_77dce955-a90f-4883-84a3-2ecf12cbb7b4"
      decimals="-3"
      id="F_f3006af6-fbfc-4ca4-9e5b-87bed9c6bae7"
      unitRef="U_USD">2749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b4ca8ae3-3bfd-4c53-99ad-240c6fa58860"
      decimals="-3"
      id="F_3786300f-eca2-4df9-aba9-5896fcec4fb3"
      unitRef="U_USD">620390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_60fac651-18d8-44ed-9d9c-07d7f1f63e2f"
      decimals="-3"
      id="F_ae44f2a6-13c7-44ac-9be3-6fbc56c7384a"
      unitRef="U_USD">16698000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_f497f166-f60f-4783-b578-7fc1e03156d6"
      decimals="-3"
      id="F_d9e5b0f1-3efa-4e37-a3ee-4e9832b0313c"
      unitRef="U_USD">36813000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_b7f07760-d62f-4512-a664-d49bed1a90cf"
      decimals="-3"
      id="F_6310cedd-2f3a-4607-af2f-0444e3c2e1e5"
      unitRef="U_USD">-53511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc"
      decimals="-3"
      id="F_a7f32fe2-06b6-41a6-b1e7-4e479bf04a8c"
      unitRef="U_USD">600951000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842"
      decimals="-3"
      id="F_90fd043d-c2ee-4a25-be79-d5bd0d10d75d"
      unitRef="U_USD">33388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"
      decimals="-3"
      id="F_0d072588-f387-4c37-9e63-58df9c6a6ae1"
      unitRef="U_USD">39562000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"
      decimals="-3"
      id="F_d4027799-f0d3-412e-ba9f-ab2307a9b701"
      unitRef="U_USD">-53511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_7d248818-ac89-4a5e-81f0-03f537d5b5fc"
      unitRef="U_USD">620390000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc"
      decimals="-3"
      id="F_c8bf46ef-52a8-45ce-96f5-26d998321d1d"
      unitRef="U_USD">512668000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842"
      decimals="-3"
      id="F_858dca01-7e01-49e5-9bd6-1b0034e5817f"
      unitRef="U_USD">27139000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"
      decimals="-3"
      id="F_e38c4457-936d-4b39-896a-65410fda1bf2"
      unitRef="U_USD">25818000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"
      decimals="-3"
      id="F_900bb35d-8fbf-4659-9f77-c07ac3f683ad"
      unitRef="U_USD">-16564000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_6d50e5da-1f36-4f98-9c02-ba4abef47b7e"
      unitRef="U_USD">549061000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc"
      decimals="-3"
      id="F_7658162f-48ac-4a82-893f-7747e7a5a030"
      unitRef="U_USD">44068000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842"
      decimals="-3"
      id="F_cf622bcd-29b6-43f8-b86a-a34415947afb"
      unitRef="U_USD">9357000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"
      decimals="-3"
      id="F_e861f943-a247-49b4-a348-fe71f93ada6f"
      unitRef="U_USD">10209000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"
      decimals="-3"
      id="F_12ffd247-a7e6-4938-8563-f07682b0287a"
      unitRef="U_USD">-36950000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b"
      decimals="-3"
      id="F_418f703a-ac26-454f-a54c-3473aa1b067d"
      unitRef="U_USD">24062000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_afd5dcb8-b20a-4c07-82fd-e938e613965a"
      unitRef="U_USD">50746000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc"
      decimals="-3"
      id="F_977f52cf-b645-445e-a666-dfcfcc9f915b"
      unitRef="U_USD">556736000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842"
      decimals="-3"
      id="F_9a7c5a8c-c0b6-4f77-9f0c-20bff7d3b58c"
      unitRef="U_USD">36496000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"
      decimals="-3"
      id="F_5cee79f6-84ca-4536-8137-7c9f2d661c94"
      unitRef="U_USD">36027000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"
      decimals="-3"
      id="F_c3d113c3-d03d-4872-b1f4-10f817d6d30b"
      unitRef="U_USD">-53514000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b"
      decimals="-3"
      id="F_11c7ded6-c64f-45f2-b2d0-a1a3a3c9546b"
      unitRef="U_USD">24062000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_d1eabf7e-bf20-4b90-8cde-b7de327b5174"
      unitRef="U_USD">599807000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_93eb1e59-ba73-4807-8847-1e31de1feffc"
      decimals="-3"
      id="F_cf60b6d4-9930-4224-9a19-642309e77e19"
      unitRef="U_USD">44215000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_a0be7500-06cf-4f7d-a434-0f961d061842"
      decimals="-3"
      id="F_be708269-c538-4ffe-9e5c-5ef3a1aaf7f3"
      unitRef="U_USD">-3108000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_c185d1ee-34d1-428d-ab9d-b462d8cc41f6"
      decimals="-3"
      id="F_a14ec555-7390-4336-a686-6b6e290095fa"
      unitRef="U_USD">3535000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_fa1d045c-893a-4fe4-bf41-4750c11195d4"
      decimals="-3"
      id="F_54d5a39c-323f-43ea-8bd9-1a5fa4aee59e"
      unitRef="U_USD">3000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_1d59be4b-b34b-4728-812e-5ec35bef5c3b"
      decimals="-3"
      id="F_4c35d7cb-99ac-4c0c-93af-d243eaceb0c7"
      unitRef="U_USD">-24062000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_51541cda-d223-4a41-83d9-3957c943c7dc"
      unitRef="U_USD">20583000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_6399433e-def4-4d84-b6b6-f762bf6ee833"
      decimals="-3"
      id="F_87f3c5b4-998d-4f5c-8098-b657f2ebdfcb"
      unitRef="U_USD">382318000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_2756304c-de02-4a8c-b11b-0af4c1d0f72b"
      decimals="-3"
      id="F_54957fde-6549-4d13-95f5-63881cde9217"
      unitRef="U_USD">17878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8f4dfe63-7e3c-4550-a1aa-0d1885663f72"
      decimals="-3"
      id="F_72fdb3af-fa7a-464b-bb7c-9e9517cd8676"
      unitRef="U_USD">4160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_3d384b8a-36f4-49d6-9e03-2c663c6f6dae"
      decimals="-3"
      id="F_a709d0bf-d15f-4469-bee0-f5a6759942f8"
      unitRef="U_USD">404356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_455ccf48-8afa-43f7-9084-96bed70ceb5b"
      decimals="-3"
      id="F_4b1ad028-d5af-42ed-b5d2-3ba7db1d96bf"
      unitRef="U_USD">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_83766bc6-44a6-4789-9671-394dba982518"
      decimals="-3"
      id="F_65789043-6b1d-4e55-ba5c-83dddf0fa7ff"
      unitRef="U_USD">12841000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_e6d48615-5367-4a0f-ad3d-86dd6a0bbd6c"
      decimals="-3"
      id="F_6c1483ed-7afb-4068-9cde-94c5175bc37a"
      unitRef="U_USD">29114000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_d455b109-46c4-4ef7-9caf-6da6c644c797"
      decimals="-3"
      id="F_5da61e24-cde4-4bd9-b25b-401ac891f57c"
      unitRef="U_USD">-41955000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"
      decimals="-3"
      id="F_8b38eacc-cafb-438a-ae0e-0b7ec3d0f99d"
      unitRef="U_USD">382318000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c"
      decimals="-3"
      id="F_108d48aa-6685-4a54-b4ae-6e3377fdf329"
      unitRef="U_USD">30719000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74"
      decimals="-3"
      id="F_6d8e3a55-8151-4c2c-bc61-2598a22dcee4"
      unitRef="U_USD">33274000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"
      decimals="-3"
      id="F_200fca29-bb18-4289-a4fd-ec9fd402076b"
      unitRef="U_USD">-41955000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_2b10ab9f-de44-47a9-b5ff-d5371fcc2105"
      unitRef="U_USD">404356000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"
      decimals="-3"
      id="F_2ae03f78-ade3-4f12-9a34-109e90935781"
      unitRef="U_USD">300189000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c"
      decimals="-3"
      id="F_8a26a82f-0480-474a-9ec9-ab539efab0e5"
      unitRef="U_USD">24794000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74"
      decimals="-3"
      id="F_1717dbba-5ecc-4471-9a38-2f6924b342ee"
      unitRef="U_USD">17373000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"
      decimals="-3"
      id="F_22724ca4-6ab1-4273-9ffd-6a3b074d4eba"
      unitRef="U_USD">-11957000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_83c047f7-8e8c-4e51-8e9d-041a8a4d4ead"
      unitRef="U_USD">330399000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"
      decimals="-3"
      id="F_9ea5abeb-40b0-4ee2-a982-e69cea603983"
      unitRef="U_USD">38933000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c"
      decimals="-3"
      id="F_69bb3186-5695-4c45-98c6-a2d09d83933e"
      unitRef="U_USD">6163000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74"
      decimals="-3"
      id="F_2de3e6fc-e07d-45ac-9e97-f1b2b56a06a1"
      unitRef="U_USD">12397000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"
      decimals="-3"
      id="F_cbd38380-ccc4-416c-a10d-0df979639153"
      unitRef="U_USD">-30075000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df"
      decimals="-3"
      id="F_ae31d8e6-eecb-469b-8ea4-81972a78c94e"
      unitRef="U_USD">16400000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_3fd67aee-2e19-4967-9041-802dd4dac5dc"
      unitRef="U_USD">43818000</asth:GeneralAndAdministrativeExpensesAndDepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"
      decimals="-3"
      id="F_f4a2a8b8-2dd3-4e97-915a-e75fe5f77f4c"
      unitRef="U_USD">339122000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c"
      decimals="-3"
      id="F_fe50fb62-8040-4c9d-9c56-e00796acbbf7"
      unitRef="U_USD">30957000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74"
      decimals="-3"
      id="F_90a61c0a-79a5-43e6-8578-42dea7751b14"
      unitRef="U_USD">29770000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"
      decimals="-3"
      id="F_d796c397-3743-40b9-a077-b41b79dcf2d0"
      unitRef="U_USD">-42032000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df"
      decimals="-3"
      id="F_477d4bb2-ef8e-4a56-8f42-bb1a5e9d825f"
      unitRef="U_USD">16400000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_e9abd8e6-38c2-4bd1-8997-d1332ec7b42a"
      unitRef="U_USD">374217000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_4bbeb5ac-5579-4bec-887a-12754b13daa5"
      decimals="-3"
      id="F_d8c878e8-bb6d-474b-9458-e47d3ce9522d"
      unitRef="U_USD">43196000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_98479280-cc4c-40f7-b636-b708537e9e1c"
      decimals="-3"
      id="F_b351abe7-cc75-41ca-a3b4-94779c400384"
      unitRef="U_USD">-238000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_22d1feea-c756-468e-ac13-0faa2e9eac74"
      decimals="-3"
      id="F_99d579e8-5c88-4e96-a57d-a8189529bae9"
      unitRef="U_USD">3504000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_8d9216f2-efcf-4dbd-839e-57cbe2fd391e"
      decimals="-3"
      id="F_b8f9378f-eec4-4ad5-945c-10cd986afabf"
      unitRef="U_USD">77000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_4d9ecf8e-dd25-4e6f-8934-50379d4be7df"
      decimals="-3"
      id="F_ba67c5ec-912f-4f3b-8874-beb523d44f77"
      unitRef="U_USD">-16400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_cfa3ebb0-6499-4f16-961e-4ba25f1c9012"
      unitRef="U_USD">30139000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_150972c4-d74f-44d3-bfc4-abc6a07c501a">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;19. Fair Value Measurements of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, are presented below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market accounts*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health call option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest rate collar&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADSC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CFC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;PCCCV contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CHS contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Included in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, are presented below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market accounts*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health call options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest rate collar&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,051&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADSC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CFC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;PCCCV contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CHS contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Included in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the fair value of Level 3 &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_a6133d98-7b94-492e-8834-b1b4530ae2ee;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;liabilities is recognized in unrealized loss on investments, other income, or general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the accompanying condensed consolidated statements of income. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at January 1, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of existing Level 3 liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ninety days&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, certificates of deposit amounted to approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the equity securities were approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, in the accompanying condensed consolidated balance sheets. Gains and losses recognized on equity securities sold are recognized in the accompanying condensed consolidated statements of income as other income. &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in fair value on equity securities held are as follows (in thousands) for the periods listed below and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; securities had been sold in the respective periods:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized gains (losses) recognized on equity securities held at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest Rate Collar Agreements&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company enters into agreements designed to limit the interest rate risk associated with the Company&#x2019;s Revolver Loan, including the collar agreement. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit&#x201d; for further information on the Company&#x2019;s debt. Under the terms of the agreement, the ceiling is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and the floor is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.  The collar agreement is not designated as a hedging instrument. Changes in the fair value of this contract are recognized as unrealized gain or loss on investments in the accompanying condensed consolidated statements of income and reflected in the accompanying condensed consolidated statements of cash flows as unrealized (gain) loss on investments. The estimated fair value of the collar was determined using Level 2. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the fair value of the collar was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and presented within&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; other liabilities in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, the fair value of the collar was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and presented within prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;I Health Call Option&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:8pt;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The Company acquired a &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in I Health, which included a call option that allows the Company to purchase an additional &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest on each of the first, second, and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; third anniversaries from when certain triggering events occur. The Company determined the fair value of the call option using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of the purchase price based on EBITDA and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the value of the call option was valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The I Health call option is presented within other assets in the accompanying condensed consolidated balance sheet. The &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;25&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% equity interest in I Health&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; is accounted for under the equity method (see Note 5 &#x2014; &#x201c;Investments in Other Entities &#x2014;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; Equity Method&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:4pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Remaining equity interest purchase&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In 2021, the Company entered into a financing obligation to purchase the remaining equity interest in Sun Clinical Laboratories (&#x201c;Sun Labs&#x201d;) within &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;three years&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; from the date the Company consolidated Sun Labs. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The purchase of the remaining Sun Labs equity value is considered a financing obligation with a carrying value of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; as of March 31, 2025 and December 31, 2024, respectively.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; As the financing obligation is embedded in the non-controlling interest, the non-controlling interest is recognized in other liabilities in the accompanying condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;All American Medical Group&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;AAMG&#x201d;)&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon acquiring &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the equity interest in AAMG, the purchase price consisted of cash funded upon close of the transaction and additional consideration (&#x201c;AAMG stock contingent consideration&#x201d;) in the form of the Company&#x2019;s common stock. The additional consideration is contingent on AAMG meeting certain revenue and capitated member targets in 2023 (&#x201c;2023 target metric&#x201d;) and in 2024 (&#x201c;2024 target metric&#x201d;). Additional shares would be further issued for exceeding the revenue targets in 2023 (&#x201c;2023 growth metric&#x201d;) and in 2024 (&#x201c;2024 growth metric&#x201d;). The total amount of stock that can be issued for the 2023 target and growth metrics and 2024 target and growth metrics is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;157,059&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;184,357&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. At the end of the earnout periods, the Company concluded on the achievement of the 2023 target and growth metrics and the 2024 target and growth metrics based on actual revenue and the value of the Company stock (Level 1) to calculate payment, representing the fair value of the contingent consideration.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The 2023 and 2024 growth metrics were considered variable and were presented within other liabilities in the accompanying consolidated balance sheet. As of March 31, 2025 and December 31, 2024, the AAMG stock contingent consideration for the 2024 growth metric had a fair value of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.1&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. Changes in the AAMG stock contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;During the year ended December 31, 2024&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the Company had concluded that both the 2023 target metric and the 2023 growth metric were met and issued &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;157,059&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; shares of common stock to the sellers in 2024.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Advanced Diagnostic and Surgical Center (&#x201c;ADSC&#x201d;)&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon acquiring &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;95&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the equity interest of ADSC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent on ADSC achieving revenue and EBITDA metrics for fiscal years 2023 (&#x201c;ADSC 2023 Metric&#x201d;) and 2024 (&#x201c;ADSC 2024 Metric&#x201d;) (collectively, &#x201c;ADSC contingent consideration&#x201d;). The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the ADSC 2023 Metric and the 2024 Metric were valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and were included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the ADSC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income. &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;In April 2025, the Company paid $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million in cash to the sellers of ADSC for the contingent consideration that was achieved. As a result, the contingent liabilities are no longer outstanding.&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon acquiring certain assets of CFC in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash contingent upon CFC maintaining or exceeding the target member month amount for the first, second, and third measurement period (&#x201c;CFC contingent consideration&#x201d;). The first measurement period means the period commencing on the first day of the month immediately following the close of AHMS and ending on the one-year anniversary thereof. The second measurement period is for one year after the first measurement period, and the third measurement period is for one year after the second measurement period. The contingent liability will be paid after achieving the metric in each measurement period. The Company will pay $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for each metric achieved for each measurement period, or a total of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million. In the event that the CFC first and/or second contingent consideration metrics are not achieved during the first and/or the second measurement period, if the metric is met within the second and/or third measurement period, there is a catch-up payment that shall be paid concurrently with the payments of the CFC second contingent consideration and/or CFC third contingent consideration. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31,&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;2024, the first metric was valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.9&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.2&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively, and was included in other liabilities in the accompanying condensed consolidated balance sheets. As of March 31, 2025 and December 31, 2024, the second and third metrics were valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in aggregate, and&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CFC contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon acquiring certain assets of PCCCV in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled in cash, contingent upon PCCCV meeting certain metrics related to financial ratios and member months for the first and second measurement periods (&#x201c;PCCCV contingent consideration&#x201d;). The first measurement period is the first day of the month immediately following the close and ending on June 30, 2024. The second measurement period is for one year after the first measurement period. The Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and assigned probabilities to each such scenario in determining fair value. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, the first metric had been met, and $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million was paid in the fourth quarter of 2024. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, the second metric was valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1.4&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively and was included in other liabilities in the accompanying condensed consolidated balance sheets. Changes in the PCCCV contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;CHS&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Upon acquiring &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;100&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% of the equity interest of CHS in 2024, the total consideration of the acquisition included contingent consideration. The contingent consideration will be settled i&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;n cash, contingent upon CHS achieving a gross profit per total member months metric for fiscal year 2025 (&#x201c;CHS 2025 Gross Profit PMPM Metric&#x201d;) and member enrollment metrics (&#x201c;CHS Member Enrollment Metrics&#x201d;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;) measured over four measurement periods and an additional fifth measurement period contingent upon acquisition of an entity (the &#x201c;earnout period&#x201d;) (collectively, &#x201c;CHS contingent consideration&#x201d;). For the CHS Member Enrollment Metrics, the first measurement period means the period commencing on the first day immediately following the closure of CHS and ending on the one-year anniversary thereof. The second, third, fourth, and fifth measurement periods are for one year after each of the previous respective measurement periods. If the metrics are achieved, the contingent liability will be paid after the end of the earnout period. The Company will pay up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.8&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for the CHS 2025 Gross Profit PMPM Metric, and up to $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million for each metric achieved for each measurement period, or up to a total of $&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21.5&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million, for the CHS Member Enrollment Metrics. T&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;he Company determined the fair value of the contingent consideration using a probability-weighted model that includes significant unobservable inputs (Level 3). Specifically, the Company considered various scenarios of revenue and membership and assigned probabilities to each such scenario in determining fair value. As of March 31, 2025 and December 31, 2024, the CHS contingent consideration was valued at &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.7&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. The CHS 2025 Gross Profit PMPM Metric was included in other liabilities and the CHS Member Enrollment Metrics were included in other long-term liabilities in the accompanying condensed consolidated balance sheets. Changes in the CHS contingent consideration are presented in general and administrative expenses in the accompanying condensed consolidated statements of income.&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_3cfc17aa-cb70-4055-aaa1-465344402da3">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, are presented below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market accounts*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,755&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,313&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;84&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health call option&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,152&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,867&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest rate collar&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADSC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CFC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;11,170&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;PCCCV contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CHS contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,741&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,075&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;32,133&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Included in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The carrying amounts and fair values of the Company&#x2019;s financial instruments as of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;December 31, 2024, are presented below (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:50.38%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.22%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:9.184000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="10" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Money market accounts*&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,673&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; certificates of deposit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,289&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Marketable securities &#x2013; equity securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;I Health call options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Interest rate collar&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;6,051&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;19&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;3,778&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,848&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="background-color:#ffffff;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;white-space:pre-wrap;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;AAMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;VOMG contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Sun Labs remaining equity interest purchase&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;7,352&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;ADSC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;4,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CFC contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;9,949&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;PCCCV contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,351&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;CHS contingent consideration&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5,643&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Total liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2,110&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,705&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;* Included in cash and cash equivalents&lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"
      decimals="-3"
      id="F_61d5dd12-b416-44f6-a07e-6fd49d327b17"
      unitRef="U_USD">2755000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6"
      decimals="-3"
      id="F_d6e66681-5e32-4136-90a2-4473d1b3890b"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"
      decimals="-3"
      id="F_2e73e434-2954-4a7e-8545-81f0ffc71b92"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_5074e64b-4b91-4b31-920f-f7bef8d4633f"
      unitRef="U_USD">2755000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"
      decimals="-3"
      id="F_21395125-d0c5-48f3-838d-27c836dd6100"
      unitRef="U_USD">2313000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6"
      decimals="-3"
      id="F_41645851-ab8a-44de-bd17-97c5364e30fd"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"
      decimals="-3"
      id="F_280868c3-378f-44f1-b937-ed9cddba43aa"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_0ef023b0-369a-4790-bfdf-a9af73c62184"
      unitRef="U_USD">2313000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"
      decimals="-3"
      id="F_d44dc7bd-1e20-4dd7-b984-b751a7dbe3de"
      unitRef="U_USD">84000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6"
      decimals="-3"
      id="F_d9b6afac-e903-4d4c-af56-6d16674c4c8c"
      unitRef="U_USD">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"
      decimals="-3"
      id="F_5657e497-0266-409e-9dd1-565a1bafb0cc"
      unitRef="U_USD">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_d293f803-e403-4b37-8955-0f722d37f1fa"
      unitRef="U_USD">84000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="C_5edf9e77-4494-4d12-9667-31e210c6227e"
      decimals="-3"
      id="F_e51bd416-d9e0-4004-b15c-3580df7469f6"
      unitRef="U_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_eaf785cb-d155-4317-8f80-24864238f6c1"
      decimals="-3"
      id="F_88c46c28-d16e-4ccb-ba0d-871473f0dfae"
      unitRef="U_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_3b445780-6235-4a8f-ba3b-abd685c6ec2e"
      decimals="-3"
      id="F_b7b7e235-f5ec-4381-b3d9-99e9efbb1c8b"
      unitRef="U_USD">3867000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_a2bea5f5-db89-471f-9592-a236454f04a8"
      decimals="-3"
      id="F_f9547812-49ad-48f9-a76b-2b8a458ef9eb"
      unitRef="U_USD">3867000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"
      decimals="-3"
      id="F_f39796ed-104e-419c-9a45-10095c55f075"
      unitRef="U_USD">5152000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6"
      decimals="-3"
      id="F_faa8dfc4-6673-44bc-a720-23c4eae0df4c"
      unitRef="U_USD">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"
      decimals="-3"
      id="F_30979f97-e62c-43a7-a326-f78f8fc0f9c6"
      unitRef="U_USD">3867000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_ec64b9cf-0c02-45ae-b026-9fffad2c469a"
      unitRef="U_USD">9019000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="C_9fa5f4aa-a01c-4fb8-b531-d0b936d239ba"
      decimals="-3"
      id="F_f66cd7d7-e9b9-4994-b2bf-ab562c539182"
      unitRef="U_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_d15c567f-3397-4492-8383-e863d7384893"
      decimals="-3"
      id="F_84611a84-9f43-4a1e-b84b-6ec0addecac0"
      unitRef="U_USD">21000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_84a45b5b-15c0-41fe-adf1-ca456ce3cf0b"
      decimals="-3"
      id="F_c9bbac46-0cb8-4a26-8a57-64e3f435844f"
      unitRef="U_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495"
      decimals="-3"
      id="F_764ede08-e906-4c03-b8e0-8d2cb15da22b"
      unitRef="U_USD">21000</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_b1c3604a-49e6-44ea-82e9-36f2015f5d4d"
      decimals="-3"
      id="F_20924cf5-3c11-4b73-bb04-efff09bfd52f"
      unitRef="U_USD">2075000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_0b125a20-c6ed-4951-af84-bbf48d18d034"
      decimals="-3"
      id="F_4b8524f2-4293-4133-a925-07ee527a4428"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_beef7b88-15ad-4fab-977d-5bf2e6bb0e4d"
      decimals="-3"
      id="F_f5a705ce-c844-47d4-9ad0-bdecb806a604"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_c3a3893e-219e-41f0-a38f-79683aa82945"
      decimals="-3"
      id="F_055235b9-620f-4924-92d2-31099850066b"
      unitRef="U_USD">2075000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_ceaebce1-eadc-44b5-9828-3ae63b4a713d"
      decimals="-3"
      id="F_1942abaf-97fd-4d62-9112-15d59f8b1087"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_03eaf310-f4d6-4b4c-9ee7-e536dd3096e1"
      decimals="-3"
      id="F_445d0533-57a1-455a-9389-c2047173c194"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_48e4959b-0f1f-4be5-ab14-031e03179f1a"
      decimals="-3"
      id="F_09022ae0-9050-4588-b1a3-01234ea8d24d"
      unitRef="U_USD">15000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_3b9afbd5-4210-4cba-a0f1-a98c07823a3b"
      decimals="-3"
      id="F_550e012d-554e-4d24-af89-5a4ce3180b76"
      unitRef="U_USD">15000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_a38c3842-fb3a-4695-9d09-f0d2fbf7975a"
      decimals="-3"
      id="F_e304972a-7f17-4b72-9ff0-d987fb77e00d"
      unitRef="U_USD">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_3bc8f5ef-23a9-4f96-bc10-a52d7a540f3d"
      decimals="-3"
      id="F_f782ac3e-16ec-48eb-85bc-e308c9b4cd0a"
      unitRef="U_USD">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_02359f56-b244-409f-85a6-c9122ce3d2a6"
      decimals="-3"
      id="F_7d402425-467f-4ab4-8dd7-4ffe9fa95da9"
      unitRef="U_USD">7352000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_58fba134-3b96-4623-9e04-19f42b73f4cd"
      decimals="-3"
      id="F_fa79ee1f-1e3f-4c44-8b07-315bad4fc4ce"
      unitRef="U_USD">7352000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_b046e187-8392-4a7d-a3ab-f5065c36bf0b"
      decimals="-3"
      id="F_b754591b-14bf-4160-93aa-80563681460e"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_beafc79c-c290-4d5a-b082-1dafd30fba26"
      decimals="-3"
      id="F_e59a1e28-2c76-4aa3-afa5-6a708542b8bc"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_0aa38d95-e047-40ed-aae1-7c7af01d8b45"
      decimals="-3"
      id="F_b5449c40-a910-454e-8a8c-d89e9cba17ed"
      unitRef="U_USD">4309000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_713fe850-c7c0-4c74-bb89-374b329bb348"
      decimals="-3"
      id="F_d9ca9a9f-9d59-4e0c-b13c-8ebf97650105"
      unitRef="U_USD">4309000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_65d1d249-71f7-46a2-a28a-9474d27d86f3"
      decimals="-3"
      id="F_94e0a45f-ac74-4092-8918-2449897b4a0b"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_0c97d0ad-d27f-4202-b033-a921a4fd1636"
      decimals="-3"
      id="F_b97c9022-94a0-40ee-a1c4-ec4e5ae1b83c"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_48d15767-6248-4bb8-9a0c-0543b84f6436"
      decimals="-3"
      id="F_74c579f6-3000-4c48-9dea-65767c7fc40d"
      unitRef="U_USD">11170000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_3952c0ce-7c90-43a0-8800-607b699b17a9"
      decimals="-3"
      id="F_aee26e74-4bbe-45b0-bf49-ad4a9803691b"
      unitRef="U_USD">11170000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_16aa46eb-3f05-457c-861c-643f3c663612"
      decimals="-3"
      id="F_e4b9e166-a576-4e78-b809-58573dbbf8ee"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_766601e2-a6b4-4052-99ed-c5eca3f68c15"
      decimals="-3"
      id="F_36ca12a4-e918-48ab-9ed4-8efefa2062a5"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_e5cdd2bb-60a6-4ebb-b03f-2092771d6a9f"
      decimals="-3"
      id="F_9f2b5538-bb60-4fb1-ad19-9b824ea71a61"
      unitRef="U_USD">1450000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_2a1a51c2-b17e-483d-80bc-bbee2ba2992a"
      decimals="-3"
      id="F_378cb768-f7ff-4d55-a1ee-4735a5852fac"
      unitRef="U_USD">1450000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_c3a4e452-1161-4a5d-850f-16c304a662ee"
      decimals="-3"
      id="F_d9edaf4f-1a48-4b67-9b2c-dbdc252803b4"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_5632426d-baaa-4109-8b29-9f7796b165df"
      decimals="-3"
      id="F_675bc572-21bd-43be-b5b8-2c303cc3c153"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_c8ddf934-6d23-4f44-9b9a-94254e17fd2e"
      decimals="-3"
      id="F_629b0d7b-392c-4511-9437-7f4f2b0002e8"
      unitRef="U_USD">5741000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_71250632-5809-4877-9e5a-4ea18f63b9b1"
      decimals="-3"
      id="F_b4608770-6763-4058-94ae-97fe3cae1eac"
      unitRef="U_USD">5741000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_2adaf179-943d-442d-a91a-d9bfbc4f0d30"
      decimals="-3"
      id="F_e0477741-1207-48a4-b638-6e00fbd55836"
      unitRef="U_USD">2075000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_384def41-401d-433b-a083-2f0ed1630ae6"
      decimals="-3"
      id="F_ca672535-c71b-4a0d-9c38-7c4836570112"
      unitRef="U_USD">21000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_1883b4c7-cb2a-42ba-b965-ea28f051d37a"
      decimals="-3"
      id="F_c3d449dd-201a-4ce0-a153-f01ad89e5cb3"
      unitRef="U_USD">30037000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_1999093c-4b13-48ba-8e28-ca88db419a1e"
      unitRef="U_USD">32133000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"
      decimals="-3"
      id="F_474ac1c4-e15b-4dfc-ae41-d80d1879a45d"
      unitRef="U_USD">3673000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"
      decimals="-3"
      id="F_c23b09f7-c77d-49d7-b9e6-3f6e531b4d3a"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"
      decimals="-3"
      id="F_a43b3f38-1c25-4017-9cbe-2e6aa55b4ea2"
      unitRef="U_USD">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_26ffca1d-a179-4bd5-b14a-0676859eba89"
      unitRef="U_USD">3673000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"
      decimals="-3"
      id="F_0395d847-ebd1-4526-837b-ee4fa22e3319"
      unitRef="U_USD">2289000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"
      decimals="-3"
      id="F_72668719-655a-44b3-9e33-e822fd6e6547"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"
      decimals="-3"
      id="F_6078738e-c56f-484f-b25a-a2de34079a55"
      unitRef="U_USD">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_def159c9-46f5-426a-91a6-22e37b25e151"
      unitRef="U_USD">2289000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"
      decimals="-3"
      id="F_09587f3f-c95d-4304-99c0-6c3fd1240e0a"
      unitRef="U_USD">89000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"
      decimals="-3"
      id="F_d988699c-4114-4361-8151-974e1b22158b"
      unitRef="U_USD">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"
      decimals="-3"
      id="F_94bd6b5c-a465-468f-94b7-e82f664c97bb"
      unitRef="U_USD">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_98df7779-e1fd-4de0-b36f-72448e409b5e"
      unitRef="U_USD">89000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="C_f645eb5f-2f94-46c5-98c1-1dabebffc600"
      decimals="-3"
      id="F_df39b108-4e00-459a-96b6-babc0da49928"
      unitRef="U_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_f0efa117-c0df-40e9-9b6c-2738c0931341"
      decimals="-3"
      id="F_e0f28208-8995-40a9-b014-7094d69b955d"
      unitRef="U_USD">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_b75ed518-5871-4767-8792-56c29fff2189"
      decimals="-3"
      id="F_22d6d93b-ab96-4f05-b3e0-6f314d963cd5"
      unitRef="U_USD">3778000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="C_f58ff657-ab10-466b-ac21-a56b042b8f8e"
      decimals="-3"
      id="F_f6a8fafc-c360-4678-9a50-5b971319d60a"
      unitRef="U_USD">3778000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeLiabilities
      contextRef="C_ca2b1674-f053-4711-99b6-46e02ae62634"
      decimals="-3"
      id="F_51333c7f-415a-4cf4-b7dd-6935cc6f996a"
      unitRef="U_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_c4e85806-bf8b-4a55-ac88-31f987995966"
      decimals="-3"
      id="F_f0c77fc2-88fb-47eb-a979-6b8370299cc6"
      unitRef="U_USD">19000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_4119ea9a-9b96-42d3-bd3c-d9d8cc88b66c"
      decimals="-3"
      id="F_6fbe9197-4e79-450b-b657-e2d54b3b7690"
      unitRef="U_USD">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="C_c7b860f3-00e7-4af6-b919-b03da362adc5"
      decimals="-3"
      id="F_229dbe50-06ff-40d5-bfa9-cc3b01d87afd"
      unitRef="U_USD">19000</us-gaap:DerivativeLiabilities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"
      decimals="-3"
      id="F_e506c6c2-1c53-4372-929d-ddbef64e775a"
      unitRef="U_USD">6051000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"
      decimals="-3"
      id="F_b163252a-00e4-43e1-8fed-4ccda61dcd84"
      unitRef="U_USD">19000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"
      decimals="-3"
      id="F_70a3738a-caa6-4dd2-a541-b41c1c82d1cf"
      unitRef="U_USD">3778000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_a23d0fd0-223b-4a4a-be37-78f5711f711c"
      unitRef="U_USD">9848000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_cb205433-1776-4986-8156-9590d16dcda6"
      decimals="-3"
      id="F_abe3ecba-897b-4973-9e7a-d000635859f3"
      unitRef="U_USD">2110000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_11101c20-415e-4281-8227-fa000c36a1ad"
      decimals="-3"
      id="F_737bd98a-1e4a-46cd-8851-1a8b273ac1e1"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_acc8f0ee-cf35-491f-b1bc-f32657bd0a84"
      decimals="-3"
      id="F_849e0441-19a9-4be6-926d-4c271b3327e2"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_38586056-d9a0-4723-b06e-423ac77877ea"
      decimals="-3"
      id="F_4c70876a-cc55-462c-95b8-37494a3ec264"
      unitRef="U_USD">2110000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_0f2b4746-765e-4a23-95d4-385fe1476cce"
      decimals="-3"
      id="F_3f63681e-4b83-4b21-823d-b6389233effe"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_8ef40c99-631c-434b-8193-71f59194c695"
      decimals="-3"
      id="F_6c06efb7-e104-42d4-a716-64b14e002335"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_88dd1103-5401-475c-b0d3-88c0af26a48e"
      decimals="-3"
      id="F_91c437dd-dd2b-4f1b-9c07-cf458d319c90"
      unitRef="U_USD">15000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_d7ac3eef-52f1-4e2c-8d64-851c37c3ee9c"
      decimals="-3"
      id="F_58c0c4e6-d57b-4b78-a09b-6258da5d3318"
      unitRef="U_USD">15000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_b6dd06dd-3e1a-4e3d-bd37-70d3a5857d75"
      decimals="-3"
      id="F_d5228273-4001-4cfb-8c45-e039f8b6eb3e"
      unitRef="U_USD">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_6ce72f59-77e8-4dbe-aae6-f5d7f9f30d70"
      decimals="-3"
      id="F_830be410-fc7a-4d35-9350-59e63d878529"
      unitRef="U_USD">0</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_40132981-89ba-4e41-815e-8b46af618908"
      decimals="-3"
      id="F_86de7f94-ded2-4e75-94d1-9bc179804bcb"
      unitRef="U_USD">7352000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_fbb3c763-fbfe-4d2d-bb20-60c7ade4a0d2"
      decimals="-3"
      id="F_49df278d-ddd9-46ca-9589-0b00df1f01fc"
      unitRef="U_USD">7352000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_cf778192-a620-4a66-876e-1b3bee77789f"
      decimals="-3"
      id="F_abff10bc-610a-4750-aa3a-ce9ef88c84c5"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_47dc46dc-5dad-4a5f-967c-32e72a07d19c"
      decimals="-3"
      id="F_7f66784b-9c5f-45ce-a6ca-352d0f2581e4"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_fd640251-91ea-4cc7-9495-ffa5d748fb28"
      decimals="-3"
      id="F_df8ffa59-8b58-428e-bbeb-97fdccbb44da"
      unitRef="U_USD">4285000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_cd8693a7-bcaa-4246-bc4f-8864b40faac7"
      decimals="-3"
      id="F_ceb77823-312a-45a7-8905-cc6bebe2464f"
      unitRef="U_USD">4285000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_3696b868-57c7-4c52-8b1e-a7409de802a3"
      decimals="-3"
      id="F_9d8b580a-3afe-4949-a2ae-60d36335c804"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_bf6be12f-f3ab-4aa9-a56c-870966b9a04a"
      decimals="-3"
      id="F_6dd4cbe2-9a04-4493-a9d6-3c3e619a00f0"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_222bd65b-18c2-4e1e-ae1b-cbccc1f49d96"
      decimals="-3"
      id="F_ea43e9c2-2b1d-441b-95c1-dd27e31cb292"
      unitRef="U_USD">9949000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_0b13f834-ee62-4361-8e5b-68ea07a37e23"
      decimals="-3"
      id="F_893064cb-d667-4db1-a2c0-192908c08c6f"
      unitRef="U_USD">9949000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_3acc1c89-3076-4ee5-a26e-94c06be58c7e"
      decimals="-3"
      id="F_b4742f6a-14d9-4231-a9a8-6783536a7f42"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_08a19b8a-9cd6-4016-9557-28e48707eeb4"
      decimals="-3"
      id="F_00a1cead-642e-438b-af71-c90529898773"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_dc8d6e4a-2466-4667-9a1b-22764f551de8"
      decimals="-3"
      id="F_9590505b-4bb4-4cbf-8be4-e81a2947ded6"
      unitRef="U_USD">1351000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_beaa67cb-6b14-49ee-84da-6671434aed28"
      decimals="-3"
      id="F_b86e87b7-00aa-406f-91ac-da6247606df6"
      unitRef="U_USD">1351000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_af039a31-ee84-42a7-82dd-8c7deb252ff1"
      decimals="-3"
      id="F_dcb07dbf-fdf5-4417-84ee-ace580d33b50"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_ee076df7-779d-41be-82fa-78965cf2bb7f"
      decimals="-3"
      id="F_ac2357f5-eed9-4a1f-b515-2fc5285e4a3b"
      unitRef="U_USD">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_22f45f1e-8c8c-4614-b22e-19a67b75190b"
      decimals="-3"
      id="F_6736093b-53c9-4e7a-87dd-2487de355152"
      unitRef="U_USD">5643000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_6a8368f0-8774-4b22-a45d-899d1800a379"
      decimals="-3"
      id="F_cc686e30-6743-4ae6-a4fa-97272d39244c"
      unitRef="U_USD">5643000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_9191345b-50ce-4b0d-ad78-28bea9b72a9e"
      decimals="-3"
      id="F_5db75fd0-adbf-4246-b8b4-b24a194a2f5b"
      unitRef="U_USD">2110000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_9aad9a42-4d28-4aa9-9013-36f94bf8fdd2"
      decimals="-3"
      id="F_2ecc87b7-b24a-4430-a5c1-effe2caa80a7"
      unitRef="U_USD">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_e25182cb-8ed3-4b97-ae24-e13bdc9cfe19"
      decimals="-3"
      id="F_8942bcb0-773b-45e5-9410-120600e79f29"
      unitRef="U_USD">28595000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_71a6fba8-854d-44e5-9f3c-cd9c088a5cfd"
      unitRef="U_USD">30705000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_769d4af5-fbdd-4801-b337-679b6616e83b">&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in the fair value of Level 3 &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_a6133d98-7b94-492e-8834-b1b4530ae2ee;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;liabilities is recognized in unrealized loss on investments, other income, or general and administrative expenses&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; in the accompanying condensed consolidated statements of income. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the reconciliation of our Level 3 liabilities was as follows (in thousands):&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:80.24%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.94%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:15.82%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Amount&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at January 1, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;28,595&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Change in fair value of existing Level 3 liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;1,442&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Balance at March 31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;30,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-3"
      id="F_a62da82d-9d69-4d23-990b-45d02477f6ac"
      unitRef="U_USD">28595000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_2f7f6f8b-b4fa-439e-94f8-c0d1f22bf8ee"
      unitRef="U_USD">1442000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-3"
      id="F_a94bde21-ab06-453f-9044-96f98d06c9b9"
      unitRef="U_USD">30037000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_a49a5b02-3ca2-49a1-b428-810f7349f118">&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Investments in Marketable Securities&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Certificates of deposit are reported at par value, plus accrued interest, with maturity dates greater than &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;ninety days&lt;/span&gt;&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025 and December 31, 2024, certificates of deposit amounted to approximately &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.3&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; million&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;, respectively. Investments in certificates of deposit are classified as Level 1 investments in the fair value hierarchy.&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;Equity securities are reported at fair value. These securities are classified as Level 1 in the valuation hierarchy, where quoted market prices from reputable third-party brokers are available in an active market and unadjusted.&lt;/span&gt;</us-gaap:MarketableSecuritiesPolicy>
    <asth:MarketableSecuritiesCurrentMaturityPeriod
      contextRef="C_ca44cbaa-887f-4bf8-b193-1e7fba9ea4ab"
      id="F_90f2a6b3-4df9-4f54-ac25-0b2eb1e99dcc">P90D</asth:MarketableSecuritiesCurrentMaturityPeriod>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_c24d9fbe-5f15-4c99-b3b6-14bc8e5f8a34"
      decimals="-5"
      id="F_b85e9561-1d70-49e7-a906-e773e07786c4"
      unitRef="U_USD">2300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_9c3af7b7-7fc8-4c10-9520-574b3555c4e0"
      decimals="-5"
      id="F_b521569e-c8f8-4f6a-85ce-571387c240ac"
      unitRef="U_USD">2300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_99ea2791-355d-432f-b116-de8fe51581b6"
      decimals="-5"
      id="F_eda81d53-acd3-432f-ae6a-ee474faf8889"
      unitRef="U_USD">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="C_9ac0c6d0-4628-4820-9917-37da7e90084b"
      decimals="-5"
      id="F_a1095286-28d2-48fc-9b2b-647542b8d128"
      unitRef="U_USD">100000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_9b591eaa-614f-450f-8920-b71a6cc6a961">&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;The change in fair value on equity securities held are as follows (in thousands) for the periods listed below and &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;no&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; securities had been sold in the respective periods:&lt;/span&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
       &lt;table style="margin-left:auto;border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
        &lt;tr style="visibility:collapse;"&gt;
         &lt;td style="width:66.993%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1.62%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:12.883000000000001%;box-sizing:content-box;"&gt;&lt;/td&gt;
         &lt;td style="width:1%;box-sizing:content-box;"&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="6" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;text-align:left;"&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #ffffff03;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td colspan="2" style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:0.5pt solid #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr style="height:10pt;background-color:#cff0fc;word-break:break-word;"&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;Unrealized gains (losses) recognized on equity securities held at end of period&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;text-indent:10pt;white-space:pre-wrap;padding-left:0in;vertical-align:top;padding-bottom:0.03in;padding-right:0.01in;"&gt;&lt;p style="margin-left:1.853%;text-indent:0;font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #ffffff03;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:pre-wrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;text-align:center;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:right;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;(&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;td style="padding-top:0.06in;white-space:nowrap;padding-left:0in;vertical-align:bottom;padding-bottom:0.03in;border-bottom:2.25pt double #000000;padding-right:0.01in;"&gt;&lt;p style="font-size:10pt;margin-top:0;line-height:1.05;font-family:Times New Roman;margin-bottom:0;text-align:left;"&gt;&lt;span style="color:#000000;font-kerning:none;min-width:fit-content;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;/tr&gt;
       &lt;/table&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <asth:NumberOfEquitySecuritiesSold
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="INF"
      id="F_14c44236-8c67-4a3c-8a67-971a75ad66fc"
      unitRef="U_Securities">0</asth:NumberOfEquitySecuritiesSold>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      decimals="-3"
      id="F_b9bed2f8-17da-4998-a948-09cbc8074e70"
      unitRef="U_USD">5000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="C_8f134208-f6d5-4c50-a680-3e055aa91882"
      decimals="-3"
      id="F_5d1cef67-5f06-45d7-89f5-a3cf2e826aa2"
      unitRef="U_USD">-116000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_175ce601-0760-442b-9abc-d2230c4835f1">&lt;p style="font-size:10pt;margin-top:0;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font-size:10pt;margin-top:12pt;line-height:1.38;font-family:Times New Roman;margin-bottom:0;text-align:justify;"&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"&gt;Interest Rate Collar Agreements&lt;/span&gt;&lt;/p&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;From time to time, the Company enters into agreements designed to limit the interest rate risk associated with the Company&#x2019;s Revolver Loan, including the collar agreement. The principal objective of the collar agreement is to eliminate or reduce the variability of the cash flows in interest payments associated with the Company&#x2019;s floating-rate debt, thus reducing the impact of interest rate changes on future interest payment cash flows. Refer to Note 9 &#x2014; &#x201c;Credit Facility, Bank Loans, and Lines of Credit&#x201d; for further information on the Company&#x2019;s debt. Under the terms of the agreement, the ceiling is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;% and the floor is &lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;2.34&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;%.  The collar agreement is not designated as a hedging instrument. Changes in the fair value of this contract are recognized as unrealized gain or loss on investments in the accompanying condensed consolidated statements of income and reflected in the accompanying condensed consolidated statements of cash flows as unrealized (gain) loss on investments. The estimated fair value of the collar was determined using Level 2. As of &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;March 31, 2025, the fair value of the collar was &lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt;$&lt;/span&gt;&lt;span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"&gt;21,000&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; and presented within&lt;/span&gt;&lt;span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"&gt; other liabilities in the accompanying condensed consolidated balance sheets.&lt;/span&gt;</us-gaap:DerivativesPolicyTextBlock>
    <asth:DerivativeCeilingInterestRate
      contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495"
      decimals="3"
      id="F_293ba942-759a-42c0-8d96-a1b2bad9e806"
      unitRef="U_pure">0.05</asth:DerivativeCeilingInterestRate>
    <us-gaap:DerivativeFloorInterestRate
      contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495"
      decimals="4"
      id="F_ad2a6db9-d163-4ee7-89d0-960ca837df13"
      unitRef="U_pure">0.0234</us-gaap:DerivativeFloorInterestRate>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="C_fbc31d75-110d-425d-9f53-3d8451a0d495"
      decimals="0"
      id="F_33449e42-c929-47f1-ba84-042143fff51a"
      unitRef="U_USD">21000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="C_c7b860f3-00e7-4af6-b919-b03da362adc5"
      decimals="0"
      id="F_df84df5b-ef79-4ed4-9977-8ba849c4d19b"
      unitRef="U_USD">19000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="2"
      id="F_e5282557-b333-46ce-931f-e8e16eaaed5e"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_82a128ab-24f6-4bd4-9c31-08a2effd7c78"
      decimals="2"
      id="F_5ee22fbe-5531-47cd-a787-82459b450dff"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <asth:ValueOfCallOption
      contextRef="C_44dfee64-65b5-496e-98a1-6b501aa3532a"
      decimals="-5"
      id="F_4b243496-080b-4b20-806d-ec16b64016f2"
      unitRef="U_USD">3900000</asth:ValueOfCallOption>
    <asth:ValueOfCallOption
      contextRef="C_66914d11-6398-4518-9398-8ccb5e2da66d"
      decimals="-5"
      id="F_6d477c89-07bf-4fdb-a9b8-72bbeb50bab2"
      unitRef="U_USD">3800000</asth:ValueOfCallOption>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="C_21dd06cf-9d3c-43d2-9980-e998c5f6f0c9"
      decimals="2"
      id="F_57c140a0-4dce-47d7-bef0-0fc4561ced78"
      unitRef="U_pure">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase
      contextRef="C_dfa9936b-5186-4152-84d7-699c1a534b33"
      id="F_bb73b5bf-96fc-4dd2-ad43-b273eabca51f">P3Y</asth:BusinessCombinationEquityInterestPurchaseObligationPeriodToPurchase>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_8f301b9f-cd6b-4eac-bd0f-1c2f7c9543f6"
      decimals="-5"
      id="F_1bcee59a-5f27-435b-a328-2a79060f1215"
      unitRef="U_USD">7400000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent
      contextRef="C_8b9280f1-8e3e-4e01-b2b8-0697e6c860d0"
      decimals="-5"
      id="F_60bf1bc3-1d8e-4823-8d95-ab07b350f959"
      unitRef="U_USD">7400000</asth:BusinessCombinationEquityInterestPurchaseObligationNoncurrent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="C_1bff3c75-ef8c-43c8-8cd4-ddb311389b41"
      decimals="2"
      id="F_b5060a0e-9769-4a60-ac9a-6a8b3a0912e3"
      unitRef="U_pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_7111af93-0249-4601-b68b-7488d9494f44"
      decimals="INF"
      id="F_86e8e206-0c88-4464-9265-84fc2645704e"
      unitRef="U_shares">157059</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_df83f06c-1bd7-4a08-a59a-dbb0d00b045d"
      decimals="INF"
      id="F_50285000-b0ca-4508-abda-b275deee80a6"
      unitRef="U_shares">184357</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_9f0059b7-fc7c-4e0a-9e5b-a7e9d0745aaa"
      decimals="-5"
      id="F_030d3694-5168-4020-b419-408b7f8e8241"
      unitRef="U_USD">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_660533f2-bb98-4221-8734-e0be6ba384e1"
      decimals="-5"
      id="F_9b07ab2c-4dfd-4b1b-a8b3-75b3e741224f"
      unitRef="U_USD">2100000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="C_1dd1d251-19bf-4cd5-8a5d-6055b3033882"
      decimals="INF"
      id="F_cbbb7ce9-af69-48f8-b601-5a29f246e140"
      unitRef="U_shares">157059</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="C_1365a955-4128-4b28-a0bb-c35ac458d684"
      decimals="2"
      id="F_d7f33da3-4bcb-4481-87a0-843bbde4763a"
      unitRef="U_pure">0.95</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_23f8c634-36f7-44cf-9399-7b2106a9fe93"
      decimals="-5"
      id="F_e0a84a42-4cae-447f-ad26-27283e50f7b3"
      unitRef="U_USD">4300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_71a445c4-c7ab-4d90-a288-fe1fead886c3"
      decimals="-5"
      id="F_cd06594e-3cd3-4509-915b-6bc7befb7ff1"
      unitRef="U_USD">4300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="C_a0db209d-d0ac-4fda-b0be-cbfb62c51851"
      decimals="-5"
      id="F_6af95a4f-510e-4c71-9ee9-4762862b3cb6"
      unitRef="U_USD">4500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod
      contextRef="C_b7aa5384-1c58-4d97-a748-b46442622060"
      decimals="-5"
      id="F_2db2016c-2230-4585-a4bf-efee9987e29a"
      unitRef="U_USD">5000000</asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_b7aa5384-1c58-4d97-a748-b46442622060"
      decimals="-5"
      id="F_ac7772dd-6f3b-40df-8589-c98dfdd7146f"
      unitRef="U_USD">15000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_080805e0-71f9-466e-995d-e3d7a0793b53"
      decimals="-5"
      id="F_e5d252d9-336c-4497-bd53-f05ac55ada90"
      unitRef="U_USD">4900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_017c6b7e-32c1-4fc0-bb28-bb5b23e4d7dc"
      decimals="-5"
      id="F_047b3fd4-87f0-4184-85d7-c8428787e010"
      unitRef="U_USD">4200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_388ec8dd-e407-47aa-b88b-930866d15cfe"
      decimals="-5"
      id="F_e35dbfbc-6997-4ae1-b67e-bfb073077cd0"
      unitRef="U_USD">6300000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_1e5aa272-935d-4f32-9bfb-416c2178e6aa"
      decimals="-5"
      id="F_8e98bb24-334a-48fc-b277-47e342204f1f"
      unitRef="U_USD">5800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_b1bd11cd-8dd6-4de9-a5ed-b6ef0413b392"
      decimals="-5"
      id="F_6e680922-dddf-409e-90fa-d5cb1ddfb644"
      unitRef="U_USD">1000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_bbf6403d-9162-483c-8776-b0ea02605c69"
      decimals="-5"
      id="F_58f7c07b-abb5-4734-aebe-13fcf6fd6969"
      unitRef="U_USD">1500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_5b43a6c1-a998-439d-ba82-792676c6568d"
      decimals="-5"
      id="F_29310a2f-51c4-472b-bcb0-c9ac9d3c95e9"
      unitRef="U_USD">1400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="C_a5fa8d3f-8630-436e-bb55-37a26df286f9"
      decimals="2"
      id="F_c329dd67-b134-4163-bb6d-ad71a6387f5d"
      unitRef="U_pure">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod
      contextRef="C_f9e21867-5350-4ee9-bd3d-e27eaf98771f"
      decimals="-5"
      id="F_b745f278-3041-4957-8923-289155b6df22"
      unitRef="U_USD">4800000</asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod>
    <asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod
      contextRef="C_caa6bff7-c546-4734-8b91-b9cc35d645f7"
      decimals="-5"
      id="F_78dc050f-dd6c-4f9a-8475-266c2e9ab4f9"
      unitRef="U_USD">4300000</asth:BusinessCombinationContingentConsiderationLiabilityEachMeasurementPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_b899ab26-e619-4d58-a07b-38bf2016ab41"
      decimals="-5"
      id="F_47faa085-a5d3-456f-a800-e0e3a6a23a32"
      unitRef="U_USD">21500000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_4103c318-abec-4453-8eb0-b888e91d21a3"
      decimals="-5"
      id="F_dbe3866a-236b-4f34-bea2-ffd0bf345fc8"
      unitRef="U_USD">5700000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="C_495d4051-3ab2-4ec4-aac2-eb89210fcf3b"
      decimals="-5"
      id="F_06215318-f47b-46d2-8ca8-1e83e3053853"
      unitRef="U_USD">5600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <ecd:Rule10b51ArrAdoptedFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_421321c1-4e61-465c-8746-f0e3f8a693f3">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_894d3541-4b0e-4817-88cb-4e81f8837d6a">false</ecd:NonRule10b51ArrAdoptedFlag>
    <asth:Rule10B51ArrModifiedFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_98727147-92d7-4c4f-9ef7-39b7e338e405">false</asth:Rule10B51ArrModifiedFlag>
    <asth:NonRule10B51ArrModifiedFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_1ea7016b-1f2f-483c-96c9-1eff59f66562">false</asth:NonRule10B51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_a6158cd1-03f1-4e0a-96e4-9e34dedbf8d9">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag
      contextRef="C_5866792a-f02f-4281-bb96-b527c6b93742"
      id="F_435bc974-1f25-4b7a-aa76-ca4a9f254ad7">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#F_eeaffbef-52aa-44cf-b09d-2ce37173ba27"
          xlink:label="F_eeaffbef-52aa-44cf-b09d-2ce37173ba27"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_c7e2d019-0bd5-48b6-9f3d-aa213600f006"
          xlink:label="F_c7e2d019-0bd5-48b6-9f3d-aa213600f006"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_3caa0f8b-7e96-491f-8b69-dc963eefb25d"
          xlink:label="F_3caa0f8b-7e96-491f-8b69-dc963eefb25d"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#F_b5a02926-a7d8-4244-8588-e131eb0d1fca"
          xlink:label="F_b5a02926-a7d8-4244-8588-e131eb0d1fca"
          xlink:type="locator"/>
        <link:footnote id="FNT_99e48291-d907-4bff-bdda-34e68217cbf2" xlink:label="FNT_99e48291-d907-4bff-bdda-34e68217cbf2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company&#x2019;s condensed consolidated balance sheets include the assets and liabilities of its consolidated VIEs. The condensed consolidated balance sheets include total assets that can be used only to settle obligations of the Company&#x2019;s consolidated VIEs totaling </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">678.1</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">712.3</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively, and total liabilities of the Company&#x2019;s consolidated VIEs for which creditors do not have recourse to the general credit of the primary beneficiary of </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">212.1</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">207.9</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> as of March 31, 2025 and December 31, 2024, respectively. These VIE balances do not include </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">190.2</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.5</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of March 31, 2025, and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">224.9</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of investment in affiliates and </xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$</xhtml:span><xhtml:span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">48.1</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> million</xhtml:span><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> of amounts due to affiliates as of December 31, 2024, as these are eliminated upon consolidation and not presented within the condensed consolidated balance sheets. See Note 16 &#x2014; &#x201c;Variable Interest Entities (VIEs)&#x201d; for further details.</xhtml:span><xhtml:p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><xhtml:span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</xhtml:span></xhtml:p><xhtml:p style="margin-left:1.867%;font-size:10pt;margin-top:0;line-height:1.15;font-family:Times New Roman;margin-bottom:0;text-align:center;"><xhtml:span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</xhtml:span></xhtml:p></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_eeaffbef-52aa-44cf-b09d-2ce37173ba27"
          xlink:to="FNT_99e48291-d907-4bff-bdda-34e68217cbf2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_c7e2d019-0bd5-48b6-9f3d-aa213600f006"
          xlink:to="FNT_99e48291-d907-4bff-bdda-34e68217cbf2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_3caa0f8b-7e96-491f-8b69-dc963eefb25d"
          xlink:to="FNT_99e48291-d907-4bff-bdda-34e68217cbf2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="F_b5a02926-a7d8-4244-8588-e131eb0d1fca"
          xlink:to="FNT_99e48291-d907-4bff-bdda-34e68217cbf2"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
